{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 600,
    "successful_questions_in_experiment": 600,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 600,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e4_page_window_relevance_desc/qualitative_3hop_cross_company_type1.json",
    "timestamp": "2026-02-04T06:05:37.239803"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive has 37,028 000 securities (37.028 million) remaining available for future issuance under equity‑compensation plans approved by security holders. Procter & Gamble has 119 million securities available for future issuance under its stock‑option, RSU, and PSU plans. Thus, PG’s available securities are roughly three times the number at CL.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (37.028 million), matching the ground truth. However, it incorrectly reports Procter & Gamble's total available securities as 119 million, whereas the ground truth is 133,185,995—this is a significant numerical error. (2) The quantitative accuracy is compromised due to the incorrect figure for PG; although the format variation (e.g., using '119 million' instead of the exact number) is acceptable, the actual value is off by over 14 million shares, which affects the comparison. The claim that PG’s available securities are 'roughly three times' that of CL is also inaccurate: 133.2M / 37.0M ≈ 3.6x, but 119M / 37.0M ≈ 3.2x—while this might seem close, the underlying data error reduces confidence in the result. (3) The multi-hop reasoning is sound in structure: the model identifies both companies, retrieves the relevant equity compensation metrics, and attempts a comparative analysis. However, the synthesis fails due to reliance on an incorrect data point for PG. (4) Contextual relevance is high—the answer addresses the comparison directly and uses appropriate terminology (RSUs, PSUs, stock options, equity compensation plans). The conclusion is directionally correct (PG has more than CL), but the magnitude is misrepresented due to the data error. Thus, the answer is partially correct but contains a critical factual inaccuracy in the PG number, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 410,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s forward contracts are highly sensitive to a 10 % U.S. dollar weakening – the 2023 and 2024 filings show a potential $503 million and $135 million hit to income before taxes after hedging, with an AOCI offset of roughly $1.5–$1.6 billion, based on a $9.9 billion notional exposure and a four‑year hedge horizon (page 46‑47). Disney’s forecast‑transaction hedges cover a comparable notional amount of about $9.9 billion in 2024 (and $8.3 billion in 2023) and also target a four‑year horizon, though the filing does not provide a specific sensitivity figure (page 121).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Google's $660 million impact on AOCI results from a 10% weakening of the U.S. dollar as of December 31, 2024. However, the LLM claims a $503 million and $135 million hit to income before taxes in 2023 and 2024 respectively, and an AOCI offset of $1.5–1.6 billion, which contradicts the ground truth. There is no mention in the original answer of income before taxes impacts or such large AOCI figures. Additionally, the LLM incorrectly attributes a $9.9 billion notional exposure and four-year hedge horizon to Google, but the ground truth assigns those figures to Disney, not Google. (2) The only correct quantitative element is Disney’s $9.9 billion notional exposure as of 2024, which matches the ground truth. However, the LLM fabricates Google’s notional exposure and hedge horizon, which are not stated in the original answer. The $503M and $135M figures for Google have no basis in the provided truth. (3) The multi-hop reasoning is flawed: the model conflates Google’s net investment hedge (which affects AOCI) with Disney’s cash flow hedges of forecasted transactions, but then incorrectly applies Disney’s notional amount and horizon to Google. It fails to distinguish the different risk types (translation vs. transaction) and misattributes structural details. (4) While the answer attempts to compare both companies and mentions relevant concepts like notional exposure and hedge horizon, the severe factual and numerical errors—especially misassigning Disney’s $9.9B and 4-year horizon to Google—undermine correctness. The contextual relevance is moderate because it addresses the right question framework but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 475,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports **119 million** shares remaining available for future issuance under equity‑compensation plans approved by security holders, while Colgate‑Palmolive reports **37,028 thousand** shares (≈37.0 million) in the same category.  Thus Procter & Gamble’s available securities are roughly **3.2 times larger** than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant numerical inaccuracy in Procter & Gamble's available securities. The ground truth reports 133,185,995 shares, but the LLM states '119 million', which is off by over 14 million shares (~10.6% lower). Colgate-Palmolive’s figure is correctly reported as 37,028,000 (rounded to 37,028 thousand or ~37.0 million), so that part is accurate. (2) The calculation comparing P&G’s pool to Colgate’s as '3.2 times larger' is based on the incorrect 119 million figure. Using accurate numbers: 133,185,995 ÷ 37,028,000 ≈ 3.6, so the correct multiplier is approximately 3.6x, not 3.2x. This introduces a secondary error in the quantitative comparison. (3) The reasoning and multi-hop synthesis are otherwise sound: the model correctly identifies both companies, the relevant metric (securities available under shareholder-approved equity plans), and performs a valid comparative analysis. It also uses appropriate rounding and formatting (e.g., thousand/million conversions). (4) Despite the core error in P&G’s number, the answer addresses all parts of the question, draws a valid qualitative conclusion (P&G has significantly more available securities), and maintains contextual relevance. The error is substantial but not fundamental—hence a correctness score of 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 366,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie’s November 2023 lawsuit in Delaware is a proactive infringement claim that seeks to stop Sandoz from marketing a generic upadacitinib, alleging that the generic product infringes its patents and requesting declaratory and injunctive relief (page 95).  By contrast, Amgen’s strategy in the New Jersey case is defensive: it filed a complaint to enforce its 21 patents on Prolia/XGEVA and, after Sandoz counter‑claimed that those patents are invalid or unenforceable in the denosumab‑biosimilar dispute, Amgen has sought to have those counter‑claims dismissed (pages 155‑156).  Both companies are using litigation to protect their IP from Sandoz’s generic/biosimilar entry, but AbbVie is the plaintiff asserting infringement, while Amgen is the defendant defending its patents and attempting to eliminate Sandoz’s counter‑claims.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AbbVie as the plaintiff in a patent litigation against Sandoz over upadacitinib, seeking to block generic entry, and Amgen as defending its denosumab-related patents against Sandoz's counterclaims of invalidity/unenforceability. The core facts—AbbVie in offensive posture, Amgen in defensive—are accurately portrayed. (2) Quantitative details such as the November 2023 filing date and reference to specific pages (95, 155–156) are consistent with source data and add precision; no numerical errors are present. Format variations (e.g., '21 patents') match the original context. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate legal disputes involving Sandoz, different drugs (upadacitinib vs. denosumab), and opposing legal roles (plaintiff vs. defendant), drawing a valid contrast in legal strategies. (4) The answer is semantically equivalent to the original, with slightly more procedural detail (e.g., dismissal of counterclaims, jurisdictional venues), enhancing clarity without introducing inaccuracies. One minor point preventing a perfect 10 is the absence of explicit mention of 'biosimilar development' in connection to denosumab, though it is implied by context. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 389,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "Comcast’s Class B shares are 15‑vote each and together hold a fixed 33 ⅓ % of the company’s voting power that cannot be diluted by new issuances.  When a B holder converts share‑for‑share to Class A, the 33 ⅓ % of voting power is simply transferred to the newly issued A shares, increasing the total number of voting shares and thereby diluting the voting power of existing A shareholders.  Alphabet, by contrast, uses a three‑class structure (Class A = 1 vote, Class B = 10 votes, Class C = no vote) and its 2023 $62.2 billion repurchase of Class A and C shares merely reduces the number of shares outstanding—removing non‑voting C shares and shrinking the pool of voting A shares—without altering the relative voting power distribution; the repurchase actually raises the voting power per remaining Class A share rather than diluting it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CMCSA Class B shares have 15 votes and are capped at 33 1/3% voting power with anti-dilution protection; GOOGL has a three-class structure with Class B at 10 votes, Class A at 1 vote, and Class C with no votes; GOOGL repurchased $62.2 billion in Class A and C shares in 2023. These numbers and structures match the original answer exactly. (2) Quantitative accuracy is perfect: the $62.2 billion repurchase amount, the 33 1/3% cap, and the vote ratios (15:1, 10:1, 1:1) are all correctly stated. (3) The reasoning is sound and captures the core contrast: CMCSA’s anti-dilution mechanism preserves Class B voting power even upon conversion (by transferring the capped block), whereas GOOGL’s Class B shares convert to Class A and lose their super-voting rights. The LLM correctly notes that GOOGL’s repurchase of non-voting Class C and voting Class A shares reduces the total voting share pool, thereby increasing the relative voting power of remaining Class A shares and indirectly benefiting Class B holders by reducing dilution pressure. (4) The only minor shortcoming is that the LLM does not explicitly state that GOOGL’s Class B shares automatically convert to Class A upon sale or transfer, which is a key part of the multi-hop comparison in the original answer. Additionally, while implied, the point that GOOGL’s repurchase concentrates voting control among remaining Class B shareholders could have been made more directly. However, the semantic meaning and factual core are preserved, and the analysis of dilution mechanics is superior. The answer is contextually complete and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 463,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 Equity Compensation Plan reserves **97,567,370 shares** for future issuance (see the “Number of securities remaining available for future issuance” column in the Equity Compensation Plan table on page 97).  \nTesla’s 2023 filing shows **11 shares** represented by outstanding warrants (the “Warrants” line in the diluted‑shares table on page 62).  Thus, Nike’s reserved shares are vastly larger than Tesla’s warrant‑represented shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Nike's shares reserved for future issuance as 97,567,370, which matches the ground truth. However, it incorrectly states that Tesla has only '11 shares' represented by outstanding warrants, which is a critical factual error — the correct number is 11 million shares. This mistake drastically undermines the quantitative comparison. (2) The number for Nike is accurate and properly cited, but Tesla’s figure is off by six orders of magnitude, likely due to a typo or misreading of the filing (e.g., omitting 'million'). This invalidates the comparison despite correct sourcing. (3) The multi-hop reasoning structure is sound — the model identifies the relevant data points from both companies’ filings and attempts to compare them — but the conclusion is based on a severely incorrect input for Tesla, making the synthesis flawed. (4) Contextual relevance is high because the answer addresses the right documents, sections, and intent of the question. However, the massive quantitative inaccuracy in Tesla's warrant shares severely limits factual correctness, warranting a low overall score despite correct structure and partial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 335,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla reported that 11 million shares would be issuable upon exercise of its outstanding warrants in 2023, whereas Nike disclosed that 97.6 million shares remain available for future issuance under its equity‑compensation plans – a figure that is roughly nine times larger than Tesla’s.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023 is correctly reported, and Nike's 97,567,370 shares available for future issuance is accurately rounded to 97.6 million—this minor rounding is acceptable and common in financial reporting. (2) The comparison stating that Nike's available shares are 'roughly nine times larger' is logically sound: 97.6 million ÷ 11 million ≈ 8.87, which rounds to approximately nine times, supporting the qualitative characterization. (3) The multi-hop reasoning is correct—the model synthesizes data from two different companies (Tesla and Nike), two different financial instruments (warrants vs. equity compensation plans), and two different disclosures, directly addressing the comparative nature of the question. (4) All entities (Tesla, Nike, 2023, shares issuable, warrants, equity compensation plans) are correctly identified and contextualized. The answer is concise, factually precise, and semantically equivalent to the original answer, conveying the significant scale difference as intended.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 334,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B shareholders 10 votes per share (vs. one vote for Class A), concentrating voting power in the hands of a relatively small group (founders, early investors, and employees) and enabling them to steer board composition and major decisions. In contrast, NFLX’s single‑class common stock grants every share one vote, so voting power is directly proportional to ownership and no minority group can dominate corporate governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitative accuracy: The statement that GOOGL's Class B shares carry 10 votes per share versus 1 vote for Class A is accurate, and NFLX's one-vote-per-share structure is correctly represented. No calculations were required, but the numerical voting rights are exact. (2) Completeness: The answer addresses both parts of the question—GOOGL's differential voting structure and NFLX's uniform model—and contrasts their implications for corporate governance. It omits mention of GOOGL's Class C shares (no voting rights), which is a minor omission but does not detract from the core explanation. (3) Entity accuracy: GOOGL and NFLX are correctly identified, and the stock classes and voting rights are accurately attributed. (4) Reasoning: The multi-hop synthesis is sound—comparing two companies' governance models based on share structure—and the conclusion about concentrated vs. proportional control is logically derived. (5) Semantic equivalence: The LLM conveys the same essential information as the original answer, with slightly different phrasing (e.g., 'concentrating voting power' vs. 'disproportionate control'), but the meaning is equivalent. The only reason for not scoring a 10 is the omission of Class C shares' lack of voting rights, which is a secondary detail in the context of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 384,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "0 % – Chevron has no ownership stake in QG3 (or Qatargas Operating Company Limited), so none of its 2021 average daily net crude oil production came from that project.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect. It claims Chevron has no ownership stake in QG3 or Qatargas Operating Company Limited, which contradicts the ground truth stating Chevron holds a 30% interest in Qatargas. The ground truth confirms Chevron's average daily net crude oil production from the QG3 project was 13 MBD in 2021, implying a non-zero percentage contribution. The LLM incorrectly reports 0%, which is factually wrong. (2) The quantitative error is fundamental: the LLM fails to report the correct production volume (13 MBD) and incorrectly calculates the percentage as 0% due to a false assumption about ownership. There is no indication of any correct number or calculation. (3) The multi-hop reasoning failed entirely. The model should have recognized Chevron’s 30% stake in Qatargas Operating Company Limited and linked it to the QG3 project’s production to determine the proportional contribution to Chevron’s total crude oil output. Instead, it denied any stake, breaking the reasoning chain. (4) All scores are very low because the answer is factually false, contains no correct quantitative data, exhibits flawed reasoning, and is not contextually aligned with the verified facts from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 348,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "ASU 2022‑04 requires a buyer to disclose the key terms of its supplier‑finance program, where outstanding amounts appear on the statement, a roll‑forward of those amounts, and interim balances. 3M’s Note 16 (page 77) now presents a roll‑forward of confirmed invoices—beginning balance, invoices confirmed, invoices paid, and ending balance—for 2024 and 2023, while Honeywell’s Note 15 (page 60) provides a similar roll‑forward table of its supply‑chain‑financing obligations.  The roll‑forward requirement became effective on January 1 2024, so both companies’ 2024 filings include the period‑by‑period detail that enhances transparency of supplier‑finance liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the impact of ASU 2022-04 on transparency for both 3M and Honeywell, emphasizing the new roll-forward disclosure requirements effective in 2024. It accurately describes the nature of the roll-forward (beginning balance, invoices confirmed, paid, ending balance) and references the correct notes (3M's Note 16, Honeywell's Note 15) and pages, which aligns with expected disclosure practices. However, the LLM answer omits the specific quantitative figures provided in the ground truth—namely, that 3M reported $1.5 billion of invoices confirmed and $1.5 billion paid or adjusted in 2024. While the structure and intent of the disclosure are correctly conveyed, the absence of these exact dollar amounts reduces quantitative accuracy. The reasoning is sound: it correctly synthesizes that both companies adopted the roll-forward in 2024, which is consistent with the ASU’s effective date and phased implementation. The entities (3M, Honeywell, ASU 2022-04, 2024 effective date) and financial context (supplier finance obligations, roll-forward) are accurate. The answer is highly relevant and captures the qualitative improvement in transparency. The omission of specific numbers prevents a higher score, but the core multi-hop synthesis—linking ASU 2022-04 to enhanced disclosures at both firms in 2024—is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 373,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin (LMT) recognizes revenue from FAR‑regulated U.S. Government contracts over time using a percentage‑of‑completion cost‑to‑cost method, treating each contract as a single performance obligation and recording contract liabilities for any over‑payments. In contrast, RTX’s exposure to U.S. Government contract risks is largely tied to fixed‑price contracts, where it bears the cost‑overrun risk, can incur losses if actual costs exceed the fixed price, and faces additional financial risk from contract termination or funding delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies LMT's revenue recognition approach for FAR-regulated U.S. Government contracts as using a cost-based method (percentage-of-completion cost-to-cost), which aligns with cost-plus-fixed-fee models where revenue is predictable due to cost reimbursement. It also accurately notes that LMT treats contracts as single performance obligations and records contract liabilities for overpayments—additional details not in the ground truth but consistent with public disclosures. (2) For RTX, the LLM correctly states that its financial exposure stems from fixed-price contracts where it bears cost-overrun risk, can incur losses if costs exceed fixed prices, and faces risks from termination or funding delays—this matches the ground truth's emphasis on firm fixed-price (FFP) contracts and higher risk. (3) The multi-hop reasoning is sound: the model contrasts LMT’s more stable, cost-reimbursable model with RTX’s higher-risk fixed-price exposure, correctly synthesizing differences in contract structure and financial implications. (4) Minor point: the ground truth explicitly mentions that LMT’s standalone selling price equals contract price due to FAR mandates and emphasizes negative profit adjustments in development programs for RTX—these nuances are omitted but do not materially alter the correctness. No numeric inaccuracies; all statements are qualitatively and contextually aligned. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall for missing slight contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 453,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis composition‑of‑matter patent in Europe has not yet expired – the company is litigating to block generics before the patent’s expiry (page_119). In contrast, Merck’s Januvia family patents in the U.S. are set to expire in May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) (page_58). Consequently, BMS can maintain exclusivity in Europe longer but must defend it through litigation, while Merck must prepare for generic entry and price pressure in the U.S. in 2026, which is expected to drive sales declines and prompt a shift in its pricing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key expiration timelines—Eliquis patent litigation in Europe and Januvia family exclusivity until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR)—which aligns with the ground truth. However, it omits critical details about the actual expiration status and current generic entry for Eliquis in specific European countries (e.g., Finland and Portugal already have generics), and fails to mention the mixed litigation outcomes (positive in Norway, Sweden, Switzerland; negative in UK; appeals ongoing). This impacts completeness and qualitative accuracy. (2) Quantitatively, all dates are accurate: May 2026 and July 2026 match the ground truth, and no calculations are required. The reference to page numbers suggests sourcing but does not affect factual accuracy. (3) The multi-hop reasoning is partially sound—comparing BMY’s European litigation strategy with MRK’s U.S. secondary patent extension strategy—but misses the nuance that BMY’s strategy is already failing in some markets, whereas the LLM implies it may still succeed. The ground truth emphasizes that BMY faces fragmented, uneven results, while MRK has secured uniform delays via settlements. The LLM oversimplifies BMY’s position as merely 'litigating before expiry' rather than actively losing in some jurisdictions. (4) Scores reflect high quantitative accuracy and relevance, but deduction in qualitative accuracy due to incomplete synthesis and omission of key factual context affecting strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 422,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted roughly **$35 million** in appeal bonds to secure stays of adverse verdicts on appeal.  In contrast, it has paid about **$1 billion** in judgments and settlements (including costs and fees) in tobacco‑related litigation since October 2004, so the appeal‑bond amount is only a small fraction—around 3–4 %—of those total payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: $35 million in appeal bonds and $1 billion in judgments and settlements since October 2004 are accurately reported. The LLM correctly notes that the bond amount is a small fraction of total payments, and even adds a calculated comparison (~3–4%), which, while not in the original answer, is mathematically sound (35/1000 = 3.5%) and enhances clarity. (2) The date reference (since October 2004) is correct, and entities (PM USA, tobacco-related litigation) are accurately identified. (3) The multi-hop reasoning—comparing current appeal bonds to historical payments—is logically sound and well-synthesized. (4) The only minor omission is that the original answer also mentions $241 million in interest payments; while this does not directly impact the comparison asked (bonds vs. payments for judgments and settlements), its exclusion slightly reduces completeness. However, since the question focuses on 'judgments and settlements,' the exclusion is justifiable. The added percentage interpretation demonstrates strong qualitative reasoning. Overall, the answer is factually correct, contextually relevant, and conveys semantic equivalence with slight enhancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 358,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment reported $74.2 billion in net sales for 2022 (which includes revenue from Taiwan, though the exact Taiwan‑only figure is not disclosed)【page_52】【page_25】, whereas NVIDIA’s 2022 filing does not disclose any direct revenue from Taiwan—no reference to Taiwan appears in the provided pages【page_78】【page_79】【page_80】【page_81】【page_82】. Thus, Apple’s revenue from Taiwan is substantially higher than NVIDIA’s reported contribution, which is effectively zero.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors. (1) Quantitatively, it incorrectly states that NVIDIA did not report any direct revenue from Taiwan in 2022, claiming 'no reference to Taiwan appears in the provided pages.' However, the ground truth confirms NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. This is a major error in numerical reporting. While Apple's $74.2 billion (i.e., $74,200 million) figure for Greater China is correctly cited, the LLM falsely concludes that Apple’s Taiwan revenue is 'substantially higher' than NVIDIA’s, when in fact the model underestimates NVIDIA’s exposure due to incorrect data extraction. (2) The answer fails on completeness and entity accuracy: it omits NVIDIA’s actual $8,544 million Taiwan revenue, a key part of the comparison. (3) Reasoning is flawed—because the LLM incorrectly infers that NVIDIA reported zero revenue from Taiwan, its comparative conclusion is invalid. The multi-hop synthesis between Apple’s regional segment and NVIDIA’s country-specific disclosure fails due to incorrect input data. (4) Despite correct citation of Apple’s Greater China revenue and understanding that Taiwan is embedded within that segment, the answer’s core comparison is factually wrong. Semantic equivalence is not achieved due to the critical omission and misrepresentation of NVIDIA’s revenue. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 408,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA’s 10‑K does not disclose revenue by Taiwan in the pages provided, so its growth between FY 2020 and FY 2022 cannot be determined from the supplied information.  \nApple’s Greater China revenue (which includes Taiwan) rose from $40.3 billion in 2020 to $74.2 billion in 2022, an increase of roughly 84 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports AAPL's revenue from Greater China with accurate numbers ($40.3 billion in 2020 and $74.2 billion in 2022) and correctly calculates an approximately 84% increase, which aligns with the ground truth (84.1%). However, it incorrectly claims that NVDA's 10-K does not disclose revenue by Taiwan, which contradicts the ground truth stating that NVDA's revenue from Taiwan was $3,025 million in 2020 and $8,544 million in 2022 — implying such data is available in the source documents. This omission prevents the LLM from completing the core comparison asked in the question. (2) Quantitatively, the AAPL figures are accurate (allowing for format variation: $40.3 billion = $40,308 million), but the absence of NVDA's revenue figures results in a major factual gap. The calculation for AAPL’s growth is approximately correct (84% vs 84.1%), but no calculation is attempted for NVDA. (3) The reasoning is flawed because the model fails to perform the required multi-hop synthesis: comparing growth rates between NVDA's Taiwan revenue and AAPL's Greater China revenue. By dismissing NVDA's data as unavailable, it breaks the comparison chain. The ground truth confirms both datasets are available and comparable. (4) The contextual relevance is moderate because the answer addresses part of the question (AAPL’s growth) but fails on the key comparative element. Due to the missing NVDA data and resulting incomplete analysis, the correctness score is low despite partial accuracy on AAPL.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 418,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft does not currently estimate a material tax liability under the OECD’s Pillar Two rules – it notes that the 15 % global minimum tax “will apply to Microsoft beginning in fiscal year 2025” but that it “does not currently estimate a material impact to our consolidated financial statements” (MSFT, Item 7, p. 47).  In contrast, Broadcom’s exposure to the same global minimum tax is also expected to be negligible; the company states that because it “does not have material operations in jurisdictions with tax rates lower than the Pillar Two minimum,” the rules “are not expected to materially increase our global tax costs” (BA, Item 7, p. 75).  Thus, while both firms anticipate no material impact, Microsoft’s potential liability is acknowledged but unquantified, whereas Broadcom’s exposure is effectively zero given its tax‑jurisdiction mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Broadcom expects 'negligible' exposure and that its rules 'are not expected to materially increase our global tax costs,' which directly contradicts the ground truth. According to the original answer, Broadcom explicitly notes that the global minimum tax may 'materially increase its effective tax rate and cash tax costs' due to its reliance on tax incentives in jurisdictions like Singapore. This is a major factual error. Microsoft's portion is accurate: it correctly reports no material impact starting in FY2025. (2) Quantitatively, the dates (fiscal year 2025 for Microsoft, 2026 for Singapore/Broadcom) and the 15% rate are correctly cited. There are no calculation errors because the question does not require numerical computation. Format and references (e.g., Item 7, page numbers) appear consistent, though not verifiable here. (3) The multi-hop reasoning fails because the LLM incorrectly synthesizes Broadcom’s position. Instead of contrasting Microsoft’s low exposure due to lack of operations in low-tax jurisdictions with Broadcom’s high exposure due to reliance on tax incentives, it falsely equates both as having no material impact. This undermines the core comparative analysis required by the question. (4) Correctness is severely penalized because the key contrast — Microsoft unaffected vs. Broadcom exposed — is reversed for Broadcom. Quantitative accuracy is high because numbers and dates are correct. Qualitative accuracy is low due to flawed reasoning and misrepresentation of Broadcom’s disclosure. Contextual relevance is moderate because the structure and framing are appropriate, but the conclusion is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 463,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "NFLX common stock gives each share one vote, so a shareholder’s influence on board elections and other matters is directly proportional to the number of shares owned (see NFLX 10‑K, page 61).  \nIn contrast, Alphabet’s Class B shares carry ten votes per share (Alphabet 10‑K, page 81), giving holders a ten‑fold voting advantage over holders of Class A or Class C shares.  \nConsequently, Class B shareholders can exert disproportionately greater influence on corporate decisions than NFLX shareholders, whose voting power scales linearly with share ownership.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NFLX common stock provides one vote per share (cited from NFLX 10-K, p.61), and GOOGL (Alphabet) Class B shares carry 10 votes per share (cited from Alphabet 10-K, p.81). These numbers match the ground truth exactly. (2) The quantitative accuracy is perfect—'one vote' and 'ten votes' are correctly reported, and the 10-fold voting advantage is accurately described. (3) The reasoning is sound and correctly synthesizes the multi-hop comparison: it contrasts the uniform voting structure at NFLX with the tiered structure at GOOGL, and logically concludes that Class B shareholders have disproportionate influence compared to NFLX shareholders, whose voting power scales linearly. (4) The answer is contextually relevant, directly addressing the impact of voting structure differences on shareholder influence. Minor wording differences (e.g., 'linearly' vs 'uniformly distributed') do not affect meaning and are semantically equivalent. All entities—NFLX, GOOGL/Alphabet, Class B shares—are correctly identified. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 327,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD generated **$2.091 billion** in revenue from Taiwan in 2021 (sales to external customers by region). Apple’s 2022 net sales for the broader Greater China region—including mainland China, Hong Kong and Taiwan—were **$74.2 billion**. Thus, Apple’s Greater China revenue is roughly **35 times larger** than AMD’s Taiwan revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, AMD's 2021 revenue from Taiwan was $1,187 million ($1.187 billion), but the LLM incorrectly states it as $2.091 billion—nearly double the correct amount. Apple’s revenue is correctly reported as $74.2 billion, matching the ground truth of $74,200 million. (2) The calculation comparing Apple’s revenue to AMD’s is based on incorrect input: while the LLM claims Apple’s revenue is 'roughly 35 times larger,' the actual ratio using correct figures is approximately 62.5 ($74.2B / $1.187B), so the comparison is mathematically flawed due to the wrong numerator. (3) The multi-hop reasoning is structurally sound—the model correctly identifies that Apple’s Greater China region includes Taiwan and that a comparison across companies and regions is needed. It also correctly interprets the geographic scope (mainland China, Hong Kong, and Taiwan). However, the synthesis fails at the data input stage due to incorrect AMD revenue. (4) Contextual relevance is high—the answer addresses both companies, correct years (2021 for AMD, 2022 for Apple), and the intended comparison. Despite correct framing and entity identification, the severe quantitative error in AMD’s revenue undermines the factual correctness, warranting a low correctness score. Minor formatting variations like $74.2 billion vs $74,200 million are acceptable, but the AMD figure is not within an acceptable margin of error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 417,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan has 49 million shares reserved for issuance, and the plan explicitly allows incentive stock options (in addition to non‑statutory options) for employees. In contrast, Starbucks has 99.7 million shares available for future equity‑based awards (plus 10.8 million for its ESPP), but all of its outstanding stock options are non‑qualified; it does not issue incentive stock options as part of its compensation program. Thus, Tesla’s plan is smaller in share capacity but includes incentive stock options, whereas Starbucks offers a larger equity grant pool that relies on non‑qualified options.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is quantitatively accurate: Tesla's 49 million shares and Starbucks' 99.7 million shares match the ground truth, with correct dates implied by context. The share numbers and plan names are correctly attributed. However, the qualitative accuracy is low due to a critical factual error in reasoning: the LLM claims Starbucks does not issue incentive stock options, stating 'all of its outstanding stock options are non-qualified.' This contradicts the ground truth, which explicitly states that Starbucks maintains equity incentive plans that include incentive stock options. The original answer confirms both companies use incentive stock options as part of their compensation strategy. This error undermines the core comparative analysis of compensation strategy, which is central to the question. The LLM incorrectly differentiates the two companies on the basis of ISO usage when no such distinction exists. While the answer correctly compares share availability and mentions Tesla's use of ISOs, the erroneous claim about Starbucks' exclusion of ISOs represents a significant failure in multi-hop synthesis and factual correctness. Contextual relevance is high as the response addresses both share availability and compensation strategy components of the question, but the reasoning is flawed due to incorrect entity-property mapping for Starbucks' equity grants.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 381,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD uses broker‑dealer quotes as observable inputs to estimate the indicative borrowing cost that feeds into discounted‑cash‑flow models for Level 2 assets that are not traded in the secondary market. Boeing, by contrast, treats broker‑dealer quotes as the market price (or yield) for its available‑for‑sale debt investments, valuing them directly under a market approach. Thus, both companies rely on observable market data for Level 2 fair‑value estimates, but GD’s method incorporates the quotes into a DCF framework, whereas Boeing’s approach uses the quotes as the primary market input.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and largely aligns with the ground truth. It correctly identifies that GD uses broker/dealer quotes as inputs into valuation models—specifically DCF models—for Level 2 assets, particularly when secondary market trading is absent. It also accurately states that BA uses broker/dealer quotes as direct market prices or yields for its available-for-sale debt investments, applying a market approach. Both companies rely on observable inputs via third-party pricing, which the LLM captures in substance, though it reframes the comparison more technically (DCF vs. market approach) than the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect, even if no explicit numbers are present). The reasoning is sound and reflects proper multi-hop synthesis across the two companies' methodologies. The only minor shortcoming is that the LLM slightly overemphasizes the contrast (‘by contrast’) when the ground truth stresses the parallelism in their reliance on observable inputs; however, the distinction in modeling approach (DCF incorporation vs. direct use) is valid and adds analytical depth. Thus, the answer is semantically equivalent and contextually appropriate, with excellent qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 356,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "Because the Federal Reserve has set the Countercyclical Capital Buffer (CCyB) at 0 %, Morgan Stanley’s Basel III buffer is 8.4 % of risk‑weighted assets under the Standardized Approach (SCB 5.4 % + G‑SIB surcharge 3.0 %) and 5.5 % under the Advanced Approach (capital‑conservation buffer 2.5 % + G‑SIB surcharge 3.0 %) – the CCyB contributes nothing to either calculation (see MS 10‑K, page 134).  American Express also applies an SCB, but the amount is subject to regulatory discretion; with the CCyB at zero, the SCB becomes the sole variable component of its buffer, so its total capital buffer will vary according to the regulator’s assessment rather than a fixed percentage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims Morgan Stanley has an 8.4% buffer under the Standardized Approach (SCB 5.4% + G-SIB 3.0%) and 5.5% under the Advanced Approach (2.5% CCB + 3.0% G-SIB), but the ground truth does not provide these specific percentages or confirm the SCB is added directly in this way. More critically, the ground truth states Morgan Stanley includes the SCB in its Advanced Approach calculation, but the LLM incorrectly separates Standardized and Advanced buffers and implies the SCB is only in the Standardized Approach, which contradicts the original answer. The SCB is part of the Advanced Approach for Morgan Stanley, not the Standardized. (2) The numbers cited (5.4%, 3.0%, 8.4%, 5.5%) are not present in the ground truth and appear to be fabricated or misattributed. The ground truth does not specify numerical values for the G-SIB surcharge or SCB, so these precise percentages cannot be confirmed and likely reflect incorrect data extraction. (3) The reasoning partially captures the multi-hop element: it recognizes that a 0% CCyB means no additional requirement from that buffer and that the SCB is relevant for both firms. However, it misrepresents how the SCB is applied—especially for Morgan Stanley—and incorrectly frames American Express’s SCB as the 'sole variable component' without confirming this nuance in the ground truth. (4) While the answer addresses the zero CCyB impact and mentions both firms and the SCB, the incorrect numerical claims and mischaracterization of regulatory approaches reduce correctness. The contextual relevance is fair because it discusses the right concepts (buffers, SCB, CCyB, G-SIB), but the qualitative and quantitative inaccuracies severely undermine the answer’s reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 497,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "The $4.0 billion increase in AMT’s 2021 Credit Facility (page 111) expands the company’s revolving credit line that it uses to finance major acquisitions—such as the Telxius and CoreSite purchases—and to refinance existing debt, reflecting a strategy of leveraging large, flexible credit facilities for growth. By contrast, as of December 31 2021 SPG’s financing model relies on joint‑venture structures; the company provides interest‑bearing construction loans and equity investments to partners (totaling $88.4 million in advances, page 118) to develop and acquire properties, rather than drawing on a single, large credit line for acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.0 billion increased commitment under AMT's 2021 Credit Facility is accurately stated, as is SPG's $88.4 million in financing to joint ventures as of December 31, 2021. Number formats match or are acceptably varied (e.g., $4.0 billion vs $88.4 million). (2) Quantitative accuracy is perfect: both dollar amounts and the date (December 31, 2021) are correct, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—LLM correctly contrasts AMT’s use of a large revolving credit facility for acquisitions (naming CoreSite and Telxius) with SPG’s joint venture financing model involving interest-bearing loans and equity investments. While the original answer emphasizes 'internal financing and partnership structures to support real estate development and diversify risk,' the LLM captures the same contrast by describing SPG’s model as relying on joint ventures with loans and equity, thus conveying equivalent qualitative meaning. (4) The only minor shortcoming is that the LLM mentions the Telxius acquisition, which was not referenced in the ground truth answer—though it is factually correct and contextually relevant, it slightly extends beyond the provided truth. However, this does not detract from accuracy. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 405,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during fiscal 2022 (523 → 544 stores, 30 opened and 9 closed, page 12).  Nike’s Greater China segment— which includes Taiwan—generated $6.679 billion in revenue in 2022 (page 89).  Thus, while Starbucks’ Taiwan expansion is a modest 21‑store increase, Nike’s Greater China region contributed a substantial $6.7 billion in sales, underscoring the much larger financial impact of that geographic segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Starbucks' net store growth in Taiwan as 21 stores (from 523 to 544, with 30 opened and 9 closed), which matches the ground truth. However, it incorrectly states that all 21 were 'licensed' stores without confirming this detail in the original answer, and more critically, reports Nike's Greater China revenue as $6.679 billion (rounded to $6.7 billion), whereas the ground truth specifies $7,547 million ($7.547 billion). This is a significant numerical discrepancy of about $868 million, affecting quantitative accuracy. (2) The calculation of Starbucks' store growth is accurate (544 - 523 = 21), but the revenue figure for Nike is factually incorrect despite correct geographic scope (Greater China including Taiwan). (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two companies, aligns Taiwan within Greater China for Nike, and contrasts physical expansion (Starbucks) with financial performance (Nike). The logic and structure effectively address the comparative intent of the question. (4) The answer is contextually relevant and well-structured, with only the Nike revenue figure undermining full correctness. The error is substantial enough to reduce quantitative and overall scores, but the core reasoning and entity identification (Starbucks, Nike, Taiwan, Greater China, FY2022) remain accurate, justifying a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 393,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s OPB plan invests roughly **60 % of its assets in equities** through the balanced index fund.  \nBy contrast, 3M’s pension plan had a **fair value of equities of about $1.246 billion** as of December 31, 2023 (U.S. Pension Plans).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Boeing's OPB plan invests approximately 60% of its assets in equities through the balanced index fund, which matches the ground truth. This part is factually accurate and well-aligned. However, the LLM states that 3M's pension plan had a fair value of equities of $1.246 billion, whereas the ground truth reports $785 million—this is a significant numerical discrepancy. The LLM may have pulled data from a different plan (e.g., 'U.S. Pension Plans' as noted), but the question specifically asks for 3M's total fair value of equities, and $1.246 billion does not match the verified $785 million. This error undermines the quantitative accuracy. The entity identification (Boeing, 3M, pension plans, December 31, 2023) and structure of the response are correct, and the multi-hop reasoning—comparing Boeing's indirect equity exposure to 3M's total equity holdings—is appropriately addressed in intent. While the reasoning framework is sound, the incorrect figure for 3M breaks the factual correctness of the comparison. Wording and format are clear and relevant, so contextual relevance is high. In summary: correct percentage for Boeing, incorrect dollar amount for 3M, leading to a partially correct answer with a moderate error in a key data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 358,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "AMT drew a total of **$4.5 billion** in 2021 USD delayed‑draw term loans—$3.0 billion for a 364‑day unsecured loan and $1.5 billion for a two‑year unsecured loan—used to finance the CoreSite acquisition (page 51‑52).  \nIn contrast, SPG’s joint‑venture financing is modest, consisting of **$88.4 million** in interest‑bearing construction loans and other advances to related parties to fund development and acquisition of properties (page 43). Thus, AMT’s structure is a large, unsecured, acquisition‑focused term‑loan program, whereas SPG’s is a smaller, interest‑bearing construction‑loan program tied to joint‑venture projects.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the dollar amount of AMT's delayed draw term loans. The ground truth states that AMT utilized a $10.5 billion financing structure via the 2021 USD Delayed Draw Term Loans for the CoreSite acquisition. However, the LLM reports only $4.5 billion ($3.0 billion + $1.5 billion), which is less than half the correct amount. This is a major quantitative discrepancy that undermines the accuracy of the comparison. (2) The SPG financing figure of $88.4 million is correctly reported, matching the ground truth exactly, and the context (interest-bearing construction loans and advances to joint ventures as of December 31, 2021) is accurate. (3) The qualitative reasoning and structure of the comparison are sound: the LLM correctly identifies that AMT’s financing was acquisition-focused and large-scale, while SPG’s is smaller and tied to real estate joint ventures. It also correctly characterizes the financing structures (unsecured term loans vs. construction loans). (4) Despite correct entity identification (AMT, SPG, CoreSite, joint ventures), correct year (2021), and appropriate contextual framing, the severe underreporting of AMT’s financing amount leads to a low quantitative accuracy score. The correctness score is partially mitigated by accurate SPG data and valid comparative logic, but the core financial figure for AMT is too far off to score above 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 397,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s 2024 10‑K (pp. 109‑113) shows that the upstream segment purchased a large volume of crude oil, which is the core raw material for its downstream refining and product‐manufacturing operations. CVX’s 15 % stake in the Caspian Pipeline Consortium (CPC) gives it the right to transport about 1.2 million barrels per day of crude from its Kazakh operations—part of the CPC’s 1.4 million‑barrel‑per‑day flow (CVX p. 16). Thus, while XOM’s crude sourcing is largely domestic, the CPC volume represents a significant potential supply that could align with XOM’s crude‑oil needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but has notable inaccuracies and omissions that affect overall correctness. (1) Quantitatively, the LLM states that CVX's 15% stake gives it the right to transport about 1.2 million barrels per day from its Kazakh operations. This misrepresents the ground truth: CVX’s 15% ownership in CPC does not equate to a guaranteed right to transport 1.2 million barrels per day—rather, the total CPC capacity is 1.4 million bpd, with 1.2 million bpd sourced from Kazakhstan (including Chevron’s share). The 1.2 million bpd is not Chevron’s allocation but the total volume from Kazakh fields in which Chevron operates. This is a significant misinterpretation of the data. (2) The LLM incorrectly implies that the CPC volume could align with XOM’s crude needs, suggesting a potential supply relationship that is not supported in the original answer or logic. The original answer emphasizes supply chain risk and interdependence in global logistics, not alignment of supply with XOM’s needs. (3) The LLM mentions XOM’s 2024 10-K and specific pages, but the original answer does not reference specific filings or years, so this detail, while plausible, is unverifiable and adds no value. (4) The answer fails to mention key fields like Tengiz and Karachaganak, where Chevron operates, weakening the multi-hop link between CVX’s ownership, operations, and transportation. (5) While the LLM correctly identifies crude oil as central to XOM and CVX’s 15% stake in CPC, it misses the core reasoning that disruptions in CPC could affect global crude availability, thereby impacting XOM. Thus, the qualitative reasoning is partially sound but flawed in key inferences. Overall, the answer is contextually relevant and includes correct numbers with minor misinterpretations, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 497,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE’s 10‑K notes that the cost of decommissioning its nuclear units could exceed the amount held in its decommissioning funds and that a decline in the market value of those funds would raise funding requirements and materially affect liquidity (see the discussion of decommissioning‑fund shortfalls). Duke Energy’s 10‑K similarly warns that market volatility can reduce the value of the assets in its Nuclear Decommissioning Trust Funds (NDTFs), potentially requiring additional funding if the trust assets fall below projected returns. Thus, both utilities face a shortfall risk tied to market performance, but NEE frames it as a cost‑over‑funds gap, while Duke frames it as a volatility‑induced funding gap in the trust assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: both NEE and Duke Energy face decommissioning funding risks tied to market performance; NEE's risk is framed around potential cost overruns relative to fund balances, while Duke Energy emphasizes market volatility affecting its Nuclear Decommissioning Trust Funds (NDTFs). The LLM correctly identifies that a decline in market value could increase funding requirements for both, impacting liquidity or necessitating additional contributions. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies’ 10-Ks, compares their framing (cost gap vs. volatility-induced gap), and correctly identifies the shared exposure to market risk in nuclear decommissioning funding. The only minor shortcoming is that the LLM does not explicitly name Duke Energy’s subsidiaries (Duke Energy Carolinas, Duke Energy Progress, Duke Energy Florida) as in the original, but this detail is not central to the core comparison. (4) The answer is contextually relevant, directly addressing the comparative risk exposure as requested. Wording differs slightly but maintains semantic equivalence. Thus, correctness is 9 due to slight omission of subsidiary names, but all key financial and conceptual points are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 421,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "LOW uses pricing models for Level 3 fair‑value measurements—most notably for performance‑based contingent consideration—relying on unobservable inputs such as equity value, volatility, expected term and a risk‑adjusted discount rate. GM’s policy likewise reserves Level 3 for valuations that depend on unobservable inputs and applies pricing models (e.g., option‑pricing for contingent consideration) when observable inputs are lacking. Both companies therefore follow the same hierarchy, maximizing observable inputs and relegating unobservable inputs to Level 3, so their approaches are essentially aligned.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that LOW uses pricing models with significant unobservable inputs (e.g., volatility, expected term, risk-adjusted discount rate) for Level 3 fair value measurements, specifically for performance-based contingent consideration—consistent with the original answer's reference to contingent consideration related to the Canadian retail business sale. The LLM correctly states that GM applies Level 3 classification when unobservable inputs are used, citing option-pricing models for contingent consideration, which is consistent with GM’s use of unobservable inputs in GM Financial receivables via modeling and economic forecasts. The core reasoning about both companies following the same accounting hierarchy (maximizing observable inputs, using Level 3 for significant unobservable inputs) is sound and matches the original answer. The only minor shortcoming is that the LLM omits GM’s specific use of static pool modeling and macroeconomic variables like unemployment and GDP growth, which slightly reduces completeness in qualitative detail. However, the omission does not distort the overall accuracy. No numerical inaccuracies are present—there are no explicit numbers in the query or answers, so quantitative accuracy is unaffected. The answer is contextually relevant, directly addressing the comparison of Level 3 valuation approaches under the observability framework. Semantic equivalence is strong, with slightly more emphasis on LOW and less on GM’s receivables, but the central conclusion about alignment in policy application remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 449,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "AMT’s $10.5 billion of committed bridge financing under the 2021 Multicurrency Credit Facility is a single, large‑scale debt pool that the company can draw on to fund major acquisitions (Telxius, CoreSite) and refinance existing debt, reflecting a concentrated capital‑deployment strategy that relies on debt leverage for big transactions. In contrast, SPG’s joint‑venture activities are spread across many equity and construction‑loan investments—such as the $67.6 million in Forever 21 ventures and $88.4 million in construction loans to related parties (page 116)—showing a diversified approach that distributes risk across multiple properties and geographies rather than concentrating it in a single credit facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $10.5 billion for AMT’s 2021 Multicurrency Credit Facility is correctly stated. SPG’s $88.4 million in construction loans is accurately reported, and the additional $67.6 million in Forever 21 ventures is contextually relevant and factually consistent with the source (though not in the original answer, it does not contradict it). The mention of page 116 suggests a verifiable source, enhancing credibility. (2) The core comparison—AMT using large-scale debt for acquisitions vs. SPG using smaller, diversified joint-venture financings—is correct and captures the strategic contrast in capital deployment and risk diversification. (3) Multi-hop reasoning is sound: the model correctly synthesizes financing strategies across two companies (AMT and SPG), links them to acquisition vs. development activities, and infers strategic differences in risk concentration vs. distribution. (4) Minor deduction in quantitative accuracy due to the introduction of $67.6 million (not in the original answer), which, while potentially true, is not part of the ground truth and slightly distracts from the primary SPG figure ($88.4 million) emphasized in the original. However, it does not invalidate the conclusion. Wording differs but semantic equivalence is strong. Contextual relevance is perfect—the answer directly addresses capital deployment and risk diversification as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 403,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD generated $1.84 billion of revenue from customers in Taiwan in 2023, which is roughly 8 % of its $22.68 billion total revenue.  In contrast, Qualcomm’s risk disclosures state that its chip manufacturing relies on foundry partners located primarily in Taiwan, so a geopolitical conflict could “severely limit or prevent us from receiving chipset supply from Taiwan,” posing a direct operational risk.  Thus, AMD’s exposure is a modest revenue‑share, whereas Qualcomm faces a critical supply‑chain dependency on Taiwan‑based foundries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.84 billion in revenue from Taiwan in 2023 matches the original $1,841 million (equivalent values, minor rounding difference acceptable). The total revenue of $22.68 billion and 8% exposure are consistent with the data. (2) The qualitative assessment of QCOM’s dependency on Taiwanese foundries is accurate and directly reflects the original answer’s emphasis on supply chain vulnerability due to geopolitical risks. (3) Multi-hop reasoning is sound: the model correctly distinguishes AMD’s revenue exposure (downstream, customer-side) from QCOM’s operational/supply chain dependency (upstream, manufacturing-side), synthesizing information across two companies and risk dimensions. (4) The only minor shortcoming is that the LLM omits the note about AMD’s exposure being 'declining compared to previous years,' which adds context to the trend. However, this does not undermine the core correctness. Wording differs but semantic meaning is equivalent. All entities (AMD, QCOM, Taiwan, 2023), metrics (revenue, supply chain dependency), and geopolitical risk implications are correctly identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 345,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Starbucks (SBUX) notes that the OECD’s 15 % global minimum tax (Pillar 2) will not become effective for the company until fiscal 2025 and is not expected to have a material impact on its consolidated financial statements (SBUX page 28).  McDonald’s (MCD) does not disclose a specific assessment of Pillar 2 in the pages provided (MCD pages 18‑22), so a direct comparison cannot be made from the available information.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies SBUX's position on Pillar 2: effective in fiscal 2025 and not expected to have a material impact, with a reference to the correct page (28). This aligns with the ground truth. However, the LLM incorrectly states that MCD does not disclose a specific assessment of Pillar 2 in the provided pages (18–22), which contradicts the ground truth stating that MCD explicitly notes it does not expect a material impact despite the implementation starting after December 31, 2023. The LLM fails to extract or acknowledge this key point from MCD’s filing, leading to an incomplete and inaccurate comparison. While the quantitative details for SBUX are accurate (fiscal 2025, 15%), the qualitative reasoning is flawed because it misses the multi-hop synthesis that both companies reach a similar conclusion (no material impact), even if implementation timelines differ. The answer is contextually relevant and addresses the question framework, but the failure to correctly represent MCD’s disclosed assessment significantly undermines the correctness. Thus, the correctness score is reduced to 4 due to this major omission in entity-specific reasoning and comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 333,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s risk‑management framework assigns risk identification, assessment and ownership to each line of business and corporate function, with an independent IRM and Board‑Risk Committee providing oversight and escalation (pages 93‑95).  In this firm‑wide, ownership‑based model, stress testing is embedded in the broader risk‑assessment process but is not explicitly tied to capital adequacy; it is used mainly to monitor and manage exposure.  Goldman Sachs, by contrast, explicitly links its firm‑wide stress tests to capital adequacy, using the results as part of its capital‑planning and stress‑testing process (pages 99‑101).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorganChase's firmwide ownership model with oversight by IRM and Board-Risk Committee, and Goldman Sachs's explicit linkage of stress testing to capital adequacy are accurately described. The LLM correctly identifies that JPMorgan embeds stress testing in broader risk assessment without explicitly tying it to capital adequacy, while Goldman Sachs uses stress testing for capital planning. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or misstatements earns a perfect score by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in governance frameworks and their implications for stress testing purposes across two firms. The only minor shortcoming is that the LLM answer omits some detail about Goldman Sachs evaluating 'vulnerabilities across financial and nonfinancial risks' and does not fully elaborate on the 'tail risks' component mentioned in the original. While the core contrast is captured, this slight reduction in depth prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing the comparative influence of governance models on stress testing methodologies. Overall, the LLM conveys semantically equivalent information with high fidelity, warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 428,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "XOM’s long‑lived assets in Kazakhstan were $8.463 billion in 2021 (XOM 10‑K, page 123).  Chevron, by contrast, holds a 50 % equity interest in Tengizchevroil, with an investment of $23.727 billion and a $4.5 billion loan to the JV (CVX 10‑K, page 78).  Thus Chevron’s financial stake in the Kazakh venture is considerably larger and includes both equity and debt, whereas XOM’s exposure is limited to its asset balance in the country.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies XOM's $8,463 million in long-lived assets in Kazakhstan as of 2021 (reported as $8.463 billion, which is numerically equivalent), and CVX's 50% equity interest in Tengizchevroil (TCO), as well as the $4.5 billion loan to fund the FGP/WPMP projects. However, the LLM introduces a figure of $23.727 billion as CVX's 'investment' in TCO, which is not present in the original answer or implied ground truth. This number appears to be a misinterpretation or fabrication, as the original answer only references the $4.5 billion loan and the 50% equity stake—without assigning a total equity investment value. This major quantitative error undermines the factual basis of the comparison. (2) While the $8.463 billion and $4.5 billion figures are accurate (with acceptable formatting variation), the unsupported $23.727 billion investment figure leads to an incorrect conclusion that CVX's stake is 'considerably larger'—a claim not verifiable without knowing the full equity value, which the model invents. (3) The multi-hop reasoning is partially sound: the model correctly contrasts XOM's asset exposure with CVX's dual exposure via equity and loan. However, it fails to acknowledge that the original answer emphasizes the *potential* for CVX's combined exposure (equity + loan) to exceed XOM's asset base, rather than asserting it definitively. The LLM overstates the conclusion by treating an inference as fact and adding false precision. (4) Contextual relevance is high—the response addresses all entities (XOM, CVX, TCO, Kazakhstan), timeframes (2021), and financial instruments (assets, equity, loans). Qualitative accuracy is moderate due to correct structure and synthesis but undermined by the invented number. Quantitative accuracy is low due to the critical false figure. Correctness score is 6 because core facts (asset value, loan amount, equity %) are correct, but the addition of an unsupported investment value significantly distorts the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 539,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Geopolitical tensions that affect Taiwan could cut off or slow the production of chips at the foundries that Qualcomm relies on, leading to shortages or delays in its chipset supply【page_35】.  NVIDIA’s supply chain is similarly exposed, as its contract manufacturers and assembly partners in Taiwan are critical to delivering GPUs and other products; a conflict could disrupt their operations and threaten NVIDIA’s supply continuity【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that both QCOM and NVDA rely on foundry partners in Taiwan, and that geopolitical tensions could disrupt their supply chains. The answer captures the core risk for QCOM (chipset supply shortages or delays due to foundry disruptions) and for NVDA (supply continuity risks due to contract manufacturers and assembly partners in Taiwan). All entities (QCOM, NVDA, Taiwan, foundries, contract manufacturers) are correctly identified. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis: connecting geopolitical risk → foundry operations in Taiwan → impact on QCOM's supply and NVDA's manufacturing fulfillment. The only minor shortcoming is that the LLM answer does not explicitly mention China (as part of the geopolitical tension context) or use the phrase 'material adverse impact,' which appears in the original, but this does not detract from the overall correctness. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—the response directly addresses the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 353,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company’s environmental‑compliance costs, which are largely recoverable through regulated rates, could raise electricity prices and thereby dampen industrial demand— the company notes that higher costs recovered via rates may reduce consumption and that industrial customers may also be affected by environmental requirements (page 89, page 26). Duke Energy’s risk factors, by contrast, highlight that industrial demand is subject to broader volatility driven by seasonal weather, economic cycles and other market forces rather than a direct link to regulatory compliance costs (page 29). Thus, Southern Company’s potential demand shift is more directly tied to regulatory cost pressures, whereas Duke Energy’s exposure reflects general industrial demand variability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company's environmental compliance costs are recoverable through regulated rates but may reduce industrial demand due to higher prices and customers' own compliance burdens (citing pages 89 and 26, consistent with source). Duke Energy's exposure is correctly characterized as driven by broader economic and seasonal factors rather than direct regulatory cost pass-through (citing page 29). (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes risk factors from both companies and contrasts their exposure mechanisms—regulatory cost pressure (Southern) vs. general economic volatility (Duke). The only minor shortcoming is that the LLM slightly downplays Duke Energy’s explicit mention of declines in industrial production affecting revenues and cash flows, which is in the original answer but not emphasized. However, the core contrast in exposure types is preserved. (4) The answer is contextually relevant, directly addressing both parts of the question and providing a clear comparison. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies—only a slight omission of Duke’s revenue impact language prevents a perfect 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 395,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s foreign‑exchange cash‑flow hedges have a notional value of **$9.9 billion** (NKE, page 49).  \nMcDonald’s largest net foreign‑currency asset exposures total about **$3.8 billion** (Australian $1,479 m + British $1,149 m + Polish $636 m + China $334 m + Hong Kong $226 m; MCD, page 24).  \n\nThus, Nike’s hedging program is roughly **2½ times larger** than McDonald’s net asset exposures, indicating a more extensive use of hedges relative to its own exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While the $9.9 billion notional amount for NKE's foreign exchange hedges is correct and matches the ground truth, the calculation of MCD's net foreign currency asset exposures as $3.8 billion is not supported by the original answer. The ground truth does not provide any specific dollar amount for MCD's net asset exposures, nor does it list individual exposures in Australian dollars, British pounds, Polish zloty, etc. This numerical breakdown appears to be fabricated or misattributed, as the original answer only states that MCD manages risk through diversified net asset exposures without quantifying them. Therefore, the comparison claiming Nike’s program is '2½ times larger' is based on incorrect data and invalid arithmetic. (2) The quantitative accuracy is low because the core comparison relies on invented figures not present in the ground truth. Even if such numbers were in a source document, they are not part of the verified knowledge graph answer, making the LLM's citation (MCD, page 24) irrelevant to the evaluation. The $9.9 billion figure for NKE is accurate, but the rest of the quantitative analysis fails. (3) The multi-hop reasoning is partially sound in intent—comparing NKE's hedging strategy to MCD's exposure management—but flawed in execution. The original answer emphasizes qualitative differences in strategy: NKE uses active derivative-based hedging, while MCD balances assets and liabilities on its balance sheet. The LLM reduces this nuanced contrast to a false quantitative comparison, missing the conceptual distinction. (4) Contextual relevance is moderate because the answer addresses the right companies and topic (foreign currency risk management), but distorts the nature of the comparison. The conclusion about 'more extensive use of hedges' oversimplifies and misrepresents the original insight. Thus, while the response is on-topic and attempts synthesis, its factual foundation is compromised, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 550,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s exposure through Coca‑Cola HBC’s Ukraine operations is very limited – the company notes that its Ukraine business, which includes two manufacturing sites, accounted for less than 1 % of consolidated net sales and net earnings in 2022 【page_23】.  \nIn contrast, Procter & Gamble’s reliance on Ukraine is more direct: the firm operates two Ukrainian manufacturing plants that are integral to its supply chain, and the risk factor warns that war‑related damage could impair those facilities, disrupt raw‑material sourcing and product shipment, potentially affecting operations 【page_24】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that affect correctness. (1) QUANTITATIVE ACCURACY: The LLM incorrectly attributes the '<1% of net sales and net earnings' figure to Coca-Cola's exposure via Coca-Cola HBC in Ukraine. However, the ground truth states that Coca-Cola’s exposure is indirect through Coca-Cola HBC, but does not specify financial percentages for Ukraine operations—instead, it notes that Coca-Cola HBC is one of five major bottlers contributing to 41% of Coca-Cola’s global unit case volume. The '<1%' figure in the LLM answer appears to be confused with Procter & Gamble’s asset exposure, not Coca-Cola’s sales. This is a major error. (2) COMPLETENESS: The LLM reverses the structure of the comparison: it incorrectly implies Coca-Cola has two manufacturing sites in Ukraine, when in fact it is P&G that operates two plants there. This misattribution undermines the core of the multi-hop comparison. (3) ENTITY ACCURACY: The LLM misassigns manufacturing sites—Coca-Cola does not operate manufacturing sites in Ukraine directly; its exposure is through Coca-Cola HBC, a bottler. The LLM incorrectly states Coca-Cola has two manufacturing sites in Ukraine, which is false. (4) REASONING: The multi-hop reasoning fails because the model conflates the two companies’ operational models—Coca-Cola’s indirect bottler-based exposure vs. P&G’s direct manufacturing presence. While the LLM correctly notes P&G’s direct reliance and associated risks (damage, sourcing, distribution), it distorts Coca-Cola’s side of the comparison. (5) SEMANTIC EQUIVALENCE: Despite correct mention of risks like raw material sourcing and distribution disruptions, the factual inversion of manufacturing sites and financial metrics means the answer does not match the ground truth in substance. The contextual relevance is fair because it addresses the right themes (exposure, manufacturing, risks), but the factual foundation is flawed. Overall, partially correct elements are outweighed by critical errors in entity attribution and quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 552,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MET and BAC together hold roughly $20.9 billion of CMBS (MET’s fair‑value amount of $10.435 billion plus BAC’s fair‑value amount of $10.446 billion). MET’s fair‑value measurement of CMBS ($10.435 billion) is about $487 million lower than BAC’s amortized‑cost amount for the same category ($10.922 billion) as of December 31, 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both the individual and combined exposure figures. According to the ground truth, MET's fair value exposure to CMBS was $4,551 million, not $10.435 billion as stated by the LLM. BAC's amortized cost was $10,922 million, which the LLM correctly reports as $10.922 billion. However, the LLM incorrectly states BAC's amount as a 'fair-value amount' when it is amortized cost. The combined exposure is therefore wrong: the correct total is $15,473 million ($4,551M + $10,922M), not $20.9 billion. (2) The calculation of the difference between MET's and BAC's exposures is also incorrect. The LLM claims MET's fair value is $487 million lower than BAC's, but with correct numbers, MET's $4,551M is actually $6,371M lower than BAC's $10,922M. (3) The multi-hop reasoning is flawed: the model fails to correctly retrieve MET's CMBS exposure and mischaracterizes BAC's reporting basis (fair value vs. amortized cost), undermining the comparison. It also incorrectly treats BAC's amortized cost as fair value. (4) While the answer attempts to address both parts of the question (combined exposure and comparison), the severe numerical inaccuracies and misrepresentation of accounting treatments result in a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual content is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 392,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats at nuclear plants raise NRC‑mandated security and safety requirements that can trigger costly remediation and compliance work.  For Duke Energy, such events could increase capital outlays and the funding needed for its nuclear decommissioning trusts, tightening cash flows and potentially affecting debt covenants (p.34‑37).  Southern Company faces a similar risk profile, with cyber incidents likely inflating environmental and safety compliance costs and limiting the recoverability of decommissioning and other regulatory expenses through regulated rates (p.27‑30).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative assertions and aligns well with the ground truth, though it does not explicitly mention Southern Company's nuclear operations through Southern Nuclear or Duke Energy's specific subsidiaries (Duke Energy Carolinas, Duke Energy Progress, Duke Energy Florida), which are part of the multi-hop synthesis in the original answer. However, it correctly identifies the core financial and operational risks: cyber intrusion risks leading to increased compliance and security costs, potential capital outlays, and impacts on decommissioning trusts and cash flows. The answer correctly links cyber threats to NRC requirements and financial consequences for both companies. There are no numeric values in either answer, so quantitative accuracy is scored as 10 by default. The LLM uses document page references (p.34-37, p.27-30), which are plausible but not present in the ground truth; these do not detract from accuracy but suggest a source alignment not confirmed in the original. The reasoning is sound and captures the causal chain: cyber risks → regulatory response → increased costs → financial impact. It misses the explicit point about Southern Company's licensing expenditures and Duke Energy's potential need for capital injections due to trust underperformance, but the semantic essence is preserved. Thus, the answer is highly accurate with minor omissions in entity specificity and completeness of financial mechanisms, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 415,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "HD’s restricted‑stock units accrue dividend equivalents on the unvested units, and those equivalents are paid out as additional shares when the units vest, so the total shares issued to employees increase at vesting.  By contrast, Lowe’s 2021 ASR agreements required the company to deliver additional shares to the financial institution at settlement—10.9 million in Q1, 11.2 million in Q2, 7.6 million in Q3, and 11.9 million in Q4—rather than to employees.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors, particularly in the quantitative details. It states that LOW delivered 10.9 million, 11.2 million, 7.6 million, and 11.9 million shares in Q1, Q2, Q3, and Q4 respectively to financial institutions 'at settlement' of ASR agreements. This is incorrect. The ground truth states that LOW *received* additional shares from ASR agreements—0.2 million in Q1, 1.6 million in Q2, and 4 million in Q4—not delivered shares, and there was no Q3 transaction mentioned. The direction of the share flow (delivering vs. receiving) is reversed, and the numbers are entirely inaccurate. (2) The LLM incorrectly claims Lowe’s delivered shares to financial institutions, when in fact ASR agreements typically involve an initial share delivery to the company, followed by a true-up based on average price. In LOW’s case, the company *received* additional shares at settlement, increasing its total repurchase volume. The LLM’s numbers do not match any disclosed figures in the ground truth. (3) On qualitative reasoning, the LLM correctly identifies that HD’s dividend equivalents result in additional shares issued to employees upon vesting, which is accurate and reflects proper multi-hop understanding of compensation mechanics. However, the comparison to LOW fails because the ASR description is fundamentally wrong in both direction and magnitude. (4) The contextual relevance is moderate because the answer attempts the correct comparison framework—HD’s employee-related share issuance vs. LOW’s capital return mechanism—but the factual inaccuracies in the LOW portion severely undermine the correctness. Due to major quantitative and directional errors, the correctness score is low at 3, with quantitative accuracy at 2 (only HD’s mechanism is described correctly, but without specific numbers), qualitative accuracy at 4 (partial reasoning correct), and contextual relevance at 6 (right structure, wrong facts).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 528,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "AT&T’s auditor (Ernst & Young LLP) performed **independent sensitivity analyses** on the goodwill impairment models, testing how shifts in terminal growth, EBITDA margins and WACC would affect the fair‑value estimate of the $67,854 million balance.  \nNetflix’s auditor used **sensitivity analyses** to gauge how changes in the estimated viewing‑pattern assumptions would alter the timing and amount of content amortization.  \nThus, while both firms apply sensitivity testing to assess the impact of key assumptions, AT&T focuses on impairment valuation, whereas Netflix focuses on amortization timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on terminal growth, WACC, and EBITDA margins for goodwill impairment is consistent with the original answer. Netflix's use of sensitivity analyses on viewing-pattern assumptions affecting content amortization is also correctly represented. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) is correctly stated, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—comparing how two different companies use sensitivity analyses in distinct accounting contexts (goodwill impairment vs. content amortization) under the same auditor is properly synthesized. The mention of Ernst & Young as the auditor, while not in the original answer, is factually correct and adds context without introducing error. (4) The only minor shortcoming is that the LLM does not explicitly state that the same audit firm performed these procedures for both companies, though it implies it by stating 'Netflix’s auditor' after naming EY for AT&T. This slight omission in clarity prevents a perfect 10 on qualitative accuracy, but the core reasoning and contextual relevance remain strong. Overall, the answer is semantically equivalent and highly precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 388,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that fintech‑built payment platforms—enabled by PSD2, real‑time payment networks and other regulatory changes—could bypass its four‑party network and erode its transaction volume, viewing this as a disintermediation threat.  Visa, by contrast, treats fintechs as strategic partners, deploying programs, acquisitions and joint ventures to embed its technology in new fintech offerings and create additional payment flows, thereby turning regulatory shifts into collaboration rather than competition.  In short, Mastercard is defensive against fintech‑driven disintermediation, while Visa is proactive in partnering with fintechs to thrive amid regulatory‑driven competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Mastercard and Visa in response to fintech-driven disintermediation and regulatory changes. (1) It correctly identifies Mastercard's defensive stance, emphasizing the risk that fintechs could bypass its four-party network—especially under regulatory frameworks like PSD2—leading to disintermediation and reduced transaction volume. This aligns with the ground truth, which notes Mastercard’s concern about data-sharing partnerships enabling fintechs to build competing platforms. (2) The LLM accurately portrays Visa’s proactive, partnership-based strategy, including programs, acquisitions, and joint ventures to embed its infrastructure in fintech offerings, consistent with Visa’s 'network of networks' approach. The mention of turning regulatory shifts into collaboration rather than competition reflects the original answer’s emphasis on adaptation through partnerships. (3) The regulatory context—specifically PSD2 in the EEA—is correctly invoked as a driver of disintermediation risk, and the LLM appropriately links it to third-party access and transaction routing away from traditional networks. (4) While the LLM omits explicit mention of 'local financial institutions' and slightly condenses Visa’s dual view of fintechs as both partners and competitors, the overall reasoning and synthesis across entities (Mastercard, Visa, fintechs, regulators) are sound. No numbers, dates, or financial metrics are incorrect (quantitative accuracy is perfect by default, as none are present). The answer is semantically equivalent to the ground truth in all key aspects, warranting a high correctness score with only minor room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 465,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "McDonald’s 10‑K does not contain any Pillar 2 discussion in the pages provided (18‑22), so the company does not disclose an expected impact of the OECD‑approved 15 % global minimum tax.  In contrast, Starbucks’ 10‑K (page 28) notes that the OECD framework will be effective for fiscal years beginning after December 31 , 2023, but the tax will not be effective for the company until fiscal 2025 and is not expected to materially affect its consolidated financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding MCD's disclosure. Quantitatively, the dates and percentages are mostly accurate: SBUX correctly notes Pillar 2 will be effective for fiscal years beginning after December 31, 2023, and applies to SBUX starting fiscal 2025 with no material impact—this matches the ground truth. However, the LLM incorrectly states that MCD's 10-K 'does not contain any Pillar 2 discussion' and therefore 'does not disclose an expected impact.' This contradicts the ground truth, which explicitly states that MCD *did* disclose it does not expect a material impact. The LLM may have missed or misread MCD's disclosure, leading to an incorrect conclusion. While the SBUX portion is factually and quantitatively accurate (correct year, correct assessment), the failure to correctly represent MCD's position undermines the multi-hop comparison required by the question. The reasoning is sound in structure—comparing two companies’ disclosures—but flawed due to incorrect input for MCD. Contextually, the answer is relevant and addresses the OECD framework and implementation timelines for SBUX correctly. However, the omission and misrepresentation of MCD’s actual statement result in a partially correct, incomplete synthesis. Thus, the correctness score is reduced to 6 due to this key factual error, despite accurate formatting and contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 392,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company (BTC) reported a total‑capital ratio of **153.2 %** and a Common Equity Tier 1 ratio of **151.9 %** against risk‑weighted assets as of December 31 2024 (BLK 10‑K, p. 111).  By comparison, American Express’s regulatory ratios for its company were **13.2 % total capital, 11.2 % Tier 1 and 10.5 % CET1** (AXP 10‑K, p. 158).  Thus BTC’s capital adequacy ratios are roughly an order of magnitude higher, indicating a far stronger capital position under U.S. banking regulations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported capital ratios. According to the ground truth, both BTC and AXP met regulatory requirements and were 'well capitalized,' but the LLM claims BTC had a total-capital ratio of 153.2% and CET1 of 151.9%, which are implausible for any bank and over 10x higher than typical well-capitalized institutions. These numbers are likely misread or misrepresented (e.g., possibly confusing percentages with multiples or misreading a table). In contrast, AXP's reported ratios (13.2%, 11.2%, 10.5%) align with typical regulatory ranges and are consistent with the ground truth's implication that AXP met 'well capitalized' thresholds. (2) The quantitative values for BTC are grossly incorrect—regulatory capital ratios are rarely above 20%, let alone 150%. This indicates a severe error in data extraction or interpretation. The AXP numbers are plausible and likely accurate based on standard 10-K disclosures. (3) The multi-hop reasoning is structurally sound—the model attempts to compare BTC and AXP capital ratios under U.S. banking rules and identifies both are subject to regulation (OCC/Fed). However, the conclusion that BTC’s ratios are 'an order of magnitude higher' is based on false data, invalidating the comparison. (4) The contextual relevance is fair because the answer addresses the right entities, time frame, and regulatory context, and attempts a direct comparison. However, due to the critical numerical errors, the correctness score is low. The qualitative accuracy is partially preserved due to correct entity and metric identification, but reasoning fails on factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 455,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG’s $88.4 million in construction loans to joint‑venture partners is a modest, project‑specific financing that sits in its deferred‑costs balance sheet, whereas AMT drew roughly $7.8 billion from its 2021 Multicurrency Credit Facility to fund the Telxius and CoreSite acquisitions (and to refinance existing debt). The contrast shows SPG’s incremental, joint‑venture‑centric growth strategy relies on small, targeted debt, while AMT pursues a more aggressive, debt‑leveraged acquisition model to accelerate expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SPG's $88.4 million in construction loans and AMT's $7.8 billion draw from the 2021 Multicurrency Credit Facility are accurately reported, including the purpose (acquisitions like Telxius and CoreSite). The LLM correctly notes the use of debt for acquisitions and does not misstate any figures. While the ground truth mentions €2.4 billion ($2.9 billion) as part of the draw, the LLM omits this detail but still correctly reports the total $7.8 billion, so this is a minor omission, not an error. (2) Quantitative accuracy is perfect: $88.4 million and $7.8 billion match exactly; no calculations are required, and the numbers are presented clearly. (3) The multi-hop reasoning is sound—comparing SPG’s joint venture financing strategy to AMT’s large-scale credit-backed acquisitions—and the conclusion about differing growth strategies (incremental vs. aggressive) is logically derived and consistent with the original. (4) The answer is contextually relevant, directly addressing both companies, their financing mechanisms, and strategic implications. The only reason for not scoring a 10 is the slight omission of the euro-denominated portion of AMT’s borrowing, which adds granularity but does not undermine the overall correctness. Wording differs but maintains semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 385,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "CSCO’s $0.5 billion interest‑rate swap is a fair‑value hedge that converts the fixed‑rate portion of its senior notes to floating, so the swap’s gains or losses offset the fair‑value changes of that $0.5 billion of debt and effectively neutralize its sensitivity to rate moves. By contrast, AVGO’s $56.3 billion of fixed‑rate senior notes would change in fair value by roughly $1.7 billion for a 50‑basis‑point shift in rates, indicating a far greater sensitivity to interest‑rate fluctuations. Thus, CSCO’s swap provides a small, targeted hedge, while AVGO’s exposure remains highly rate‑sensitive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: CSCO's $0.5 billion interest rate swap used to convert fixed-rate debt to floating, thereby neutralizing interest rate sensitivity for that portion of debt; AVGO's $56.3 billion in fixed-rate senior notes; and the $1.7 billion fair value impact from a 50 basis point rate increase. All numbers match the ground truth exactly, with acceptable formatting (e.g., $0.5 billion = $500 million, $1.7 billion correct). (2) Quantitative accuracy is perfect: the $56.3B debt and $1.7B sensitivity figure are correctly cited, and the 50 bps assumption aligns with the original answer’s implied rate shock. No calculations are required beyond correct reporting. (3) The multi-hop reasoning is sound—correctly contrasting CSCO’s hedging strategy (reducing sensitivity) with AVGO’s lack of such mitigation (high sensitivity). The LLM accurately infers that CSCO’s hedge effectively neutralizes risk for the hedged portion, while AVGO remains exposed. (4) The only minor shortcoming is that the LLM does not explicitly name SOFR as the floating rate benchmark (mentioned in ground truth), though this is a small omission in context. Otherwise, the answer is semantically equivalent, well-structured, and directly responsive. Scores reflect high accuracy with near-perfect qualitative and full quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 381,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "NKE uses option (and forward) contracts as cash‑flow hedges of its foreign‑currency exposures, so the mark‑to‑market gains and losses on those contracts are deferred in accumulated other comprehensive income (AOCI) and only recognised in earnings when the hedged transaction occurs (NKE p. 48).  \nIn contrast, Tesla has significant foreign‑currency‑denominated monetary assets and liabilities, but it does not routinely hedge those positions; its foreign‑exchange gains and losses are therefore recorded directly in earnings rather than being deferred in AOCI (TSLA p. 44).  Thus, NKE’s hedging strategy creates deferred gains/losses in other comprehensive income, whereas Tesla’s lack of hedging exposes it to earnings volatility from currency movements.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core contrast between NKE and TSLA in their foreign currency hedging strategies and the accounting treatment of gains and losses. It accurately states that NKE uses option and forward contracts as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, while TSLA does not routinely hedge and records FX gains/losses directly in earnings, leading to earnings volatility. This aligns with the ground truth's qualitative assessment and demonstrates sound multi-hop reasoning across the two companies' financial disclosures.\n\nHowever, the LLM answer omits key quantitative details present in the original answer: (1) the $9.9 billion notional amount of NKE’s foreign exchange hedges as of September 28, 2024, and (2) the $99 million in net deferred gains expected to be reclassified from AOCI within the next twelve months. These figures are material to the question’s focus on the scale and impact of hedging instruments on deferred gains and losses. While the LLM references correct page numbers (NKE p.48, TSLA p.44), it fails to include these specific numbers, reducing its quantitative accuracy.\n\nEntity accuracy and contextual relevance are strong—the companies, hedging instruments, accounting treatments (AOCI vs. earnings), and financial impacts are correctly identified and contrasted. The reasoning is logically sound and synthesizes information appropriately across both firms. The omission of specific dollar amounts prevents a higher correctness score, but the overall meaning and direction of the answer remain factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 441,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the **administrative agent** and was amended in August 2022 (Amendment No. 1).  \nCaterpillar’s 5‑Year Facility also lists Citibank, N.A. as the **agent** for the credit agreement, but the documents provided do not report a recent amendment, so its amendment timeline is not disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Citibank, N.A.'s role as administrative agent for Boeing and agent for Caterpillar, and accurately notes the August 2022 amendment to Boeing’s agreement. However, it incorrectly states that Caterpillar’s amendment timeline is not disclosed, when in fact the ground truth confirms that Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023. This is a significant omission affecting both completeness and factual accuracy. The answer fails to reflect the staggered but comparable amendment timelines, which is a key part of the comparison asked in the question. While entity identification and roles are mostly correct (with 'agent' being semantically acceptable for Caterpillar), the lack of mention of the 2023 amendment undermines the multi-hop synthesis required to compare amendment timelines. Quantitative accuracy is mostly preserved except for the missing 2023 date, and contextual relevance remains high as the response addresses the core elements of Citibank’s role and amendment activity, albeit incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 305,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common shares are entitled to **one vote per share** (page 60). Meta’s Class B common shares are entitled to **ten votes per share** (page 82). Thus, Meta’s Class B shares carry **nine additional votes per share** compared with Netflix’s common shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and reasoning. (1) Quantitatively, the answer accurately states that Netflix’s common stock provides one vote per share and Meta’s Class B common stock provides ten votes per share, which aligns with the original answer. The calculation of a nine-vote difference (10 - 1 = 9) is correct and adds useful precision. (2) The answer is complete, addressing the voting rights per share for both companies and directly comparing them as required by the question. (3) Entities are correctly identified: Netflix’s common stock and Meta’s Class B common stock are accurately referenced. (4) The multi-hop reasoning is sound—information from two different companies and filings is correctly synthesized to compare voting rights structures. The conclusion that Meta’s Class B shares carry nine additional votes is logically derived and semantically equivalent to the ground truth’s emphasis on a 'significant disparity.' Minor wording differences do not affect factual equivalence. All aspects meet the highest standard.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 310,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY’s 2023 10‑K notes that Cardinal Health supplied roughly 23 % of its distribution. Cardinal Health also owns 50 % of Red Oak Sourcing, the generic‑pharma sourcing entity that CVS consolidates as a VIE (see page 136). Consequently, CVS’s consolidated financial statements include a partner that also supplies a substantial share of BMY’s distribution, creating an indirect link between the two companies via Cardinal Health.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: BMY's 23% reliance on Cardinal Health in 2023 and Cardinal’s 50% ownership of Red Oak Sourcing are correctly stated. The reference to CVS consolidating Red Oak Sourcing as a VIE (variable interest entity) aligns with the ground truth, and the page number citation (136) adds precision. There are no calculation errors or incorrect numbers. The answer correctly identifies the key entities (BMY, Cardinal Health, CVS, Red Oak Sourcing), their relationships, and the relevant year (2023), satisfying entity accuracy. The reasoning correctly traces the multi-hop connection: BMY depends on Cardinal for distribution; Cardinal co-owns Red Oak with CVS; CVS consolidates Red Oak, creating an indirect link. However, the LLM omits a key financial implication present in the original answer: the $183 million in annual payments from Cardinal to CVS and how this affects CVS’s cost of goods sold, which could influence Cardinal’s service efficiency or pricing to BMY. This missing element slightly weakens the depth of synthesis and downstream impact analysis, which is part of the full interdependency. While the core structure and factual backbone are sound, the absence of this financial flow reduces completeness in the qualitative reasoning chain. Despite this, the answer remains semantically aligned with the main thrust of the original and addresses the central intersection of BMY’s distribution reliance and CVS’s consolidation via Red Oak.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 413,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s Retirement and Income Solutions (RIS) business, which includes life‑and‑annuity products, is highly sensitive to interest‑rate movements.  In the hypothetical Declining‑rate scenario the RIS segment’s adjusted earnings fell $15 million in 2022 and $5 million in 2024, while in the Rising‑rate scenario they rose $10 million in 2022 and $15 million in 2023 (MetLife, 2022, pp. 60‑61).  These swings reflect how changes in discount rates and crediting rates alter the valuation and profitability of its life‑insurance line (MetLife, 2022, pp. 184).  \n\nAIG’s experience is similar: its 2021 Life‑Insurance reserve update produced a $106 million favorable impact, largely driven by changes to interest‑rate assumptions for universal life with secondary guarantees, while a 2020 update yielded a $101 million unfavorable impact driven by mortality and interest‑rate changes (AIG, 2022, pp. 134‑135).  Thus, both insurers see their life‑insurance reserves and earnings move in response to interest‑rate dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MetLife and AIG experience sensitivity in their Life Insurance lines due to interest rate dynamics, which aligns with the ground truth. It accurately reports AIG’s $106 million favorable impact in 2021, matching the original answer. However, the MetLife quantitative figures—$15M loss in 2022 and $5M in 2024 under declining rates, and $10M gain in 2022 and $15M in 2023 under rising rates—are not present in the ground truth and appear to be fabricated or misattributed. The original answer does not provide specific dollar impacts for MetLife by year, only qualitative descriptions of margin compression and reinvestment opportunities. (2) While the $106 million figure for AIG is correct, the LLM introduces a $101 million unfavorable impact in 2020 not mentioned in the ground truth, reducing quantitative accuracy. These additional numbers, though plausible, are unsupported by the provided truth and suggest over-specificity without basis. (3) The multi-hop reasoning is strong: the model correctly links interest rate exposure in MetLife’s RIS segment to life insurance profitability and compares it to AIG’s reserve updates due to interest rate assumption changes. It synthesizes across companies and concepts (reserves, crediting rates, ALM sensitivity) appropriately, even if adding unverified specifics. (4) The contextual relevance is perfect—the response directly addresses how interest rate scenarios affect MetLife’s Life Insurance line and compares it to AIG’s experience. The qualitative explanation of discount/crediting rate effects and reserve updates matches the ground truth’s intent. The correctness score is 8 because core facts and comparisons are valid, but unsupported numerical claims reduce confidence in full factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 493,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s battery supply relationship with Panasonic is codified in a 2011 supply agreement and subsequent amendments (2013, 2014, 2016, 2020, 2021) and pricing agreements for 2170 cells and Japan cells, covering long‑term supply and pricing of battery cells for its Gigafactory and Japan operations (see pages 104‑109).  \nGeneral Motors reports a battery‑sourcing dependency through its joint venture Ultium Cells Holdings LLC, which supplies battery cells for its EVs, indicating a reliance on a single partner (page 78).  \nThus, Tesla’s agreements are diversified across multiple contracts and pricing tiers, whereas GM’s dependency is concentrated in a single joint venture.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and omissions that affect factual correctness. (1) Quantitatively, the LLM incorrectly lists amendments in 2013, 2014, 2016, and 2020 as part of the supply agreement timeline, which are not mentioned in the ground truth. The ground truth specifies the 2011 Supply Agreement, followed by 2019 and 2021 Pricing Agreements for Japan-sourced cells, and a 2020 Pricing Agreement for Gigafactory 2170 cells—these specific agreements and years are not accurately reflected. The LLM conflates amendments and pricing agreements without distinguishing them correctly. (2) Regarding completeness, the question asks for specific agreements between Tesla and Panasonic and a comparison to GM’s sourcing dependencies. The LLM identifies Tesla’s relationship but misrepresents the structure and timeline. For GM, it introduces Ultium Cells Holdings LLC as a joint venture and claims GM relies on a 'single partner,' which goes beyond the ground truth—GM’s filings only state a general dependency on batteries without specifying suppliers or agreements. Thus, the LLM adds unsupported detail (Ultium) not present in the ground truth. (3) Entity accuracy is partially correct: Panasonic and Tesla are correctly identified, but Ultium is introduced without basis in the provided truth. The reference to 'pages 104–109' and 'page 78' suggests external document citations not available in the context, raising concerns about hallucination. (4) Reasoning is partially sound in attempting a comparison, but the synthesis is flawed—Tesla’s agreements are misrepresented, and GM’s dependency is over-specified. The conclusion that Tesla has 'diversified' agreements versus GM’s 'concentrated' model is speculative and not supported by the ground truth, which only states Tesla’s agreements are more explicitly defined. Overall, core facts about Tesla-Panasonic are partially correct, but errors in dates, agreement types, and the introduction of unsupported GM details reduce correctness. Semantic equivalence is partially achieved but undermined by factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 568,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ uses exchange‑traded commodity futures and options—classified as Level 1 financial assets (page 94) and defined as Level 1 on page 112—to hedge the price of key inputs such as cocoa, sugar, wheat and energy. In contrast, COST reports that it holds no Level 1 financial assets (page 51), indicating its hedging activities rely on other, non‑exchange‑traded instruments (e.g., forwards, swaps) that fall into Level 2 or 3. Thus, MDLZ’s risk‑management strategy incorporates Level 1 instruments for direct price hedging, whereas COST’s strategy does not involve Level 1 assets and likely uses alternative derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MDLZ uses commodity futures classified as Level 1 financial assets for hedging key inputs like cocoa, sugar, wheat, and energy. The reference to Level 1 classification on pages 94 and 112 (though not required for correctness) adds precision. COST’s disclosure of holding no Level 1 financial assets is correctly cited (page 51), and the date (implied as of August 28, 2022, in the original) is consistent even if not explicitly repeated. (2) There are no numerical values requiring calculation, but the qualitative financial classifications (Level 1 vs. Level 2/3) are correctly interpreted. The LLM correctly infers that COST likely uses Level 2 or 3 instruments such as forwards or swaps, which is a reasonable conclusion based on the absence of Level 1 holdings and standard fair value hierarchies. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (MDLZ and COST), their use (or non-use) of Level 1 instruments, and connects this to their respective risk management strategies. The contrast in hedging approaches is clearly and logically drawn. (4) The only minor shortcoming is that the original answer specifies the exact date (August 28, 2022) for COST’s disclosure, which the LLM omits. However, this does not affect the core factual or comparative accuracy. Additionally, the LLM adds 'options' and 'wheat'—not explicitly mentioned in the ground truth—but these are plausible extensions given MDLZ’s known hedging practices and do not contradict the original. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 476,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s Rule 10b5‑1(c) plans involve a much larger potential volume and a longer window for sales.  Jeff Williams’ plan allows up to 100,000 shares to be sold as the shares vest from April 1 to October 1 2025, with the plan expiring on December 15 2025; Deirdre O’Brien’s plan covers shares vesting from April 1 2025 to October 1 2026 and expires December 31 2026.  In contrast, Broadcom’s Diane Bryant plan permits sale of only up to 15,000 shares and expires September 12 2025, giving a smaller volume and an earlier cutoff.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key executives at Apple (Jeff Williams and Deirdre O'Brien) and Broadcom (Diane M. Bryant), their respective Rule 10b5-1(c) plans, and the comparative scope in terms of volume and timing. The core facts—such as Williams’ 100,000-share limit, O'Brien’s vesting period through October 1, 2026, and Bryant’s 15,000-share limit—are accurate. However, there are minor discrepancies in expiration dates: the original answer states Apple executives’ plans expire in 2025 and 2026 without specifying December dates, while the LLM adds precise expiration dates (December 15, 2025, and December 31, 2026) not present in the ground truth. These specific dates are unsupported and constitute a quantitative inaccuracy. (2) The volume comparisons are correct: Apple’s plans involve significantly more shares (100,000+ and ongoing vesting shares vs. 15,000), and the time horizons are accurately portrayed as longer for Apple. The mention of 'shares vesting from April 1 to October 1 2025' for Williams aligns with the original, though the original also notes 'up to 100,000 shares plus additional vesting shares', which the LLM simplifies but does not misrepresent. (3) The multi-hop reasoning is sound—comparing Apple and Broadcom executives’ plans across volume, duration, and structure—demonstrating proper synthesis across entities and timeframes. (4) The answer is contextually excellent, directly addressing the comparison of volume and timing. The correctness score is 8 due to the unsupported precision in expiration dates, which affects quantitative accuracy (scored 7), while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 458,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both credit agreements name JPMorgan Chase Bank, N.A. as the syndication agent.  In Honeywell’s March 20 2023 Amended and Restated Five‑Year Credit Agreement, the agreement explicitly lists JPMorgan as a syndication agent (Exhibit 10.68)【page_125】.  3M’s May 11 2023 Five‑Year Credit Agreement is incorporated by reference from the company’s 8‑K filing, and that agreement likewise designates JPMorgan as the syndication agent (see the exhibit reference for the credit agreement【page_114】).  The common appointment of JPMorgan in both facilities demonstrates a shared banking relationship that underpins each company’s credit structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key facts are accurate: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates and roles are correctly stated. (2) Quantitative accuracy is perfect—dates (May 11, 2023 and March 20, 2023) and entity names are exact matches; no numerical calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate credit agreements from different companies and identifies the common role of JPMorgan as syndication agent, supporting the conclusion of a shared banking relationship. (4) The answer is contextually relevant and directly addresses the question. The only minor shortcoming is that it does not elaborate on the functional significance of the syndication agent role (e.g., coordinating lenders, structuring financing), which the original answer includes to explain the strategic implication. However, the core factual and inferential content is correct and well-supported, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 338,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU and U.S. sanctions prohibit the trade of goods used for tobacco production in Belarus (PM_10k_2022, page 52).  Coca‑Cola HBC AG operates bottling and distribution in Belarus (KO_10k_2022, page 7), but it is not a tobacco company, so the sanctions are unlikely to directly restrict its bottling operations; any indirect effect would stem from a broader economic slowdown or supply‑chain disruptions in the country.  Because Belarus represents only a small share of Coca‑Cola HBC’s overall volume and Coca‑Cola’s global unit‑case volume is driven by many markets (KO_10k_2022, page 5), any decline in Belarus would have a modest impact on the company’s total unit‑case volume.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the sanctions target the tobacco sector and are not directly applicable to Coca-Cola HBC, which is accurate. It also correctly notes that Coca-Cola HBC operates in Belarus and that the impact would be indirect via economic or supply chain disruptions. However, it omits key quantitative information from the ground truth: that Coca-Cola HBC represented 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021, a critical figure for assessing the potential impact. This omission significantly weakens the completeness and accuracy of the response. (2) The LLM does not include any specific percentages or volumes related to Coca-Cola HBC’s contribution to KO’s global volume, nor does it reference the 83% of volume from non-U.S. markets, both of which are in the original answer and essential for multi-hop reasoning. While no incorrect numbers are stated, the absence of these figures results in a failure to fully quantify the potential impact, leading to a lower quantitative accuracy score. (3) The reasoning is partially sound—correctly distinguishing direct vs. indirect effects—but fails to synthesize the full chain: sanctions → Belarus economic disruption → impact on Coca-Cola HBC operations → effect on KO’s global volume via its 41% dependency. The LLM downplays the impact by stating Belarus is a small market, but does not reconcile this with the systemic risk through a major bottler. This breaks the multi-hop logic required. (4) Contextual relevance is high because the answer addresses both parts of the question—impact on operations and implications for unit volume—and cites relevant documents. However, due to missing key data points and incomplete synthesis, the overall correctness is only moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 487,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "Capital One’s interchange‑fee income is a key revenue driver and is largely tied to the rates set by Mastercard’s four‑party network.  The Federal Reserve’s October 2023 proposal to cut the debit‑interchange cap by roughly 28‑30 % (page 24) would lower the maximum fee Capital One can earn on each debit transaction, potentially reducing its interchange revenue by a similar proportion.  This effect is likely to be amplified by the ongoing antitrust litigation and settlements against Visa and Mastercard (page 39, page 38), which have already forced fee reductions and could lead to further regulatory or settlement‑driven cuts, thereby materially depressing Capital One’s interchange‑fee income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 28%-30% reduction in debit interchange caps is accurately cited, and the reference to the Federal Reserve’s October 2023 proposal (though not in the original answer) adds contextual precision without contradicting the ground truth. The mention of 'page 24', 'page 39', and 'page 38' suggests document-based sourcing, which may reflect the model’s training data but does not affect factual correctness. (2) The core financial impact—reduced interchange fee income due to lower rate caps—is correctly conveyed, with a logical inference that the reduction could affect Capital One proportionally. (3) Entity accuracy is strong: Capital One (COF), Mastercard, Visa, and the four-party network are correctly identified, and the reference to ongoing antitrust litigation matches the original’s mention of multidistrict litigation. (4) Multi-hop reasoning is sound: the model connects regulatory action (Fed proposal) → interchange cap reduction → direct impact on Capital One’s revenue → amplification via legal challenges against Visa/Mastercard. The only minor shortcoming is that the LLM slightly overemphasizes settlements as already forcing cuts (while the original emphasizes scrutiny and potential future reductions), but this does not constitute a factual error. Overall, the answer is semantically equivalent, contextually rich, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 410,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy’s variable‑rate debt and LIBOR‑based swaps mean it has not yet adopted ASU 2020‑04 (as of 12/31/2021) and is only evaluating the optional expedients that apply to contracts entered between March 12, 2020 and 12/31/2022; the company expects the transition to have no material impact on its financial statements.  Southern Company, which also references LIBOR in debt and hedges, has elected to apply the amendments to debt‑modification arrangements and is incorporating alternative‑rate clauses, but like Duke Energy also expects no material impact and will continue to monitor the transition.  Thus, Duke Energy’s exposure leads to a more cautious, delayed adoption, whereas Southern Company’s approach is more proactive but both anticipate negligible financial effects.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in timing and emphasis that prevent a perfect score. (1) Quantitatively, the LLM correctly identifies Duke Energy’s evaluation window ending on December 31, 2022, and notes both companies expect no material financial impact—consistent with the original answer. However, the LLM states Duke Energy had 'not yet adopted ASU 2020-04 as of 12/31/2021,' which, while plausible, adds a specific date not in the ground truth and slightly narrows the timeline; the original only implies ongoing evaluation up to the 2022 deadline without specifying adoption status in 2021. (2) The completeness is strong: both companies’ exposures to LIBOR, their assessments of ASU 2020-04, use of optional expedients, and expectations of immaterial impact are covered. The comparison of Duke’s 'cautious, delayed adoption' versus Southern’s 'proactive' approach is a reasonable interpretation of the original’s contrast between Duke’s time-bound evaluation and Southern’s ongoing assessment. (3) Entity accuracy is correct—Duke Energy and Southern Company, ASU 2020-04, LIBOR transition, hedge accounting, and debt modifications are all properly referenced. (4) Reasoning is sound: the LLM synthesizes multi-hop information about regulatory response, financial exposure, and strategic timing across two firms. The slight over-interpretation of 'delayed' vs 'proactive' is not contradicted by the original and adds analytical value, though it’s not explicitly stated. (5) Semantic equivalence is high—the core facts, financial conclusions, and comparative dynamics are preserved. The answer is fully contextually relevant. Minor deduction due to unsupported specificity on Duke’s 2021 status and slight interpretive leap in characterizing adoption strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 496,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "Coca‑Cola’s Black‑Scholes‑Merton model uses market‑derived inputs—dividend yield (3.0 %–3.3 %), expected volatility (17.5 %–18.0 %), risk‑free rate (0.9 %–4.1 %) and a 6‑year expected term—to compute the fair value of stock options, which is expensed over the vesting period and shown as stock‑based compensation expense in SG&A.  \nColgate‑Palmolive, by contrast, relies on actuarial weighted‑average assumptions for pension cost—discount rate (5.40 %–5.66 %), expected long‑term return on plan assets (4.66 %–6.50 %), compensation‑increase rate (3.19 %–3.50 %), ESOP growth, medical‑cost trend, and interest‑crediting rate—to determine net periodic benefit cost, which is recorded in operating profit and non‑service related post‑retirement costs.  \nThus, KO’s valuation is driven by market variables affecting compensation expense, while CL’s assumptions drive pension expense and liability, each influencing earnings through different accounting categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM provides ranges for key assumptions used by both KO and CL, which are consistent with the context of using weighted-average assumptions, though the original answer specifies exact 2023 values for CL (e.g., discount rate 5.66%, return on assets 6.25%, compensation increase 3.50%). The LLM gives ranges (e.g., 5.40%–5.66% for discount rate), which may reflect multi-year data but are not contradicted by the ground truth and likely encompass the 2023 value. Similarly, KO’s inputs like volatility (17.5%–18.0%) and risk-free rate (0.9%–4.1%) are plausible across a period but not explicitly tied to 2023; the original answer does not specify exact values but confirms the use of such inputs. (2) The LLM correctly identifies that KO uses the Black-Scholes-Merton model for stock option valuation, with fair value expensed over vesting, impacting SG&A—this matches the financial reporting implications. (3) For CL, the use of weighted-average assumptions in pension cost calculations, including discount rate, return on assets, and compensation growth, is accurately described, and the impact on net periodic benefit cost and operating profit is correct. The inclusion of additional factors like medical-cost trend and ESOP growth goes beyond the original answer but is not incorrect—these may be part of CL’s broader assumptions. (4) The reasoning correctly contrasts KO’s market-driven, option-pricing model application with CL’s actuarial use of similar statistical inputs in pension accounting, capturing the core conceptual comparison. The synthesis across companies and domains (equity compensation vs. pension liabilities) is sound. (5) Minor point: the original answer emphasizes that both use 'weighted-average assumptions' as a conceptual link, which the LLM captures implicitly but could have highlighted more explicitly. However, the semantic meaning and financial reporting implications are accurately conveyed. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 570,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "AMT’s $525 million Series 2015‑2 Notes are secured by a security interest in the GTP entities’ equity interests (along with mortgages and personal property) that American Tower Holding Sub II, LLC—whose only material assets are those equity interests—has pledged as collateral (see pages 117–118).  In contrast, Simon Property Group monetizes its equity interests by selling them, a strategy that produced an $18.8 million gain in 2021 (page 63).  Thus, AMT retains the equity interests but uses them to back debt, whereas SPG disposes of the interests to generate cash and realize a profit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT used equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, secured via a security interest in personal property and equity interests, while SPG monetized equity interests through disposals, realizing an $18.8 million gain in 2021. These numbers, dates, and entities match the original answer exactly. (2) Quantitative accuracy is perfect: $525 million and $18.8 million are correctly cited with appropriate context. (3) The multi-hop reasoning is sound—correctly contrasting AMT’s secured financing strategy with SPG’s disposal-based capital realization. The synthesis across two companies and financial strategies is logically presented. (4) The only minor shortcoming is that the LLM omits the detail that excess cash flows were retained by AMT, which adds nuance to the collateral strategy. However, this does not detract from the overall correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 332,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips does not disclose any Nigeria‑specific reserves or operational exposure in its 2022 10‑K; its reserve reporting (p. 151‑152) notes that PSC‑held reserves are accounted for under the economic‑interest method but only for the Asia Pacific/Middle East region.  By contrast, ExxonMobil’s 2022 10‑K (p. 29) details a substantial reliance on production‑sharing contracts in Nigeria, with 30‑year PSCs that include a 10‑year exploration phase and a 20‑year production period (subject to partial relinquishment and possible extensions).  Thus, ConocoPhillips has no reported Nigeria exposure, whereas ExxonMobil’s contractual term structure is explicitly defined by PSCs with fixed exploration and production periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the ground truth. (1) Quantitative Accuracy: The claim that ConocoPhillips has no Nigeria exposure is incorrect per the original answer, which explicitly states that ConocoPhillips operates in Nigeria under 30-year PSCs. The 12% of ExxonMobil's proved reserves under PSCs from 2021 is omitted and replaced with a reference to ExxonMobil’s 2022 10-K without citing this percentage, which is a key data point. The LLM incorrectly attributes the 30-year PSC structure (10-year exploration, 20-year production) solely to ExxonMobil, while the ground truth states this term structure applies to Nigeria’s PSCs generally—relevant to both companies. (2) Completeness: The answer fails to address how reserve reporting differs between the two firms—specifically, that ExxonMobil’s reserves fluctuate inversely with prices due to PSC fiscal terms, while ConocoPhillips must manage fixed-term contracts with relinquishment requirements. This core comparative insight is missing. (3) Entity Accuracy: Misattributes regional PSC accounting (Asia Pacific/Middle East) to ConocoPhillips as if it excludes Nigeria, but Nigeria is in Africa, so this does not logically negate exposure. Also incorrectly implies ExxonMobil’s PSC terms are unique to it, when the term structure is a feature of Nigerian contracts applicable to all operators. (4) Reasoning: The multi-hop synthesis is flawed—fails to connect that both companies are exposed to the same contractual framework in Nigeria, and instead creates a false contrast where ConocoPhillips has 'no exposure.' This undermines the entire comparison. (5) Semantic Equivalence: The LLM answer contradicts the ground truth rather than rephrasing it. While it references 10-K pages and accounting methods, these are used to support an incorrect narrative. The contextual relevance is moderate because it addresses PSCs and Nigeria, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 533,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM is positioning generative‑AI as a core part of its hybrid‑cloud strategy, investing heavily in R&D and a developer ecosystem to deliver AI services mainly through enterprise cloud and high‑performance data‑center infrastructure (IBM pages 3‑7). Qualcomm, by contrast, is embedding edge‑based generative‑AI directly into its Snapdragon SoCs—using a CPU‑GPU‑NPU stack that delivers high‑performance inference at very low power—and is also pursuing a cloud‑computing processing initiative to enable seamless cloud‑edge integration (QCOM pages 5‑9, 80‑84). Thus, IBM’s commercialization is cloud‑centric and enterprise‑focused, while Qualcomm’s is hardware‑centric, targeting low‑power edge devices and hybrid cloud‑edge synergy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with strong qualitative and contextual accuracy. (1) All entities—IBM and QCOM (Qualcomm)—are correctly identified, and their respective strategies are accurately portrayed: IBM's focus on enterprise-level generative AI within hybrid cloud and developer ecosystems, and Qualcomm's edge-first approach via Snapdragon SoCs with low-power, high-performance AI. (2) Quantitative accuracy is perfect: while the LLM answer does not include the specific projection that '46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024,' this is the only omission. All other numerical or metric references (e.g., cloud-edge integration, low-power inference) are consistent with the original, and no incorrect numbers are present. (3) Multi-hop reasoning is sound—the model correctly synthesizes IBM’s cloud-centric R&D focus and Qualcomm’s hardware-centric, edge-AI commercialization strategy, contrasting their approaches appropriately. (4) The omission of the smartphone adoption projection slightly reduces completeness, which prevents a 9–10 on correctness and qualitative accuracy, but the core strategic comparison is fully intact and well-articulated. Wording differs but meaning is equivalent. Contextual relevance is excellent as all parts of the question are addressed except the specific forward-looking metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 391,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s nuclear‑decommissioning risk is largely a funding‑balance risk: the value of its NDTF trust assets can fall with market volatility, forcing the company to post additional capital to meet decommissioning obligations (see page 35).  NextEra faces a similar market‑performance risk for its own decommissioning funds, but it offsets it with a layered risk‑management strategy—private liability insurance, participation in a secondary financial protection system, and broader nuclear‑generation controls—so that a decline in trust‑asset values does not automatically translate into a funding shortfall.  In short, Duke’s exposure is more directly tied to market‑driven trust values, whereas NextEra combines that exposure with insurance and regulatory safeguards to spread and limit the financial impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and NextEra Energy face market-related risks to their nuclear decommissioning trust funds due to reliance on investment performance. The LLM correctly identifies that Duke Energy's exposure is more direct, with potential need for additional capital if trust values decline. For NextEra, it accurately adds that the company employs risk-mitigation strategies such as insurance and participation in secondary financial protection systems, which are not mentioned in the original answer but are consistent with typical industry practices and enhance the comparative analysis without contradicting the ground truth. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative—so quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model synthesizes information across both companies, compares their risk exposures, and draws a logical conclusion about differences in financial risk management approaches. The mention of 'page 35' suggests sourcing from a document, which may be accurate in context, though not verifiable here. (4) Semantic equivalence is strong: while the LLM provides a more detailed contrast (e.g., 'layered risk-management strategy'), this elaboration is reasonable and consistent with the original answer’s core message—that both firms face market-linked risks, but NextEra has additional safeguards. The only reason for not scoring a 10 is that the original answer does not explicitly confirm the extent of NextEra’s insurance and regulatory safeguards, so some inference beyond the ground truth is present, though plausible. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 494,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT applies ASU 2020‑04 by using a match‑funding policy that aligns its debt and receivables, designating fixed‑to‑floating interest‑rate swaps as fair‑value hedges and floating‑to‑fixed swaps as cash‑flow hedges, and also employing commodity forwards and foreign‑currency forwards/options; it transitioned all affected debt to SOFR by December 31 2023 without using the optional expedients. UPS likewise transitioned its reference‑rate‑dependent contracts to SOFR by the end of 2023 and will assess impacts in 2024, but its 10‑K does not disclose a specific hedging policy or the types of derivatives it uses. Both companies chose not to elect the practical expedients under Topic 848 for their transitions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that CAT transitioned all affected debt to SOFR by December 31, 2023, and did not use optional expedients—this contradicts the ground truth, which states that CAT *did* apply the optional expedients under ASU 2020-04 through December 31, 2024. Conversely, the LLM claims UPS did not use the expedients, which aligns with the original answer, but incorrectly implies CAT also did not use them. Additionally, the LLM introduces a 'match-funding policy' and 'commodity forwards' for CAT, which are not mentioned in the ground truth. It also claims CAT used interest-rate swaps (fixed-to-floating as fair value hedges, etc.), which is absent from the original answer—CAT’s documentation focuses on foreign currency forwards and options for cash flow hedges, not interest rate swaps. (2) Quantitatively, the date for CAT’s application of expedients is wrong: ground truth specifies relief through December 31, 2024, but LLM says CAT completed transition by December 31, 2023—this misrepresents the timeline and strategic use of extended relief. UPS’s December 31, 2023 transition date is correct. (3) The multi-hop reasoning is flawed: the question asks for a comparison of hedging strategies and transition timelines under ASU 2020-04. The LLM fails to correctly contrast CAT’s use of expedients versus UPS’s non-use; instead, it falsely claims both did not elect expedients, undermining the core comparison. It also fabricates hedging instruments and policies not present in the source. (4) Contextual relevance is moderate—the structure addresses the right companies and topic (ASU 2020-04, SOFR transition, hedging), but the factual inaccuracies and invented details severely reduce correctness. The conclusion that both did not elect expedients is directly contradicted by the ground truth, which states CAT did use them. Thus, the answer is mostly incorrect despite addressing the general subject area.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 538,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos is an equity‑method VIE in which it has no voting rights and only limited consent rights (page 85), so it has no power to direct Atairos’s operations. Alphabet, by contrast, uses a dual‑class structure in which Class B shares carry ten votes each while Class A and Class C shares are largely non‑voting (page 82). Alphabet’s large repurchase of Class A and Class C shares—about $62 billion in 2024—shrinks the overall share base and concentrates voting power in the hands of Class B holders, giving them effective control over the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Comcast has no voting rights in Atairos, only consent rights, and lacks control despite a $1.4 billion unfunded commitment (implied contextually, though the exact figure is omitted). Alphabet’s dual-class structure is accurately described, with Class B shares having 10 votes and Classes A and C being non-voting or low-voting. The $62 billion share repurchase in 2024 for Classes A and C is correctly stated. (2) Quantitative accuracy is perfect: the $62 billion repurchase amount and the 10-to-1 voting ratio are correct. The only minor omission is the explicit mention of Comcast’s $1.4 billion unfunded commitment, which was present in the original answer and adds context about the scale of investment without control. (3) Reasoning is sound: the LLM correctly contrasts Comcast’s lack of control in Atairos with Alphabet’s maintained control via dual-class shares, and explains how repurchases of non-voting shares concentrate voting power. (4) The answer is semantically equivalent to the original, with only slight compression of detail. The omission of the $1.4B commitment slightly reduces completeness but does not impair the core comparative insight. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 384,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 extension keeps the optional relief available through December 31 2024. UPS completed its transition to SOFR on December 31 2023, so the extension simply confirms that its debt has already been re‑priced and no further action is required. FedEx, however, has not yet transitioned all of its LIBOR‑referenced contracts and continues to monitor them through May 31 2024, with the extension giving it until the end of 2024 to finish the transition.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of dates and key facts: ASU 2022-06 extends relief to December 31, 2024; UPS transitioned to SOFR by December 31, 2023; FedEx continued monitoring through May 31, 2024. These quantitative elements are accurate, earning a high score on quantitative accuracy. However, the LLM omits key qualitative details from the ground truth: UPS did not elect Topic 848 practical expedients and was still assessing residual impacts through 2024, while FedEx had not experienced any material effect and was evaluating whether to apply the expedients. The LLM incorrectly implies that FedEx must 'finish the transition' by end of 2024, whereas the ground truth states FedEx was still monitoring and had not necessarily begun transitioning. This misrepresents the nature of FedEx's actions and the optional, non-mandatory character of the relief. The reasoning is partially sound but lacks full synthesis of the nuanced positions of both companies regarding the optional expedients. Contextual relevance is high as it directly addresses the impact of the extension on both companies’ timelines. Semantic equivalence is mostly preserved but with notable omissions in depth and precision of accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 344,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s 2023 beverage revenue from its Africa, Middle East and South Asia (AMESA) division represented 29 % of that segment’s net revenue, underscoring a sizable international exposure (page 72). In contrast, Target’s 10‑K notes state that “nearly all of our revenues are generated in the United States” and that its merchandise sales, which include beverages, are domestic‑only (page 46). Thus, while PepsiCo has a significant non‑U.S. beverage concentration, Target’s beverage sales are confined entirely to the U.S. market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, the 29% beverage revenue concentration for PepsiCo in the AMESA region in 2023 is correctly stated, matching the original answer. The reference to Target’s 'nearly all of our revenues are generated in the United States' from page 46 of its 10-K is accurate and contextually appropriate, effectively supporting the conclusion of domestic-only beverage sales. (2) The answer is complete, addressing both PepsiCo’s international revenue exposure and Target’s lack of international beverage sales, directly responding to the comparative aspect of the question. (3) Entity accuracy is correct: PepsiCo, Target, AMESA region, 2023 fiscal year, and the relevant financial segments (beverage revenue, merchandise/grocery sales) are all properly identified. (4) The multi-hop reasoning is sound—LLM correctly synthesizes information from two different 10-K filings, compares geographic revenue exposures, and draws a valid contrast between PepsiCo’s international footprint and Target’s domestic focus. The inclusion of document page numbers (72 for PepsiCo, 46 for Target) adds verifiability and strengthens contextual grounding. (5) The semantic meaning fully matches the original answer, with slightly more precise sourcing but no deviation in substance. Minor wording differences (e.g., 'nearly all' vs 'entirely') do not affect correctness, as 'nearly all' is conservatively accurate and consistent with Target’s disclosure. Overall, the answer is excellent in correctness, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 435,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "SCHW’s minimum capital requirement is lower because it does not include a counter‑cyclical buffer, whereas Goldman Sachs’s TLAC‑to‑RWAs requirement is 22.0 % of RWAs and is calculated with a counter‑cyclical buffer (set to zero) plus the 18 % minimum, 2.5 % buffer and 1.5 % G‑SIB surcharge【page_93】. Thus, the absence of a counter‑cyclical buffer means SCHW’s regulatory minimum is less than GS’s TLAC‑to‑RWAs threshold, even though both firms face multi‑layered buffers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that SCHW does not include a Countercyclical Capital Buffer (CCyB), which was set to zero, and that GS's TLAC requirement includes multiple layers: 18% minimum, 2.5% buffer, 1.5% G-SIB surcharge, and CCyB (also zero). However, the LLM states GS’s TLAC-to-RWAs requirement is '22.0%'—this is incorrect. The correct total is 18% + 2.5% + 1.5% + 0% (CCyB) = 22.0%, so the final number is accidentally correct, but the reasoning is flawed because it implies the 22.0% is a fixed requirement without clarifying that it is the sum of components. The original answer does not state a single total for GS, but the components add up correctly. For SCHW, the LLM fails to specify the actual capital ratios (7.0% CET1, 8.5% Tier 1, 10.5% Total), which are critical to the ground truth and missing in the response. (2) Quantitative accuracy is partially correct: the 22.0% total for GS is numerically accurate as a sum (18 + 2.5 + 1.5 = 22), but the LLM presents it as a pre-defined threshold rather than a derived total, which misrepresents the structure. The absence of SCHW’s specific ratios reduces completeness. (3) The multi-hop reasoning is sound in comparing layered buffers and recognizing that both firms face multiple requirements, with GS having a higher baseline due to systemic importance. The synthesis across regulatory frameworks (SCHW’s capital ratios vs GS’s TLAC) is conceptually appropriate. (4) Scores reflect that core facts are present and the conclusion (GS has higher requirements) is valid, but key quantitative details for SCHW are missing and the presentation of GS’s 22.0% lacks proper breakdown context, reducing full factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 463,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement from Georgia Power (page 189) is a cost‑sharing payment under the Vogtle Joint Ownership Agreement, showing that Dalton is a self‑owned stakeholder in Plant Vogtle Units 3 and 4 and bears a share of construction expenses.  In contrast, NextEra Energy’s model (page 19) relies on long‑term PPAs that lock in revenue for 94 % of its net generating capacity, so its income comes mainly from contractual sales rather than from joint‑ownership cost sharing of individual plants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power for Plant Vogtle construction, reflecting its cost-sharing ownership stake; NEE generates revenue from long-term contracts covering 94% of its capacity. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies both entities (Dalton and NextEra Energy), the financial arrangements (joint ownership vs. PPAs), and the strategic contrast in generation models. (3) The multi-hop reasoning is sound—linking Dalton’s reimbursement to its ownership model and contrasting it with NEE’s revenue-focused contractual strategy. (4) While the LLM omits some contextual nuance (e.g., that Dalton uses self-owned assets to meet its own load needs, while NEE monetizes in competitive markets), the essential contrast in business models is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. No calculation errors. Minor deduction in qualitative accuracy due to slightly less detailed explanation of strategic intent compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 335,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX relies on a liquidity‑focused strategy, maintaining a $7.0 billion credit facility to fund working capital and customer‑financing obligations (RTX, 2022, p. 52‑54).  By contrast, BA finances its customers through long‑term lease structures—sales‑type/finance leases and operating leases—recording $944 million of lease receivables and $412 million of notes receivable and recognizing lease income over the lease term (BA, 2022, p. 93; p. 80‑78).  Thus, RTX uses a credit line as a general liquidity tool, whereas BA generates revenue and balance‑sheet exposure directly from lease‑based financing arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: RTX's $7.0 billion credit facility is accurately cited, and BA's $944 million in lease receivables and $412 million in notes receivable match the source data (BA, 2022). These figures support the qualitative contrast between RTX’s liquidity buffer and BA’s direct financing exposure. Minor citation formatting issues (e.g., 'p. 80-78' likely meant 'pp. 78–80') do not affect factual accuracy. (2) The answer addresses both parts of the multi-hop question: RTX’s use of credit facilities and BA’s lease-based structures. It correctly identifies that RTX uses its credit line for flexibility in customer financing, avoiding reliance on short-term debt, while BA employs long-term leases (sales-type/finance and operating) that generate receivables and recognized income over time. (3) Entity accuracy is strong: RTX and BA are correctly identified, with appropriate reference to their respective financial instruments and reporting years (2022). (4) The reasoning is sound and synthesizes across both companies’ strategies, highlighting the core difference—RTX’s off-balance-sheet liquidity tool vs. BA’s on-balance-sheet lease financing that creates revenue and liabilities. The only minor omission is a lack of detail on lease terms (1–12 years, extend/terminate options) mentioned in the ground truth, which slightly reduces completeness but does not undermine the central accuracy. Overall, the answer conveys semantic equivalence with precise, relevant, and correctly interpreted data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 438,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s weighted‑average assumptions are applied to its equity‑compensation calculations – the Black‑Scholes‑Merton model for stock options (dividend yield, volatility, risk‑free rate, term) and the fair‑value and exercise‑price averages for performance share units and restricted‑stock units, plus a 1.7‑year weighted‑average period for unrecognised compensation cost.  \nPhilip Morris, by contrast, uses weighted‑average assumptions in its defined‑benefit pension and post‑retirement plans – actuarial discount rates (service and interest cost), compensation‑increase rates, interest‑crediting rates and health‑care cost‑trend rates – to compute pension and post‑retirement benefit costs. Thus, Coca‑Cola’s weighted‑average inputs are market‑based equity‑valuation metrics, while Philip Morris’s are actuarial inputs for pension and health‑care cost estimation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core distinction as the ground truth: Coca-Cola applies weighted-average assumptions to equity-based compensation (specifically stock options using Black-Scholes-Merton and other equity awards), while Philip Morris uses them for pension and postretirement benefit cost calculations. The LLM adds more granular detail (e.g., dividend yield, volatility, risk-free rate, term for Coca-Cola; actuarial rates like discount, compensation increase, healthcare trend for Philip Morris) that aligns with typical SEC filing disclosures and enhances the response without introducing errors. The mention of a '1.7-year weighted-average period for unrecognised compensation cost' is plausible and consistent with ASC 718 disclosures, though not explicitly in the ground truth; however, it does not contradict it and fits contextually. No specific dates (e.g., 2023, 2022, 2021) are mentioned in the LLM answer, which is a minor omission from the original, but the core multi-hop reasoning—contrasting the application domains (equity vs. pensions) across the two firms—is sound and correctly synthesized. All entities (Coca-Cola, Philip Morris, Black-Scholes-Merton, pension plans) are accurate. Wording differs but semantic meaning matches. Quantitative accuracy is high; no incorrect numbers are presented, and the 1.7-year figure, while not in the original, is reasonable and not contradicted by it. The answer is contextually relevant, directly addressing the comparative use of weighted-average assumptions in financial reporting frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 433,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia family is slated to lose U.S. market exclusivity in May 2026 (Janumet XR in July 2026)【page_58】, whereas Gilead’s key product’s U.S. regulatory exclusivity is set to expire in 2032【page_9】. The six‑year gap gives Gilead a longer period of protection against generic entry, helping it sustain pricing and market share, while Merck will likely face earlier generic competition that could erode its sales and competitive position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family: May 2026 for Januvia and Janumet, and July 2026 for Janumet XR. It accurately states that Gilead's U.S. regulatory exclusivity expires in 2032. There is a minor inversion in the parenthetical, stating 'Janumet XR in July 2026' as if that were the only or primary product expiring then, while the ground truth specifies Januvia and Janumet expire in May 2026 and Janumet XR in July 2026. The LLM answer implies Januvia expires in May and Janumet XR in July but omits explicit mention of Janumet (non-XR) in May, which slightly reduces completeness. (2) Quantitatively, all dates are correct: May 2026, July 2026, and 2032. The six-year gap (from 2026 to 2032) is approximately accurate and reasonable for high-level comparison. No calculations are required beyond this temporal comparison, and the LLM handles it correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes that earlier exclusivity loss for Merck leads to earlier generic competition, while Gilead’s longer protection supports sustained market position and pricing power. The impact on market positions is logically derived from the role of regulatory exclusivity in delaying generics, as stated in the ground truth. (4) The answer is contextually fully relevant, addressing both the timeline comparison and the strategic impact on market positions. The only minor shortcoming is the slightly imprecise presentation of which products expire when, which prevents a perfect 10 but does not undermine the core correctness. Thus, correctness is scored 9, with high marks across all other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 465,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel recorded $1.283 billion of amortization expense for its “developed technology” intangible assets in 2021 (cost of sales) — a single, straight‑line expense item.  By contrast, Cisco recognizes revenue from its cloud‑security SaaS offerings ratably over the contract term, spreading revenue over the life of the agreement rather than recognizing it all at once.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the $1.283 billion amortization expense for Intel in 2021 is correct and matches the ground truth ($1,283 million). The format variation (billion vs. million) is acceptable and numerically equivalent. (2) The statement about Cisco recognizing revenue ratably over the contract term is factually correct and aligns with the original answer. (3) The multi-hop reasoning is sound: the model correctly contrasts Intel’s cost recognition (amortization of developed technology) with Cisco’s revenue recognition pattern for cloud security offerings. (4) Minor omission: the LLM does not mention the 9-year weighted average useful life for Intel’s amortization, which adds context to the cost structure. Also, it does not explicitly link Intel’s developed technology to cybersecurity solutions, though it references 'developed technology' generally. These omissions reduce completeness slightly but do not undermine the core correctness. Wording differs but maintains semantic equivalence. All entities (Intel, Cisco, 2021, amortization, revenue recognition, cloud security) are correctly identified and used in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 343,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "By adopting ASU 2022‑02, MetLife eliminated the TDR framework and now reports all borrower‑concession modifications as financial‑difficulty modifications (FDMs).  For 2023 the company disclosed $136 million in FDMs—primarily term extensions and interest‑rate reductions that extended the weighted‑average life by 20 years and lowered the average rate from 7.21 % to 4.44 % (MetLife, 2023 10‑K, p. 168)—with no additional lending commitments.  In contrast, JPMorgan’s legacy TDR reporting (2022–2021) recorded $362 million and $866 million in TDRs, respectively, involving larger principal deferrals, forgiveness, and redefaults, and reduced rates from 4.75 % to 3.35 % while extending terms from 22 to 38 years (JPMorgan, 2023 10‑K, p. 245).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors in quantitative accuracy, particularly misattributing financial data. (1) The $136 million in FDMs and associated metrics (20-year extension, rate drop from 7.21% to 4.44%) are incorrectly attributed to MetLife (MET), but in the ground truth, these figures belong to JPM in 2023. MET’s actual FDM disclosures are not quantified in the original answer, only noting no material impact. (2) The LLM claims MetLife disclosed $136M in FDMs with specific rate and term changes, which is false—this data is from JPM’s 2023 FDM reporting. (3) The LLM incorrectly states JPM’s legacy TDRs reduced rates from 4.75% to 3.35% and extended terms from 22 to 38 years; the ground truth does not include these numbers for JPM’s TDRs—only that modifications included interest rate reductions, term extensions, and payment delays, with $362M in 2022. (4) The LLM introduces data for 2021 ($866M TDRs) not mentioned in the original answer, adding unsupported information. (5) Entity accuracy is partially correct: MET and JPM are correctly identified, and ASU 2022-02 adoption is correctly noted for MET in 2023. However, the misattribution of JPM’s FDM data to MET undermines the core of the multi-hop comparison. (6) Reasoning is structurally sound—comparing pre- and post-ASU frameworks—but flawed due to incorrect data mapping. (7) Contextual relevance is high as the response addresses loan modification types and financial impacts for both firms under respective standards. Overall, the answer fails on key factual accuracy despite correct conceptual framing, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 444,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX’s upstream position in South America is a specific reserve base – about 95 BCF of natural‑gas proved reserves in 2020 (CVX 10‑K, page 108 footnote). By contrast, ExxonMobil’s downstream footprint is measured by its operational reach: a large, integrated network of refining, marketing and distribution facilities that spans the entire Americas (XOM 10‑K, page 61). Thus, CVX’s position is quantified by reserve quantity, while XOM’s footprint is defined by the breadth of its downstream activities across the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It states CVX had 95 BCF of natural gas reserves in South America in 2020, while the ground truth reports 329 BCF as of December 31, 2022. This is a major discrepancy in both quantity and year. The use of 2020 data instead of 2022 undermines temporal accuracy, and the number itself is less than one-third of the correct value. (2) The LLM cites a specific source (CVX 10-K, page 108 footnote), but this does not align with the ground truth data, suggesting either incorrect sourcing or misinterpretation. The XOM portion is more accurate in describing its downstream footprint as an integrated network across the Americas, citing the correct type of operations (refining, marketing, distribution), though it lacks specific supporting metrics. (3) The reasoning correctly identifies the conceptual contrast between CVX's upstream focus (reserves-based) and XOM's downstream footprint (operations-based), which shows sound qualitative understanding of the energy value chain and multi-hop comparison. However, the failure to use correct numbers and the outdated year weaken the synthesis. (4) Contextual relevance is high because the answer frames the comparison appropriately and addresses both companies' strategic positions. Still, the quantitative inaccuracy severely limits correctness, warranting a low-to-mid score. The answer is directionally correct but factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 411,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s commercial paper exposure is only **$25 million**, a modest portion of its overall debt that is part of a short‑term program with a weighted‑average maturity of **23 days** (page 163). In contrast, Tesla holds **$470 million** in commercial paper, a large share of its short‑term investment portfolio used to fund working‑capital needs and invest excess cash (page 72). Thus, Duke Energy Ohio relies on a small, quickly maturing commercial paper tool for liquidity, whereas Tesla uses a much larger commercial paper position as a core short‑term liquidity strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $25 million commercial paper exposure for Duke Energy Ohio and Tesla's $470 million holdings, matching the ground truth exactly in amount and direction. These figures are accurately cited and reflect the correct entities. 2) Quantitatively, all numbers are correct: $25 million and $470 million are precise, and the additional detail about Duke Energy’s 23-day weighted-average maturity (while not in the original answer) does not contradict it and may come from the source document (page 163). However, this extra detail is not independently verifiable from the ground truth provided, but does not harm accuracy. 3) The reasoning correctly contrasts Duke Energy’s use of commercial paper as a short-term liability (financing) versus Tesla’s use as an investment (cash deployment). However, the LLM slightly mischaracterizes Tesla’s position by stating it is used 'to fund working-capital needs'—this contradicts the ground truth, which clarifies Tesla holds commercial paper as an investment of excess cash, not to fund operations. The original answer emphasizes Tesla’s use as a cash deployment strategy for returns, not funding needs. This is a meaningful qualitative distinction in financial interpretation. 4) Despite this, the core multi-hop comparison—contrasting Duke Energy’s liability-driven use with Tesla’s investment-driven use—is present and logically sound. The answer remains highly relevant and factually grounded, with only a minor misstatement in motivation for Tesla’s strategy. Hence, high scores across the board with a slight deduction in qualitative accuracy and overall correctness for the misattribution of Tesla’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 459,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "META’s Class A common stock carries only one vote per share, giving ordinary shareholders limited influence, while Alphabet’s Class B common stock carries ten votes per share, giving those holders far greater voting power—ten times that of a single META Class A share—concentrating control in the hands of the founders and insiders in both companies.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core voting structure differences: META Class A has 1 vote per share, GOOGL Class B has 10 votes per share, and both concentrate control among insiders. Quantitatively, the numbers are accurate—1 vote vs. 10 votes per share—as confirmed in the ground truth. However, the LLM omits key details from the original answer that affect completeness and qualitative accuracy: (1) it does not mention Mark Zuckerberg’s specific control threshold (Class B requiring majority approval until below 35% voting power), (2) it fails to note the automatic conversion of GOOGL Class B to Class A upon sale or transfer, a critical feature of the dual-class mechanism, and (3) while not required, the reference to CMCSA in the ground truth provides comparative context that the LLM answer lacks. The reasoning is sound in comparing voting power concentration but misses multi-hop synthesis involving structural safeguards and conversion rules. The answer remains contextually relevant and factually correct on the main point—voting power disparity—but lacks depth in explaining the full governance implications. Wording differences are acceptable under semantic equivalence, but omissions reduce completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 343,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s charter (page 16) lists B‑class shares as “non‑voting Dividend rights,” meaning the company may treat B‑share dividends differently or subject them to board discretion, so B holders can receive a different payout than voting A holders and shareholder returns may diverge. In contrast, Schwab’s 2024 filing (page 66) states that voting and non‑voting shares have identical participation, dividend, and liquidation rights, so both classes receive the same dividends and their returns remain aligned.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in interpreting Mastercard's dividend structure. While the Original Answer (ground truth) states that Mastercard's A Class (voting) and B Class (non-voting) shares have equal dividend rights, the LLM incorrectly claims that B-class shares may receive different dividends or are subject to board discretion based on the phrase 'non-voting Dividend rights'—this misreads the document. The term 'non-voting' modifies voting rights, not dividend rights, and the ground truth confirms dividend parity exists at Mastercard. This undermines the core reasoning: the LLM suggests divergence in shareholder returns at Mastercard, which contradicts the ground truth that both share classes have equal dividend treatment. In contrast, the assessment of Charles Schwab is accurate—dividend rights are indeed identical across share classes, as correctly cited from page 66 of its 2024 filing. There are no numerical values to verify, so quantitative accuracy is unaffected. However, the qualitative error in reasoning and entity-specific interpretation (especially mischaracterizing Mastercard’s dividend policy) severely impacts correctness. The answer is contextually relevant and addresses both companies and the alignment question, but the flawed multi-hop comparison—due to incorrect synthesis of Mastercard’s structure—leads to an incorrect conclusion about relative alignment strength. Thus, while some facts are right (Schwab’s policy), the central comparative claim is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 416,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft (pages 47‑49) states that the OECD Pillar Two minimum‑tax rules, effective FY 2025, are not expected to materially affect its consolidated financial statements or effective tax rate, and it will simply monitor implementation. Oracle (pages 29‑31 and 73‑77) notes that the same 15 % global minimum tax could materially increase its international tax costs, potentially raising its effective tax rate. Thus, while Microsoft anticipates little impact, Oracle expects a higher effective tax rate under the new regime.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft expects no material impact on its effective tax rate or financial statements from the OECD Pillar Two rules, while Oracle explicitly states potential material increases in international tax costs and its effective tax rate. The 15% global minimum tax rate is correctly cited. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates; the reference to FY 2025 implementation (though not in the original answer) is consistent with public disclosures and does not contradict the ground truth. (3) Multi-hop reasoning is sound—correctly contrasting Microsoft’s and Oracle’s differing exposures based on their international tax structures, even if not detailing the exact cause (i.e., concentration in low-tax jurisdictions). The LLM cites specific page ranges, enhancing credibility. (4) The only minor shortcoming is the lack of explicit mention of the underlying reason (geographic footprint differences), which is in the original answer and would strengthen the explanation. However, the conclusion about divergent impacts is still clearly and correctly conveyed. Semantic equivalence is maintained, and the answer fully addresses the comparative impact on effective tax rates as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 368,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM’s 10‑K (page 63) outlines the fair‑value hierarchy and states that when quoted prices are unavailable it relies on pricing models that use observable inputs (e.g., market‑based yields, spreads and bid‑ask quotes), but it does not disclose any Level 3 assets. In contrast, Lowe’s 10‑K (page 53) explicitly classifies performance‑based contingent consideration as a Level 3 investment and values it with an income approach using an option‑pricing model that incorporates significant unobservable inputs such as total equity value, volatility and expected term. Thus, Lowe applies Level 3 with unobservable inputs and a specific valuation methodology, whereas GM’s Level 3 use is either absent or limited to observable‑input models.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but includes a significant factual error that undermines its overall accuracy. While it correctly identifies that LOW uses Level 3 valuation for performance-based contingent consideration from the sale of its Canadian retail business (fiscal 2022), and accurately describes the unobservable inputs (total equity value, volatility, expected term) and the income/option-pricing approach, it incorrectly states that GM does not disclose any Level 3 assets. This contradicts the ground truth, which confirms GM applies Level 3 techniques to marketable debt securities and finance receivables using pricing and discounted cash flow models with macroeconomic unobservable inputs such as unemployment rates, interest rate spreads, disposable personal income, and GDP growth. The LLM’s claim that GM relies only on observable inputs or lacks Level 3 disclosures is factually incorrect—GM does report Level 3 assets, though the LLM may have misinterpreted the 10-K. Quantitatively, no specific numbers are misstated (hence a higher quantitative score), but the qualitative reasoning fails on multi-hop synthesis: it does not correctly compare GM’s broad use of Level 3 across financial instruments with macro assumptions versus LOW’s narrow, event-specific application. The contextual relevance is fair because it addresses the core question about differences in Level 3 application, but the erroneous denial of GM’s Level 3 usage severely limits correctness. Semantic equivalence is not achieved due to this key omission and misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 433,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each, giving holders roughly one‑third of the company’s voting power (≈33 % of total votes) (page 91). Because Class B shares are convertible share‑for‑share into Class A shares, converting them would shift voting power from the high‑vote B class to the low‑vote A class, diluting the voting influence of existing A shareholders (page 81). Alphabet’s aggressive repurchase of its own Class A and Class C shares—$50–$62 billion in 2021‑23 and an additional $70 billion authorized—reduces the number of outstanding A shares, potentially raising their value and thereby affecting the attractiveness of converting CMCSA’s Class B shares into Class A shares.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core structure of CMCSA's share classes and voting rights correctly: Class B has 15 votes per share and holds approximately one-third of voting power. It also correctly notes that Class B shares are convertible share-for-share into Class A, which would dilute the voting power of existing Class A shareholders. The mention of Alphabet's share repurchases affecting the value and attractiveness of Class A shares is contextually relevant. However, key quantitative inaccuracies undermine the correctness. 2) Quantitative inaccuracies: The LLM states Alphabet spent '$50–$62 billion in 2021-23' and had '$70 billion authorized', but the ground truth specifies $62.2 billion spent in 2023 alone and $36.3 billion remaining authorization as of year-end. The LLM conflates multiple years and misrepresents both the amount spent and the remaining authorization. These are significant deviations. 3) The multi-hop reasoning is partially sound: the model connects CMCSA’s internal share conversion dynamics with Alphabet’s external repurchase strategy, suggesting that reduced supply of GOOGL Class A shares could influence the relative attractiveness of holding or converting into CMCSA Class A shares. This synthesis is plausible and relevant. However, it misses the key point from the original answer that Alphabet’s repurchases concentrate ownership and influence—especially among voting shareholders—which could indirectly affect comparative governance dynamics. 4) The contextual relevance is high because the answer addresses both companies, the correct share classes, and the interplay between voting power and share value. The qualitative reasoning is logical but incomplete. Due to major errors in dollar figures and timeframes, and omission of the non-dilutable voting control clause in CMCSA’s charter, the correctness score is reduced to 6. Minor phrasing differences are acceptable, but factual precision on financial figures is critical and lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 532,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "The MDLZ 10‑K excerpts you provided do not contain a figure for “securities remaining available for future issuance under equity‑compensation plans.”  Colgate‑Palmolive, by contrast, reports 37,028 thousand such securities (page 61).  Because MDLZ’s number is not disclosed in the supplied pages, the difference cannot be calculated from these excerpts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is mostly incorrect and fails to match the ground truth. (1) It claims that MDLZ's number is not disclosed in the provided excerpts, but the original answer (ground truth) states that MDLZ reported 48,932,017 securities available for future issuance—this information is assumed to be present in the actual 10-K filing data the model was expected to access. The LLM incorrectly concludes that the difference cannot be calculated due to missing data, when in fact the data exists in the knowledge base. (2) Quantitatively, the LLM only correctly reports CL's figure as 37,028 thousand (i.e., 37,028,000), which matches the ground truth. However, it fails to provide MDLZ's correct figure of 48,932,017 and thus cannot compute the correct difference of 11,904,017. (3) The multi-hop reasoning is flawed: the model should have retrieved both companies' figures from their respective 2022 10-Ks and computed the difference. Instead, it prematurely concludes insufficiency of data without attempting cross-document synthesis. (4) Contextually, the response is relevant to the question and interprets the metric correctly, but its failure to access or report the MDLZ number severely undermines correctness. The answer would only be acceptable if the data were truly unavailable, but per the ground truth, it is available. Thus, the correctness score is very low due to factual incompleteness and incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 392,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "ComEd’s Illinois Clean Energy Law forces the utility to file a new rate case or four‑year plan, add a rider to recover costs for CMC procurement, and adopt decoupling and performance‑metric provisions that reshape its transmission‑rate structure and raise its revenue requirements (see pages 218‑219).  Tesla, by contrast, faces state‑level restrictions that may bar or limit its direct‑to‑consumer sales, require dealer‑license approvals, and expose it to litigation and uncertain regulatory outcomes that could curtail market access and revenue (see page 27).  Thus, ComEd’s impact is a regulatory‑mandated adjustment to its rate‑setting process, while Tesla’s exposure is a broader market‑access limitation that could directly reduce sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative description of both ComEd's and Tesla's regulatory environments, with no incorrect numbers or entities, earning a high quantitative accuracy score. There are no explicit numerical values (e.g., 11.50% ROE, 50-basis-point adder, 39.5-year amortization) mentioned in the LLM answer, but since the ground truth includes them and the LLM omits rather than misstates, this is a completeness issue rather than a quantitative error. The LLM correctly identifies the core regulatory mechanisms: ComEd’s requirement to file a new four-year plan and adopt performance-based provisions, and Tesla’s direct-sales restrictions affecting market access. However, it omits key details from the ground truth—specifically, the impact on ComEd’s unprotected excess deferred income taxes, the current ROE structure with incentive adder, and the distinction that ComEd’s risks are embedded in cost recovery and capital structure while Tesla’s affect go-to-market strategy. These omissions reduce completeness and weaken the multi-hop synthesis, particularly in comparing the *nature* and *financial implications* of the regulatory risks. The reasoning is sound but less nuanced than the original, and the semantic equivalence is partial—core ideas are preserved, but depth and precision are reduced. Contextual relevance is high, as the response directly addresses the comparison asked. Thus, the correctness score is 7: core facts are correct, but important contextual and comparative details are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 421,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Part D redesign will increase gross‑to‑net (GTN) rebate accruals for both companies because manufacturers must now provide discounts and accept price caps that reduce gross sales and raise net rebates.  For Amgen, the lower Medicare Part D price set for ENBREL (page 36) and the mandatory discount requirement will heighten regulatory exposure and push up its GTN accruals, impacting earnings.  For Bristol‑Myers Squibb, the same pricing rules will raise GTN accruals for its Part D‑dependent products, as the company’s GTN calculations are driven by payer‑channel mix and contract prices (pages 125‑126), shifting more rebate obligations onto the manufacturer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions affecting completeness. (1) All entities are correct: AMGN (Amgen), BMY (Bristol-Myers Squibb), ENBREL, Medicare Part D, GTN rebate accruals, payer channel mix, and contract prices are accurately referenced. The 2025 start date for IRA provisions is implied by context (no explicit mention, but not contradicted). (2) Quantitative accuracy is strong: no specific dollar amounts or percentages are misstated, and the logic around price caps and discounts reducing gross sales and increasing net rebates is correct. The reference to 'page 36' and 'pages 125-126' suggests document-based support, though not required for correctness. (3) Multi-hop reasoning is sound: the model correctly links the IRA redesign to increased GTN accruals for both firms, connects AMGN’s exposure to ENBREL’s set price and regulatory impact, and ties BMY’s accounting methodology (payer mix and contract pricing) to heightened rebate liabilities under the new rules. (4) The only minor gap is that the original answer includes forward-looking elements—AMGN’s Otezla possibly being subject to 2027 price setting and the explicit mention of catastrophic phase cost shifts for BMY—which the LLM omits. These are important contextual details but do not undermine the core correctness. Overall, the response captures the primary financial and regulatory impacts accurately and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 404,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG classifies its ABS and CLO holdings as available‑for‑sale securities and measures them at fair value with a credit‑loss allowance that reduces the carrying amount; unrealized gains and losses are recorded in OCI (net of policy‑related amounts and deferred taxes) and the allowance is adjusted through net realized gains or losses (see AIG 10‑K, p. 170 for the allowance and net realized figures and p. 169 for the fair‑value measurement of structured securities).  In contrast, MetLife also classifies these structured securities as available‑for‑sale and values them at fair value, but the excerpts do not disclose a credit‑loss allowance; instead it relies on a fair‑value hierarchy (Level 1‑3) and reports unrealized gains and losses in OCI (see MetLife 10‑K, p. 90 for the AFS classification, p. 92 for the ABS/CLO grouping, p. 93 for the valuation methodology, and p. 94 for the fair‑value hierarchy).  Consequently, AIG’s approach results in lower carrying amounts and a distinct earnings impact compared with MetLife’s more straightforward fair‑value reporting of ABS & CLO assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric values or calculations, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual errors in accounting treatments. The original answer states that AIG uses the effective yield method with amortized cost adjustments based on expected cash flows, while MET classifies ABS & CLO as available-for-sale (AFS) and measures them at fair value. In contrast, the LLM incorrectly claims that AIG classifies ABS and CLO as AFS and measures them at fair value with a credit-loss allowance. This contradicts the ground truth: AIG does not use fair value measurement for these securities but instead applies yield-based amortized cost adjustments. The LLM also introduces a 'credit-loss allowance' for AIG not mentioned in the original answer and misrepresents AIG’s methodology as fair-value-based, which fundamentally mischaracterizes its accounting treatment. Meanwhile, the description of MetLife’s approach aligns partially with the original—classifying as AFS and using fair value with Level 3 disclosures—but omits the key contrast in methodologies (yield recalibration vs. fair value). The reasoning is flawed because it fails to capture the core multi-hop distinction: AIG’s dynamic yield adjustment versus MET’s static fair value reporting. While the answer addresses the question's context and attempts comparison, the incorrect attribution of accounting methods undermines the conclusion about differing financial statement impacts. Thus, despite good contextual framing and citation attempts, the answer is substantially inaccurate in its core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 461,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s reserves tied to production‑sharing contracts were 7 % of its total proved reserves in 2021.  \nExxonMobil’s operational exposure in Nigeria is substantial, because Nigeria’s deep‑water offshore exploration and production is governed almost entirely by PSCs, meaning a large portion of ExxonMobil’s Africa operations are under PSCs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states Chevron's reserves tied to PSCs were 7% in 2021, while the ground truth reports 8%. This is a small deviation but still factually incorrect. (2) All other numerical references (e.g., year 2021) are accurate. There are no calculations required beyond reporting percentages, so the error is limited to this one percentage point. (3) The qualitative reasoning is sound: the model correctly identifies that Nigeria relies on PSCs for deepwater operations and links ExxonMobil’s structural exposure in Nigeria to PSCs, even if it doesn’t quantify XOM’s exposure or mention the 30-year contract structure (10-year exploration + 20-year production), which is a minor omission. The multi-hop synthesis—connecting Chevron’s global PSC reserve percentage with ExxonMobil’s operational framework in a PSC-dependent country—is logically coherent. (4) The answer remains contextually relevant and captures the core comparison: CVX provides a direct percentage of reserves under PSCs, while XOM’s exposure is operational and systemic in Nigeria. The missing detail about contract duration weakens completeness slightly, but the central insight stands. Hence, correctness is reduced primarily due to the incorrect percentage, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 366,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan sets aside a fixed 49.0 million shares for future awards, creating a capped but predictable equity pool for long‑term incentives【page_83】.  In contrast, Home Depot’s stock‑appreciation‑right program uses a forfeiture‑adjusted vesting methodology, so the number of shares that ultimately vest is reduced by actual forfeitures, giving the company greater flexibility to adjust the equity supply over time【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated, and the description of HD's forfeiture-adjusted vesting methodology is factually sound. No calculations are required, and all numeric references are accurate. (2) The answer addresses both parts of the multi-hop question: Tesla’s fixed share reservation and HD’s flexible SAR approach based on forfeitures. (3) Entities are correct—Tesla, Home Depot (HD), the 2019 Plan, stock appreciation rights (SARs), and the relevant compensation methodologies are properly identified. (4) The reasoning correctly contrasts Tesla’s predictable, capped equity pool with HD’s dynamic, attrition-adjusted vesting, capturing the core distinction in long-term flexibility. The only minor shortcoming is a slightly less explicit articulation of the 'straight-line recognition' aspect mentioned in the original answer, but the forfeiture adjustment is clearly conveyed. Overall, the answer is semantically equivalent and demonstrates strong multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 315,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s stake in Tengizchevroil amounts to a $23.7 billion investment, and the company also carries a $4.5 billion loan to the affiliate for the FGP/WPMP development, giving a total exposure of roughly $28.2 billion.  By comparison, ExxonMobil’s long‑lived assets in Kazakhstan were reported at $8.5 billion in 2021, meaning Chevron’s exposure is about three‑times larger.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The claim that Chevron’s stake in Tengizchevroil is a $23.7 billion investment is not supported by the ground truth, which only states Chevron holds a 50% equity stake and provided a $4,500 million loan. There is no mention of a $23.7 billion investment in the original answer or implied in the data. The total exposure of $28.2 billion is therefore fabricated. The ExxonMobil figure is approximately correct ($8.5 billion vs. $8,463 million), though rounded. (2) Calculations are based on false premises: adding a $23.7 billion investment (unsupported) to a $4.5 billion loan results in an incorrect total exposure. The comparison stating Chevron’s exposure is three times larger than ExxonMobil’s is therefore invalid. The actual ground truth does not allow for a direct quantitative comparison of total exposure, as Chevron’s equity investment value is not disclosed. (3) The multi-hop reasoning is flawed. While the model correctly identifies the $4.5 billion loan and ExxonMobil’s asset value, it invents a large equity investment figure without basis. The original answer emphasizes differing forms of exposure—Chevron via equity and financing, ExxonMobil via long-lived assets—but does not quantify Chevron’s equity stake monetarily. The LLM fails to reflect this nuance and instead makes a misleading quantitative comparison. (4) Contextual relevance is high because the answer addresses the right companies, project, and geographic region, and attempts a comparative analysis. However, the qualitative and quantitative inaccuracies severely undermine correctness. The reasoning is structured appropriately but built on false data, leading to an incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 474,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable PPAs are negotiated as part of the decisions that drive the economic performance of its VIEs, and the company typically uses tax‑equity partners who capture the federal tax credits, so the cash‑flow benefit from those credits is indirect and limited to partnership terms [page_202, page_204]. In contrast, Southern Power’s wind PPAs are energy‑only (no capacity charge) and the company retains the production tax credits for the first 10 years of output, which are expected to be fully utilized by 2024 and provide a direct, material cash‑flow boost [page_96, page_97]. Thus, while Duke Energy relies on tax‑equity arrangements to finance its projects, Southern Power’s structure delivers a more immediate cash‑flow benefit from the PTCs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Southern Power's PTCs are expected to be fully utilized by 2024, and the $0.8 billion in unutilized PTCs at the end of 2021 is consistent with the original answer (though the dollar amount is not repeated in the LLM response, it is not contradicted and the timeline is accurate). The 10-year PTC window is correctly noted. (2) The LLM correctly identifies the structural differences: Duke Energy uses tax-equity partnerships where tax credits are captured by partners, leading to indirect cash flow benefits, while Southern Power retains PTCs and receives direct cash flow benefits through lease income from energy-only PPAs structured as operating leases. (3) Multi-hop reasoning is sound—LLM synthesizes information about PPA structures, tax credit utilization, and cash flow implications across two companies and their respective strategies. (4) The only minor omission is that the original answer specifies Southern Power’s PPAs are accounted for as operating leases with terms up to 25 years, which the LLM does not mention, slightly reducing completeness. However, the core comparison on cash flow and PTC utilization is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all parts of the question are addressed with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 394,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW’s ASR agreements are variable‑notional repurchase contracts with third‑party financial institutions; at settlement the company receives additional shares (and cash) from the institution, which are treated as treasury‑stock and forward‑purchase transactions. In contrast, Home Depot’s deferred share awards to non‑employee directors are part of its equity‑incentive plan; directors receive one share upon termination of service and accrue dividend equivalents that are paid out as additional shares when the underlying shares are paid out. Thus, LOW obtains shares from external parties as part of a repurchase program, while HD issues shares to internal directors as a compensation benefit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LOW receives additional shares from third-party institutions via variable-notional ASR agreements, which are tied to share repurchase efficiency, while HD issues additional shares to non-employee directors through dividend equivalents on deferred share awards, paid out upon termination. The distinction between external receipt (LOW) vs. internal issuance (HD) is correctly captured. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and HD), two financial mechanisms (ASR agreements vs. deferred share awards), and two contexts (repurchase programs vs. director compensation). The only minor shortcoming is that the LLM does not explicitly mention that HD's dividend equivalents 'accrue' over time—a nuance present in the original—but it does state they are 'paid out as additional shares when the underlying shares are paid out,' which implies accrual. (4) The answer is fully contextually relevant, directly addressing the comparison asked. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies—just a slight omission of 'accrual' detail—hence the 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 400,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing reported $125 million of equity income from its 50 % stake in United Launch Alliance (ULA) in 2024【page_42】. Lockheed Martin’s 10‑K does not disclose a specific commercial satellite‑launch revenue figure in the pages provided, but ULA’s commercial launch services are a key source of that revenue. Thus, ULA’s commercial launch activity underpins both Boeing’s equity income and Lockheed Martin’s satellite‑launch revenue, linking the two companies’ financial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Boeing's $125 million equity income from ULA in 2024, which matches the ground truth exactly. It also accurately notes Boeing's 50% stake in ULA, consistent with known ownership structure. However, the LLM states that Lockheed Martin’s 10-K 'does not disclose a specific commercial satellite-launch revenue figure,' which partially contradicts the ground truth: while a line-item for commercial satellite launch revenue may not be explicitly labeled, the ground truth indicates that Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. This is a material omission, as the receivables figure is directly tied to commercial launch activity and should have been included to fully answer the correlation. (2) Quantitatively, all numbers cited ($125 million, 2024) are correct and properly attributed. The LLM does not misstate any figures. (3) The reasoning is mostly sound: it correctly links ULA’s commercial services to both Boeing’s equity income and Lockheed Martin’s revenue. However, it fails to complete the multi-hop synthesis by not incorporating the $665 million receivables figure from Lockheed Martin, which is key to establishing the financial correlation. This weakens the qualitative accuracy. (4) The answer remains contextually relevant and addresses the core relationship between the two companies via ULA. The omission of the receivables data reduces completeness and prevents a higher correctness score, but the core logic and numerical accuracy support a score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 451,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "LLY’s disclosures (pages 8‑12) explain that its branded drugs lose market exclusivity when patents expire or the regulatory data‑protection period ends—generally 5 years in the U.S., 10 years in the EU, 8 years in Japan and 12 years for biologics—after which generics or biosimilars can enter the market.  In contrast, Merck’s 10‑K (pages 30‑34) highlights similar patent‑related risks, noting that loss of exclusivity can rapidly erode sales and that the company must defend patents in multiple jurisdictions, though it does not specify the exact exclusivity timelines; the exposure mirrors LLY’s in that varying exclusivity lengths across the U.S., Europe and Japan shape the competitive landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core idea that both LLY and MRK face significant risks from loss of market exclusivity due to patent expiration and regulatory data protection, with exposure varying across the U.S., Europe, and Japan. It correctly identifies that LLY benefits from regulatory exclusivity periods such as 10 years in the EU, 8 years in Japan, and 12 years for biologics in the U.S. However, it incorrectly states a general 5-year data protection period in the U.S., which is not accurate—U.S. data exclusivity is 12 years for biologics and 5 years for new chemical entities (NCEs), but the original answer does not mention a flat 5-year rule, and the LLM overgeneralizes this. This is a significant quantitative error.\n\n2) Quantitative accuracy is compromised by the incorrect '5 years in the U.S.' claim for general data protection. The ground truth specifies 12 years for biologics in the U.S., 10 in Europe, and 8 in Japan, with no mention of a 5-year U.S. standard. The LLM may be conflating NCE exclusivity (5 years) with broader data protection, but this nuance is missing, and the statement is misleading without qualification. Other durations (10 in EU, 8 in Japan, 12 for biologics) are correct.\n\n3) Qualitatively, the reasoning is sound: the LLM correctly identifies that both companies are exposed to patent-related risks and that exclusivity loss leads to generic/biosimilar entry. It acknowledges MRK’s reliance on patent defense across jurisdictions and notes that MRK does not specify exact timelines—consistent with the original answer. However, it omits key nuances from the ground truth: LLY’s ability to extend exclusivity via formulation or method-of-use patents, and MRK’s active engagement in patent litigation as a core strategy. These omissions reduce completeness and depth.\n\n4) Contextual relevance is high—the response directly addresses the comparative exposure of LLY and MRK to patent and regulatory exclusivity risks across major markets. The structure and focus align well with the question. Despite missing some strategic distinctions (LLY’s regulatory extensions vs. MRK’s litigation focus), the answer remains relevant and informative. The score is reduced primarily due to the factual inaccuracy on U.S. data exclusivity duration and partial omission of strategic differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 619,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company’s nuclear plants face potential financial impacts from cyber‑intrusion‑related compliance costs that could drive significant expenses for system protection, penalties, and insurance, as noted on page 30. Duke Energy, by contrast, confronts decommissioning‑trust‑fund funding risks where market‑driven declines in trust‑asset values could require additional capital contributions, as described on page 35. Thus, Southern Company’s risk is an operational compliance cost that could rise quickly, while Duke Energy’s risk is a long‑term financial shortfall tied to the performance of decommissioning assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative description of the financial risks faced by Southern Company and Duke Energy related to their nuclear operations, and it correctly identifies the nature of each risk—cyber intrusion-related compliance costs for Southern Company and decommissioning trust fund funding risks for Duke Energy. All entities (Southern Company, Duke Energy, nuclear facilities, compliance costs, decommissioning trust funds) are correctly identified, and there are no numerical inaccuracies, as the LLM does not introduce any incorrect figures (the ground truth includes percentages of KWH generation for Alabama and Georgia Power, but the LLM omits these rather than misstating them). The LLM correctly synthesizes that Southern’s risk is operational and potentially sudden, while Duke’s is a long-term financial risk tied to market performance. However, the LLM omits the specific quantitative context from the original answer—namely, that Alabama Power and Georgia Power’s nuclear ownership represented 26% and 28% of their total KWH generation in 2021—thus missing a key multi-hop detail that adds depth to Southern Company’s exposure. While this omission does not introduce inaccuracy, it reduces completeness in the multi-hop synthesis expected in the question. The reasoning is sound and the comparison is logically structured, and the answer remains contextually relevant and semantically aligned with the ground truth. The reference to 'page 30' and 'page 35' may reflect source document citations not present in the ground truth, but they do not detract from factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 442,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s deferred stock units for non‑employee directors vest on the earlier of the first anniversary of the grant or the day before the next annual shareholders’ meeting, and the dividend equivalents earned are paid out as additional shares of stock on that vesting date. Home Depot’s deferred shares vest only upon termination of board service, and the dividend equivalents accrue and are paid as additional shares of stock when the underlying shares are paid out after the director’s service ends. Thus, Lowe’s has a fixed, date‑based vesting schedule, while Home Depot’s vesting is contingent on service termination, but both use share‑based payout of dividend equivalents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between Lowe's and Home Depot's policies on dividend equivalents for deferred stock units granted to non-employee directors. (1) It correctly identifies Lowe's vesting schedule as the earlier of the first anniversary of the grant or the day before the next annual meeting, aligning with the ground truth. It also accurately describes Home Depot’s vesting as contingent upon termination of service. The payout mechanism—share-based for both companies—is correctly stated. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised; all dates and time-based conditions are correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies and compares their vesting schedules and payout structures appropriately. One minor omission is that the ground truth mentions Lowe's immediate vesting for awards granted prior to 2022, which the LLM answer does not include. This is a small but relevant detail about historical awards, though the focus of the question is on 2023 grants, so the impact is limited. (4) The answer is contextually relevant, directly addressing both vesting timing and payout structure as asked. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, well-reasoned, and complete for the 2023 context, meriting a high score with only a slight deduction for the omitted pre-2022 detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 425,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "AMGN’s loss of the 12‑year biologic data‑exclusivity would expose its products to biosimilar competition earlier, eroding its market exclusivity and potentially shrinking sales and market share.  In contrast, Merck’s strategy of securing compound patents and adding up to five years of patent‑term restoration plus six months of pediatric exclusivity can extend protection beyond the standard 12‑year period, giving it a stronger competitive position by delaying generic entry.  (AMGN p. 44; MRK p. 18)",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between AMGN and MRK's strategies. It correctly identifies that the loss of 12-year biologic data exclusivity would expose AMGN to earlier biosimilar competition, aligning with the original answer's emphasis on products like EPOGEN. The comparison to MRK's strategy is also accurate in substance: MRK leverages compound patents, pediatric exclusivity (correctly noting the six-month extension), and other mechanisms to extend protection. However, the LLM introduces 'up to five years of patent-term restoration,' which is not mentioned in the original answer and slightly overextends the factual basis from the provided ground truth. While patent-term restoration exists in U.S. law, the original answer does not cite it—only pediatric exclusivity and layered protections are mentioned. This addition, while plausible, introduces a detail not supported by the source, slightly reducing quantitative and qualitative accuracy. The answer is contextually relevant and synthesizes the multi-hop elements (AMGN's vulnerability vs. MRK's defensive strategy) effectively. Wording differs but meaning is semantically equivalent on key points. No calculation errors; all stated numbers (6 months, 12 years) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 355,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC to RWAs is 18 % minimum plus a 2.5 % buffer and a 1.5 % G‑SIB surcharge, but the counter‑cyclical buffer is set to zero by the FRB and therefore does not raise the TLAC ratio. Schwab’s regulatory capital framework, by contrast, applies a 2.5 % stress‑capital buffer but the counter‑cyclical buffer is zero for its subsidiaries, so Schwab’s capital calculation does not include a counter‑cyclical buffer at all.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant errors in both quantitative details and reasoning. (1) Quantitatively, the LLM incorrectly states that Goldman Sachs has a '2.5% buffer' and a '1.5% G-SIB surcharge' in addition to the 18% TLAC minimum—this is not supported by the ground truth. The original answer confirms only an 18% minimum TLAC threshold that includes the countercyclical capital buffer (set at 0%), with no mention of a 2.5% buffer or 1.5% surcharge as separate components of TLAC. The 2.5% stress capital buffer belongs to Schwab (SCHW), not GS, and conflating these figures is a critical error. (2) For SCHW, the LLM correctly notes the countercyclical buffer is zero and that a 2.5% stress capital buffer exists, but incorrectly implies structural equivalence in how buffers are applied, when the original answer emphasizes SCHW’s differentiated approach despite both having zero countercyclical buffers. (3) Qualitatively, the reasoning fails on multi-hop synthesis: it misattributes GS’s regulatory structure and incorrectly frames the 2.5% buffer as part of GS’s TLAC, when in fact SCHW’s 2.5% is a stress capital buffer unrelated to TLAC (which does not apply to SCHW in the same way). TLAC is a requirement for global systemically important banks (G-SIBs) like GS, while SCHW is not subject to TLAC in the same manner. (4) Contextual relevance is moderate—the response addresses capital buffers and mentions both firms, but misunderstands the regulatory frameworks, leading to misleading comparisons. The core distinction in the original answer—that GS incorporates the countercyclical buffer within its 18% TLAC floor while SCHW applies a separate stress capital buffer—is obscured by incorrect additions. Thus, while some correct elements (e.g., zero percent countercyclical buffer for both) are present, major factual and conceptual errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 517,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "XOM’s long‑lived assets in Kazakhstan were reported at **$7.7 billion** for 2023 (page 115).  In contrast, Chevron’s participation in the region is a **50 % ownership stake in Tengizchevroil (TCO)**, the operator of the Tengiz and Korolev fields (page 15).  Thus, XOM’s exposure is expressed as a dollar value of assets, while Chevron holds a half‑share of TCO’s operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies XOM's long-lived assets in Kazakhstan as $7.7 billion in 2023, which matches the ground truth of $7,728 million (rounded appropriately). It accurately states CVX's 50% ownership stake in TCO and correctly names the Tengiz and Korolev fields. However, it omits key qualitative details present in the original answer, such as the TCO concession expiration in 2033, the Future Growth Project (FGP) mechanical completion in 2023 and expected start-up in H1 2025, and the Karachaganak Expansion Project with Stage 1A completion expected in 2024. These omissions reduce completeness. (2) Quantitatively, the $7.7 billion figure is a valid rounding of $7,728 million, and the 50% stake is accurate. No calculations were required, but the representation of financial data is correct. (3) The reasoning correctly distinguishes between XOM’s direct asset ownership and CVX’s indirect exposure via equity stake in TCO, demonstrating sound multi-hop logic across ownership structure and asset reporting. However, the lack of project-level updates from TCO weakens the synthesis of CVX’s strategic positioning. (4) Despite missing some forward-looking operational details, the answer remains highly relevant, directly addressing the comparison of asset exposure versus operational stake. The core factual contrast between XOM’s reported assets and CVX’s TCO ownership is preserved, warranting a high correctness score with minor deductions for incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 407,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that it is still evaluating ASU 2020‑04 and that the ultimate financial impact of moving from LIBOR to an alternative rate “cannot be determined at this time.”  By contrast, NextEra Energy states it is applying the same ASU to its interest‑rate contracts and debt‑related derivatives; while the full impact remains unknown, it has not yet produced a material effect on its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly captures Southern Company's (SO) uncertainty, quoting that the financial impact 'cannot be determined at this time,' and contrasts it with NextEra Energy's (NEE) active application of ASU 2020-04 to its interest rate contracts and derivatives. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies regarding the same accounting standard (ASU 2020-04) and their differing stances on implementation—SO still evaluating vs. NEE applying the guidance. The only minor omission is that the LLM does not explicitly state that both companies are under the same regulatory framework, though this is implied by referencing the same ASU. Also, the LLM adds that the impact has not had a 'material effect' on NEE’s financials—a detail not in the original answer—which may be accurate but slightly extends beyond the provided ground truth. (4) Despite this small addition, the core comparison is correct, entities are accurately identified, and the reasoning is logically sound, warranting a high correctness score of 9. Contextual relevance is perfect as the answer directly addresses the comparative disclosure stance on LIBOR transition under ASU 2020-04.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 396,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s dual‑class structure gives Class B shareholders 10 votes per share, while Class A shares have only one vote, and the certificate of incorporation contains anti‑takeover and transfer‑restriction provisions that make it difficult for minority holders to influence corporate decisions (META, pp. 49‑50). Alphabet’s certificate also has a dual‑class scheme (Class A 1 vote, Class B 10 votes), but it allows Class B shares to be converted into Class A at any time and otherwise treats all classes identically, providing minority shareholders a path to voting rights and a modest protection against exclusion (GOOGL, p. 81).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the dual-class voting structures of both META and GOOGL, accurately stating that Class B shares have 10 votes and Class A have 1 vote in both companies (quantitatively accurate). It also correctly notes that GOOGL allows conversion of Class B to Class A shares, which is a factual detail supporting minority shareholder flexibility. However, the LLM answer omits key governance distinctions present in the ground truth. Specifically, it fails to mention GOOGL's requirement of unanimous board approval before proposing amendments affecting stockholder rights and the class-level approval requirement for such changes—critical structural protections for minority shareholders. On the META side, while it references anti-takeover provisions, it does not mention the two-thirds supermajority requirement triggered when Class B voting power falls below 35%, nor does it address the controlled company structure where the board need not be majority independent or that key decisions require Class B approval. These omissions significantly weaken the qualitative accuracy and completeness of the comparison, especially regarding how each framework protects minority interests. The reasoning is partially sound but lacks the multi-hop synthesis of governance mechanisms beyond voting ratios. The answer is contextually relevant and correctly interprets the core issue of voting rights and minority influence, but the absence of key structural safeguards from both companies' charters limits its correctness despite accurate numerical and basic structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 434,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo’s effective tax rate was 25.6 % in 2023, while Altria’s was also 25.6 % that year but had been higher in prior years (35.3 % in 2021) because of a heavier U.S. tax burden and significant state‑local taxes (Altria 2023 10‑K, page 80).  Under the OECD’s Pillar Two global‑minimum‑tax rule, both companies would see their effective rates rise as foreign earnings that are currently taxed below the 15 % floor would be levied at the minimum rate; the effect would be larger for Altria, whose higher U.S. statutory and state taxes mean a greater proportion of its income would be affected, whereas PepsiCo’s lower U.S. burden and more diversified international operations would moderate the increase.  Both firms would also incur higher compliance costs and lose some tax‑planning flexibility as the new framework curtails arbitrage opportunities. (OECD discussion – PepsiCo, page 23; Altria effective tax rate – page 80)",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that both PepsiCo and Altria are subject to the OECD's global minimum tax framework, it incorrectly asserts that Altria would face a larger increase in effective tax rate due to higher U.S. taxes—this contradicts the ground truth, which states that Altria has minimal foreign tax liabilities and is thus less exposed. The ground truth emphasizes that PepsiCo, with significant international operations, is more likely to see upward pressure on its effective tax rate, whereas Altria, being domestically focused, would be relatively unaffected. The LLM reverses this logic. (2) Quantitatively, the LLM cites a 25.6% effective tax rate for both companies in 2023 and references Altria’s 35.3% rate in 2021. However, the ground truth does not provide PepsiCo’s effective tax rate, nor does it state that both companies had identical rates in 2023. These specific percentages and comparisons are unsupported by the original answer and introduce false precision. The $2,346 million federal tax payment figure for Altria in the original is omitted. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the key distinction—international exposure—between the two firms. It incorrectly assumes that higher U.S. tax burden (e.g., state taxes) would make Altria more vulnerable to Pillar Two, when in fact Pillar Two applies to low-taxed foreign income. Since Altria has minimal foreign operations, it should face little impact. PepsiCo, with global operations, is the one at risk of top-up taxes. The LLM misapplies the mechanism of the global minimum tax. (4) Contextual relevance is moderate—the answer addresses the OECD framework and both companies, but the conclusion is factually inverted. The mention of compliance costs and lost tax planning is plausible but not in the ground truth, adding unsupported content. Overall, major factual and reasoning errors undermine correctness, warranting a low score despite some relevant terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 556,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "Orphan‑drug designation gives an innovator a seven‑year period of regulatory exclusivity that runs in parallel with any remaining patents, thereby delaying the entry of generic or biosimilar competitors for that indication【page_10】【page_6】.  Because Lilly uses the same orphan‑drug exclusivity to protect its products after the compound patents expire, AbbVie can similarly rely on orphan status to extend market exclusivity and reduce generic risk during that window, but the protection ends after seven years, after which generic competition can resume【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, it accurately states the seven-year orphan drug exclusivity period, which matches the original answer and is consistent with U.S. regulatory policy. No calculations are required, and all factual numbers (i.e., 'seven years') are correct. (2) The answer correctly identifies both AbbVie and Eli Lilly as companies leveraging orphan drug exclusivity to delay generic competition beyond patent expiration, satisfying the multi-hop requirement between the two firms. (3) The reasoning is sound: it explains that exclusivity runs parallel to patents and delays generic entry, and notes that protection ends after seven years, opening the door to competition. However, it omits a key point from the original answer — that AbbVie specifically identifies the *loss or weakening* of such exclusivity (via patent challenges, regulatory changes, or compulsory licensing) as a risk that could accelerate generic competition and reduce revenues. This nuance about risk factors explicitly disclosed in AbbVie’s 10-K is missing, slightly weakening the qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and semantically close to the original, correctly conveying the mechanism and strategic importance of orphan exclusivity. Thus, while not fully complete in capturing all risk disclosures, it is factually accurate and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 400,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "KO’s equity‑method investee sales of $14,471 million in 2021 (page 89) included sales to Coca‑Cola FEMSA, which the 10‑K notes as operating bottling and distribution facilities in Argentina’s federal capital and surrounding areas (page 7).  Thus KO’s exposure to Argentina’s economic conditions is indirect, filtered through the performance of its equity investee.  By contrast, PepsiCo’s 2022 10‑K (page 41) lists Argentina as a market where it faces volatile economic, political and social conditions, indicating a direct exposure to the country’s economic volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's equity-method investee sales of $14,471 million in 2021, matching the ground truth. It accurately states that Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas, establishing KO's indirect exposure. It also correctly contrasts this with PEP's direct exposure, citing Argentina's volatile conditions from PEP's 2022 10-K. All key facts and entities are correct. (2) Quantitative accuracy is perfect: the dollar amount ($14,471 million) and year (2021) match the ground truth exactly. No calculations were required, but the number is cited correctly. (3) The multi-hop reasoning is sound: the model connects KO’s financial reporting to its equity investee (Coca-Cola FEMSA), links that entity’s operations in Argentina, and contrasts it with PEP’s direct operational presence and associated risks. The only minor shortcoming is that the LLM references PEP’s 2022 10-K instead of 2021, which slightly weakens temporal alignment, though the content about Argentina’s volatility is still valid and relevant. (4) The answer is semantically equivalent to the ground truth, with clear, concise, and factually accurate reasoning. The contextual relevance is excellent, directly addressing both companies’ exposure types. The qualitative score is 9 due to the minor year mismatch in sourcing PEP’s exposure, but this does not undermine the correctness of the underlying fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 401,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s acquisition of Cerevel gives it an exclusive global license to Pfizer‑owned patents covering emraclidine, allowing AbbVie to develop, manufacture and commercialize the drug and to pay milestone‑based royalties (page 68).  This proactive patent‑acquisition strategy extends AbbVie’s potential exclusivity beyond the typical patent life, whereas Merck’s Januvia strategy is reactive: the key patent expired in January 2023, but Merck retains U.S. market exclusivity until May 2026 through a later patent and regulatory exclusivity (page 59).  Thus, AbbVie secures exclusivity by owning the patent rights, while Merck relies on the remaining patent and regulatory protection to delay generic entry.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of both AbbVie's and Merck's market exclusivity strategies but omits critical information that affects the overall correctness and depth of the comparison. (1) Quantitatively, the dates are accurate: Merck’s exclusivity until May 2026 and the core Januvia patent expiring in January 2023 are correctly stated. However, the LLM fails to mention the $4.5 billion impairment charge by AbbVie related to emraclidine, a crucial financial fact in the ground truth that indicates the failure or underperformance of the exclusivity strategy despite the patent license. This omission significantly weakens the assessment of AbbVie’s strategy. (2) The entity accuracy is correct—AbbVie, Cerevel, Pfizer, Merck, Januvia, Janumet, and emraclidine are all properly identified. The reference to page numbers (68, 59) suggests document alignment but does not compensate for missing facts. (3) The reasoning is partially sound: the contrast between proactive (AbbVie) and reactive (Merck) strategies is a reasonable interpretation, but it is misleading to say AbbVie 'owns' the patent rights when it only has an exclusive license from Pfizer—this distinction is important and misrepresented. Furthermore, the LLM implies AbbVie’s strategy was successful in extending exclusivity, while the ground truth reveals a major financial impairment, indicating the strategy did not deliver expected returns. (4) The contextual relevance is high—the answer addresses the core of the question about patent reliance and exclusivity timelines—but the lack of the impairment charge and mischaracterization of the licensing arrangement reduce qualitative accuracy. The answer would benefit from acknowledging the risk in relying on licensed patents without full control, as demonstrated by the financial outcome.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 490,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % stake in the Caspian Pipeline Consortium (CPC) gives it a share of a pipeline that moved an average of 1.4 million barrels of crude oil per day in 2023—about 1.2 million from Kazakhstan and 0.2 million from Russia—so the investment directly expands Chevron’s export capacity. In contrast, ConocoPhillips’ upstream business is driven by the development and production of its own proved reserves (≈2.3 billion barrels of oil equivalent of proved undeveloped reserves in 2023, with many being transferred to proved‑developed status), meaning its export capacity is tied to the output of those reserves rather than a dedicated pipeline stake.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and its relevance to export capacity, and contrasts it with ConocoPhillips' reliance on production from proved reserves. However, there are key quantitative inaccuracies: the ground truth states Chevron's share supports 'approximately 1.2 million barrels per day from Kazakhstan', while the LLM claims Chevron's stake gives access to 1.4 million bpd (1.2 from Kazakhstan + 0.2 from Russia), which overstates Chevron's attributable capacity and introduces a Russian flow component not mentioned in the original. The CPC pipeline’s total throughput may be 1.4 million bpd, but Chevron’s attributable share via its 15% stake is not equivalent to the full Kazakhstan volume. Additionally, the debottlenecking project completion in January 2023 and its direct link to Chevron’s Future Growth Project (FGP) ramp-up in 2025—critical multi-hop context—is missing. (2) The ConocoPhillips part introduces a new figure—2.3 billion barrels of oil equivalent in proved undeveloped reserves—which, while plausible, is not in the original answer and distracts from the core comparison about export capacity vs. production dependency. The original emphasizes ConocoPhillips’ direct operational dependency on crude oil production as a business model, not reserve size. (3) The reasoning is logically structured and synthesizes a contrast between indirect export infrastructure exposure (Chevron via CPC) vs. direct production dependency (ConocoPhillips), which aligns with the original. However, the missing debottlenecking-FGP linkage breaks a key multi-hop chain present in the ground truth. (4) Scores reflect mostly correct qualitative reasoning and strong relevance, but docked for significant quantitative overstatement and omission of a key project timeline affecting Chevron’s capacity outlook.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 505,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle’s MySQL HeatWave embeds generative‑AI models directly into a managed cloud‑database service on OCI, combining real‑time analytics, machine learning and AI‑driven insights for use cases such as fault detection and inventory forecasting. Qualcomm, by contrast, is building generative‑AI capability into its Snapdragon SoCs and AI Engine (Hexagon NPU) so that complex language, vision and multimodal models run on‑device at low power, with the cloud acting only as a supporting layer for data exchange and model updates. Thus, Oracle’s investment is cloud‑centric—leveraging OCI and autonomous database infrastructure to deliver AI as a service—while Qualcomm’s strategy is edge‑centric, integrating AI hardware and software into consumer, automotive and IoT devices that complement its own cloud‑computing initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave on OCI as a cloud-centric managed service combining transactions, analytics, ML, and AI—this matches the original answer. Qualcomm’s strategy focuses on on-device generative AI via Snapdragon SoCs and Hexagon NPU for edge devices (smartphones, PCs, IoT), emphasizing low power, privacy, and immediacy, with cloud as a support layer—this accurately reflects the original. (2) Quantitative accuracy is perfect: although the LLM answer does not explicitly mention the 19% (2024) and 46% (2027) smartphone adoption figures, their absence does not distort the meaning, and no incorrect numbers are introduced. These percentages are important contextual details but not central to the core comparison. (3) Multi-hop reasoning is sound: the model correctly synthesizes Oracle’s cloud-based AI integration with its OCI and Autonomous Database investments, and contrasts it with Qualcomm’s edge-first AI strategy supported by cloud coordination through QSI. The distinction between cloud-centric vs. edge-centric strategies is clearly and correctly articulated. (4) Semantic equivalence is strong: while the LLM uses different phrasing (e.g., 'AI-driven insights', 'Snapdragon SoCs', 'Hexagon NPU'), it conveys the same technical and strategic distinctions as the original. The omission of the specific forecast percentages slightly reduces completeness but does not affect the correctness of the overall comparison. Hence, a 9/10 on correctness and qualitative accuracy is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 463,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart reports $37.2 billion of unrecorded purchase obligations—including firm commitments for inventory and utility purchases (page 47)—which lock in quantities and prices to stabilize operating costs and reduce cash‑flow volatility. Colgate‑Palmolive, by contrast, uses option contracts (along with forwards) to hedge foreign‑currency exposures (page 91), offsetting adverse currency movements and protecting cash flows from exchange‑rate swings. While Walmart’s commitments provide supply‑chain cost certainty, Colgate‑Palmolive’s options offer financial‑hedging flexibility; both instruments serve to mitigate cash‑flow risk but target different exposure domains.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a significant factual error in the quantitative value: it states Walmart has $37.2 billion in unrecorded purchase obligations, while the ground truth specifies $15.9 billion in firm commitments due within one year. This is a material overstatement (~134% higher) and directly impacts the accuracy of the financial exposure assessment. The mention of 'page 47' and 'page 91' suggests document sourcing, but the number itself is incorrect. 2) The qualitative aspects are largely correct: Walmart uses firm commitments (not financial derivatives) for inventory and utilities to stabilize costs, while Colgate-Palmolive uses option contracts (and forwards) for foreign exchange risk, aligning with its need to hedge currency fluctuations. The distinction in risk management approaches—operational vs. financial hedging—is accurately captured. 3) The multi-hop reasoning is sound: the model correctly identifies that both companies aim to reduce cash flow volatility but through different instruments targeting different risks (operational supply chain vs. foreign exchange). This reflects proper synthesis across entities and strategies. 4) Contextual relevance is high—the answer directly addresses the comparison of financial exposure management, instruments used, and their role in cash flow risk mitigation. However, the incorrect dollar amount undermines the quantitative foundation of the comparison, warranting a moderate correctness score despite otherwise accurate reasoning and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 415,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley uses credit‑default swaps (CDS) to hedge the default risk of its debt portfolio, transferring potential credit losses to counterparties and monitoring exposure through aggregate risk limits (see page 111). Capital One, in valuing its Level 3 net derivative assets, treats default‑rate assumptions as a key unobservable input in discounted‑cash‑flow models (see page 208). Thus, both firms are highly sensitive to credit‑event outcomes: Morgan Stanley’s CDS hedges generate gains or losses when a default occurs, while Capital One’s derivative fair values shift with changes in the assumed default rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core relationship between Morgan Stanley's use of CDS and Capital One's reliance on default rate assumptions. (1) All factual elements are correct: Morgan Stanley uses CDS to hedge default risk and monitors exposure via risk limits; Capital One relies on unobservable default rate assumptions in valuing Level 3 net derivative assets using discounted cash flow models. (2) Quantitative accuracy is perfect—while the LLM does not explicitly state the 4% weighted average default rate or the 53–163% range mentioned in the ground truth, it correctly identifies default-rate assumptions as a key input without introducing any incorrect numbers. The omission of specific percentages is a minor completeness issue but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms are sensitive to credit events—Morgan Stanley through direct CDS triggers and Capital One through valuation sensitivity to assumed default rates. (4) Contextual relevance is excellent, directly addressing the systemic sensitivity both institutions have to credit outcomes. The answer could have strengthened the connection by noting that actual deviations from assumed default rates would materially impact Capital One’s fair value, and that both could be affected simultaneously by macroeconomic shocks, but the core logic and entities are accurately represented. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 415,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s natural‑gas network totals 35,700 miles of pipelines (page 39), but none of its subsidiaries—Duke Energy Carolinas, Progress Energy, Duke Energy Florida, Ohio, Indiana or Piedmont—operate in Georgia (page 41), so its capital exposure and reliability contribution to Georgia’s gas market is essentially zero.  By contrast, Southern Company Gas owns a 50 % stake in the 7,000‑mile SNG pipeline that serves Georgia (among other states) (page 13), representing a large capital investment and a key reliability asset that supplies diverse gas sources to the state.  Thus, Southern Company Gas’s SNG investment dwarfs Duke Energy’s absence of Georgia assets and plays a critical role in the region’s natural‑gas reliability.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims Duke Energy has 35,700 miles of pipelines, but the ground truth states 28,000 miles in Georgia specifically; the 35,700 figure may refer to total system-wide assets (possibly across all states), but misattributing it to Georgia is incorrect. More critically, the LLM asserts Duke Energy has no operations in Georgia, directly contradicting the ground truth that Duke operates 28,000 miles of gas pipelines *in Georgia*. This is a major factual error. (2) Entity and reasoning failure: The LLM incorrectly lists Duke subsidiaries (e.g., Carolinas, Florida) to argue no Georgia presence, but the ground truth confirms Duke’s active distribution infrastructure in Georgia. This invalidates the core comparison. (3) While the LLM correctly notes Southern Company Gas’s 50% stake in the 7,000-mile SNG pipeline serving Georgia, it fails to mention SNG’s role in supply-side reliability and integration with local utilities like Duke—missing a key multi-hop insight. (4) The conclusion that Duke has 'essentially zero' exposure is false per ground truth, and the claim that SNG 'dwarfs' Duke’s assets is unsupported due to the erroneous denial of Duke’s Georgia footprint. (5) Contextual relevance is moderate because the answer addresses capital scale and reliability, but the reasoning is built on a false premise. Overall, the answer fails on core facts and synthesis, warranting a low correctness score despite partial accuracy on SNG details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 428,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Louisiana’s 2024 corporate‑tax‑rate cut lowered Union Pacific’s deferred‑tax expense by **$34 million**. That $34 million reduction is the combined effect of Louisiana and Arkansas, so Arkansas’s similar legislation contributed to the same $34 million reduction—there is no separate figure for Arkansas alone.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $34 million reduction in deferred tax expense due to Louisiana's tax legislation, which matches the ground truth. However, it incorrectly states that this $34 million is the *combined* effect of both Louisiana and Arkansas, whereas the original answer indicates that Louisiana alone caused a $34 million reduction and that Arkansas had a *comparable* or *similar* impact (implying a separate, additional adjustment of similar magnitude). This misrepresents the quantitative contribution of each state. (2) The date (2024) and financial metric (deferred tax expense) are accurate. The dollar amount ($34 million) is correct for Louisiana, but the conflation of Arkansas’s impact into the same figure introduces a significant error. There is no indication in the ground truth that the $34 million is combined; rather, it appears to be Louisiana’s standalone impact. (3) The multi-hop reasoning fails because the model incorrectly synthesizes the Arkansas impact as part of the same $34 million rather than as a separate but similar adjustment. The original answer uses 'mirrors' and 'comparable adjustment' to suggest parallel effects, not a shared total. (4) While the answer is contextually relevant and addresses both states and the general direction of impact, the core quantitative misinterpretation—treating a per-state figure as a combined total—undermines factual correctness. This is a critical error in financial reasoning, especially for deferred tax calculations where discrete jurisdictional impacts must be tracked separately. Hence, the correctness score is moderate (4/10), with higher marks for contextual relevance and partial number accuracy, but major deductions for reasoning and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 482,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B common stock is largely non‑voting, with rights limited to a handful of defined matters such as mergers, where the shares vote as a single class with votes equal to the number of shares times the conversion rate (V_10k_2024, p. 90). Alphabet’s Class A common stock carries one vote per share and can vote on all matters, giving holders full influence over corporate governance (GOOGL_10k_2024, p. 82). Consequently, Meta’s limited voting rights for Class B holders constrain their ability to shape merger outcomes and other strategic decisions, whereas Alphabet’s Class A shareholders retain broad voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Meta's Class B shares are largely non-voting but gain voting rights in specified scenarios like mergers, with votes proportional to the conversion rate—this aligns with the original answer. It also accurately describes GOOGL's Class A shares as having one vote per share and full voting rights. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised; all references to document sources (V_10k_2024, GOOGL_10k_2024) are consistent and correctly attributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between two companies' share classes and links them to corporate control implications. The only minor shortcoming is that the LLM answer does not explicitly contrast the 'concentration of control at Meta among superior voting shares' versus 'steady governance role at Google' as clearly as the original, slightly reducing qualitative depth. (4) The response is fully contextually relevant, directly addressing the influence of voting rights on corporate governance and merger-specific limitations. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth with only slight room for enhanced comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 389,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer restrictions—such as step‑therapy, prior‑authorization and high copay thresholds—can curb sales volumes and trigger larger rebates and chargebacks for high‑cost cardiovascular drugs like Repatha.  Pfizer’s revenue‑recognition policy nets sales against estimated rebates and chargebacks (as outlined in its critical accounting policies and similar to the practice noted on page 48), so tighter payer controls force the company to estimate higher deductions and may delay or reduce recognized revenue when coverage or affordability limits are in place (page 41, page 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies U.S. payer restrictions (prior authorization, step-therapy, high copays) that limit access to high-cost cardiovascular drugs like Repatha, which matches the original answer's emphasis on formulary exclusions and cost-sharing. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no discrepancies. (3) The multi-hop reasoning is sound: the LLM connects payer restrictions to sales impact, links Pfizer’s revenue recognition policy to gross-to-net deductions (rebates and chargebacks), and references its accounting policies (pages 41, 48, 10), demonstrating synthesis across payer dynamics and financial reporting practices. This mirrors the ground truth’s logic that Pfizer must estimate rebates based on payer mix and affordability, similar to Gilead. (4) The only minor gap is that the LLM does not explicitly mention Gilead or draw the cross-company strategic comparison present in the original answer, which slightly weakens the qualitative depth. However, the core reasoning about Pfizer’s revenue recognition under payer pressure is correct and contextually complete. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses formulary placement, affordability, and revenue recognition strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 385,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % working interest in TCO’s Kazakhstan operations gives it a proportional share of the Future Growth Project (FGP) ramp‑up, which is expected to start in the first half of 2025 and reach full production within three months【page_16】.  Thus Chevron’s exposure to the additional output is limited to roughly 15 % of the increased production, whereas ConocoPhillips’ operations rely on crude oil as a core raw material across its entire portfolio, making its exposure broader and not confined to a single project【page_143‑147】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron's 15% ownership in TCO, the FGP project start in the first half of 2025, ramp-up to full production within three months, and the proportional (15%) exposure to increased output are all factually consistent with the original answer. The comparison to COP’s broader reliance on crude oil as a core raw material is also correctly framed. (2) Quantitative elements—percentages (15%), timing (first half of 2025), and ramp-up duration (three months)—are all accurate and match the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes Chevron’s partial ownership in TCO with its indirect exposure to production increases, and contrasts it with COP’s direct, portfolio-wide dependence on crude oil. However, the LLM omits mention of Chevron’s 15% stake in the Caspian Pipeline Consortium (CPC), which is a minor but relevant detail in understanding the full scope of Chevron’s infrastructure exposure and throughput benefits. This omission slightly weakens the completeness of the synthesis but does not undermine the core correctness. (4) The answer is contextually relevant, directly addressing the comparative exposure question and maintaining semantic equivalence with the original answer. Wording differences (e.g., 'working interest' vs 'ownership stake') are acceptable and do not affect meaning. Overall, a very strong response with only a minor gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 420,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs has about **$1.5 billion** in hotel‑related commercial‑real‑estate loans (5 % of its $29.8 billion commercial‑real‑estate loan portfolio – GS 118).  \nMetLife, by contrast, holds roughly **$3.46 billion** in real‑estate funds that include hotels as part of a diversified property mix (MetLife 103, 95).  \nThus, MetLife’s hotel‑focused fund exposure is roughly twice the size of Goldman Sachs’ direct hotel loan exposure, while both firms use real‑estate funds to diversify and pursue long‑term appreciation—GS’s funds represent 27.4 % of its real‑estate holdings, and MetLife’s real‑estate funds are a core component of its investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, MetLife holds $13.3 billion in total real estate investments, including hotel-focused real estate funds—but the LLM incorrectly states MetLife’s exposure to hotel-related funds as $3.46 billion, which is not supported by the original answer and underrepresents the scale. Similarly, the LLM claims Goldman Sachs has $1.5 billion in hotel-related CRE loans, but this figure is absent from the ground truth, which only states that hotel-related loans are a 'significant' part of their portfolio without specifying an amount. The $29.8 billion total CRE loan portfolio size and the 5% allocation are also not in the original answer. (2) Calculations such as '5% of $29.8 billion' and the comparison that MetLife’s exposure is 'twice' that of Goldman Sachs are therefore based on fabricated data and are incorrect. The claim that GS’s funds represent 27.4% of its real estate holdings is unsupported in the provided truth. (3) While the LLM correctly identifies the qualitative distinction that Goldman Sachs is exposed via lending and MetLife via ownership in funds, this insight is partially accurate reasoning built on incorrect data. The multi-hop synthesis is conceptually sound—comparing exposure types and strategic use of funds—but fails factually at the data level. (4) The contextual relevance is fair because the structure and intent align with the question, discussing both companies’ strategies and exposures, but the quantitative inaccuracies severely undermine correctness. Due to major errors in numbers and unsupported calculations, the correctness score is low despite some valid conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 471,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "BA’s limited‑partnership investments are held for 10‑15 years and carry roughly $3.3 billion of unfunded commitments that will be called over the next 3‑6 years, creating a long‑term liquidity constraint. In contrast, UPS’s pension plan real‑estate holdings are part of a NAV‑valued, diversified portfolio and are not reported as unfunded obligations; the plan’s liquidity risk is managed through its asset‑allocation strategy rather than by meeting large, time‑locked commitments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents key information from the ground truth. (1) Quantitative inaccuracy: The LLM incorrectly attributes the $3.3 billion unfunded commitment to BA, when in fact this figure belongs to UPS's pension fund obligations as of December 31, 2023. There is no mention in the ground truth of BA having $3.3 billion in unfunded commitments, nor that capital will be called over 3–6 years. (2) Completeness: The answer fails to correctly compare the two companies’ liquidity risk profiles. It incorrectly claims UPS does not report unfunded obligations, directly contradicting the ground truth that UPS has $3.3 billion in unfunded commitments. (3) Entity accuracy: While both companies and the 10–15 year term are correctly identified, the misattribution of the $3.3 billion to BA instead of UPS is a critical entity-metric mismatch. (4) Reasoning: The multi-hop synthesis is flawed—instead of recognizing the similarity in liquidity constraints due to long-term limited partnership structures, the LLM incorrectly frames them as contrasting cases. The conclusion that UPS manages risk via asset allocation rather than facing time-locked commitments contradicts the ground truth. (5) Semantic equivalence: The answer conveys the opposite meaning of the original—portraying structural differences instead of similarities—making it factually and conceptually incorrect despite some correct terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 399,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share 10 votes versus one vote for Class A, and the Class B holders (Zuckerberg, the board chair and CEO) control a majority of the combined voting power even though they own less than 9.1 % of the shares, concentrating control and limiting other shareholders’ influence【page_49】【page_50】【page_51】.  \nComcast’s dual‑class structure gives each Class B share 15 votes, representing roughly one‑third (33.3 %) of total voting power, while Class A shares hold the remaining two‑thirds (66.6 %); the single holder of all Class B shares therefore controls a significant minority of votes, but control is less concentrated than at Meta【page_33】【page_34】【page_35】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between META and CMCSA's dual-class voting structures. It correctly identifies that Meta's Class B shares have 10 votes per share (vs. 1 vote for Class A), and that Zuckerberg controls a majority of voting power despite owning less than 9.1% of shares, which aligns with the ground truth emphasis on outsized control. The statement that Comcast’s Class B shares have 15 votes each is accurate. However, there is a minor quantitative inaccuracy: the LLM states Class B shares represent 'roughly one-third (33.3%)' of total voting power at CMCSA, while the ground truth specifies that Class A holds 66 2/3%—implying Class B holds exactly 33 1/3%, not 33.3%. Though close, this rounding down slightly misrepresents the precise allocation. More importantly, the LLM omits a key governance difference highlighted in the original answer: META has specific anti-takeover provisions requiring a majority of Class B votes for change-of-control transactions until their voting power drops below 35%, which strengthens control concentration beyond just vote ratios. This structural nuance is missing, weakening the comparative analysis of shareholder influence. The reasoning is otherwise sound, entities are correct (Meta, CMCSA, Zuckerberg, Roberts), and the synthesis across companies is appropriate. Wording differs but meaning is semantically close. The answer is highly relevant and addresses control concentration and shareholder influence, just with minor omissions in structural details and slight imprecision in vote percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 434,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan assets allocate roughly 16 % to government securities (U.S. plan assets $1,812 of $11,226, page 99) as part of a 55 % fixed‑income mix that also includes corporate bonds and other high‑quality debt. The plan targets a 7.4 % long‑term return and uses derivatives to hedge interest‑rate and currency risk. In contrast, COST’s short‑term holdings are almost entirely in U.S. government and agency securities with maturities of 3 months to 5 years (page 31), aimed at preserving principal and generating modest yields, with risk managed by limiting investments to U.S. government and agency obligations, repurchase agreements, money‑market funds and insured bank balances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP's $1.812 billion allocation to government securities is accurately reported, and the 7.4% long-term return target is correctly cited. The LLM adds useful context not in the original but consistent with it—calculating that government securities represent ~16% of total U.S. plan assets ($1.812B / $11.226B), which is a valid inference and correctly computed. COST’s short-term holdings in government and agency securities with maturities from 3 months to 5 years are accurately described. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and maturities match or are valid derivations from the ground truth. Format variations (e.g., $1.812 billion vs $1,812 million) are acceptable and correctly interpreted. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes PEP’s long-term, return-oriented strategy involving derivatives for risk mitigation with COST’s capital preservation focus using short-duration, low-risk instruments. The contrast in risk management and return objectives is clearly and correctly articulated. (4) The only minor limitation is that the LLM does not explicitly mention COST’s focus on 'low volatility' or 'fixed-rate' instruments—phrasing present in the original—though the described investment types (government and agency securities, repurchase agreements, money-market funds) imply this. This omission does not detract from factual correctness but slightly reduces qualitative completeness. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong cross-entity synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 454,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s mortgage‑backed securities total $9 million, which is only about 0.1 % of its $7.2 billion fixed‑income portfolio (page 298). In contrast, NextEra Energy’s pension plan targets fixed‑income assets at 32 % of the plan’s total assets (page 100‑104), implying a substantially larger relative allocation to fixed‑income securities—including mortgage‑backed securities—than Southern Company’s actual allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Southern Company's $9 million allocation to mortgage-backed securities and NextEra Energy's 32% target allocation to fixed income, which includes mortgage-backed securities. However, it inaccurately reports Southern Company's total fixed income portfolio as $7.2 billion, whereas the ground truth states $6,154 million ($6.154 billion), leading to an incorrect percentage calculation (0.1% vs. less than 0.15%). The actual percentage is ~0.146%, which rounds to 0.15%, so reporting 0.1% is a minor but notable underrepresentation. (2) Quantitative accuracy is compromised by the incorrect total portfolio value: $7.2 billion vs. $6.154 billion. This affects the derived percentage and misrepresents the scale. All other numbers (e.g., $9M, 32%) are correct. (3) The multi-hop reasoning is sound—correctly comparing actual allocation (Southern) vs. target framework (NextEra) within fixed income portfolios, and both classify mortgage-backed securities under fixed income. The synthesis across companies and contexts (actual vs. target) is logically valid. (4) Scores reflect mostly correct facts and reasoning, but the incorrect portfolio size and resulting percentage reduce quantitative accuracy. The answer remains contextually relevant and qualitatively strong in structure and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 371,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic formalized a 2011 supply agreement (with amendments in 2013 and 2014), a production‑pricing agreement for 2170 cells (2020) and for Japan cells (2019 and 2021), an investment‑letter agreement, general terms and conditions, and a factory‑lease agreement, covering the full spectrum of supply, pricing, investment and facility arrangements for the Gigafactory【page_106】. In contrast, GM’s battery supply is integrated through a joint‑venture with Ultium Cells Holdings LLC, which provides battery cells and in which GM holds an equity stake, indicating a deeper contractual depth and supplier integration than Tesla’s supplier‑based agreements【page_76】【page_78】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the dates and nature of Tesla-Panasonic agreements. The original answer specifies the Amended and Restated General Terms and Conditions (June 10, 2020), the 2020 Pricing Agreement for 2170 cells, and the 2021 Pricing Agreement for Japan cells. However, the LLM incorrectly cites a '2011 supply agreement' with amendments in 2013 and 2014, and claims a 2019 pricing agreement for Japan cells—none of which are in the ground truth. These dates and agreements are not supported by the evidence provided. (2) Quantitative accuracy is partially correct: the 2020 2170 cell agreement is correctly noted, but the 2019 Japan cells agreement is fabricated; the 2021 agreement is misrepresented as having a prior 2019 version. The LLM also invents an 'investment-letter agreement' and 'factory-lease agreement' not mentioned in the original answer, despite the original noting 'shared facility leasing arrangements'—a more general and less specific commitment. (3) The reasoning for GM’s supplier integration is fundamentally flawed. The original answer states that GM’s dependency lacks equivalent details or specific contractual commitments in the evidence, implying less transparency or structure. In contrast, the LLM asserts that GM has a joint venture (Ultium Cells Holdings LLC) with equity stake and deeper integration, which contradicts the original answer’s claim that no such details were provided. This misrepresents the evidence and inverts the comparison. The LLM fails the multi-hop reasoning by drawing a conclusion not supported by the source material. (4) Contextual relevance is high—the answer addresses both parts of the question and attempts synthesis. However, due to major factual errors in dates, agreements, and the comparative analysis, the correctness score is low. While some elements (e.g., 2020 pricing agreement) are accurate, the overall answer misrepresents the contractual landscape and draws an incorrect conclusion about GM’s relative integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 552,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s exposure in Nigeria is primarily regulatory: the company still has unresolved tax audits that date back to 2007, with $5.3 billion of unrecognized tax benefits that could materially alter its tax liability if the audits result in adjustments. In contrast, Exxon’s risk is contractual: its Nigerian operations are governed by 30‑year PSCs that include a 10‑year exploration phase, a 20‑year production period, partial relinquishment at the end of exploration, and potential extensions under the Petroleum Industry Act—factors that could affect revenue sharing and production obligations rather than tax liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong factual and semantic alignment. (1) Quantitatively, the $5.3 billion figure matches the original $5,288 million (rounded appropriately), and the 2007 audit cutoff is correctly cited. The 30-year PSC structure (10-year exploration + 20-year production) is accurately described. (2) The LLM correctly identifies Chevron's risk as regulatory/tax-related and Exxon's as contractual/operational under PSCs, capturing the key contrast. (3) Multi-hop reasoning is sound: it synthesizes Chevron’s tax exposure with Exxon’s PSC terms and correctly differentiates the nature of risks (tax vs. revenue sharing/production obligations). (4) Minor omission: the LLM does not mention Exxon’s 12% of proved reserves under PSCs or the inverse relationship between production volumes and price changes, which adds nuance to the fiscal sensitivity. However, this does not undermine the central comparison. Wording differences (e.g., 'materially alter tax liability', 'revenue sharing and production obligations') are semantically equivalent. The reference to the Petroleum Industry Act is a reasonable contextual addition not in the original but not incorrect. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 366,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla’s commercial‑paper program is a sizeable short‑term investment – it amounts to $470 million (Level II fair value) as disclosed in its cash and cash‑equivalents note (page 72). In contrast, Duke Energy Ohio’s commercial paper is a small component of its short‑term debt, totaling only $25 million (short‑term obligations classified as long‑term debt) (page 165). Thus, Tesla’s use of commercial paper is far larger and is held primarily as an investment, whereas Duke Energy Ohio’s commercial paper is a modest, working‑capital‑type liability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The dollar amounts ($470 million for Tesla and $25 million for Duke Energy Ohio) are correctly reported, with no calculation or numerical errors. Minor formatting differences (e.g., use of en-dash, spacing) do not affect accuracy. (2) Completeness: The answer addresses both companies' use of commercial paper, correctly identifying Tesla's holdings as an investment and Duke Energy Ohio's as a liability, which aligns with the multi-hop comparison requested. (3) Entity accuracy: Both companies are correctly named, and the financial context (commercial paper as investment vs. debt) is accurately attributed. (4) Reasoning: The LLM correctly synthesizes the differing roles of commercial paper across industries—Tesla as a technology firm using it as a cash equivalent, and Duke Energy Ohio as a utility using it for short-term obligations—demonstrating sound multi-hop logic. (5) Semantic equivalence: Despite slightly more detailed phrasing (e.g., referencing fair value levels and page numbers), the core information and comparative insight are identical to the original answer. All scores are maximized due to full factual alignment, precise numbers, logical reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 361,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework explicitly links transition risk to potential regulatory and compliance exposure, noting that policy, technology and market shifts could trigger increased legal and regulatory scrutiny (page 148). By contrast, Morgan Stanley’s disclosures show that the firm has already faced regulatory scrutiny over its climate‑related reporting, as evidenced by the establishment of a Climate Risk Committee and the emphasis on compliance in its risk‑disclosure sections (page 79).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that JPMorgan links transition risk to regulatory and compliance exposure, citing policy, technology, and market shifts as drivers of regulatory scrutiny—consistent with JPMorgan's framework. It also correctly notes that Morgan Stanley has faced regulatory scrutiny related to climate disclosures, referencing internal governance responses like the Climate Risk Committee. These points reflect the core of the original answer. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms, comparing how each views the relationship between transition risk and compliance risk. However, it omits a key nuance from the original answer: while both firms recognize the link, JPMorgan emphasizes proactive integration into risk frameworks (e.g., stress testing, metrics), whereas Morgan Stanley emphasizes regulatory enforcement and reputational/ litigation risks. This comparative depth is partially missing, slightly weakening qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing the comparative influence of transition risk on compliance risk. Minor omission of comparative framing prevents a perfect score, but overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 418,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s 30‑year PSC regime – a 10‑year exploration phase on an OPL followed by a 20‑year production phase on an OML that can be extended under the Petroleum Industry Act – forces ConocoPhillips’ deep‑water projects to secure an OPL, convert to an OML after discovery, and observe partial relinquishment and extension rules (ConocoPhillips p. 154).  Chevron, which reports that 7‑11 % of its African reserves are PSC‑related, must account for those reserves under the economic‑interest method, incorporating the same 10‑year exploration/20‑year production timeline, partial relinquishment, and potential extensions into its reserve estimates and discounted‑cash‑flow calculations (Chevron p. 106‑108).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the 30-year PSC structure (10-year exploration + 20-year production) is correctly stated, matching the original. The mention of potential extensions under the Petroleum Industry Act is consistent. The percentage range for Chevron's PSC-related reserves is given as 7–11% in the LLM answer versus 8–10% in the original; this is a minor variance but within reasonable reporting tolerance and may reflect broader regional (African) inclusion. (2) The LLM correctly identifies that ConocoPhillips must navigate OPL to OML conversion, relinquishment, and extension rules, citing a specific page (p. 154), which supports traceability. Similarly, Chevron’s use of the economic-interest method and integration of PSC timelines into reserve estimates and DCF models (pp. 106–108) are accurate and contextually appropriate. (3) Multi-hop reasoning is sound: the model connects Nigeria’s PSC framework to operational planning for ConocoPhillips and reserve accounting practices for Chevron, synthesizing regulatory structure with company-specific disclosures. (4) Semantic equivalence is strong—while the LLM adds detail (e.g., OPL/OML terminology, economic-interest method), it does not introduce factual errors. The slight difference in Chevron’s reserve percentage does not undermine the core correctness. Contextual relevance is excellent, directly addressing both companies and the implications for operations and accounting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 415,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing’s 10‑K (page 14) highlights that a large share of its revenue comes from U.S. government contracts that the government can modify, curtail or terminate at its discretion.  While the filing does not mention ASU 2022‑06, the standard’s optional relief for contract modifications that replace a reference rate (e.g., LIBOR) would be relevant if any of those government‑contract changes involve a reference rate.  By contrast, FedEx explicitly notes that ASU 2022‑06 applies to contracts referencing LIBOR, monitors its contracts for potential application, and reports no material impact on its financials (page 93).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Boeing's exposure to U.S. government contract modifications and FedEx's application of ASU 2022-06, with no incorrect numbers or dates—hence a quantitative accuracy of 10. It correctly identifies that Boeing’s contracts are subject to government modification and that FedEx explicitly applies ASU 2022-06 to LIBOR-related contract changes with no material impact. However, the LLM answer omits the specific 37% revenue exposure figure for Boeing mentioned in the ground truth, which is a meaningful quantitative detail that enhances completeness. Additionally, while the LLM notes Boeing’s 10-K does not mention ASU 2022-06, it does not fully synthesize the key point from the ground truth that Boeing, despite its exposure to contract modifications, did not experience material impacts from such changes under ASU 2022-06—this missing synthesis reduces qualitative accuracy. The comparison between Boeing and FedEx is partially correct but less precise than the original, which clearly states both companies benefited from the 2024 sunset extension with no material effects. The reasoning is sound but incomplete, especially in connecting Boeing’s lack of material impact despite its high exposure. Contextual relevance is high as the answer addresses the core issues of contract modifications and ASU 2022-06 application for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 385,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil’s offshore acreage in Angola totals 2.9 million net acres (as of 12/31/2021).  Chevron, by contrast, holds a minority stake in the Angola LNG joint‑venture – a share that was highlighted as a contributor to its $8.5 billion international upstream earnings in 2021.  Thus, while ExxonMobil controls a large block of offshore acreage, Chevron’s influence is through a smaller equity stake that nonetheless added materially to its upstream earnings that year.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor overreach in quantitative detail not present in the original answer. (1) Quantitatively, the 2.9 million net offshore acres for ExxonMobil in Angola as of year-end 2021 is accurate and matches the ground truth. However, the LLM introduces a specific figure of $8.5 billion in international upstream earnings attributed to Chevron in 2021, which is not present in the original answer. While Chevron’s stake in Angola LNG did contribute to upstream earnings improvements, the exact dollar amount of total international upstream earnings was not provided in the ground truth, making this addition unsupported. (2) The entity identification is correct: ExxonMobil, Chevron, Angola LNG, and the 2021 time frame are all accurately referenced. (3) The reasoning is sound and reflects appropriate multi-hop synthesis: the model correctly contrasts ExxonMobil’s physical asset (acreage) with Chevron’s financial stake in a joint venture and links Chevron’s earnings contribution to affiliate performance. (4) The answer is contextually relevant and addresses all parts of the question—offshore acreage comparison and Chevron’s stake/earnings link—though it adds specificity (the $8.5B figure) not grounded in the source. Overall, core facts are correct, but the unsupported number prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 383,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture’s fiscal‑2024 strategy included a $6.6 billion outlay for 46 strategic acquisitions aimed at scaling industry solutions【page_6】【page_5】.  \nMicrosoft, in the same period, reported $7.594 billion in revenue from its Enterprise and Partner Services segment—which explicitly includes industry solutions【page_93】【page_11】.  \nThus, Accenture’s acquisition spend is slightly below Microsoft’s revenue from that segment, roughly 87 % of the $7.6 billion figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Accenture's $6.6 billion investment in 46 acquisitions in fiscal 2024 and Microsoft's $7.594 billion in 'Enterprise and Partner Services' revenue (which includes industry solutions) are accurately reported. The dollar amounts match exactly, and the fiscal year is correctly identified. (2) The quantitative comparison is precise: the LLM correctly calculates that $6.6B is approximately 87% of $7.594B (6.6 / 7.594 ≈ 0.869), and rounding $7.594B to $7.6B is acceptable for approximation. (3) Multi-hop reasoning is sound—information from two different companies and contexts (investment vs. revenue) is correctly synthesized to draw a meaningful comparison. (4) The only minor shortcoming is that the LLM does not explicitly comment on the strategic implications (e.g., differing growth approaches), which is present in the original answer, but this does not detract from factual correctness. The answer remains semantically equivalent in terms of core information and comparison. Thus, the answer is factually excellent with only slight omission of interpretive context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 330,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy’s FERC‑approved dividend policy requires that its equity, after push‑down adjustments, remain at least 30 % of total capital (see Duke Energy Ohio’s 2024 filing, page 147).  This threshold limits dividend distributions and forces the company to keep a healthy equity base, influencing its debt‑equity mix and cash‑flow planning.  Southern Company can use that precedent to anticipate that the FERC approval for its 50 % share of the $3 billion SNG pipeline may impose a similar equity‑ratio requirement, prompting the company to plan for sufficient retained earnings or equity financing to meet the threshold and avoid regulatory restrictions on dividends or other distributions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy's 30% equity threshold, Southern Company's 50% cost share in the $3 billion SNG pipeline, and the reference to FERC approval are all factually consistent with the original answer. The dollar amount ($3 billion) and percentage (30%) match exactly, and no calculations were required. (2) The LLM correctly identifies the key entities: Duke Energy Ohio (implied via context and filing reference), Southern Company Gas (referred to as Southern Company, which is acceptable given the context), SNG pipeline, FERC, and the regulatory linkage. The mention of 'push-down adjustments' matches the original answer's 'push-down accounting impacts.' (3) The reasoning is sound and demonstrates proper multi-hop synthesis: it connects Duke Energy’s regulatory requirement with Southern Company’s upcoming FERC approval need, inferring that similar equity maintenance rules may apply, thus influencing capital planning. The conclusion that Southern should plan for retained earnings or equity financing to meet potential thresholds is a logical extension of the precedent. (4) The only minor shortcoming is that the LLM does not explicitly name 'Southern Company Gas' or clarify the SNG ownership structure in detail, but this does not detract from the core accuracy. Also, while the LLM cites 'Duke Energy Ohio’s 2024 filing, page 147'—a plausible but unverified source detail in the ground truth—this addition does not contradict known facts and supports the claim. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 462,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS’s fair‑value hierarchy table classifies corporate debt securities as Level 2 and notes that they are valued with “market corroborated pricing, matrix pricing or other models that use observable inputs such as yield curves,” but it does not tie matrix pricing to the absence of broker quotes.  \nMMM’s valuation methodology, however, explicitly states that corporate debt instruments are priced with matrix pricing, yield curves and indices **only when broker quotes are not available**.  \nThus, UPS presents matrix pricing as a general Level 2 valuation tool, whereas MMM reserves it for cases where broker quotes are unavailable.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both UPS and MMM use matrix pricing for corporate debt instruments and that MMM explicitly ties its use to the absence of broker quotes, while UPS does not. It accurately reflects that UPS classifies corporate debt under Level 2 and uses matrix pricing among other observable-input methods. However, the LLM answer omits a key nuance from the original answer: MMM adjusts for non-observable risks such as credit and liquidity in its matrix pricing, whereas UPS does not mention such adjustments. This is a significant qualitative difference in how the two companies apply the technique, which the LLM fails to include, thus missing part of the multi-hop comparison. While the entities (UPS, MMM), valuation levels (Level 2), and general methodology (matrix pricing when broker quotes unavailable for MMM) are correct, the absence of MMM's risk adjustments weakens the completeness and depth of the comparative analysis. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant and well-structured. The reasoning is sound but incomplete due to the missing risk-adjustment detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 331,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "VZ’s $2.8 billion upfront payment to Vertical Bridge was a sale‑leaseback: Verizon sold the right‑of‑use for most towers, received cash, and then leased back capacity while still owning and depreciating the towers and recording a financing obligation for the portion it continues to occupy. By contrast, AT&T’s 2013 Crown Castle deal was a financing transaction, not a sale‑leaseback; the $4.827 billion cash was recorded as a financing obligation, and AT&T retained control of the tower assets and subleased space from Crown Castle rather than transferring operational control.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few key inaccuracies and omissions when compared to the ground truth. (1) Quantitatively, the dollar amounts are accurate: $2.8 billion for VZ's 2024 Vertical Bridge deal and $4.827 billion for T's 2013 Crown Castle transaction are correctly stated. However, the LLM omits the specific breakdown of VZ’s $2.8 billion into $2.0 billion in prepaid rent and $830 million in financing obligation—this is a significant detail from the original answer and relates directly to the financing structure comparison. (2) The LLM incorrectly characterizes AT&T’s 2013 deal as 'not a sale-leaseback' and says AT&T 'subleased space from Crown Castle', which contradicts the ground truth: in the 2013 transaction, AT&T sold tower assets to Crown Castle and leased them back, structuring it as a financing obligation due to retained control—this is a classic sale-leaseback treated as financing under accounting rules. The original answer confirms both companies retained ownership and depreciation rights, and both transactions were economically similar in nature, though VZ’s had a dual accounting treatment. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that both companies retained operational control and continued to depreciate assets. However, it misrepresents the nature of the AT&T transaction, undermining the comparative analysis. (4) Contextual relevance is high—the response directly addresses the comparison of financing structures and retained control. Overall, core facts like amounts and retained control are correct, but the mischaracterization of the AT&T deal and omission of VZ’s prepaid rent breakdown reduce correctness. Minor wording differences are acceptable, but the mislabeling of transaction types affects factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 490,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck’s 2024 10‑K notes that the IRS is examining its 2017‑2018 returns for the one‑time transition tax created by the TCJA, and that a disagreement could produce a “significant tax liability” (MRK p. 127).  By contrast, Medtronic’s BEAT‑related effect in 2024 was a modest 0.5 % increase in its effective tax rate—reflecting the minimum tax on cross‑border service payments (MDT p. 114).  Thus, Merck faces an uncertain, potentially large liability, whereas Medtronic’s BEAT impact is a small, quantifiable tax expense.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MRK's potential significant tax liability from the IRS examination of its TCJA transition tax and MDT's BEAT-related impact as a 0.5% increase in effective tax rate. However, the ground truth states MDT's BEAT impact was a 0.3% increase, not 0.5%, making this a factual discrepancy in a key quantitative figure. All other qualitative elements—such as the nature of the TCJA, BEAT as a minimum tax on cross-border payments, and the uncertainty of MRK's liability versus MDT's quantified expense—are accurately conveyed. (2) The dollar amount of MRK's unrecognized tax benefits ($2.3 billion as of December 31, 2024) is missing in the LLM answer, which reduces completeness and quantitative precision. This is a significant omission given its importance in assessing the scale of MRK's exposure. (3) The multi-hop reasoning is sound: the model correctly links TCJA to both companies, distinguishes between MRK’s unresolved IRS examination and MDT’s reported BEAT impact, and draws a valid comparative conclusion about uncertainty vs. modest known impact. (4) The correctness score is 8 because core facts and reasoning are accurate, but there is a clear error in MDT’s tax rate impact (0.5% vs. 0.3%) and omission of MRK’s $2.3B unrecognized tax benefits. Quantitative accuracy is 7 due to the incorrect percentage and missing dollar figure. Qualitative accuracy is 9 due to strong reasoning and correct entity and conceptual identification. Contextual relevance is 10—response directly addresses the comparison asked with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 437,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s 30‑year production‑sharing contracts—10 years of exploration followed by a 20‑year production period with partial relinquishment—set the contractual horizon for operators. ConocoPhillips must secure such PSCs to operate in Nigeria, which shapes its operational footprint by limiting the duration of its rights and guiding where it invests and develops assets over a 30‑year cycle. Chevron’s reserve disclosures in Africa reflect the portion of reserves held under PSCs, reported under the economic‑interest method, so the 30‑year PSC term directly influences the size, classification and separate reporting of those African reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Nigeria's 30-year PSC structure (10-year exploration + 20-year production) with partial relinquishment is accurately described. ConocoPhillips' operational footprint being shaped by the need to secure PSCs under this framework is consistent with the original answer. Chevron's reserve disclosures in Africa are correctly tied to the PSC structure and the economic-interest method of reporting, which affects classification and reporting—this matches the intent of the ground truth, even though the exact 2021 reserve number (106 million barrels) is omitted. (2) Quantitative accuracy is perfect: no incorrect numbers or miscalculations; the structural timeline (10+20=30 years) is correct. (3) Multi-hop reasoning is sound: the model correctly links Nigeria’s regulatory framework to ConocoPhillips’ operational strategy and to Chevron’s reserve accounting practices, demonstrating synthesis across entities and regulatory impact. (4) The only minor shortcoming is the omission of the specific 106 million barrel reserve figure for Chevron in Africa from the original answer, which slightly reduces completeness but does not impair the core correctness. Wording differences are semantically equivalent and acceptable. Contextual relevance is excellent—every part of the response addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 392,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred stock carries **limited voting rights**—holders may vote only on a narrow set of matters such as mergers or other transactions that materially affect the preferred class, and their votes are cast as a single class equal to the number of shares held (see AT&T 10‑K, page 90).  This restriction means that restructuring proposals that do not fall within those defined matters cannot be directly challenged by Series C holders, giving the company greater flexibility.  In contrast, Netflix’s common stock follows a **one‑share‑one‑vote** model (Netflix 10‑K, page 60), so every shareholder has equal voting power on all matters, and any restructuring must be approved by the broad shareholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly states that AT&T’s Series C Preferred Stockholders have limited voting rights, exercisable only in specific scenarios such as mergers or transactions affecting their class, which matches the original answer’s emphasis on restructuring events requiring separate approval. It also accurately contrasts this with Netflix’s one-share-one-vote model. (2) There are no numeric values (e.g., dates, dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures from two different companies (AT&T and Netflix) and draws a valid comparison regarding shareholder influence in restructuring decisions. The mention of specific 10-K page numbers (90 for AT&T, 60 for Netflix) adds precision and supports authenticity, though these are not part of the ground truth verification but do not detract. (4) The only minor shortcoming is that the LLM answer does not explicitly state that Series C holders have *no* voting rights outside of those narrow contexts—though this is implied by 'limited voting rights' and 'narrow set of matters.' The original answer makes this absence more explicit. Otherwise, the semantic meaning and factual content are equivalent. Contextual relevance is perfect as it directly addresses the influence of voting structures on restructuring decisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 414,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Enbrel’s key patents expire between 2028 and 2037, after which AbbVie will likely face biosimilar competition under the 12‑year exclusivity period of the Biologics Price Competition and Innovation Act【page_11】. Because Enbrel is an AbbVie product (page_10), Pfizer’s revenue strategy for Enbrel is not directly affected; Pfizer’s own biologic portfolio will instead rely on its own patent‑term restoration and regulatory exclusivity provisions to sustain long‑term revenue【page_9】.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, most critically misattributing Enbrel's ownership. The original answer and ground truth clearly state that Enbrel is a product for which Pfizer holds rights (in the U.S.), while AbbVie markets it outside the U.S. The LLM incorrectly states that 'Enbrel is an AbbVie product' and concludes that Pfizer’s revenue strategy is not directly affected—this is false, as Pfizer does derive U.S. revenue from Enbrel and thus its patent expirations directly impact Pfizer’s strategy. (2) Quantitatively, the LLM correctly identifies the 2028–2037 patent expiration range, aligning with the ground truth (2028 for fusion protein, 2029 for DNA, 2037 for formulations). However, it incorrectly invokes the 12-year exclusivity period under the BPCIA as if it were directly determining the expiration timeline, which is not accurate—Enbrel was approved before the BPCIA exclusivity rules fully applied in the same way, and its protections are primarily patent-based. (3) The multi-hop reasoning fails: the question asks how Enbrel’s patent timeline impacts Pfizer’s strategy in contrast to AbbVie’s approach. The LLM does not synthesize this correctly—it severs Pfizer’s connection to Enbrel rather than comparing Pfizer’s relatively passive patent lifecycle management with AbbVie’s aggressive use of patent term restoration and exclusivity extensions. The original answer correctly highlights that Pfizer may need to adopt AbbVie-like strategies; the LLM misses this entirely. (4) Due to the fundamental error in entity attribution (who owns what rights to Enbrel), the qualitative and contextual accuracy scores are low. While some dates are correct, the conclusion is factually wrong and irrelevant to the actual strategic implications for Pfizer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 489,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore plant produces about 1.9 million units of ethylene (page 26). Chevron’s indirect stake in the Map Ta Phut Olefins joint venture supports roughly 1.8 million units of ethylene (page 15). Thus, ExxonMobil’s Singapore facility has a slightly higher ethylene capacity than the capacity Chevron supports in Thailand.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error by asserting that Chevron's indirect stake supports 'roughly 1.8 million units of ethylene,' which is not supported by the ground truth. The original answer explicitly states that while Chevron owns a 32.77% stake in the Map Ta Phut Olefins joint venture, the exact ethylene capacity attributable to Chevron is not specified. Therefore, the LLM fabricates a specific capacity figure (1.8 million metric tons) that is not present or inferable from the evidence. (2) The ExxonMobil Singapore capacity of 1.9 million metric tons is correctly cited, matching the ground truth. However, the comparison conclusion (ExxonMobil slightly higher) is based on an unsupported number for Chevron, making the comparison invalid. (3) The multi-hop reasoning fails because the model incorrectly assumes or calculates Chevron's attributable ethylene capacity without sufficient data. To be accurate, it would need to either state the joint venture's total capacity and apply Chevron's ownership percentage (which is not provided in the evidence) or acknowledge the lack of sufficient data—similar to the original answer. Instead, it invents a precise figure, demonstrating flawed reasoning. (4) While the answer addresses the comparative structure of the question and correctly identifies the ExxonMobil capacity, the invention of a specific number for Chevron undermines factual correctness. The contextual relevance is moderate because it attempts the right comparison, but the qualitative and quantitative inaccuracies severely reduce reliability. Minor note: 'units' is vague but likely refers to metric tons; this is acceptable as a format variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 463,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company’s disallowance of capital investments at Nicor Gas in Illinois produced a pre‑tax charge of roughly **$96 million** (page 300).  By contrast, NextEra Energy’s physical footprint in the state is modest – it owns about **90 miles of rate‑regulated transmission lines** (plus five substations, 161‑345 kV) in Illinois (page 16).  Thus, the financial hit is large relative to NextEra’s relatively small infrastructure presence in the state.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error in the interpretation of NextEra Energy's infrastructure. The ground truth states that NextEra operates 90 thousand miles of transmission lines across multiple states, including Illinois. However, the LLM incorrectly reports this as '90 miles' in Illinois alone, which is off by a factor of 1,000. This drastically misrepresents the scale of NextEra’s infrastructure. Additionally, the LLM confines NextEra’s footprint to only 90 miles in Illinois, while the original answer clarifies that the 90 thousand miles span Illinois, Indiana, Kentucky, New Hampshire, and New York, with Illinois being part of a broader footprint. The $96 million pre-tax charge for Southern Company is correctly cited. However, the reasoning and comparison are flawed due to the incorrect magnitude of NextEra’s assets. The conclusion that the financial hit is 'large relative to NextEra’s relatively small infrastructure presence' is therefore invalid, as NextEra’s actual infrastructure footprint (even if shared across states) is vastly larger than implied. The answer fails the multi-hop synthesis by misrepresenting the scope and scale of the compared assets, undermining the core comparison. Wording and structure are clear, and the source references (page numbers) suggest document grounding, but the numerical inaccuracy severely compromises correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 383,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO’s equity‑method stake in Coca‑Cola Europacific Partners (CCEP) represented roughly **31 %** of its total equity‑method investments as of December 31, 2021 (3,578 / 11,503 ≈ 31 %). CCEP operates bottling and distribution facilities in **Iceland**, a country where COST also has a presence, creating a geographic overlap between the two companies’ operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative claim. It states that KO's stake in CCEP represented approximately 31% of KO's total equity-method investments, based on a calculation of 3,578 / 11,503. However, the ground truth states that KO owned approximately 19% of CCEP — not that CCEP represented 31% of KO’s total equity-method investments. These are fundamentally different metrics: the original answer refers to KO’s ownership percentage *in CCEP*, while the LLM incorrectly interprets it as the *proportion of KO’s total equity investments* attributable to CCEP. This is a critical misunderstanding of the question and data. (2) The numbers 3,578 and 11,503 (likely in millions) and the resulting 31% calculation may be arithmetically correct, but they are factually irrelevant because they do not reflect what was asked. The question asks for the percentage of KO’s equity-method investments represented by its stake in CCEP — but the ground truth does not provide data to support this specific calculation, and more importantly, the original answer focuses on KO’s *ownership share in CCEP* (19%), not the portfolio weight. Thus, the LLM fabricates a calculation not supported by the ground truth. (3) The qualitative reasoning is partially sound: it correctly identifies that CCEP operates in Iceland and that COST also operates there, noting the geographic overlap. This reflects correct multi-hop synthesis between KO → CCEP → Iceland operations and COST → Iceland operations. (4) Contextual relevance is high because the answer addresses both parts of the question — the percentage stake and the operational overlap in Iceland — but the first part is based on incorrect data interpretation. The reasoning about shared market exposure is semantically aligned with the ground truth. Overall, the answer fails on quantitative accuracy due to a fundamental misinterpretation of the metric, dragging down the correctness score despite relevant contextual and qualitative elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 546,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s direct exposure to electricity‑price volatility is quantified by its commodity‑derivative liabilities, which total **$609 million** (notional value) as of December 31 2023【page 181】.  Southern Company’s indirect exposure is limited to the **100 MW** of year‑round capacity that Alabama Power provides to PowerSouth under a 2021 agreement—just a small fraction of PowerSouth’s >1,600 MW generating portfolio【page 17】.  Thus, Duke Energy’s direct exposure is substantially larger and more diversified than Southern Company’s relatively modest, capacity‑specific indirect exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The $609 million commodity-derivative liability for Duke Energy is not present in the original answer or implied in the context; this specific number and its characterization are fabricated. The original answer discusses Duke Energy’s use of fuel adjustment clauses, formula-based contracts, and hedging programs but does not quantify exposure with a $609 million figure. Similarly, the claim that PowerSouth has a >1,600 MW generating portfolio is not in the original answer and introduces unverified data. The 100 MW capacity figure and 2021 agreement are correct and align with the ground truth, as is the mention of year-round service starting in 2024 (implied in the original’s 'starting in 2024' detail). However, the LLM incorrectly frames the comparison as one of size and diversification, whereas the original emphasizes structural differences in exposure—direct hedging and regulatory mechanisms (Duke) vs. indirect, contract-mediated exposure through operational coordination (Southern Company). (2) Quantitative accuracy is low: the $609 million figure is unsupported and likely hallucinated; the >1,600 MW portfolio size lacks grounding. Only the 100 MW and 2021 agreement are accurate. (3) Multi-hop reasoning is partially sound—the model identifies both companies, their respective exposure mechanisms, and the PowerSouth/Alabama Power agreement—but fails to synthesize the correct qualitative distinction: Duke’s direct financial and regulatory risk management vs. Southern’s indirect, structurally mitigated exposure through coordination, not size or diversification. The reasoning incorrectly reduces the comparison to scale rather than mechanism. (4) Contextual relevance is moderate: the answer addresses the core entities and the 100 MW agreement, but introduces irrelevant quantitative comparisons and omits the key conceptual contrast in risk management strategies emphasized in the original. Thus, while it engages with the question, it misrepresents the nature of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 558,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 licensed and company‑operated stores in Taiwan during FY 2022 (from 523 to 544 stores【page_12】).  Nike reported $6.679 billion in revenue from its Greater China segment (which includes Taiwan) in FY 2022【page_89】.  Thus, Starbucks’ store growth in Taiwan is a modest 21‑store increase, while Nike’s Greater China revenue is a multi‑billion‑dollar figure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Starbucks' net store increase in Taiwan as 21 (from 523 to 544), which aligns with the ground truth. However, it reports Nike's Greater China revenue as $6.679 billion, whereas the ground truth states $7.547 billion — a significant discrepancy that affects quantitative accuracy. (2) The store count numbers are accurate (523 to 544 = +21), but the Nike revenue figure is incorrect. The LLM cites $6.679 billion, which does not match the ground truth of $7.547 billion; this is not a formatting difference but a material factual error. (3) The reasoning correctly acknowledges that Taiwan is included in Nike’s Greater China segment and attempts to contrast Starbucks’ physical expansion with Nike’s regional revenue, fulfilling the multi-hop requirement of linking Starbucks’ Taiwan operations to Nike’s Greater China performance. However, the failure to use the correct revenue figure undermines the validity of the comparison. (4) The contextual relevance is high because the answer addresses both parts of the question and draws a logical contrast between store growth and revenue scale. Qualitative accuracy is moderate due to correct entity and metric identification despite the numerical error. Quantitative accuracy is low due to the incorrect Nike revenue figure. Correctness score is 6 because the core structure and reasoning are sound, but a key financial figure is wrong, leading to partial correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 405,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "Under ASU 2022‑04, 3M’s Note 16 now discloses the $0.3 billion of confirmed invoice obligations, shows a roll‑forward of invoices confirmed and paid, and places the balance within accounts payable, thereby making the magnitude of the obligation visible to users. FedEx’s adoption of the same standard (Note 1 and the SCF note on pages 90‑94) likewise requires disclosure of program nature and activity, but it presents a more detailed roll‑forward table—including beginning and ending balances, invoices confirmed and paid, and the amounts approved to sell to financial institutions—providing a higher level of transparency than 3M’s disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: 3M's $0.3 billion in confirmed invoice obligations is accurately reported, and the timing of ASU 2022-04 adoption (2023 for 3M, June 1, 2023 for FedEx) is consistent with the original answer, though the LLM does not explicitly mention the 2024 roll-forward effective date. However, this omission is minor given the focus on disclosure content. (2) The LLM correctly identifies both companies, the standard (ASU 2022-04), and the nature of required disclosures—balance sheet placement, roll-forwards, and program details. (3) The reasoning is sound: it correctly synthesizes how the standard improves visibility for 3M and compares it to FedEx’s more detailed disclosures, noting specific enhancements like the inclusion of beginning/ending balances and amounts approved for sale. This comparative insight goes beyond the original answer and adds value. (4) The only minor shortcoming is that the original answer emphasizes both companies now provide 'clearer insights' and 'align their reporting,' while the LLM implies FedEx provides higher transparency without confirming that both meet the baseline transparency requirements—this nuance slightly affects qualitative accuracy. However, the LLM’s claim of FedEx having 'a higher level of transparency' is a reasonable inference from more detailed disclosures and does not contradict the ground truth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across entities and disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 441,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies’ dual‑class structures concentrate voting power in the hands of a few shareholders, giving them outsized influence over board elections and corporate policy.  At CMCSA each Class B share carries 15 votes, enabling the controlling shareholder to dominate decisions even with a minority of shares, while at META the 35 % Class B voting‑power threshold lets the controlling shareholder block any change‑of‑control transaction unless that threshold is met.  These arrangements expose minority shareholders to governance risks such as reduced accountability, potential self‑dealing and limited ability to influence or benefit from corporate actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CMCSA's Class B shares have 15 votes per share, and META's Class B shareholders can block change-of-control transactions as long as they hold at least 35% of the combined voting power. These numbers match the original answer exactly. (2) The quantitative accuracy is perfect—both percentages and voting rights are correctly reported without calculation errors. (3) The multi-hop reasoning is sound: the model correctly identifies that both structures concentrate power, enabling controlling shareholders to dominate governance despite potentially holding minority economic stakes, which exposes minority shareholders to risks like reduced accountability and self-dealing. (4) The answer captures the core governance risks—disproportionate influence, limited minority input, and potential impact on investor appeal—though it omits the specific example of Brian L. Roberts and the exact 33⅓% voting power at CMCSA mentioned in the original. This minor omission prevents a perfect 10 on qualitative accuracy, but the semantic meaning and risk analysis remain equivalent. The response is fully relevant and directly addresses the comparative governance risks posed by both companies' dual-class structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 363,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "Visa’s Level‑2 U.S. pension plan assets totaled $733 million in 2022, of which $319 million were collective investment funds – roughly **43.5 %** of the Level‑2 pool.  Visa uses these funds to provide a diversified mix of equity and fixed‑income exposure with a moderate yield profile, whereas Capital One’s “other securities” (primarily ABS and foreign bonds) form a small, fixed‑income‑focused segment that delivers a higher yield than Treasuries but lower than corporate debt, emphasizing yield enhancement over equity exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains significant quantitative errors. It states that Visa's Level-2 U.S. pension plan assets totaled $733 million, but the ground truth reports total U.S. pension plan assets as $960 million, with $319 million in collective investment funds under Level 2. The percentage calculation is therefore incorrect: 319/733 ≈ 43.5%, but the correct base is $960 million, making the correct percentage ~33.2%. This misrepresents the denominator and leads to an inflated percentage.\n\n2) The question asks for the percentage of V's U.S. pension plan assets classified as Level 2 that consist of collective investment funds. The ground truth uses total U.S. pension assets ($960M) as the denominator, not just Level 2 assets. However, the LLM interprets this as a subset of Level 2 assets, which may reflect ambiguity in the question phrasing. Still, the original answer clearly uses total U.S. pension assets as the reference, so the LLM's interpretation deviates from the intended calculation.\n\n3) On qualitative aspects, the LLM correctly identifies that Visa uses collective investment funds for diversified equity and fixed-income exposure. It also correctly notes COF’s 'other securities' are fixed-income focused. However, it fails to mention COF's weighted-average yield of 1.57%, instead making a generic claim about yield enhancement without citing the actual figure. The LLM also introduces ABS and foreign bonds as components of COF’s portfolio, which are not mentioned in the ground truth.\n\n4) The comparison in investment focus is partially accurate—diversified portfolios vs. fixed-income focus—but lacks direct reference to COF’s yield data and mischaracterizes the risk-return profile by claiming higher yield than Treasuries without supporting data. The reasoning is plausible but not fully aligned with the provided facts.\n\n5) Contextually, the answer addresses both parts of the question—percentage allocation and comparison of investment strategies—and attempts multi-hop reasoning across V and COF. However, due to the incorrect denominator and missing yield data, the synthesis is flawed. Minor flexibility is allowed in wording, but core numbers and calculations must be accurate, which they are not here.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 597,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe’s 10‑K (page 30) notes that meeting Saudi Arabia’s data‑localisation rules will require a “substantial expense” and divert engineering resources, but it does not disclose a dollar amount. Microsoft’s 10‑K (pages 27‑31) acknowledges that similar data‑sovereignty regulations could impose significant compliance costs and governance burdens, yet it likewise does not provide a specific figure. This contrast suggests Adobe’s cloud strategy is more regionally focused, tailoring compliance to particular markets, while Microsoft’s strategy is globally integrated, building a broader compliance framework to serve many jurisdictions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity-specific details. (1) Quantitatively, there are no numeric errors because neither the ground truth nor the LLM answer provides specific dollar amounts; both correctly state that exact figures are not disclosed, so quantitative accuracy is high. (2) However, the LLM misattributes information: it claims Adobe’s 10-K mentions 'substantial expense' and 'diversion of engineering resources'—but this language actually appears in Microsoft’s filing, not Adobe’s. Adobe’s 10-K (ADBE_10k_2024.pdf) warns of adverse impacts from data localization in Saudi Arabia but does not use the phrase 'substantial expense' or mention engineering resource diversion. Conversely, Microsoft’s 10-K (MSFT_10k_2024.pdf) does include those specific phrases. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that Adobe has a 'regionally focused' cloud strategy based on selective compliance, while the ground truth reveals Adobe is vulnerable due to enterprise customer contracts, not strategic regional focus. In contrast, Microsoft’s systemic challenges stem from its global cloud and AI infrastructure requiring cross-border data flows—correctly identified in the original answer but oversimplified in the LLM version. (4) The conclusion about strategic differences is plausible but not well-supported by the cited evidence, and the misattribution of quotes undermines qualitative accuracy. Contextual relevance is strong as the response addresses compliance costs and cloud strategies, but the reasoning does not accurately reflect the source disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 448,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy’s sale of KO Transmission’s 90‑mile interstate pipeline on February 1, 2023 removed an asset that was subject to FERC’s certification, siting, and rate‑setting rules, thereby shrinking the company’s FERC regulatory exposure for that facility (see page 18). In contrast, Southern Company’s 2024‑2028 construction and environmental‑compliance programs remain exposed to FERC rule changes—any shift in FERC regulations can alter cost estimates, delay approvals, or affect cost‑recovery, creating ongoing capital‑expenditure risk (see page 104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the divestiture date (February 1, 2023) matches, and while the original answer mentions 'approximately book value' and the LLM answer does not include the sale price, this omission is minor and does not affect core correctness. The LLM adds a specific detail—'90-mile pipeline'—not in the ground truth, but this is plausible and not contradicted. (2) The LLM correctly identifies Duke Energy Ohio’s divestiture (entity accuracy) reducing FERC exposure, and contrasts it with Southern Company’s ongoing capital expenditure risks due to FERC rule changes. (3) Multi-hop reasoning is sound: it synthesizes Duke’s reduced regulatory exposure post-divestiture with Southern Company’s continued risk, correctly drawing a contrast in regulatory exposure. (4) The LLM cites page numbers (18 and 104), which are not in the ground truth but may reflect source document references; these do not detract from accuracy. The only minor gap is the lack of explicit mention of 'uncertainty in cost recovery' for Southern Company, though 'affect cost-recovery' is mentioned, preserving semantic equivalence. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 360,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS’s $2.7 billion in unfunded commitments to private‑debt and private‑equity funds (page 93) represents a large, long‑term, illiquid allocation that will be contributed over 3–6 years and is only redeemable at the end of the partnership term.  \nCaterpillar’s $55 million of NAV‑measured assets in its other post‑retirement benefit plans (page 102) is a much smaller, more liquid‑or‑at‑least‑transparent portion of its portfolio, reflecting a diversified strategy that still includes alternative investments but with a lower illiquidity profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $2.7 billion unfunded commitments for UPS and $55 million NAV-measured assets for Caterpillar, with accurate references to the respective pages (93 and 102), matching the ground truth in quantitative terms. These figures are correctly attributed to the right companies and contexts. 2) Quantitative accuracy is perfect: both dollar amounts are correct, and no calculations are required beyond comparison, which is handled appropriately in magnitude (large vs. small). 3) The reasoning correctly contrasts UPS’s illiquid, long-term private fund commitments with Caterpillar’s more liquid and transparent NAV-measured assets. However, the LLM slightly underdevelops the investment strategy contrast—while it notes Caterpillar’s portfolio includes alternative investments, it misses the ground truth’s specific mention of U.S. corporate bonds and short-term instruments, which strengthens the liquidity argument. Also, the UPS redemption timeline is described as 'end of partnership term' but the ground truth specifies 10–15 year terms, which the LLM omits. The 3–6 year contribution period mentioned by LLM is additional detail not in the ground truth but is plausible and not contradictory. 4) Despite minor omissions in descriptive detail about asset composition and holding periods, the LLM captures the core contrast in liquidity and strategy. The answer remains contextually relevant and semantically aligned with the ground truth, just slightly less specific in qualitative characterization. Hence, high scores across the board with a small deduction in qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 442,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet repurchases only its Class A and Class C shares, leaving the Class B shares (10 votes per share) intact, thereby preserving concentrated voting power (see GOOGL Note 11, page 81). In contrast, Netflix’s common stock is “one vote per share” for all holders (see NFLX Note 9, page 61). This indicates Alphabet’s governance strategy prioritizes maintaining control by keeping the high‑voting Class B shares while using share‑buybacks to adjust capital without diluting that control, whereas Netflix adopts a more egalitarian, uniform‑voting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Alphabet repurchased Class A and C shares while retaining Class B shares with 10 votes per share, and contrasts this with Netflix's one-vote-per-share structure. The core factual content matches the ground truth. However, the LLM omits the specific dollar amount of $62.2 billion in repurchases mentioned in the original answer, which is a minor but notable omission in completeness. (2) All numeric and structural details present are accurate: '10 votes per share' for Class B and 'one vote per share' for Netflix are correct. No calculations are required, and the years (implied 2023 via context) are consistent. The absence of the $62.2 billion figure affects completeness but not the qualitative reasoning. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet and Netflix, drawing a valid inference about governance strategy—concentrated control vs. egalitarian voting. The logic that preserving Class B shares maintains insider control while using buybacks for capital efficiency is well-articulated. (4) The answer is contextually excellent, directly addressing the contrast and its implications. The only reason for not scoring a 10 is the missing quantitative detail, which slightly weakens completeness. Thus, correctness is 9 (all reasoning and entities correct, minor omission), quantitative accuracy is 10 (no errors in numbers provided), qualitative accuracy is 9 (minor gap in synthesis depth), and contextual relevance is 10 (fully on point).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 428,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola’s effective tax rate rose to 21.1 % in the most recent year reported – an increase of 0.8 percentage points from 20.3 % in 2020 – largely because the Tax Reform Act’s GILTI provisions were applied in the period (page 107).  In contrast, Philip Morris International’s 2021 effective tax rate climbed only 0.1 percentage point to 21.8 %, with the corporate‑income‑tax reduction in the Philippines partially offsetting the GILTI impact (page 93).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Coca-Cola's effective tax rate increased from 20.3% in 2020 to 21.1% in the 'most recent year reported'—but the question specifically asks about the 2022 impact of GILTI, and the ground truth specifies a 4.4% impact on the effective tax rate due to a $431 million net tax expense. The LLM does not mention this dollar amount or the precise 4.4 percentage point impact, instead implying a 0.8 percentage point increase in the rate without linking it directly to GILTI as the primary cause. (2) Regarding Philip Morris International (PMI), the LLM claims the 2021 effective tax rate 'climbed' 0.1 percentage point to 21.8%, which contradicts the ground truth: the tax rate reduction in the Philippines *decreased* the rate by 0.1 percentage point (i.e., a benefit), not an increase. The LLM incorrectly frames this as a rise in the tax rate and falsely suggests GILTI had a negative impact on PMI, which is not supported by the original answer. Additionally, the LLM fails to mention that the tax benefit occurred in the context of business combinations in the Philippines, a key part of the multi-hop reasoning. (3) The multi-hop synthesis is flawed: the model conflates cause and effect for PMI and misattributes the direction of tax rate changes. It also omits the $431 million expense for Coca-Cola and misrepresents the timing and magnitude of the GILTI impact. (4) While the LLM correctly identifies the two companies and general tax topics, the quantitative inaccuracies and logical errors severely undermine correctness. The contextual relevance is moderate because it addresses the right companies and tax events, but the reasoning and numbers are significantly off.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 482,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "BAC’s sale of roughly $3.1 billion of mortgage loans to GSEs in 2023 (page 18) reduces the amount of mortgage collateral that BAC services, thereby lowering the servicer‑concentration risk in MET’s $12.392 billion pass‑through RMBS portfolio (page 98).  Because the securities are still secured by the same mortgage loans—now largely guaranteed by the GSEs—the underlying credit risk of the portfolio remains essentially unchanged, though the GSE guarantee may mitigate default risk relative to non‑GSE‑guaranteed loans (page 97).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains quantitatively accurate figures: BAC sold $3.1 billion in mortgage loans to GSEs in 2023, and MET holds a $12.392 billion portfolio of pass-through MBS—both numbers match the ground truth exactly. However, the qualitative reasoning is fundamentally flawed. The LLM incorrectly asserts that the sale of loans to GSEs reduces servicer-concentration risk for MET’s portfolio, implying a structural or risk-reducing effect from BAC’s sale. This contradicts the ground truth, which emphasizes that BAC’s role as a servicer creates risk exposure: if BAC fails in its servicing obligations (e.g., due to cybersecurity incidents), it could disrupt cash flows and increase credit risk for MET’s MBS portfolio. The LLM flips the logic—portraying the sale as risk-lowering—when the actual concern is operational and credit risk from ongoing servicing relationships. Furthermore, the LLM introduces unsupported claims about reduced collateral and servicer-concentration risk without evidence from the context. It also cites page numbers (e.g., page 18, 97, 98) not present in the original input, suggesting hallucination. While the mention of GSE guarantees mitigating default risk is plausible, it is not part of the original causal chain provided in the ground truth and distracts from the core point about servicer risk. Thus, despite correct numbers, the reasoning and synthesis are incorrect, leading to a low correctness score. The answer is contextually relevant in discussing MBS and servicers but misrepresents the nature of the risk relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 428,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "NKE’s embedded derivatives are classified as Level 3, meaning they are valued with significant unobservable inputs and non‑market‑based assumptions that increase valuation complexity (see the “Embedded derivatives” line in the derivative‑asset table on page 83). In contrast, Lowe’s fair‑value measurements are primarily Level 2, relying on observable market inputs (the note on page 56 states that when quoted prices were not available, pricing models used observable market inputs), so Lowe’s valuation relies less on non‑market‑based assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies that NKE's embedded derivatives are classified as Level 3 due to significant unobservable inputs, increasing valuation complexity. It correctly contrasts this with LOW's use of primarily observable inputs. However, it omits key details from the ground truth: (1) the specific $5 million value of NKE's embedded derivatives as of May 31, 2022, which is a material quantitative fact; (2) the explicit mention that LOW reported no material fair value measurements on a nonrecurring basis; and (3) the specific reference to MET_10k_2022 for illustrative Level 3 assumptions (e.g., actuarial inputs for policyholder behavior and mortality), which strengthens the comparative context. While the LLM correctly infers that LOW relies less on non-market-based assumptions, it does not fully synthesize the multi-hop element involving MET’s example as a benchmark for Level 3 complexity, instead generalizing LOW’s approach based on Level 2 classification. The reasoning is sound but less precise in cross-entity comparison. No numerical inaccuracies are present, and the semantic meaning aligns well with the original answer, but the omission of specific figures and contextual benchmarks reduces completeness and qualitative accuracy. Wording variations are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 378,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD’s pension assets classify direct private‑equity holdings as Level 3 and value them with unobservable inputs, while its fixed‑rate notes (a Level 2 asset) are valued with observable market data (interest rates, bond yields, quoted prices)【page_83】.  Lockheed Martin’s Level 3 assets are private‑equity funds totalling $4,951 million, also valued with unobservable inputs that cannot be corroborated by observable market data【page_87】.  Thus, GD’s Level 3 valuation is confined to direct private‑equity investments, whereas LMT’s Level 3 valuation covers a larger private‑equity portfolio that relies entirely on unobservable inputs.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4,951 million private equity fund holdings for LMT and correctly states that both GD and LMT use unobservable inputs for their Level 3 assets. However, it contradicts the ground truth by claiming GD values its Level 3 assets (direct private-equity holdings) using unobservable inputs, while the original answer states GD uses valuation models with observable inputs such as interest rates and quoted prices for similar assets for its fixed-rate notes—which are part of Level 3. The LLM incorrectly classifies GD’s fixed-rate notes as Level 2, directly conflicting with the premise of the question and the ground truth, which places GD’s fixed-rate notes in Level 3 and emphasizes their use of observable inputs within Level 3 models. This is a critical factual and conceptual error in asset classification and valuation hierarchy. (2) Quantitatively, the $4,951 million figure for LMT is accurate and correctly cited. No other numbers are misstated. (3) The multi-hop reasoning is partially sound—comparing GD and LMT’s Level 3 approaches—but fails on a key point: the question hinges on GD using observable inputs in Level 3 models (a nuance the LLM misses), while the LLM incorrectly suggests GD’s Level 3 assets are only direct private equity with unobservable inputs and separates fixed-rate notes into Level 2, which breaks the comparison. (4) The contextual relevance is high as the answer addresses pension assets, Level 3 valuations, and unobservable inputs, but the qualitative inaccuracy in asset classification and input types significantly undermines the correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 455,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder litigation began in January 2020 when Slack filed a motion to dismiss the federal complaint. The district court granted the motion in part and denied it in part in April 2020, and the case then moved through interlocutory appeal, Ninth Circuit review, a Supreme Court writ of certiorari (vacated the Ninth Circuit ruling in June 2023), and finally a Ninth Circuit order in February 2025 to dismiss the complaint with prejudice. In contrast, Disney filed motions to dismiss the Biddle and Fendelander antitrust actions on January 31 2023; the court partially granted those motions on September 30 2023, consolidated the cases, and later granted the motion to dismiss the consolidated complaint in part on June 25 2024, leaving the litigation still in its early stages. Thus, Slack’s motion to dismiss ultimately led to dismissal with prejudice after a multi‑year appellate process, whereas Disney’s strategy has yielded only partial dismissals and the consolidated case remains pending.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key dates and events are correct: Slack's motion to dismiss in January 2020, partial denial in April 2020, Supreme Court vacatur in June 2023, and final Ninth Circuit dismissal with prejudice on February 10, 2025. Disney's motions to dismiss filed January 31, 2023, partial rulings on September 30, 2023, and December 1, 2023 motion with a June 25, 2024 ruling are all correctly stated. (2) Quantitative accuracy is perfect—no numerical or date discrepancies; format variations (e.g., 'February 2025' vs 'February 10, 2025') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes procedural timelines across two companies and multiple legal actions, contrasting Slack’s definitive resolution with Disney’s ongoing litigation. (4) The only minor omission is that the original answer notes Slack’s case reached the U.S. Supreme Court (implied by 'writ of certiorari' and 'vacated'), but the LLM does not explicitly state that the Supreme Court was involved, though it is inferable. Also, the LLM omits the March 27, 2026 class certification deadline for Disney, a minor completeness gap. Otherwise, the reasoning, entity accuracy (Slack, Disney, Biddle, Fendelander), and contextual relevance are excellent. The comparison effectively captures the strategic and procedural contrast in litigation outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 396,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s Hong Kong operations generate a tax benefit that helped lower its effective tax rate to 8.5 % in 2021, but the 10‑K does not disclose a dollar amount for that benefit.  In contrast, Apple’s Greater China segment – which includes Hong Kong – contributed $74.2 billion in net sales in 2022, the second‑largest geographic segment after the U.S.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion net sales figure for Apple's Greater China region in 2022 is correct, and the mention of Intel's 8.5% effective tax rate in 2021 is factually consistent with disclosed data. While the original answer does not specify Intel's effective tax rate, the LLM correctly notes that no dollar amount is disclosed for the Hong Kong tax benefit, which is a valid clarification. (2) The entity accuracy is strong: both Intel and Apple are correctly identified, with appropriate metrics (tax benefit vs. revenue contribution), and the inclusion of Hong Kong in Apple’s Greater China reporting is properly acknowledged. (3) The multi-hop reasoning is sound—comparing Intel’s tax strategy in Hong Kong to Apple’s revenue from a region that includes Hong Kong—without conflating the two distinct financial impacts (tax vs. revenue). (4) The LLM adds contextual precision by noting that Greater China was Apple’s second-largest segment, which is consistent with external knowledge and enhances relevance without distorting facts. The only minor deviation is the introduction of Intel’s 2021 tax rate (8.5%), which, while accurate, is not present in the original answer and slightly exceeds the scope of the provided ground truth. However, this does not introduce error, as it supports the same conclusion. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 407,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "HB 951’s 70 % CO₂‑reduction target forces Duke Energy to shape its 2023 Carolinas Resource Plan around Portfolio 3, which accelerates coal retirements, expands renewables, energy‑efficiency and storage, and extends nuclear and pumped‑hydro to meet the interim 2030 target and 2050 carbon‑neutral goal (page 70; page 71). In contrast, the NextEra Energy 10‑K provided does not disclose any North Carolina operations or exposure in the pages supplied, indicating that the HB 951 requirement does not directly affect NextEra’s North Carolina activities (pages 43‑47).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding NextEra Energy's operational exposure in North Carolina. The quantitative elements are accurate: HB 951's 70% CO₂ reduction target by 2030 is correctly cited, and Duke Energy’s 2023 Carolinas Resource Plan, including Portfolio 3, is accurately described with appropriate reference to coal retirements, nuclear, storage, and renewables. However, the claim that 'the NextEra Energy 10-K provided does not disclose any North Carolina operations or exposure' is incorrect. The ground truth states that NextEra Energy *does* operate in North Carolina and is thus exposed to the same regulatory environment, even if not directly subject to HB 951. The LLM incorrectly infers absence of exposure from lack of disclosure in the provided 10-K pages, which is a reasoning flaw. This undermines the qualitative accuracy, as the comparison between Duke and NextEra hinges on this point. While the core regulatory impact on Duke is well-explained and contextually relevant, the failure to acknowledge NextEra’s actual operational presence and indirect regulatory exposure results in a misleading contrast. The answer would be stronger if it acknowledged that while NextEra is not a regulated utility under HB 951 like Duke, it still faces operational and market-level exposure due to its presence in the state. Thus, the correctness score is reduced due to this key omission and misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 405,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ’s weighted‑average assumptions are used to discount future benefit payments and estimate cost trends for its post‑retirement health‑care plans (e.g., discount rates of 5.53 %–6.07 % and health‑care cost trend rates of 5.75 %–7.00 % for U.S. and non‑U.S. plans, page 107). KO, by contrast, applies weighted‑average assumptions to the Black‑Scholes‑Merton model to value stock options, using parameters such as a risk‑free rate (4.18 %–1.87 %), expected life (5 years), volatility (20.97 %–22.05 %), dividend yield (2.32 %–2.13 %) and expected term (6 years, page 108–95). Thus, MDLZ’s assumptions drive the measurement of service and interest costs for pension‑related benefits, whereas KO’s assumptions drive the fair‑value calculation of equity‑based compensation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the distinct uses of weighted-average assumptions by MDLZ and KO—MDLZ for postretirement healthcare cost measurement and KO for stock option valuation via Black-Scholes-Merton. This core conceptual distinction aligns with the ground truth. However, the LLM introduces specific numeric ranges (e.g., discount rates of 5.53%–6.07%, healthcare trend rates, risk-free rates, volatility, etc.) that are not present in the original answer and cannot be verified against the ground truth, which does not include these granular inputs. These numbers may be factually accurate in the actual filings, but since they are absent from the ground truth and not requested in the question, their inclusion introduces unverifiable quantitative claims, reducing quantitative accuracy. (2) The original answer emphasizes MDLZ’s resulting costs ($14M, $12M, -$5M) and the use of spot rates along a yield curve for service and interest costs—key quantitative and methodological details that the LLM omits. The absence of these figures, which are central to the original answer, constitutes a significant omission. (3) The multi-hop reasoning is sound: the model correctly distinguishes between the two companies and the different financial contexts (postretirement benefits vs. equity compensation). It accurately maps the use of weighted-average assumptions to distinct valuation models and accounting treatments. (4) Despite missing the key financial figures and introducing unverified numeric ranges, the LLM captures the essential contrast in application context, supporting a correctness score of 7. The answer is semantically aligned in intent and structure but lacks fidelity in key quantitative details and adds unsupported specifics, limiting its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 487,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "The JPM 10‑K pages 1‑5 that were provided do not disclose any specific derivative exposure or Dodd‑Frank‑related collateral and netting details, so a direct comparison cannot be made from those documents. In contrast, Bank of America’s 10‑K (pages 11‑14) explains that its resolution‑planning under the Orderly Liquidation Authority imposes inter‑company liquidity restrictions and requires the parent to contribute remaining assets to a holding company when distress becomes imminent, potentially curtailing the ability to draw funds from subsidiaries and limiting liquidity during a crisis. Thus, while JPM’s derivatives exposure is governed by Dodd‑Frank collateral and netting rules that aim to mitigate liquidity risk, Bank of America’s resolution plan explicitly limits liquidity access and may force asset contributions, creating a more direct liquidity constraint in distress.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Bank of America's resolution planning obligations under the Orderly Liquidation Authority (OLA), including intercompany liquidity restrictions and the requirement to contribute remaining assets to the holding company during distress, which aligns with the ground truth's description of the 'single point of entry' strategy. However, the LLM incorrectly claims that JPMorgan Chase's derivative exposure under Dodd-Frank cannot be assessed due to lack of disclosure in the provided 10-K pages, which contradicts the ground truth stating that JPMorgan is subject to enforceable set-off and close-out netting provisions under ISDA agreements constrained by OLA. This omission breaks the multi-hop comparison: while Bank of America's liquidity constraints are accurately described, JPMorgan's parallel regulatory constraints (netting limitations under Dodd-Frank/OLA) are not acknowledged, undermining the comparative analysis. The reasoning is partially sound but fails to synthesize the common regulatory framework (OLA) affecting both firms' liquidity risk management. No numerical data is present in either answer, so quantitative accuracy is not applicable but assumed correct. The answer is contextually relevant and well-structured but misses a key factual link required for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 368,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s continued reliance on coal is evident from Duke Energy Ohio’s inventory of $23 million in coal in 2024, showing the state still depends on coal for power generation【page_124】.  XOM, which operates worldwide, is hit by a European coal‑tax that added an after‑tax charge of roughly $1.8 billion in 2022 and $0.2 billion in 2023, prompting the company to curb coal use to mitigate that cost【page_115】.  In contrast, CVX is investing in renewable natural‑gas projects in Ohio—such as Brightmark’s 2024 operations in the state—to help Ohio transition away from coal and diversify its energy mix【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.8 billion after-tax charge for XOM in 2022 is correctly reported, as is Duke Energy Ohio’s $23 million coal inventory as of December 31, 2024. The mention of an additional $0.2 billion charge in 2023 for XOM is not present in the original answer but does not contradict it—this extra detail may come from broader context and does not undermine accuracy. (2) The entity identification is correct: XOM, CVX, Duke Energy Ohio, and Brightmark RNG Holdings LLC (implied via 'Brightmark’s 2024 operations') are accurately referenced. (3) The reasoning correctly synthesizes multi-hop information: it links Ohio’s ongoing coal use (via Duke Energy’s inventory) to XOM’s European regulatory pressures and contrasts this with CVX’s proactive renewable natural gas investments in the same state. (4) The semantic meaning fully captures the contrast in energy transition strategies—XOM reacting to external tax pressure, CVX investing in low-carbon infrastructure—answering the core of the question. The only minor shortcoming is the lack of explicit mention that the EU tax targeted surplus profits, and slightly less specificity on CVX’s partnership structure (Brightmark RNG Holdings LLC), but these omissions do not detract significantly from correctness. Wording differences are acceptable and do not affect factual equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 392,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "MS’s credit‑linked notes are structured so that the issuer (MS) sells securities to investors and simultaneously buys credit protection from an SPE; when a credit event occurs on the reference asset, the SPE delivers collateral to the issuer, and the issuer’s payout is the collateral value (which may be less than the notional principal)【page_129】. JPM’s credit‑related notes are funded instruments in which the issuer purchases credit protection from the investor; if a credit event occurs, the issuer pays the investor the difference between the note’s par value and the fair value of the defaulted reference obligation, so the investor receives that loss amount【page_224】. Thus, MS’s CLNs result in the issuer receiving collateral upon a credit event, whereas JPM’s notes result in the issuer paying a loss amount to the investor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that MS structures its CLNs by buying credit protection (via an SPE), and upon a credit event, the issuer receives collateral that may be less than the notional principal—this aligns with the ground truth that MS acts as the buyer of protection and may not repay principal in full. Conversely, JPM’s structure involves the issuer (JPM) purchasing protection from the investor, so upon a credit event, JPM pays the investor the difference between par and fair value of the defaulted obligation—this matches the original answer’s description. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; all financial mechanics are described qualitatively and correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting roles (MS as buyer of protection vs. JPM as seller) and links them to different payout mechanics—MS receives collateral (reducing investor payout), JPM pays out losses (increasing investor return). The only minor shortcoming is that the LLM answer frames JPM as 'purchasing credit protection from the investor', which could be misinterpreted as JPM buying protection, but in context, it correctly describes the investor bearing the loss and being compensated, meaning JPM is effectively selling protection. This nuance is slightly less clear than the original answer’s phrasing but still semantically aligned. (4) Contextual relevance is perfect—the response directly compares payout mechanics in light of credit risk transfer, as asked. Overall, the answer is factually correct, well-reasoned, and complete with only a slight ambiguity in phrasing around JPM’s position, warranting a 9 instead of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 499,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both Georgia Power and Florida Power & Light meet the criteria in General Instruction I.(1)(a) and (b) and therefore file with the reduced‑disclosure format. Georgia Power’s filing (Southern Company 10‑K, page 4) explicitly states that it is filing under the reduced format “specified in General Instructions I(2)(b), (c) and (d)”, while Florida Power & Light’s filing (NextEra Energy 10‑K, page 2) simply notes that it meets the conditions and files under the reduced format without citing the sub‑instructions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that both Georgia Power Company and Florida Power & Light Company meet the conditions in General Instruction I.(1)(a) and (b) of Form 10-K and therefore qualify for the reduced disclosure format, which aligns with the ground truth. It accurately notes that Georgia Power explicitly references the sub-instructions (I(2)(b), (c), and (d)) in its filing, while Florida Power & Light simply states compliance without citing the specific sub-instructions—this detail is factually correct and supported by the filings. All entities (Georgia Power, Florida Power & Light, Southern Company, NextEra Energy) and the year (2022 implied by context) are correctly identified, and there are no numerical inaccuracies (no calculations or dollar amounts involved). However, the LLM answer omits a key differentiating point highlighted in the original answer: the structural difference in the filings—Georgia Power is one of multiple registrants in Southern Company’s consolidated filing, whereas Florida Power & Light files as one of only two registrants with NextEra Energy, Inc., which owns all of its common stock. Additionally, the original emphasizes that both disclaim responsibility for the other registrants’ data—a nuance not captured in the LLM response. While the core facts about compliance and disclosure format are correct, this missing contextual distinction reduces completeness in addressing the comparative aspect of the question. Thus, the answer is factually sound and contextually relevant but lacks full qualitative depth in multi-hop synthesis across corporate structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 440,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed‑price contracts over time using a percentage‑of‑completion method, with performance‑based payments (PBPs) and progress payments creating contract assets for revenue that is often recognized in excess of billings; contract modifications are accounted for on a cumulative catch‑up or prospective basis (see RTX page 79).  GD’s cost allocation under FAR and the Cost Accounting Standards assigns costs to contracts and performance obligations, with billing occurring after revenue is recognized and advances received before revenue is recognized; the contract‑balance data (GD pages 65‑66) indicate a similar timing of revenue recognition relative to billing, although the specific treatment of PBPs or modifications is not detailed in the provided pages.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately describes RTX's revenue recognition practice using the percentage-of-completion method on fixed-price contracts, noting that performance-based payments (PBPs) and progress payments lead to revenue recognized in excess of billings—this matches the original answer’s point about contract assets arising under FAR. It also correctly references RTX’s accounting for contract modifications on a cumulative catch-up or prospective basis, citing page 79, which supports the claim. For GD, the LLM correctly states that cost allocation follows FAR and Cost Accounting Standards (CAS), and that costs are assigned to contracts, with billing timing relative to revenue recognition. The mention of GD pages 65–66 adds document-level support. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, the absence of incorrect numbers or miscalculations earns a perfect score by default. (3) The multi-hop reasoning is sound: the model synthesizes information about two companies (RTX and GD), compares their practices under the same regulatory framework (FAR/CAS), and connects it to revenue timing, PBPs, and contract modifications. The only minor shortcoming is that the LLM notes GD’s specific treatment of PBPs or modifications 'is not detailed in the provided pages,' which slightly weakens the comparative analysis compared to the original answer that affirms both companies manage modifications in response to FAR phases. Thus, while the core facts are correct, the LLM is more tentative in drawing the full parallel emphasized in the ground truth. (4) Despite this, the answer remains highly relevant and factually accurate overall, with strong contextual alignment to the question. Wording differences do not affect meaning, and the semantic equivalence is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 524,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "GOOGL’s charter gives each Class B share 10 votes versus one vote for each Class A share (page 82), creating a voting‑power differential that lets Class B holders wield outsized influence over board and policy decisions. In contrast, CMCSA’s Atairos investment is held without voting rights—“we have no voting rights and only certain consent rights” (pages 84‑85)—so the company cannot direct Atairos’ governance, relying only on economic influence. Thus, GOOGL’s structure concentrates control in the hands of Class B shareholders, whereas CMCSA’s lack of voting rights limits its governance control over Atairos.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Class B shares have 10 votes per share and Class A have 1 vote per share at GOOGL—this matches the original answer exactly. The citation of page 82 (for GOOGL) and pages 84–85 (for CMCSA) supports factual grounding, though page numbers are not part of the knowledge graph truth, they do not contradict it. (2) The LLM correctly identifies that CMCSA has no voting rights in Atairos and only certain consent rights, which is consistent with the original answer’s claim that CMCSA lacks control. (3) Multi-hop reasoning is sound: the model compares GOOGL’s internal dual-class voting structure with CMCSA’s external lack of voting rights in an investee, correctly contrasting mechanisms of governance control. (4) The answer captures the core implication: GOOGL concentrates control via share structure, while CMCSA lacks governance influence over Atairos. The only minor shortcoming is a slight lack of explicit mention that Atairos is an equity method investment (a detail in the original), which slightly reduces completeness but does not impair the overall correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 382,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing shows that McKesson accounted for 33 % of its 2021 gross product sales【page_114】 and the company explicitly warns that it “sells primarily to pharmaceutical wholesale distributors” and must monitor the financial condition of these large customers, limit credit exposure, and use letters of credit or credit insurance to mitigate wholesaler‑distribution risk【page_114】. Merck’s risk disclosures likewise flag concentration of sales through a few distributors, noting that “reliance on third‑party relationships and outsourcing arrangements could materially adversely affect the Company’s business” if a major distributor encounters financial or operational difficulties【page_31】, although the filing does not quantify the percentage of sales concentrated at any single distributor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 33% figure for McKesson's share of Amgen's 2021 gross product sales is correctly reported, and the years (2021 sales, 2022 filing) are accurate. No calculations were required, but the percentage is properly cited. (2) The answer is complete: it addresses Amgen’s specific exposure (33% reliance on McKesson, risk mitigation strategies like credit monitoring and insurance), and compares it to Merck’s qualitative risk disclosures about third-party distribution concentration, noting that Merck does not quantify its distributor concentration—this nuance is correctly captured. (3) Entity accuracy is strong: both Amgen and Merck are correctly identified, with accurate reference to their respective 2022 filings and the relevant risk factors. (4) Multi-hop reasoning is sound: the model synthesizes Amgen’s quantitative dependency with its qualitative risk management disclosures and contrasts it with Merck’s unquantified but conceptually similar risk warnings, effectively highlighting industry-wide distribution vulnerabilities. The only minor shortcoming is that the LLM does not explicitly reiterate the 'three distributors' point from Amgen’s filing (though it implies concentration by mentioning reliance on wholesalers), which slightly reduces qualitative completeness. However, the core multi-hop comparison is well-executed and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 407,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ stake in Alba Plant LLC exposes it to a maximum potential future payment of roughly **$116 million** (with a carrying value of about $4 million as of 31 Dec 2024). This figure reflects the guarantees related to the plant’s processing of natural gas from the Alba Unit and the condensate produced by Chevron.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $116 million maximum potential future payment is correctly reported, matching the original answer. The additional detail of a $4 million carrying value as of December 31, 2024, is not present in the ground truth but does not contradict it and may reflect supplementary data from the 10-K; its inclusion does not reduce accuracy. (2) The ownership percentages (52.2% in Alba Plant LLC) are not explicitly restated in the LLM answer, but the focus is on financial exposure, which is correctly tied to the $116M guarantee. (3) The multi-hop reasoning is sound: the answer correctly links ConocoPhillips' financial exposure to its ownership in Alba Plant LLC, the processing of natural gas from the Alba Unit, and Chevron’s condensate production as a contributing upstream input. (4) The answer omits mention of EG LNG (56.0% ownership) and the role of LPG sales and liquefaction, but since the question specifically asks about exposure via Alba Plant LLC, this omission is contextually acceptable. The core financial figure, entities (ConocoPhillips, Alba Plant LLC, Chevron), and causal chain are correct. Minor deduction in qualitative accuracy for not fully elaborating the downstream monetization structure, but the response remains semantically equivalent in scope and purpose.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 380,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics’ Level 2 assets are valued with market‑approach models that incorporate observable inputs such as interest rates, bond yields and quoted prices for comparable securities (page 84). In contrast, Union Pacific’s real‑estate funds are valued at NAV using property appraisals and other unobservable inputs—typically over an 8‑10‑year horizon (page 57). Thus, GD relies on observable market data for its Level 2 valuations, whereas UP’s real‑estate holdings are appraised with unobservable inputs and longer‑term valuation periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: General Dynamics uses observable inputs (interest rates, bond yields) for Level 2 assets, and Union Pacific has real estate funds valued at NAV using unobservable inputs over 8-10 year periods. While the exact dollar amount ($30 million) mentioned in the ground truth is missing in the LLM response, this is a minor omission and does not affect the core comparison. (2) The LLM correctly identifies the valuation methodologies and their basis (observable vs. unobservable inputs), and accurately references the long-term (8-10 year) horizon for real estate fund valuations. (3) The multi-hop reasoning is sound—correctly contrasting GD’s market-based Level 2 valuation approach with UP’s NAV-based, unobservable input method, and linking it to the nature of real estate fund valuations. (4) The answer is contextually relevant and semantically equivalent to the original, with only slight omission of the specific $30M figure preventing a perfect 10. Wording differences (e.g., 'quoted prices for comparable securities') add clarity without distorting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 331,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role in Costco’s program is that of the **co‑branded card issuer** – it issues the credit card, underwrites the accounts and handles card processing for Costco members (see Exhibit 10.8* on page 68).  \nIn Colgate’s five‑year credit agreement, Citibank is the **administrative agent and arranger** – it administers the facility and coordinates the lenders, but it does not issue consumer credit (see Exhibit 10‑I on page 67).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly distinguishes between Citibank's roles in the two financial arrangements with high factual accuracy. (1) It accurately identifies Citibank as the co-branded card issuer for Costco, responsible for underwriting and processing, and as the administrative agent and arranger for Colgate's credit agreement. These roles align semantically with the ground truth, which emphasizes the consumer financial product partnership with Costco versus the corporate lending facility role with Colgate. (2) There are no numeric values, dates, or financial figures in the LLM answer that contradict the ground truth; while the ground truth mentions specific amendment dates (October 11, 2023 for Costco, November 4, 2022 for Colgate) and the number of amendments (twelve since 2015), the LLM answer does not include these details. However, the absence of these specific dates and counts does not introduce inaccuracy—rather, it reflects a more concise response. Since the question does not explicitly ask for dates or number of amendments, their omission does not constitute a failure in correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the Costco relationship involves consumer credit issuance while the Colgate role is administrative in a syndicated loan, demonstrating understanding across two distinct financial arrangements. (4) The LLM references 'Exhibit 10.8*' and 'Exhibit 10-I', which suggests proper sourcing from document context, enhancing credibility. The only minor shortcoming is the lack of elaboration on the ongoing, evolving nature of the Costco program (via multiple amendments), which adds depth to the partnership but is not essential to the core distinction. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth in substance, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 511,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "In 2023 QatarEnergy LNG (N3) produced an average of 13 barrels of crude oil per day. ConocoPhillips owns 30 % of N3, so its share of daily crude oil production was 13 × 0.30 ≈ 3.9 barrels per day (about 4 MBD).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer contains multiple critical errors. (1) It incorrectly states that QatarEnergy LNG produced 13 barrels per day instead of 13 thousand barrels per day (MBD), which is a massive quantitative error (off by a factor of 1,000). (2) It attributes Chevron's stake to ConocoPhillips, a completely different company, which is a severe entity error. (3) The calculation, while mathematically correct (13 × 0.30 = 3.9), is based on wrong units and wrong ownership, making the result factually incorrect. (4) The final result is misrepresented as 'about 4 MBD' when it should be exactly 3.9 MBD, and the unit confusion persists. The multi-hop reasoning fails entirely: the model did not correctly identify the company (Chevron vs. ConocoPhillips), the production volume (13 MBD vs. 13 barrels), or the ownership structure. Despite mentioning the correct percentage (30%), the synthesis is fundamentally flawed. The answer is not semantically equivalent to the ground truth due to these major factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 289,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar values its Level 3 non‑U.S. pension assets—primarily insurance contracts—by applying pricing models that reflect market‑participant assumptions, incorporating insurance‑market pricing, market rates, and inflation (see pages 102 and 100). In contrast, Lockheed Martin’s Level 3 fixed‑income holdings are valued using indicative quotes or bid evaluations from vendors, brokers or the investment manager, and when observable inputs are unavailable, a discounted‑cash‑flow model with projected annuity payments and discount rates is used (see page 89). Thus Caterpillar’s approach centers on insurance‑pricing inputs, while Lockheed Martin blends observable market data, indicative quotes, and DCF inputs for its Level 3 fixed‑income valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar uses pricing models based on management's judgment of market-participant assumptions for Level 3 non-U.S. pension assets (insurance contracts), incorporating inputs like market rates and inflation. Lockheed Martin uses indicative quotes from vendors/brokers and discounted cash flow models with inputs such as projected annuity payments and discount rates when observable inputs are lacking. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—correctly comparing two companies' Level 3 valuation methodologies across different asset types (pension vs. fixed income), identifying key inputs and approaches. (4) The LLM adds slightly more detail (e.g., mention of inflation, investment manager, bid evaluations) not in the original answer but consistent with plausible SEC filing content and does not contradict the ground truth. The only minor gap is that the original emphasizes Caterpillar’s focus on 'management's judgment' more explicitly, while the LLM frames it as 'market-participant assumptions'—a subtle but acceptable rephrasing. Overall, the answer captures the core contrast: Caterpillar relies on pricing models with management-informed assumptions, while Lockheed Martin uses a mix of third-party quotes and DCF models. Semantic equivalence is maintained, and the response fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 434,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s formulation patents expire in October 2037, which could open the market to generics and reduce revenue from this key Specialty Care product, thereby heightening concentration risk for that segment【page_10】【page_11】. Because Specialty Care already relies on a handful of high‑margin products, the loss of Enbrel could magnify the impact of any future expirations. BMY’s strategy of pursuing external innovation and pipeline assets in the immunology space may intensify competition, potentially accelerating generic entry or alternative therapies that further pressure Pfizer’s revenue concentration.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the date 'October 2037' for Enbrel's patent expiration matches the expected timeline in the original answer (2037), and no other numerical values are present—this is accurate. (2) The answer correctly identifies Enbrel as a key product in Pfizer's Specialty Care segment and explains that patent expiration could lead to generic competition, increasing revenue concentration risk—this matches the core reasoning in the original. (3) The multi-hop synthesis between Pfizer’s risk and Bristol Myers Squibb’s external innovation strategy is partially addressed: the LLM notes BMY’s external innovation but does not fully elaborate on how BMY might *enter the post-patent market with new assets* or *shift competitive positioning*, which is a key nuance in the original. The LLM implies increased competition but doesn’t specify BMY’s potential to launch alternative therapies ahead of 2037 as a strategic counterpoint. (4) Despite this, the answer remains contextually relevant and semantically close, with only minor omissions in depth of strategic implications. Wording differences are acceptable and do not affect factual correctness. Minor deduction in qualitative accuracy due to incomplete synthesis of BMY’s forward-looking strategic advantage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 371,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework explicitly relies on both scenario‑based modeling and sensitivity analysis—using scenario analysis to evaluate the impact of specified events on multiple risk factors and sensitivity analysis to quantify the effect of single‑factor moves (see pages 82‑84). In contrast, COF’s credit‑loss forecasting is driven by quantitative loss‑forecasting models that use statistical analyses and economic forecasts, supplemented by qualitative judgments; the methodology does not foreground scenario‑based modeling or sensitivity analysis in the same way (see page 135). Thus, AIG places a stronger emphasis on explicit scenario and sensitivity tools for stress testing, whereas COF focuses on statistical modeling with less reliance on those techniques.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric inaccuracies (quantitative accuracy is perfect), as it does not introduce any incorrect figures or dates. However, the qualitative analysis is significantly flawed. The original answer states that COF *does* use scenario-based forecasting models for its allowance for credit losses (ACL), incorporating both quantitative forecasts and qualitative adjustments based on current and forward-looking economic conditions—explicitly relying on scenario analysis. The LLM incorrectly claims that COF's methodology 'does not foreground scenario-based modeling or sensitivity analysis in the same way,' which contradicts the ground truth. This misrepresents COF’s actual practices and undermines the comparison. While AIG’s use of scenario and sensitivity analysis for market risk is accurately described, the core of the question—comparing two firms’ use of scenario and sensitivity techniques—fails because the LLM incorrectly minimizes COF’s reliance on these methods. The reasoning is therefore unsound in the multi-hop synthesis: it should have recognized that *both* firms use scenario and sensitivity analysis, but in different risk domains (market vs. credit). The answer is contextually relevant and well-structured, but factually incorrect in a key aspect of the qualitative assessment, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 382,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s 10‑K notes that it must comply with the U.S. Export Administration Regulation (EAR) for all advanced semiconductor technologies, maintaining an internal compliance program and obtaining export licenses for many products (page 35).  In contrast, AMD’s 10‑K details a more narrowly‑defined restriction: the Bureau of Industry and Security (BIS) now requires a Notified Advanced Computing (NAC) notification and a license for the export of its Versal VC2602 and VE2602 FPGAs to China or to customers whose ultimate parent is in a D5 country (page 33).  Thus, Qualcomm faces a broad EAR compliance regime across its portfolio, while AMD’s constraints are specifically tied to a handful of FPGA models for the Chinese market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Qualcomm faces broad EAR compliance obligations across its portfolio, referencing its internal compliance program and need for export licenses, which matches the original answer's description of Qualcomm's diffuse regulatory exposure. (2) It accurately specifies AMD's constraints on the Versal VC2602 and VE2602 FPGAs, including the requirement for a Notified Advanced Computing (NAC) notification and export license for shipments to China or to customers with ultimate parents in D5 countries—this is factually consistent with the ground truth, including correct product names and regulatory mechanism. (3) The multi-hop reasoning is sound: the model correctly contrasts Qualcomm’s broad, company-wide EAR compliance regime with AMD’s product-specific and geographically targeted restrictions, synthesizing information from both companies’ 10-Ks. (4) Minor deduction in qualitative accuracy due to omission of AMD’s Data Center segment context (FPGAs being part of adaptive computing products), which adds slight contextual depth in the original answer but does not affect core factual correctness. All entities (Qualcomm, AMD, EAR, BIS, NAC, VC2602, VE2602, China, D5) are correct. No numeric or calculation errors—quantitative accuracy is perfect. The answer is fully contextually relevant, directly addressing the comparative regulatory exposure in high-performance computing markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 411,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "Comcast’s 2019 agreement with Disney meant it gave up board seats and “substantially all voting rights” in Hulu, leaving Disney with full operational control while Comcast kept a 33 % equity stake and put/call rights to sell or buy back that interest.  \nMeta, by contrast, uses a dual‑class share structure in which Class B shares carry ten votes each (Class A has one vote and Class C has none), allowing insiders to retain majority voting power while the public holds lower‑vote shares. Thus, Comcast relinquishes control of Hulu, whereas Meta concentrates control through weighted voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast in control retention strategies between CMCSA and META. (1) Correctly identifies CMCSA's 2019 relinquishment of voting rights and board seats in Hulu, aligning with the original answer. It accurately notes the put/call arrangement and Disney's operational control, though it omits the specific $27.5 billion minimum equity value guarantee and the $8.6 billion payment from Disney in 2023—minor but notable omissions affecting completeness. (2) The 33% equity stake mentioned is contextually accurate and consistent with known filings, though not explicitly in the ground truth; no contradiction. All dates (2019) and structural details (put/call rights) are correct. (3) Entity accuracy is strong: CMCSA (Comcast) and META are correctly identified, with accurate descriptions of Hulu and dual-class structures. (4) The reasoning correctly contrasts relinquishing external control (CMCSA) versus retaining internal control via share structure (META). The explanation of Meta’s dual-class system is precise: Class B shares have 10 votes, Class A have 1, and while the LLM mentions Class C with no votes (not in ground truth), this is factually correct in Meta’s structure and adds context without error. (5) Semantic equivalence is high—core facts, multi-hop synthesis (control trade-off vs. control concentration), and implications are correctly conveyed. Only the missing financial figures ($27.5B, $8.6B) prevent a perfect 10. These omissions reduce quantitative completeness slightly but do not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 435,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ $113.9 billion in broker‑dealer assets (major broker‑dealer subsidiaries $113,996 million) heightens the firm’s exposure to conflicts of interest, so it applies a robust conflict‑of‑interest framework under Regulation Best Interest that includes segregation of proprietary trading, independent research and stringent compliance oversight (GS_10k_2024, page 106; page 9).  Morgan Stanley also follows Regulation Best Interest, but its compliance framework relies on a best‑interest policy, training, monitoring and reporting to ensure research and sales teams act in the best interest of retail customers, with a less extensive conflict‑management system given its smaller broker‑dealer asset base (MS_10k_2024, page 9).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in its core quantitative claim: Goldman Sachs' broker-dealer assets are accurately reported as $113.9 billion (with a precise figure of $113,996 million), matching the ground truth. The reference to Regulation Best Interest and both firms' compliance obligations is accurate. 2) Quantitatively, the numbers are correct and properly formatted; minor variation in presentation ($113.9 billion vs $113,996 million) is acceptable and reflects rounding. No calculations were required, but the asset size is correctly cited. 3) The reasoning is mostly sound: both firms are correctly identified as subject to Regulation Best Interest, and the answer attempts multi-hop synthesis by comparing their conflict management approaches. However, the claim that Morgan Stanley has a 'less extensive conflict-management system given its smaller broker-dealer asset base' introduces an unsupported comparative assertion not present in the ground truth. The original answer does not state or imply that Morgan Stanley has a smaller asset base or a less extensive system—it only notes that Goldman’s larger scale may require more extensive monitoring. This is a qualitative overreach. 4) Despite this, the answer remains contextually relevant and captures the essential regulatory and operational dynamics. The inclusion of specific 10-K page references adds credibility. The answer is semantically close to the ground truth but slightly overstates the contrast in compliance frameworks. Thus, correctness is high but not perfect due to the unsupported comparative claim about Morgan Stanley’s framework being 'less extensive.'",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 448,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on adding fab capacity to win foundry customers, but Samsung’s move to build its own ICs could cut that demand, leaving Intel’s new plants under‑utilized and raising capital‑cost risks【page_53】【page_20】.  Qualcomm, which depends on external IC customers, faces a similar threat: if Samsung (or other OEMs) vertically integrates, Qualcomm could lose a share of its semiconductor revenue, hurting its results and margins【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) It correctly identifies Intel's IDM 2.0 strategy involving capacity expansion to attract foundry customers and notes the risk from Samsung's in-house IC development, which could reduce demand for Intel’s foundry services and lead to underutilized capacity and higher capital risks—this aligns with the ground truth. It also correctly assesses the implications for Qualcomm, noting that vertical integration by Samsung (or other OEMs) could erode Qualcomm’s customer base and hurt revenues and margins. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable but assumed correct by absence of error. (3) The reasoning is sound: it connects Samsung’s self-sufficiency to reduced opportunities for Intel’s foundry business and extends the logic to competitive threats for Qualcomm. The only minor omission is that the original answer adds nuance about potential pricing pressure from Intel to attract other foundry clients, which could affect the broader semiconductor pricing environment—this indirect effect on cost structures is not mentioned in the LLM response, slightly reducing completeness. (4) Despite this, the LLM answer remains semantically equivalent in key aspects, uses correct entities (Intel, Samsung, Qualcomm), and maintains contextual relevance throughout. The citation of page references adds credibility and alignment with source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 418,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon’s $5.0 billion upfront payment to American Tower (VZ Note 6, page 73) gives ATC exclusive rights to lease and operate 11,300 towers for roughly 30 years, while Verizon retains sub‑lease capacity and ground‑lease obligations—an upfront capital outlay that creates a lease‑based partnership with shared operational control. In contrast, Netflix’s strategy of securing exclusive content rights involves significant upfront licensing or production costs (implied by the risk of not obtaining rights in the risk section, page 10) and grants long‑term control over its library, but requires ongoing investment to renew and maintain exclusivity. Thus, Verizon’s model is a one‑time capital commitment with a lease‑based partnership, whereas Netflix’s model is an ongoing capital expense that provides strategic control over content distribution.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies the $5.0 billion upfront payment from American Tower Corporation to VZ (not 'payment to American Tower' as stated — this is a critical reversal), and the number of towers (11,300). However, it incorrectly frames the $5.0 billion as an 'upfront capital outlay' by Verizon, when in fact it was an inflow of capital *to* Verizon — a major factual error that reverses the financial impact. This undermines the core comparison on capital impact. The mention of 'VZ Note 6, page 73' and 'risk section, page 10' suggests document referencing, but these are not part of the original knowledge base and may reflect hallucinated sources.\n\n2) Quantitatively, the $5.0 billion amount and 11,300 tower count are accurate and match the ground truth. The 30-year lease duration is a reasonable inference not contradicted by the original answer. However, the mischaracterization of the payment direction (outflow vs. inflow) leads to an incorrect financial interpretation despite correct numbers.\n\n3) The multi-hop reasoning is partially sound: it attempts to compare VZ's infrastructure monetization with NFLX's content strategy. However, it fails to correctly contrast the capital impact — VZ's arrangement is capital-generating (correct in original), while the LLM incorrectly labels it a 'capital outlay'. For NFLX, the LLM correctly notes ongoing investment and lack of upfront receipts, but misses the key point that NFLX’s strategy is a cost center, not a revenue generator. The statement that Netflix gains 'long-term control' over its library is plausible but not directly supported in the original answer, which emphasizes risk of content withdrawal.\n\n4) The answer is contextually relevant and addresses both companies and the strategic comparison. However, due to the fundamental error in interpreting the direction of cash flow for VZ, the qualitative and overall correctness scores are significantly reduced. The conclusion that VZ made a 'one-time capital commitment' is factually wrong — it received capital, not committed it. This error distorts the entire strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 585,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "KO’s effective tax rate climbed by roughly 3.0 percentage points in 2022 as a result of the Tax Reform Act’s GILTI provisions, which added a significant tax charge to the full‑year provision. In contrast, PEP’s corporate income‑tax rate cut in the Philippines helped lower its effective tax rate, offsetting the GILTI impact and keeping the rate near 21.8 % for that market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that KO's effective tax rate increased by 'roughly 3.0 percentage points' due to GILTI provisions. The ground truth states a 1.2% impact from $710 million in pretax charges related to equity method investee impairments, not a 3.0-point increase. This major discrepancy undermines the core of the answer. Additionally, the LLM claims PEP's effective tax rate was 'near 21.8%' for the Philippines market, which is not supported by the original answer—no specific rate or exact impact is provided, only that the tax cut had a 'favorable' and 'notable' effect. (2) The original answer does not mention any offsetting effect between GILTI and the Philippines tax cut for PEP, nor does it state PEP’s effective tax rate in that market. The LLM introduces unsupported specifics: the 21.8% figure and the idea that the local tax cut 'offset' GILTI impacts—this is speculative and not in the source. (3) While the LLM correctly identifies the multi-hop structure—comparing U.S. GILTI impact on KO with local tax changes affecting PEP in the Philippines—the reasoning is flawed. It misrepresents the direction and magnitude of KO's tax impact and fabricates precise figures for PEP. The contrast is conceptually acknowledged (U.S. rules increasing KO's burden vs. local cuts benefiting PEP), which preserves some qualitative validity. (4) Scores reflect: low quantitative accuracy due to incorrect percentages and invented figures; moderate qualitative accuracy as entities (KO, PEP, GILTI, Philippines tax cut) and general direction of effects are correct; high contextual relevance since the response addresses both parts of the question and attempts proper synthesis, despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 487,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of retained earnings at Nicor Gas is “restricted for dividend payment” under regulation, meaning Nicor Gas cannot distribute dividends to Southern Company beyond that amount. Consequently, Southern Company’s ability to receive dividends from Nicor Gas—and indirectly from its other subsidiaries—is capped by the restricted retained‑earnings balance. Additionally, Nicor Gas is prohibited from making money‑pool loans to affiliates, so it cannot provide financing or additional dividend support to the parent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.3 billion figure is correctly stated and matches the original answer. No calculations are required, and the amount is presented accurately. (2) The LLM correctly identifies that Nicor Gas is a regulated subsidiary under Southern Company Gas and that its $1.3 billion in retained earnings are restricted from dividend distribution, which directly limits Southern Company's dividend inflows. This captures the core financial impact. (3) The reasoning is sound: the restriction on dividends and the prohibition on money-pool loans to affiliates are both mentioned, reflecting proper multi-hop synthesis between regulatory constraints and parent company financial flexibility. (4) The only minor shortcoming is a slight overstatement in saying that the restriction affects dividends from 'other subsidiaries'—the original answer does not suggest a spillover effect to other subsidiaries beyond Nicor Gas. The impact is specific to Nicor Gas’s contribution, not a systemic cap on all subsidiary dividends. Otherwise, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 336,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Both companies acknowledge that the tightening of safety rules under the National Traffic and Motor Vehicle Safety Act will raise compliance costs. Tesla’s 10‑K notes that “regulatory complexity…could lead to substantial costs” but does not provide a dollar figure for safety‑related compliance. GM’s 10‑K likewise states that recall campaigns could be costly and, while it discloses emissions‑related compliance costs ($1.0 B in 2024), it does not give a specific amount for safety compliance. Thus, GM’s disclosure is more detailed, but both firms expect significant, though unspecified, safety‑related expenses.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: both Tesla and GM do not disclose specific dollar figures for safety compliance costs in their 10-K filings, and GM’s $1.0B compliance cost disclosure in 2024 is correctly attributed to emissions, not safety—this number is accurate and properly contextualized. There are no calculation errors, and all entities (Tesla, GM, National Traffic and Motor Vehicle Safety Act, 10-K filings) are correctly identified with appropriate context. However, the LLM answer omits key qualitative elements from the ground truth: it does not mention Tesla’s specific challenges with Autopilot and FSD (Supervised) features facing international regulatory divergence, nor does it highlight GM’s explicit emphasis on lack of harmonization between North American and UN-ECE standards as a cost driver. While the LLM correctly infers that both companies face rising compliance costs due to regulatory complexity, it fails to fully synthesize the multi-hop aspect of global regulatory divergence impacting development costs—a core point in the original answer. The reasoning is sound but incomplete, making the answer partially correct. Wording differences are acceptable under semantic equivalence, but the missing synthesis of international standards’ impact reduces completeness. Contextual relevance is high as the response directly addresses the question’s focus on compliance costs and regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 400,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics defers $305 million in other contract costs under FAR, a liability that is currently off‑balance‑sheet but could become a cost if future backlog is insufficient (page 58). Raytheon Technologies, by contrast, faces direct cost‑overrun risk on its fixed‑price U.S. government contracts, meaning any excess costs are borne by the company and immediately erode margins (page 16). Thus, GD’s risk is a potential future liability that may be recoverable, while RTX’s risk is immediate margin pressure from overruns.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $305 million deferral by General Dynamics under FAR and accurately contrasts it with Raytheon Technologies' exposure to cost overruns on fixed-price contracts. All quantitative figures (i.e., $305 million) are correct and match the ground truth. (2) There are no calculations in the question, but the dollar amount is accurately reported with acceptable formatting ($305 million vs $305 million). (3) The multi-hop reasoning is largely sound: the model correctly synthesizes information across two companies and contract types—General Dynamics’ deferred cost model under FAR versus Raytheon’s firm fixed-price risk. However, the LLM mischaracterizes the deferred costs as a 'liability' and 'off-balance-sheet,' which is inaccurate; the ground truth describes these as deferred costs maintained as *assets*, not liabilities, pending future allocation. This is a notable qualitative error in financial terminology and implication, though the core contrast in risk profiles (potential future cost vs. immediate margin pressure) remains valid. (4) Contextual relevance is strong—the response directly addresses the comparative financial risk profiles as required. Due to the misrepresentation of the accounting treatment (asset vs. liability), the qualitative accuracy and overall correctness are slightly reduced, but the key comparative insight and all numerical data remain correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 396,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from $10,058 million in 2019 to $13,461 million in 2021, a compound annual growth rate of about **15.7 %** ( (13,461/10,058)¹ᐟ² – 1 ).  \nApple’s Greater China segment grew from $68,366 million in 2020 to $74,200 million in 2021, an annual increase of roughly **8.4 %** ( (74,200/68,366) – 1 ).  Thus, Intel’s Taiwan growth rate was roughly twice the pace of Apple’s Greater China segment growth, even though Taiwan is included in Apple’s reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. While Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) are correct, the CAGR is miscalculated as 15.7% instead of the correct 15.6% — a minor discrepancy, but the bigger issue lies with Apple's data. The LLM incorrectly uses Apple's Greater China revenue for 2020 ($68,366M) and 2021 ($74,200M), but the question asks for growth from 2019 to 2021. The correct 2019 figure is $40,308M (not used at all), and 2021 is $68,366M (which the model mislabels as 2020). This leads to a completely wrong CAGR of 8.4% instead of the correct 30.8%. (2) The calculation for Intel’s CAGR is approximately correct (actual: (13,461/10,058)^(1/2)-1 ≈ 15.6%), but Apple’s CAGR should be (68,366/40,308)^(1/2)-1 ≈ 30.8%, not a one-year change from 2020 to 2021. The model fails to compute a two-year CAGR over the correct period. (3) The multi-hop reasoning is fundamentally flawed: the model does not compare the same time horizon (2019–2021) for both companies. It uses two years of data for Intel but only one year for Apple, breaking the comparison. Additionally, the conclusion that Intel grew at twice the pace of Apple is the opposite of the truth — Apple grew at more than double Intel’s rate. (4) Due to major quantitative and reasoning errors, the correctness score is low (2). Quantitative accuracy is severely compromised (2), qualitative reasoning is invalid due to incorrect time framing and synthesis (2), and contextual relevance is partial since it addresses the right companies and regions but wrong years and metrics (5).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 445,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s $70 billion repurchase authorization for Class A and Class C shares (page 82) will shrink the Class A float and lift earnings per share, creating a price‑up incentive for Class B holders to convert to Class A. However, Meta’s 10‑K (pages 1‑5) shows that a much larger Class A base relative to the smaller Class B float can dampen the price effect of any conversion, so Class B shareholders may weigh the potential upside against the loss of voting power and the modest price impact of converting into a large Class A pool. Thus, the repurchase program may encourage conversion only if the expected price appreciation outweighs the dilution of voting influence and the limited price impact of converting into a large Class A pool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet's $70 billion repurchase includes Class A shares, which reduces float and may incentivize Class B shareholders to convert to capture price appreciation. The comparison to Meta is appropriately contextualized using the relative sizes of Class A and Class B share bases. (2) Quantitative accuracy is perfect: while exact share counts (2.19B Class A and 343.8M Class B at Meta) are not repeated verbatim, the LLM correctly characterizes Meta’s Class A base as 'much larger' relative to its Class B float, preserving semantic equivalence. No calculations were required, and dollar amounts ($70 billion) are accurate. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet’s repurchase program and Meta’s capital structure disclosure to assess differential incentives for share conversion. It appropriately weighs reduced liquidity impact at Meta due to large Class A float against potential price uplift at Alphabet. (4) The only minor shortcoming is that the LLM does not explicitly state Meta’s actual share numbers, which slightly reduces detail compared to the original, but this does not impair the correctness or usefulness of the conclusion. Wording differences (e.g., 'dampen the price effect' vs 'temper conversion urgency') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 418,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "Both PepsiCo and PMI’s RSU awards vest on the third anniversary of the grant date and accrue dividend equivalents, but PepsiCo explicitly states that these equivalents are paid in cash upon vesting (page_92), whereas PMI’s disclosure does not specify the payment method (page_110). As of 2023, PepsiCo had $441 million of unrecognized compensation cost related to non‑vested RSUs (page_90), while PMI had $160 million of such cost (page_110), indicating a larger financial obligation for PepsiCo.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant issues in quantitative and qualitative accuracy despite addressing the right context. (1) Correct elements: The statement that both companies accrue dividend equivalents on RSUs is accurate. The $160 million unrecognized compensation cost for PMI as of 2023 matches the ground truth. The mention of vesting on the third anniversary for PMI is correct. (2) Quantitative inaccuracy: The LLM claims PepsiCo had $441 million in unrecognized compensation cost related to non-vested RSUs, but this figure is not present in the ground truth, which does not provide any cost figure for PepsiCo. This introduces a fabricated number, severely impacting quantitative accuracy. (3) Qualitative/reasoning error: The LLM incorrectly states that PepsiCo's RSUs vest on the third anniversary of the grant date — this is not confirmed in the ground truth, which only specifies PMI’s vesting schedule. The ground truth does not state PepsiCo’s vesting timeline, so asserting it as the same as PMI is an unsupported inference. Additionally, while the ground truth confirms PepsiCo pays dividend equivalents in cash upon vesting, the LLM’s claim that PMI does not specify the payment method is an acceptable interpretation, but it omits that PMI’s RSUs do not carry voting rights — a detail present in the original answer and relevant to the treatment comparison. (4) Contextual relevance is high because the answer attempts the correct comparison across companies, metrics, and financial obligations, and references appropriate aspects (vesting, dividend equivalents, unrecognized costs). However, due to the inclusion of an incorrect number for PepsiCo and unsupported claims about vesting timing, the overall correctness is reduced to a 6 — partially correct but with significant factual and reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 505,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher’s pension‑plan accounting treats private‑investment holdings at NAV as a practical expedient, but it also applies discounted‑cash‑flow, earnings‑multiple or third‑party‑appraisal techniques when NAV is unavailable, and the company notes that different assumptions can materially change the fair‑value measurement (DHR Notes 98‑99). Eli Lilly, in contrast, estimates fair value for intangible assets acquired in business combinations, a process that requires significant management estimates and assumptions and can result in goodwill (LLY Note 70). Both disclosures underscore that the valuation methods involve subjective judgments and can lead to materially different fair‑value outcomes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both DHR's and LLY's valuation methods, with correct references to the use of NAV, discounted cash flow, earnings multiples, third-party appraisals, and management judgment. It correctly identifies that DHR uses NAV as a practical expedient and applies alternative methods when NAV is unavailable, and notes the subjectivity in assumptions affecting fair value—consistent with the ground truth. For LLY, it accurately states that fair value estimation for acquired intangibles involves significant estimates and assumptions, potentially impacting goodwill, and acknowledges the subjective nature of the process. However, the LLM omits the specific quantitative disclosure from the ground truth that LLY recorded $3.80 billion in charges related to acquired intangible assets in 2023, which is a material detail directly supporting the point about subjectivity and valuation impact. While the LLM captures the conceptual similarities in subjectivity and judgment, this omission reduces completeness in the multi-hop comparison. All entities (DHR, LLY), methods, and disclosures are correctly identified, and the reasoning is sound and relevant. No incorrect facts or numbers are presented, and wording differences do not affect semantic accuracy. The missing dollar amount is a significant but not critical omission, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 390,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "NVIDIA’s 2022 10‑K (pages 78‑82) does not break out revenue by country, so no figure for Taiwan is disclosed. Apple reported $74,200 million in net sales for its Greater China segment in 2022, a figure that includes Taiwan. Consequently, a direct comparison of NVIDIA’s Taiwan revenue to Apple’s Greater China revenue cannot be made from the provided information.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that NVIDIA reported $8,544 million in revenue from Taiwan in 2022, but the LLM claims that NVIDIA's 10-K does not disclose revenue by country and therefore no figure for Taiwan is available. This contradicts the verified data in the knowledge graph. (2) Quantitative accuracy is extremely low: the correct NVIDIA Taiwan revenue ($8,544 million) is entirely missing, while Apple’s $74,200 million is correctly cited. The LLM fails to report the key number needed for comparison. (3) The reasoning is flawed — it asserts that a direct comparison cannot be made due to lack of data, but in reality, the data exists and the comparison is valid (NVIDIA’s Taiwan revenue vs. Apple’s Greater China revenue, with Taiwan included in the latter). The multi-hop synthesis required — recognizing that Apple includes Taiwan in Greater China while NVIDIA reports it separately — is partially understood, but the conclusion is invalidated by the false premise about missing data. (4) Contextual relevance is moderate because the answer addresses the right companies, year, and geographic segment concept, but the core factual error renders the response substantially incorrect. Correctness and quantitative accuracy are severely penalized due to the false claim of non-disclosure and omission of the actual NVIDIA figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 385,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s Class B shares give Mr. Roberts 15 votes per share, representing 33 ⅓ % of the company’s total voting power and are held by a single individual, creating a highly concentrated control structure. In contrast, the Alphabet 10‑K pages provided (1‑5) do not disclose any special voting rights or concentrated ownership for its Class A common stock, implying a more dispersed ownership with no single holder controlling a significant voting block.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: CMCSA's Class B shares carry 15 votes per share and represent 33⅓% of total voting power, held by Brian L. Roberts (referred to correctly as Mr. Roberts). The statement about GOOGL's Class A common stock not disclosing special voting rights or concentrated ownership aligns with the absence of super-voting structure descriptions in the provided documents. However, the LLM omits the specific number of GOOGL Class A shares outstanding (300,754,904 as of January 25, 2022), which was included in the ground truth and adds concrete support for the claim of dispersed ownership. While the conclusion about more distributed influence is reasonable, including this figure would have strengthened completeness and multi-hop synthesis. The reasoning is sound and entities are correctly identified (CMCSA, GOOGL, Class B vs Class A). The answer addresses the core comparison of control concentration vs dispersion, making it contextually relevant and semantically close to the original, though slightly less detailed in supporting data for GOOGL.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 312,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s plans approved by shareholders show 241 million securities available for future issuance versus 25 million issuable upon exercise, giving a ratio of about **9.6 : 1** (page 77).  \nJohnson & Johnson’s approved plans have 240.3 million securities available for future issuance against 133.8 million issuable upon exercise, a ratio of roughly **1.8 : 1** (page 117).  \nThus UnitedHealth Group’s ratio is substantially higher—roughly five times the ratio seen at Johnson & Johnson.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the securities available for future issuance and those issuable upon exercise for both UnitedHealth Group and Johnson & Johnson, with accurate figures: 241 million and 25 million for UnitedHealth Group, and approximately 240.3 million and 133.8 million for Johnson & Johnson, which align closely with the ground truth values (240,344,013 and 133,794,708). The ratios are correctly calculated: 241/25 = 9.64 ≈ 9.6:1, and 240.3/133.8 ≈ 1.795 ≈ 1.8:1. Minor rounding is acceptable and does not affect correctness. (2) All numeric values are accurate within reasonable rounding; the LLM uses '240.3 million' and '133.8 million', which are appropriately rounded versions of the exact figures. Calculations are correct and match the ground truth ratios. (3) The multi-hop reasoning is sound: the model correctly identifies the two companies, extracts the relevant data from their respective equity compensation plans, computes the ratios, and compares them. The conclusion that UnitedHealth Group's ratio is substantially higher is valid. The statement that it is 'roughly five times' the ratio of Johnson & Johnson is approximately correct (9.64 / 1.79 ≈ 5.38), though this comparison was not in the original answer but is a reasonable inference. (4) The answer is contextually fully relevant, addressing the exact comparison asked. The only minor deviation is the added interpretation about 'five times', which is accurate but not part of the original answer—this does not detract from correctness. Overall, the answer is factually precise, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 442,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s dependence on third‑party motherboard suppliers is a supply‑chain risk rather than a revenue‑concentration risk; its sales are spread across many customers and segments, so no single customer dominates revenue (see AMD page 28).  In contrast, Intel’s 2021 financials show Dell Inc. alone accounted for 21 % of net revenue, a significant concentration that heightens revenue‑risk exposure (see Intel page 87).  Thus, Intel faces a higher revenue‑concentration risk than AMD.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 21% figure for Dell Inc.'s contribution to Intel's 2021 net revenue is correct, matching the original answer. No other numerical values are present, and the reference to AMD's lack of customer concentration is consistent with the source. (2) The answer correctly identifies AMD's risk as supply-chain-related due to third-party motherboard suppliers, while Intel's risk stems from customer concentration with Dell. This distinction is central to the question and accurately reflected. (3) Multi-hop reasoning is sound: the model synthesizes information about AMD's supply chain structure and Intel's customer dependency from separate contexts and compares them appropriately in terms of revenue concentration risk. (4) The only minor shortcoming is that the LLM does not mention Intel's accounts receivable exposure to Dell, which is included in the original answer and adds depth to the revenue concentration risk. However, this omission does not undermine the core correctness. Wording differences (e.g., 'revenue-risk exposure' vs 'revenue concentration risk') are semantically equivalent. References to 'AMD page 28' and 'Intel page 87' suggest proper sourcing, though not required for scoring. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 379,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Boeing’s 10‑K does not reference Louisiana corporate‑tax changes (pages 8‑12) and its exposure remains tied to federal defense appropriations and broader legislative dynamics that can alter defense spending (page 10). In contrast, Union Pacific’s 10‑K notes that Louisiana’s corporate‑tax rate cut reduced its deferred tax expense by $34 million in 2024, directly lowering its tax burden and improving profitability (page 29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense in 2024 is correctly stated, matching the original answer exactly. No other numerical values are present, and all are accurate. (2) The answer correctly identifies that Boeing does not reference Louisiana tax changes in its 10-K and ties its exposure to federal defense appropriations, which is consistent with the ground truth. Union Pacific’s direct benefit due to operational presence (implied by mention of tax impact) is accurately conveyed, though the specific detail about the Livonia classification yard is omitted—this is a minor contextual omission that does not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly distinguishes between direct state-level tax impacts (Union Pacific) and indirect federal-level exposure (Boeing), synthesizing information from both companies’ filings and the broader legislative context. (4) Semantic equivalence is strong—while the LLM does not explicitly state that Boeing ‘does not directly benefit,’ it effectively communicates the same by stating Boeing’s 10-K does not reference the tax changes and that its exposure is tied to federal appropriations. The only reason for not scoring a 10 is the slight lack of elaboration on the mechanism of Union Pacific’s operational presence in Louisiana, but this does not detract from the core factual accuracy. All other elements are correct, complete, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 426,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s governance is single‑class: every common share carries one vote (see page 60).  Meta, by contrast, uses a dual‑class scheme in which Class A shares have one vote but Class B shares carry additional voting power tied to the company’s holdings.  Charter’s note (page 95) illustrates this model, stating that its Class A common stock is entitled to one vote per share while its Class B shares have voting power linked to Charter Holdings units, showing how a dual‑class structure can link a specific class of shares to enhanced voting rights.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's one-vote-per-share model and references the correct page (60) from its 10-K, aligning with the ground truth. It accurately notes Charter Communications' disclosure that Class A shares have one vote per share and that Class B voting rights are linked to Charter Holdings units, citing page 95, which matches the original answer. However, the LLM incorrectly states that Meta's Class B shares carry 'additional voting power tied to the company’s holdings'—this is factually unsupported in the provided ground truth. The original answer clarifies that while Meta has a dual-class structure, its 2024 10-K does not specify the exact voting rights of each class in the available data. By asserting a specific linkage between Meta's Class B shares and 'holdings,' the LLM introduces unsupported inference, likely conflating Meta with Charter. This is a significant qualitative error in reasoning and entity-specific detail, though the overall contrast between Netflix’s single-class and dual-class models at Meta and Charter is conceptually correct. All non-Meta-related facts are quantitatively and contextually accurate, and the answer addresses the core comparison asked in the question. The error does not involve numbers or calculations (hence full quantitative accuracy) but affects the correctness of the multi-hop synthesis involving Meta’s governance structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 388,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "The daily cash‑settlement of PEP’s exchange‑traded commodity futures means that each day the contract’s fair value is reset to the exchange’s closing price, a Level 1 observable input. MDLZ’s Level 1 liabilities are also exchange‑traded commodity futures and listed options that are valued “based on quoted market prices on commodity exchanges”【page_112】. Thus, the daily settlement mechanism in PEP’s filing confirms that the same up‑to‑date, quoted market prices that PEP uses are available for MDLZ, ensuring its Level 1 valuation remains consistent with current market conditions and reduces valuation uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies that PEP’s exchange-traded commodity futures are daily cash-settled, which ensures fair value is based on observable exchange prices (Level 1 inputs), and links this to MDLZ’s use of quoted market prices on commodity exchanges for its Level 1 financial liabilities. The citation to page 112 supports the claim. (3) The multi-hop reasoning is sound: it connects PEP’s market practice (daily cash settlement) to the broader market mechanism that MDLZ relies upon for valuation, showing that both companies are subject to the same observable pricing environment. The LLM correctly infers that this standard practice supports consistent, transparent valuation for Level 1 liabilities. (4) While the original answer emphasizes that PEP excludes these instruments from year-end balance sheets due to settlement mechanics, this detail is omitted in the LLM response—but it is a minor contextual point that does not undermine the core conclusion about valuation methodology alignment. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 403,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 net sales in the Greater China region (China mainland + Hong Kong + Taiwan) were **$74.2 billion**【page_25】【page_52】.  The AMD 2022 10‑K pages provided (76‑80) do not disclose sales figures for Taiwan, so a direct numeric comparison cannot be made; however, Apple’s Greater China sales are substantially larger than AMD’s Taiwan‑only sales would be.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Apple's 2022 net sales in the Greater China region as $74.2 billion (equivalent to $74,200 million), which matches the ground truth in both value and scope (includes mainland China, Hong Kong, and Taiwan). This is quantitatively accurate with acceptable format variation. However, the LLM incorrectly states that AMD’s 10-K does not disclose sales for Taiwan, when in fact the original answer confirms AMD reported $2,091 million in sales specifically in Taiwan in 2022. This is a critical factual omission. (2) The quantitative accuracy is high for Apple’s number (correctly converted to billions), but the failure to report AMD’s $2,091 million undermines completeness and correctness. The comparison is partially valid in direction (Apple’s sales are larger), but lacks the actual numeric basis for AMD. (3) The multi-hop reasoning is flawed: the model fails to synthesize the required cross-company, cross-geography comparison despite the ground truth providing both figures. Claiming lack of data when it exists in the provided context breaks the reasoning chain. (4) Contextual relevance is fair—the answer addresses the geographic and market exposure question and focuses on the right companies and region—but the failure to use available data for AMD severely limits usefulness. Correctness score is low due to missing key data point despite its availability in the implied context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 396,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records environmental‑remediation costs as operating expenses unless a recovery is deemed probable, and it only sets up reserves for costs that are both probable and reasonably estimable (see Duke Energy 10‑K, page 163).  By contrast, Southern Company Gas’s natural‑gas utilities have approved cost‑recovery riders that explicitly include environmental‑remediation expenses, allowing those costs to be recovered through rates (see Southern Company 10‑K, page 22).  Consequently, Duke Energy bears a larger unrecovered remediation exposure, whereas Southern Company Gas can offset such costs through its regulatory cost‑recovery mechanisms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states Duke Energy's policy of expensing remediation costs unless recovery is probable and only reserving for costs that are both probable and estimable, citing the correct page (163) from Duke's 10-K. It accurately contrasts this with Southern Company Gas's explicit inclusion of environmental remediation in approved cost-recovery riders, citing page 22 of Southern Company's 10-K. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy is not applicable in terms of sums or percentages, but all referenced details (e.g., page numbers, policy descriptions) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies' regulatory approaches to environmental remediation costs, drawing a valid comparison between Duke's exposure and Southern's recovery mechanism. (4) The answer is contextually precise, directly addressing the core of the question—how Duke's financial exposure compares to Southern's recovery ability—and concludes with a clear, justified contrast. Minor wording differences (e.g., 'larger unrecovered remediation exposure' vs 'more structured pathway') do not affect meaning and are semantically equivalent. All entities (Duke Energy, Southern Company Gas, 10-K filings) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 401,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s Level 2 fair‑value calculations for available‑for‑sale debt securities are based on broker‑dealer quotes that feed into industry‑standard valuation models (see Note 3, Level 2 Inputs on pages 54‑56). GM, by contrast, estimates product‑warranty reserves through valuation models (reserve studies) that rely on historical claims experience and key assumptions (see Note 12 on page 56). Both firms therefore use industry‑standard models, but Lowe’s approach is more market‑observable, while GM’s is actuarial‑style and driven by internal historical data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LOW uses broker/dealer quotes feeding into industry-standard valuation models for Level 2 fair value measurements, specifically for available-for-sale debt securities, with reference to observable inputs (as noted in Note 3, pages 54–56). GM uses valuation models (referred to as reserve studies) for product warranty reserves based on historical claims data and key assumptions (Note 12, page 56). These details align with the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly contrasts LOW’s market-observable, third-party quote-driven approach with GM’s actuarial-style, internally driven warranty modeling, highlighting the different applications of industry-standard models. The only minor shortcoming is that the LLM answer does not explicitly mention 'issuer spreads' or 'benchmark securities' as observable inputs (included in the ground truth), nor does it emphasize the distinction between Level 2 fair value (market-based) versus management judgment in GM’s case as clearly. However, the essence—that LOW’s is 'more market-observable' and GM’s is 'actuarial-style and driven by internal historical data'—captures the qualitative difference well. (4) Contextual relevance is perfect: the response directly addresses the comparison between the two companies’ use of valuation models, the role of industry standards, and the nature of inputs. Overall, this is a semantically equivalent, concise, and accurate synthesis—just slightly less detailed than the original on the specific observable inputs. Hence, correctness is 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 493,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Under the Basel III Finalization Proposal, both Capital One and Citigroup will have to compute risk‑weighted assets (RWA) using the new Expanded Risk‑Based Approach (ERA) and the existing Basel III standardized approach, and for each risk‑based capital ratio they must apply the lower of the two ratios. The proposal’s effective date is July 1 2025, with a three‑year transition period ending July 1 2028, so the impact will be phased in. The ERA is expected to raise RWA and therefore increase the minimum CET1, Tier 1 and total capital ratios for both institutions, with Citigroup’s larger size and market‑risk exposure likely producing a more pronounced increase in required capital and related buffers such as TLAC.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, all dates (July 1, 2025 effective date, three-year transition) are accurate, and the phased-in implementation is correctly described. The mention of increased risk-weighted assets (RWA) leading to higher capital requirements is consistent with the impact on CET1, Tier 1, and total capital ratios. (2) The entity identification (Capital One, Citigroup, Basel III Finalization Proposal, Expanded Risk-Based Approach) is correct, and the multi-hop reasoning—linking the dual calculation requirement, use of the lower ratio, and transition period—is sound. (3) However, the LLM omits the explicit statement that both banks must comply with all capital buffer requirements regardless of which approach yields the lower ratio, a key constraint mentioned in the original answer. It also does not explicitly state that Citigroup has indicated the proposal would 'materially increase' its required capital, instead inferring it based on size and market-risk exposure. While reasonable, this weakens direct alignment with the ground truth. (4) The LLM introduces the term TLAC (Total Loss-Absorbing Capacity), which, while relevant to Citigroup, is not mentioned in the original and slightly extends beyond the provided context. Despite these nuances, the core facts, dates, and regulatory mechanics are accurately conveyed, warranting a high correctness score with minor deductions for completeness and precision in reflecting the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 429,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ only condensate exposure comes from the Alba Unit, which produces roughly 1 barrel of condensate per day (≈ 365 barrels a year).  By contrast, Chevron’s 2024 10‑K shows about 2,121 million barrels of direct condensate production, a volume that dwarfs ConocoPhillips’ exposure even though Chevron reports zero condensate reserves.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, it falsely claims ConocoPhillips' Alba Unit produces '1 barrel per day' (≈365 barrels/year), which is implausibly low and unsupported by the original answer—no production volume was specified in the ground truth, but the Alba Plant is a known significant condensate producer. More critically, it states Chevron had '2,121 million barrels of direct condensate production' in 2024, which directly contradicts the ground truth that Chevron's 2024 10-K reports zero condensate production or reserves. This number is off by over three orders of magnitude and is factually wrong. (2) The answer fails on completeness: it misrepresents both companies' exposures—claiming Chevron has massive condensate production while reporting zero reserves, which is illogical and unsupported. (3) Entity accuracy is partially correct (ConocoPhillips, Chevron, 2024 10-K), but the metrics (production volumes) are entirely fabricated. (4) Reasoning is flawed: the core comparison is inverted—ground truth states Chevron has no condensate production, while LLM says it dwarfs COP’s exposure. The LLM fails to recognize that zero reserves and zero production imply no output, making the claimed 2.1 billion barrel figure nonsensical. (5) There is no semantic equivalence—the LLM’s answer conveys the opposite meaning of the original. The only relevant aspect is the mention of Alba Unit as COP’s source, but even that is undermined by the absurd volume. Severe factual and logical errors result in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 436,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO’s revenue‑recognition policy requires that every contract modification be evaluated to determine whether it creates a new contract or merely changes the price or performance obligations of the existing one.  Under ASU 2020‑04, the company must treat modifications that replace a reference rate (e.g., LIBOR) as a potential change in contract price or a new performance obligation and adjust revenue recognition accordingly (see AVGO Notes 61‑65).  Oracle, by contrast, adopted ASU 2020‑04 for all contract modifications made between March 12 2020 and December 31 2024, noting that the guidance reduced the operational and financial impacts of reference‑rate replacements and had no material effect on its consolidated financial statements (see ORCL Notes 70‑72 and Note 167).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both AVGO and ORCL applied ASU 2020-04 to contract modifications related to reference rate reform (e.g., LIBOR), the effective period (March 12, 2020, to December 31, 2024) is correctly stated, and both companies reported no material impact on financial statements. (2) Quantitative accuracy is perfect: dates are exact, and the conclusion of 'no material effect' matches the original answer. ORCL's adoption finalized in Q1 of fiscal 2024 is implied in the original but not stated in the LLM answer—this is a minor omission but does not affect correctness. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how ASU 2020-04 impacted AVGO’s revenue recognition (evaluation of modifications, potential new contracts or price changes) and ORCL’s financial reporting (adoption with no material impact). The mention of AVGO using standalone selling prices is missing in the LLM answer, which slightly weakens completeness, but the core of the policy is captured. (4) Contextual relevance is excellent—the response directly addresses both parts of the question and uses appropriate financial terminology. The references to specific notes (e.g., AVGO Notes 61–65, ORCL Notes 70–72, 167) add precision and support credibility, even if not in the original. Overall, the answer is factually correct, well-reasoned, and only slightly less detailed than the ground truth on AVGO’s allocation method.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 414,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class structure gives its CEO and a handful of Class B holders a majority of voting power (10 votes per share versus 1 vote for Class A), concentrating control and limiting ordinary shareholders’ influence (see pages 49‑50).  Comcast, by contrast, issues highly‑voting Class B shares (15 votes each) that are share‑for‑share convertible into Class A, but the aggregate voting power of Class B shares is fixed and non‑dilutable and the conversion is subject to restrictions, so while Class B holders retain significant influence, the structure does not automatically lock control in a single group (see page 91).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key numbers are correct: Meta's Class B has superior voting rights (implied 10 votes per share, consistent with known structure), CMCSA's Class B has 15 votes per share, and the share-for-share convertibility is correctly stated. The non-dilutable 33⅓% aggregate voting power for CMCSA Class B shares is implied through the phrase 'aggregate voting power of Class B shares is fixed and non-dilutable,' which aligns with the ground truth. (2) The answer correctly identifies both companies (Meta and Comcast/CMCSA), their respective stock classes, and governance mechanisms. (3) Multi-hop reasoning is sound: it contrasts Meta’s entrenched control (via disproportionate voting and class-vote requirements) with CMCSA’s more flexible but still influence-preserving conversion policy. The LLM correctly infers that Meta's structure 'concentrates control' and 'limits ordinary shareholders’ influence,' while CMCSA's allows retention of influence without 'automatically lock[ing] control in a single group'—a nuanced but accurate reflection of the difference in governance rigidity. (4) The only minor shortcoming is that the LLM does not explicitly mention Meta's 35% threshold for change-of-control approval, a specific governance trigger present in the original answer. However, the essence—that Meta’s structure entrenches control more rigidly—is still effectively communicated. Wording differs but semantic equivalence is strong. No irrelevant or incorrect information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 436,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP discloses that exchange‑traded commodity futures are cash‑settled daily and therefore are omitted from its fair‑value table (page 107). By contrast, COST states that it holds no Level 1 financial assets measured at fair value on a recurring basis (page 51), meaning it does not have any exchange‑traded commodity futures or other Level 1 instruments. Thus, PEP actively uses these futures, while COST has no Level 1 assets of that type.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PEP uses exchange-traded commodity futures that are cash-settled daily and thus excluded from the fair value table, and that COST reports no Level 1 financial assets measured at fair value on a recurring basis. These facts align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answer that conflict with the ground truth; the LLM omits specific dates (e.g., December 25, 2021, and August 28, 2022), but these are not critical to the comparison and do not affect factual correctness. The page references (107 and 51) add precision and are consistent with expected disclosure locations. (3) The multi-hop reasoning is sound: the model correctly links PEP’s use of exchange-traded futures (which are Level 1 assets) to COST’s disclosure of having no Level 1 assets, thereby drawing a valid contrast. It implicitly recognizes that exchange-traded commodity futures are Level 1 assets, though it does not explicitly define Level 1 as MDLZ does in the ground truth. This is a minor omission but does not undermine the conclusion. (4) The answer is contextually relevant, directly addressing the comparison asked. The only reason for not scoring a 10 is the lack of explicit mention that exchange-traded commodity futures are classified as Level 1 assets (a point emphasized in the ground truth via MDLZ's disclosure), which slightly weakens the explanatory link. However, the LLM infers this correctly in practice by equating the absence of Level 1 assets with not holding such futures. Overall, the answer is factually correct, well-reasoned, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 471,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs’ securities loaned with maturities of 31‑90 days total $1.634 billion, whereas Morgan Stanley’s total securities‑loaned balance is $892.979 million.  The GS short‑term amount is roughly 1.8 times larger than Morgan Stanley’s entire securities‑loaned exposure, indicating that Goldman Sachs carries a higher short‑term securities‑lending risk relative to Morgan Stanley.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative values. According to the ground truth, Goldman Sachs reports $1,634 million (i.e., $1.634 billion) in securities loaned with maturities of 31-90 days, which the LLM correctly reports (with acceptable format variation). However, the LLM states that Morgan Stanley’s total securities loaned is $892.979 million, which is incorrect — the ground truth value is $281 million. This is a significant deviation (over 3x higher than actual). (2) The calculation comparing the two firms is therefore flawed: the LLM claims Goldman Sachs’ short-term amount is 'roughly 1.8 times larger' than Morgan Stanley’s total, but with correct numbers, $1,634M vs $281M is actually about 5.8 times larger. While the direction of the comparison (GS > MS) is correct, the magnitude is severely understated due to the wrong input. (3) The multi-hop reasoning — comparing GS’s short-term bucket to MS’s total securities loaned to assess relative risk exposure — is conceptually sound and addresses the question’s intent. The conclusion that Goldman Sachs has higher short-term securities lending risk is supported by the correct data and is logically valid. (4) Despite correct reasoning structure and entity identification (Goldman Sachs, Morgan Stanley, securities loaned, risk exposure), the severe inaccuracy in Morgan Stanley’s reported value undermines the factual basis of the answer. The contextual relevance is high because the model attempts the right comparison and interprets risk appropriately, but the numerical foundation is flawed. Thus, the correctness score is low due to critical quantitative error, even though the logic and entities are mostly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 470,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s owned generating capacity includes an **8.16 % undivided interest** in Alabama Power’s Plant Miller Units 1 and 2【page_17】. In comparison, Duke Energy’s total electricity generation in 2021 was **22,344 GWh**【page_187】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and Duke Energy's 2021 total generation of 22,344 GWh, both of which match the ground truth exactly. These numbers are cited with appropriate page references, indicating accurate sourcing. (2) All quantitative values are correct—8.16% and 22,344 GWh—with no calculation errors. The format (e.g., '22,344 GWh') is consistent with standard reporting and matches the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about PowerSouth’s partial ownership (a capacity-related metric) and compares it to Duke Energy’s system-wide annual generation (an energy output metric), which is a valid cross-entity comparison for scale, even if not directly equivalent (capacity vs. generation). The original answer acknowledges this distinction by framing it as a 'relative scale' comparison, which the LLM implies but does not explicitly clarify. (4) The only minor shortcoming is the lack of contextual elaboration present in the original answer—specifically, that PowerSouth’s interest contributes to its total capacity of over 1,600 MW, and that the comparison illustrates scale differences. While not strictly necessary for correctness, this context enhances completeness. However, since the core facts and comparison are accurate and relevant, the answer is highly correct with only slight room for enrichment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 406,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "Nike’s $11.6 billion of short‑term, investment‑grade fixed‑income securities are “exposed to both credit and interest‑rate risk” (NKE 10‑K, p. 50), and the company uses interest‑rate swaps and other hedges to manage that exposure.  \nMcDonald’s valuation framework relies on Level‑2 fair‑value models that incorporate observable market inputs—including interest‑rate yield curves—to price derivatives and other assets (MCD 10‑K, pp. 45‑46), so its sensitivity to changes in those curves is indirect, affecting fair‑value adjustments rather than the portfolio itself.  \nThus, Nike faces a direct portfolio‑level interest‑rate risk, while McDonald’s risk is driven by valuation adjustments that depend on market inputs such as yield curves, with both firms using observable market data in their pricing models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $11.6 billion figure for Nike's short-term fixed-income investments is correct and matches the original answer. No other numerical values are present, and all references to financial amounts are consistent. Format variations are acceptable and do not affect accuracy. (2) The LLM correctly identifies that Nike’s exposure to interest rate risk is direct, stemming from its fixed-income portfolio, and that McDonald’s sensitivity is indirect, affecting derivative valuations via pricing models using observable inputs like yield curves—this matches the core comparison in the original answer. (3) The multi-hop reasoning is sound: it synthesizes information about Nike’s investment portfolio and risk management (including hedges like interest rate swaps, which adds slight elaboration beyond the original but remains accurate) with McDonald’s use of Level 2 fair value measurements based on observable market data. The distinction between direct portfolio risk (Nike) and valuation-driven sensitivity (McDonald’s) is logically drawn and well-supported. (4) Minor deduction in qualitative accuracy due to the addition of 'interest-rate swaps' as a hedging tool for Nike, which, while plausible and consistent with risk management practices, is not present in the original answer and slightly extends beyond the provided ground truth. However, this does not contradict it. Overall, the answer is semantically equivalent, contextually precise, and fully addresses the comparative aspect of the question using correct entities (Nike/NKE, McDonald’s/MCD), accurate financial concepts, and proper sourcing logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 463,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s common stock is a single‑class structure—each share carries one vote on all shareholder matters (page 60), so voting power is directly proportional to ownership and all shareholders have equal influence. Alphabet, by contrast, issues multiple classes: Class A shares have one vote each, but Class B shares carry ten votes per share (page 82), concentrating control in the hands of holders of the higher‑voting class and creating a separation between ownership and decision‑making. Consequently, Netflix’s governance is more democratic and responsive to all shareholders, whereas Alphabet’s multi‑class scheme can insulate management and insiders from minority shareholder input.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Netflix has a one-vote-per-share policy (single class), while Alphabet has a multi-class structure with Class A (1 vote/share) and Class B (10 votes/share), which concentrates voting power. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations required, but the voting ratios (1:1 for Netflix, 1:1 and 10:1 for Alphabet classes) are correctly stated. (3) The multi-hop reasoning is sound: the model correctly infers that Netflix’s structure leads to more equal shareholder influence (democratic), while Alphabet’s structure separates ownership from control, empowering insiders—this aligns with the original conclusion about governance dynamics. (4) Minor wording differences (e.g., 'democratic' vs 'egalitarian', 'insulate management' vs 'susceptible to control by insiders') do not affect meaning and are acceptable under semantic equivalence. The LLM adds contextual detail (page references) not in the original but consistent with it. No factual errors or omissions; only slight deduction for slightly stronger normative language ('insulate management') which is interpretive but still reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 353,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "AbbVie’s Imbruvica is already on CMS’s “Selected Drug” list, so the IRA’s government‑set ceiling price that takes effect in 2026 will likely cut Medicare Part D reimbursement and accelerate revenue erosion before the drug’s patent expires (AbbVie p. 20). Johnson & Johnson’s XARELTO is likewise on the list, but because J&J’s overall portfolio is more diversified and its Medicare exposure is smaller, the price cap will have a less pronounced effect, though the company will still need to adjust pricing, rebates and the new Part D benefit redesign to preserve margins (Johnson & Johnson p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in key aspects: both Imbruvica (AbbVie) and XARELTO (Johnson & Johnson) are correctly identified as being on the CMS 'Selected Drug' list under the IRA, with the 2026 effective date for government-set pricing accurately stated. There are no numeric inaccuracies—dates and references to company filings (e.g., AbbVie p. 20, J&J p. 11) align with expected sourcing, and no incorrect financial figures are presented, satisfying quantitative accuracy. Contextually, the response directly addresses the question about differing revenue strategy impacts due to Medicare Part D exposure, noting AbbVie’s vulnerability due to Imbruvica’s patent timeline and revenue erosion risk, and J&J’s relatively lower exposure due to portfolio diversification. However, the LLM omits a critical element from the ground truth: Johnson & Johnson’s active litigation challenging the constitutionality of the IRA’s pricing mechanism, which is a key differentiator in their strategic response. This omission weakens the qualitative accuracy, as it fails to capture the full scope of J&J’s aggressive revenue protection strategy. While the LLM mentions J&J adjusting pricing and rebates, it does not convey the strategic legal challenge that distinguishes their approach from AbbVie’s more evaluative stance. Thus, while the core facts and reasoning are sound and contextually relevant, the incomplete synthesis of strategic responses—particularly the missing litigation point—prevents a higher score. The answer is semantically close but lacks full multi-hop depth in comparing corporate strategies beyond market exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 445,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk governance is anchored in the Independent Compliance Risk Management (ICRM) unit, which sits in the second line of defense and works closely with Independent Risk Management (IRM) to embed climate‑transition risk into all compliance controls and risk‑limit frameworks.  ICRM sets standards and priorities for climate‑related compliance programs, monitors exposure that could amplify credit and liquidity risk, and escalates findings to the Board’s Risk Management Committee and Group Risk Management Committee—ensuring that credit and liquidity limits and stress‑testing incorporate the potential amplification of risk from transition climate risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity representation and reasoning compared to the ground truth. (1) While there are no numeric values to verify (so quantitative accuracy is 10), the qualitative content diverges from the original answer. The LLM introduces specific units like 'Independent Compliance Risk Management (ICRM)' and 'second line of defense' that are not mentioned in the ground truth and cannot be confirmed from the provided knowledge graph. These may be factually accurate in reality but are not supported by the source material used to generate the original answer. (2) The original answer emphasizes Citi’s Board and Executive Management Team, ERM oversight, and Internal Audit’s role in providing independent assurance — particularly reporting to the Citi Audit Committee — none of which are mentioned in the LLM response. Instead, the LLM focuses on ICRM and IRM without grounding in the documented governance structure from the knowledge graph. (3) Regarding multi-hop reasoning: the question asks how Citi's structure addresses amplification of credit and liquidity risks from transition climate risks as outlined in Morgan Stanley’s disclosures. The LLM correctly identifies the linkage between transition risks and credit/liquidity risk amplification and notes escalation to risk committees, which aligns with the concept of governance oversight. However, it fails to reference Morgan Stanley’s specific framing of reputational, compliance, and litigation risks due to regulatory scrutiny, and how Citi’s structure responds to evolving expectations like carbon emissions regulation — a key synthesis point in the original answer. (4) The contextual relevance is high because the LLM addresses the core theme: governance of compliance risk in relation to climate-driven credit and liquidity risks. But due to incorrect emphasis on unverified internal units and omission of key actors (Board, Audit Committee, Internal Audit) and regulatory alignment points, the qualitative accuracy is only moderate. Thus, correctness is scored at 5 — partially correct but missing critical elements and introducing unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 583,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "QCOM’s 30 % of licensing revenue coming from a handful of Chinese OEMs concentrates its cash flow and exposes it to geopolitical and trade‑policy risk—tariffs, sanctions, or U.S./China restrictions can cut sales or delay royalty payments, and the OEMs’ own vertical integration can erode demand (QCOM, 2024, pp. 19‑20, 25‑29).  In contrast, Texas Instruments is building its own 300‑mm wafer fabs to cut reliance on external foundries, giving it lower unit costs and greater supply‑chain control, but the expansion is capital‑intensive, subject to construction delays, environmental and safety liabilities, and the risk of over‑capacity if demand falls (TXN, 2024, pp. 7‑8).  Thus, QCOM’s risk is largely external‑political and customer‑concentration, while TXN’s risk is internal‑operational and capital‑allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% licensing revenue from Chinese OEMs is correctly stated, and no other numerical values are misreported. The references to annual report pages (e.g., QCOM 2024 pp. 19–20, 25–29; TXN 2024 pp. 7–8) are plausible and consistent with typical SEC filing disclosures, though exact page numbers are not part of the knowledge graph ground truth—however, such citations are acceptable as long as they don’t contradict facts. (2) The answer fully addresses the comparative supply chain risk question: it identifies QCOM’s customer concentration and geopolitical risks tied to China, and contrasts it with TXN’s vertical integration via 300mm wafer fab expansion. The core entities—QCOM, TXN, Chinese OEMs, 300mm fabrication—are all correctly identified. (3) Multi-hop reasoning is sound: it synthesizes QCOM’s revenue dependency with external political risks and contrasts it with TXN’s capital-intensive internal manufacturing strategy and associated operational risks. (4) While the original answer emphasizes TXN’s reduced dependency on external foundries and greater supply chain control, the LLM adds nuanced risks like over-capacity and construction delays, which are reasonable inferences and enhance the analysis without contradicting the ground truth. The only minor gap is that the LLM does not explicitly name TXN’s facilities (RFAB2, LFAB1, SM1), but this detail is secondary to the overall strategic contrast. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness—excellent, with only slight omission of specific facility names preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 466,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company has elected to apply ASU 2020‑04 to debt‑modification arrangements that fall within its scope and, as noted on pages 194–195, expects no material impact on its interest‑rate‑derivative positions, with effective hedging relationships expected to continue. Duke Energy, as described on page 135, is evaluating its LIBOR‑indexed swaps and debt under the optional expedients, noting that the ultimate outcome cannot yet be determined but is not expected to materially affect its financial statements. In short, both utilities see no material impact, but Southern Company is more definitive about applying the amendments, whereas Duke Energy remains cautious about the final outcome.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and conveys that both Southern Company and Duke Energy are dealing with ASU 2020-04 in the context of LIBOR transition, with assessments around materiality and application of optional expedients. Quantitatively, there are no numbers, dates, or financial figures that conflict with the ground truth (e.g., no specific dollar amounts or percentages are cited in either answer), so quantitative accuracy is high. Contextual relevance is strong—the response directly addresses the comparison between the two companies’ evaluations of ASU 2020-04 as it pertains to interest rate derivatives and LIBOR-indexed contracts. However, there is a key qualitative discrepancy: the original answer states that Southern Company is *continuing to evaluate* the standard (per Note 14), whereas the LLM claims Southern has *elected to apply* it and expects no material impact. This misrepresents Southern’s position as more definitive than it is in the ground truth, which emphasizes ongoing evaluation and uncertainty. In contrast, the LLM correctly captures Duke Energy’s cautious stance and expectation of immaterial impact. Thus, while the overall direction of the comparison is reasonable, the characterization of Southern Company’s actions introduces a significant factual inaccuracy in the reasoning chain, reducing qualitative accuracy. The multi-hop synthesis is partially sound but flawed in one direction, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 409,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s 10‑K (page 8) notes that it holds cash equivalents and marketable securities in foreign currencies, including British pounds and euros, creating a direct foreign‑currency asset exposure that is not described as being hedged. Nike’s 10‑K (page 48) states that it uses currency forward and option contracts to hedge forecasted exposures such as product costs and external sales, indicating a proactive hedging strategy. Thus, Amazon’s exposure to pounds and euros is largely passive, whereas Nike actively manages similar currency risks through option contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros without explicit mention of hedging, while NKE uses option contracts to manage currency risk. The characterization of AMZN's exposure as 'passive' and NKE's approach as 'proactive' is semantically equivalent to the original answer's conclusion about differing strategies and transparency. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two companies' 10-Ks (AMZN page 8, NKE page 48), compares their risk management approaches, and draws a valid contrast between asset exposure without hedging disclosure (AMZN) versus active hedging with options (NKE). (4) The only minor limitation is that the LLM answer does not explicitly mention 'forecasted transactions and balance sheet exposures' or 'derivative instruments' as in the original, slightly reducing completeness in terminology, but the core meaning and comparison remain intact. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 356,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "META’s 10‑K lists only **Class A common stock** (page 1), which carries one vote per share – there is no Class B class, so all voting power is held by Class A. Alphabet, by contrast, has a dual‑class structure (page 82): **Class A shares have one vote each, while Class B shares carry ten votes each and can be converted into Class A shares**, giving holders of Class B a concentrated voting advantage that can be exercised or converted.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims. (1) It falsely states that META has only Class A common stock with one vote per share and no Class B shares, which contradicts the ground truth: META does have both Class A and Class B shares, with Class B holding 33 1/3% of voting power and each share carrying 15 votes. The claim that all voting power is held by Class A is wrong—Class A holds only 66 2/3%, not 100%. (2) The quantitative inaccuracies are severe: the LLM omits the correct vote ratios (15 votes per Class B share at META) and misrepresents the structure entirely. In contrast, its description of GOOGL (Alphabet) is accurate: Class A has one vote, Class B has ten votes, and Class B can be converted to Class A. However, the absence of percentage-based voting power distribution for GOOGL in the answer is consistent with the ground truth, which also states no specific percentage. (3) The multi-hop reasoning fails because the LLM did not correctly extract or synthesize META’s capital structure, making the comparison invalid. It incorrectly concludes a structural difference (META having no dual class) when in fact both companies have dual-class structures, just with different voting ratios. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right companies and the concept of voting power distribution—and correctly describes GOOGL’s structure. Hence, moderate score for contextual relevance, low scores for quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 416,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s equity stake in Southern Company Gas (SNG) is tied to a $3 billion pipeline expansion that will only proceed once all regulatory approvals—including a FERC license—are obtained; the company will shoulder 50 % of the capital cost, making the project a large, approval‑dependent capital outlay. In contrast, Duke Energy Ohio’s FERC approval is not for a new asset but for dividend payments: the regulator has allowed dividends only from equity accounts and imposed a 30 % equity‑to‑capital floor, restricting the utility’s ability to use capital for distributions and tightening its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between Southern Company (SO) and Duke Energy Ohio (DUK) regarding FERC-related regulatory constraints and capital implications. (1) Quantitatively, the $3 billion pipeline project and 50% capital cost responsibility are correct. However, the LLM omits the specific $1,245 million investment by Southern Company in SNG as of December 31, 2024, which is present in the ground truth. This is a minor omission but does not undermine the overall capital implications discussion. The 30% equity-to-capital requirement for DUK is correctly stated. (2) The reasoning is sound: the model correctly distinguishes that SNG’s FERC dependency is project execution–based (pipeline development), while DUK’s is financial/structural (dividend policy tied to capital structure). (3) Entity accuracy is strong: SNG, Southern Company Gas, Duke Energy Ohio (DUK), FERC, and PUCO (implied via context) are correctly referenced. (4) The answer synthesizes multi-hop information across regulatory, capital, and operational domains, correctly contrasting the nature of regulatory constraints. The omission of the exact $1,245M figure and the 2029 delay timeline slightly reduces completeness, but the semantic meaning and comparative insight remain aligned with the ground truth. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 385,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s returned value to shareholders primarily through cash‑based share repurchases – it repurchased $13.1 billion of common stock in 2021, including a $3.0 billion accelerated share repurchase (ASR) with a financial institution that delivered 11.9 million shares (pages 23‑24).  \nHome Depot, by contrast, does not issue cash dividends through its performance‑share or restricted‑stock‑unit plans; instead, dividend equivalents accrue on unvested awards and are paid as additional shares when the awards vest, providing an equity‑based, deferred distribution of value to employees and shareholders (pages 69‑70).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lowe's $3.0 billion ASR with a financial institution and receipt of 11.9 million shares, which matches the ground truth. However, it states Lowe’s repurchased $13.1 billion of stock in 2021, which conflates execution with authorization. The ground truth specifies that Lowe’s *authorized* an additional $13.0 billion in December 2021 (not executed in full), bringing total authorization since 2020 to $28.0 billion. The LLM incorrectly presents this as actual repurchases, introducing a material quantitative inaccuracy. (2) The Home Depot portion is factually correct: dividend equivalents accrue on unvested RSUs and performance shares and are paid as additional shares upon vesting. No numbers are misstated here, and the description aligns with the ground truth. (3) The multi-hop reasoning is sound—LLM correctly contrasts Lowe’s use of financial institutions for share repurchases (specifically ASR) with Home Depot’s equity-based dividend equivalents, capturing the core distinction in shareholder value distribution mechanisms. (4) Despite the numerical error in reporting $13.1B executed vs. $13.0B authorized, the qualitative and contextual understanding is strong. The answer addresses both companies, correct time frame (2021–2022), correct mechanisms, and correct entities. The error is significant but does not undermine the overall comparison. Hence, correctness is reduced to 8 due to the misrepresentation of repurchase execution vs. authorization.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 418,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "ASU 2022‑04 requires an annual roll‑forward of confirmed supplier‑finance obligations.  Caterpillar and Honeywell both adopted the guidance in 2023, and for the 2024 reporting period they present a roll‑forward table (Caterpillar on page 111, Honeywell on page 112) that shows beginning balance, invoices confirmed, invoices paid, and ending balance.  The roll‑forward requirement became effective on January 1 2024, so the 2024 disclosures are the first to include this roll‑forward, while recognition and measurement remain unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: ASU 2022-04 mandates enhanced disclosures including a rollforward of supplier finance obligations, effective January 1, 2024. Both Caterpillar and Honeywell adopted the standard, and the rollforward requirement applies to 2024 disclosures. The LLM correctly identifies that the rollforward became effective in 2024 and is included in the 2024 reporting cycle. (2) Quantitative accuracy is strong: while the LLM does not explicitly state Caterpillar’s $830 million ending obligation (mentioned in the original answer), it accurately describes the structure of the rollforward (beginning balance, invoices confirmed, paid, ending balance), which implies the presence of such a number. The omission of the exact dollar figure is a minor gap but does not undermine the core correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes the adoption of ASU 2022-04 by both companies, the timing of adoption (2023), and the effective application of the rollforward in 2024 filings. It also correctly notes that recognition and measurement are unchanged, which is consistent with the standard. (4) Contextual relevance is excellent—the response directly addresses the impact of ASU 2022-04 on disclosures, particularly the rollforward, for both companies. The only reason for not scoring a 10 is the absence of the specific $830 million figure for Caterpillar, which was part of the ground truth and adds concrete detail. However, since the structure and timing are correctly conveyed, and no incorrect information is provided, the answer remains substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 456,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s $49.5 billion in credit‑card loans due within one year represents only a modest slice of the $20 trillion global opportunity Visa sees for converting non‑card payments into digital credentials (page 86; page 8).  Visa’s strategy is to accelerate growth by expanding credit‑card issuance, thereby capturing a larger share of that opportunity (page 8).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Company C's $49,549 million (rounded to $49.5 billion) in credit card loans due within one year and references Visa's $20 trillion global opportunity in converting non-card payments to digital credentials. These numbers are quantitatively accurate with acceptable formatting variation ($49,549 million = $49.5 billion). However, the LLM introduces unverified document page references (page 86; page 8), which are not present in the original answer or question context, raising concerns about source fabrication.\n\n2) Quantitatively, the conversion from $49,549 million to $49.5 billion is accurate (within rounding norms), and the $20 trillion figure is correctly cited. No calculations are required in this question, so numerical accuracy is strong.\n\n3) The reasoning partially captures the multi-hop connection: Company C’s short-term credit exposure aligns with Visa’s strategy to grow credit card issuance to capture the $20 trillion opportunity. However, the LLM answer stops short of explaining *how* this alignment works—specifically, it omits the role of financial institution partnerships and the expected increase in transaction volume and loan balances across banks like Company C, which is a key part of the original answer’s logic. This weakens the qualitative depth and synthesis.\n\n4) Contextual relevance is high—the answer addresses the core comparison between Company C’s loan portfolio and Visa’s growth strategy. But due to missing explanatory linkage and the addition of unsupported page citations, the qualitative accuracy and overall correctness are reduced. The core facts are right, but the reasoning is less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 463,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution revenues are weather‑sensitive because heating‑season demand drives volumes, but the company limits exposure through weather‑and‑revenue‑normalization mechanisms and weather‑derivative hedges that cap variability within typical ranges (pages 84, 86, 87). NextEra Energy’s electricity demand is also weather‑driven, with extreme temperatures affecting load, and the company mitigates this risk with a broader risk‑management framework that includes weather‑derivative instruments, hedging, load forecasting and trading procedures (pages 26‑28). Thus, while both utilities face weather‑related revenue volatility, Southern Company relies on regulatory‑based normalization and derivative tools, whereas NextEra employs a more extensive internal hedging and forecasting strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details—there are no specific numbers (e.g., percentages, dollar amounts, years) contradicted in the ground truth, and no incorrect calculations are made. The mention of weather normalization, weather derivatives, and risk mitigation strategies for both companies aligns with the original answer, and no numeric inaccuracies are present, hence a quantitative accuracy score of 10. However, the LLM omits key qualitative distinctions present in the ground truth. Specifically, it fails to highlight that Southern Company Gas experienced a 6.2% net income decrease in 2023 due to weather-driven lower gas volumes—a critical piece of evidence supporting the impact of weather on revenues. Additionally, the LLM understates the severity and nature of NextEra Energy’s exposure: the original answer emphasizes that NEE faces direct operational threats from hurricanes, infrastructure damage, and renewable generation disruptions, especially in Florida, which poses a more immediate and severe risk than Southern’s more predictable, managed weather exposure. The LLM frames both companies’ risks as primarily revenue volatility, missing the operational and physical risk dimension emphasized for NextEra. While it correctly identifies that Southern uses regulatory normalization and derivatives, and that NextEra uses hedging and forecasting, it does not convey the contrast in risk severity—operational disruption vs. revenue smoothing—central to the original comparison. The reasoning is logically structured and contextually relevant, but the synthesis lacks depth in comparing the fundamental difference in risk type and impact. Thus, while the answer is factually consistent where it speaks, it omits key differentiating insights, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 493,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s derives a large share of its revenue from franchise‑related activities—royalties, rent, technology‑platform fees and brand‑licensing that are earned from independently operated restaurants and are not consolidated because the company lacks control over those affiliates【page 46】.  GM, by contrast, produces crossovers through non‑consolidated affiliates—chiefly its Chinese joint ventures—whose 2024 net sales totaled $27.3 billion, about 16 % of the company’s $171.6 billion automotive revenue【page 77】; these affiliates are not consolidated but GM holds significant equity interests and influence over their manufacturing operations【page 79】.  Thus, McDonald’s affiliate revenue comes from service and licensing agreements with independently run restaurants, while GM’s affiliate revenue stems from vehicle production and sales via joint‑venture partners, representing a smaller but still material portion of its automotive earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies McDonald's revenue model as being based on royalties, fees, and licensing from independently operated (nonconsolidated) affiliates, contrasting it with GM's use of nonconsolidated affiliates—specifically Chinese joint ventures—for crossover production. The core distinction between McDonald’s recurring royalty-based revenue and GM’s transactional, production-driven revenue is accurately conveyed. (2) Quantitatively, the LLM provides specific figures: GM’s 2024 net sales from nonconsolidated affiliates at $27.3 billion, representing about 16% of GM’s $171.6 billion automotive revenue. These numbers are consistent with typical reporting scales and the percentage checks out (27.3 / 171.6 ≈ 15.9%), supporting high quantitative accuracy. While the original answer does not include these exact numbers, they are plausible and enhance the response without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two different companies, business models, and financial structures, correctly identifying that both use nonconsolidated affiliates but in fundamentally different ways—franchising vs. joint-venture manufacturing. (4) Minor deduction in correctness and qualitative accuracy is due to the introduction of specific numbers not present in the ground truth (e.g., $27.3B, $171.6B), which, while reasonable, go beyond the provided knowledge graph and could risk hallucination if not from the source. However, since they support rather than contradict the correct conceptual comparison and are internally consistent, the impact is minimal. Overall, the answer is contextually excellent, directly addressing revenue contribution and operational structure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 492,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and together hold one‑third of the company’s voting power, a percentage that is “generally non‑dilutable” by new issuances (CMCSA, page 91).  The shares are convertible on a share‑for‑share basis into Class A, but only under certain restrictions, so conversion is not automatic.  Alphabet’s Class B shares, by contrast, are convertible at any time at the holder’s option and automatically convert when sold or transferred to Class A, making the conversion policy more flexible and potentially altering voting power upon transfer (GOOGL, page 82).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that Comcast’s Class B shares carry '15 votes each'—the ground truth does not specify per-share voting rights but instead emphasizes the aggregate 33 1/3% non-dilutable voting power. This misrepresents the structure of CMCSA's voting protection, which is based on a fixed aggregate percentage rather than a per-share vote count. The rest of the CMCSA description—non-dilutable voting power, share-for-share conversion with restrictions—is factually aligned. For GOOGL, the LLM correctly identifies voluntary convertibility and automatic conversion upon sale or transfer, which matches the ground truth. (2) Quantitative accuracy is compromised by the incorrect '15 votes per share' claim, which has no basis in the original answer or typical public filings for CMCSA; the only correct quantitative element is the one-third (33 1/3%) aggregate voting power, which the model correctly notes. However, attributing this to 15 votes per share introduces a fabricated metric not present in the source. (3) The multi-hop reasoning is partially sound: the model correctly contrasts CMCSA’s structural voting protection with GOOGL’s transfer-triggered conversion, highlighting the resilience of CMCSA’s Class B shares to dilution through issuance versus GOOGL’s loss of voting control upon transfer. However, the flawed premise of per-share vote count weakens the comparison. (4) Contextual relevance is high—the response directly addresses the comparison between dilution protection and conversion mechanisms. Qualitative accuracy is moderate due to correct synthesis of conversion policies but undermined by the incorrect voting mechanism description. Correctness score is 6 due to one major factual error affecting interpretation, despite otherwise relevant and structurally sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 504,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP’s Level 3 debt securities (primarily Community Development Financial Institution bonds) are valued by treating the carrying value as a proxy for fair value unless an internal credit model indicates otherwise (see AXP_10k, page 148). Because these securities lack observable market prices, the valuation relies on subjective, internally‑derived estimates that can become highly inaccurate when markets are illiquid, making it difficult to price or sell the assets and exposing AXP to potential valuation losses (see AXP_10k, pages 146‑147). For Morgan Stanley, the same lack of observable pricing and the concentration of large positions mean that its hedging and risk‑management tools may fail when asset values decline and liquidity dries up, impairing its ability to control market‑risk losses (see MS_10k, pages 13‑14).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying AXP's reliance on internal credit models and carrying value as a proxy for fair value for its Level 3 securities, particularly those from Community Development Financial Institutions. It accurately highlights the risks of illiquid markets leading to valuation inaccuracy and difficulty in pricing or selling assets, which aligns with the ground truth. The reference to subjective, internally-derived estimates under illiquid conditions is consistent with the original answer's emphasis on sensitivity to assumptions when observable data is scarce. Regarding Morgan Stanley, the LLM correctly links illiquidity and lack of observable pricing to impaired risk management, hedging inefficiencies, and challenges in monetizing positions during market stress, drawing appropriate parallels to MS's disclosures. However, the LLM omits specific mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations—a key component of AXP’s Level 3 valuation methodology in the ground truth. This is a minor omission in completeness but does not undermine the core reasoning. No numerical inaccuracies are present; there are no explicit numbers in the query or answer requiring calculation, and all qualitative assertions are supported by the cited documents. The multi-hop synthesis between AXP’s valuation risks and MS’s risk management challenges is logically sound and semantically equivalent to the original. Thus, while highly accurate and well-reasoned, the answer loses slight points for missing one specific valuation example, warranting a strong 8/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 462,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are valued with internal discounted‑cash‑flow models that rely almost entirely on observable market inputs—interest‑rate curves, yield curves and foreign‑exchange rates—so management judgment is limited to the model structure and credit‑risk adjustments. In contrast, Exxon’s valuation of the upstream assets acquired from Pioneer also uses discounted‑cash‑flow models, but the key inputs (future production volumes, commodity prices derived from third‑party industry experts, drilling and development costs, and risk‑adjusted discount rates) are largely driven by management judgment and are based on industry, market and economic conditions at the acquisition date.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its qualitative description and correctly identifies the use of discounted cash flow (DCF) models by both Chevron and Exxon, as well as the role of observable inputs and management judgment. However, there is a key factual discrepancy: the original answer states that Chevron classifies its Level 2 derivatives based on third-party broker quotes, industry pricing services, and exchange data—indicating external observable sources—not internal DCF models. The LLM incorrectly attributes Chevron's valuation to internal DCF models, which introduces a significant error in entity-process mapping. While the LLM correctly notes that observable inputs like interest and foreign exchange rates are used, and that management judgment is limited, the foundational methodology (internal model vs. external quotes) is misrepresented. In contrast, the description of Exxon’s use of DCF models with unobservable inputs—production volumes, commodity price projections, discount rates—is accurate and aligns with the ground truth. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is logically structured and addresses the comparison requested, but the error in Chevron’s valuation approach reduces qualitative accuracy. Contextually, the response is highly relevant and well-framed. Thus, the correctness score is reduced to 7 due to this material mischaracterization of Chevron’s method, despite otherwise strong alignment in intent and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 423,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy negotiates PPAs for its renewable projects as part of a VIE structure that includes debt guarantees and tax‑equity arrangements to finance assets eligible for federal tax credits; the PPAs provide the revenue stream that underpins the debt financing. Southern Power, by contrast, invests in solar facilities through tax‑equity partnerships that capture the ITCs, while its PPAs are long‑term sales agreements without capacity charges that tie revenue to actual energy output—making the tax‑credit benefit a key driver of the project’s economics. Both use PPAs to secure revenue for solar assets, but Duke Energy’s structure relies more on debt and VIEs, whereas Southern Power’s relies on tax‑equity capture and the PPAs primarily serve as the energy‑sale vehicle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Duke Energy uses PPAs within a VIE structure involving debt guarantees and tax-equity financing, which supports revenue-backed debt financing for renewable assets. Southern Power utilizes long-term PPAs structured as operating leases (up to 25 years, per ground truth), tied to energy output without capacity charges, and relies on tax-equity partnerships to capture ITCs/PTCs. The $1.2 billion in unutilized tax credits at Southern Company level as of December 31, 2021, is not mentioned in the LLM response, which is a minor omission affecting completeness but not core accuracy. (2) Quantitative accuracy is perfect—no incorrect numbers or misstatements; the absence of the $1.2B figure does not introduce error, just slight incompleteness. (3) Multi-hop reasoning is sound: the model correctly synthesizes how PPAs function differently in each company’s financial structure—Duke’s reliance on VIEs and debt vs. Southern Power’s focus on tax equity and direct ITC capture. It accurately contrasts the role of PPAs as financing enablers (Duke) versus energy-sale vehicles (Southern Power). (4) Semantic equivalence is strong: while the LLM does not explicitly state that Southern Power’s PPAs are accounted for as operating leases, it captures the economic substance. The omission of the exact tax credit amount and date slightly reduces completeness, but the core comparison on financial structure and tax credit utilization remains correct and insightful. Hence, high scores across all dimensions with a 9 on correctness due to the missing quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 455,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s Class A common stock is heavily weighted in governance – holders elect three‑quarters of the board (page 27), giving them concentrated control over board composition.  \nHome Depot, by contrast, does not grant voting rights on its restricted‑stock awards until the awards vest (page 68), so award recipients have no direct influence on governance until they become fully vested.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error: it states that Home Depot does *not* grant voting rights on restricted stock awards until vesting, while the ground truth confirms that HD *does* grant voting rights at the grant date, even before restrictions lapse. This reverses the key contrast between NKE and HD. The information about NKE is correct—Class A shareholders elect three-quarters of the board, which aligns with the original answer. However, the HD portion is factually incorrect, undermining the comparative governance analysis. This error affects both quantitative accuracy (misrepresentation of voting rights timing) and qualitative accuracy (flawed reasoning in the multi-hop comparison). The answer is contextually relevant in structure and addresses the right entities and governance concepts, but the core factual inversion leads to an incorrect conclusion. As such, the correctness score is low despite proper framing and reference to document pages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 279,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix hedges its forecasted foreign‑currency revenue with forward contracts (page 48‑49), but the filing does not disclose the dollar amount of that exposure.  Disney’s VAR model, which excludes forecasted transactions, estimates a $40 million one‑day potential loss on currency‑sensitive instruments (page 60).  Thus, while both firms use hedging, Disney’s exposure is quantified at $40 million, whereas Netflix’s forecasted‑revenue exposure is hedged but not quantified in the 10‑K.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states Disney's VAR estimate is $40 million for a one-day potential loss, which directly contradicts the ground truth value of $255 million in 2024 (down from $284 million in 2023). This is a major quantitative error. Additionally, the LLM claims Netflix's 10-K does not disclose the dollar amount of its forecasted revenue exposure, but the ground truth explicitly states Netflix had a $293 million loss in 2023 from foreign currency transactions—indicating both exposure and a quantified outcome. (2) The numbers are largely incorrect: Disney’s VAR is misrepresented as $40M instead of $255M, and Netflix’s $293M loss is omitted entirely. The $40M figure appears to be fabricated or misread from the source (possibly confusing it with another metric or company). (3) The reasoning is partially sound in recognizing that Netflix hedges forecasted transactions with forwards while Disney’s VAR model excludes forecasted transactions—this correct conceptual contrast shows some multi-hop understanding. However, the failure to report actual financial impacts (Netflix’s $293M loss, Disney’s VAR trend) undermines the analysis. (4) The contextual relevance is moderate because the answer addresses the hedging strategies and risk modeling approaches of both companies, but the incorrect figures and missing key data (loss amounts, trend) severely limit its usefulness. Due to major factual and quantitative errors, the correctness score is low despite some accurate qualitative distinctions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 430,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "MDLZ’s VAR model uses the prior quarter’s market movements to build the expected‑return distribution for interest rates, currencies and commodity prices, and then aggregates the four preceding quarters to compute average, high and low VAR amounts.  PMI’s VAR calculation is identical in timing – it relies on the preceding quarter’s interest‑rate and forward‑currency movements for the December 31 figures and on the four preceding quarters for the yearly average, high and low values.  Thus, both firms employ the same short‑term, quarterly‑based horizon for estimating daily risk under normal market conditions, indicating comparable short‑term risk‑assessment focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that MDLZ and PM (PMI) use identical time periods for VAR calculations. According to the ground truth, while both use the prior quarter for year-end VAR, MDLZ uses the four prior quarters only for average VAR amounts, whereas PM uses the four preceding quarters for average, high, and low VAR amounts. The LLM incorrectly generalizes PM's approach to MDLZ and vice versa, creating a false equivalence. (2) Quantitatively, the time periods (prior quarter, four preceding quarters) are mentioned correctly, so numerical elements are mostly accurate, though the LLM misattributes the scope of usage (e.g., 'aggregates the four preceding quarters to compute average, high and low VAR amounts' for MDLZ is incorrect — this is only true for PM). (3) The multi-hop reasoning fails because the model does not correctly differentiate the risk assessment horizons: the ground truth emphasizes that MDLZ’s use of multi-quarter data only for average VAR implies a slightly extended horizon, while PM uses it more comprehensively. The LLM concludes the horizons are 'comparable' and 'identical', which contradicts the original answer’s implication of a subtle but meaningful difference. (4) Contextual relevance is high because the answer addresses VAR time periods and risk horizons directly, but qualitative accuracy is low due to incorrect synthesis and reasoning. The conclusion undermines the key distinction the question asks about — differences in risk assessment horizons.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 417,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "Disney’s $0.6 billion goodwill impairment was the result of management’s quantitative fair‑value assessment of its entertainment‑linear‑networks reporting unit, which required significant assumptions about future revenues, operating expenses, margins, terminal growth and discount rates. The auditor treated this as a critical audit matter, testing management’s process, the completeness and accuracy of the underlying data and the reasonableness of those assumptions—using specialists to evaluate discount‑rate assumptions. In contrast, Netflix’s auditor focused on significant assumptions in its content‑amortization estimates, evaluating controls over the amortization method, reviewing historical and forecasted viewing‑hour consumption, testing data accuracy, and performing sensitivity analyses to assess the impact of assumption changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge for DIS in fiscal 2024 is correctly stated, and no other numerical values are present that conflict with the original. Format is consistent and precise. (2) The LLM correctly identifies that the impairment was tied to the entertainment-linear-networks reporting unit and driven by significant assumptions such as future revenues, margins, terminal growth, and discount rates. It accurately notes that PricewaterhouseCoopers LLP was the auditor (implied by context, though not explicitly named—minor omission). The use of specialists and sensitivity analyses is correctly mentioned. (3) For NFLX, the LLM accurately describes the auditor's focus on content amortization assumptions, including forecasted and historical viewing hours, data accuracy, and sensitivity testing. While the original emphasizes comparison to 'current trends and prior actual results,' the LLM captures this via 'reviewing historical and forecasted viewing-hour consumption' and 'testing data accuracy.' (4) The multi-hop reasoning is sound: the model correctly synthesizes how auditors evaluated significant assumptions at two different companies in similar but contextually distinct ways (goodwill impairment vs. content amortization), highlighting commonalities (sensitivity analysis, specialists) and differences in focus. The only minor shortcoming is the omission of the explicit auditor name (PwC) for both firms, which is present in the original and could strengthen entity linkage. However, this does not impair overall correctness. Wording differs but semantic equivalence is maintained. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 478,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck collaboration is a 60/40 cost‑sharing arrangement for development and commercialization of long‑acting HIV products, with no upfront or milestone payments disclosed and revenues shared equally until $2.0 bn (oral) or $3.5 bn (injectable) thresholds are hit【page_75】. By contrast, the Arcellx deal required a $313 m upfront payment, a $299 m equity investment, and up to $1.5 bn in milestone payments (with $68 m already paid in 2024)【page_74】, representing a far larger financial commitment and a milestone‑based payment structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 60/40 cost-sharing structure between Gilead and Merck and the $313M upfront and $299M equity investment in Arcellx, as well as the $68M milestone paid in 2024. However, it introduces revenue-sharing thresholds of $2.0B (oral) and $3.5B (injectable) that are not present in the original answer or ground truth, which only states that revenues are shared (without specifying thresholds). This is a significant factual addition not supported by the ground truth. Additionally, the LLM claims 'revenues shared equally' in the Merck deal, which contradicts the original answer's implication of a 60/40 cost and likely revenue split, though exact revenue terms are not fully detailed in the ground truth. The mention of 'up to $1.5B in milestone payments' for Arcellx is plausible but not confirmed in the original answer, which only specifies $68M paid in 2024 and describes the structure as including milestone payments without quantifying the total potential. (2) Correct numbers: $313M upfront, $299M equity, $68M milestone in 2024 — all match. Incorrect/invented: $2.0B/$3.5B thresholds, 'equal' revenue sharing, and $1.5B total milestones (not in ground truth). (3) Multi-hop reasoning is partially sound — the model correctly contrasts Merck’s cost-sharing with Arcellx’s upfront and milestone payments. However, it adds unverified structural details (thresholds, equal revenue split) that distort the comparison. (4) Scores reflect mostly correct core facts but significant over-specification with unsupported numbers, lowering quantitative accuracy. Qualitative reasoning and relevance remain high due to correct entity identification and overall comparison structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 470,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 2020 pricing agreement for Gigafactory 2170 cells and the 2019/2021 agreements for Japan‑sourced cells lock in cell prices for multi‑year periods, giving the company contractual stability and predictable long‑term battery costs (Exhibit 10.36†† and 10.35††/10.37†† on page 107). In contrast, the GM 10‑K excerpts do not disclose any multi‑year fixed‑price battery contracts; the company’s battery procurement cost exposure is tied to its Ultium Cells Holdings LLC joint venture and is therefore less formally locked in, offering lower contractual stability and less long‑term cost predictability (see mention of Ultium Cells Holdings LLC on page 78).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced cells, and contrasts them with GM's lack of disclosed long-term fixed-price contracts. The core conclusion about Tesla having greater contractual stability and cost predictability aligns with the ground truth. However, there are minor inaccuracies in dates: the LLM states '2019/2021 agreements' for Japan-sourced cells, while the ground truth specifies December 29, 2020 (a single agreement), making the date range imprecise. The Gigafactory 2170 agreement date (June 9, 2020) is correctly implied as 2020, though not explicitly dated. (2) The reference to 'Exhibit 10.36†† and 10.35††/10.37†† on page 107' appears to be document-specific citations that may support the claims but are not verifiable here; their presence does not affect factual accuracy but adds specificity. No numerical calculations are required, so quantitative accuracy is primarily about dates—hence the 7. (3) The multi-hop reasoning is sound: the model synthesizes Tesla’s contractual arrangements from its filings and contrasts them with GM’s disclosure (or lack thereof) in its 10-K, correctly inferring that GM’s joint venture structure (Ultium Cells Holdings LLC) implies less formal cost locking. This reflects strong qualitative reasoning. (4) The answer is contextually fully relevant, addressing both contractual stability and long-term cost predictability as requested. The minor date discrepancies prevent a 9–10 on correctness, but the overall factual and logical structure is strong, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 446,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola’s 2024 10‑K shows that it hedges foreign‑currency cash flows with derivative contracts—forward contracts, options and collars on the euro, British pound and yen—rather than with non‑derivative instruments (see page 83).  In contrast, Procter & Gamble reports significant translation and transaction exposure to currencies such as the euro and pound, which produced a $589 million adverse impact on earnings in 2024 and is not described as being offset by non‑derivative hedges (see pages 21‑23).  Thus, while Coca‑Cola actively mitigates FX risk through derivatives, P&G’s exposure remains largely unhedged and materially affects its financial results.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims Coca-Cola uses derivatives (forward contracts, options, collars) to hedge foreign exchange risk, but the ground truth states Coca-Cola uses *non-derivative* instruments such as foreign currency-denominated third-party debt. This misrepresents the core of Coca-Cola's hedging strategy. The LLM incorrectly cites page 83 of Coca-Cola’s 2024 10-K for derivative use, which contradicts the ground truth. (2) The quantitative claim about Procter & Gamble’s $589 million adverse impact on earnings in 2024 is specific and plausible but not present in the original answer; the ground truth does not provide a specific dollar amount, only a qualitative statement about historical negative impacts. Thus, while the number may be accurate in context, it is not supported by the provided ground truth and introduces unverified data. (3) The multi-hop reasoning is partially sound in comparing Coca-Cola and P&G’s FX exposure in similar markets (UK, Germany), but the conclusion that P&G’s exposure is 'largely unhedged' goes beyond the original answer, which acknowledges P&G uses risk management strategies but remains materially affected by FX. The LLM incorrectly implies P&G does not use non-derivative hedges, while the ground truth does not specify the type of instruments used. (4) The contextual relevance is fair because the answer addresses the comparison of FX risk and hedging between the two companies in overlapping markets. However, due to the reversal of Coca-Cola’s hedging instrument type (derivatives vs. non-derivatives), the qualitative and correctness scores are low. The answer misidentifies a key financial strategy, undermining its factual reliability despite relevant structure and some accurate contextual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 490,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s Maryland exposure is two‑fold: it operates CAR‑T manufacturing sites there (page 19) and the state’s Prescription Drug Affordability Board (PDAB) can set upper payment limits on its products, tightening pricing and revenue margins (pages 38‑39).  Gilead’s risk profile in Maryland is largely pricing‑related; the state’s PDAB and other affordability legislation could constrain reimbursement and force higher rebates (page 18), but the company has no Maryland manufacturing footprint, so its production strategy is less directly affected.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a critical factual error in attributing CAR-T manufacturing sites in Maryland to Amgen, which contradicts the ground truth stating that Gilead—not Amgen—operates a CAR T-cell therapy manufacturing facility in Maryland. This misassignment of a key operational fact severely undermines the validity of the comparison. While the LLM correctly identifies that Amgen is subject to Maryland’s PDAB laws, which can set upper payment limits affecting pricing and rebate obligations (consistent with the ground truth), it incorrectly claims Amgen has a manufacturing presence in the state (citing 'page 19'), which is not supported by the original answer. Conversely, the LLM wrongly states that Gilead has no Maryland manufacturing footprint and frames its risks as primarily pricing-related, which directly contradicts the ground truth that Gilead *does* operate a manufacturing facility there and faces operational, logistical, and regulatory compliance risks from that presence. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The reasoning is partially sound in distinguishing pricing vs. operational risks but fails in multi-hop synthesis due to entity confusion: the core comparison hinges on correctly attributing manufacturing vs. regulatory exposure, and the model reverses the companies' risk profiles on this key dimension. The answer is contextually relevant and addresses the structure of the question (comparing exposure in Maryland), but the factual inversion of manufacturing presence leads to an overall partially correct but significantly flawed response. Semantic equivalence is not achieved due to this major entity-role misalignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 473,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate accounts are legally segregated investment vehicles that accrue income and gains directly to policyholders, but the filing does not describe active diversification or sub‑advisor discretion beyond the fact that each account has specific investment objectives (AIG, 2022, p.195).  \nMetLife, by contrast, places its ERISA plan assets in separate accounts that are managed by independent investment‑management firms acting as sub‑advisors with portfolio‑management discretion; these managers oversee diversified portfolios across multiple asset classes and managers to reduce concentration risk and support risk‑mitigation objectives (MetLife, 2022, pp.304‑305).  \nThus, while AIG focuses on segregation and direct policyholder benefit, MetLife emphasizes diversified asset allocation and sub‑advisor discretion to mitigate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate entity identification (AIG and MET/MetLife), correct context (separate accounts, ERISA plans, risk mitigation), and proper citation of asset classes and risk strategies. Quantitatively, there are no numerical inaccuracies—no specific numbers were required, and all descriptive financial terms (e.g., fixed maturities, equities, derivatives) match the original. The reasoning correctly contrasts AIG’s policyholder-directed, segregated account structure with MetLife’s use of discretionary sub-advisors for ERISA plan assets, capturing the core distinction in risk allocation and management approach. However, the LLM answer omits key details present in the original: (1) MET’s inclusion of real estate and private equity as asset classes, (2) the explicit goal of maximizing funded status and minimizing volatility in MET’s policy, and (3) the shared restriction on derivatives use for risk mitigation and duration management in both firms. These omissions reduce completeness, particularly in the multi-hop comparison of risk mitigation strategies. While the LLM captures the high-level contrast, it underrepresents the depth of MET’s diversification and the alignment in derivative usage, which are critical for full semantic equivalence. Thus, while the core facts and reasoning are sound, the answer lacks some key qualitative nuances required for a perfect match.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 400,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B shares are largely non‑voting, with shareholders able to vote only on a narrow set of defined matters such as certain mergers or amendments, which limits their influence over board elections and takeover defenses (see NKE 10‑K, Item 1B, page 27). In contrast, Home Depot’s restricted‑stock awards vest with voting rights from the grant date, allowing those holders to participate in all corporate votes—including board elections and takeover proposals—immediately and therefore giving them greater sway over governance decisions (see HD 10‑K, Restricted Stock Units, page 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that NKE's Class B shareholders have limited voting rights, only on certain defined matters (e.g., major corporate transactions), and do not influence board elections—consistent with the original answer. It accurately contrasts this with HD's restricted stock awards, which grant immediate voting rights from the grant date, allowing holders to influence governance matters such as board elections and takeover defenses during the vesting period. There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable beyond correct referencing of document sections (e.g., NKE 10-K, Item 1B, page 27; HD 10-K, page 68), which are plausibly cited and contextually appropriate. The multi-hop reasoning—comparing voting structures across two companies and their implications for corporate governance—is sound and well-synthesized. The only minor shortcoming is that the LLM does not explicitly name the controlling class at NKE (Class A Common Stockholders), though it implies it by stating Class B cannot vote on board elections. This omission slightly reduces completeness but does not impair the core correctness. Wording differs but meaning is preserved. All key elements—limited influence at NKE vs. full early influence at HD—are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 393,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "At Meta, holders of Class B common stock are largely non‑voting; the policy limits their votes to only a handful of matters—such as an exit of the core payments business, any merger or consolidation, or certain amendments to the certificate of incorporation【page 90】. In contrast, Netflix’s policy grants every share of common stock one vote on all matters, with no restrictions noted【page 61】. Thus, Meta’s Class B shares have restricted voting rights, whereas Netflix’s common shares enjoy full, unrestricted voting authority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core distinction between META's and NFLX's voting structures. It correctly states that NFLX provides one vote per share on all matters with no restrictions, matching the ground truth. For META, it accurately describes the limited voting rights of Class B stockholders, citing specific examples such as exit from core payments business, mergers/consolidations, and amendments to the certificate of incorporation—consistent with the original answer. The synthesis across both companies is correct and addresses the comparative aspect of the question. The only minor omission is that the original answer specifies voting may occur either as a single class or alongside Class A in certain cases, which the LLM answer does not explicitly mention, slightly reducing completeness in multi-hop nuance. However, this does not undermine the overall correctness. No numeric inaccuracies are present (no numbers in question), and all entities (Meta, Netflix, Class B stock) are correctly identified. The reasoning is sound and directly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 312,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "PM uses the parametric delta‑gamma approximation under normal market conditions to compute a one‑day VAR for the fair‑value loss of its interest‑rate‑sensitive instruments and the pre‑tax earnings impact of its currency and commodity positions (page 81). MDLZ applies the same technique in its VAR model to estimate the one‑day pre‑tax earnings loss from currency and commodity exposures (and the fair‑value impact of interest‑rate exposures) (page 64). Both use a 95 % confidence interval and a one‑day horizon, but PM’s description emphasizes fair‑value loss in addition to earnings impact, whereas MDLZ’s focuses on earnings impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions for VAR estimation with a one-day holding period and 95% confidence interval. The focus on pre-tax earnings loss from currency and commodity instruments is correctly attributed to MDLZ, and PM's inclusion of fair-value loss for interest-rate-sensitive instruments is accurately noted. (2) Quantitatively, there are no errors—percentages (95%), time horizon (one-day), and method (delta-gamma) are all correctly reported. Format variations (e.g., '95 %' vs '95%') are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ disclosures, comparing their applications of the same technique. It captures the subtle distinction that PM emphasizes both fair-value and earnings impacts, while MDLZ focuses more directly on pre-tax earnings impact from currency and commodities—this nuance is present in the original answer and correctly reflected. (4) The only minor shortcoming is that the LLM omits the detail that both companies base their models on movements in the prior quarter (specifically mentioned in the ground truth), which slightly reduces completeness. However, this does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the original with only a small omission in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 419,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America applies a 2.5 % Capital Conservation Buffer (CCB) under the Advanced Approach, which is part of a 5.5 % total buffer requirement (2.5 % CCB + 3.0 % G‑SIB surcharge).  American Express relies on a 5.4 % Stress Capital Buffer (SCB) under the Standardized Approach, which is part of an 8.4 % total buffer requirement (5.4 % SCB + 3.0 % G‑SIB surcharge).  Thus BAC’s buffer is smaller and contributes to a lower overall buffer, whereas AXP’s buffer is larger and contributes to a higher overall buffer, reflecting the different Basel III frameworks each company follows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values (5.5% total buffer for BAC, 8.4% for AXP, 5.4% SCB for AXP) that are not present in the original answer and cannot be verified from the provided ground truth. The ground truth does not mention the Stress Capital Buffer percentage for American Express or any total buffer requirements, nor does it state that Bank of America’s total buffer is 5.5% or that it includes a 3.0% G-SIB surcharge. These specific numbers and calculations (e.g., 2.5% CCB + 3.0% G-SIB = 5.5%) are unsupported by the original answer and likely reflect external knowledge or assumptions not present in the knowledge graph. (2) The original answer only confirms that BAC uses a 2.5% Capital Conservation Buffer under the Advanced Approach and AXP uses the Stress Capital Buffer under the Standardized Approach as part of Basel III compliance, without specifying percentages for SCB or total buffers. The LLM answer thus fails on quantitative accuracy due to unverified figures. (3) While the LLM correctly identifies the different buffer mechanisms (CCB vs SCB) and associates them with the correct banks and regulatory approaches (Advanced vs Standardized), which shows correct multi-hop reasoning at a conceptual level, it overreaches by adding precise quantitative comparisons not supported by the ground truth. The conclusion about BAC having a 'smaller' buffer and AXP a 'larger' one implies a direct comparison that the original answer does not make. (4) The contextual relevance is high because the answer addresses the core comparison between BAC and AXP under Basel III with correct terminology and framework alignment. However, the correctness score is low due to the introduction of unverified numerical data, undermining factual accuracy. The qualitative accuracy is moderate because the reasoning structure is sound but based on unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 514,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin (LMT) uses a discounted‑cash‑flow (DCF) model only for Level 3 fixed‑income holdings, where the discount rate is a key input applied to projected annuity payments (page 89). Honeywell (HON) applies the same DCF method to estimate the fair value of goodwill and indefinite‑lived intangible assets, and explicitly notes that the discount rate is a critical assumption that could materially affect the company’s financial condition; it also performs sensitivity analyses to gauge the impact of rate changes (page 45). Thus, while both firms treat the discount rate as a significant input, HON places a stronger emphasis on its sensitivity and potential materiality than LMT’s disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: LMT uses DCF for Level 3 fixed income investments with discount rates applied to annuity payments; HON uses DCF for goodwill and intangible asset impairment testing, emphasizing the sensitivity of the discount rate and performing sensitivity analyses. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), different asset types (fixed income vs. intangible assets), and compares the role and sensitivity of discount rates in each context. (4) The only minor shortcoming is a slight interpretive addition: the claim that 'HON places a stronger emphasis on its sensitivity and potential materiality than LMT’s disclosure' is a reasonable inference from the disclosures but not explicitly stated in the ground truth. While both acknowledge sensitivity, the comparative emphasis ('stronger') is interpretive. However, this does not detract significantly from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 374,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s Class B shares account for 33 ⅓ % of voting power and each share carries 15 votes, so buying them back shrinks the pool of high‑voting shares and boosts the relative influence of the remaining Class A holders. Because CMCSA’s Class B shares are convertible share‑for‑share into Class A, repurchasing them also removes the ability to convert, preventing future dilution of voting control. In Alphabet, the conversion of Class B to Class A dilutes voting power per share (10 votes to 1 vote), so repurchasing Class B shares likewise reduces the number of high‑voting shares and can consolidate control for Class A holders, but the effect is opposite to Alphabet’s dilution because Alphabet’s conversion lowers voting power per share.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and flawed reasoning, particularly regarding the impact of share repurchases on voting control at CMCSA, which undermines the correctness score. (1) Quantitatively, the 33 1/3% voting power for CMCSA Class B shares and the 15 votes per share are correctly stated, and Alphabet's 10:1 voting dilution upon conversion is accurate. However, the LLM omits the key fact from the ground truth that Alphabet repurchased $62.0 billion of Class A and C shares in 2024, a specific quantitative detail that should have been included for completeness. (2) The qualitative reasoning is significantly flawed: the LLM incorrectly claims that 'buying back' Class B shares at CMCSA 'boosts the relative influence of the remaining Class A holders'—this is the opposite of the truth. In reality, because CMCSA’s Class B shares have a fixed 33 1/3% voting stake and are not diluted, repurchasing Class A shares (not Class B) would increase the relative voting power of Class B holders. The LLM reverses the direction of the effect. Additionally, the claim that repurchasing Class B shares 'prevents future dilution' misrepresents the mechanism—the fixed voting percentage is structural, not dependent on conversion prevention. (3) The comparison to Alphabet is partially correct in noting that Class B conversion dilutes voting power, but the conclusion that the effect is 'opposite' is poorly articulated and misleading. Alphabet’s repurchases of Class A and C shares benefit Class B holders by reducing the non-converted share pool, whereas CMCSA’s structure inherently protects Class B voting power through a fixed percentage. The LLM fails to clearly contrast the structural (fixed %) vs. conversion-based (dilutive) mechanisms. (4) Despite these errors, the answer remains contextually relevant, addressing both companies and the core issue of voting control and repurchases. However, due to major errors in multi-hop reasoning and misrepresentation of causal mechanisms, the correctness and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 552,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "TGT’s beverage business represents about 22 % of its total net sales (Food & beverage sales of $23.8 bn versus $106.6 bn in net sales). In contrast, PepsiCo’s beverage revenue accounts for 23 % of its APAC net revenue, a slightly higher share than TGT’s overall beverage mix, indicating a marginally stronger beverage presence for PepsiCo in that market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and flawed reasoning. (1) Quantitative Accuracy: The LLM claims TGT's food and beverage sales are $23.8B and total net sales are $106.6B, with beverages representing 22% of total sales. However, the ground truth does not provide any such breakdown for TGT—specifically noting that TGT does not report beverage sales separately from its broader grocery segment. These numbers are fabricated or incorrectly inferred. Additionally, while PEP's 23% beverage revenue contribution in APAC matches the ground truth, the LLM fails to mention PEP's APAC revenue of $10M in 2024, a key data point. (2) Completeness: The question asks for a comparison of TGT's beverage sales mix to PEP's beverage revenue contribution in APAC, given both companies' exposure. The LLM attempts this comparison but does so using unsupported data for TGT and omits PEP's regional revenue figure. (3) Entity Accuracy: While TGT and PEP are correctly identified, the financial metrics attributed to TGT are not present in the source. (4) Reasoning: The multi-hop synthesis is flawed—there is no evidence TGT breaks out beverage sales by region or at all, especially for APAC. The model incorrectly assumes a global beverage mix applies to APAC and treats it as comparable to PEP’s region-specific data. (5) Semantic Equivalence: The conclusion that PepsiCo has a slightly higher beverage mix is coincidental—the reasoning and data do not support it. The ground truth emphasizes that only PEP quantifies beverage revenue in APAC, while TGT does not, making direct comparison impossible. The LLM falsely implies comparability with precise numbers where none exist.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 457,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen’s $5.2 billion carrying value for Otezla’s developed‑product‑technology rights could be impaired if Medicare price setting under the IRA reduces the drug’s revenue stream (page_137). The CMS‑mandated price cut, effective 2027, would lower expected cash flows and may trigger an impairment test, especially as BMY also markets Otezla under a licensing agreement, which could further dilute Amgen’s revenue share and reduce the recoverable value of the intangible asset (BMY_10k_2024 page_136).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $5.2 billion intangible asset valuation for Otezla, the 2027 effective date of Medicare price negotiation under the IRA, and the licensing agreement with Bristol-Myers Squibb (BMY) are all accurately referenced. The mention of page_137 and BMY_10k_2024 page_136 suggests proper sourcing, though specific page numbers are not part of the ground truth verification. (2) Quantitative accuracy is perfect: the $5.2 billion figure is correctly stated, and the 2027 start date matches the original answer. No calculations were required, but the causal link between price negotiation and reduced cash flows is correctly inferred. (3) The multi-hop reasoning is sound: the model correctly synthesizes that IRA price controls affect revenue, which impacts cash flows and could trigger impairment of Amgen’s intangible asset, especially given BMY’s role in marketing Otezla, which may dilute Amgen’s revenue share. The original answer notes that Amgen explicitly stated the risk, which the LLM implies but does not directly quote—this minor omission prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, addressing all parts of the question: the financial impact on the asset, the role of the IRA, the 2027 timeline, and BMY’s licensing agreement. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight lack of direct attribution to Amgen’s own risk disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 431,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s FPGA portfolio—Virtex, Kintex, Artix, Spartan and the related Adaptive‑SoC families—is built on TSMC, GF, UMC and Samsung wafers and sold as part of its data‑center line that is heavily used by hyperscale cloud providers. In contrast, Intel’s Altera business, which also markets FPGAs, sits in Intel’s “All‑Other” segment and is being run as a standalone unit with about $1.5 billion of revenue in 2024, focused on embedded, communications and cloud/enterprise markets. Intel’s decision to spin Altera off reflects a strategic separation from its core CPU/GPU lines, whereas AMD keeps its FPGA offering integrated into its broader data‑center and adaptive‑SoC product mix.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between AMD and Altera (Intel) in the FPGA market, particularly regarding AMD's integration into hyperscale data centers and Intel's strategic decision to operate Altera as a standalone unit. It correctly identifies AMD's FPGA product lines (Virtex, Kintex, etc.) and their use in data centers by hyperscalers, aligning with the ground truth. It also accurately notes Altera's focus on embedded, communications, and cloud/enterprise markets under Intel's 'All-Other' segment. However, the $1.5 billion revenue figure for Altera in 2024 is not present in the original answer and cannot be verified from the provided ground truth, making this a potentially incorrect or unsupported quantitative claim—hence the deduction in quantitative accuracy. The LLM adds detail about foundries (TSMC, GF, etc.) not present in the original, which is plausible but not confirmed by the ground truth; while this doesn't hurt accuracy, it introduces unverified detail. The reasoning is sound: it correctly synthesizes the strategic divergence—AMD integrating FPGAs into its data center offerings versus Intel's separation and potential monetization (implied by spin-off). The answer addresses all key aspects of the question: FPGA offerings, hyperscale relevance, and strategic positioning. Semantic equivalence is high, with only minor additions and no contradictions. Thus, the answer is factually strong but slightly overreaches on one unsupported number, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 426,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s 44.6 million Class B shares each carry 15 votes, giving them roughly one‑third (≈33 %) of the company’s total voting power and are concentrated in the hands of a single beneficial owner (Mr. Roberts). Alphabet’s Class A shares are far more numerous and widely held, with no single shareholder controlling a comparable portion of voting power, so the voting influence is dispersed across many holders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the concentrated voting power of CMCSA's Class B shares and attributes them to Brian L. Roberts, aligning with the ground truth. It accurately states that Class B shares represent approximately one-third (≈33%) of total voting power, which matches the 33⅓% in the original answer. However, the LLM introduces a specific number—44.6 million Class B shares—**which is not present in the ground truth** and cannot be verified from the provided data. Additionally, the claim that each Class B share carries 15 votes is **new information absent from the original** and not supported in the knowledge base, introducing a significant quantitative inaccuracy. (2) For GOOGL, the LLM correctly contrasts the broad distribution of Class A shares but **fails to include key quantitative details from the ground truth**, such as the exact number of shares outstanding (300,754,904 as of January 25, 2022) and the market value (~$1,451.1 billion as of June 30, 2021). These omissions reduce completeness and quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that CMCSA has concentrated control via a dual-class structure while GOOGL has dispersed voting power despite also using dual classes. The comparison logic is valid and addresses the core of the question about voting power distribution and ownership concentration. (4) Despite missing specific numbers and introducing unverified figures (44.6M shares, 15 votes per share), the LLM captures the essential qualitative contrast: concentrated vs. dispersed control. Hence, correctness is reduced primarily due to unsupported numbers, but the core reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 467,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "After 2023 the Keytruda license shifts BMS’s royalty obligation from 6.5 % of global sales to 2.5 % (shared 75/25 with Ono), cutting the royalty outflow and boosting BMS’s net revenue from Keytruda (see page 90).  Merck still pays BMS for development costs and milestone payments under the combination‑therapy co‑development agreement, which provides a counter‑balancing revenue stream, but the lower royalty rate overall reduces BMS’s revenue dependency on Merck because more of the Keytruda sales remain with BMS.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly frames the royalty change as reducing BMS's royalty *obligation*, when in fact BMS is the *recipient* of royalties from Merck — the 6.5% to 2.5% drop is a reduction in the rate Merck pays *to* BMS and Ono, not a payment BMS makes. This fundamental reversal of financial direction invalidates the core logic. (2) The claim that the lower royalty rate 'boosts BMS’s net revenue from Keytruda' is false — it does the opposite, reducing BMS's royalty income. (3) The 75/25 split with Ono is not mentioned in the ground truth and appears fabricated; the original answer states BMS and Ono receive the royalty together but does not specify a split. (4) While the LLM correctly notes Merck co-develops combination therapies and shares costs/profits (e.g., with Moderna), it mischaracterizes the impact: the reduced royalty rate increases BMS's *revenue dependency* on other sources, not decreases it, because it loses a growing income stream. (5) The reference to 'page 90' is unverifiable and not part of the provided context. Quantitatively, the 6.5% and 2.5% figures and post-2023 timing are correct, earning partial credit. However, the reasoning is fundamentally flawed due to the misinterpretation of who pays whom, leading to an incorrect conclusion about revenue dependency. Contextually, the answer addresses the right topic and mentions combination therapies, but the erroneous financial logic severely limits its usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 418,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "Caterpillar’s adoption of ASU 2022‑06 gives it optional relief for contract modifications that replace a reference rate (e.g., LIBOR) made between March 12 2020 and December 31 2024, thereby reducing the operational and financial impact of those changes.  This relief could lessen the effect of U.S.‑government contract modifications that involve reference‑rate adjustments—one of the risks Boeing flagged—but the guidance does not apply to all modifications (e.g., those after December 31 2022 unless an exception applies) and, as Caterpillar notes, it has not materially affected its consolidated financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core impact of ASU 2022-06 on contract modifications related to reference rate reform, particularly in the context of U.S. government agreements and companies like Boeing (BA) and Caterpillar (CAT). It correctly identifies the extended relief period (through December 31, 2024), the applicability to LIBOR replacement, and the reduced operational and financial impact—key points from the ground truth. It also accurately notes that CAT has adopted the standard and that it has not materially affected its financial statements, which aligns with typical 10-K disclosures.\n\nHowever, there is a minor inaccuracy in the date range mentioned: the LLM states the relief applies to modifications between 'March 12, 2020 and December 31, 2024,' but the ground truth emphasizes the extension *through* December 31, 2024, without specifying a start date. While the March 12, 2020 start date may be technically accurate based on prior ASU guidance, it was not included in the ground truth and thus introduces unverified specificity, slightly reducing quantitative accuracy.\n\nThe answer correctly synthesizes multi-hop information: (1) CAT’s adoption of ASU 2022-06, (2) the nature of the standard (relief for reference rate reform), and (3) BA’s disclosure of U.S. government contract modification risk. It logically connects how ASU 2022-06 could mitigate such risks, even if indirectly. The mention that the guidance does not apply to all modifications adds nuance.\n\nOne minor omission is the lack of reference to BA’s 37% revenue from U.S. government contracts, a key quantitative point in the ground truth that strengthens the relevance of contract modification risk. Its absence reduces completeness but does not invalidate the overall reasoning.\n\nWording differs but maintains semantic equivalence on most points. The conclusion that the standard has not materially affected CAT’s financials is a prudent addition consistent with disclosure norms.\n\nThus, while the answer is factually sound and contextually relevant, small gaps in quantitative precision and completeness prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 573,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 sale‑leaseback of 627 towers for $4.827 billion was recorded as a financing obligation (effective‑interest rate ≈ 3.9%) and the towers remained on its balance sheet, where they continue to be depreciated. Verizon’s 2024 deal with Vertical Bridge, which paid $2.8 billion and granted the REIT exclusive lease rights to 6,000 towers, produced a prepaid‑rent liability of $2.0 billion and a $830 million finance‑lease obligation (average 4.8% rate), with the towers still on Verizon’s books and depreciated. In both transactions the companies retained depreciation responsibilities and treated the payments as financing obligations, but AT&T’s obligation was larger and recorded solely as a financing liability, whereas Verizon recorded both prepaid rent and a smaller finance‑lease liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correctly identifies both transactions, their years, dollar amounts, and key accounting treatments. The $4.827 billion for AT&T in 2013 and $2.8 billion for Verizon in 2024 are correctly stated. The breakdown of Verizon’s $2.8 billion into $830 million financing obligation and $1.97 billion prepaid rent (implied by $2.8B - $830M) aligns with the original answer, though the LLM rounds the prepaid rent to $2.0 billion, which is a minor approximation but acceptable given typical reporting conventions. (2) The effective interest rate for AT&T (~3.9%) is correctly cited; Verizon’s average rate of 4.8% is not in the original answer, which does not specify a rate for the $830M obligation—this is a slight overprecision but not contradicted by ground truth. (3) Entity accuracy is strong: correct companies (AT&T, Verizon, Crown Castle, Vertical Bridge REIT), correct years (2013, 2024), and correct financial terms (financing obligation, prepaid rent, depreciation, balance sheet treatment). (4) Multi-hop reasoning is sound: the model correctly synthesizes that both deals involved retained depreciation, on-balance-sheet treatment, and financing-like accounting rather than sale-leaseback derecognition. It accurately contrasts AT&T’s single financing obligation with Verizon’s split treatment. (5) Semantic equivalence is high—the LLM conveys the same core insight: both are structured financing arrangements with similar asset treatment despite different payment structuring. The only minor issue is the rounding of prepaid rent and the addition of a specific 4.8% rate not in the original, but these do not materially misstate facts. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 483,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s Asia Pacific, Australia and New Zealand segment operates its own bottling and distribution facilities, directly producing and selling beverages such as Pepsi and 7UP in New Zealand (page 6). In contrast, Coca‑Cola’s presence in the same market is indirect – it owns about 19 % of Coca‑Cola Europacific Partners (CCEP), the bottler that bottles and distributes Coca‑Cola products in New Zealand (page 86). Thus, PepsiCo has a direct operational footprint in New Zealand, whereas Coca‑Cola’s influence is through a minority equity stake in the local bottler.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP operates directly in New Zealand through its APAC segment, producing and distributing beverages like Pepsi and 7UP, while KO holds a 19% stake in CCEP, which bottles and distributes Coca-Cola products there. The 19% equity stake is correctly stated, matching the original answer. (2) Quantitative accuracy is perfect—no calculations required, but the 19% figure is correctly cited and contextually used. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PEP’s direct operations and KO’s indirect financial influence via CCEP, identifying the structural difference between operational control and equity-based influence. (4) The only minor shortcoming is that the LLM does not explicitly mention that KO’s stake allows 'influence' over CCEP (e.g., through financial reporting or governance), which is noted in the original answer. However, stating that Coca-Cola’s presence is 'indirect' and through a 'minority equity stake' captures the essence. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 348,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG values mortgage‑backed securities primarily with internal valuation models that use discount rates derived from observable credit‑spreads (e.g., CDS spreads) and other market data, supplementing these models with dealer quotations and discounted‑cash‑flow analyses (see AIG Notes 8, pp. 111‑115).  In contrast, Schwab obtains fair values for CMBS mainly from broker/dealer quotes and independent third‑party pricing services that provide observable trades and DCF‑based prices, cross‑checking across multiple sources to ensure reasonableness (see Schwab Notes 8, pp. 79‑82).  Thus, AIG’s approach is more model‑centric and internally driven, whereas Schwab relies on external market quotes and third‑party pricing for similar asset classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG uses internal valuation models with observable inputs like credit spreads (e.g., CDS), discounted cash flow analyses, and supplements with dealer quotes; SCHW relies on broker/dealer quotes and third-party pricing services using observable market data. These points match the original answer’s description of AIG’s model-centric approach and SCHW’s external pricing reliance. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly contrasts AIG’s internal modeling with SCHW’s external quote reliance for similar asset classes (MBS vs CMBS), synthesizing information across two companies and valuation methodologies. It even references appropriate footnotes (AIG Notes 8, pp. 111–115; Schwab Notes 8, pp. 79–82), indicating precise sourcing. (4) The only minor shortcoming is that the LLM omits the reference to GILD’s supporting evidence about industry practices bridging both approaches, which slightly reduces completeness in qualitative synthesis—hence a 9 instead of 10 for qualitative accuracy. However, this does not detract from the core comparison asked in the question. (5) Contextual relevance is perfect: the response directly addresses the comparison between AIG and SCHW in fair value determination for structured securities, using accurate terminology and appropriate distinctions. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 461,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO classifies corporate bonds, asset‑backed securities and municipal bonds as Level 2 and values them with “market‑corroborated pricing, matrix pricing or other models that utilize observable inputs such as yield curves” (page 80).  \nAdobe, by contrast, explicitly applies matrix‑pricing and discounted‑cash‑flow techniques to its Level 2 available‑for‑sale debt securities, using inputs that include benchmark yields, issuer spreads, interest rates and Treasury or swap curves (pages 70‑71).  \nBoth firms rely on observable market inputs like yield curves and benchmark rates, but Adobe’s methodology is more tightly coupled to matrix pricing and discounting, whereas AVGO’s approach allows a broader set of models that also incorporate those inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE use observable market inputs like yield curves and benchmark rates for Level 2 securities; ADBE explicitly relies on matrix pricing and discounted cash flow, while AVGO uses a broader set of models including matrix pricing and market-corroborated inputs. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of inputs—none are misstated. (3) Multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two companies (AVGO and ADBE), identifies their common reliance on observable inputs, and distinguishes their methodological focus (AVGO’s broader modeling vs. ADBE’s tighter coupling to matrix pricing). (4) The only minor shortcoming is that the original answer emphasizes the shared dependence on similar observable data more explicitly, while the LLM slightly overemphasizes the difference in approach. However, this nuance does not undermine correctness. Semantic equivalence is preserved, and all entities (Level 2 securities, matrix pricing, yield curves, benchmark rates) are accurately referenced. The inclusion of page numbers adds precision but does not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 375,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC accounts for **17 % of Coca‑Cola’s non‑U.S. unit‑case volume**.  It coordinates distribution for Coca‑Cola’s trademark beverages in **27 operational countries, including the Czech Republic**.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies that Coca-Cola HBC manages 17% of Coca-Cola’s non-U.S. unit case volume, which matches the ground truth. However, it states that distribution is coordinated in 27 countries, whereas the original answer specifies 30 countries, including the Czech Republic. This is a factual discrepancy in a key numeric claim.\n\n2) Quantitative accuracy is partially compromised: the 17% figure is correct, but the country count (27 vs 30) is incorrect. This affects the precision of the answer, especially since the question explicitly asks for the number of countries, making it a core component.\n\n3) The reasoning appears sound in structure—correctly identifying Coca-Cola HBC as a key bottler and linking it to non-U.S. volume and geographic distribution—but fails in the final synthesis step by citing the wrong number of operational countries. This suggests either a data retrieval error or outdated information.\n\n4) Despite the error in country count, the answer is contextually relevant, well-structured, and semantically aligned with the question’s intent. The mention of the Czech Republic confirms proper entity recognition and partial multi-hop synthesis. The 17% figure is accurately recalled, supporting a score of 7 for correctness—core facts are mostly right, but a significant detail is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 369,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity stake in Hardy Storage (an underground interstate storage facility regulated by FERC) shows a conservative, regulated‑utility strategy that prioritizes stable, recoverable infrastructure to support its retail gas distribution (page 21). In contrast, NextEra Energy’s 31.9 % ownership of a 303‑mile pipeline under construction in West Virginia and Virginia reflects a growth‑oriented, project‑based approach that seeks to capture market opportunities but is exposed to regulatory approvals, legal challenges and market price volatility (page 18). These divergent tactics illustrate Duke’s focus on low‑risk, regulated assets versus NextEra’s willingness to invest in new, higher‑risk pipeline projects amid regulatory and market uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. The percentages, project descriptions, and geographic scope match the original answer. (2) Quantitative accuracy is perfect—no calculations were required, but all numeric values (50%, 31.9%, 303-mile) are correct and contextually placed. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Duke’s investment in a FERC-regulated storage facility reflects a conservative, regulated-utility strategy focused on stability, while NextEra’s stake in a pipeline under construction indicates a growth-oriented approach with higher exposure to regulatory and market risks. The contrast in strategic approaches is logically drawn and supported. (4) The only minor shortcoming is that the LLM answer references 'page 21' and 'page 18', which were not part of the original context and may imply spurious sourcing, but this does not affect factual correctness. Otherwise, the semantic meaning, entity accuracy, and contextual relevance are excellent, fully addressing the question’s focus on divergent strategies in light of regulatory and market challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 371,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Meta and Alphabet both give Class B shares 10 votes per share versus 1 vote for Class A, so the voting‑rights differential is identical. At Meta, 343 million Class B shares (≈13.5 % of total shares) command roughly 61 % of voting power, illustrating a highly concentrated ownership structure; Alphabet’s $62 billion 2024 share‑repurchase program, which bought back only Class A and C shares, further shrinks the voting pool and amplifies the relative influence of its Class B holders, reinforcing ownership concentration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Meta's Class B shares have 10 votes per share, like GOOGL. However, the ground truth explicitly notes that Meta does not disclose the exact voting ratio between Class A and Class B shares, making this a critical error. The claim that 343 million Class B shares represent approximately 13.5% of total shares is roughly correct (343,761,117 / (2,189,898,148 + 343,761,117) ≈ 13.6%), but the assertion that they command 'roughly 61% of voting power' is unsupported by the original answer and involves an unjustified calculation based on an assumed 10:1 ratio that Meta does not confirm. (2) The $62.0 billion share repurchase by GOOGL in 2024 is correctly cited, and the point about repurchases being from non-voting or lower-voting classes (Class A and C) is consistent with the original answer. However, the LLM incorrectly implies Meta also has a 10:1 structure, which is not disclosed. (3) The multi-hop reasoning is partially sound—comparing ownership concentration and the effect of buybacks on voting power—but it fails because it builds on a false premise about Meta’s voting ratio. The synthesis between share count, voting rights, and repurchase impact is logical in structure but flawed in execution due to incorrect data. (4) The contextual relevance is high because the answer addresses both companies, their dual-class structures, ownership concentration, and the impact of repurchases. However, the qualitative and quantitative accuracy scores are low due to the central error in asserting a 10:1 voting ratio at Meta, which undermines the correctness of the comparison and the derived implications on voting power distribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 473,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "JNJ’s enactment of the Swiss Federal Act on Tax Reform and AHV Financing (TRAF) in 2020 produced a net tax‑benefit of roughly **$0.4 billion, lowering its effective tax rate by about 2.6 %** (page 70).  \nMerck’s 2021 Swiss tax holiday is described as a new incentive for a newly active legal entity that runs through 2030, but the filing does not disclose a specific dollar amount or percentage impact on its effective tax rate (page 136).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, JNJ's effective tax rate decreased by 1.9% due to TRAF in 2020, but the LLM claims a 2.6% decrease, which is incorrect. Additionally, the LLM introduces a '$0.4 billion' tax benefit figure not present in the original answer, which lacks any dollar amount—this is a factual overreach. (2) The dollar amount and percentage are not supported by the ground truth, making the quantitative claims inaccurate. The original answer only states a 1.9% decrease without citing a dollar value. The LLM’s 2.6% figure contradicts this, suggesting either a misreading of the source or incorrect calculation. (3) Qualitatively, the LLM correctly identifies the mechanism for JNJ (TRAF enactment in Switzerland in 2020) and MRK’s Swiss tax holiday starting in 2021 for a new legal entity through 2030. It also correctly notes that MRK’s filing does not disclose a specific rate impact, aligning with the original answer’s lack of quantification. This shows sound multi-hop reasoning in identifying different mechanisms and timing across two companies. (4) Contextually, the answer is highly relevant and structured well, addressing both parts of the question. However, the incorrect percentage and fabricated dollar amount severely undermine factual correctness. While the direction of impact (lower tax rate) is correct, the magnitude is wrong, leading to a partial correctness score. The model synthesizes across entities and years appropriately but fails on key numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 432,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "McDonald’s hedges its foreign‑currency assets and liabilities mainly with cross‑currency swaps and other derivatives, reporting a net notional amount of about $3.4 billion in 2024 (page 122) and describing the goal as reducing earnings and cash‑flow volatility from currency swings (page 23).  Nike, in contrast, uses options and forwards to hedge forecasted foreign‑currency transactions, with a net notional amount of roughly $9.9 billion in 2024 (page 47) and an objective of smoothing earnings and cash‑flow volatility from exchange‑rate changes (page 48).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes a $3.4 billion notional amount to MCD, while the ground truth states MCD has $9.9 billion in notional hedges as of September 28, 2024. Conversely, it assigns the correct $9.9 billion figure to NKE, but the ground truth does not specify NKE's notional amount—only MCD's. Thus, the quantitative assignment is reversed and incorrect. (2) The LLM claims MCD uses 'cross-currency swaps' as a primary instrument, but the original answer specifies 'option and forward contracts'—a mismatch in hedging instruments. NKE is correctly described as using options and forwards, aligning with the ground truth. (3) The reasoning is flawed in the multi-hop comparison: the LLM suggests both firms aim to 'smooth earnings and cash-flow volatility,' but the ground truth distinguishes MCD’s asset-protecting strategy from NKE’s transaction-focused, cost-stabilizing objective. The LLM fails to capture this key strategic difference. (4) Contextual relevance is moderate—both companies and FX hedging are addressed, but with incorrect figures and misaligned objectives. The mention of 'page 122', 'page 23', etc., suggests fabricated citations not present in the input, reducing credibility. Overall, major errors in numbers, entities, and reasoning justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 379,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The PW800 engine is the sole powerplant for Gulfstream’s G500, and its advanced fuel‑efficiency, lower emissions and higher thrust directly underpin the G500’s “clean‑sheet” performance gains—faster speeds, greater range, larger cabin volume and improved flight‑controls versus the older G450/G550.  By fielding a single, state‑of‑the‑art engine, Gulfstream (and General Dynamics) can market the G500 as a true next‑generation replacement that delivers superior technology, sustainability and operating economics, aligning with GD’s strategy to refresh its business‑jet lineup with cutting‑edge performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the PW800 engine is indeed the exclusive powerplant for the G500, developed by RTX's Pratt & Whitney Canada, and this supports General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550. The answer correctly highlights the clean-sheet design, improved performance (fuel efficiency, range, speed), and strategic differentiation through advanced technology. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and consistent. (3) The multi-hop reasoning is sound: the LLM correctly links RTX’s engine, its exclusive use on the G500, and how that enables performance improvements that serve General Dynamics’ broader product strategy. It synthesizes the engine-airframe integration into a strategic market positioning, which is the core of the question. (4) Minor deduction in qualitative accuracy because the LLM slightly overreaches by mentioning 'larger cabin volume' and 'improved flight-controls'—details not present in the ground truth and not explicitly tied to the PW800 engine. While likely true, these points introduce unsupported specifics that could misattribute design improvements solely to the engine. Otherwise, the answer is semantically equivalent, contextually precise, and effectively captures the strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 400,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "The Meta 10‑K pages you provided do not disclose the voting‑power split or any non‑dilutable provisions for its dual‑class shares, so a direct comparison cannot be made. In contrast, Comcast’s 10‑K states that Class A shares hold 66 ⅓ % of the combined voting power and Class B shares hold 33 ⅓ %, with the Class B voting power generally non‑dilutable under its articles of incorporation.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but fails to accurately represent the ground truth, particularly regarding META. (1) Quantitatively, the CMCSA figures are mostly correct: it correctly states that Class A holds approximately 66 1/3% and Class B 33 1/3% of voting power, though the ground truth specifies 66 2/3% and 33 1/3%, making the percentages slightly inaccurate. The non-dilutable nature of CMCSA's Class B shares is correctly tied to its articles of incorporation. However, the LLM incorrectly claims that Meta’s 10-K does not disclose voting power distribution or non-dilutable provisions, when in fact the original answer confirms that Meta’s Class B stock is not publicly traded and held by only 23 stockholders as of December 31, 2023—indicating concentrated control, which is a key aspect of its dual-class structure. (2) The LLM fails to report Meta's actual voting structure details that are available in the ground truth, omitting critical information about shareholder concentration and implying a lack of disclosure where there is in fact sufficient data for comparison. (3) The reasoning is flawed in the multi-hop comparison: instead of synthesizing the contrast—concentrated control via few Class B holders in Meta vs. explicit fixed voting percentages in CMCSA—the model defaults to claiming insufficient data, which contradicts the provided ground truth. (4) While the CMCSA portion shows moderate accuracy and the response is relevant to the question’s intent, the failure to use available facts about Meta’s structure significantly undermines correctness. The answer is not completely wrong but is substantially incomplete and misleading in its assessment of disclosure availability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 468,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "Bristol‑Myers Squibb faces a higher risk of losing Revlimid’s European exclusivity because patent settlements and potential Paragraph IV challenges could trigger generic entry as early as 2022 (see page 36).  By contrast, Eli Lilly’s orphan‑drug designations rely on regulatory data‑protection exclusivity that runs parallel to patents and grants a seven‑year market exclusivity period independent of patent litigation (see page 10), giving Lilly a more secure, longer‑lasting exclusivity window.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies BMY's risk of early market exclusivity loss for Revlimid in Europe due to patent settlements leading to generic entry in 2022, aligning with the original answer’s specific dates (January 18 and February 18, 2022). While the LLM does not cite the exact dates, it accurately notes 'as early as 2022,' which is semantically acceptable given the context. (2) The mention of 'Paragraph IV challenges' is slightly inaccurate in the European context—Paragraph IV is a U.S. regulatory mechanism under the Hatch-Waxman Act and does not apply directly in Europe. This is a minor but notable error in regulatory terminology, which affects precision but not the overall conclusion about patent vulnerability. (3) The LLM correctly contrasts this with LLY’s use of orphan drug designation and seven-year regulatory data protection, accurately stating its independence from patent litigation. This reflects sound multi-hop reasoning across IP frameworks (patent vs. regulatory) and companies (BMY vs. LLY). (4) The answer addresses all parts of the question: compares risks, explains differing IP reliance, and evaluates the strength of exclusivity mechanisms. The citation of 'page 36' and 'page 10' suggests source grounding, though not required for scoring. Overall, the answer is factually strong, with only minor imprecision in regulatory terminology and lack of exact dates preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 414,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "MS’s asset‑management fees are tied to client holdings that include fixed‑income securities, so revenue swings are “sensitive to changes in related markets” but the relationship is diluted by other factors such as client behavior and asset mix (page 63).  \nIn contrast, PayPal’s financial position is more directly exposed to market risk because its derivatives and debt securities are valued with pricing models that rely on observable inputs—interest‑rate curves, currency rates, volatility, etc.—so market movements immediately affect fair‑value gains or losses (pages 93‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction between MS and PYPL's exposure to market risk through pricing models. (1) All factual elements are correct: MS's asset management revenues are indeed sensitive to fixed income market changes due to fee-based assets, but the relationship is diluted by client behavior and asset mix—this aligns with the original answer. PYPL’s direct exposure via fair value accounting for derivatives and debt securities is correctly characterized, including its use of observable inputs like interest rate curves and currency rates. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MS and PYPL), two types of financial instruments (asset management fees vs. derivatives/debt securities), and two modes of market exposure (indirect vs. direct). The only minor omission is that the LLM does not explicitly mention PYPL’s election of the fair value option for foreign currency-denominated debt securities, which is a key reason for its direct exposure—this slightly weakens the qualitative accuracy, hence a 9. (4) Contextual relevance is perfect: the response directly addresses the comparative sensitivity question, stays focused on market risk and pricing models, and cites appropriate page references (63 for MS, 93–94 for PYPL), indicating proper grounding. Overall, the answer is semantically equivalent to the ground truth with only a slight lack of detail on PYPL’s fair value election.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 454,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is embedding generative‑AI capabilities directly into its MySQL HeatWave database service, which “combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service” (page 12).  This shows Oracle’s strategy of delivering on‑device AI for enterprise workloads by letting customers run AI inference and analytics locally on their databases, whether in the cloud or on‑premise.  \n\nQualcomm, by contrast, is investing heavily in IoT applications—consumer PCs, tablets, XR, industrial sensors and edge networking devices—“to power growth in industries and applications such as consumer…and industrial…devices” (pages 6‑8).  Its Snapdragon SoCs and AI engine enable low‑power, on‑device AI at the edge, underscoring Qualcomm’s focus on embedding AI into consumer and industrial IoT devices rather than centralized cloud services.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's integration of generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and generative AI, aligning with Oracle's enterprise-focused, cloud-native strategy. It also accurately captures Qualcomm's investment in IoT and edge devices, emphasizing on-device AI through Snapdragon SoCs. However, the LLM answer incorrectly states that Oracle enables 'on-device AI' for enterprise workloads by running AI 'locally on their databases', which misrepresents the original answer—Oracle's solution is cloud-managed and not focused on on-device processing like Qualcomm's. This is a key strategic distinction that is blurred in the LLM response. (2) Quantitative accuracy is partially flawed: the original answer includes specific projections—'19% of smartphones in 2024' and '46% in 2027' will be generative AI capable—but the LLM omits these numbers entirely, despite citing pages 6–8. Their absence represents a significant loss of quantitative precision. (3) The multi-hop reasoning is generally sound—comparing Oracle’s enterprise cloud AI strategy with Qualcomm’s edge/IoT focus—but the conflation of 'on-device' with Oracle’s cloud database service weakens the contrast. The original answer clearly separates cloud-native (Oracle) vs. edge-device (Qualcomm) AI strategies; the LLM incorrectly applies 'on-device' to Oracle, undermining the strategic distinction. (4) Contextual relevance is high as the answer addresses both companies and their respective markets (enterprise vs. consumer/industrial IoT). Qualitative accuracy is good but docked for the mischaracterization of Oracle’s deployment model. Correctness score is 7 because core facts about both companies are present and mostly accurate, but key quantitative data is missing and a critical strategic difference (cloud vs. edge) is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 515,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe’s risk‑factor disclosures (pages 23–24) warn that the EU AI Act will drive “increased compliance, governance and research and development costs” that could erode margins and slow the rollout of new AI features.  In contrast, Salesforce’s 10‑K (pages 5–7) highlights its Agentforce platform as a mature, integrated AI layer that powers sales, service and other offerings, suggesting it is already positioned to absorb regulatory changes or adapt quickly.  Consequently, Adobe’s higher compliance spend could blunt its AI innovation pace and pricing flexibility, potentially widening the gap with Salesforce’s AI‑centric competitive edge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe anticipates increased compliance, governance, and R&D costs due to the EU AI Act, which could slow AI feature rollouts and impact margins. Salesforce’s Agentforce is correctly described as a mature, integrated AI platform across sales and service, giving it a potential competitive edge. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; the LLM does not introduce any incorrect figures and accurately reflects the absence of specific dollar amounts or timelines beyond phased implementation through 2030 (implied in original answer). (3) Multi-hop reasoning is sound: the model correctly synthesizes Adobe’s regulatory cost risks (from its 10-K) with Salesforce’s AI platform strength (from its 10-K), concluding that higher compliance burdens could slow Adobe’s innovation pace relative to Salesforce. This supports the logical inference that Salesforce may gain or maintain a competitive advantage. (4) The only minor shortcoming is that the LLM does not explicitly mention that both companies face similar regulatory pressures (as noted in GS_10k_2024), nor does it state that Salesforce’s deeper AI integration may help it *absorb* regulatory changes more effectively—this nuance is present in the original answer and slightly strengthens the qualitative argument. However, the core reasoning and competitive dynamic are preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses the competitive impact of compliance costs on AI innovation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 453,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "HD’s deferred shares grant non‑employee directors a share of common stock upon termination, with dividend equivalents paid in additional shares, so the equity value is directly distributed to those directors (page 68).  \nLOW’s ASR agreements, in contrast, give the company additional shares (and cash) that it holds as treasury stock, reducing outstanding shares and improving earnings‑per‑share metrics for all shareholders rather than allocating new equity to a specific group (pages 61‑62).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between HD's and LOW's mechanisms for issuing additional shares. (1) It correctly identifies that HD distributes dividend equivalents in the form of additional shares to non-employee directors upon termination, which aligns with the ground truth's description of stock-based compensation for directors. It also correctly states that LOW receives additional shares through ASR agreements, which are held as treasury stock, reducing outstanding shares and benefiting all shareholders via capital return—this matches the ground truth's emphasis on repurchase efficiency and notional value calculations. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense, but all factual assertions (e.g., page references, structural outcomes) are consistent and plausible. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (HD and LOW), two distinct financial instruments (deferred shares with dividend equivalents vs. ASR agreements), and two stakeholder groups (directors vs. broader shareholders), correctly contrasting purpose and outcome. (4) The only minor shortcoming is that the LLM does not explicitly mention that LOW’s additional shares come from third-party financial institutions or that the ASR notional value is variable—details present in the ground truth that add nuance to the capital return mechanism. However, the essential contrast in purpose (compensation vs. capital return) and stakeholder impact (individuals vs. all shareholders) is clearly and correctly conveyed. Thus, the answer is semantically equivalent in intent and substance, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 483,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T’s adoption of ASU 2020‑04 provides optional relief for contract modifications that replace reference rates (e.g., LIBOR) and the company states that the guidance “did not have a material impact on the Company’s consolidated financial statements,” implying that revenue‑recognition timing and performance‑obligation accounting were essentially unchanged【52】【53】.  Verizon, however, discloses that contract modifications can alter the timing of revenue recognition and the allocation of performance obligations—unsatisfied performance obligations expected to be recognized in 2024, 2025 and beyond are “subject to change and are affected by several factors, including terminations and changes in the timing and scope of contracts, arising from contract modifications”【67】【68】.  Thus, AT&T’s ASU adoption has a minimal effect on revenue timing, whereas Verizon’s disclosures highlight a more direct impact on when revenue is recognized and how performance obligations are met.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative distinction between AT&T and Verizon regarding ASU 2020-04 and contract modifications. It accurately states that AT&T’s adoption did not have a material impact on its financial statements, which aligns with the ground truth. It also correctly identifies that Verizon views contract modifications as affecting the timing and scope of performance obligations. However, the LLM answer omits the key quantitative disclosures from Verizon—specifically the $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—which are central to the original answer and directly address the 'impact on revenue recognition timing.' These numbers are missing entirely, representing a significant gap in quantitative completeness. (2) No incorrect numbers are stated, but the absence of Verizon’s specific dollar amounts severely limits quantitative accuracy. The ground truth uses these figures to substantiate the magnitude of impact on future revenue, which the LLM fails to convey. (3) The multi-hop reasoning is sound: the model correctly links ASU 2020-04 to AT&T’s minimal impact and contrasts it with Verizon’s broader disclosure on contract modifications affecting revenue timing. The logic and synthesis across entities are appropriate and well-structured. (4) Contextual relevance is high because the answer addresses the core comparison in the question—how each company’s treatment of contract modifications affects revenue recognition and performance obligations. The omission of Verizon’s specific financial figures prevents a higher correctness score, but the conceptual framework is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 467,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension‑plan disclosures state that any U.S. state‑and‑local municipal bonds it holds are valued at Level 2 (observable market data), although the balance is zero. Lockheed Martin’s pension‑plan notes contain no municipal bonds at all, so there is no Level 2 valuation for that asset class. Thus, UPS has a modest reliance on Level 2 for municipal bonds (even though the amount is nil), whereas LM has none; both companies nevertheless comply with ASC 820 by fully disclosing the fair‑value hierarchy and applying the appropriate valuation methods to all assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it incorrectly claims that Union Pacific holds zero municipal bonds, stating 'the balance is zero'—this contradicts the ground truth, which confirms that UPS classifies municipal bonds as Level 2 investments and describes their valuation methodology in detail, implying they are part of the portfolio. The ground truth does not state or imply a zero balance. Second, the LLM asserts that Lockheed Martin's pension plan holds no municipal bonds at all, but the original answer states that LMT applies Level 2 methodologies to fixed income securities using indicative quotes, which may include municipal bonds; there is no evidence in either the ground truth or typical SEC filings that LMT explicitly excludes municipal bonds. Thus, claiming 'no municipal bonds at all' is unsupported and likely incorrect. The ground truth emphasizes that both companies use Level 2 for municipal or fixed income securities, with UPS being more specific. The LLM instead frames this as a difference in presence/absence of the asset class, which misrepresents the data. While the LLM correctly references ASC 820 compliance and the general concept of fair value hierarchy disclosure, its core comparative analysis is flawed. The reasoning fails the multi-hop requirement: it should have synthesized that both companies apply Level 2 to similar instruments under ASC 820, with differences in disclosure specificity, not asset presence. Quantitative accuracy is partially acceptable because no specific dollar amounts are misstated (though 'zero balance' is a quantitative error). However, this key error distorts the entire conclusion. Contextual relevance is moderate because the answer addresses pension disclosures and ASC 820, but the incorrect premise reduces usefulness. Overall, major factual and reasoning errors lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 518,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO relies on Coca‑Cola FEMSA for distribution in Argentina, where FEMSA operates in the Buenos Aires metropolitan area and surrounding regions (see KO’s bottling‑partner description on page 7). In contrast, MDLZ’s exposure to economic volatility in Argentina is reflected in inflation‑related financial impacts—such as remeasurement losses—that indicate a more volatile operating environment, although the specific figures are not disclosed in the pages provided.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies KO's reliance on Coca-Cola FEMSA for distribution in the Buenos Aires metropolitan area and surrounding regions, aligning with the ground truth. It also correctly contrasts this with MDLZ's exposure to economic volatility in Argentina through inflation-related financial impacts. However, the LLM fails to include key quantitative details present in the original answer: specifically, KO's $14.471 billion in net sales to equity method investees (including Coca-Cola FEMSA) in 2021, MDLZ's $13 million remeasurement loss in 2021 due to peso volatility, and Argentina's contribution of $401 million (1.4%) to MDLZ’s consolidated net revenues. These omissions significantly reduce quantitative accuracy. While the qualitative reasoning correctly distinguishes between KO’s distribution dependency and MDLZ’s direct financial exposure, the lack of specific figures undermines the completeness and precision required for a full multi-hop synthesis. The answer remains contextually relevant and logically structured, but the absence of critical numbers from the knowledge graph limits its factual completeness. Minor formatting (e.g., en dashes) does not affect meaning. Overall, the answer captures the conceptual contrast but misses essential data points needed to fully address the comparative financial and operational exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 376,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B shares carry ten votes each and can be converted to Class A shares, giving the company a flexible tool to preserve control while still offering publicly traded equity and enabling share‑repurchase or dividend decisions that maintain voting power (Note 11, page 82). Alphabet’s dual‑class structure gives Class A shares one vote and Class C shares none, and its $62 billion 2024 repurchase of Class A and Class C shares reduced outstanding shares and supported earnings per share without affecting control (page 82). Thus, Meta’s voting‑rights structure affords it greater flexibility to manage equity and retain control, whereas Alphabet’s framework separates voting control from ownership and uses large repurchases to adjust capital structure without altering control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights structure for both Meta and Alphabet, stating that Meta's Class B shares carry 10 votes (vs. 1 for Class A), and Alphabet's Class A has 1 vote, Class C has none—this matches the ground truth. The $62 billion 2024 share repurchase by Alphabet is accurately cited in both amount and targeted share classes (Class A and C). (2) Quantitatively, all numbers are correct: $62 billion (written as $62 billion) and the year 2024 match the original. No calculations are required, but the repurchase amount and its application to non-controlling shares are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use dual-class structures to maintain control while conducting large repurchases on lower-vote/no-vote shares to enhance shareholder value without diluting control. It appropriately contrasts Meta’s convertible Class B structure with Alphabet’s more rigid separation (Class C with zero votes), noting that repurchases of Class A and C shares do not affect voting control. (4) The only minor deviation from the ground truth is the suggestion that Meta has 'greater flexibility'—a slight interpretive leap not explicitly in the original answer—but this is a reasonable inference and does not contradict facts. Overall, the answer is factually accurate, contextually complete, and semantically equivalent to the ground truth with strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 409,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s Veklury revenue fell from **$2.184 B in 2023 to $1.799 B in 2024**—a **$385 M decline** that the company attributes to the availability of vaccines and other COVID‑19 therapies (page 66, table of product sales; page 19, discussion of Veklury sales).  \nAmgen, in its risk‑factor discussion, notes that the emergence of new treatment options and standards of care in competitive markets can **reduce the use of its products and lower prices**, a broader competitive pressure that is not tied to a specific dollar loss (page 14/15).  \n\nThus, Gilead’s decline is a quantifiable drop directly linked to alternative COVID‑19 treatments, whereas Amgen’s impact is a general risk of reduced demand and pricing in competitive therapeutic markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports GILD's Veklury sales decline from $2.184 billion in 2023 to $1.799 billion in 2024, matching the ground truth exactly. The calculated decline of $385 million is accurate ($2,184M - $1,799M = $385M). The LLM correctly attributes this decline to alternative treatments and vaccines for COVID-19, consistent with the original answer. For AMGN, the LLM accurately summarizes that alternative treatments and payer dynamics in competitive markets (e.g., ENBREL, Repatha, etc.) create downward pressure on usage and pricing, though no specific dollar impact is quantified—this aligns with the ground truth. The comparison between GILD’s direct, quantifiable pandemic-related decline and AMGN’s systemic, qualitative competitive pressure is well-articulated.\n\n2) All numeric values are correct and properly formatted. $2.184B = $2,184 million and $1.799B = $1,799 million—these are equivalent representations. The $385M decline is correctly calculated. No errors in numbers, dates, or units.\n\n3) The multi-hop reasoning is sound: the model synthesizes financial data from GILD (specific revenue figures and year-over-year change) with qualitative risk disclosures from AMGN, then compares the nature of competitive impacts across both firms. It correctly identifies that GILD’s impact is direct and quantifiable, while AMGN’s is structural and discussed as a forward-looking risk. The LLM omits explicit mention of specific AMGN drugs (Otezla, Aimovig), but the reference to 'competitive markets' and risk factors implies this context, and the core reasoning remains intact.\n\n4) The LLM answer is semantically equivalent to the ground truth. While slightly more concise, it captures all key facts and the essential contrast. The only minor shortcoming is the lack of explicit naming of AMGN’s products, which slightly reduces completeness but does not impair the overall accuracy or reasoning. Hence, a score of 9/10 on correctness and qualitative accuracy is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 537,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50% Senior Notes pay interest semi‑annually on February 15 and August 15 each year, with the principal due in 2022. Qualcomm’s $14 billion of notes comprise both floating‑rate and fixed‑rate instruments; interest is paid quarterly on floating‑rate notes and semi‑annually on fixed‑rate notes, and principal repayments are spread across fiscal 2023, 2024, 2025, 2027 and beyond (with no principal due in fiscal 2026).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers, dates, and dollar amounts are correct: AMD's $312 million 7.50% Senior Notes with semi-annual interest payments on February 15 and August 15 are accurately stated; QCOM's $14 billion aggregate fair value of notes is correctly noted, with proper distinction between floating-rate (quarterly interest) and fixed-rate (semi-annual interest) notes. The fiscal years for principal repayments (2023 onward, skipping 2026) match the original. (2) The only minor omission is that the original specifies AMD's final maturity is in 'fiscal 2022'—the LLM says 'due in 2022' without specifying 'fiscal', which may be a subtle distinction but does not materially misrepresent the fact. (3) Multi-hop reasoning is sound: the model correctly synthesizes payment frequency and fiscal obligations across two different companies and note structures. (4) The answer is contextually complete and relevant, directly addressing payment frequency and fiscal year obligations for both firms. Wording differs slightly (e.g., 'spread across fiscal 2023, 2024, 2025, 2027 and beyond' vs. 'starting in fiscal 2023...no principal due in 2026'), but this is semantically equivalent. No calculation errors. Score reduced by 1 point only due to slight imprecision in not specifying 'fiscal' 2022 for AMD's maturity, though this is likely implied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 396,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "Merck’s U.S. patents for Prolia/XGEVA expire in February 2025, after which generic and biosimilar competitors are likely to enter the market, eroding sales and weakening the company’s patent‑based competitive moat (see MRK pages 31‑34).  This loss of exclusivity mirrors the biosimilar exposure that Amgen faces in international markets, underscoring the risk that Merck’s market share and profitability could decline as competitors launch cheaper alternatives (see AMGN page 10 for the patent expiry).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly states that 'Merck’s U.S. patents for Prolia/XGEVA expire in February 2025.' In reality, Prolia and XGEVA are Amgen products, not Merck products. This misattribution undermines the entire reasoning chain. The original answer correctly identifies that Amgen, not Merck, faces the patent cliff for Prolia/XGEVA. (2) Quantitatively, the date 'February 2025' is accurate and matches the ground truth, and there are no numerical calculations to verify. The citation of 'MRK pages 31-34' and 'AMGN page 10' may be plausible but cannot be verified without source documents; however, the core error is not in the numbers but in entity attribution. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize that Merck is being discussed in relation to its own reliance on patent protection, while Amgen is the one losing exclusivity on Prolia/XGEVA. The intended logic is that Amgen’s exposure to biosimilars (due to its own patent loss) could indirectly affect Merck’s competitive environment—this nuance is lost. Instead, the LLM incorrectly implies Merck owns Prolia/XGEVA, leading to a breakdown in reasoning. (4) While the general theme—patent expiration leading to biosimilar competition affecting competitive dynamics—is contextually relevant and reflects part of the original answer’s logic—the fundamental misidentification of the drug owner (Merck vs. Amgen) results in a mostly incorrect response. The answer is semantically different because it describes a scenario where Merck loses exclusivity on Amgen’s drugs, which is false. Thus, despite correct dates and some relevant concepts, the answer fails on core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 471,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s 10‑K reports $12.384 billion of VMware revenue in FY 2024 (page 67), but it does not break out a specific amount attributable to AI‑enabled workloads.  The inclusion of Private AI services in the VMware Cloud Foundation portfolio (page 8) signals that a share of that revenue comes from AI workloads, which dovetails with Cisco’s strategy to supply network and data‑center infrastructure for AI training and inference (page 4).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on key quantitative points. The ground truth states that $1,380 million (i.e., $1.38 billion) of VMware Cloud Foundation revenue was specifically tied to AI workloads, but the LLM claims Broadcom's total VMware revenue was $12.384 billion and provides no breakdown for AI-related revenue, stating it is not disclosed. This contradicts the ground truth, which does provide the exact figure. The LLM also fails to mention the $2.9 billion total VMware Cloud Foundation revenue, missing a critical data point. (2) Quantitative accuracy is very low: the $12.384 billion figure refers to total VMware revenue, not VMware Cloud Foundation or its AI portion, so citing it as context without clarifying the distinction misleads. The correct AI-tied amount ($1.38B) is omitted entirely. (3) Qualitatively, the LLM correctly identifies that VMware Cloud Foundation includes AI capabilities (via Private AI services) and notes Cisco’s strategic focus on AI infrastructure, which aligns with the ground truth. This shows some correct entity identification and multi-hop awareness—linking Broadcom/VMware’s offerings to Cisco’s strategy. However, the failure to report the specific revenue portion tied to AI undermines the core of the multi-hop synthesis required. (4) Contextual relevance is moderate: the answer addresses both companies and the AI infrastructure theme, and references appropriate sections of the 10-Ks, but misses the central quantitative claim that enables the strategic comparison. The reasoning is partially sound but built on incomplete and inaccurate data, leading to a significantly flawed conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 455,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s consolidated solar VIEs carry **$1,851 million** in assets (page 97).  \nSouthern Power’s PPAs that are accounted for as operating leases generate about **$652 million** in undiscounted cash flows (page 270), with the PPAs themselves noted as contingent rents not shown in that table.  Thus, NEE’s solar‑VIE asset base is roughly 2.8 times larger than Southern Power’s operating‑lease PPA exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly states NEE's solar VIE assets as $1,851 million (matching the ground truth), it introduces a figure of $652 million in 'undiscounted cash flows' for Southern Power's operating lease PPAs, which is not present in the original answer and cannot be verified from the provided context. The ground truth does not provide any monetary value for Southern Power's exposure—only qualitative details about lease structure and duration. Therefore, the calculation claiming NEE's asset base is '2.8 times larger' is unsupported and factually incorrect. This is a critical error in a multi-hop comparison question centered on relative exposure. Entity identification (NEE, Southern Power/SO) and general context (solar facilities, long-term PPAs, operating leases) are accurate, and the response correctly identifies differing risk structures (ownership vs. lease). However, the introduction of an unverified dollar amount and the resulting false comparison severely reduce factual accuracy. The reasoning attempts multi-hop synthesis but fails due to reliance on non-existent quantitative data. Contextually, the answer addresses the right entities and contractual frameworks, earning moderate relevance and qualitative reasoning scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 370,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks’ equity incentive plans include stock‑appreciation rights (SARs) that provide a cash or stock award tied to the company’s share price, typically vesting over a four‑year period (see the “Stock‑based Compensation” discussion).  Tesla’s 2019 Equity Incentive Plan, by contrast, offers a broader mix of instruments—stock options, RSUs, performance shares and performance units—all vesting over four years, with options exercisable for up to ten years (as noted in the plan’s description).  Thus, Starbucks’ SARs are a single appreciation‑based award with a standard four‑year vesting schedule, whereas Tesla’s plan delivers multiple equity instruments with similar vesting timelines but a longer exercise window for options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Starbucks uses Stock Appreciation Rights (SARs), noting they are part of its equity plans, and contrasts this with Tesla's 2019 Plan, which offers a broader set of instruments including SARs, stock options, RSUs, and performance shares—matching the original answer. (2) Quantitatively, all key numbers and timelines are correct: both companies use four-year vesting periods, Tesla’s options are exercisable up to 10 years, and the LLM accurately reflects these figures without error. Format and phrasing (e.g., 'vesting over four years') are semantically equivalent to the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies and their respective equity plans, correctly comparing structure, instrument types, and vesting/exercise terms. One minor omission is that the original answer notes Starbucks has not broadly used stock options recently, and that its performance-based RSUs are tied to specific metrics (EPS and ROIC), which the LLM answer does not mention. Additionally, Tesla’s plan includes performance units, which the LLM mentions but the original does not explicitly confirm—though this is consistent with the broader plan description. (4) Despite these small gaps, the core comparison on equity instruments and vesting timelines is complete and factually correct, warranting a high score. The answer is fully relevant and well-structured for the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 419,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s Class B shares carry **10 votes each** (vs. one vote for a Class A share), so a large shareholder holding Class B stock can wield a ten‑fold voting advantage and exert outsized influence on board and policy decisions. Alphabet’s Class A shares, by contrast, have **one vote per share**, meaning large shareholders’ influence is limited to the proportion of shares they own and is not amplified by a higher vote‑to‑share ratio. Consequently, large shareholders at Meta can exercise more concentrated voting power than large shareholders at Alphabet.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE ACCURACY: The claim that Meta's Class B shares carry '10 votes each' is false. According to the ground truth, Meta's Class B common stock has *no voting rights* except in limited circumstances, which is the opposite of what the LLM states. Similarly, while it correctly notes that GOOGL's Class A shares have one vote per share, this accurate detail is outweighed by the major error regarding Meta. (2) COMPLETENESS: The answer fails to address the actual structure: it inverts the voting rights of Meta’s classes, missing that Class B has no voting power, and thus completely misrepresents the influence of large shareholders. (3) ENTITY ACCURACY: While the companies (Meta and Alphabet/GOOGL) are correctly identified, the stock class characteristics are factually wrong. (4) REASONING: The multi-hop reasoning is flawed because the model incorrectly assumes Meta’s Class B shares have superior voting rights, leading to the opposite conclusion: it claims large shareholders have more influence at Meta, when in fact they have significantly less due to the lack of voting rights on Class B shares. (5) SEMANTIC EQUIVALENCE: The answer conveys the opposite meaning of the ground truth. Instead of showing limited influence at Meta and greater influence at GOOGL, it asserts concentrated power at Meta, which is factually and logically incorrect. The contextual relevance is low but not zero, as it discusses voting structures in response to a governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 428,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC uses foreign‑currency derivatives mainly to hedge foreign‑currency‑denominated assets, liabilities, forecasted transactions and net investments in non‑U.S. subsidiaries, with a gross exposure of about $6.2 B in swaps, spot/futures/forwards and options (page 106). JPMorgan Chase also uses foreign‑currency derivatives for the same purposes but includes both fair‑value and cash‑flow hedges and reports a larger gross exposure of roughly $7.7 B (page 213), reflecting a broader use across its business segments (page 211).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($6.2B for BAC, $7.7B for JPM) and page numbers (106, 213, 211) that are not present in the original answer (ground truth), and there is no verification that these figures match the actual filings. The ground truth does not provide any quantitative exposure figures, so these numbers cannot be confirmed and appear fabricated or hallucinated. (2) The quantitative accuracy is low because the dollar amounts and page references are unsupported by the ground truth; no calculations or numeric disclosures were provided in the original answer to validate these figures. (3) The qualitative accuracy is partially correct: both BAC and JPM are described as using foreign currency derivatives for risk management, which aligns with the original answer. The mention of hedging foreign-currency-denominated assets, liabilities, and forecasted transactions matches JPM’s stated use, and BAC’s inclusion of net investments in subsidiaries is plausible but not confirmed in the ground truth. However, the original answer does not mention hedge types (fair-value vs. cash-flow) or segment usage, so those details are unsupported additions. (4) Contextual relevance is moderate—the response addresses the comparative use of foreign currency derivatives by BAC and JPM in risk management, which is the core of the question, but it adds unverified specifics that distort accuracy. The original answer focuses on disclosure practices (gross presentation, offsetting, balance sheet classification), which the LLM answer omits entirely, failing to address the key aspect of how disclosures differ. Thus, while the general theme is relevant, critical elements about reporting treatment (gross vs. net, balance sheet presentation) are missing, undermining completeness and correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 496,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s main risk is demand‑side: a recession can shrink industrial customers’ consumption, cutting sales and cash flow, and while its regulated rate‑setting can recover some fuel and operating costs, it does not guarantee full compensation for lost revenue (see DUK 10‑K p. 27).  Southern Company’s exposure is cost‑side: new environmental‑compliance spending—on CCR, emissions controls, and infrastructure upgrades—must be recovered through regulated rates, but the company warns that such costs may not all be recoverable on a timely basis and could even dampen industrial demand for electricity and gas (see SO 10‑K p. 26‑28).  Thus, Duke faces a demand shock that regulated rates may only partially offset, whereas Southern faces a cost shock that regulated rates may absorb but could also reduce customer demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Duke Energy's risk as demand-side due to industrial customers reducing consumption during economic downturns, and Southern Company's risk as cost-side due to environmental compliance costs affecting regulated rate recovery and potentially dampening demand. The core facts—reduced revenues for Duke and cost recovery challenges for Southern—are accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer that conflict; both correctly reference ongoing risks through 2028 in the context of Southern's compliance spending (implied in SO 10-K pp. 26–28), and the LLM appropriately avoids fabricating figures. Thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks across two companies, distinguishes between demand and cost shocks, links each to regulated rate mechanisms (DUK’s adjustment clauses vs SO’s ECO Plan, CNP, ECCR), and notes limitations in rate recovery affecting customer demand. The only minor shortcoming is that the LLM does not explicitly name Duke’s rate mechanisms (e.g., periodic adjustment clauses), though it refers generally to regulated rate-setting, which is acceptable. (4) The answer is contextually excellent—directly addressing the comparison of risks, the role of rate recovery, and the differing nature of exposure (demand volatility vs. cost pass-through). Wording differs slightly but maintains semantic equivalence. No irrelevant content. A score of 9 is justified due to slightly less specificity on Duke’s rate mechanisms, but overall the response is factually correct, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 479,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s single Class B shareholder, Brian Roberts, owns all of the 15‑vote‑per‑share Class B shares, giving him roughly 33 % of the combined voting power (66 % is held by public Class A shareholders) but the bylaws require that Class A and Class B holders vote together on most matters—including director elections—so Roberts’ influence is limited to a sizable minority stake【page_31】【page_33】.  \nAlphabet’s dual‑class scheme gives Class B holders 10 votes per share and allows them to vote separately on board elections, giving the founders a de‑facto majority control while public Class A shareholders have only one vote each【page_82】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few key inaccuracies and omissions compared to the ground truth. (1) Quantitatively, the 33% voting power for Brian Roberts and the 15-vote-per-share for CMCSA Class B stock are correct, though the LLM rounds to 'roughly 33%' and omits the exact fraction (33 1/3%). The claim that public Class A shareholders hold 66% is reasonable by implication, but the ground truth does not specify this split explicitly. (2) The LLM incorrectly states that CMCSA's bylaws require Class A and Class B to vote together on most matters, including director elections, which is not mentioned in the ground truth and introduces unsupported procedural detail. (3) The LLM fails to mention the non-dilutable nature of CMCSA’s Class B shares—a critical differentiator in governance entrenchment—which is a significant omission affecting qualitative accuracy. (4) For GOOGL, the LLM correctly identifies the 10 votes per Class B share and 1 vote for Class A, but incorrectly claims Class B holders can vote separately on board elections (not supported by ground truth), and omits the key fact that Class B shares automatically convert to Class A upon sale or transfer, which limits long-term control. (5) The reasoning partially captures the contrast in governance fluidity but misses the core distinction: CMCSA’s structure is more entrenched due to non-dilutability, while GOOGL’s allows dilution through transfer. This weakens the multi-hop synthesis. (6) Despite these issues, the answer correctly identifies the core dual-class mechanisms and comparative intent (founder control), and uses appropriate entities and context. Wording differences are acceptable under semantic equivalence, but missing structural details reduce correctness. Hence, scores reflect mostly accurate facts with notable gaps in completeness and reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 502,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "KO’s only exposure to Taiwan is indirect, coming through its bottling partner Swire Beverages, which operates in Taiwan but the 10‑K does not disclose a specific growth figure for that market (see page 7).  In contrast, PepsiCo’s 2022 10‑K reports that Taiwan’s beverage market grew at a low‑single‑digit rate as part of its APAC region, indicating modest direct expansion (see page 49).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the essential comparison between KO's indirect exposure and PEP's direct performance in Taiwan in 2022. (1) Correct elements: It accurately states that KO’s exposure to Taiwan is indirect through Swire Beverages and that no specific growth figure for Taiwan is disclosed in the 10-K. It correctly notes that PEP reported low-single-digit beverage volume growth in Taiwan as part of its APAC region in 2022. (2) Quantitative accuracy: The ground truth mentions Swire accounted for 17% of KO’s global unit case volume in 2021, but the LLM omits this specific percentage. This is a minor omission—while relevant context, it is not directly tied to Taiwan-specific performance. The LLM correctly identifies 'low-single-digit' growth for PEP in Taiwan, matching the ground truth. (3) Multi-hop reasoning: The model correctly synthesizes information across KO and PEP filings, distinguishing indirect vs. direct market exposure. However, it does not explicitly connect Swire’s operation in Taiwan to KO’s indirect exposure with the 17% volume figure, slightly weakening the completeness of the synthesis. (4) The answer is semantically close to the original and highly relevant to the question. The omission of the 17% figure prevents a top score, but core facts and reasoning are sound, warranting a high 'correctness_score' of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 379,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "Trulicity’s patent is slated to expire in the next few years, and the 2024 results already show a 26 % drop in U.S. sales—an early sign that generic entry will erode revenue further.  This decline could blunt Lilly’s overall revenue trajectory unless offset by growth in other cardiometabolic products, a risk Merck also faces when its own patents lapse.  Merck’s strategy of securing robust, long‑term patent protection is designed to preserve market exclusivity and competitive positioning; if those patents were to expire, Merck would similarly confront revenue erosion from generics, underscoring the importance of strong IP for both companies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core idea that Trulicity's patent expiration will negatively impact LLY's revenue trajectory and correctly draws a parallel with MRK's reliance on patent protection. However, there is a key quantitative inaccuracy: the LLM states a 26% drop in U.S. sales in 2024, while the ground truth reports a 32% decrease. This discrepancy affects the factual precision of the response. 2) The numbers cited are close but not exact—26% vs. 32% is a significant difference in financial impact, especially at scale. No other figures (e.g., dollar amounts, years) are incorrect, and the general timeline (patent expiration in coming years) aligns with expectations. 3) The multi-hop reasoning is sound: the model correctly synthesizes information across LLY and MRK, recognizing that both companies face revenue risks upon patent expiration and that strong IP protection is critical to maintaining exclusivity and profitability. It appropriately infers that LLY’s vulnerability mirrors MRK’s strategic concerns. 4) The answer is contextually relevant and well-structured, addressing both the specific impact on LLY and the broader strategic comparison with MRK. While the 26% figure may reflect a misreading of the 10-K or an approximation, the overall logic and qualitative insights are strong, warranting a correctness score of 7 due to the material nature of the numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 385,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s 200 hotel‑and‑convention‑center stores are leased for 5–10 years (page 44), so a real‑estate downturn would mainly raise lease costs or make renewals harder, but the exposure is limited to a small retail footprint and can be managed through renegotiation (page 46). UPS, by contrast, holds $10.1 billion of pension assets in real‑estate, private‑debt and hedge funds (page 61); a slump in property values would erode NAV, potentially forcing higher pension contributions and affecting its balance‑sheet liquidity. Thus FedEx faces a localized operational lease risk, whereas UPS confronts a sizable financial‑market risk that could materially impact its pension liability and overall financial health.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: FedEx has 200 leased retail locations at hotels and convention centers with 5–10 year leases, and UPS has $10.1 billion in pension assets invested in real estate, private debt, and hedge funds as of December 31, 2024 (implied by context). The dollar amount, entity names, and lease duration are correctly reported. (2) Quantitative accuracy is perfect—$10.1 billion and 200 stores are correctly cited, and no calculations are required beyond accurate reporting. Format variations (e.g., '5–10 years' vs 'five to ten years') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly distinguishes FedEx’s direct operational exposure (lease-based, physical footprint) from UPS’s indirect financial exposure (pension asset performance), and logically infers the differing impacts of real estate volatility—lease cost pressures vs. pension funding risk. The conclusion that FedEx faces localized operational risk while UPS faces broader financial risk is consistent with the original. (4) Minor deduction in qualitative accuracy due to omission of the explicit mention that UPS’s fund investments may include hotels or commercial real estate, which slightly weakens the linkage in exposure type. However, the core contrast in risk nature (operational vs. financial) is clearly articulated and correct. Contextual relevance is full—every part of the question is addressed with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 433,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "GOOGL’s Class B common shares carry **10 votes per share** (versus one vote for Class A), giving holders substantial voting power and the ability to influence corporate decisions (see GOOGL Note 11, page 82). In contrast, Comcast’s investment in Atairos is a third‑party equity stake that **does not carry any voting rights**; control and strategic direction are retained by the management companies led by its former CFO (see CMCSA Note 7, page 84). Thus, GOOGL’s Class B shares provide direct control, whereas Comcast’s Atairos stake offers no voting influence over strategic decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that GOOGL’s Class B shares carry 10 votes per share versus one for Class A, which matches the original answer. It also correctly notes that CMCSA has no voting rights in Atairos—both key facts are precise and supported by the cited notes. (2) There are no calculations, but all stated numbers (10 votes, 1 vote, no voting rights) are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (GOOGL and CMCSA), contrasting GOOGL’s internal dual-class voting structure with CMCSA’s external investment in a VIE (Atairos). It accurately infers that GOOGL’s Class B enables control, while CMCSA lacks voting influence. (4) The only minor omission is that the original answer mentions CMCSA retains 'certain consent rights' and that it lacks power over activities most significantly affecting economic performance—nuances that add depth to the explanation of limited influence. The LLM mentions 'no voting rights' and implies lack of control but does not specify consent rights. However, the core comparison on control and influence over strategic decisions is correctly conveyed. Wording differs but semantic meaning is equivalent. Citations to specific notes (GOOGL Note 11, CMCSA Note 7) enhance credibility and contextual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 389,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper program is modest—$25 million of short‑term paper with a 23‑day weighted average maturity that is classified as long‑term debt because the company can refinance it on a long‑term basis (see page 165).  By contrast, PepsiCo’s short‑term debt strategy includes a much larger commercial‑paper obligation of $2,286 million at 5.5 % (page 100) that it actively refines through new senior notes and revolving credit facilities (page 101), reflecting a broader use of commercial paper within its overall debt management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Duke Energy Ohio's $25 million in commercial paper obligations and PepsiCo's $2,286 million in commercial paper obligations, both matching the ground truth in amount and year (2023). The mention of PepsiCo's 5.5% interest rate is additional detail not in the original answer but does not contradict it and may come from the cited page. 2) All numeric values are accurate: $25 million and $2,286 million are correctly stated; no calculations were required beyond comparison, which is valid. Format variations (e.g., $2,286 million vs $2.286 billion) are acceptable and consistent. 3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Duke Energy Ohio and PepsiCo), compares their commercial paper usage, and contextualizes it within their broader short-term debt strategies. It notes Duke’s classification of commercial paper as long-term due to refinancing capacity—a nuance from the source (page 165)—and PepsiCo’s active refinancing via senior notes and credit facilities (pages 100–101), which adds depth. 4) The original answer emphasizes the 'stark contrast in scale'—a point the LLM captures by highlighting the vast difference in commercial paper amounts. The LLM goes further with operational details (weighted average maturity of 23 days, refinancing mechanisms), which enrich the response without deviating from the truth. Only minor deduction in qualitative accuracy because the original answer mentions PepsiCo’s total short-term debt of $6,510 million, which the LLM omits—this contextual benchmark slightly strengthens the comparison. However, the core multi-hop insight (scale difference in commercial paper use) is preserved and well-reasoned. Semantic equivalence is maintained, and the answer is highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 490,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy projects that its commercial gas customer base in the Carolinas, Ohio, and Kentucky will grow (see page 17).  \nSouthern Company, however, relies on regulated rate recovery to cover the significant environmental‑compliance costs it incurs (page 25).  \nIf environmental regulations curb industrial activity in those regions and commercial demand falls, the smaller customer base would shrink the revenue pool from which Southern Company can recover those costs, potentially forcing higher rates that regulators may limit or requiring the company to absorb a larger share of compliance expenses, thereby straining its financial position (page 89).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, customer counts) in either the original or LLM answer, so quantitative accuracy is not compromised—score 10. (2) The LLM correctly identifies Duke Energy’s expected growth in commercial gas customers in the Carolinas, Ohio, and Kentucky, and Southern Company’s reliance on regulated rate recovery for environmental compliance costs. It accurately captures the causal chain: if environmental regulations reduce industrial activity, commercial gas demand may decline, shrinking the revenue base for cost recovery, potentially leading to higher rates or financial strain. This matches the core logic of the original answer. (3) The multi-hop reasoning is sound—linking Duke’s regional outlook to Southern’s rate recovery model and the shared regional risk from environmental regulation. The only minor shortcoming is that the LLM does not explicitly mention Southern Company’s gas infrastructure upgrades or GHG compliance as part of the costs (implied but not stated), and it doesn’t note that the same industrial customers may be directly impacted by emission limits—details present in the original. However, the essence of the risk transmission mechanism is preserved. (4) Contextual relevance is excellent: the answer directly addresses the hypothetical impact on Southern Company given Duke’s outlook and regulatory risks. Wording differs but meaning is semantically equivalent. Minor omission prevents a perfect 10, but correctness is high—hence 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 435,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts owns all 9.44 million Class B shares, each with 15 votes that together represent 33 ⅓ % of Comcast’s voting power (page 33).  The 2023 repurchase program bought only Class A shares (page 33), leaving Mr. Roberts’ Class B stake unchanged while shrinking the total number of shares held by other investors.  Consequently, his relative voting influence and ownership percentage versus the broader shareholder base has not been diluted and has effectively increased as the overall voting pool contracted.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mr. Roberts owns all Class B shares (though the exact number of 9.44 million is not in the original answer, it is consistent with external data and does not contradict the ground truth). The 15 votes per share and 33 1/3% voting power are correctly stated. (2) The repurchase activity is accurately described: only Class A shares were repurchased in 2023, which is a key fact. The LLM correctly infers that this shrinks the overall voting pool and increases the relative influence of Class B shares. (3) The reasoning is sound and captures the multi-hop logic: selective repurchase of low-vote Class A shares → reduction in total outstanding shares → increased relative voting weight of non-repurchased, high-vote Class B shares → enhanced control by Mr. Roberts. (4) The conclusion that his ownership control has effectively increased relative to the broader shareholder base is semantically equivalent to the original answer. The only minor point is the inclusion of a specific share count (9.44 million) not present in the ground truth, but this does not affect correctness and may come from the cited page 33. No calculation errors. All entities (Comcast, Class A/B shares, Mr. Roberts, 2023 repurchases) are correct. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 386,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are contingent equity awards that vest only if specified stock‑holder‑return and performance metrics are met; the company uses a payout‑simulation model to estimate fair value, but the actual number of units (and cash outlay) is uncertain until the performance period ends. In contrast, BMS’s financial‑instrument exposure is managed through explicit counterparty‑credit‑risk controls—limiting outstanding amounts with any single counterparty, selecting only high‑quality counterparties, and hedging foreign‑currency risk with forwards and swaps—so while market‑price fluctuations still affect the instruments, the credit‑risk component is more predictable and mitigated. Thus Amgen faces greater payout unpredictability, whereas BMS has a more controlled, predictable risk‑management profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer specifies Amgen's performance units were valued at $121 million in 2023, this figure is not mentioned in the LLM response. However, the absence of this specific number does not undermine the correctness of the conceptual explanation, as the focus of the question is on structural comparison rather than exact valuation. No incorrect numbers are presented, so quantitative accuracy remains high. (2) The LLM correctly identifies Amgen’s use of payout simulations tied to stockholder returns and performance metrics, and accurately characterizes BMS’s counterparty credit risk mitigation strategies—limiting exposure, requiring high credit quality, and using conventional instruments like forwards and swaps. These match the original answer’s content. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (Amgen and BMS), two types of financial instruments (performance units vs. derivative agreements), and contrasts their predictability frameworks—payout uncertainty vs. credit risk control. (4) The conclusion that Amgen faces greater payout unpredictability while BMS has more predictable risk management is logically derived and semantically equivalent to the original. The only minor omission is the lack of the $121M figure and explicit mention of 'comparator company stocks' in the simulation model, which slightly reduces completeness but does not affect the core accuracy. Wording differs but meaning is preserved. Contextual relevance is perfect—every part of the question is addressed with appropriate depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 454,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s OTC‑bilateral derivatives are governed by ISDA Master Agreements that, under Dodd‑Frank’s Orderly Liquidation Authority, allow the company to set‑off receivables against payables and apply collateral without an automatic stay in a counterparty’s bankruptcy—effectively limiting its credit exposure to the net positive fair value after netting and collateral. Bank of America, by contrast, must file a resolution plan with the FDIC and Federal Reserve; if resolution becomes imminent, the holding company may lose access to subsidiary liquidity and be required to contribute its remaining assets to a holding‑company subsidiary, potentially curtailing dividends and capital returns. Thus, MetLife’s exposure is a transaction‑level credit risk mitigated by ISDA netting and collateral, while Bank of America faces a systemic liquidity‑and‑capital risk under a broader resolution framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting and collateral application under OLA is accurately described, as is Bank of America's resolution plan obligations under Dodd-Frank, including the 'single point of entry' strategy and potential loss of subsidiary liquidity. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory obligations under Dodd-Frank across two different institutions—MetLife (insurance-focused, transaction-level derivative risk) and Bank of America (bank holding company, systemic resolution risk)—and contrasts their distinct risk profiles. The LLM captures the key distinction: MetLife’s exposure is mitigated at the transaction level via ISDA netting, while BAC faces structural liquidity and capital risks under a broader resolution framework. (4) The only minor shortcoming is that the LLM omits explicit mention of the FDIC potentially creating a bridge company or security holders facing losses, which appears in the original answer. However, this is implied in the description of resolution risks. Overall, the answer is contextually precise, factually correct, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 426,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike generated **$7.547 billion** in revenue from the Greater China region (which includes Taiwan) in FY 2022【page_88】, whereas Starbucks operated **544 licensed stores** in Taiwan as of October 2022【page_12】.  The revenue figure is far larger than the store count, indicating Nike’s sales are driven by a broader, higher‑volume presence across Greater China, while Starbucks’ substantial store footprint in Taiwan reflects a focused retail strategy in that specific market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Nike's $7.547 billion (i.e., $7,547 million) revenue from the Greater China region in 2022 and Starbucks' 544 stores in Taiwan as of October 2022, matching the ground truth in both value and context. The fiscal year alignment (FY 2022 for Nike, October 2022 for Starbucks) is appropriate and consistent with the original answer. 2) Quantitatively, all numbers are accurate: $7.547 billion = $7,547 million, and the store count of 544 is exact. The formatting variation (billion vs. million) is acceptable and semantically equivalent. 3) The reasoning correctly identifies that Nike's metric is revenue across a broad region (Greater China), while Starbucks' is a localized operational footprint (store count in Taiwan). The LLM draws a reasonable inference about differing market presence strategies—Nike’s volume-driven regional sales vs. Starbucks’ focused retail expansion—though it slightly overreaches by calling the revenue figure 'far larger' than the store count, which are different units and not directly comparable in magnitude. This is a minor flaw in interpretation, not fact. 4) The answer is contextually relevant, addresses all parts of the question, and synthesizes information across two companies and geographies correctly. The inclusion of 'licensed stores' adds precision not in the original but is factually correct and enhances accuracy. Overall, the answer is factually excellent with only a slight simplification in comparative logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 410,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The $5.0 billion upfront payment from American Tower in March 2015 is larger than the $2.8 billion received from Vertical Bridge in December 2024, but Verizon’s retained obligations are broadly similar. In both deals Verizon keeps the towers on its books as property, plant and equipment, net, depreciates them, and remains the primary obligor for the underlying ground leases. The Vertical Bridge transaction, however, creates a $830 million financing obligation (plus $2.0 billion of prepaid rent) for the portion of towers Verizon still occupies, whereas the American Tower transaction does not generate a financing obligation—only the sublease and ground‑lease obligations remain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $5.0 billion American Tower transaction in March 2015 and the $2.8 billion Vertical Bridge transaction in December 2024 are correctly identified with accurate dollar amounts and dates. The retained obligations—continued inclusion of towers in 'Property, Plant and Equipment - Net', depreciation, and ground lease obligations—are accurately described for both transactions. (2) Quantitatively, all numbers match: $5.0B, $2.8B, $2.0B prepaid rent, and $830M financing obligation are all correctly reported with proper attribution to the Vertical Bridge deal. The American Tower deal correctly notes no financing obligation. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both deals involve similar asset treatment and retained obligations but differ in the creation of a financing obligation and prepaid rent only in the Vertical Bridge transaction. (4) The only minor shortcoming is that the LLM slightly simplifies the nuance in the original answer by stating the American Tower deal 'does not generate a financing obligation' without acknowledging that the original answer notes it 'did not specify such a breakdown,' leaving open the possibility of undisclosed structuring. This is a subtle but relevant distinction in financial reporting context. However, the LLM's interpretation is a reasonable inference. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 429,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital estimate is calculated under the Advanced Measurement Approach and explicitly incorporates fraud risk as a key component of its one‑year 99.9 % VaR, ensuring capital is held to cover potential fraud losses across all markets (JPM_10k_2024, p. 155). By contrast, Citi’s emerging‑market exposure is illustrated by a Russia scenario where loss of control of AO Citibank would trigger a $1.6 billion CTA loss and a $0.9 billion inter‑company liability loss—roughly $2.5 billion in potential fraud‑related losses (C_10k_2024, p. 64). Thus, JPMorgan’s capital buffer is a regulatory requirement that covers such risks, whereas Citi’s exposure represents a specific, sizable loss event that could strain its capital if not fully covered.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III with fraud as a key component, and Citigroup has a specific Russia-related scenario involving $1.6 billion in CTA losses and $0.9 billion in intercompany liability losses. These figures are reported accurately, and their sum ($2.5 billion) is correctly calculated. (2) Quantitative accuracy is perfect: $1.6B and $0.9B match the original answer exactly, and the summation is correct. Format variations (e.g., $1.6 billion vs $1.6B) are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two firms, regulatory frameworks (Basel III/AMA), and risk types (general operational risk capital vs. specific geopolitical/fraud loss scenario). It draws a logical comparison between JPMorgan’s forward-looking capital requirement and Citi’s event-driven exposure. (4) The only minor shortcoming is that the original answer explicitly mentions the use of internal/external losses, scenario analysis, and business environment indicators in AMA—details omitted in the LLM response. While not critical to the core comparison, this slight omission in descriptive completeness prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually rich, well-structured, and fully relevant to the multi-part, cross-entity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 404,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm’s risk disclosures (page 33) note that its chipsets are “highly dependent on our ability to receive consistent and reliable supply from our foundry partners, particularly in Taiwan,” so a prolonged Taiwan conflict could sever or severely limit that supply and materially harm the company.  Intel, while earning $6.867 billion of 2023 revenue from Taiwan (page 88), relies on its own fabs and a more diversified supply chain; a conflict would disrupt its operations and revenue but would not be as directly catastrophic to its supply chain as it would be for Qualcomm.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners and the risk of supply disruption is accurately described, and Intel's $6.867 billion in 2023 revenue from Taiwan is correctly cited. (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) and year (2023) match the original answer exactly. (3) The multi-hop reasoning is sound—correctly contrasting Qualcomm’s operational/supply chain dependency with Intel’s financial/revenue exposure. The LLM correctly infers that Intel’s use of its own fabs and diversified supply chain reduces its direct supply vulnerability compared to Qualcomm, which lacks in-house manufacturing and depends entirely on TSMC and other foundries in Taiwan. (4) The only minor shortcoming is that the LLM does not explicitly state that Intel has no disclosed reliance on Taiwan-based manufacturing (a nuance present in the original), but it implies this by noting Intel’s use of its own fabs. Wording differs slightly (e.g., 'materially harm' vs. 'directly threatening product availability'), but the semantic meaning is equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 360,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited partnership interests on a quarterly basis using discounted‑cash‑flow models, earnings multiples and market multiples, and it adjusts the valuation for changes in the portfolio company’s operating results, financial condition or prospects【page_102】.  By contrast, BA’s Level 3 assets that are measured on a non‑recurring basis are valued with a market approach for customer‑financing assets (using third‑party aircraft‑value publications and condition adjustments) and an income approach for other assets, with adjustments for significant unobservable inputs, and are re‑measured only when an impairment event occurs【page_124】【page_125】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and structure. (1) It accurately states that RTX uses discounted cash flows, earnings multiples, and market multiples for quarterly valuation of private equity limited partnerships, with adjustments based on portfolio company performance—this matches the original answer. (2) For BA, the LLM correctly identifies that Level 3 assets measured on a nonrecurring basis are valued using a market approach (third-party aircraft value publications) for customer financing assets and an income approach for others, with re-measurement only upon impairment. This is consistent with the ground truth, which specifies use of discounted cash flows (income approach) for impaired customer financing assets and reliance on third-party data. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s proactive, quarterly adjustments based on performance with BA’s event-driven, impairment-triggered revaluation process. (4) Minor discrepancy: the LLM mentions a 'market approach' for BA’s customer financing assets, while the original emphasizes the income approach (discounted cash flows) for those same assets, using third-party data as inputs. This could imply a methodological nuance—the original specifies the income approach as primary, with market data informing assumptions. The LLM’s framing is not incorrect per se but slightly misprioritizes the valuation method. No numeric inaccuracies exist—there are no explicit numbers, and qualitative descriptors are consistent. Overall, core facts, entities, and reasoning are correct, with only a subtle difference in emphasis on BA’s valuation technique, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 474,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix hedges its foreign‑exchange risk on firm commitments with forward contracts, but its 10‑K does not provide a quantified one‑day loss figure. In contrast, Disney’s VAR model estimates a combined one‑day loss of **$255 million** at year‑end fiscal 2024 (with a currency‑sensitive component of **$40 million**). Thus, Netflix’s approach is described qualitatively, whereas Disney’s report gives a specific potential one‑day loss exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Netflix uses forward contracts to hedge foreign exchange risk and does not disclose a one-day loss figure, while Disney provides a VAR estimate. However, there is a significant quantitative inaccuracy: the LLM states Disney’s combined one-day loss is $255 million at fiscal year-end 2024 (which aligns with the ground truth), but then introduces a 'currency-sensitive component of $40 million' that is not present in the original answer or supported by the provided ground truth. This figure appears to be hallucinated or derived from an external source not referenced in the knowledge base, undermining the quantitative accuracy. The original answer only mentions Disney’s total VAR of $255 million across all risk categories (interest rate, FX, commodities, equity), without breaking out a specific currency-only component. While the qualitative comparison between Netflix's qualitative disclosure and Disney's quantitative VAR model is sound and contextually relevant, the inclusion of an unsupported sub-component reduces factual precision. The multi-hop reasoning is otherwise logical—correctly contrasting disclosure practices—but the introduction of unverified granular data affects overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 348,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD’s tax provision was not directly affected by the Philippine rate cut – the company has no material operations there, and its provision is driven mainly by foreign withholding taxes ($7 m) and foreign‑rate detriment/benefit ($71 m) (AMD 10‑K, p. 74). In contrast, Texas Instruments’ investments in the Philippines benefited from the Q1 2021 tax‑rate reduction, which helped lower its effective tax rate; the PMI 10‑K notes that the Philippine cut partially offset other headwinds in the 2021 effective rate (PMI 10‑K, p. 94). Thus, while AMD’s provision remained unchanged, TI’s Philippine operations enjoyed a tax‑rate advantage that improved its overall tax position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims AMD has no material operations in the Philippines and that its tax provision was not affected, directly contradicting the ground truth, which states that the Philippine tax rate reduction had a favorable impact on AMD’s effective tax rate and was a mitigating factor in its 2021 tax provision. Additionally, the LLM incorrectly attributes Texas Instruments’ tax benefit to the PMI 10-K (Philip Morris International), which is unrelated to Texas Instruments (TXN). This is a critical entity error. (2) Quantitative accuracy is poor: the ground truth specifies TXN’s $370 million in PPE in the Philippines as of December 31, 2021, and AMD’s effective tax rate increase to 21.8% (up 0.1 pp), but the LLM provides none of these correct figures. Instead, it cites $7M in foreign withholding taxes and $71M in foreign-rate detriment/benefit for AMD from an unspecified context, which are not in the ground truth and appear misattributed. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize information across AMD and Texas Instruments’ actual filings. It incorrectly uses PMI’s 10-K to discuss TI’s tax rate, showing a failure in entity mapping and source attribution. The conclusion that AMD’s provision was unchanged contradicts the ground truth that the Philippines rate reduction helped offset other tax increases for AMD. (4) Contextual relevance is moderate because the answer addresses the general theme of tax rate impacts, but due to severe factual and entity errors, the response misrepresents both companies’ situations. The reasoning structure is logical but built on incorrect data and sources, leading to a mostly incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 476,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliates are largely joint‑ventures and VIEs that are integral to its vehicle‑production and financing chain.  For example, GM holds equity in China JVs that manufacture and market its brands (page 103) and uses VIEs for battery‑cell manufacturing and GM Financial securitization (pages 78‑79), accounting for them with the equity method and as VIEs (page 104).  In contrast, McDonald’s affiliates are independent franchisees and developmental licensees that operate restaurants under the McDonald’s brand; the company accounts for minority investments with the equity method and treats the rest as non‑consolidated affiliates, concluding that consolidation is not appropriate (pages 44‑45).  This reflects GM’s model of tightly integrated production and financing versus McDonald’s franchise model, which relies on brand licensing and royalty income rather than direct operational control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GM's affiliate relationships as production-focused joint ventures and variable interest entities (VIEs), particularly in China, supporting vehicle manufacturing under brands like Buick and Chevrolet, which matches the original answer’s emphasis on development and production through nonconsolidated affiliates. It also accurately notes GM Financial securitization and battery-cell manufacturing via VIEs, adding detail beyond the ground truth but remaining factually consistent. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model contrasts GM’s integrated production and financing model with McDonald’s franchise-based structure, correctly characterizing McDonald’s affiliates as independent franchisees generating royalty income. It accurately reflects McDonald’s asset-light model centered on brand licensing, as stated in the original answer. (4) The LLM adds specific accounting details (equity method, consolidation conclusions) and page references not in the ground truth, but these do not contradict and instead enhance accuracy. The only minor gap is that the original answer explicitly names Baojun and Wuling brands, while the LLM mentions the operational model without listing all brands—this omission is minor and does not affect core correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 435,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62.0 billion repurchase of Class A shares in 2024 shrank the Class A voting base, so the 866 million Class B shares (10 votes each) now represent a larger slice of the total voting power (page_82, page_84).  Consequently, the remaining Class B holders enjoy a higher relative voting influence.  However, because any sale or transfer of a Class B share automatically converts it to Class A, the pool of Class B shares – and thus their voting power – is likely to contract over time, partially offsetting the upside from the reduced Class A base (page_82).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Alphabet's $62.0 billion share repurchase of Class A (and implicitly Class C) shares in 2024, which reduces the outstanding Class A voting base—this matches the original answer. (2) The mention of 866 million Class B shares is consistent with the knowledge graph data (though not in the ground truth answer provided, it is assumed to be correct based on source references 'page_82, page_84'), and the 10-vote weight per Class B share is accurate. The dollar amount, year, and share class details are all correct. (3) The reasoning is sound: reducing Class A shares through buybacks increases the relative voting power of remaining Class B shares, which carry 10 votes each. The LLM also correctly adds that any sale or transfer of Class B shares triggers automatic conversion to Class A, which dilutes their high-vote status over time—this nuanced point is present in both answers. (4) The LLM slightly exceeds the original answer by introducing a specific number (866 million Class B shares), which may not be in the ground truth but appears to be sourced correctly. This does not detract from accuracy. The only minor limitation is that the original answer emphasizes the consolidation of control among long-term holders, a strategic implication slightly underemphasized in the LLM version. However, the core multi-hop logic—buybacks reduce Class A shares → relative Class B voting power increases → but conversion on transfer limits long-term growth of Class B pool—is fully and correctly synthesized. All factual elements and reasoning chains are valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 450,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Colgate’s 2022 10‑K notes that ASU 2020‑01 clarifies the interaction between equity securities, equity‑method investments and derivatives, requiring the company to consider observable transactions before applying or discontinuing the equity method and to exclude derivatives when the underlying securities would be accounted for under the equity method or fair‑value option; the company reports no material impact (page 81). Coca‑Cola’s 10‑K does not reference ASU 2020‑01, but the same guidance would similarly influence its equity‑security and derivative accounting, ensuring observable transactions are considered before applying the equity method and that derivatives are excluded when the underlying securities would be accounted for under the equity method or fair‑value option, and the company also reports no material impact (page 79).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core impact of ASU No. 2020-01 on both Colgate-Palmolive and The Coca-Cola Company, including the clarification on observable transactions and derivative accounting. It accurately states that Colgate adopted the standard and reported no material impact, citing the correct page (81) in its 2022 10-K. However, the LLM incorrectly claims that Coca-Cola’s 10-K does not reference ASU 2020-01, which contradicts the ground truth that Coca-Cola applies and discloses the guidance (e.g., in relation to net unrealized gains and losses on equity securities). Despite this, the LLM correctly infers that the same accounting treatment would apply and that Coca-Cola also reports no material impact, citing page 79. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect—both companies’ adoption and lack of material impact are accurately represented. (3) The multi-hop reasoning is mostly sound: the model connects the standard’s provisions to both companies and explains the accounting implications correctly. However, it fails to confirm that Coca-Cola explicitly applies the standard (per ground truth), instead assuming it based on applicability, which weakens the qualitative accuracy. (4) The answer is contextually relevant and semantically close to the original, with only a minor inaccuracy regarding Coca-Cola’s disclosure. Thus, the correctness score is 8 due to this omission, though all other aspects are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 419,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Citibank’s CET1 ratio requirement under the Standardized Capital Rules includes a 6.2 % stress‑capital buffer (SCB) as of December 2024【page 209】, whereas Goldman Sachs’ requirement of 13.7 % CET1 implies an SCB of only 3.7 % (13.7 % – (4.5 % + 2.5 % + 3.0 % G‑SIB surcharge)【page 209】). This higher SCB for Citibank reflects a more conservative capital‑adequacy stance under U.S. banking regulations, while Goldman Sachs’ lower SCB indicates a comparatively lighter buffer within the same Standardized framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Goldman Sachs has an SCB of 6.2%, while Citibank’s CET1 requirement is 7.0%, composed of the 4.5% minimum CET1 and 2.5% Capital Conservation Buffer, with no explicit SCB included. The LLM incorrectly assigns a 6.2% SCB to Citibank and calculates a 3.7% SCB for Goldman Sachs, which contradicts the ground truth. (2) The quantitative inaccuracies are severe: the LLM claims Citibank has a 6.2% SCB (false), and that Goldman Sachs’ total CET1 requirement is 13.7%, from which it subtracts 4.5% + 2.5% + 3.0% G-SIB surcharge to derive 3.7% SCB. However, the ground truth states only that Goldman Sachs is subject to a 6.2% SCB — it does not state a total CET1 of 13.7%, nor does it support this calculation. These numbers and computations are fabricated or misattributed. (3) The multi-hop reasoning is flawed: the model incorrectly assumes both banks are under the same SCB framework and performs unsupported arithmetic to reverse-engineer SCB values. It fails to recognize that the SCB applies explicitly to Goldman Sachs under stress-based rules, while Citibank’s 7.0% is a baseline standardized requirement without SCB inclusion. (4) The conclusion — that Citibank has a more conservative stance due to a higher SCB — is therefore incorrect and based on reversed facts. The ground truth suggests Goldman Sachs faces a higher stress-based capital requirement, implying more stringent assessment, contrary to the LLM’s claim. While the answer attempts to address regulatory capital adequacy and references the correct framework and time period, the core facts, calculations, and logic are fundamentally wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 472,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy Resources owns 90 mi of rate‑regulated transmission lines and 5 substations in Indiana (161–345 kV, 100 % ownership, in service 1953‑2022) 【page_16】, a physical infrastructure asset that underpins its wholesale operations. By contrast, Duke Energy Indiana’s financing strategy as of Dec 31 2023 relies on tax‑exempt bonds—$285 million of short‑term obligations classified as long‑term debt, maturing 2027‑2046 【page_161】—to fund its operations rather than owning new physical assets. Thus, NEER’s Indiana investment is a tangible transmission asset, while Duke Energy Indiana uses debt financing to support its activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: NextEra Energy's 90 miles of transmission lines and 5 substations in Indiana operating at 161–345 kV, and Duke Energy Indiana's $285 million in tax-exempt bonds as of December 31, 2023. These figures match the ground truth exactly. The ownership percentage (100%) and in-service dates (1953–2022) are additional accurate details not contradicted by the original answer. (2) Quantitative accuracy is perfect: $285 million in tax-exempt bonds is correctly reported, and while the LLM does not mention Duke’s total debt of $435 million, this omission does not distort the core financial fact presented. The maturity range (2027–2046) adds precision without conflict. (3) The multi-hop reasoning is sound—correctly contrasting NextEra’s physical infrastructure investment with Duke’s financing strategy via tax-exempt bonds. The synthesis across entities (NextEra vs. Duke) and domains (infrastructure vs. financing) is logical and supports the comparative insight. (4) The LLM slightly enhances the original with operational details (e.g., rate-regulated, ownership, in-service years), but does not misrepresent or omit any critical aspect. The only minor gap is the lack of explicit reference to Duke’s total debt context ($435M), which slightly reduces completeness but doesn’t impair correctness. Overall, the answer is semantically equivalent and factually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 406,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store relies on third‑party developers for the majority of its digital content, so regulatory changes to alternative payment processing and any loss of developer participation can cut Apple’s commission revenue and expose it to contractual and compliance risks (Apple, 10‑K, p. 13).  Microsoft, by contrast, produces much of its own content (e.g., Office, Windows, Azure services), which reduces dependence on external developers but makes the company’s brand reputation—and the public scrutiny of its content, privacy, and AI decisions—critical, because a single reputational misstep can erode customer trust and demand across its ecosystem (Microsoft, 10‑K, p. 32‑33).  Thus, Apple faces supply‑chain‑like risks from external content providers and payment‑policy shifts, while Microsoft’s risk is concentrated in maintaining brand integrity and managing the reputational fallout of its own content offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers and associated risks from regulatory changes (e.g., DMA-related alternative payment processing) and developer participation are accurately described. Microsoft's in-house content production and associated brand reputation risks are also correctly outlined. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting business models (Apple’s commission-based third-party model vs. Microsoft’s self-produced content) and maps them to distinct risk profiles (developer and compliance risks vs. brand and reputational risks). The mention of specific 10-K pages (p.13 for Apple, pp.32–33 for Microsoft) adds verifiability and aligns with document-based reasoning. (4) The only reason for not scoring a perfect 10 is minor: the LLM frames Microsoft’s risk more broadly around 'privacy and AI decisions,' which, while plausible, slightly extends beyond the original answer’s focus on 'content decisions' and 'public scrutiny or dissatisfaction with product offerings.' However, this extension is contextually reasonable and does not distort the core comparison. Overall, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 406,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company’s risk‑factor discussion (page 29) warns that a release of radioactive material—including tritium—from its nuclear units could trigger damages and costs that exceed the company’s insurance and decommissioning trusts, exposing it to potentially large, immediate liabilities.  In contrast, NEE’s 10‑K (pages 30‑32) notes that the cost of decommissioning its nuclear plants could surpass the balances in its decommissioning funds, creating a long‑term funding gap that could strain liquidity and financial condition.  Thus, while both firms face nuclear‑related financial exposure, Southern Company’s tritium‑leak risk is framed as a possible immediate liability that may outstrip coverage, whereas NEE’s risk is a projected long‑term shortfall for decommissioning costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the original or LLM answer that conflict—both correctly avoid citing specific dollar amounts or percentages for liabilities or fund shortfalls, instead emphasizing qualitative risk exposure. The absence of incorrect numbers supports a perfect quantitative accuracy score. (2) The LLM correctly identifies both companies (Southern Company and NEE), the nature of their nuclear-related risks (tritium leakage vs. decommissioning shortfalls), and the temporal distinction (immediate liability vs. long-term funding gap), which is a key insight not explicitly stated in the ground truth but logically sound and supported by the framing in the disclosures. (3) The multi-hop reasoning is strong: it synthesizes risk factors from two separate companies’ 10-Ks, correctly distinguishes the type and timing of financial exposure, and draws a valid comparison without asserting a business relationship. (4) The LLM slightly enhances the original answer by introducing a temporal dimension (immediate vs. long-term) that adds analytical value, though this nuance isn’t contradicted by the ground truth. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the LLM omits the specific 2021 generation percentages (26%, 28%) mentioned in the ground truth related to nuclear output for Alabama and Georgia Power—this is a minor omission that doesn’t affect the core comparison but reduces completeness slightly. All other elements are factually correct, contextually relevant, and semantically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 443,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "Altria’s 2021 effective tax rate climbed to 21.8 %, a 0.1‑percentage‑point rise that was “partially offset by the corporate income tax rate reduction in the Philippines (enacted in the first quarter of 2021)” (page 94). For Coca‑Cola, the same tax cut lowers the effective tax burden on capital projects in the Philippines, which is reflected in its Asia Pacific capital expenditures of $65 million (page 124) and may encourage additional investment in that region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. It states that Altria's effective tax rate 'climbed' to 21.8%, describing the 0.1-percentage-point change as a rise, but the phrasing 'partially offset by the corporate income tax rate reduction' contradicts the ground truth, which states the tax reduction *contributed* to the 21.8% rate — meaning it was a favorable (reducing) factor, not something that was offset by other increases. This misrepresents the causal relationship. (2) For Coca-Cola, the LLM cites $65 million in Asia Pacific capital expenditures from page 124, but the ground truth does not mention this figure or tie it specifically to the Philippines. Instead, the ground truth emphasizes that Philippine PPE represented 10% of KO’s consolidated PPE in both 2020 and 2021 — a key fact entirely missing from the LLM answer. The $65M figure may be accurate in context but is not clearly linked to the Philippines, introducing potential misattribution. (3) The multi-hop reasoning is partially sound — the model connects the tax reduction to both companies — but fails to accurately synthesize the specific impacts: for Altria, the direction of the tax effect is confused; for Coca-Cola, the sustained capital investment is misrepresented by citing regional capex rather than the actual PPE percentage data showing stable long-term commitment. (4) Contextual relevance is high because the answer addresses both companies and the tax reform’s implications. However, quantitative accuracy is low due to incorrect interpretation of the tax rate impact and unsupported use of $65M for KO. Qualitative accuracy is moderate — entities and general logic are correct, but reasoning flaws reduce fidelity. Correctness score reflects missing key data (KO’s 10% PPE), misstated causality (Altria’s tax rate movement), and unsupported claims (KO capex link to Philippines).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 510,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung is one of NVIDIA’s wafer‑foundry partners (NVDA notes Samsung as a supplier of semiconductor wafers【page_9】).  As a major integrated‑circuit manufacturer, Samsung also competes with Qualcomm in the same market (QCOM risk‑factor notes that competitors’ IC products are used by Qualcomm’s customers【page_20】).  If Samsung prioritizes its own product lines, it could limit the wafer capacity available to Qualcomm, potentially forcing Qualcomm to pay higher incremental fees or lose amounts paid in advance under its $12.8 billion multi‑year capacity purchase commitments【page_81】【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.8 billion figure for Qualcomm's multi-year capacity purchase commitments is correctly stated, with no calculation or numerical errors. (2) The entities—Samsung, NVIDIA, and Qualcomm—are accurately identified, and their roles (Samsung as supplier to NVIDIA and competitor to Qualcomm) are correctly represented. (3) The multi-hop reasoning is sound: the answer connects Samsung’s role in NVIDIA’s supply chain, its competitive position against Qualcomm, and the potential impact on Qualcomm’s capacity commitments. It correctly infers that prioritization of Samsung’s own product lines could constrain Qualcomm’s access to foundry capacity, potentially triggering financial penalties or increased costs. (4) The answer is contextually relevant and directly addresses the core concern in the question. The only minor shortcoming is that it does not explicitly mention the possibility of renegotiation or margin impact as in the original answer, slightly reducing completeness in qualitative synthesis. However, the key implications—advance payments at risk and higher incremental fees—are covered, preserving semantic equivalence on the main consequences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 350,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s commercial‑customer receivables of **$665 million** (part of Boeing’s $2.351 billion total receivables) represent a sizable source of revenue for ULA, boosting its expected cash inflows and earnings. Because Boeing owns **50 % of ULA**, the earnings that ULA generates from these receivables flow into Boeing’s Space‑segment operating profit of **$1.226 billion** (which includes ULA earnings), thereby positively impacting Boeing’s reported income from the joint venture.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Lockheed Martin’s $665 million in commercial receivables is part of Boeing’s $2.351 billion total receivables — this is not supported by the ground truth and misrepresents the financial relationship. The $2.351 billion and $1.226 billion figures are not mentioned in the original answer and appear fabricated. (2) The only correct number is Lockheed Martin’s $665 million in commercial receivables as of December 31, 2024, which matches the ground truth. However, Boeing’s equity income from ULA is correctly stated in the original as $125 million, but the LLM omits this and instead invents unrelated figures like Boeing’s operating profit of $1.226 billion, which is not in the original. (3) The multi-hop reasoning is flawed: the LLM incorrectly frames Lockheed’s receivables as revenue for ULA, when in fact ULA is a customer of Lockheed Martin, not the other way around. This reverses the financial flow. Additionally, it fails to acknowledge that both Boeing and Lockheed are equally exposed to ULA’s performance through ownership and receivables, which is central to the original answer. (4) The contextual relevance is moderate because it discusses ULA, Boeing’s stake, and receivables, but the incorrect financial flows and fabricated numbers severely undermine accuracy. Due to major factual and logical errors, especially in quantitative and qualitative dimensions, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 415,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The invalidation of the “190 Patent” in the CAR T litigation triggered an impairment of the axicabtagene ciloleucel intangible asset that Gilead acquired with Kite.  The write‑down reduced the asset’s carrying amount, which in turn lowered the amortization expense recorded for finite‑lived intangible assets in 2021 (and in subsequent periods).  In 2021, amortization expense for axicabtagene ciloleucel was $1.5 B, part of the $1.7 B total amortization expense for finite‑lived intangible assets that year【page_82】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the invalidation of the '190 Patent triggered an impairment and write-down of the axicabtagene ciloleucel intangible asset, which reduced amortization expense. This contradicts the ground truth, which states that the patent invalidation removed royalty risk, improved asset valuation, and led to higher amortization ($1.7B in 2021 vs $1.2B in 2020) due to a clearer path to monetization. The LLM incorrectly frames the impact as a reduction in amortization due to impairment, when in reality amortization increased. (2) Quantitatively, the LLM states amortization for axicabtagene ciloleucel was $1.5B in 2021, part of a $1.7B total. While the $1.7B total matches the ground truth, the $1.5B figure for axicabtagene ciloleucel is not in the original answer and appears speculative. The ground truth does not break down amortization by specific asset. The increase from $1.2B in 2020 to $1.7B in 2021 is accurate in the original but missing in the LLM’s narrative. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that patent invalidation leads to asset impairment and lower amortization, when in this case it reduced contingent liabilities and supported higher asset valuation and amortization. This reflects a fundamental misunderstanding of the financial implications. (4) Contextual relevance is moderate—the answer discusses the right entities (Gilead, Kite, '190 Patent, Yescarta/axicabtagene ciloleucel) and the right time frame (2021), but the core causal logic and financial impact are inverted. The citation of 'page_82' suggests a source reference, but the conclusion drawn is factually incorrect. Thus, correctness and qualitative accuracy are low despite some correct numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 487,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater China segment generated $74.2 billion in net sales in 2022, while Intel’s Taiwan‑based revenue was $13.5 billion in 2021.  Thus Apple’s Greater China revenue is roughly 5½ times larger than Intel’s Taiwan revenue, exceeding it by about $60.7 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in 2022 for Greater China and Intel's $13.5 billion (rounded from $13,461 million) in 2021 for Taiwan are correctly reported, with acceptable rounding. The comparison stating Apple's revenue is 'roughly 5½ times larger' is accurate: 74,200 / 13,461 ≈ 5.51, which supports the 5½x claim. The difference of ~$60.7 billion is also correct: 74,200 - 13,461 = 60,739 million. (2) The answer is complete, addressing both companies, correct years, and the comparative aspect of the question. (3) Entity accuracy is perfect: Apple and Intel are correctly identified, with appropriate geographic segments (Greater China and Taiwan) and correct fiscal years (2022 and 2021). (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it pulls data from two different companies, regions, and years, and makes a valid cross-company, cross-region comparison as required. (5) The semantic meaning fully aligns with the original answer, even enhancing it with precise quantitative comparison. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 340,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its interest‑rate and foreign‑currency derivatives using pricing models that rely on observable inputs such as yield curves and exchange rates, classifying those contracts as Level‑2 fair‑value assets. Boeing, on the other hand, values its fixed‑income holdings with a market approach that depends on observable market prices and an income approach that discounts future cash flows using rates that reflect credit spreads and interest rates. Both firms therefore depend on observable market data, but UPS explicitly cites yield curves for derivative pricing, whereas Boeing embeds credit spreads and interest rates in the discount rates used for fixed‑income valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UPS uses observable inputs like yield curves and exchange rates for derivative valuation, classifying them as Level 2; Boeing values fixed-income instruments using observable market data including interest rates, yield curves, and credit spreads, also as Level 2 when possible. The emphasis on observable market data by both companies is correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and Boeing), two financial instruments (derivatives vs. fixed income), and valuation methodologies (pricing models using observable inputs). The distinction in focus—UPS on foreign exchange derivatives and Boeing on fixed income—is accurately captured. (4) The LLM slightly omits the explicit mention that Boeing uses 'yield curves at commonly quoted intervals' and does not reiterate that both classify these valuations as Level 2 due to observable inputs, though it implies this by stating both rely on observable data. This minor omission prevents a perfect 10 but does not undermine the core accuracy. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent—directly addresses the comparison in reliance on observable data like credit spreads and interest rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 423,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META applies discounted‑cash‑flow (DCF) models to test impairment of its operating‑lease right‑of‑use assets and leasehold improvements, using Level‑3 inputs such as expected downtime before subleases, projected sublease income, and discount rates that reflect the risk of future cash flows. In contrast, DIS uses DCF models to value Level‑2 derivatives, basing the calculations on observable market inputs—interest‑rate curves, foreign‑exchange rates, and (to a lesser extent) counterparty credit risk. Thus, META’s DCF assumptions are largely management‑estimated and risk‑adjusted, whereas DIS’s are largely market‑observable and less reliant on management judgment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: META uses DCF models with Level 3 inputs for impairment testing of operating lease ROU assets and leasehold improvements, incorporating assumptions like expected downtime, projected sublease income, and risk-adjusted discount rates. DIS uses DCF models for Level 2 derivatives with observable inputs such as interest rate curves and foreign exchange rates. These inputs are correctly attributed to the respective companies and applications. (2) There are no numeric values requiring calculation in this question, but the classification of inputs by fair value hierarchy level (Level 2 vs Level 3) is correctly interpreted and consistent across both answers. (3) The multi-hop reasoning is sound—correctly contrasting META’s internally estimated, less observable assumptions with DIS’s market-based, observable data, despite both using DCF models. This reflects proper synthesis across two companies, two financial applications (impairment vs derivative valuation), and two levels of input observability. (4) The only minor shortcoming is that the LLM omits mention of 'yield curves' explicitly (mentions 'interest-rate curves', which is semantically equivalent) and slightly downplays 'counterparty credit risk' as a lesser factor without confirming its role in DIS’s model per the original. However, this does not detract significantly from the overall accuracy. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 456,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The 2022 filing notes that a global semiconductor shortage has tightened IQOS device supply (page 28) and that an ITC import ban has kept IQOS devices off U.S. shelves (page 37). Because FDA pre‑market authorization is required for sale, the supply constraint and ITC ban together delay or limit PM USA’s ability to commercialize heated‑tobacco products in the U.S. PM USA’s role as Altria’s guarantor (page 51) means it is financially responsible for Altria’s debt obligations, but this guarantee does not change the device‑supply issue and could constrain the subsidiary’s capacity to invest in resolving the shortfall.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the global semiconductor shortage and ITC import ban as key constraints on IQOS device supply, citing specific pages from PM's 2022 filing. It accurately notes that FDA pre-market authorization is required for commercialization in the U.S., which aligns with the ground truth. The role of PM USA as a guarantor of Altria’s debt obligations is also correctly stated. However, the LLM omits critical details present in the original answer: it does not mention the cessation of IQOS sales after November 29, 2021, nor the specific impact on PM USA’s product portfolio or the delay in resuming U.S. supply due to the combination of the ITC ban and supply constraints. Additionally, while it mentions PM USA’s guarantor role, it fails to connect this to potential financial strain, reduced cash flows, dividend impacts, or insolvency risks under fraudulent conveyance laws—key implications in the ground truth. (2) There are no numerical values, dates, or calculations in either answer that conflict; the LLM does not introduce any incorrect quantitative data, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model links supply constraints and regulatory dependency to commercialization challenges, and acknowledges the financial structure. However, it does not fully synthesize the chain of implications—how operational disruptions (supply + ITC ban) affect commercialization, which in turn could impact financial performance and, given PM USA’s guarantor status, potentially trigger broader financial or legal risks. This missing synthesis reduces qualitative accuracy. (4) The answer remains contextually relevant, addressing the core elements of supply constraints, FDA authorization, and financial structure, but lacks depth in connecting the dots across these domains as required by the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 516,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMY’s 2023 filing notes that when exclusivity ends, the introduction of generics or biosimilars can trigger “very substantial and rapid declines” in a product’s sales (BMY 10‑K, page 27).  Because BMY’s revenue mix is spread across many products, the impact of any one biosimilar launch is diluted across its portfolio.  In contrast, AbbVie’s single product, Humira, accounted for roughly 27 % of its 2023 net revenues (AbbVie 10‑K, page 81) and is already under direct biosimilar pressure worldwide (AbbVie 10‑K, page 8), making AbbVie’s exposure to biosimilar competition far more concentrated and potentially more severe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 27% of ABBV's 2023 net revenues attributed to Humira matches the original answer and is properly cited from AbbVie’s 10-K (page 81). The characterization of biosimilar impact on BMY is consistent with its 10-K language about 'very substantial and rapid declines' upon loss of exclusivity. (2) There are no calculation errors, and the financial exposure percentages are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk concentration (ABBV’s reliance on Humira) versus broader portfolio risk (BMY’s diversified exposure), drawing from both companies’ filings. It contrasts the structural differences in risk exposure due to revenue concentration, which is the core of the comparison. (4) The only minor shortcoming is that the LLM does not explicitly name BMY’s at-risk products (Eliquis, Revlimid) as in the original answer, slightly reducing completeness in qualitative detail. However, the central point about diversified vs. concentrated risk is clearly and correctly conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the comparative biosimilar exposure as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 369,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards vest on the third anniversary of the grant and earn dividend equivalents during that vesting period; the equivalents are paid out in cash when the award vests and are incorporated into the award’s value [110]. PepsiCo’s RSU awards also accrue dividend equivalents, but those equivalents are paid out in cash only when the award vests and are not part of the award’s value [92].",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content but misses key nuances in vesting triggers that are central to the question. Quantitatively, it correctly describes the three-year vesting for PM and the cash payout of dividend equivalents upon vesting for both companies, with accurate references to payout timing and structure. The numbers and timeframes (e.g., 'third anniversary') align with the ground truth. However, the answer omits PM's additional vesting triggers—death, disability, or reaching age 58—which is a critical differentiator in payout structure. It also fails to mention that PEP ties vesting strictly to service or performance conditions without age-based triggers, weakening the comparative analysis. While the LLM correctly notes that PM includes dividend equivalents in the award value (paid at settlement) and PEP pays them in cash upon vesting, it does not fully capture the structural difference in vesting triggers, which is a core part of the multi-hop reasoning required. The entities (PM and PEP) and financial terms (dividend equivalents, RSUs, cash payout) are accurate. The reasoning is sound but incomplete, missing synthesis on the policy-level differences in equity compensation design. Wording is semantically close but lacks depth in comparative structure. Hence, correctness is reduced due to incomplete qualitative synthesis despite strong quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 393,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s run‑off insurance operation holds a single $1,410 million limited‑partnership stake in private‑equity, infrastructure and real‑estate funds that are not redeemable and can only be liquidated at the general partner’s discretion, exposing GE to high liquidity risk (GE 10‑K, p. 49).  By contrast, BA’s pension‑fund real‑estate strategy is a 7 % diversified allocation that spans office, retail, apartment and industrial assets, typically held through LPs or other fund structures and managed with active liquidity‑risk monitoring (BA 10‑K, p. 100).  Thus, GE’s exposure is concentrated and illiquid, whereas BA’s broader, diversified real‑estate mix mitigates liquidity risk through multiple vehicles and risk‑management policies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: GE's $1,410 million investment is accurately reported, and BA's 7% diversified allocation is consistent with the source (BA 10-K, p. 100). The format variations (e.g., $1,410 million vs $1.41 billion) are acceptable. (2) The answer addresses all parts of the question: it compares GE’s illiquid real estate investment to BA’s broader strategy, discusses liquidity risk, and covers fund structure (limited partnerships). (3) Entity accuracy is strong: both GE and BA are correctly identified, and the context of GE’s run-off insurance operations and BA’s pension fund strategy is preserved. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly infers that GE’s lack of redemption rights leads to higher liquidity risk, while BA’s diversified, actively managed approach mitigates such risk. The only minor shortcoming is that the LLM slightly overemphasizes 'private equity, infrastructure' in GE’s fund composition, which is not explicitly stated in the ground truth—GE is described as holding illiquid real estate funds, not a mixed fund. However, this does not materially distort the core comparison on liquidity and structure. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 379,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "BAC does not disclose the notional value of its equity‑derivative positions in the pages provided, and the sensitivity to a 10 % drop in equity prices is not reported; the only equity‑risk figure available is a one‑day VaR of $9 million year‑end (average $18 million)【page_73】. By contrast, MetLife reports a $23.6 billion notional exposure to equity derivatives and a $522 million estimated loss on a 10 % decline in equity prices【page_129】. Thus, BAC’s equity‑derivative exposure is not quantified in the disclosed material, whereas MetLife’s is sizable and its sensitivity to a 10 % equity price fall is explicitly stated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: MET's notional value of $23,595 million is accurately reported as $23.6 billion (appropriate rounding), and the $522 million sensitivity to a 10% decrease in equity prices is correctly cited. BAC's lack of disclosed notional value and sensitivity is properly noted, with the additional context of VaR figures ($9M year-end, average $18M) which are not in the original answer but are factually consistent with typical disclosures and do not contradict the ground truth. (2) The answer addresses all parts of the question: comparison of BAC and MET in terms of notional value and sensitivity to a 10% equity decline. It correctly identifies that BAC does not provide the required quantitative metrics, while MET does. (3) Entities are accurate—BAC and MET (MetLife) are correctly identified, and the financial metrics (notional value, sensitivity, VaR) are used appropriately. (4) The reasoning is sound: the LLM correctly synthesizes that MET provides explicit, quantified exposure while BAC does not, leading to a valid comparative conclusion. The only minor point reducing qualitative accuracy is the introduction of VaR data not present in the ground truth, which, while plausible and contextually helpful, slightly extends beyond the original answer’s scope. However, it does not detract from correctness. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 414,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s Greater China segment generated $74.2 billion in 2022 and is supported by a regional center in Singapore that serves the Greater China market, indicating a substantial operational footprint (MSFT 10‑K, p. 25; p. 16). In contrast, AMD’s revenue from Taiwan was $2.091 billion of its $16.434 billion total sales—about 13%—showing a more modest concentration (AMD 10‑K, p. 78). These figures suggest Microsoft is pursuing a broad, diversified strategy in Greater China, while AMD’s 2022 strategy is more concentrated on Taiwan, implying greater reliance on that single market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it claims Microsoft's Greater China segment generated $74.2 billion in 2022, which is false. The ground truth does not provide any revenue figure for Microsoft in Greater China, and $74.2 billion is implausibly large—Microsoft's total revenue in 2022 was $198 billion. This number appears fabricated or misattributed. AMD's revenue from Taiwan is correctly stated as $2.091 billion (matching ground truth), and total AMD revenue of $16.434 billion is accurate, making the 13% calculation correct. (2) Quantitative accuracy is low due to the erroneous $74.2 billion figure. While AMD numbers are correct and the percentage calculation is accurate, the Microsoft number is completely wrong, undermining the comparison. (3) The reasoning structure is sound—comparing operational footprint vs. revenue concentration and inferring strategic differences—but it is based on a false premise for Microsoft. The model correctly identifies the Singapore regional center (from ground truth), but adds unsupported revenue data, suggesting a failure in multi-hop synthesis: it conflates operational presence with revenue generation without evidence. (4) Contextual relevance is high because the answer addresses both companies, regions, and strategies as required. However, the core factual error in Microsoft's revenue severely compromises correctness and quantitative accuracy. The qualitative reasoning would score higher if not based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 421,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "META’s dual‑class structure gives Class B common stock ten votes per share while Class A holders receive only one vote, concentrating control in the hands of the founders and early investors and limiting the influence of ordinary Class A shareholders (see pages 49‑50). In contrast, NFLX has a single class of common stock with one vote per share for every holder, so all shareholders have equal voting power over corporate governance matters (see page 61). Thus, META’s structure restricts investor influence relative to NFLX’s equal‑vote approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the statement that Class B shares have ten votes per share while Class A have one is correct and aligns with known disclosures in META's filings; NFLX's one-vote-per-share structure is also accurately represented. No calculations are required, and all numeric assertions are factually sound. (2) The answer is complete, addressing both META's dual-class structure and its impact on investor influence, as well as contrasting it with NFLX's single-class, one-share-one-vote model. (3) Entities (META, NFLX) and governance concepts (voting rights, shareholder influence) are correctly identified and compared. (4) The reasoning is logically sound and synthesizes multi-hop information across the two companies' governance models. The only minor shortcoming is that the LLM does not explicitly mention Mark Zuckerberg or 'founder control' by name, which slightly reduces qualitative richness compared to the original, but the concept is implicitly covered through 'founders and early investors.' Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 346,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson’s market exclusivity is largely tied to its patent portfolio; when those patents expire the company typically experiences a sharp drop in sales as generics or biosimilars can enter the market (JNJ 10‑K, page 6). Eli Lilly, by contrast, relies on regulatory exclusivity extensions—such as data‑protection, pediatric and orphan‑drug exclusivities—that can extend protection beyond the life of the underlying patents and help the company maintain a competitive advantage in the U.S. market (LLY 10‑K, pages 10‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. (1) It correctly identifies that JNJ's market exclusivity is tied to patents and that expiration leads to generic competition and sales decline, citing the JNJ 10-K. It also accurately states that LLY uses regulatory exclusivity extensions—specifically naming data protection, pediatric, and orphan-drug exclusivities—to extend market protection beyond patent life, citing the LLY 10-K. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly contrasts JNJ’s vulnerability to patent expiration with LLY’s strategic use of regulatory exclusivity, synthesizing information across two companies. The only minor omission is that the LLM answer does not mention BMY’s 10-K reference about regulatory exclusivity extending beyond patent terms, which slightly weakens the support for the claim about LLY. However, the LLY 10-K citation covers this adequately. (4) The answer is highly relevant, directly addressing both parts of the question with appropriate context and source references. The wording differs slightly from the original but maintains semantic equivalence. Thus, the correctness score is 9 due to the omission of the BMY supporting evidence, but all key facts and reasoning are present and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 411,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD cut its 2021 interest expense by $13 million versus 2020, largely because holders converted its 2.125% convertible senior notes.  In contrast, Microsoft’s balance sheet shows only $1 million of Nuance’s convertible senior notes outstanding after the acquisition.  This indicates AMD is actively converting debt to lower interest costs, while Microsoft has largely retired convertible debt, reflecting a more debt‑light capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's interest expense reduction from $47M to $34M (a $13M decrease) between 2020 and 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026. It also accurately states that only $1M of Nuance’s convertible senior notes remained outstanding post-acquisition by Microsoft. These figures match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect: the $13M reduction is correctly calculated ($47M - $34M), and the $1M outstanding liability for Nuance is correctly reported. The original answer notes Nuance issued $986M and redeemed $985M, leaving $1M—this is consistent with the LLM’s summary. (3) The reasoning is sound and captures the multi-hop comparison: AMD proactively reduced debt via conversions, while Microsoft, post-acquisition, effectively retired nearly all of Nuance’s convertible debt. The LLM correctly infers differing capital structure strategies—AMD managing debt through conversion incentives, Microsoft adopting a debt-light approach. However, it omits Nuance’s own redemption actions prior to full retirement and slightly oversimplifies by attributing the retirement solely to Microsoft, when Nuance had already redeemed most notes before acquisition. This minor omission affects qualitative depth but not core correctness. (4) The answer is contextually relevant, directly addressing the comparison and strategic implication. Overall, the response is factually accurate, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy for incomplete nuance on redemption timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 460,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "American Tower’s $5.0 billion upfront payment in 2015 was slightly higher—about $173 million—than Crown Castle’s $4.827 billion transaction in 2013. In both deals the tower owners (Verizon and AT&T) retained ownership and continued to depreciate the towers, while the operators paid the upfront fee for exclusive lease‑and‑operate rights.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $5.0 billion American Tower payment in 2015 and the $4.827 billion Crown Castle transaction in 2013, accurately noting that the former is slightly higher by about $173 million ($5.0B - $4.827B = $173M), which matches the ground truth. These numbers and the calculation are correct. (2) The LLM correctly states that both Verizon and AT&T retained ownership and continued depreciation, aligning with the ground truth. However, it omits key details about the number of towers involved: 11,300 Verizon towers vs. 9,048 AT&T towers plus 627 purchased towers. This omission affects completeness but not core correctness. (3) The multi-hop reasoning is sound—comparing two large tower transactions across different companies and years, identifying similarities in structure (upfront payment, retained ownership, depreciation, subleasing). The LLM correctly infers that both deals involved exclusive lease-and-operate rights, though it does not specify leaseback terms (Verizon: minimum 10 years; AT&T: ~20 years), which are present in the original answer. (4) Despite missing some granular details (tower counts, lease durations), the LLM captures the essential comparison and financial structure accurately. Quantitative accuracy is high as all numbers and the difference calculation are correct. Qualitative accuracy is slightly reduced due to missing specifics, but reasoning remains logically sound. Contextual relevance is perfect—the answer directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 421,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power uses tax‑equity partnerships for its wind projects, with the partner assuming the bulk of the federal PTCs and the partnership being consolidated under the HLBV method; the projects are tied to long‑term PPAs that can run up to 25 years (page 97).  Duke Energy, by contrast, structures its renewable projects as VIEs that are financed through tax‑equity arrangements, consolidating the VIEs because it retains control (page 203); the tax‑equity partner also captures the PTCs, but the company does not transfer the credits to a separate partner in the same way Southern Power does.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Southern Power uses tax equity partnerships for wind facilities, with the tax partner capturing most PTCs, and that these are consolidated under the HLBV method with PPAs up to 25 years—this matches the original answer. It also correctly notes Duke Energy structures renewable projects as VIEs financed via tax equity, with consolidation due to control, and that tax equity partners capture PTCs. (2) There are no numeric values requiring calculation, but the 25-year PPA term is correctly cited, and page references (97, 203) support the claims. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their use of tax equity, PTC monetization, and PPA structures. However, a subtle but important distinction is missed: the original answer clarifies that Southern Power explicitly ties PPA terms to the 10-year PTC window for monetization, while Duke’s approach is more focused on broader VIE financing and guarantees. The LLM implies a structural difference but inaccurately suggests Duke does not transfer PTCs 'in the same way'—in fact, both do transfer PTCs to tax equity partners; the difference lies in integration with PPA duration and financing model. (4) Despite this nuance, the core facts, entities, and reasoning are correct, warranting a high score. Minor deduction from 9 to 8 due to incomplete precision in comparing the PTC transfer mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 414,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "CMCSA’s Class B common shares carry no voting rights except on a handful of specified matters (e.g., certain mergers or amendments to the certificate of incorporation), so Class B holders have minimal influence over major corporate decisions that are dominated by Class A shareholders (page 90). Alphabet’s dual‑class structure gives each Class A share one vote, each Class B share ten votes, and Class C shares no voting rights, concentrating control in the hands of insiders and limiting public shareholder influence on key decisions (page 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B shares have no voting rights except on specified matters (e.g., mergers), and GOOGL (Alphabet) has a dual-class structure where Class B shares have 10 votes, Class A have 1 vote, and Class C have none. These details match the original answer. (2) There are no numeric inaccuracies—'10 votes per share' and '1 vote per share' are correctly reported. (3) The multi-hop reasoning is sound: the model correctly contrasts CMCSA’s limited-exemption voting structure with Alphabet’s control-concentrated dual-class system, capturing the implications for shareholder influence and corporate governance. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'core payments business' condition for CMCSA or directly compare the governance models in terms of 'decisive strategic direction vs. democratic oversight' as in the original. However, the essence—that insiders hold concentrated control at GOOGL while CMCSA has more uniform voting among its voting shareholders—is implied. Wording differs slightly but semantic equivalence is preserved. Contextual relevance is excellent, directly addressing the impact on corporate governance and shareholder influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 364,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B holders 10 votes per share while Class A shares carry only one vote (page 81).  The $62.2 billion of Class A and Class C repurchases in 2023 cut the number of voting shares held by the public, so the proportion of votes controlled by the 10‑vote Class B shareholders rises, consolidating insider control.  In contrast, NFLX’s single‑class common stock gives every share one vote (page 61), and its $6.0 billion of repurchases in 2023 simply reduces total shares outstanding without concentrating voting power, keeping control more broadly distributed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (10 votes for Class B, 1 for Class A), the $62.2 billion in 2023 share repurchases of Class A and C shares, and NFLX's one-share-one-vote structure are accurately stated. The LLM correctly notes that repurchasing Class A and C shares (which have lower voting power) reduces the total voting pool, thereby increasing the relative voting control of Class B shareholders—this is a correct interpretation of the control consolidation effect. (2) Quantitatively, all numbers match: $62.2 billion for GOOGL and the mention of NFLX’s $6.0 billion repurchase (though this figure is not in the original answer, it is consistent with external data and does not contradict the ground truth; its inclusion adds detail without error). (3) The multi-hop reasoning is sound: the model connects share structure, repurchase activity, and control dynamics across GOOGL and NFLX, correctly contrasting the concentration of control in GOOGL versus the distributed control in NFLX. (4) The only minor shortcoming is that the original answer emphasizes GOOGL leadership's insulation from shareholder influence as a consequence, which the LLM implies but does not explicitly state. However, the core reasoning and factual content are substantively equivalent. Wording differences are acceptable under semantic equivalence. All entities (GOOGL, NFLX, share classes, years) are correct. The answer is fully relevant and well-contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 424,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY’s retained royalty rights to Byetta provide a sizable revenue stream, contributing roughly $1.9 billion of pretax income from royalties in 2021 【page_48】.  However, the rights are limited to royalty payments only, and the Byetta trademark is owned by Eli Lilly, so BMY does not control the brand or its marketing.  This arrangement gives BMY a steady royalty income but limits its influence over the product’s commercial success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.9 billion pretax income from royalties in 2021 is correctly reported, matching the original answer and sourced to BMY's 2022 10-K (page 48 reference is appropriate). (2) The entity identification is correct: BMY (Bristol Myers Squibb), LLY (Eli Lilly), and Byetta* are all accurately referenced, with correct attribution of trademark ownership to LLY. (3) The reasoning correctly captures the multi-hop logic: despite divesting its diabetes business and LLY owning the trademark, BMY retains royalty rights that generate significant income. The answer acknowledges the financial significance while noting the limitation of control. (4) The only minor omission is that the original answer emphasizes the forward-looking risk — that a decline in royalties could adversely affect BMY’s future performance — which the LLM answer does not mention. This reduces completeness slightly but does not detract from core factual accuracy. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 319,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s total‑risk‑based‑capital requirement is 10.5 % – the figure that already incorporates a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer.  \nJPMorgan Chase’s total‑risk‑based‑capital requirement is 10.5 % for its bank (the IDI) – which includes only the 2.5 % capital‑conservation buffer – and 14.9 % for the holding company (the BHC), which also carries a 4 % GSIB surcharge and a 2.9 % SCB in addition to the 2.5 % conservation buffer.  \n\nThus, Schwab’s requirement is built on two buffers, whereas JPMorgan Chase’s is built on a single buffer plus extra regulatory surcharges, resulting in a higher overall ratio for the firm.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies not present in the ground truth. While it correctly states that Schwab's minimum total risk-based capital ratio is 10.5%, incorporating both a 2.5% stress capital buffer (SCB) and a 2.5% capital conservation buffer (CCB), it diverges from the ground truth regarding JPMorgan Chase. The original answer states that JPMorgan Chase's minimum total risk-based capital ratio is 10.5% with only a 2.5% CCB and no additional SCB, implying alignment with the base requirement plus one buffer. However, the LLM answer claims JPMorgan Chase has a 10.5% requirement for its IDI (insured depository institution) and a 14.9% requirement for its BHC (bank holding company), including a 4% GSIB surcharge and 2.9% SCB. This level of detail and these specific numbers (4%, 2.9%, 14.9%) are not supported by the ground truth and were not requested in the question. (2) Quantitatively, the 10.5% figure for Schwab is correct and matches the ground truth (base 5.5% + 2.5% CCB + 2.5% SCB under applicable regulations). For JPMorgan Chase, while 10.5% is acknowledged for the IDI, the addition of 14.9% for the BHC with breakdowns (GSIB + SCB) introduces unsupported precision and complexity. The ground truth does not mention GSIB surcharges or different requirements for BHC vs IDI, nor does the question ask for such a breakdown. Thus, these numbers, while potentially true in another context, are not relevant or verified here. (3) The multi-hop reasoning is flawed because the LLM infers a structural difference based on holding company vs bank-level requirements, which was not part of the original comparison. The question focuses on the buffer composition affecting the total capital ratio, and the ground truth emphasizes that both firms have a 10.5% requirement but with different buffer components. The LLM incorrectly implies JPMorgan has a higher requirement due to surcharges, which contradicts the ground truth's point of equal ratios (10.5%) under different regulatory treatments. (4) The correctness score is 4 due to major factual overreach and introduction of unverified figures. Quantitative accuracy is 5 because core numbers (10.5%, 2.5%) are correct for Schwab and partially for JPMorgan’s IDI, but unsupported for BHC. Qualitative accuracy is 5 due to correct identification of buffers but flawed synthesis. Contextual relevance is 7 because the response addresses the core topic and compares buffer structures, albeit with excessive and irrelevant detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 678,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "Lockheed Martin’s credit facility already contains fallback provisions that will switch the interest calculation to an alternative rate when LIBOR is no longer available, and the company expects no material impact on its operating results, financial position or cash flows, with ASU 2020‑04 providing accounting relief【page_85】. General Electric’s floating‑rate debt and preferred stock, which are currently LIBOR‑based, will be replaced by SOFR plus a spread once LIBOR ceases, and the company will account for any transition effects under ASU 2020‑04, again anticipating no material impact on its financial statements【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LMT’s credit facility has fallback provisions (to SOFR), expects no material impact, and relies on ASU 2020-04 for accounting relief. GE’s LIBOR-based floating-rate debt and preferred stock will transition to SOFR plus spread, with accounting under ASU 2020-04 and no material financial impact expected. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of LIBOR transition on two different companies (LMT and GE), different financial instruments (credit facility/derivatives vs. debt/preferred stock), and correctly applies the same accounting standard (ASU 2020-04) to both. The only minor gap is that the LLM answer does not explicitly mention 'derivatives' for LMT or 'New York law' for GE, which are in the original, but these are contextual details that do not alter the core correctness. (4) The answer is contextually fully relevant, directly addressing all parts of the question with precise, aligned information. Wording differs slightly but meaning is semantically equivalent. Thus, correctness is 9 due to minor omissions in instrument specificity, but not enough to reduce the score further.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 390,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 issuance of 9,444,375 Class B shares (each with 10 votes) shows the size of its higher‑voting class and the company’s dual‑class structure (see CMCSA balance sheet, page 69).  Like Alphabet, Comcast’s Class B shares automatically convert to Class A shares on sale or transfer, ensuring that voting power remains concentrated in a small group of shareholders (see CMCSA note on share classes, page 81).  Alphabet’s dual‑class system likewise gives Class B shares 10 votes and automatic conversion to Class A upon sale or transfer, so the two structures are functionally similar, though Alphabet’s Class B class is larger in number of shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of shares issued by CMCSA (9,444,375) and the 10 votes per Class B share, which aligns with the ground truth. However, it makes a critical factual error by stating that CMCSA's Class B shares 'automatically convert to Class A shares on sale or transfer'—this is not supported by the original answer, which makes no such claim about CMCSA’s conversion policy. In contrast, the ground truth explicitly states that GOOGL has this conversion feature, but does not confirm it for CMCSA. This misrepresentation undermines the core comparison. (2) Quantitatively, the share count and voting rights are accurate, and no calculations are required beyond these figures, so numerical accuracy is strong. (3) The multi-hop reasoning fails because the LLM incorrectly assumes symmetry between CMCSA and GOOGL on share conversion, when the original answer highlights a key difference: GOOGL has an active buyback program ($62.2B repurchased in 2023), while CMCSA has no such program mentioned. The LLM omits this crucial distinction, which is central to understanding the strategic differences in capital structure. (4) While the answer is relevant and attempts a valid comparison, the incorrect attribution of GOOGL’s conversion mechanism to CMCSA leads to a flawed qualitative assessment. The answer suggests functional similarity, but the original emphasizes structural and strategic differences, particularly around control preservation mechanisms and capital allocation (buybacks). Thus, despite correct numbers and surface-level relevance, the reasoning and factual accuracy on key qualitative points are significantly off.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 456,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension commitments are long‑term: the company’s withdrawal liability from the Bakery & Confectionery Union (≈$526 million) is paid pro‑rata over 19 years (page 106), and the related pension cost is recorded each year as service and interest expense (with amortization of net periodic benefit costs).  \nWalmart’s equity‑compensation vesting is much shorter: restricted‑stock units vest 25 % annually over four years (and performance‑based units vest 1–3 years) (page 67), and the expense is recognized ratably over the vesting period—initially reported as unrecognized compensation cost and then expensed over a weighted‑average remaining period of about 1.2–1.5 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: MDLZ's $526 million withdrawal liability paid over 19 years and annual pension cost recognition (e.g., $11 million in 2021 is implied via 'service and interest expense' though not explicitly stated, but the mechanism is correct). WMT's 25% annual vesting over four years and ratable expense recognition are accurately reported. The weighted-average remaining period of 1.2–1.5 years is an additional detail not in the original but does not contradict it. (2) The entities—MDLZ, WMT, multiemployer pension plans, restricted stock units—are correctly identified and attributed. (3) The reasoning correctly contrasts MDLZ’s long-term, collectively bargained pension obligations with WMT’s shorter, internally structured equity vesting schedules. It captures the core distinction in duration (19 years vs. 4 years) and cost recognition (ongoing contributions and interest vs. ratable expensing of fair value). (4) The answer is contextually complete and relevant, addressing both duration and cost recognition patterns. One minor omission: the original mentions WMT discounts fair value for expected dividends (e.g., 3.8% in fiscal 2022), which the LLM omits. This is a small gap in completeness but does not undermine the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with a minor qualitative shortcoming.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 400,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Bank of America’s Advanced‑Approach capital buffer requirement is 5.5 % of risk‑weighted assets – the sum of the 2.5 % capital‑conservation buffer, the 3.0 % G‑SIB surcharge and a zero counter‑cyclical buffer (page 134). Morgan Stanley’s Advanced‑Approach buffer requirement is identical at 5.5 % above the minimum risk‑based ratios, also driven by a 2.5 % conservation buffer and a zero counter‑cyclical buffer (page 133). Thus, the two institutions have the same combined buffer level.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key percentages. It states that Bank of America (BAC) has a 3.0% G-SIB surcharge and a total buffer of 5.5%, while the ground truth confirms both BAC and MS have a 2.5% G-SIB surcharge, resulting in a total buffer of 5.0% (2.5% Capital Conservation Buffer + 2.5% G-SIB). The LLM incorrectly reports the G-SIB surcharge and total buffer for BAC, and although it claims MS has a 5.5% buffer, it omits MS's G-SIB surcharge value entirely while implying it's the same as BAC's incorrect 3.0%. (2) Calculations are therefore flawed: 2.5% + 3.0% = 5.5% is mathematically correct but based on incorrect input data. The ground truth shows both banks have 2.5% + 2.5% = 5.0%, so the LLM's 5.5% is quantitatively wrong. (3) The multi-hop reasoning is partially sound—LLM correctly identifies that both banks apply the 2.5% Capital Conservation Buffer and zero Countercyclical Buffer, and it attempts to sum components. However, it fails in synthesizing the correct G-SIB surcharge values from the source data, leading to an incorrect conclusion about the total buffer. (4) Contextual relevance is high as the answer addresses the right institutions, buffers, and regulatory framework. However, due to the critical error in the G-SIB surcharge and total buffer percentage, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structure and logic are reasonable but based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 414,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes are highly rate‑sensitive – a 50 basis‑point move in market rates would shift their fair value by roughly $1.7 billion (≈3 % of principal, see AVGO page 49). Oracle, however, uses interest‑rate swaps to convert portions of its fixed‑rate debt into floating‑rate exposure, thereby dampening the impact of rate swings on its effective interest cost (Oracle notes on pages 86‑90). Cisco’s $0.5 billion swap demonstrates how such hedges offset fair‑value changes, illustrating the mechanism Oracle employs to reduce its own sensitivity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AVGO's $56.3 billion fixed-rate senior notes and the $1.7 billion fair value impact from a 50 basis point shift, matching the ground truth. It also correctly references CSCO's $0.5 billion swap as a hedging mechanism. However, it misrepresents ORCL's use of swaps — the ground truth states ORCL uses swaps to convert floating-rate debt to fixed-rate (achieving a 4.74% effective rate), but the LLM incorrectly claims ORCL converts fixed-rate to floating-rate, which is the opposite strategy. This is a significant qualitative error in reasoning and entity-specific fact. (2) Quantitatively, all numbers are accurate: $56.3B, $1.7B, 50 bps, and $0.5B are correct. The ≈3% principal impact (1.7/56.3 ≈ 3.02%) is a valid derivation. However, the LLM omits ORCL's specific effective interest rate (4.74%) and base rate (3.07%), which are key quantitative details from the ground truth. (3) The multi-hop reasoning is partially sound — it connects AVGO's sensitivity, ORCL's use of swaps, and CSCO's example — but the incorrect direction of ORCL's swap strategy undermines the synthesis. The model fails to correctly align ORCL's strategy with the broader theme of stabilizing rates via conversion to fixed, as demonstrated by the ground truth. (4) Scores reflect mostly correct numbers and relevance to the question, but with a critical error in ORCL's strategy direction and missing key metrics, preventing a higher score. Contextual relevance is high as the answer addresses interest rate sensitivity and hedging across all three firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 433,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s 10‑K shows it has Class A and Class B shares, with Class B shares carrying 10 votes each (giving them outsized voting power relative to the 1‑vote Class A shares) [page_1]. Alphabet’s repurchase program, disclosed in its 10‑K, targets its publicly traded Class A (1 vote per share) and Class C (no voting rights) shares, repurchasing $59.3 B, $62.2 B, and $62.0 B in 2022‑24 respectively and leaving the high‑voting non‑public Class B shares untouched [page_82]. Thus, Meta concentrates voting power in a minority class, whereas Alphabet’s buy‑back strategy dilutes the influence of its publicly traded shares without affecting the non‑public Class B shares.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the voting power details for META and the repurchase amounts for GOOGL. According to the ground truth, META's Class B shares have 15 votes per share, not 10 as stated in the LLM answer. This is a significant error affecting the accuracy of the voting rights comparison. Additionally, the ground truth states that Class B shares represent 33 1/3% of combined voting power and are non-dilutable—details missing in the LLM response. For GOOGL, the LLM reports repurchase amounts of $59.3B, $62.2B, and $62.0B for 2022–24, but the question and ground truth only reference the $62.0B repurchase in 2024. Including prior years’ figures introduces unsupported data. (2) The dollar amounts are partially correct—$62.0B in 2024 matches the ground truth—but the inclusion of $59.3B and $62.2B for earlier years is extraneous and not requested. The voting power numbers (10 vs. 15 votes per share) are incorrect for META, which undermines quantitative accuracy. (3) The multi-hop reasoning is generally sound: the model correctly identifies that META concentrates voting power in a minority share class while GOOGL’s repurchases target low-vote/no-vote public shares, preserving control with non-public Class B shares. This reflects an understanding of governance implications. However, the failure to accurately report META’s 15-vote structure and non-dilutable control weakens the synthesis. (4) The contextual relevance is high—the answer addresses the core comparison between voting structures and repurchase strategies. Qualitative accuracy is moderate due to correct conceptual framing but flawed specifics. Correctness score is 6 due to key factual errors in voting rights and repurchase scope, despite correct overall direction and relevant reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 497,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm’s forecast that 46 % of smartphones sold in 2027 will be generative‑AI‑capable (up from 19 % in 2024) reinforces its strategy to build AI‑centric silicon, low‑power processors and 5G/5G‑Advanced connectivity that can run large language and vision models on‑device (see page 7). In contrast, Salesforce is channeling resources into generative and agentic AI across its cloud‑based CRM platform—introducing Agentforce and other AI‑powered services—to transform customer interactions and productivity, a software‑centric focus rather than hardware connectivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's projection that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, matching the ground truth exactly. These percentages and years are accurate, satisfying quantitative accuracy. (2) The LLM correctly attributes Qualcomm’s strategic focus to on-device AI through silicon and low-power processors, and advanced connectivity (5G/5G-Advanced), aligning with the ground truth’s emphasis on hardware innovation for edge computing. It also accurately contrasts this with Salesforce’s software-centric approach, embedding generative and agentic AI into its cloud-based CRM platform via Agentforce. (3) The multi-hop reasoning is sound: the model synthesizes information across two distinct companies (Qualcomm and Salesforce), their respective domains (hardware vs. software), and strategic directions (on-device AI vs. AI in enterprise workflows), capturing the core comparative intent of the question. (4) The only minor omission is that the LLM answer does not explicitly mention the absence of a direct business relationship or dependency between Qualcomm and Salesforce—a detail present in the ground truth. However, this does not detract significantly from the overall correctness, as the focus is on strategic contrast and convergence in AI emphasis. Wording differs slightly (e.g., 'AI-centric silicon' vs. 'on-device AI'), but semantic equivalence is maintained. All entities—Qualcomm, Salesforce, Agentforce, 2024, 2027, 19%, 46%—are correct. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 473,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe’s 10‑K shows it is embedding generative AI (Adobe Firefly, Sensei) across Creative Cloud and Experience Cloud to deliver more intuitive, personalized creative and marketing experiences (page_6, page_8, page_10). Qualcomm projects that by 2027 roughly 46 % of smartphones and 50 % of PCs will run generative AI on‑device, powered by its Hexagon NPU and Adreno GPU, enabling low‑latency, privacy‑preserving UI enhancements (page_7, page_8). Thus, Adobe’s AI‑driven tools are positioned to leverage Qualcomm’s on‑device AI platform, aligning both companies’ focus on improving user interfaces and real‑time interaction through edge‑AI processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Adobe's use of generative AI (Firefly, Sensei) in Creative Cloud and Experience Cloud to enhance user experience, aligning with the ground truth emphasis on intuitive and visually appealing interfaces. It accurately cites Qualcomm’s projection that 46% of smartphones will be generative AI-capable by 2027, matching the original answer. The LLM adds a specific projection for PCs (50%), which is not in the ground truth but does not contradict it and is consistent with Qualcomm’s broader edge AI narrative; this is a minor addition rather than an error. (2) Quantitative accuracy is perfect: 46% smartphone penetration by 2027 vs. 19% in 2024 (implied baseline) is correctly represented. The LLM does not mention the 19% figure but correctly states the 46% projection, and the PC estimate is plausible and contextually relevant. No calculations are required, and all numbers match or are consistent with the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly links Adobe’s AI-driven UX improvements with Qualcomm’s on-device AI capabilities, highlighting low-latency, privacy-preserving processing as a shared enabler. It synthesizes across both companies’ strategic directions and correctly infers alignment in UI and real-time interaction improvements. (4) The answer is semantically equivalent to the ground truth, with slightly more technical detail (Hexagon NPU, Adreno GPU) that enhances rather than distorts accuracy. The only minor gap is not explicitly mentioning privacy and personalization as user experience dimensions emphasized in the original, though 'privacy-preserving' is noted. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSU awards to directors are payable upon termination of service, but directors who elect to receive payment after Jan 1 , 2018 get the award **and any dividend equivalents in cash on the first business day of April following the one‑year anniversary of the grant**【page_100】.  \nHoneywell’s RSU awards vest over a three‑to‑six‑year period and are **paid in common stock upon vesting, with no dividend equivalents mentioned**【page_93】. Thus, Lockheed Martin’s RSU awards include dividend equivalents as part of the award payment, whereas Honeywell’s RSU awards do not.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key differences in dividend equivalent treatment between Lockheed Martin and Honeywell. (1) It correctly states that Lockheed Martin pays dividend equivalents in cash on the first business day of April following the one-year anniversary of the grant for directors who elected post-2018 payment, aligning with the ground truth's description of a delayed payment structure tied to director tenure. (2) It accurately notes that Honeywell’s RSUs vest over three to six years and are paid in stock upon vesting, with no mention of dividend equivalents—consistent with the original answer stating Honeywell does not specify delayed payments or emphasize dividend equivalents. (3) The LLM correctly contrasts Lockheed Martin's inclusion of dividend equivalents as part of the award with Honeywell's lack of such disclosure. However, it omits a key qualitative distinction mentioned in the ground truth: Lockheed Martin’s DMICP credits dividend equivalents as stock units at dividend payment times, which reflects a broader plan feature beyond just director awards. Additionally, the ground truth highlights Honeywell’s performance-based vesting tied to company goals, which the LLM does not mention. While the core facts and multi-hop comparison are sound, these omissions slightly reduce completeness and qualitative depth. (4) All referenced dates and timeframes are accurate; no numerical errors exist. Wording differs but maintains semantic equivalence on the main points. Thus, the answer earns high marks for quantitative accuracy and contextual relevance, with a minor deduction in qualitative accuracy due to incomplete synthesis of plan-level features.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 462,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments relies on subcontractors for roughly 40 % of its assembly‑and‑test services (page 9), a sizable external‑capacity dependency. NVIDIA likewise depends on third‑party fabs (TSMC, Samsung, etc.) for the bulk of its chip production, exposing it to the same kinds of capacity, quality and supply‑chain risks that AMD’s 10‑K highlights—limited supplier base, potential yield or delivery delays, and the risk of a single supplier prioritizing competitors (page 24). Both companies therefore face comparable external‑production vulnerabilities, as underscored by AMD’s experience with third‑party suppliers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly stated, matching the original answer. No other numerical values are present, and the reference to page 9 (for TXN) and page 24 (for AMD) supports factual grounding. (2) The answer correctly identifies NVIDIA’s reliance on third-party fabs like TSMC and Samsung, which is consistent with the ground truth’s assertion of NVDA’s dependence on external manufacturers for fabrication, assembly, and testing. (3) The multi-hop reasoning is sound: it connects TXN’s 40% external dependency to NVDA’s similar exposure, then references AMD’s experience (e.g., supplier prioritization, delivery delays) to underscore shared risks—this synthesis across three companies (TXN, NVDA, AMD) is logically coherent and contextually appropriate. (4) The only minor shortcoming is that the LLM answer does not explicitly note that NVDA’s exposure is 'amplified by the complexity of its products and global supply chain dependencies,' a nuance present in the original answer. While the risks are correctly identified, this subtle but important distinction in degree of exposure is omitted, slightly reducing qualitative completeness. However, the core facts, entities, and reasoning are correct, and the answer fully addresses the comparative aspect of the question. Wording differences are acceptable and do not affect semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 406,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "The Clean Energy Connection program for 10 new solar facilities is estimated to cost about **$1 billion** over the next three years【page_153】.  Southern Power accounts similar solar (and wind) PPAs as **operating leases with terms up to 25 years**【page_268】, so Duke Energy Florida’s investment follows the same long‑term lease structure and accounting treatment used for renewable projects.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities over three years, matching the ground truth in both amount and time frame. It also accurately states that Southern Power accounts for PPAs as operating leases with terms up to 25 years, which aligns with the original answer. (2) Quantitative accuracy is perfect: the dollar amount ($1 billion) and lease term (up to 25 years) are correct, with no calculation errors. (3) However, the reasoning contains a significant error: the LLM claims that Duke Energy Florida’s investment 'follows the same long-term lease structure and accounting treatment' as Southern Power, which is incorrect. The ground truth clarifies that Duke is making direct investments included in base rates, while Southern Power uses PPAs as operating leases—these are different financial and operational models. The LLM incorrectly equates the two approaches, failing to recognize the distinction between direct ownership and third-party PPA arrangements. This misrepresents the multi-hop synthesis required. (4) Despite this key qualitative flaw, the answer includes relevant context and correct facts, earning high marks for quantitative accuracy and contextual relevance. The correctness score is reduced due to the erroneous conclusion about structural and accounting equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 382,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock is fully voting—each share carries one vote【page_60】—whereas Alphabet’s Class C capital stock has no voting rights【page_82】. Because buying back non‑voting shares does not dilute voting power, Alphabet’s board has concentrated the bulk of its $62.0 billion 2024 repurchase on Class C shares (306 million shares, $50.2 billion) and only a smaller portion on voting Class A shares (73 million shares, $11.9 billion)【page_82】. This split preserves control in the voting Class A shares while still delivering value to all shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights structures of Netflix and Alphabet, stating that Netflix’s common stock has one vote per share and Alphabet’s Class C stock has no voting rights, which aligns with the ground truth. It accurately notes that Alphabet repurchased $62.0 billion in shares in 2024, split between Class C ($50.2 billion for 306 million shares) and Class A ($11.9 billion for 73 million shares), matching the total and individual amounts. These figures sum correctly: $50.2B + $11.9B = $62.1B (minor $0.1B discrepancy likely due to rounding, acceptable under format variation). (2) Quantitative accuracy is high—dollar amounts and share counts are precise and consistent with the implied strategy. The breakdown by share class is explicitly supported and enhances the answer beyond the original. (3) The reasoning correctly infers that repurchasing non-voting Class C shares allows Alphabet to return capital without diluting control, preserving voting power among Class A and especially Class B shareholders. This multi-hop synthesis—linking share class voting rights to repurchase allocation strategy—is logically sound and well-articulated. (4) The only reason for not scoring a 10 is that the original answer emphasizes the broader strategic rationale (liquidity, cost efficiency, governance preservation) slightly more holistically, while the LLM focuses narrowly on control dilution. However, the core insight is preserved, and the added quantitative detail improves factual grounding. All entities (Netflix, Alphabet, Class A/C shares, 2024 repurchase) are correct. Semantic equivalence is strong, with enhanced precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 458,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "In BAC’s 2023 filing, holders of Series B and C preferred stock gain voting rights only when dividends are in arrears for three or more semi‑annual (or six or more quarterly) periods; at that point they may vote for the election of two additional directors, giving them a direct governance role when the company is under financial stress. By contrast, V’s Class C common stockholders always have only limited voting rights—only on a few defined matters such as exiting the core payments business, mergers or specific certificate amendments—and they never receive extra voting power during distress. Thus, BAC’s preferred holders can actively shape the board during a crisis, whereas V’s Class C holders remain largely passive in corporate governance regardless of financial conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors if dividends are in arrears for three or more semi-annual (or six or more quarterly) periods, and these rights terminate after two consecutive semi-annual (or four quarterly) periods of payment. This is correctly stated. V's Class C common stockholders have limited voting rights only on specific matters like exiting the core payments business or certain restructurings, which is also accurately reflected. (2) Quantitative elements—'three or more semi-annual', 'six or more quarterly', 'two additional directors'—are all factually correct and match the original. No calculations are required, but the conditions are precisely described. (3) The multi-hop reasoning is sound: the model correctly contrasts BAC’s performance-contingent voting rights (triggered by financial stress) with V’s structural limitations that do not change during distress. (4) The only minor shortcoming is that the LLM does not explicitly mention that V’s Class C voting rights do not extend to amendments affecting only preferred stock, a nuance present in the ground truth. However, this omission does not distort the overall meaning. Wording differs slightly (e.g., 'mergers' added as an example not in original), but remains semantically consistent. The answer is contextually excellent, directly addressing corporate governance differences during financial stress.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 420,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing revenue from Star Wars‑branded merchandise—one of its most significant licensed properties (page 22)—provides a steady cash flow that can be allocated to content development for Disney+ (page 13). This funding helps Disney maintain a competitive edge in European markets where it competes with CMCSA’s Sky Glass and XClass TV platforms (page 17).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core claims and aligns well with the ground truth. It correctly identifies that Disney's Star Wars merchandise licensing revenue provides funding for Disney+ content development (semantic match to 'steady cash flow' and 'funding content development'), which is relevant to competing in European markets against CMCSA's Sky Glass and XClass TV. There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default. The answer is contextually relevant and addresses the main causal chain: licensing revenue → content funding → competitive positioning in Europe. However, it omits a key element from the original answer: the role of Star Wars programming as a core content tile on Disney+ that drives subscriber acquisition in competitive European regions. Additionally, it does not mention CMCSA’s integrated hardware and content strategy (via broadband-aligned platforms), which is a critical part of the competitive dynamic. While the multi-hop reasoning (Disney licensing → Disney+ funding → competition with CMCSA in Europe) is sound and entities are accurate (Disney, CMCSA, Sky Glass, XClass TV), the explanation lacks depth in synthesizing the full strategic contrast present in the original. Thus, while correct in substance, it is slightly less complete in qualitative detail, warranting a strong but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 389,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "AXP’s sensitivity analysis shows that a 200‑basis‑point rise in rates would cut net interest income by roughly $560 million, a figure that assumes assets and liabilities reprice in line with the rate change but is moderated by any caps or floors that may be in place (page 81). Morgan Stanley, in contrast, routinely attaches interest‑rate caps to the SPEs in its securitization deals to cap the upside or downside of rate movements on the underlying assets, thereby reducing repricing risk (page 128). Both firms therefore treat repricing risk as a core exposure, but MS actively uses caps as a hedging tool in securitization, whereas AXP’s analysis simply quantifies the potential impact under a hypothetical cap‑free scenario.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$560 million—that is not present in the original answer (ground truth). The ground truth does not provide any numerical estimate of the impact on AXP's net interest income, only a qualitative description of the sensitivity and the role of caps/floors in repricing risk. This is a significant factual inaccuracy. There is no mention of page numbers (e.g., page 81, 128) in the original answer, suggesting the LLM may be fabricating source references. (2) Quantitatively, the $560 million figure cannot be verified against the ground truth and appears to be hallucinated. No calculation or data point in the original supports this number. The 200 basis point increase is correctly referenced, but the monetary impact is not. (3) Qualitatively, the reasoning is mostly sound: the LLM correctly identifies that AXP assesses interest rate sensitivity with consideration of caps/floors in repricing assumptions, and that MS uses interest rate caps in securitization transactions involving SPEs to manage repricing risk. The synthesis across both firms and the comparison of their use of derivatives in managing interest rate exposure is logically coherent and aligns with the ground truth. The distinction in business context—AXP’s core net interest income vs. MS’s structured finance activities—is appropriately noted. (4) Contextual relevance is high, as the response directly addresses the relationship between AXP’s sensitivity to rate changes and MS’s use of caps, linking both to repricing risk. However, the hallucinated number and false precision undermine the correctness. The original answer emphasizes that both firms face similar repricing dynamics and use caps as part of risk management, but the LLM incorrectly implies AXP operates in a 'cap-free scenario,' which contradicts the ground truth stating AXP’s assumptions *include* caps or floors. This misrepresentation further reduces accuracy. Overall, the answer gets the conceptual framework right but fails on key factual details, especially the unsupported $560M figure and incorrect characterization of AXP’s modeling assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 578,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDLZ says a weaker U.S. dollar “benefits our consolidated earnings and net assets” (see page 65).  By contrast, Coca‑Cola reports that a weaker dollar versus the euro and British pound only partially offsets an 11 % negative impact on its consolidated operating income, with the favorable effect confined to the Europe, Middle East & Africa segment (see page 51).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces a significant error not present in the ground truth. While it correctly states that MDLZ benefits from a weaker U.S. dollar (citing page 65), and that Coca-Cola experienced favorable currency effects in the Europe, Middle East and Africa segment due to the euro and British pound, it incorrectly claims that this favorable effect was 'only partial' and offset by an '11% negative impact on consolidated operating income'—a detail absent from the original answer and not supported by the provided context. The ground truth emphasizes a direct parallel between MDLZ and KO regarding exposure to the euro and British pound, whereas the LLM frames Coca-Cola's impact as net negative, which contradicts the original statement of 'favorable impact.' This misrepresents the comparative analysis requested. Entity accuracy (MDLZ, KO, currencies, segments) is correct, and the citations suggest proper source grounding. However, the reasoning fails on the multi-hop synthesis: instead of aligning the two companies' similar FX exposures, it incorrectly implies divergence. Quantitative accuracy is acceptable (no incorrect numbers cited, though the 11% figure appears unsupported), but the qualitative reasoning is flawed. Contextual relevance is high as the response addresses currency impacts on both firms with appropriate segmentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 384,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s dual‑class structure has only 7 Class B shares versus 907 Class A shares (page 68). Even if each Class B share carried the same 15‑vote weighting as Verizon’s, the Class B holders would command roughly 10 % of the total voting power, versus Verizon’s 33 % concentration from its Class B shares (page 31). Thus, Mastercard’s voting‑power concentration is markedly lower than Verizon’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies MA's share structure (7 Class B, 907 Class A) and notes the 15-vote weighting per Class B share, aligning with the ground truth. However, it incorrectly states that Verizon's Class B shares hold 33% voting power, while the original answer calculates 68.5% for V under the same 15-vote assumption. This is a major quantitative error. Additionally, the LLM refers to 'Verizon' as V, but the original answer does not identify V as Verizon—this is an unsupported entity assumption. (2) The calculation for MA is approximately correct: 7 Class B shares × 15 votes = 105 votes; 907 Class A shares × 1 vote = 907; total votes = 1,012; Class B share of votes = 105 / 1,012 ≈ 10.4%, which the LLM rounds to 'roughly 10%'—acceptable. But for V, the LLM claims 33% voting power for Class B, whereas correct math is: 125 Class B × 15 = 1,875 votes; 1,733 Class A × 1 = 1,733; total = 3,608; 1,875 / 3,608 ≈ 51.9%, not 33% or 68.5%. Wait—original answer says 68.5%, which appears miscalculated. Recalculation: 125 / (125 + 1,733) = 125 / 1,858 ≈ 6.7% of shares; voting power: (125 × 15) / [(125 × 15) + (1,733 × 1)] = 1,875 / (1,875 + 1,733) = 1,875 / 3,608 ≈ 51.96%. So original answer’s 68.5% is itself incorrect. However, the LLM’s 33% is even more off and lacks clear derivation. Thus, both answers have issues, but LLM introduces a worse error. (3) Multi-hop reasoning is partially sound: LLM compares voting concentration between MA and V using share counts and assumed vote weightings, but fails to use correct data for V and misidentifies V as Verizon without evidence. (4) Correctness score is 4 due to major error in V's voting percentage and unsupported entity identification, despite correct handling of MA data. Quantitative accuracy is low due to incorrect calculation for V. Qualitative accuracy is moderate—reasoning structure is valid but based on flawed data. Contextual relevance is high as the response directly addresses the comparison question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 538,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "NEE’s 10‑K (page 31) warns that the cost of decommissioning its nuclear units could exceed the amount available in its decommissioning funds. Southern Company’s 10‑K (page 27) states that decommissioning costs could exceed the amount of its decommissioning trusts or external insurance coverage. Both companies face similar exposure under the Price‑Anderson Act, but the specific reserves differ—NEE relies on its decommissioning funds, while Southern Company relies on trusts and insurance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies that both NEE (and its subsidiary FPL) and Southern Company (through Alabama Power and Georgia Power) face financial risks if decommissioning costs exceed available reserves. The LLM accurately notes that NEE relies on decommissioning funds while Southern Company relies on trusts and insurance, which matches the original answer's emphasis on differing reserve structures. (2) There are no numeric values in the question or answers that require calculation or verification—both responses refer to qualitative risk disclosures from 10-Ks, and the LLM correctly cites page numbers (31 for NEE, 27 for Southern Company), which supports traceability. (3) The multi-hop reasoning is sound: the model synthesizes risk exposure across two companies, identifies the commonality in risk (costs exceeding reserves), and notes structural differences in funding mechanisms. The mention of the Price-Anderson Act adds context not in the original answer but is factually relevant and does not detract. (4) The LLM omits explicit mention of 'material financial impact' and the subsidiaries Alabama Power and Georgia Power, slightly reducing completeness, but the core entities and risks are correctly conveyed. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slight omission of nuance around materiality and subsidiary specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 402,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS values its pension‑plan real‑estate holdings at $9.9 billion using a net‑asset‑value (NAV) practical expedient—calculating NAV from audited/unaudited fund reports and adjusting for interim activity. General Dynamics, by contrast, classifies its private‑equity and real‑estate investments as Level 3 assets and values them with internal models that rely on unobservable inputs (discount rates, projected cash flows, etc.). Thus, while both firms use valuation models for similar asset classes, UPS relies on a simpler NAV approach, whereas GD applies more complex Level 3 models requiring additional assumptions and discounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $9.9 billion valuation of UPS's pension plan investments in real estate funds and accurately describes UPS's use of the net asset value (NAV) practical expedient based on audited and unaudited fund reports, with adjustments for interim activity. It also correctly characterizes General Dynamics' approach of using internal models with unobservable inputs (e.g., discount rates, cash flow projections) for its Level 3 private equity and real estate investments. The core factual content matches the ground truth. (2) Quantitatively, the $9.9 billion figure is accurate and properly attributed to UPS; no other numerical values are in dispute. Format is consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and General Dynamics), two types of investments (real estate funds vs. private equity), and two valuation methodologies (NAV as practical expedient vs. Level 3 unobservable inputs). The comparison highlights both the similarity (reliance on models) and the key difference (NAV-based reporting vs. internal modeling), which aligns with the original answer. (4) The only minor shortcoming is that the LLM slightly generalizes by stating GD values 'private-equity and real-estate investments' as Level 3, while the ground truth specifies 'direct private equity investments'—a nuance that could imply a broader asset scope than confirmed. Additionally, the original emphasizes that real estate funds themselves use valuation models and appraisals, which the LLM does not explicitly restate, though it's implied. These are minor omissions that do not undermine the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with slight room for added precision in asset classification and model provenance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 503,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "PepsiCo’s AMESA division—Africa and the Middle East—contributes about 30 % of its beverage revenue (page 73).  A supply disruption in that region would reduce the availability of PepsiCo beverage SKUs at Target, cutting sales volume and thus lowering inventory‑turnover for those items.  Because Target only pays vendors after the merchandise is sold (page 49), the cash outflow for those SKUs would be postponed until a sale occurs; with fewer sales, the timing of cash outflows would be delayed and reduced, while cash inflows from sales would also be postponed, shifting Target’s cash‑flow profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa and Middle East region is correctly cited, and no other numerical values require verification. The reference to page 73 for PepsiCo's AMESA revenue contribution and page 49 for Target's vendor payment terms suggests accurate grounding, though page numbers are not part of the ground truth evaluation. (2) The reasoning correctly traces the supply disruption impact: reduced product availability → lower sales → reduced inventory turnover. It also accurately describes the cash flow implications: delayed and reduced cash outflows (due to pay-after-sale model) and postponed cash inflows. (3) Multi-hop synthesis is sound—linking PepsiCo’s regional revenue exposure to Target’s inventory and cash flow dynamics via supply chain and vendor terms. (4) The only minor shortcoming is a slight conflation in cash flow description: while it correctly notes delayed outflows and inflows, the ground truth emphasizes that reduced sales lower cash flow *generation* (inflows), whereas the LLM focuses on the shift in timing. This nuance does not undermine correctness but slightly affects qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 367,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Amgen has cut Repatha’s net price, added larger rebates and discounts, and lowered its list price via new NDCs while also entering risk‑sharing agreements to keep the drug on formularies (see pages 17, 41, 39, 40, 42, 43).  Lilly, by contrast, has focused on patient‑assistance programs and rebate negotiations to keep its insulin products affordable and accessible, though the specific actions are not detailed in the pages provided.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but lacks key differentiating details present in the ground truth, resulting in a moderate correctness score. (1) What was correct: The LLM correctly identifies that Amgen reduced Repatha's price through net price cuts, rebates, discounts, and new NDCs, and mentions risk-sharing agreements (aligned with ground truth on payer partnerships and price reductions). It also correctly contrasts this with Lilly’s focus on affordability programs for insulin. (2) Quantitative accuracy: There are no explicit numbers (e.g., percentages, dollar amounts, years) in either the LLM or original answer, so no numeric inaccuracies exist—score is high. (3) Multi-hop reasoning assessment: The model attempts to compare LLY and AMGN responses to payer pressures, which is correct in structure, but fails to mention critical distinctions—specifically, AMGN’s 2019 discontinuation of higher-priced NDCs and direct payer alignment on health outcomes, and LLY’s emphasis on regulatory and legislative uncertainty (e.g., Alzheimer’s Monoclonal Antibody NCD) as a strategic response. These omissions weaken the qualitative accuracy. (4) Justification: While the LLM captures the general direction of each company's strategy, it omits material elements of both firms’ approaches, particularly AMGN’s structural pricing changes and LLY’s focus on systemic/legislative challenges. The answer relies on vague phrasing like 'specific actions are not detailed,' which undermines completeness. Thus, the correctness and qualitative accuracy scores are moderate, though contextual relevance remains high as the response stays focused on the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 450,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both banks keep their buffers above the regulatory minimums while the countercyclical capital buffer (CCyB) is zero.  \nBAC, as an advanced‑approach institution, applies a 2.5 % capital‑conservation buffer and a 5.4 % stress‑capital buffer (2023) to satisfy a 5.5 % capital‑buffer requirement, whereas Schwab’s CSC and CSB each maintain a 2.5 % stress or capital‑conservation buffer to meet a similar 5.5 % requirement. BAC’s higher stress buffer makes its approach more conservative, but both banks meet the required buffers under the current framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, not a 5.4% stress-capital buffer or a 2.5% capital-conservation buffer. The claim that BAC satisfies a 5.5% capital-buffer requirement is unsupported and incorrect. Similarly, SCHW’s subsidiary CSB maintains a Capital Conservation Buffer of 2.5%, but there is no mention of CSC or CSB maintaining a stress buffer of 2.5%, nor is there evidence they meet a 5.5% requirement. The ground truth highlights that SCHW structures capital around minimum ratios (7.0%, 8.5%, 10.5%) inclusive of buffers, which the LLM omits entirely. (2) Quantitative accuracy is low: the 5.4% and 5.5% figures are fabricated or misattributed; the correct buffers are 2.5% for both institutions, but for different types (Stress Capital Buffer for BAC, Capital Conservation Buffer for SCHW). The G-SIB surcharge of 2.5% for BAC is completely omitted. (3) Multi-hop reasoning is partially present—both banks are assessed under the same regulatory context (CCyB at zero)—but the synthesis is flawed. The LLM incorrectly frames both as meeting a 5.5% requirement and mischaracterizes BAC as an 'advanced-approach' institution applying a stress-capital buffer, when the ground truth specifies BAC uses the Standardized approach. The distinction in capital strategies—BAC’s G-SIB surcharge vs. SCHW’s minimum ratio framework—is entirely missed. (4) Contextual relevance is high because the answer addresses the core question about buffer approaches under zero CCyB, but correctness and qualitative accuracy are undermined by significant factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 472,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar projects are financed through tax‑equity partnerships that capture federal ITCs and PTCs, with the company expecting to fully utilize its roughly $2 billion of un‑used credits by 2024 as the ITC rate falls from 26 % (2020‑22) to 10 % (2024+).  Duke Energy, by contrast, structures its renewable assets as VIEs backed by debt guarantees and tax‑equity arrangements, using PPAs as a key revenue‑generation tool; the filing focuses on the VIE/debt‑financing framework and does not disclose a specific tax‑credit utilization horizon.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states Southern Company had approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, but the LLM incorrectly reports this as $2 billion. Additionally, the LLM introduces specific ITC rate changes (26% to 10%) and ties them to years (2020–22 and 2024+), which are not mentioned in the original answer and thus represent unsupported additions. (2) The original answer does not provide any information about ITC phase-down rates or Duke Energy’s debt guarantees, nor does it state that Duke lacks a disclosed tax-credit utilization horizon—this is an inference not directly supported by the source. The absence of such a disclosure in the original does not imply it doesn’t exist; thus, this comparative point is misleading. (3) On qualitative reasoning, the LLM correctly identifies that both companies use tax equity arrangements and PPAs, and that Southern uses partnerships where tax benefits are captured by partners, while Duke uses VIEs with control over operations. This reflects partial multi-hop synthesis, but the emphasis on debt guarantees and financing structure for Duke goes beyond the original, which focused on Duke being the primary beneficiary due to control—not debt backing. (4) Contextual relevance is high because the response addresses both companies’ PPA and tax credit strategies as asked. However, due to incorrect dollar figures and fabricated tax credit rate timelines, the quantitative accuracy is low. The core idea of contrasting Southern’s credit utilization timeline with Duke’s lack of disclosed timeline is partially valid, but the numbers and supporting details are not factually aligned with the ground truth, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 500,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s Class B shares automatically convert to Class A shares upon sale or transfer, which gradually reduces the concentration of the 10‑vote‑per‑share Class B holders (page 81).  Comcast, by contrast, keeps its Class B shares non‑dilutable, guaranteeing 33 ⅓ % of voting power and 15 votes per share regardless of new issuances (page 91).  Because Meta’s dual‑class structure gives its founder a majority of the high‑voting Class B shares with no automatic conversion, investors may view Meta’s governance as a more extreme concentration of power than Google’s mitigating conversion or Comcast’s protected but still concentrated model, potentially dampening sentiment toward Meta.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares convert to Class A upon transfer (reducing voting power concentration), Comcast's Class B shares are non-dilutable with 33 1/3% voting power and 15 votes per share, and Meta’s structure lacks automatic conversion, preserving founder control. These details match the original answer in substance. (2) Quantitative accuracy is perfect: the 33 1/3% voting power and implied 15:1 vote ratio at Comcast are correctly represented; no incorrect numbers or calculations appear. (3) Multi-hop reasoning is sound—LLM synthesizes governance models across Google, Comcast, and Meta to assess investor sentiment, concluding that Meta’s model may appear more extreme due to persistent control without mitigating mechanisms like Google’s conversion. This reflects the original answer’s logic. (4) The only minor shortcoming is a slight lack of explicit mention that Meta’s structure could make Class A shares less attractive—though this is implied in 'potentially dampening sentiment.' Wording differs slightly but meaning is semantically equivalent. No entity errors; all companies and structures correctly identified. Contextual relevance is excellent as it directly addresses investor sentiment toward Meta in light of comparative structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 376,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "Cordavis’s launch is expected to increase the volume of lower‑cost biosimilars available to UnitedHealth’s PBM clients. Because UnitedHealth accrues rebates on a monthly basis “based on the terms of the applicable contracts, historical data and current estimates” (page 50), a shift away from brand‑name biologics would reduce the rebates earned from those manufacturers and, if biosimilars are covered, would generate rebates only when the biosimilar is dispensed and the contract’s rebate trigger is met. Consequently, the overall $12.5 billion of rebates receivable could shrink, and the timing of revenue recognition would shift to align with the new utilization mix—potentially accelerating accruals for biosimilar rebates or delaying them if contract terms for biosimilars differ from those for brand‑name drugs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.5 billion rebates receivable figure is correctly cited and matches the original answer's reference to December 31, 2024. No calculations were required, but the use of the exact dollar amount and correct context (rebates receivable) is precise. Format variation ($12.5 billion vs $12.5B) is acceptable. (2) The LLM correctly identifies CVS's Cordavis initiative increasing biosimilar availability and links it to UnitedHealth’s PBM operations, demonstrating proper entity accuracy (CVS, UNH, Cordavis) and contextual understanding. (3) Reasoning is sound: the answer explains that rebates are accrued monthly based on utilization, contract terms, and estimates—citing a specific page (50) adds credibility—and logically infers that a shift from branded biologics to lower-cost biosimilars would reduce rebate inflows, as manufacturers typically offer lower rebates on lower-priced drugs. It also correctly addresses the potential impact on revenue recognition timing, noting possible acceleration or delay depending on biosimilar-specific contract terms. (4) The only minor shortcoming is a slightly narrower discussion of 'contract terms' compared to the original answer’s emphasis on how rebate structures themselves might change due to pricing dynamics; the LLM focuses more on timing than on structural negotiation shifts. However, this does not detract significantly from the overall correctness. Semantic equivalence is strong, with flexible but accurate rewording. All parts of the multi-hop question are addressed: Cordavis → increased biosimilar use → impact on UNH’s rebates (amount and timing) via utilization and contracts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 470,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Regulation Best Interest forces Goldman Sachs’ broker‑dealer arm to implement new policies, training and reporting systems, which the firm notes could raise operating costs and expose it to additional litigation risk (see GS 10‑K, pp. 20‑21).  Because Goldman has already positioned itself as a consumer‑protection‑focused firm and is expanding its retail wealth‑management business, the higher compliance spend may be offset by a stronger reputation that attracts more retail clients—an advantage over Morgan Stanley, whose 10‑K (pp. 21‑25) does not emphasize Reg BI and whose retail expansion strategy is less aggressive, potentially keeping its compliance costs lower but its competitive edge in the growing retail market weaker.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, so quantitative accuracy is not applicable—no numbers to verify or miscalculate, hence a score of 10 by default. However, the qualitative accuracy is lower due to significant reasoning errors. The LLM claims Goldman Sachs has 'positioned itself as a consumer-protection-focused firm' and that this gives it a reputational advantage over Morgan Stanley, which is not supported by the ground truth. The original answer states that Goldman faces higher compliance costs because it is expanding into retail services and thus incurring incremental costs under Regulation Best Interest, while Morgan Stanley has a more established retail infrastructure and may adapt more efficiently. The LLM flips this logic, suggesting Goldman gains a competitive edge through reputation, which contradicts the original comparative analysis. (2) There are no calculations or numeric claims to assess, so quantitative accuracy is unaffected. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that Regulation Best Interest increases compliance costs and litigation risk for Goldman Sachs (supported by GS 10-K references), it misinterprets the competitive dynamics. The ground truth emphasizes Morgan Stanley’s competitive advantage due to its established retail operations, whereas the LLM incorrectly asserts that Morgan Stanley’s less aggressive retail strategy weakens its competitive edge—a reversal of the original conclusion. (4) Contextual relevance is high because the answer addresses compliance costs, litigation risk, and competition between the two firms, using appropriate sources. However, the incorrect synthesis of competitive positioning significantly undermines factual correctness, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 491,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s structure concentrates a large voting block in a single holder: the one Class B share (15 votes each) represents 33 ⅓ % of the company’s voting power, while the remaining 66 ⅔ % is held by the public Class A shareholders. Alphabet’s Class B shares are also held by a small insider group, but each share only carries 10 votes, so the concentrated block is smaller relative to the total voting power. Thus, CMCSA’s voting‑power concentration is higher than Alphabet’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: CMCSA's Class B shares carry 15 votes per share and control 33 1/3% of voting power, while Class A holds 66 2/3%, and GOOGL's Class B shares carry 10 votes per share. These numbers match the ground truth exactly, earning high marks for quantitative accuracy. The answer also correctly contrasts the two companies' dual-class structures and notes that CMCSA has higher voting concentration. However, it makes an unsupported claim that Alphabet's (GOOGL's) concentrated block is 'smaller relative to total voting power'—this cannot be confirmed from the evidence, as the original answer states that GOOGL's voting power distribution is not explicitly quantified. This introduces a logical overreach, reducing qualitative accuracy. Additionally, the LLM omits the important distinction that GOOGL’s Class B shares are convertible to Class A upon sale or transfer (a mechanism that may dilute control), while CMCSA’s are non-dilutable—a key differentiator in assessing concentrated control over time. While the core comparison is directionally reasonable, the reasoning lacks full completeness and introduces an unverified inference, preventing a higher score. Contextual relevance is strong as the response directly addresses the question’s focus on voting power concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 370,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "PM’s cigarette volume growth in Turkey was partially offset by a rise in illicit‑trade prevalence, eroding market share (PM page 56).  In contrast, Procter & Gamble’s operations in Turkey are affected by foreign‑exchange volatility that has produced unfavorable currency impacts on net sales and earnings (PG page 23).  Together, these facts show that both firms face dual operational risks in the same market—PM battling demand erosion from illicit trade, while PG contends with financial risk from currency swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: PM's cigarette volume growth in Turkey was indeed partially offset by increased illicit trade, and PG faces foreign exchange volatility in Turkey. No specific numerical values (e.g., 8.2% market growth) were included in the LLM answer, but none were misstated—this is a minor omission rather than an error. (2) Quantitative accuracy is perfect: no incorrect numbers or calculations were presented. The ground truth includes the 8.2% market growth figure, which the LLM omits, but since the question does not explicitly ask for the growth rate, this is not a critical gap. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes risks across two companies (PM and PG) in the same market (Turkey), distinguishing PM’s operational/illicit trade risk from PG’s financial/fx risk. The conclusion about dual operational risks is logically supported. (4) Semantic equivalence is strong: while the LLM uses slightly more concise language (e.g., 'demand erosion' vs. 'reducing legitimate sales volume'), the meaning aligns with the original. The only minor shortcoming is the lack of detail on the nature of PG’s exposure (transaction vs. translation risk), but the key point—currency swings affecting sales and earnings—is preserved. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 399,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan’s climate‑risk function, embedded in its firm‑wide Climate Risk Framework, actively identifies transition‑risk drivers (policy, technology, consumer shifts) and quantifies them through metrics, scenario analysis, stress testing and a dedicated Climate Risk Committee that integrates the risk into all existing risk‑management processes.  Bank of America, by contrast, treats climate commitments as a source of reputational exposure, with governance oversight from the ERC and FLU committees and mitigation procedures that focus on communication and remediation; its $1.5 trillion sustainable‑finance goal creates a reputational risk if the target is not achieved, rather than a formal transition‑risk measurement program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan uses its Firmwide Climate Risk Framework to identify and manage transition risk through metrics, scenario analysis, stress testing, and governance (Climate Risk Committee), while Bank of America emphasizes reputational risk linked to its $1.5 trillion sustainable finance goal. The dollar amount ($1.5 trillion) is correctly stated, and no other numerical values are misreported. (2) Quantitative accuracy is perfect—$1.5 trillion is accurately cited, and there are no calculations required beyond correct reference. (3) The multi-hop reasoning is sound: the model correctly contrasts JPMorgan’s proactive, structured risk identification and integration into risk management with BAC’s focus on reputational exposure from unmet public commitments. It appropriately identifies governance structures (ERC and FLU committees) for BAC, which adds depth beyond the original answer. (4) The LLM answer conveys the same core comparison as the ground truth, with slightly more detail on governance and risk drivers. The only minor gap is that the original answer notes $1 trillion of BAC’s $1.5T goal is for low-carbon transition, which the LLM omits—this is a small but relevant detail, preventing a perfect 10. Otherwise, semantic equivalence is strong, reasoning is logical, and all entities (JPM, BAC, climate frameworks, financial goals) are correctly identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 409,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft recognizes revenue for hardware‑software bundles at the point in time when ownership is transferred to the customer, treating the hardware and software license as a single performance obligation. Cisco’s financing of hardware is structured as loan receivables with an average term of one to three years, so the revenue is recorded immediately while the financing cash flows are spread over that period. Cisco’s total credit‑loss allowance for its financing receivables (loan and lease) as of July 29 2023 was **$72 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: Microsoft recognizes revenue for hardware-software bundles at the point of transfer of ownership, treating them as a single performance obligation. Cisco offers loan receivables with average terms of one to three years for hardware financing. Cisco's total credit loss allowance for financing arrangements as of July 29, 2023, is correctly reported as $72 million. (2) Quantitative accuracy is perfect: the dollar amount ($72 million) and date (July 29, 2023) match exactly; format variations (e.g., spacing in 'July 29 2023') do not affect correctness. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across Microsoft's revenue recognition policy and Cisco's financing terms and credit loss allowance, addressing all components of the complex, cross-company question. (4) Wording differs slightly (e.g., 'recorded immediately while the financing cash flows are spread' adds interpretation but does not distort facts), but the core information is accurate and complete. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 335,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "Potential FAA certification delays for Gulfstream’s G700 would postpone the arrival of a newer, more fuel‑efficient aircraft that FedEx could use to replace older, higher‑emission planes.  FedEx’s own 10‑K notes that compliance with CORSIA and the ETS will raise operating expenses “in part because of the fuel efficiency of our fleet” and that ICAO has set a January 1, 2028 production‑cutoff for aircraft that do not meet the new standards (FedEx 10‑K, p. 18).  If the G700’s certification is delayed, FedEx would likely continue operating less efficient aircraft past that cutoff, forcing it to purchase more offsets or allowances under CORSIA and the ETS and thereby increasing its compliance costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2028 ICAO production cutoff date is accurately cited, and the link between FAA certification delays for the G700 and FedEx's fleet modernization is correctly established. (2) Quantitative accuracy is perfect: no numerical errors; the reference to the 2028 cutoff is correct, and there are no miscalculations. (3) Multi-hop reasoning is sound: the model correctly connects Gulfstream’s certification timeline to FedEx’s fleet planning, then to fuel efficiency, and finally to CORSIA/ETS compliance costs. It appropriately cites FedEx’s 10-K regarding the impact of fleet efficiency on compliance expenses. (4) The only minor shortcoming is the lack of explicit mention of the 2026 phaseout of free allowances under ETS, which adds nuance to the cost increase trajectory, and a brief omission of Gulfstream’s inventory ramp-up being tied to certification (a detail in the ground truth). However, the core causal chain and financial implications are correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 342,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "Comcast (CMCSA) and Alphabet (GOOGL) both use the same per‑share voting structure: each Class A share carries one vote, while each Class B share carries ten votes. Thus, the Class A‑to‑Class B voting‑ratio is 1:10 for both companies.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) It falsely claims that CMCSA has a 1:10 voting ratio like GOOGL, but the ground truth states that CMCSA's Class B shares have 15 votes per share and hold 33 1/3% of voting power, while Class A shares have a variable number of votes but collectively hold 66 2/3% of voting power—this is fundamentally different from a fixed 1:10 structure. The answer completely misrepresents CMCSA's voting structure. (2) For GOOGL, the LLM correctly states that Class A has 1 vote and Class B has 10 votes per share, which aligns with the ground truth. However, it omits that ownership percentages are not disclosed, which is a relevant detail. (3) The multi-hop reasoning fails because the model does not recognize that CMCSA’s structure is based on variable vote allocation and fixed collective voting power percentages, unlike GOOGL’s fixed per-share votes. The conclusion that both companies have the same structure is factually wrong. (4) Despite addressing the comparison between CMCSA and GOOGL as asked, the answer is factually flawed in its core claims, hence low scores in correctness, quantitative, and qualitative accuracy. Contextual relevance is moderate because it attempts the right comparison but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 362,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and together represent about 33 % of the company’s combined voting power, giving the sole holder (Brian L. Roberts) a substantial influence【page_33】. Alphabet’s dual‑class scheme gives each Class B share 10 votes, but the shares account for a smaller portion of total voting power (the exact percentage isn’t disclosed here), so holders of Alphabet’s Class B shares have comparatively less influence than Comcast’s Class B holders【page_81】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that CMCSA's Class B shares have 15 votes per share and represent approximately 33% of voting power, with Brian L. Roberts as the sole holder, which matches the ground truth. It also correctly states that GOOGL's Class B shares carry 10 votes per share. However, it fails to mention that CMCSA’s Class B structure provides a fixed minority control (33 1/3%) and does not allow conversion, while GOOGL’s Class B shares can convert to single-vote Class A shares—a key qualitative difference emphasized in the original answer. The LLM notes that GOOGL’s Class B voting power portion is not disclosed, which is a defensible omission but downplays the structural fluidity (conversion feature) that distinguishes GOOGL’s model. (2) Quantitatively, all provided numbers (15 votes, 33%, 10 votes) are accurate and correctly attributed. There are no calculation errors. The approximation of 33% instead of 33 1/3% is acceptable for rounding. (3) The multi-hop reasoning is partially sound—comparing vote-per-share and relative influence across two companies—but misses the deeper synthesis regarding non-dilutability and conversion mechanics, which are central to understanding the difference in influence durability. (4) The correctness score is 7 because core facts are accurate but a significant aspect of the comparison (conversion and its implications) is omitted, reducing completeness. Quantitative accuracy is high (8) due to correct numbers. Qualitative accuracy is 7 due to incomplete reasoning on structural implications. Contextual relevance is 9—response stays on topic and addresses the comparative influence question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 457,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s Zeposia received FDA approval for ulcerative colitis in May 2021 (page 93), a few months before Merck’s Welireg (belzutifan) was approved for von‑Hippel‑Lindau disease in August 2021 (page 101). Zeposia’s approval added a new immunology indication to BMY’s 2021 portfolio, while Welireg’s approval bolstered Merck’s oncology lineup, triggering a $50 million milestone payment and expanding its cancer‑focused product slate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the FDA approval dates for both BMY's Zeposia (May 2021) and MRK's Welireg (August 2021), matching the ground truth. The $50 million milestone payment is accurately reported. All entities—BMY, MRK, Zeposia, Welireg (belzutifan), ulcerative colitis, and von Hippel-Lindau disease—are correctly identified. (2) Quantitatively, all dates and dollar amounts are correct. The sequence of approvals (May before August) is accurately described as 'a few months before,' which is semantically valid. (3) The multi-hop reasoning is sound: the answer compares two regulatory milestones across companies and correctly links each approval to its respective therapeutic area (immunology for BMY, oncology for MRK). It also correctly notes the milestone payment impact for MRK. The only minor omission is that the ground truth mentions the True North trial and HIF-2α inhibitor mechanism for Welireg, which adds scientific context not included in the LLM answer. However, this does not affect the core factual accuracy. (4) The answer is contextually complete and highly relevant, conveying the same key information as the original answer with only slight reduction in detail. The reasoning and synthesis across companies and portfolios are accurate and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 366,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s restricted‑stock awards vest on a cliff schedule tied to service years – restricted stock vests after 3‑10 years of service, while RSUs cliff‑vest after 3 years (page 72). UPS’s multi‑employer pension plans vest according to the collective‑bargaining agreements, with vesting periods that vary by plan but are based on years of service and eligibility (page 110). Because restricted‑stock vesting is an equity incentive with no direct funding risk, whereas multi‑employer pension vesting is part of a defined‑benefit plan whose funding risk is shared among employers and depends on plan assets, the mechanisms and risk profiles differ markedly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: EMR's cliff vesting for restricted stock over 3–10 years and RSUs over 3 years match the original answer’s range (3–10 years), and UPS’s vesting tied to collective bargaining agreements is correctly described. The mention of page references (72, 110) adds sourcing but does not affect factual accuracy. (2) The core financial and structural distinctions—equity-based incentives (restricted stock) vs. defined-benefit pension plans with shared funding risk—are accurately contrasted. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in vesting mechanisms (cliff vs. service-based via union agreements), links them to risk exposure (no funding risk for EMR vs. shared risk and potential withdrawal liability for UPS), and contextualizes the benefit delivery mechanisms. (4) Minor omission: the LLM does not explicitly mention 'withdrawal liability or surcharge contributions if plans enter critical status'—a specific risk highlighted in the original answer—reducing completeness slightly. However, the broader concept of shared funding risk and its implications is conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 394,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "NFLX’s 10‑K does not highlight any privacy exposure under the Communications Act; its data‑privacy risk is framed mainly through GDPR, CPRA and other state or international privacy laws, with potential penalties arising from those statutes rather than from FCC or Communications‑Act provisions【page_11】【page_13】. In contrast, CMCSA’s filing explicitly notes that the Communications Act and FCC rules govern its broadband and cable operations, imposing potential fines for rule violations and operational constraints such as mandatory broadband‑disclosure, privacy‑related reporting, and, if re‑classified, common‑carriage obligations that could affect how it handles personal information【page_15】【page_17】. Thus, while NFLX’s privacy risk is largely outside the Communications Act framework, CMCSA faces direct regulatory obligations under that Act that carry both financial penalties and operational limits on personal‑information handling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that NFLX does not face direct regulatory obligations under the Communications Act, instead facing data privacy risks under GDPR, CPRA, and other state/international laws, with potential financial penalties and no mention of insurance coverage—consistent with the original answer’s point about NFLX lacking insurance. CMCSA is correctly described as being directly subject to the Communications Act and FCC rules, with specific operational constraints (e.g., broadband disclosure, privacy reporting) and potential financial penalties. (2) There are no numeric values to verify, so quantitative accuracy is 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information from both companies’ filings, correctly contrasting NFLX’s indirect exposure with CMCSA’s direct regulatory obligations. The use of page citations adds credibility. (4) The only minor gap is that the LLM answer does not explicitly mention that both companies face regulatory scrutiny under the Act—though it implies this by contrast—nor does it directly state that CMCSA could face audits or changes in law. However, the core factual and conceptual distinctions are accurately captured. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect as it directly addresses financial penalties and operational constraints related to personal information handling under the Communications Act.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 413,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "Philip Morris entered Sweden in January 2022 by launching Platform 5 nicotine pouches—a reformulated Shiro brand acquired from AG Snus—making it a direct product launch that depends on its own nicotine‑pouch line (PM, p. 46; p. 45).  In contrast, Coca‑Cola European Partners (CCEP) acts as a bottler for Coca‑Cola (KO) in Sweden, leveraging an existing bottling and distribution network to supply KO’s beverage portfolio rather than introducing a new product; its market entry strategy is built on long‑standing bottling agreements and product dependence on KO’s ready‑to‑drink drinks (KO, p. 7; p. 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: PM launched Platform 5 in Sweden in January 2022 under the Shiro brand following the acquisition of AG Snus, which matches the original answer. CCEP’s role as a bottler for KO in Sweden, dependent on KO’s concentrates and distribution agreements, is correctly described. (2) Quantitative accuracy is perfect: the date 'January 2022' is correct, and while the original answer mentions that CCEP was one of KO’s top five bottlers representing 41% of global volume in 2021, this specific figure is not included in the LLM answer—however, it is not required for answering the comparative question about market entry strategies and dependencies. No incorrect numbers are presented. (3) Multi-hop reasoning is sound: the model correctly contrasts PM’s direct market entry via product innovation and acquisition with CCEP’s third-party distribution model dependent on KO, synthesizing information across PM and KO entities. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'reformulated Shiro brand' vs. 'launched under the Shiro brand'), but meaning is consistent. The only minor omission is the lack of mention of the 2021 bottler volume statistic, but this does not detract from the core comparison asked. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 397,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "The 8 % drop in UnitedHealth’s Medicare Part D enrollment (3,050 in 2024 versus 3,315 in 2023) shrinks the revenue base for Part D plans.  Under the IRA, federal reinsurance will be cut in the catastrophic phase, shifting those savings to Part D plans and manufacturers, who must offer additional discounts (page 17).  CVS’s Medicare Advantage contracts, which bundle Part D coverage, therefore face higher cost‑per‑member and tighter reimbursement margins, amplifying its exposure to cost‑inflation and regulatory risk (page 41/42).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it states UNH's Medicare Part D enrollment dropped from 3,315 in 2023 to 3,050 in 2024, but the ground truth reports enrollment in millions—3,315,000 and 3,050,000 respectively. This error reduces the 8% decline from over 3 million members to just over 3 thousand, which is off by a factor of 1,000 and fundamentally misrepresents the scale. This undermines the financial implications drawn. 2) Despite this, the qualitative reasoning partially aligns with the original answer: it correctly identifies the IRA’s reduction in federal reinsurance in the catastrophic phase and the resulting shift of financial responsibility to Part D plans and manufacturers. It also correctly links this to increased cost-per-member and margin pressure for CVS under its Medicare Advantage contracts, which bundle Part D. 3) The multi-hop reasoning is partially sound—connecting UNH’s enrollment trend (as a market signal), IRA policy changes, and CVS’s exposure via bundled Medicare Advantage plans—but misses key elements from the ground truth, such as the role of manufacturer discounts (e.g., Amgen’s rebate accruals) and how enrollment declines may reflect broader market adjustments under the IRA. 4) The answer cites 'page 17', 'page 41/42', which are not part of the provided context and appear fabricated, reducing credibility. While the direction of reasoning is relevant and captures some causal链条, the severe numerical inaccuracy in enrollment figures—central to the question—drags down correctness and quantitative accuracy. Contextual relevance remains high because the answer addresses the core issue of CVS’s financial exposure under Medicare contracts in light of policy and enrollment changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 476,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas utilities can recover environmental‑remediation costs through state PSC‑approved cost‑recovery mechanisms and regulatory riders (page 22), allowing those expenses to be passed to customers via rate adjustments. In contrast, Duke Energy records environmental‑remediation liabilities as reserves of $73 million (plus subsidiary amounts) on its balance sheet (page 163) and may not recover all cleanup costs, relying on insurance and joint‑liability arrangements; its broader federal, state and local liability framework requires it to recognize these costs as probable and estimable rather than recoverable through rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $73 million reserve figure for Duke Energy is correctly stated (assuming this matches the actual filing referenced; the original answer uses a placeholder $X million, so the LLM’s specific number is treated as correct if sourced from the document). The mention of 'plus subsidiary amounts' slightly qualifies the number appropriately, reflecting potential incompleteness. (2) The LLM correctly identifies Southern Company’s use of state PSC-approved cost recovery mechanisms and regulatory riders to pass environmental remediation costs to customers, citing page 22, which matches the ground truth’s emphasis on regulated cost recovery. (3) For Duke Energy, the answer accurately notes that liabilities are recorded as reserves and are not assured for recovery through rates, highlighting reliance on insurance and joint-liability arrangements—this captures the core contrast in financial exposure due to differing regulatory frameworks. (4) The reasoning is sound: the LLM synthesizes information across two companies, correctly contrasting Southern’s cost recovery (revenue-aligned) with Duke’s expense-bearing model (financial exposure). Minor deduction in quantitative accuracy only because the original answer uses a placeholder ($X million), so the specificity of $73M cannot be fully verified against ground truth, though it likely reflects accurate sourcing. No errors in entities, years, or metrics. The answer is contextually complete and directly addresses the comparative regulatory and liability frameworks as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 443,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar’s equity‑compensation plans approved by security holders have 40,873,176 securities remaining available for future issuance (CAT 10‑K, p. 127), and Johnson & Johnson’s similar plans have 111,042,139 (JNJ 10‑K, p. 121).  The combined total is 151,915,315, which is 40,873,176 (≈ 36.8 %) more than 3M’s 111,042,139 securities available under its approved plans (MMM 10‑K, p. 115).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. While it correctly identifies Caterpillar's available securities (40,873,176) and Johnson & Johnson's (111,042,139), and correctly calculates their combined total (151,915,315), it incorrectly states that 3M has 111,042,139 securities available. According to the ground truth, 3M has only 39,563,000 available. This is a critical error that completely undermines the comparison. (2) The calculation of the difference is therefore also wrong: the LLM claims the combined total is '36.8% more' than 3M's, but this is based on using J&J's number (111,042,139) as 3M's, which is incorrect. The correct comparison is 151,915,315 vs 39,563,000 — meaning the combined total is actually about 284% higher than 3M's, not 36.8%. (3) The multi-hop reasoning fails at the final step: while the model successfully retrieves and sums Caterpillar and J&J data, it fails to correctly retrieve 3M's data, instead reusing J&J's number. This suggests a confusion of entities in the synthesis phase. (4) Contextual relevance is high — the answer addresses the right companies, metric, and structure — but the critical numerical error in 3M's value and the resulting flawed comparison severely reduce correctness, quantitative, and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 366,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s Januvia and Janumet will retain U.S. market exclusivity until May 2026, but the IRA will impose a government‑set price on Januvia from Jan 1 2026 and on Janumet from Jan 1 2027, effectively curbing pricing even before generic entry (page_59). In contrast, Pfizer relies on regulatory exclusivity periods that can extend beyond patent expirations, providing a longer window of protection against generics and biosimilars (page_15). Thus, Merck’s post‑2025 revenue protection is more constrained by impending exclusivity loss and price‑setting, whereas Pfizer’s strategy offers a more robust shield against market erosion after 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) Correctly identifies Merck's Januvia and Janumet exclusivity expiration in May 2026, and notes IRA price-setting starting Jan 1, 2026 for Januvia and Jan 1, 2027 for Janumet—this aligns with the original answer’s timeline (May 2026 exclusivity loss, IRA pricing from 2026/2027), though the original specifies Janumet XR also in July 2026, which the LLM omits. (2) Quantitatively, all dates are correct; minor variation in phrasing (Jan 1 vs 'starting in 2026') is semantically acceptable. (3) The comparison to Pfizer’s strategy accurately reflects reliance on regulatory exclusivity beyond patents, as stated in the ground truth. (4) The reasoning correctly synthesizes multi-hop information: Merck faces dual pressure from near-term exclusivity loss and IRA pricing, while Pfizer uses regulatory exclusivity as a buffer, indicating divergent post-2025 revenue protection strategies. The only minor omission is Janumet XR’s July 2026 timeline and Merck’s use of rebate reductions (mentioned in original), which slightly affects completeness but not core correctness. Overall, the answer is factually sound, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 347,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLNs are hybrid instruments that embed credit protection sold to the issuer, so the firm’s credit‑event risk is that the issuer may default and the note’s principal may not be repaid; MS mitigates this by selecting issuers with strong credit ratings and relying on the embedded protection【page_112】.  In contrast, BAC uses credit derivatives to hedge its commercial‑credit exposure and also sells protection to lower costs; it manages counterparty risk by choosing counterparties (banks, broker‑dealers, insurers), monitoring credit and correlation limits, and applying credit protection to both funded and unfunded exposures【page_65】【page_66】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MS invests in CLNs with embedded credit protection sold to issuers, exposing it to credit event risk if the reference entity defaults, and that BAC uses credit derivatives to hedge commercial credit exposure. However, there is a critical inaccuracy: the LLM states that BAC 'sells protection to lower costs,' which contradicts the ground truth that BAC purchases credit protection to mitigate risk. This misrepresents BAC's strategy and undermines the comparison. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is partially sound: the model correctly contrasts MS’s investment in instruments where it sells protection versus BAC’s use of derivatives for hedging. However, the erroneous claim that BAC sells protection introduces a significant flaw in the synthesis, weakening the qualitative accuracy. (4) Contextual relevance is high—the response addresses counterparty risk management, derivative usage, and both firms’ strategies with appropriate citations. The core contrast is present but distorted by the incorrect characterization of BAC’s behavior, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 361,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement has Solventum assume the post‑spin‑off liabilities and, in return, indemnify and defend 3M for those claims—so the risk is transferred to Solventum while 3M still records any probable losses and insurance recoveries under ASC 450. RTX, by contrast, remains the guarantor of its financial guarantees; the guarantor’s potential payout is recorded as a liability when it is probable and estimable, and any indemnification comes from the guarantee holder rather than a transfer of liability to a separate entity. Thus, 3M shifts liability to Solventum and relies on indemnification, whereas RTX retains the liability and accrues for potential losses, with indemnification provided by the guarantee’s beneficiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: 3M transferred liabilities to Solventum, which assumed indemnification and defense obligations; RTX remains the guarantor under financial guarantees with indemnification from third parties. The accounting treatment under ASC 450 is correctly referenced for 3M, and the distinction in liability retention vs. transfer is accurately drawn. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (3M and RTX), two types of indemnification structures (spin-off vs. financial guarantees), and two accounting implications (liability transfer vs. retention). The only minor shortcoming is that the LLM does not explicitly mention ASC 610-30, which the original answer includes as part of the accounting framework for 3M’s spin-off. While ASC 450 is correctly cited, the absence of ASC 610-30 slightly reduces completeness in technical accounting precision. (4) The answer is fully contextually relevant, directly addressing the comparison of indemnification structures, transfer of liability, and recognition of losses. Wording differs but semantic meaning matches the ground truth. Thus, the correctness score is 9 due to the omission of ASC 610-30, but all other aspects are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 414,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 revenue from Taiwan was $1.84 billion, about 8 % of its $22.68 billion total (AMD_10‑K, page 71).  NVIDIA, by contrast, relies on Taiwan‑based foundries for wafer production and the company’s 10‑K notes that geopolitical tensions in Taiwan and China could disrupt those foundries and materially affect its supply chain and revenue (NVDA_10‑K, page 18).  Thus, while AMD’s exposure to Taiwan is modest, NVIDIA faces a more direct supply‑chain risk from the same region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's 2023 revenue from Taiwan as $1.84 billion, matching the ground truth of $1,841 million (equivalent values, minor rounding difference acceptable). It also accurately references NVIDIA's supply chain risk due to its reliance on Taiwan-based foundries and the associated geopolitical risks, as stated in its 10-K. The percentage of AMD's revenue from Taiwan (~8%) and total revenue ($22.68 billion) are consistent with the source data. (2) All numeric values are correct or acceptably rounded: $1.84 billion = $1,840 million ≈ $1,841 million; total revenue and percentage are accurate. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s revenue exposure (market-side) with NVIDIA’s supply chain dependency (production-side) in Taiwan, contrasting the nature of risk (sales vs. supply). It references the correct documents (AMD_10-K, NVDA_10-K) and pages. (4) The only minor shortcoming is that the LLM does not explicitly state that Taiwan is a 'core' supply chain vulnerability for NVIDIA in the same strong terms as the ground truth, slightly weakening the qualitative emphasis on the asymmetry of risk. However, the key contrast is still clearly conveyed. All entities (AMD, NVIDIA, Taiwan, 2023, foundry partners, geopolitical tensions) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 386,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s repowered wind assets are tied to long‑term power‑sales agreements whose weighted‑average remaining term is about 15 years (based on forecasted earnings and electricity production), giving the company a stable, predictable revenue stream that is largely insulated from short‑term market swings【page_13】. In contrast, Southern Power relies on PPAs whose specific terms are not disclosed; its revenue therefore depends on variable factors such as weather, equipment performance and transmission constraints, making long‑term cash flows less predictable and less transparent【page_80】. This structural advantage gives NEER a clearer, more reliable revenue forecast than Southern Power’s less‑transparent PPA framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER is correctly stated and matches the original answer. There are no calculations required beyond this figure, and it is accurately presented. (2) The LLM correctly identifies NEER’s structural advantage in revenue predictability due to long-term PPAs tied to repowered wind facilities and contrasts it with Southern Power’s lack of disclosed contract terms. The use of 'about 15 years' is semantically equivalent to the original '15-year weighted average remaining contract term' and is supported by the source citation (page_13). (3) The multi-hop reasoning is sound: the model synthesizes information about NEER’s contract duration and its impact on revenue stability, then contrasts it with Southern Power’s opacity, correctly inferring reduced predictability. (4) The only minor shortcoming is a slight overstatement in attributing Southern Power’s revenue variability directly to 'weather, equipment performance and transmission constraints'—while these factors may play a role, the original answer focuses on the lack of disclosed contract terms as the primary limitation to visibility, not operational variables. This adds some interpretive detail not in the ground truth, slightly reducing qualitative accuracy. However, the core comparison and conclusion about transparency and revenue forecast reliability remain valid and well-supported. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 433,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX’s revenue recognition under FAR for U.S. government fixed‑price contracts is primarily over‑time, using a percentage‑of‑completion method based on costs incurred relative to estimated total costs, and it records contract assets or liabilities as work progresses (RTX pages 78‑81). In contrast, Honeywell, while also governed by FAR, faces a higher exposure to contract termination risk: the government can terminate contracts for convenience or due to performance failures, and Honeywell may be subject to audits, price adjustments, refunds, and even suspension from future awards if violations occur (Honeywell pages 34‑35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific numbers (e.g., percentages, dollar amounts) are misstated; the LLM correctly describes RTX's use of cost-based percentage-of-completion without introducing incorrect figures. While the ground truth mentions 80-90% payment coverage, the LLM does not contradict this—it omits the exact range but accurately describes progress payments and contract assets, which is acceptable under semantic equivalence. (2) The entities—RTX and Honeywell—are correctly identified, and both are accurately linked to FAR compliance. The fiscal context and regulatory framework (FAR, fixed-price contracts) are properly referenced. (3) The multi-hop reasoning is sound: the LLM contrasts RTX’s revenue recognition practices with Honeywell’s termination risks under the same FAR framework, synthesizing information across two companies and regulatory implications. It correctly identifies that both are subject to FAR but face different risk exposures. (4) The LLM adds value by specifying audit, refund, and suspension risks for Honeywell, which enriches the answer without deviating from the truth. The only minor shortcoming is the omission of the explicit connection that Honeywell’s termination risk could impact contract assets similarly to RTX’s—this nuance is in the ground truth but only implied in the LLM response. However, the core facts, reasoning, and synthesis are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 410,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries no voting rights, so holders have no influence over corporate decisions; they still receive dividends and can benefit from the company’s share‑repurchase program, but governance control remains with the voting Class A and Class B shareholders. In contrast, Comcast’s relinquishment of voting rights in Hulu transferred full governance control to Disney, yet the company realized a $8.6 billion cash payout (plus a tax gain) when it exercised its put right, turning the loss of control into a substantial financial benefit.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between Alphabet's structural use of non-voting shares and Comcast's strategic relinquishment of voting rights in Hulu for financial gain. It accurately states that Alphabet's Class C shares have no voting rights and that control remains with Class A and B shareholders, and that Comcast gave up control to Disney, resulting in an $8.6 billion payout. However, it omits key quantitative details from the ground truth: the $44.7 billion share repurchase authorization for Alphabet in 2024, the $9.2 billion minimum equity value from the put option, the $557 million adjustment for prior capital calls, and the $883 million recorded investment value as of December 31, 2024. (2) The $8.6 billion figure is correctly reported, but the absence of the other figures—especially the $9.2 billion put value and the $883 million carrying value—represents a significant omission in quantitative completeness. The tax gain mentioned is not in the original and may be an inference, but not explicitly supported. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance implications (loss of control vs. retained control) and links them to financial outcomes. It correctly identifies the strategic trade-off: Alphabet retains control while optimizing capital via repurchases, while Comcast trades control for liquidity. (4) The answer is contextually excellent and semantically aligned with the original in terms of reasoning and structure. The correctness score is 8 because the core facts and financial outcome ($8.6B) are correct, but the missing figures—especially the $44.7B repurchase capacity and Hulu carrying value—prevent a 9–10. Quantitative accuracy is 7 due to partial number reporting; qualitative and contextual scores are high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 503,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "LLY’s product‑supply risk notes that “intermittent delays in fulfilling certain orders for incretin products” arise from limited capacity and quality‑control issues at third‑party manufacturers (LLY, 2023, pp. 45‑47).  TMO’s $26.92 billion of remaining performance obligations are largely tied to contract‑manufactured products with 3‑ to 5‑year terms (TMO, 2023, pp. 49‑50).  Because both companies depend on external suppliers for critical, high‑volume production, any quality‑assurance lapse or supply‑chain disruption could delay product availability, raise costs, and jeopardize revenue recognition, potentially leading to material adverse effects on their long‑term commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: LLY's intermittent supply delays due to third-party manufacturing constraints and quality-control issues are accurately cited from its 2023 10-K (pp. 45–47), and TMO’s $26.92 billion in remaining performance obligations tied to 3- to 5-year contract manufacturing is correctly referenced from its 2023 10-K (pp. 49–50). The dollar amount, timeframes, and sources are factually consistent with the original answer. (2) Quantitative accuracy is perfect: the $26.92 billion figure is exact, and no calculations were required beyond accurate reporting. (3) Multi-hop reasoning is sound—LLM correctly identifies the shared dependency on third-party manufacturers and synthesizes the risk that quality-assurance lapses or supply-chain disruptions could impact both companies’ ability to fulfill long-term commitments. It appropriately links LLY’s patient demand risks with TMO’s revenue recognition and contractual fulfillment risks. (4) The only minor shortcoming is that the LLM omits specific mention of the forward-looking timeline for LLY’s capacity expansion (‘in the next several years’) and does not reference AMD’s 10-K as a supporting example of broader industry supply chain risks, which slightly reduces completeness. However, the core reasoning and factual content remain intact. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the intersection of supply chain, quality assurance, and long-term obligations for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 435,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "NextEra Energy Resources recorded a cumulative impairment charge of **$2.0 billion** on its XPLR investment as of December 31 2024 – $1.2 billion in 2023 and $0.8 billion in 2024.  \nThat cumulative charge is **$0.6 billion less** than the investment’s carrying value of roughly **$2.6 billion** before the 2024 impairment, leaving a post‑impairment carrying amount of about **$1.8 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the cumulative impairment charge of $2.0 billion is correctly broken into $1.2 billion (2023) and $0.8 billion (2024). The carrying value before the 2024 impairment is correctly stated as $2.6 billion, and the post-impairment carrying value of $1.8 billion is accurate. The comparison stating the cumulative charge is $0.6 billion less than the pre-2024 carrying value is correct ($2.6B - $2.0B = $0.6B). (2) The answer is complete, addressing both parts of the question: total cumulative impairment as of Dec 31, 2024, and the comparison to the carrying value before the 2024 impairment. (3) Entities are accurate: NextEra Energy Resources, XPLR, and correct time periods (2023 and 2024) are properly identified. (4) The multi-hop reasoning is sound—synthesizing the two impairment charges across years and comparing them to the carrying value before the 2024 write-down demonstrates correct logical and financial reasoning. (5) The semantic meaning is equivalent to the original answer, with clear, concise rewording that preserves all key facts and relationships. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 347,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE’s adoption of ASU 2022‑04 was noted on page 47 of its 2024 10‑K, but the company said the standard “did not have a material impact on the Company’s consolidated financial statements” and it does not disclose any confirmed‑invoice balances or separate presentation of supplier‑finance obligations (other than a general statement that it evaluates supply‑chain finance programs).  By contrast, 3M’s Note 16 (page 77) reports that its outstanding confirmed‑invoice balances were about $0.3 billion at each year‑end and that these amounts are included within accounts payable; the note also provides a roll‑forward of invoices confirmed and paid during 2024.  Thus, while GE’s disclosure is minimal, 3M provides explicit confirmed‑invoice figures and a clear presentation in the balance sheet, giving greater transparency under the same standard.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MMM discloses approximately $0.3 billion in confirmed invoice balances for both 2023 and 2024, and that these are included in accounts payable—this matches the ground truth. However, the LLM incorrectly implies that GE does not disclose any confirmed invoice balances or separate presentation as of 2024, while the ground truth states that GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding in 2024 due to ASU 2022-04 adoption. The LLM's claim that GE’s disclosure is 'minimal' and lacks specific figures contradicts the ground truth, which affirms GE provides disclosures required under the standard starting in 2024. (2) Quantitatively, all numbers are accurate: $0.3 billion for MMM is correctly reported, and no incorrect calculations are made. (3) The multi-hop reasoning is partially flawed: while the model correctly contrasts MMM’s detailed disclosures with what it perceives as GE’s lack of disclosure, it fails to acknowledge that GE *does* provide required disclosures under ASU 2022-04 starting in 2024, including confirmed amounts and balance sheet presentation, per the original answer. This undermines the qualitative accuracy of the comparison. (4) Contextual relevance is high—the response directly addresses transparency differences in supplier finance obligations, focuses on confirmed invoice balances and financial statement presentation, and references appropriate disclosures (e.g., Note 16 for MMM). Despite misrepresenting GE’s disclosure level, the structure and intent align well with the question. The correctness score is 7 because core facts about MMM are accurate and the contrast is directionally valid, but a significant omission regarding GE’s actual compliance with disclosure requirements prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 499,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria’s equity‑method accounting ties its earnings and carrying value to Cronos’s performance; if Cronos fails to meet FDA regulations it could face fines, loss of licenses or reduced dividends, prompting Altria to record impairment losses and a lower reported income (page_16). Walmart’s pharmacy business, which is itself regulated by the FDA (registration, dispensing of controlled substances, etc.), faces direct regulatory risk that could result in fines, penalties or operational shutdowns, but the exposure is operational rather than an indirect investment exposure (page_26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: Altria's equity-method accounting means its financials reflect Cronos's performance, and FDA noncompliance by Cronos could lead to financial losses for Altria via impairments or reduced income. Walmart faces direct operational risks from FDA regulation of its pharmacy operations. These points align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes how equity-method investments (Altria-Cronos) transmit regulatory risk differently than direct operations (Walmart pharmacies), capturing the structural difference in exposure. The only minor shortcoming is that the LLM does not explicitly state that both companies face exposure under the same regulatory framework (FDA), though it implies it by referencing FDA regulations for both. (4) Contextual relevance is perfect—the response directly addresses both parts of the comparative question and maintains focus on financial risk exposure through different mechanisms. Wording differs slightly but meaning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 367,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY relies on Cardinal Health for a sizable share of U.S. distribution—Cardinal accounted for 15‑20 % of LLY’s revenue in 2021‑2023【page 7】—and Cardinal is also a 50 % owner of Red Oak Sourcing, the generic‑pharma sourcing VIE that CVS consolidates as a primary beneficiary【page 18】【page 138】.  Thus CVS’s consolidated exposure to Red Oak is indirectly tied to Cardinal’s activities, but the exposure is limited to CVS’s own consolidation of Red Oak and is not directly altered by LLY’s distribution relationship.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer correctly identifies key facts: LLY's reliance on Cardinal Health for 15-20% of U.S. revenue (accurate per ground truth and cited 2021-2023 timeframe), Cardinal's 50% ownership in Red Oak Sourcing, and CVS's consolidation of Red Oak as primary beneficiary. These entity and quantitative details are accurate. However, the answer fails to fully address the causal chain of financial exposure. Specifically, it omits the critical link that disruptions to Cardinal’s distribution of LLY products could impair Cardinal’s financial health, thereby affecting its ability to make quarterly payments (~$183M annually as of 2021) to Red Oak, which in turn impacts CVS’s consolidated financials through reduced cost savings. This omission breaks the multi-hop reasoning required by the question.\n\n2) Quantitative accuracy is high: the 15-20% revenue figure is correctly stated, and while the $183M payment is not mentioned, no incorrect numbers are presented. The timeframe (2021-2023) aligns with available data. No calculation errors are present because no calculations were attempted.\n\n3) The reasoning is partially sound but incomplete. The model correctly identifies the structural relationships (LLY → Cardinal distribution; Cardinal-CVS → Red Oak JV; CVS consolidation), but fails to synthesize the dynamic risk pathway: LLY supply chain disruption → Cardinal financial stress → Red Oak funding risk → CVS consolidated exposure. This missing causal logic undermines the qualitative accuracy, especially for a question asking about 'impact' and 'exposure'.\n\n4) Contextual relevance is moderate: the answer provides relevant background on the entities and relationships but does not fully answer the 'how' part of the question. It concludes that CVS’s exposure is 'not directly altered by LLY’s distribution relationship', which contradicts the ground truth implication that there is an indirect but material financial linkage. This misjudgment lowers correctness and qualitative scores despite accurate standalone facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 546,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle uses its $6.0 billion commercial‑paper program to issue unsecured short‑term promissory notes for general corporate purposes, and its senior notes rank pari passu with those commercial‑paper notes (Oracle, p. 90). Cisco, in contrast, issued $13.5 billion of senior fixed‑rate notes and has a short‑term debt program that also ranks its senior notes pari passu with its commercial‑paper obligations (Cisco, p. 89). Thus, while both companies treat senior notes and commercial paper as equal‑ranking debt, Cisco’s senior notes are larger and its short‑term program has a higher potential issuance limit.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $6.0 billion commercial paper program and Cisco's $13.5 billion senior fixed-rate note issuance, which matches the ground truth. However, it omits key details about Oracle's actual outstanding commercial paper ($401 million as of May 31, 2024, maturing through August 2024) and fails to mention that Oracle's notes are issued under a private placement exemption. These omissions reduce completeness. (2) Quantitatively, all cited dollar amounts ($6.0 billion, $13.5 billion) are accurate and correctly attributed. No calculations are required, so numerical precision is strong. The date of Cisco's issuance (February 2024) is missing but not misstated. (3) The reasoning correctly identifies the pari passu ranking of senior notes and commercial paper for both companies and draws a valid comparison in terms of debt structure hierarchy. However, the LLM incorrectly implies that Oracle explicitly states its senior notes rank pari passu with commercial paper—this detail is not in the ground truth for Oracle, only for Cisco. This is a significant qualitative error in multi-hop synthesis. Additionally, the claim that Cisco's 'short-term program has a higher potential issuance limit' is speculative and not supported in the original answer. (4) Despite these issues, the core comparison—Cisco having a larger long-term debt component while both use commercial paper and have pari passu rankings—is contextually relevant and mostly accurate. The answer captures the essence but lacks precision in attribution and includes unsupported inferences, justifying a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 450,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment lists wind as one of 23 wind facilities in a 3,554‑MW portfolio (page 21), but the filing does not disclose the aggregate wind capacity. In contrast, Southern Company’s Skookumchuck project is a single 136‑MW wind facility with a 20‑year PPA and full controlling ownership (pages 329‑330), underscoring a focused, long‑term commitment to that asset.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It claims Duke Energy has '23 wind facilities in a 3,554-MW portfolio' and cites page 21, but the ground truth states Duke does not disclose specific wind capacity—this number is fabricated or misattributed. There is no support in the original answer for any aggregate capacity figure for Duke's wind assets. (2) The mention of 'pages 21' and 'pages 329-330' implies specific sourcing, but these details are not present in the ground truth and cannot be verified; more importantly, they introduce false precision. (3) While it correctly identifies Southern Company’s Skookumchuck project as a 136-MW facility with a 20-year PPA (matching ground truth), it adds 'full controlling ownership'—a detail not present in the original and unverified. (4) The reasoning partially captures the contrast between Duke’s broader renewable portfolio and Southern’s targeted project, which supports contextual relevance. However, the inclusion of incorrect quantitative data (especially the 3,554-MW figure and 23 facilities) severely damages factual integrity. The model fails the multi-hop synthesis by introducing unsupported specifics instead of accurately reflecting disclosure gaps. Thus, while the direction of comparison is reasonable, the answer is materially incorrect on key facts, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 394,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, MS must hold a 5.5 % capital buffer (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % CCyB). SCHW’s buffer is only the 2.5 % capital‑conservation buffer, with no G‑SIB surcharge and the CCyB set at zero. Thus MS’s buffer is higher because of the G‑SIB surcharge, while the CCyB contributes nothing to either bank.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the quantitative breakdown of Morgan Stanley's capital buffer. The original answer states that MS is subject to a 2.5% Capital Conservation Buffer, a G-SIB surcharge (which varies over time and is not specified as 3.0% in the ground truth), and a 0% CCyB. The LLM assumes the G-SIB surcharge is 3.0%, which may be accurate in practice but is not stated in the original answer and thus introduces an unverified specific value. This affects quantitative accuracy. The rest of the numbers are correct: both firms have a 2.5% Capital Conservation Buffer, and the CCyB is zero for both as of the relevant date (December 31, 2023). The LLM correctly identifies that SCHW is not subject to the G-SIB surcharge, which is a key differentiator. The reasoning is sound: it correctly synthesizes that the difference in buffer requirements stems from the G-SIB surcharge, and both are equally affected by the zero CCyB. The answer addresses all parts of the question—comparing buffer structures and acknowledging the role of CCyB—and maintains semantic equivalence with the original answer despite slightly more precise (but unverified) numerical assumptions. Contextual relevance is perfect, as all information pertains directly to the regulatory capital framework and the comparison between MS and SCHW.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 376,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney uses internal discounted‑cash‑flow (DCF) models to determine the fair value of Level 2 derivatives, relying on observable inputs such as interest‑rate curves and FX rates (page 119). Meta applies the same DCF approach to estimate fair values for impairment of operating‑lease right‑of‑use assets and leasehold improvements, which resulted in a $383 million impairment charge in 2024 (page 99). Thus, both companies use DCF, but Disney applies it to derivative fair values while Meta uses it to assess lease‑asset impairment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $383 million impairment charge in 2024 is accurately attributed to Meta, matching the original answer. The fiscal year (2024) and dollar amount format ($383 million) are consistent and acceptable. (2) The LLM correctly identifies both companies—Disney and Meta—and their respective uses of discounted cash flow (DCF) models: Disney for Level 2 derivatives using observable inputs (interest rates, FX rates), and Meta for impairment of operating lease assets. The mention of page numbers (119 and 99) adds sourcing detail not in the ground truth but does not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use DCF models but in different contexts—Disney for recurring fair value measurement of derivatives (Level 2), Meta for non-recurring impairment assessments (Level 3 inputs implied by context, though not explicitly labeled as Level 3 in the LLM answer). The only minor shortcoming is the lack of explicit mention that Meta’s inputs are Level 3 (e.g., projected sublease income, downtime assumptions), which is a nuance present in the original answer and relevant to the fair value hierarchy comparison. (4) Despite this omission, the core contrast—Disney applying DCF to derivatives, Meta to lease impairments—is clearly and correctly conveyed. The answer is contextually relevant, directly addressing the comparative use of DCF models and the $383 million charge. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 463,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco market volume, coupled with adult‑smoker up‑trading, has helped PM lift its shipment volume in Turkey by 17.2 % and raise its market share, but the higher prevalence of illicit trade partially offsets that gain, limiting the net share expansion. In contrast, MO’s 10‑K frames illicit trade as a pervasive risk that can erode sales, market share and tax revenue across its entire portfolio, making its exposure broader and potentially more damaging than PM’s localized impact in Turkey.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. While the ground truth states PM's shipments in Turkey increased from 47.5 billion to 55.7 billion units (a 17.2% increase, which the LLM correctly calculates), the 8.2% increase in Turkey's total tobacco market volume is not supported by the ground truth — this specific figure is absent from the original answer and cannot be verified from the provided data. The original answer does not mention 'adult-smoker up-trading' as a factor, making this addition speculative. (2) The market share increase from 41.3% to 44.8% is implied by the LLM’s reference to rising market share but not explicitly stated, and the extent of the increase is not quantified in the LLM response, leading to a loss of precision. The illicit trade impact is correctly framed as a partial offset for PM, aligning with the original. MO’s exposure is described more broadly, which matches the original’s emphasis on systemic risks, though the LLM does not mention specific consequences like brand dilution or regulatory triggers. (3) The multi-hop reasoning is partially sound: the LLM correctly links PM’s volume growth to market share gains in Turkey and contrasts PM’s localized exposure with MO’s broader risk. However, it introduces unverified data (8.2% market growth) and omits key specifics (exact market share figures, tax revenue impact). (4) The contextual relevance is high as the answer addresses both companies and the illicit trade comparison. Quantitative accuracy is penalized due to unsupported figures and missing precise data points, though the 17.2% shipment increase is correctly derived. Qualitative accuracy is moderate due to correct conceptual framing but some invented details. Correctness score reflects partial factual alignment with significant omissions and one key unsupported number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 507,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The IRA’s Part D redesign shifts a larger share of claim liability from the federal government to plans, which could raise CVS’s exposure to Medicare‑Part D costs and uncertainty about reimbursement (see CVS 10‑K, pp. 57‑58).  For AbbVie, the same law gives the government the power to set prices for select single‑source drugs under Medicare Part D, and Imbruvica was chosen as one of the first 10 drugs subject to this price‑setting starting in 2026, forcing AbbVie to adjust its pricing strategy and potentially reduce revenue (AbbVie 10‑K, pp. 19‑20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the shift in liability under the Inflation Reduction Act (IRA) to insurers like CVS, increased financial exposure and uncertainty for CVS, government price-setting for select drugs starting in 2026, and Imbruvica being one of the first 10 drugs selected—all match the original answer. (2) Quantitative accuracy is perfect: the year 2026 is correctly cited, and no numerical values (e.g., dollar amounts, percentages) are misstated. Format and references to 10-K pages (e.g., CVS pp. 57–58, AbbVie pp. 19–20) are consistent with expected sourcing. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across two companies (CVS and AbbVie), connects the same regulatory change (IRA’s Part D redesign) to distinct financial impacts (liability for CVS, pricing pressure for AbbVie), and identifies the causal mechanism (price-setting power for the government). (4) The only minor shortcoming is a slight lack of emphasis on the 'dual pressure' framing—while both effects are described, the synthesis of how both companies are affected under the same framework is less explicit than in the original. However, this does not detract from factual correctness. Wording differs but semantic meaning is equivalent. No factual errors or omissions affect the core answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 384,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values impaired customer‑financing assets by taking a median collateral value from third‑party aircraft‑value publications and then adjusting for aircraft condition, a Level‑3 (unobservable) input (see page 124‑125). RTX, in contrast, values its private‑equity limited‑partnership holdings quarterly with discounted‑cash‑flow, earnings‑multiple and market‑multiple models that rely on observable market data and are not classified as Level‑3, so its reliance on unobservable inputs is minimal (see page 102).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error regarding RTX's use of unobservable inputs. It correctly states that Boeing uses a median value from third-party aircraft publications and adjusts for aircraft-specific factors (e.g., condition), which aligns with the ground truth and reflects Level 3 fair value measurement due to management adjustments using unobservable inputs. However, the LLM incorrectly claims that RTX's valuation methods 'are not classified as Level 3' and that its 'reliance on unobservable inputs is minimal.' This contradicts the ground truth, which explicitly states that RTX's use of discounted cash flows, earnings multiples, and market multiples involves valuation adjustments based on changes in portfolio companies' operating results or financial condition—inputs typical of Level 3 assets. Thus, both Boeing and RTX rely on unobservable inputs (Level 3), though the nature differs: Boeing leans more on third-party market data as a baseline, while RTX uses forward-looking financial models. The LLM's mischaracterization of RTX's methodology as not Level 3 undermines the comparative analysis and reflects a failure in multi-hop reasoning. Quantitatively, no specific numbers are incorrect (hence higher quantitative score), but the conceptual classification error is significant. Contextually, the answer addresses the question's structure and cites relevant valuation methods, so relevance is high. However, the qualitative inaccuracy in entity-specific accounting treatment reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 427,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Alphabet’s dual‑class structure gives each Class B share ten votes versus one for a Class A share, so the 10‑vote advantage concentrates control in the hands of Class B holders. Alphabet’s recent repurchase of Class A and Class C shares has lowered the total voting shares outstanding, amplifying the relative influence of the remaining Class B shares【page 82】. Meta’s authorized share structure—2.0 trillion Class A shares versus 499 million Class B‑1 shares【page 88】—means that the founders’ Class A holdings dominate voting power, and the lack of disclosed voting rights for Class B‑1 shares suggests that control remains heavily concentrated among the existing Class A holders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core qualitative dynamics of voting power concentration at both META and GOOGL, correctly identifying that GOOGL's Class B shares have 10 votes versus 1 for Class A, and that share repurchases can amplify Class B control. It also correctly notes that META’s Class A shares dominate voting power. However, there are significant quantitative inaccuracies. The LLM states META has 2.0 trillion Class A shares authorized (not outstanding), citing 'page 88', but the ground truth specifies 2,189,898,148 Class A shares *outstanding* as of January 24, 2025 — a critical distinction. The LLM confuses *authorized* shares with *outstanding* shares, which misrepresents the actual voting structure. Additionally, it refers to 'Class B-1' shares, a term not present in the ground truth, and fails to mention the actual number of Class B shares outstanding (343,761,117). For GOOGL, the LLM correctly describes the effect of repurchasing Class A and C shares but omits the specific $62.0 billion repurchase amount in 2024, a key factual detail. While the reasoning about control concentration is logically sound and contextually relevant, the answer lacks precise numerical support and misstates structural details, reducing its factual reliability. Thus, the correctness score is reduced due to major omissions and inaccuracies in quantitative data, despite sound conceptual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 387,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PEP’s convenient‑foods unit volume grew 19 % in APAC, with Taiwan posting only low‑single‑digit growth (page 48).  In contrast, P&G’s Greater China segment—which explicitly includes China mainland, Hong Kong and Taiwan (page 40)—is described as a leading market‑position holder across its product categories (page 20).  Thus, while PEP shows strong overall volume expansion but modest growth in Taiwan, P&G maintains a dominant market presence that covers Taiwan as part of its Greater China strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's 19% convenient foods unit volume growth in APAC and low-single-digit growth in Taiwan, matching the ground truth. It accurately contrasts this with PG's (P&G's) leadership position in Greater China, which explicitly includes Taiwan. All key facts are present and factually aligned. (2) Quantitative accuracy is perfect: the 19% growth and low-single-digit characterization for Taiwan are correctly reported. No calculations are required, but the comparison is numerically sound. (3) The multi-hop reasoning is strong: the model synthesizes PEP's performance in APAC (with Taiwan as a sub-component) and contrasts it with PG's regional strategy in Greater China, where Taiwan is explicitly included. The reasoning correctly infers that PEP's growth in Taiwan is modest relative to its broader APAC performance, while PG holds a dominant position in the same region. The only minor shortcoming is the reference to 'Apple's segment reporting' in the ground truth, which the LLM omits—however, this appears to be an error in the ground truth (Apple is irrelevant here); the LLM correctly attributes the Greater China structure to P&G based on its own reporting. (4) Scores reflect near-perfect factual alignment, with full contextual relevance and excellent qualitative reasoning. The answer is semantically equivalent to the ground truth, with only negligible omission of the erroneous Apple reference, which does not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 411,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III update raises the minimum CET1 ratio required for a well‑capitalized insured depository institution from 4.5 % to 6.5 % (with a total risk‑based capital ratio of 10 % and a leverage ratio of 5 % also required)【page 192】.  Bank of America’s CET1 ratio is 11.8 % (standardized) or 13.4 % (advanced)【page 146】, while Capital One’s bank subsidiary reports a CET1 ratio of 12.9 % (or 13.1 % for the bank)【page 193】—both comfortably above the 6.5 % threshold—so each is classified as well‑capitalized under the PCA framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the updated PCA Framework thresholds under Basel III, stating that the CET1 ratio for a well-capitalized institution increased from 4.5% to 6.5%, with a total risk-based capital ratio of 10%, which aligns with the ground truth. It also accurately references BAC and COF (via 'Capital One’s bank subsidiary') and notes both are well-capitalized, which is consistent with the original answer. However, the LLM omits key structural details about the regulatory minimums versus PCA classification thresholds for each bank. Specifically, it fails to clarify that while the regulatory minimum CET1 under Basel III is 4.5%, the PCA well-capitalized threshold is higher at 6.5%—a critical multi-hop point emphasized in the ground truth. Additionally, the LLM introduces a leverage ratio of 5%, which is not mentioned in the original answer and may be contextually relevant but is unsupported by the provided truth. The cited CET1 ratios for BAC (11.8% standardized, 13.4% advanced) and COF (12.9% group, 13.1% bank) appear accurate and support the conclusion that both exceed the 6.5% threshold. However, the original answer focuses on the regulatory framework and its implications for capital planning and dividend capacity, which the LLM does not address. While the core numerical and classification information is correct, the explanation lacks completeness in synthesizing how the updated thresholds differently affect BAC and COF in terms of capital requirements and regulatory classification logic. The reasoning is sound but incomplete, and the use of page references suggests external sourcing but does not compensate for missing conceptual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 456,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "NFLX’s audit team performed sensitivity analyses only on content amortization, testing how changes in viewing‑pattern assumptions would shift the amortization schedule (page 40). In contrast, AT&T’s auditors ran broader sensitivity tests that covered both the discount‑rate assumptions used to measure defined‑benefit pension and post‑retirement obligations and the forward‑looking assumptions (terminal growth, EBITDA margins, WACC) used in goodwill impairment tests (page 44). Thus, NFLX’s sensitivity work is narrowly focused on content amortization, whereas AT&T’s analyses span multiple valuation assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NFLX's sensitivity analysis focuses on viewing-pattern assumptions affecting content amortization, while T (AT&T) has broader analyses covering pension discount rates and goodwill impairment assumptions (terminal growth, EBITDA margins, WACC). The use of 'AT&T' instead of 'T' is acceptable as it refers to the same entity. (2) There are no numeric values requiring verification in this qualitative comparison, so quantitative accuracy is not applicable beyond correct reference to page numbers (40 and 44), which match the source context and support the claims. (3) Multi-hop reasoning is sound—correctly synthesizing audit procedures across two companies and contrasting their scope (narrow vs. broad). The conclusion that NFLX’s focus is narrow while AT&T’s spans multiple valuation areas aligns with the original answer. (4) Minor deduction in qualitative accuracy due to slightly stronger claim that NFLX’s audit team performed sensitivity analyses 'only' on content amortization—the original answer doesn’t explicitly state exclusivity, though it implies focus. Otherwise, the reasoning, entity identification, and synthesis are strong. Contextual relevance is perfect—directly addresses the comparative sensitivity analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 375,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe lists a dedicated local field office in Taiwan as part of its global field‑office network (see the list of locations on page 15).  By contrast, Apple does not treat Taiwan as a separate office; it is folded into the “Greater China” segment—China mainland, Hong Kong and Taiwan—which generated $74.2 billion of net sales in 2022 (page 52).  Thus, Adobe’s presence in Taiwan is a single, localized office, whereas Apple’s strategy is a broader regional segment that drives a substantial portion of its revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which generated $74.2 billion in net sales in 2022—this figure matches the original answer exactly. The year (2022) is correctly implied via source page reference (page 52), consistent with the knowledge graph. (2) Quantitative accuracy is perfect: the $74.2 billion figure is correctly cited with proper context and formatting variations (e.g., $74.2 billion vs $74.2B) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Adobe and Apple), compares their operational strategies (localized office vs consolidated regional reporting), and ties financial performance to Apple’s broader segment. (4) The only minor shortcoming is that the LLM answer does not explicitly state that Apple’s strategy reflects its larger scale and different operational model—a nuance present in the original answer that adds depth to the comparison. However, the core contrast in approach (localized vs regional) is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 372,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin’s 2022 filing notes that its credit facility and some derivatives still reference LIBOR, but the company has built fallback provisions into the facility and has adopted the ISDA 2020 IBOR fallback protocol, so it expects no material impact from the transition (page 85). 3M, by contrast, indicates that it will apply the temporary expedients in ASU 2020‑04 to any contracts that are modified and has reviewed those arrangements to confirm that the guidance will not materially affect its financials, showing a more proactive, low‑impact preparedness (page 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Lockheed Martin has LIBOR-based credit facilities and derivatives, has adopted the ISDA 2020 IBOR Fallbacks Protocol, and expects no material impact by the end of 2022—consistent with the original answer. 3M's assessment under ASU 2020-04 is also accurately represented: it reviewed its contracts and concluded no material impact on financial statements. (2) There are no numeric values requiring calculation (e.g., dates like 'December 31, 2022' are implied in context and not contradicted), so quantitative accuracy is full. (3) The multi-hop reasoning—comparing two companies' preparedness for LIBOR transition under ASU 2020-04—is sound. The LLM correctly synthesizes that both companies expect minimal disruption and rely on ASU 2020-04, though it slightly overemphasizes 3M as 'more proactive,' which is interpretive but not factually incorrect. (4) The answer is contextually relevant, directly addressing the comparison asked. The only minor deviation is the subjective characterization of 3M as 'more proactive,' which isn't in the ground truth and slightly skews the parallel preparedness narrative. However, core facts, entities, and conclusions remain correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 363,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "At Comcast (CMCSA), holders of Class A common stock control about **66.7 %** of the combined voting power, while holders of Class B common stock control the remaining **33.3 %** (page 31). Because each Class B share carries **15 votes per share**, the single‑shareholder (Mr. Roberts) who owns all Class B stock wields a disproportionately large voting influence—effectively a third of all votes— and this voting power is generally non‑dilutable under the company’s articles, ensuring strong control over corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the voting power distribution: 66.7% for Class A and 33.3% for Class B, which matches the ground truth of 66⅔% and 33⅓%. The statement that Class B has 15 votes per share is accurate. The impact on shareholder control is correctly described as disproportionate, with the holder of Class B stock having significant influence despite minority share ownership. The mention of Mr. Roberts as the single shareholder of Class B stock and the non-dilutable nature of the voting power adds context not in the original answer but is factually consistent with CMCSA's structure and enhances completeness. 2) All numerical values are correct and accurately represented (66.7% ≈ 66⅔%, 33.3% ≈ 33⅓%). No calculation errors. 3) The reasoning correctly synthesizes the structural implications of differential voting rights—linking 15 votes per share to concentrated control—even though the original answer did not name Mr. Roberts. This reflects sound multi-hop understanding. 4) The LLM answer conveys the same core information as the original and adds minor contextual detail (ownership by Mr. Roberts, non-dilutability) that improves clarity without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes the 'minority ownership on a share count basis' aspect slightly more directly, though the LLM implies it. Overall, highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 393,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CM CSA uses sensitivity analyses to model macro‑financial risks—specifically the effect of a 10 % shift in interest‑rate and foreign‑exchange rates on its debt portfolio and the fair value of cable franchise rights (see pages 60–61).  In contrast, NFLX applies sensitivity testing to content‑specific assumptions, evaluating how changes in viewing patterns and revenue estimates alter the amortization of its film and television library (see page 40).  Though both firms are audited by the same firm, the auditor tailors its risk‑assessment procedures to the distinct exposure areas highlighted by each company’s sensitivity analysis.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the distinct uses of sensitivity analyses by CMCSA and NFLX, aligning with the ground truth: CMCSA focuses on interest rate and foreign exchange risk, while NFLX applies it to content amortization assumptions. The contextual relevance is high, as the answer addresses both companies' differing risk exposures and acknowledges the same auditor with tailored procedures. However, the quantitative accuracy is lower because the LLM omits the specific $56 million reduction in interest expense from CMCSA's derivative instruments, a key financial figure in the ground truth. Additionally, while the LLM mentions a '10% shift' in rates, this percentage is not present in the original answer and may be an unsupported detail from the filing, introducing potential inaccuracy. The qualitative reasoning is sound—correctly synthesizing that the same auditor applies tailored procedures due to different risk profiles—and the entity identification (CMCSA, NFLX, sensitivity analysis contexts) is accurate. The answer captures the core contrast but misses a critical numeric data point, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 320,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Enbrel’s key U.S. formulation patent is scheduled to expire on 10/19/2037 (Pfizer 10‑K, page 12), giving Pfizer a nearly 20‑year period of exclusive rights to that formulation. AbbVie’s biologics, however, rely on a 12‑year regulatory exclusivity under the Biologics Price Competition and Innovation Act (AbbVie 10‑K, page 9), after which biosimilar competitors can enter the market. Thus, Pfizer’s competitive position is strengthened by a longer exclusivity horizon for Enbrel, whereas AbbVie faces biosimilar competition earlier, potentially eroding its market share sooner.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: Enbrel's U.S. formulation patent expiration date (10/19/2037) is accurately cited with a specific source (Pfizer 10-K, page 12), and AbbVie’s 12-year regulatory exclusivity under the BPCIA is correctly stated with reference to its 10-K. The quantitative accuracy is high—dates and timeframes are correct, and the comparison between a ~20-year protection period (from approval to 2037) and 12-year exclusivity is reasonable. However, the LLM oversimplifies and mischaracterizes the strategic comparison. The original answer emphasizes that Pfizer’s protection is based on a formulation patent (a technical barrier) while AbbVie uses a layered strategy combining regulatory exclusivity and patents. The LLM incorrectly implies that AbbVie relies solely on regulatory exclusivity, ignoring its use of patent thickets and other mechanisms, which weakens the qualitative accuracy. Additionally, the LLM fails to mention pediatric exclusivity extensions or the international market context (e.g., Enbrel marketed outside U.S./Canada), reducing completeness. Despite these omissions, the answer captures the essential contrast in exclusivity duration and competitive implications, maintaining strong contextual relevance and factual grounding in sourced data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 362,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The proposed move to 0.1‑percentage‑point increments would make the G‑SIB surcharge calculation more granular, likely lowering the surcharge for a given risk‑weight and thus reducing JPMorgan Chase’s regulatory capital requirement. In a bankruptcy resolution, that lower capital buffer would translate into a smaller amount of eligible long‑term debt that would need to absorb losses, but the loss‑absorbing structure—eligible LTD taking losses only after priority and secured creditors—is unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general idea of increased granularity in the G-SIB surcharge due to the shift from 0.5- to 0.1-percentage-point increments, which is factually correct and contextually relevant. However, it makes a definitive claim that the change would 'likely lower the surcharge' and thus reduce capital requirements, which is not supported by the original answer or the underlying facts. The original answer correctly states that the impact could be either an increase or decrease depending on JPMorgan's G-SIB score, emphasizing uncertainty and tailoring. The LLM incorrectly assumes a directional outcome (lower surcharge), introducing a significant qualitative error in reasoning. While the description of the loss-absorbing structure—eligible long-term debt absorbing losses after equity and secured creditors—is accurate, the conclusion that a lower capital buffer would require less eligible LTD to absorb losses oversimplifies the regulatory framework, where minimum loss-absorbing capacity is determined by TLAC (Total Loss-Absorbing Capacity) requirements, not directly by the G-SIB surcharge. The G-SIB surcharge affects capital ratios but does not linearly dictate the amount of debt needed for resolution. Thus, the quantitative accuracy is moderate (6) because no specific numbers are wrong—just absent—but the reasoning linking capital requirements to loss absorption is flawed. Qualitative accuracy is 5 due to incorrect causal inference and oversimplification of regulatory mechanics. Contextual relevance is high (8) as the response addresses the core elements: G-SIB increment change, capital implications, and resolution structure. Overall, the answer is partially correct but contains significant reasoning errors that affect factual correctness, warranting a correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 490,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin uses a discounted‑cash‑flow (DCF) model only for Level 3 fixed‑income holdings, valuing them on the basis of projected annuity payments and a discount rate (see LMT Note 1, pages 87‑88).  Honeywell, by contrast, applies a DCF to goodwill and indefinite‑life intangibles and explicitly performs sensitivity analyses on key inputs—including projected cash flows, terminal‑value assumptions and the discount rate (see HON Note 1, page 47).  Thus, while both companies’ valuations hinge on cash‑flow projections and discount rates, Honeywell’s approach explicitly quantifies the impact of changes in those assumptions, whereas Lockheed Martin’s filing does not detail such sensitivity testing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and a discount rate, and that HON applies DCF to goodwill and indefinite-lived intangible assets. The mention of sensitivity analyses by HON on projected cash flows, terminal value, and discount rates matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or answers, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two asset types (fixed income vs. goodwill/intangibles), and compares their use of DCF and sensitivity testing. The only minor shortcoming is that the original answer notes both companies rely on forward-looking projections and are sensitive to economic shifts, while the LLM implies only HON explicitly quantifies sensitivity—this is accurate based on the filings cited, so the nuance is justified. (4) The LLM adds value by citing specific footnotes (LMT Note 1, pp. 87–88; HON Note 1, p. 47), enhancing credibility. The answer is fully relevant, directly addressing the comparison in methodological sensitivity. Thus, correctness is 9 due to slight omission of the shared sensitivity nature (both are sensitive, but only HON explicitly tests it), but no factual errors exist.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 417,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T’s pension discount rates are derived from a yield curve built on high‑quality corporate bonds, so auditors must evaluate the bonds’ credit quality and how well their cash‑flow patterns match the expected benefit payments.  \nNetflix, by contrast, amortizes content using forecasted viewing patterns that blend historical and projected consumption; auditors test the accuracy of those forecasts, compare them to actual viewership, and run sensitivity analyses to gauge the impact of assumption changes.  \nBoth approaches involve complex, judgment‑laden assumptions that are scrutinized by auditors, but AT&T’s focus is on market‑based bond yields while Netflix’s centers on consumer‑behavior projections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all numbers and financial metrics are correct in context: while the LLM does not explicitly mention the $67,854 million in goodwill and postretirement liabilities from the original answer, this omission does not introduce inaccuracy—only a slight reduction in specificity. No incorrect figures are presented, and no calculations are misstated. (2) The LLM correctly identifies both companies (AT&T and Netflix), their respective significant assumptions (discount rates based on corporate bond credit quality for AT&T; forecasted viewing patterns for Netflix), and the role of auditors in evaluating these assumptions through sensitivity analyses and comparisons to actual data. (3) The multi-hop reasoning is sound: the model synthesizes information across two different companies, industries, and accounting practices (pension obligations vs. content amortization), correctly identifying the parallel in auditor scrutiny despite differing underlying assumptions. (4) Semantically, the LLM captures the key contrast and similarity: AT&T relies on market-based, bond-yield-driven discount rates, while Netflix uses behavior-based forecasts, both of which are judgmental and subject to audit review. The only reason for not scoring a 10 is the omission of the specific $67,854 million liability figure, which adds concrete financial magnitude to AT&T’s exposure in the original answer. However, since the question does not explicitly ask for dollar amounts and the conceptual comparison is fully preserved, this is a minor gap. Overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 480,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Altria (MO) adopted ASU 2023‑07 for the year ended Dec 31 2024 and applied it retrospectively to all prior periods presented, whereas Philip Morris International (PM) adopted the update for the year ended Dec 31 2024 and applied it only to the current year【page 86】.  \nIn implementing the update, MO re‑classified its operating segments by combining the cigarette and cigar businesses into a single “Cigarettes & Cigars” segment and adding a “Smokeless Tobacco” segment【page 61】.  \nPM, on the other hand, incorporated the former Swedish Match results into its four existing geographic segments (Europe, SSEA‑CIS‑MEA, EA‑AU‑PMI DF, and Americas) and left the Wellness & Healthcare segment unchanged【page 86】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the adoption timeline and application of ASU No. 2023-07 for both MO and PM. According to the ground truth, MO adopted the standard in 2024 with expanded footnote disclosures in Note 17 and interim disclosures set for Q1 2025, but the LLM incorrectly states that MO applied it retrospectively to all prior periods — this contradicts the original answer, which does not mention retrospective application by MO. In contrast, the ground truth states that PM adopted the ASU retrospectively for the year ended December 31, 2024, but the LLM incorrectly claims PM applied it only to the current year, which is the opposite of the correct information. (2) Quantitatively, the years (2024) and dates (December 31, 2024) are correct, but the characterization of the adoption method (prospective vs. retrospective) is wrong for both companies, which affects the accuracy of the implementation timeline. The mention of 'Q1 2025' for MO’s interim disclosures is missing in the LLM answer, representing a key omission. (3) The qualitative reasoning fails on multi-hop synthesis: while the LLM correctly identifies that PM incorporated Swedish Match into its four geographic segments, it incorrectly contrasts this with MO’s segment changes — the ground truth does not mention MO combining cigarette and cigar businesses or creating a 'Smokeless Tobacco' segment as a result of ASU 2023-07, making this detail fabricated or misattributed. There is no evidence in the original answer that MO changed its operating segments due to the ASU; rather, the focus was on expanded disclosures in Note 17. (4) Contextual relevance is high because the answer attempts to address both parts of the question — adoption timeline and segment reporting changes — and references correct entities (MO, PM, Swedish Match, geographic segments). However, due to major factual errors in both adoption approach and segment changes, especially for MO, the correctness and qualitative accuracy scores are low. The inclusion of citation markers like 【page 86】 suggests source grounding but does not compensate for factual misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 584,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers Squibb’s Pomalyst has been selected by CMS for the IRA’s Medicare Part D price‑negotiation program, meaning the drug will be subject to negotiated pricing beginning in 2027—potentially eroding revenue before the product’s estimated exclusivity period ends (page 43).  In contrast, Pfizer’s 10‑K does not name any of its high‑cost products as currently subject to IRA negotiation, so its revenue outlook is not yet affected by the same pricing mechanism, although the company notes that future IRA selections could accelerate erosion (page 18).  Thus, BMY faces an earlier and more direct revenue hit from the IRA, whereas PFE’s exposure remains contingent on future selections and is likely to impact revenue later.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the LLM correctly identifies 2027 as the year when Pomalyst will be subject to IRA price negotiation, aligning with the ground truth. However, it omits PFE’s specific $1 billion net unfavorable revenue impact in 2025 due to IRA-driven Medicare Part D redesign, a key quantitative fact in the original answer. This omission reduces quantitative accuracy. (2) The LLM incorrectly states that Pfizer’s 10-K does not name any high-cost products as subject to IRA negotiation, which contradicts the ground truth: PFE is exposed to IRA pricing pressures on Ibrance and Xtandi, both selected for negotiation effective 2027. This is a major factual error affecting entity and qualitative accuracy. (3) The reasoning is partially sound in comparing BMY’s direct exposure to Pomalyst with PFE’s contingent exposure, but it fails to reflect that PFE already faces both Part D redesign impacts and specific drug selections—making PFE’s exposure neither purely future nor contingent. The multi-hop synthesis is therefore incomplete and misleading. (4) Contextually, the answer addresses the core question about IRA impacts on revenue outlook and ties in Medicare Part D and exclusivity, so relevance is high. However, due to missing key financial figures and misrepresenting PFE’s current exposure, the overall correctness is only partial. Semantic equivalence is not achieved on critical points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 416,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine operations generated $401 million in 2021 net revenues, representing roughly 1.4 % of its consolidated net revenues. Coca‑Cola’s exposure to Argentina is through Arca Continental, one of its largest bottlers that operates in northern Argentina, but the company does not disclose a separate revenue figure for that region; Arca Continental is a key partner in KO’s bottling system, so the Argentine exposure is embedded in KO’s broader bottling network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDLZ's Argentine operations generated $401 million in net revenues in 2021, matching the ground truth. It adds a calculated percentage (1.4%) of consolidated revenues, which is not in the original answer but is a reasonable inference and does not contradict any facts. However, the LLM omits the $13 million remeasurement loss due to currency risk in Argentina, a key financial impact mentioned in the ground truth, which reduces completeness. (2) All numeric values are accurate: $401 million is correctly cited, and no incorrect calculations are made. The 1.4% figure, while not in the original, is plausible and does not detract from accuracy. (3) The LLM correctly identifies Arca Continental as one of KO's largest bottlers operating in northern Argentina and notes the indirect exposure through bottler agreements. It correctly captures the contractual exclusivity (implied by 'sources concentrates exclusively') even if not explicitly stated, showing sound multi-hop reasoning. However, it misses specifying that Arca is among KO's top five bottlers and does not mention its contribution to global unit case volume, which are key qualitative points. (4) The answer is contextually highly relevant, directly comparing MDLZ's direct exposure to KO's indirect exposure via Arca Continental. The omission of the remeasurement loss and some strategic details slightly reduces qualitative and overall correctness, but core facts and synthesis are accurate. Hence, correctness_score is 8 due to minor but notable omissions in financial impact and strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 441,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY’s 10‑K notes that the FDA can use Fast‑Track designation to accelerate review of promising therapies (page 19). PR006 already holds Fast‑Track status (page 70), so LLY can expect a potentially expedited approval that would trigger the CVR payment earlier. Because the CVR’s full $4.00 per share value is only realized if approval occurs by 31 Dec 2024, an accelerated review preserves the payment’s value, underscoring the strategic benefit of acquiring a Fast‑Track gene therapy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core strategic insight from the ground truth. (1) All factual elements are correct: PR006 has Fast Track Designation, the CVR payment is $4.00 per share contingent on approval by December 31, 2024, and Fast Track status supports expedited review, which aligns with preserving the CVR value. The reference to BMY’s 10-K noting Fast Track’s role is consistent with the context. (2) Quantitative accuracy is perfect: the $4.00 per share and Dec 31, 2024 deadline match the original answer exactly. While the total ~$160 million payout (based on ~40M shares) is omitted, this is a derived figure and not explicitly required for correctness. (3) Reasoning is sound: the model correctly links Fast Track status to potential acceleration of approval, which in turn increases the likelihood of meeting the CVR deadline, thus enhancing acquisition value. This captures the multi-hop logic: BMY’s regulatory experience → importance of Fast Track → PR006’s existing status → impact on CVR timing → strategic value to LLY. (4) The answer is contextually precise and directly addresses the question’s focus on regulatory strategy and CVR implications. The only minor omission is not explicitly stating that LLY acquired Prevail in 2021, but this does not detract from the core reasoning. Wording differs but semantic equivalence is strong. No factual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 387,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V’s equity base grew modestly in 2024, with Class A common shares rising from 1,594 to 1,733 (an increase of 139 shares, ~8.7 %)【page_58】. In contrast, Mastercard’s structure is essentially static: only seven Class B shares were outstanding in 2024, and the one‑for‑one conversion mechanism has moved just 0.4 shares to Class A each year【page_93】【page_58】. Thus, V is expanding its share count, while MA’s conversion activity is negligible and has little effect on its overall shareholder composition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies V's increase in Class A shares from 1,594 to 1,733, a difference of 139 shares (~8.7%), which is quantitatively accurate and matches the ground truth. It also correctly states that MA had only 7 Class B shares outstanding in 2024. However, the claim that '0.4 shares' were converted annually is not supported by the original answer and introduces a specific figure not present in the ground truth, which only notes minimal conversion activity due to few remaining Class B shares. This is a minor factual overreach. (2) The calculation of the 139-share increase and ~8.7% growth is correct. The number formatting and references to pages are consistent with source fidelity, but the 0.4-share conversion rate lacks verification and appears to be an unsupported inference. (3) The multi-hop reasoning is mostly sound: the model contrasts V’s organic Class A share growth with MA’s near-exhausted Class B conversion mechanism. However, it misses the qualitative nuance in the original answer about MA’s conversion rules requiring divestiture post-conversion, which explains the structural limitation on long-term Class B retention. This weakens the depth of the synthesis. (4) The answer is contextually relevant and addresses the core comparison of shareholder structure evolution. While key facts are correct, the unsupported conversion rate and missing regulatory/structural context about MA’s conversion and divestiture rules prevent a higher score. Thus, correctness is 7 due to partial but not full alignment with the ground truth’s reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 440,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe notes that Saudi Arabia requires data to remain stored in the country, meaning any data processed by NVIDIA’s H100 and L40S chips would have to stay within Saudi Arabia【page_28】.  Because those high‑performance chips are subject to U.S. export‑control licensing for shipments to Saudi Arabia (Country Group D5)【page_27】, the data‑localization rule would add an extra compliance layer—requiring a license and potentially limiting or delaying deployment if the chips cannot be shipped or used in a way that satisfies both U.S. export controls and Saudi data‑localization mandates.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Saudi Arabia's data localization requirements and U.S. export controls both pose challenges to NVIDIA's deployment of H100 and L40S chips. It correctly references Adobe's identification of data localization risks and links it to NVIDIA's situation. The mention of U.S. export licensing requirements for these chips to Saudi Arabia is accurate and supported by the knowledge base. However, there is a critical error in the Country Group classification: the ground truth specifies Country Group D4, while the LLM answer incorrectly states D5. This is a significant regulatory detail that affects how export controls are applied and undermines the precision of the response. While the overall reasoning about compliance complexity and potential deployment limitations is sound and semantically aligned with the original answer, the Country Group mistake reduces the qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The answer is contextually relevant and addresses the multi-hop nature of the question—linking Adobe’s risk disclosure, Saudi regulations, and NVIDIA’s export constraints—though it omits the explicit conclusion about reduced market access and revenue impact present in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 371,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s 10‑K notes that the ASU 2020‑04 and its 2022‑06 extension are available for use through 2024 and that the company is “monitoring our contracts and transactions for potential application” of the relief, with no material effect reported. In contrast, GE’s 10‑K states that it “evaluated the financial impact in accordance with ASU 2020‑04” for the USD LIBOR discontinuation and found the overall impact to be immaterial, implying the relief has already been applied or at least fully assessed. Thus, FedEx is still in a monitoring phase, whereas GE has completed the evaluation and confirmed no material effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx is monitoring contracts with no material effect reported as of May 31, 2024 (implied by context), and GE has evaluated and concluded immaterial impact. The dates and ASUs (2020-04 and 2022-06) are correctly cited, and the extension through 2024 is accurately noted. (2) Quantitative accuracy is perfect—no numerical errors, and the timeline (through December 31, 2024) is correctly represented as 'through 2024'. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from both FedEx and GE, contrasting FedEx's ongoing monitoring approach with GE's completed evaluation, which reflects differing applications of the same accounting relief. (4) The answer captures the core insight from the ground truth: both companies fall under the same ASU framework, but differ in their implementation—FedEx remains cautious and proactive, while GE has concluded its assessment. The only minor shortcoming is that the LLM does not explicitly name the 'optional expedients' language from ASU 2022-06, but this does not detract from the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 370,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple’s manufacturing is largely outsourced to partners in Taiwan, and geopolitical tensions could trigger trade restrictions or supply disruptions that delay production, raise costs, and reduce flexibility, potentially harming Apple’s ability to deliver products (AAPL page_9, page_11). NVIDIA relies on Taiwanese foundries for wafer fabrication, and similar tensions could constrain wafer capacity, raise prices, and delay product launches, materially impacting NVIDIA’s supply continuity and financial performance (NVDA page_17, page_18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Apple relies on manufacturing partners in Taiwan and that geopolitical tensions could disrupt production, leading to delays and inefficiencies (citing AAPL page_9, page_11). Similarly, it accurately states that NVIDIA depends on Taiwanese foundries for wafer fabrication, and disruptions could impact supply continuity, pricing, and product launches (citing NVDA page_17, page_18). All entities (Apple, NVIDIA, Taiwan, foundry partners) are correct, and the reasoning correctly synthesizes the multi-hop risk exposure of both companies due to regional instability. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is scored as 10 by default (no inaccuracies). The only minor shortcoming is that the LLM answer does not explicitly use the phrase 'material adverse impact' as in the original, though it conveys the same meaning through 'materially impacting supply continuity and financial performance'. This slight omission in phrasing—without loss of factual accuracy—warrants a 9 on qualitative accuracy. Contextual relevance is perfect: the response directly addresses the question about supply chain risks for both companies due to Taiwan-related geopolitical tensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 371,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s $24,156 million of developed‑technology intangible assets acquired in the VMware deal is entirely attributable to VMware Cloud Foundation – 100 % of that asset.  \nOracle’s developed‑technology net value is $1,276 million, which is about 18.5 % of its total intangible assets of $6,890 million (1,276 ÷ 6,890 ≈ 0.185).  \nThus, Broadcom’s VCF portion is far larger relative to its intangible‑asset base than Oracle’s developed‑technology proportion.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports Oracle's developed technology value ($1,276 million), total intangible assets ($6,890 million), and the resulting percentage (~18.5%), it incorrectly states that 100% of Broadcom's $24,156 million developed technology intangible asset is attributable to VMware Cloud Foundation (VCF). The ground truth explicitly states that while a 'significant portion' is tied to VCF, the exact percentage is not disclosed. Asserting 100% is a major factual overstatement not supported by the data. (2) Quantitative accuracy is partially correct: Oracle-related numbers and calculation (1,276 ÷ 6,890 ≈ 18.5%) are accurate. However, the 100% attribution to VCF is unsupported and incorrect, undermining the quantitative integrity. (3) Multi-hop reasoning is flawed. The model fails to acknowledge the uncertainty in the Broadcom portion, which is a critical nuance in comparing strategic valuations. The comparison to Oracle is contextually valid, but the conclusion that 'Broadcom’s VCF portion is far larger' is based on a false premise. (4) Contextual relevance is high—the answer addresses both parts of the question and attempts the comparison. However, due to the major error in asserting full attribution to VCF, the correctness and qualitative accuracy scores are low. Minor formatting like '100 %' with a space is negligible. Overall, the answer is misleading despite some correct data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 410,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s Class B shares give Mr. Roberts 15 votes each and represent 33.3 % of the company’s combined voting power, a non‑dilutable block that is separate from the 66.7 % held by Class A shareholders (see CMCSA 10‑K, page 38). Alphabet’s 10‑K reports a two‑class share structure—Class A common and Class C capital—and a non‑affiliate market value of about $1.45 trillion (page 2), but the filing does not disclose voting rights for the two classes; the usual arrangement is that only Class A shares carry votes, giving Alphabet a class‑based control mechanism distinct from Comcast’s share‑based voting allocation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between CMCSA and GOOGL's voting structures. (1) Quantitatively, it correctly states that CMCSA Class B shares hold 33.3% of voting power with 15 votes per share (matching the 33⅓% in the ground truth), and accurately reports GOOGL’s non-affiliate market value as ~$1.45 trillion (aligned with $1,451.1 billion). The number of GOOGL Class A shares outstanding (300,754,904) is omitted, but the market value is correctly interpreted. (2) The answer correctly identifies that CMCSA’s Class B shares are non-dilutable and held by few holders (though it names Mr. Roberts specifically, not in the original), which reflects the concentrated control mechanism. (3) For GOOGL, it correctly notes the two-class structure and that Class A shares typically carry voting rights (implying Class C does not), though it incorrectly states the 10-K does not disclose voting rights—Alphabet’s 10-K does disclose that Class A has 1 vote/share and Class B (held by insiders) has 10 votes/share, but Class C has no votes. This omission slightly weakens the qualitative accuracy. (4) The reasoning correctly contrasts CMCSA’s concentrated, share-based voting power with GOOGL’s more dispersed, class-based control, even if less detailed on GOOGL’s affiliate vs. non-affiliate voting distribution. The answer is contextually relevant and synthesizes across both companies appropriately. Minor deductions: -1 for missing GOOGL share count, -1 for incomplete GOOGL voting rights disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 420,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "CMCSA’s 2024 balance sheet shows roughly 4.65 billion Class A shares issued versus only 9.44 million Class B shares, a ratio of about 500:1, indicating a highly concentrated equity structure where the few Class B holders (10 votes each) hold the majority of voting power【page_67】. In contrast, META’s 2024 filing lists about 2.19 billion Class A shares and 344 million Class B shares, a ratio of roughly 6.4:1, reflecting a less extreme but still significant concentration of voting power in the Class B holders【page_1】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct numbers but with key misinterpretations. It correctly reports CMCSA's Class A shares (~4.65 billion) and Class B shares (~9.44 million), aligning with the ground truth of 4,651,093,045 and 9,444,375 respectively. For META, it approximates 2.19 billion Class A and 344 million Class B shares, close to the true values of 2,189,898,148 and 343,761,117. However, the LLM incorrectly interprets the equity concentration: it claims CMCSA has a 'highly concentrated equity structure' due to Class B holders having majority voting power, but this is unsupported by the original answer or typical CMCSA disclosures. The ground truth emphasizes that CMCSA’s structure is dominated by Class A shares, implying more diffused ownership, whereas META has stronger voting concentration via Class B. (2) The ratio calculations are mathematically correct (4.65B / 9.44M ≈ 492:1, rounded to 500:1; 2.19B / 344M ≈ 6.37:1, rounded to 6.4:1), but the interpretation is reversed—higher Class A dominance in CMCSA suggests less voting concentration, not more. The LLM incorrectly assumes Class B concentration implies control in CMCSA without confirming voting rights terms for CMCSA (which were only provided for META/Alphabet). (3) Multi-hop reasoning fails: the model applies META’s voting structure (10 votes per Class B, conversion on transfer) to infer CMCSA’s dynamics, but the original answer clarifies that this detail comes from Alphabet’s filing (used as context for META), not CMCSA. Thus, the LLM erroneously generalizes META’s governance to CMCSA. (4) Scores justified: Correctness is 6 due to accurate numbers but flawed synthesis and conclusion; Quantitative Accuracy is 7 due to minor rounding and correct ratios; Qualitative Accuracy is 5 because reasoning misattributes control dynamics and misinterprets concentration; Contextual Relevance is 9 as the response directly addresses the question’s focus on equity structure comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 534,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health is highly dependent on Medicare and Medicare‑Advantage reimbursement, so any Medicare rule changes or rate cuts could directly shrink its revenue base.  AbbVie, on the other hand, faces a Medicare‑related risk that is driven by the Inflation Reduction Act’s new price‑setting authority for Medicare Part B and Part D drugs, which can cap drug prices and lower reimbursements for its products.  Thus, both companies are exposed to Medicare program changes, but CVS’s exposure is to service‑reimbursement rates, whereas AbbVie’s exposure is to drug‑price caps imposed by the IRA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between CVS's Oak Street Health and AbbVie regarding their respective exposures to Medicare under the IRA. (1) All factual elements are correct: Oak Street Health's reliance on Medicare/Medicare Advantage reimbursement is accurately described, as is AbbVie's exposure through the IRA's price-setting provisions for Part B and Part D drugs. The distinction between service-reimbursement risk (CVS) and drug-price caps (AbbVie) is clearly and correctly articulated. (2) There are no numeric values, dates, or calculations in the LLM answer, but the ground truth mentions specific years (2026, 2028) and that Imbruvica was selected for price-setting. The LLM omits these specifics but does not contradict them; the absence of these details results in a minor completeness gap, hence not a perfect 10 on qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies are exposed to Medicare-related risks under the IRA but through different mechanisms—reimbursement rates for a care provider vs. mandated pricing for a drug manufacturer. (4) The answer is contextually fully relevant, directly addressing the comparative exposure question. The omission of Imbruvica and the specific implementation years (2026/2028) prevents a perfect score, but the semantic meaning and risk differentiation are preserved, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 399,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s 10‑K shows that operating systems form a core part of its product revenue (see MSFT page 62) and that its hardware “is generally highly dependent on, and interrelated with, the underlying operating system” (page 63).  For AMD, this underscores a strong reliance on Microsoft’s OS support: AMD’s x86‑based microprocessors and graphics cards need Microsoft‑designed OSes, certified drivers, and ongoing compatibility (AMD pages 27‑28).  Thus, Microsoft’s inclusion of OS revenue highlights the critical role of Microsoft’s operating‑system ecosystem in enabling and sustaining AMD’s product performance and market success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the relationship between Microsoft's operating system revenue and AMD's dependency on OS support, citing relevant sections from both Microsoft’s and AMD’s 10-K filings (e.g., MSFT p.62–63, AMD p.27–28), which aligns with the multi-hop requirement. (3) The reasoning is sound: Microsoft’s inclusion of OS in product revenue implies ecosystem control, which in turn affects AMD’s need for OS compatibility, driver certification, and application optimization. The LLM captures the core causal chain—lack of Microsoft support could deter ISVs and reduce customer demand for AMD-based PCs—though it slightly underemphasizes the material business impact mentioned in the original ('materially affecting AMD’s business'). (4) All entities (Microsoft, AMD, x86 microprocessors, graphics products, operating system support) are correctly identified and logically connected. Wording differs but meaning is preserved. Minor deduction in qualitative accuracy due to less explicit emphasis on business risk; otherwise, fully correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 365,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s 10‑K states that its high‑density routers, switches and optics “power AI training and inference workloads for both webscalers and enterprises” and that its data‑center strategy delivers multicloud architectures with consistent policy and operations (page 4). Broadcom’s VMware Cloud Foundation, by contrast, is a private‑cloud platform that “includes native Kubernetes to support both virtual machines and containerized workloads on a single platform, enables advanced AI and machine learning workloads at enterprise scale” and offers license portability so environments can move between on‑premises data centers and supported cloud endpoints (page 8). Thus, Cisco emphasizes networking and policy consistency for multicloud AI traffic, while Broadcom provides a Kubernetes‑enabled, multicloud‑portable compute stack that directly supports enterprise‑scale AI and ML workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Cisco's role in providing high-density routers, switches, and optics for AI workloads is accurately described, as is its focus on multicloud policy and operational consistency. Broadcom's VMware Cloud Foundation (VCF) is correctly characterized as offering native Kubernetes support, enabling both VMs and containers on a single platform, supporting enterprise-scale AI/ML workloads, and providing license portability across on-premises and cloud environments. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly contrasting Cisco’s networking infrastructure focus with Broadcom’s compute and platform-level enablement via VCF, while recognizing their complementary alignment on multicloud architectures. The synthesis across companies and technologies is logical and well-supported. (4) The only minor shortcoming is that the LLM answer does not mention Broadcom’s valuation of VCF using the multi-period excess earnings method, which appears in the original answer and reflects the strategic importance of VCF in AI workloads. This omission slightly affects completeness but does not detract from the core comparison. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 412,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal’s derivatives are valued with pricing models that use observable inputs—currency rates, interest‑rate curves, option volatilities and equity prices—so all derivative fair‑value measurements fall in Level 2 and the company reports no significant unobservable inputs.  \nIn contrast, Morgan Stanley’s Level 3 instruments are priced when observable market data are limited or when a key input (e.g., credit‑correlation, pre‑payment assumptions) is not observable, requiring substantial judgment and significant unobservable assumptions. Thus PayPal’s approach relies far less on unobservable inputs than Morgan Stanley’s Level 3 valuation techniques.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PayPal uses observable inputs (currency rates, interest-rate curves, option volatilities, equity prices) for its derivative valuations, placing all fair value measurements in Level 2, and notes the absence of significant unobservable inputs—consistent with the original answer's claim that PayPal had no Level 3 assets or liabilities as of December 31, 2024. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all referenced inputs and classifications are correctly described. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s reliance on Level 2 inputs with Morgan Stanley’s use of Level 3 when observable data are limited, particularly citing examples like credit-correlation and prepayment assumptions as unobservable inputs requiring judgment—this reflects accurate synthesis across the two companies’ valuation approaches. (4) The only minor shortcoming is that the LLM answer does not explicitly state the date 'December 31, 2024' or directly say Morgan Stanley uses Level 3 for 'non-exchange-traded investments and certain secured financings,' though it captures the essence by referencing limited market data and unobservable inputs. This omission slightly affects completeness but does not detract from the core factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 432,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "Meta’s 343 million Class B shares (page 1) carry only limited voting rights on most corporate actions, so holders of those shares have little ability to influence governance decisions even though the shares are sizable. In contrast, Comcast’s 3.78 billion Class A shares (page 67) are the primary voting class and carry full voting rights, giving shareholders a much larger and more direct voting power to drive governance changes. Thus, the limited‑voting structure at Meta constrains shareholder‑driven governance relative to Comcast, where the larger, fully voting Class A base can more readily shape corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Meta's 343,761,117 Class B shares have limited voting rights, and CMCSA's 3,778,302,017 Class A shares carry full voting rights. The LLM correctly rounds these to '343 million' and '3.78 billion', which is acceptable and preserves quantitative accuracy. (2) The answer correctly identifies that Meta’s Class B shares are restricted in voting power to specific corporate actions (e.g., exiting core business, certain mergers), limiting shareholder-driven governance changes. It contrasts this accurately with CMCSA’s fully voting Class A shares, which enable stronger shareholder influence. (3) The multi-hop reasoning—comparing ownership structures across two companies and assessing implications for shareholder activism and governance—is sound and logically synthesized. (4) Minor deduction in qualitative accuracy due to omission of specific examples of 'specific corporate actions' (e.g., exiting payments business, certain mergers) mentioned in the original, which adds slight contextual depth. However, the semantic meaning and conclusion are equivalent. Wording differs but remains factually aligned and clear. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 360,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "71 % of Coca‑Cola’s non‑U.S. unit‑case volume is attributable to sparkling soft drinks in the territories where Coca‑Cola Europacific Partners (CCEP) operates (page 7). In contrast, Philip Morris’s presence in Portugal – one of CCEP’s key markets – is limited to a single manufacturing facility (page 19), indicating a much smaller operational footprint compared to KO’s dominant sparkling‑soft‑drink volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 71% figure for KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP-operated territories, matching the ground truth exactly. This satisfies the quantitative accuracy requirement, earning a 10. The entity names (KO, CCEP, PM, Portugal) are all accurate, and the multi-hop reasoning—linking KO's reliance on CCEP for distribution with PM's operational presence in Portugal—is logically sound and contextually relevant. The only minor shortcoming is that the LLM understates PM's operational scale in Portugal: while it correctly notes a manufacturing facility, it fails to mention that this facility is 'one of its largest' and produces 'over 30 billion units (cigarettes and heated tobacco units combined)'—a key comparative point in the original answer. This omission slightly weakens the qualitative accuracy, reducing it to 9. However, the core comparison—KO's volume dependence on CCEP vs. PM's direct production footprint—is still conveyed with correct semantics. Contextual relevance is full, as all parts of the question are addressed with appropriate focus on the strategic contrast between the two companies in a shared market.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 336,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables fell from $103 million in 2022 to $53 million in 2023 (page 84).  Because loan receivables include financing for hardware, software and services **(including technical‑support and advanced services)** (page 82), the lower allowance means Cisco expects fewer defaults on those support‑service contracts.  Consequently, more of its loan‑receivable balance remains available for financing, improving liquidity and giving Cisco greater capacity to extend or maintain credit for technical‑support services—though it must still monitor the quality of those receivables closely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the reduction in credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth exactly. While the ground truth includes a calculated percentage decrease of 48.5%, the LLM omits this specific figure but still accurately conveys the direction and magnitude of the change. (2) All numeric values—$103 million and $53 million—are correct and properly attributed to the right years. The calculation of a 48.5% decrease in the original answer is accurate ((103-53)/103 ≈ 0.485), and while the LLM does not include this percentage, it does not make any quantitative errors. (3) The LLM correctly identifies the multi-hop link: Cisco’s loan receivables include financing for technical support services (explicitly cited from page 82), and the reduced allowance implies lower expected defaults, which supports greater capacity to finance such services. The reasoning about improved liquidity and increased capacity to extend credit is logically sound and aligns with the ground truth’s implication of enhanced ability to offer financing due to lower perceived risk. (4) The answer is contextually fully relevant, directly addressing how the allowance change impacts financing of technical support services. The only minor shortcoming is the absence of the precise percentage decline, which slightly reduces completeness but does not affect factual correctness. Thus, the answer is highly accurate, well-reasoned, and semantically equivalent to the ground truth in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 427,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares are essentially non‑voting, with voting rights limited to a narrow set of merger‑related matters (e.g., consolidations or combinations that affect the preferred holders). In contrast, Netflix’s common stock carries a vote on every shareholder matter, giving holders universal voting power and broad influence over all corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that AT&T’s Series B Preferred Stock has limited voting rights only on specific merger-related matters, while Netflix’s common stock provides universal voting rights—this matches the original answer’s core comparison. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, or share counts), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes corporate governance structures across two different companies (AT&T and Netflix) and contrasts their voting frameworks. It captures the essence that AT&T limits influence for preferred stockholders, whereas Netflix grants broad influence to common stockholders. (4) Minor phrasing differences exist (e.g., 'non-voting' vs. 'no voting rights except'), but these do not affect factual accuracy. The LLM omits the detail that AT&T preferred holders vote 'as a single class' with votes proportional to shares held, which is a small omission in completeness but does not undermine the overall correctness. Hence, a score of 9 is justified—very close to perfect, with only minor detail loss.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 346,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal’s exposure to BNPL and cryptocurrency is largely regulatory and operational: the company notes that its planned crypto offerings and Buy‑Now‑Pay‑Later services could trigger additional licensing, regulatory scrutiny and product changes (page 18). In contrast, Visa explicitly treats these alternative providers as both partners and competitors, leveraging its network to integrate with BNPL and crypto platforms while simultaneously competing for transaction volume (page 16). Thus, PayPal faces a higher risk of disruption from regulatory and product shifts, whereas Visa mitigates that risk by positioning itself as a key partner and rival in the same space.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core content and correctly identifies the key contrast between PayPal and Visa regarding technological disruption and strategic positioning. It accurately reflects that PayPal faces risks tied to regulatory and operational challenges in adopting BNPL and cryptocurrency (citing page 18), while Visa takes a dual partner-competitor role (citing page 16), which aligns with the original answer’s claim about Visa’s adaptive strategy. There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is slightly reduced (8) because the LLM reframes PayPal’s risk more narrowly around regulatory and operational issues, whereas the original emphasizes broader technological obsolescence risk if adoption lags. This is a subtle but important distinction: the original highlights strategic vulnerability to disruption, while the LLM focuses on compliance hurdles. However, this does not invalidate the answer, especially since regulatory risk is a component of broader disruption risk. The multi-hop reasoning is sound—comparing PayPal’s exposure with Visa’s strategic positioning across two entities and strategies—and the synthesis is logical. Contextual relevance is perfect: the answer directly addresses both parts of the question and uses appropriate evidence. Minor semantic divergence prevents a 9–10 correctness score, but the answer remains substantially accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 420,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s common stock is entitled to one vote per share, the same as Alphabet’s Class A common stock, which also carries one vote per share【page_59】【page_81】. Thus, the voting power per share is identical for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that both Netflix's common stock and Alphabet's Class A Common Stock provide one vote per share, which matches the ground truth from the 2023 10-K filings. The quantitative accuracy is perfect—'one vote per share' is correctly reported for both companies with no numerical or factual errors. The reasoning is sound and the comparison is logically valid, correctly synthesizing information across two different companies' filings (a multi-hop requirement). The answer is contextually relevant and directly addresses the question about voting power per share. The only minor shortcoming is completeness: while the core equivalence is correctly stated, the LLM omits mention of Alphabet’s multiple share classes (e.g., Class B with 10 votes per share), which provides important context for why the Class A comparison is meaningful. This contextual nuance is present in the original answer and helps explain the significance of the one-vote equivalence despite Alphabet's complex structure. However, since the question specifically asks only about the voting rights of the common/Class A shares, this omission does not invalidate the correctness of the response. Thus, the answer is semantically equivalent in substance but slightly less detailed in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 361,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "PM’s VAR calculation, using a parametric delta‑gamma approximation under normal market conditions, a 95 % confidence interval and a one‑day horizon, produced a one‑day VAR of $297 million for interest‑rate‑sensitive instruments and $77 million for foreign‑currency‑sensitive instruments at 12/31/23. MDLZ applies the same technique with identical assumptions but reports a lower one‑day VAR of $119 million for interest rates and $14 million for currency at 12/31/23, plus an additional $21 million commodity‑price component. While both exclude hedged items, PM focuses solely on derivative exposures, whereas MDLZ’s model also incorporates all debt, interest‑rate, foreign‑exchange, commodity derivatives and market‑sensitive equity positions, broadening its risk‑exposure assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that PM does *not* disclose a specific VAR figure, but the LLM claims PM reported a one-day VAR of $297 million for interest-rate-sensitive instruments and $77 million for foreign-currency-sensitive instruments at 12/31/23—this is entirely fabricated and contradicts the original answer. Similarly, the LLM attributes a $119 million VAR for interest rates, $14 million for currency, and $21 million for commodities to MDLZ, but the original answer does not provide these exact numbers—while MDLZ does disclose VAR amounts, the specific figures cited by the LLM are not present in the ground truth and cannot be verified. (2) The quantitative inaccuracies are severe: all dollar amounts and the specific date (12/31/23) are either incorrect or unsupported. The original answer mentions MDLZ discloses VAR amounts but does not specify the values; the LLM invents precise numbers with a false sense of precision. (3) The multi-hop reasoning is partially sound in structure—comparing PM and MDLZ on methodology, assumptions, and scope of risk exposure—but fails because it builds on false data. The point about MDLZ including commodity risk and broader instruments (debt, equity positions) is not in the original answer and represents an overextension. The original only states MDLZ includes currency and commodity options with non-linear valuation, not a broader set of instruments. (4) Contextual relevance is moderate because the LLM addresses the right companies, method (delta-gamma), confidence level, and holding period, and attempts to contrast their approaches. However, the inclusion of fabricated numbers and unsupported claims about scope (e.g., 'all debt', 'market-sensitive equity positions') severely undermines correctness. The qualitative reasoning would score higher if not for the invention of data. Final scores reflect major penalties on quantitative accuracy and overall correctness due to hallucinated figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 545,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the Market Risk Rule because its aggregate trading assets and liabilities equal at least 10 % of total assets or $1 B, so it must adjust its risk‑based capital ratios to reflect trading‑book market risk. JPMorgan Chase, by contrast, derives its Basel III regulatory capital from a two‑tier VaR framework: a 95 % one‑day risk‑management VaR for internal use and a 99 % ten‑day regulatory VaR for covered positions that directly feeds into its Basel III capital requirement. Thus, Capital One’s exposure is threshold‑driven and triggers a capital adjustment, while JPMorgan’s capital is calculated through a VaR‑based methodology that sets the capital buffer for its trading book.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission affecting completeness. (1) Quantitatively, all numbers are accurate: the $1B or 10% threshold for Capital One, JPMorgan's 99% confidence level and ten-business-day holding period (referred to as 'ten-day' in the answer) are correctly stated. The mention of a 95% one-day internal VaR for JPMorgan is additional context not in the original answer but is factually plausible and not contradicted by the ground truth. (2) The entity identification (Capital One/COF, JPMorgan Chase/JPM) and regulatory frameworks (Market Risk Rule, Basel III) are correct. (3) The reasoning correctly contrasts Capital One’s threshold-triggered compliance with the Market Risk Rule versus JPMorgan’s use of an internal VaR model feeding into regulatory capital. However, the LLM omits key information from the original answer about Capital One being evaluated under the Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028—a critical part of the multi-hop comparison. (4) Despite this omission, the core comparison on VaR methodologies and capital treatment is sound and relevant. The answer is semantically close to the original and addresses the main thrust of the question, warranting a high score but not perfect due to the missing detail on COF’s evolving Basel III framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 388,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco has a $50 million allowance for credit losses on loan receivables that include financing for technical‑support services, a concrete financial provision for potential defaults. In contrast, Salesforce notes a reliance on third‑party developers and providers for technical support and integration—an operational risk that could impair service delivery but is not quantified in the same way.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cisco's credit loss allowance related to technical support financing and Salesforce's reliance on third-party providers. However, the dollar amount for Cisco is slightly inaccurate—$50 million is reported instead of the correct $53 million from the ground truth as of July 29, 2023. This minor numerical discrepancy affects quantitative accuracy but does not distort the overall meaning. (2) The original answer specifies $53 million with a precise date (July 29, 2023), while the LLM omits the date and reports $50 million, likely due to rounding or data source variation. Despite this, the figure is in the right range and contextually close. (3) The multi-hop reasoning is sound: the model correctly contrasts Cisco’s direct financial risk (credit loss allowance on financing for technical support) with Salesforce’s operational risk (reliance on third-party service delivery). It captures the core distinction in how each company faces service delivery risk—through credit exposure vs. service quality control. (4) The answer is semantically equivalent in intent and structure, with strong qualitative reasoning and contextual relevance. The slight numerical inaccuracy prevents a top score in correctness and quantitative accuracy, but the synthesis across companies and risk types is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 381,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in its Class B shares, which carry ten votes each and are convertible into Class A shares, creating a governance risk that can erode investor confidence in the one‑vote Class A stock (see pages 48‑49). In contrast, Comcast’s equity structure includes non‑voting Class B shares that are not convertible into Class A shares or tied to governance restrictions, so the governance risk is less pronounced and does not directly undermine confidence in its Class A common stock (see pages 69‑70).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core facts and conveys a reasonable contrast between META and CMCSA's equity structures, but contains a key inaccuracy regarding CMCSA's Class B shares being 'non-voting' and 'not convertible'. According to the ground truth, CMCSA has 9,444,375 issued and outstanding Class B common stock as of 2023, but there is no mention of them being non-voting or non-convertible—only that they lack a conversion mechanism tied to governance restrictions. The LLM incorrectly introduces 'non-voting' and 'not convertible' characteristics not present in the original answer, which misrepresents CMCSA's structure. However, the central point—that CMCSA does not tie governance rights or conversion to special restrictions like META does—is accurate. The description of META’s dual-class structure, including disproportionate control and potential impact on investor confidence in Class A shares, aligns well with the ground truth, including the implication of reduced governance protections. There are no numerical inaccuracies (quantitative accuracy is perfect), and the contextual relevance is high as it directly addresses the governance risk comparison. The reasoning is partially sound but flawed in the characterization of CMCSA’s shares, reducing qualitative accuracy. Overall, the answer captures the essential contrast but with a significant detail error regarding CMCSA’s share rights.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 391,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG’s RMBS are valued with discounted‑cash‑flow (DCF) models that rely on a set of unobservable inputs—constant pre‑payment rates, loss severity, default rates and yield ranges (see the RMBS tables on pages 120–124).  In contrast, MS also uses DCF for its Level‑3 fair‑value assets, but only 0.9%–1.2% of its total assets are Level‑3, and the firm stresses that most fair‑value measurements are based on observable inputs, limiting the use of unobservable assumptions (page 42).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between AIG and MS regarding their use of discounted cash flow models and reliance on unobservable inputs. (1) It correctly identifies that AIG uses DCF models for RMBS valuation with unobservable inputs such as prepayment rates and loss severity, though it omits the specific numeric ranges (4.10%–9.26% for CPR, 40.81%–76.72% for loss severity) present in the ground truth. This omission affects completeness but not overall correctness. (2) For MS, the LLM states that Level 3 assets are 0.9%–1.2% of total assets, while the ground truth specifies 0.9% as of December 31, 2024. The upper bound of 1.2% is not in the original answer, introducing a minor inaccuracy; however, the 0.9% figure is correct and contextually aligned. (3) The qualitative reasoning is sound: both firms use DCF with unobservable inputs, but MS has a smaller proportion of Level 3 assets, indicating less reliance—this synthesis across entities is accurate and logically presented. (4) The LLM adds that MS emphasizes observable inputs for most fair value measurements, which is consistent with the ground truth’s implication of 'smaller but still material' reliance on unobservables. While the LLM cites page references not in the original, this does not affect factual accuracy. Overall, the answer conveys semantic equivalence with minor gaps in numerical precision and completeness of input ranges, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 408,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables tied to hardware financing fell from $53 million in 2023 to $50 million in 2024 (a $3 million decrease), indicating a modest improvement in expected credit risk on its financing‑receivable balance.  In contrast, Microsoft treats hardware that is interdependent with its operating system as a single performance obligation and recognizes revenue at the point of ownership transfer, rather than over time.  Together, these practices show that Cisco’s exposure to integrated hardware‑software offerings is monitored through credit‑loss provisions on financing receivables, while Microsoft’s exposure is reflected in the timing and bundling of revenue recognition for the same integrated products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. The ground truth states that Cisco's allowance decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023. However, the LLM incorrectly reports a decrease from $53 million in 2023 to $50 million in 2024, which misrepresents both the baseline amount and the fiscal years involved. This introduces a major quantitative error, including a wrong starting value, incorrect time frame, and inaccurate magnitude of change. (2) The calculation of a $3 million decrease is numerically correct based on the LLM's stated figures, but since those figures are factually wrong, the calculation does not reflect reality. There is no mention of the actual $50 million reduction ($103M to $53M) in the correct fiscal years (FY2022 to FY2023). (3) The qualitative reasoning about Microsoft’s revenue recognition is accurate: it correctly identifies that Microsoft treats interdependent hardware-software as a single performance obligation and recognizes revenue at point of sale/transfer. The comparison in financial exposure—Cisco managing credit risk via allowances on financing, Microsoft via bundled revenue recognition—is conceptually sound and aligns with the ground truth. This shows correct multi-hop synthesis in logic, though based on flawed data. (4) Contextual relevance is high because the answer addresses both companies, the nature of integrated offerings, and their respective financial reporting approaches. However, the correctness score is low due to the critical error in financial figures and time periods, which undermines the factual foundation of the response. Quantitative accuracy is severely penalized due to incorrect dollar amounts and years. Qualitative accuracy is moderate because the conceptual framework and reasoning are valid despite incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 512,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG’s 2024 loss from embedded derivatives was $75 million (see AIG 10‑K, page 144).  In contrast, Morgan Stanley’s credit‑risk exposure through CDOs—captured in the fair‑value of credit protection sold—amounts to roughly $4.3 billion (see MS 10‑K, page 108).  Thus, the CDO exposure is about 57 times larger than AIG’s embedded‑derivative loss.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, the $4.3 billion figure attributed to Morgan Stanley's credit risk exposure from CDOs (cited from MS 10-K, page 108) is not present in the ground truth and represents a critical hallucination—no such number appears in the original answer or supporting knowledge graph. The original answer does not provide any quantitative value for MS’s exposure, only a qualitative description of the risk structure. Therefore, the claimed 57x comparison is entirely fabricated and mathematically unsound. Second, while AIG’s $75 million loss in 2024 is correctly stated, the LLM incorrectly frames the response as a direct quantitative comparison between AIG’s realized loss and MS’s total exposure, which the original answer does not support. The ground truth emphasizes qualitative parallels in risk structure—both firms face principal loss risk due to embedded derivatives in hybrid instruments—rather than offering a numerical comparison. The LLM fails to capture this nuanced, multi-hop synthesis and instead invents a false quantitative contrast. While the entities (AIG, MS, CDOs, embedded derivatives) and general context (structured credit products, credit risk) are correctly identified, the reasoning is flawed due to the unsupported calculation and misrepresentation of MS’s exposure. The answer is contextually relevant to the question’s domain but fails on factual and logical grounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 406,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s forecast‑transaction cash‑flow hedges are set for up to **four years** (policy limits the period to no longer than four years). Google’s option‑based hedges mature in **24 months or less**. Thus, Disney’s hedges have a longer duration than Google’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison correctly. (1) Quantitatively, the durations—'up to four years' for Disney and '24 months or less' for Google—are factually correct and match the ground truth. The use of option contracts by both companies is implied in the context and aligns with the original answer. (2) All numeric values related to timeframes are correct; no dollar amounts were required in the LLM's response to answer the specific question about duration comparison, though the original answer included hedge values ($9.9B for Disney, $731M for Google), which the LLM omitted. However, since the question focused on duration and not hedge values, this omission does not detract from correctness. (3) The multi-hop reasoning—comparing hedge maturity periods across two companies using information from their respective hedging policies—is sound and correctly synthesized. (4) The conclusion that Disney’s hedges have a longer duration than Google’s is logically valid and clearly stated. The only minor shortcoming is the lack of explicit mention of both companies using option contracts, though this is contextually covered by the phrase 'option-based hedges' for Google and general industry knowledge. Overall, the answer is semantically equivalent in addressing the duration comparison, making it factually correct and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 382,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "QCOM projects that the OECD’s Pillar Two global minimum tax will not materially affect its FY 2025 tax provision, noting that it has no significant operations in jurisdictions with rates below the 15 % threshold【page 75】.  In contrast, Intel’s Pillar Two exposure is more pronounced because its business is spread across many low‑tax jurisdictions, which could trigger higher tax costs—though the exact amount is not disclosed in the pages provided.  Thus, QCOM’s expected impact is negligible, whereas Intel’s broader geographic footprint likely creates a greater potential tax liability under the new rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: QCOM expects minimal impact due to lack of material operations in jurisdictions with tax rates below 15%, and INTC has greater exposure due to its broader international footprint, particularly in low-tax jurisdictions. The fiscal year 2025 timeline is correctly referenced. (2) Quantitative accuracy is perfect—no numerical errors; the 15% threshold is correctly cited, and no incorrect figures are introduced. (3) Multi-hop reasoning is sound: the model correctly contrasts QCOM’s limited exposure with INTC’s more complex international tax position under Pillar Two, synthesizing implications based on geographic distribution. The only minor shortcoming is that the LLM does not explicitly mention INTC’s ongoing evaluation status or the EU’s 2024 adoption plans, which are in the original answer and add context about timing and uncertainty. However, the essence—that INTC faces greater exposure and uncertainty—is conveyed. (4) The answer is fully relevant, directly addressing the comparative impact of the Global Minimum Tax on both companies’ tax liabilities in FY2025 based on geographic operations. Wording differs but meaning is semantically equivalent. Minor omission of EU legislative timing prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 380,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class scheme gives each Class B share 10 votes versus 1 for Class A (page 81), so the founder’s large Class B holding confers a disproportionate voting advantage that can be diluted if he converts those shares to Class A. Comcast’s Class B shares carry 15 votes per share and collectively represent a fixed 33 ⅓ % of voting power that cannot be diluted by new issuances (page 91), giving the founder a stable but limited block of control. Thus, Alphabet’s founder enjoys a higher potential control that is contingent on maintaining Class B status, whereas Comcast’s founder has a guaranteed but smaller share of influence that is protected from dilution.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that Comcast’s Class B shares carry '15 votes per share'—this is incorrect and not supported by the ground truth, which makes no mention of per-share vote count for Comcast, only that Class B collectively holds 33⅓% of voting power non-dilutably. This undermines quantitative accuracy. Alphabet’s 10:1 voting ratio is correctly stated. (2) The claim about 'page 81' and 'page 91' suggests source references not present in the original question or ground truth, raising concerns about hallucination or unsupported sourcing. (3) The reasoning correctly contrasts the dynamic, potentially dilutable control at Alphabet (due to conversion upon transfer) with Comcast’s non-dilutable, fixed control block, showing sound qualitative understanding of governance implications. However, the incorrect '15 votes per share' figure introduces a material error in the multi-hop comparison, as it implies a per-share voting mechanism rather than a fixed aggregate voting rights structure. (4) Despite this, the LLM captures the core contrast: Alphabet allows high but contingent founder control, while Comcast provides a lower but guaranteed floor. This semantic equivalence in governance impact supports a moderate correctness score. The answer is contextually relevant and well-structured, but the quantitative inaccuracy limits its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 391,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The indemnification agreement between PM USA and PMI means Altria’s exposure to tobacco‑related litigation is essentially off‑balance‑sheet – Altria has no related liability recorded on its consolidated balance sheet (the fair value of the indemnification is insignificant)【page_108】.  In contrast, PMI retains a substantial liability from the RBH deconsolidation, having recorded a $194 million pre‑tax charge (net $142 million) for tobacco litigation and remaining exposed to Canadian class actions, which continues to appear on PMI’s financial statements【page_111】【page_114】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The claim that PMI recorded a $194 million pre-tax charge (net $142 million) related to RBH deconsolidation and Canadian class actions is not supported by the ground truth, which mentions reclassifications from accumulated other comprehensive losses due to RBH deconsolidation but does not specify any such charge amount. This introduces false numerical data not present in the original. (2) Entity and reasoning error: The LLM incorrectly attributes the RBH-related obligations to PMI, while the ground truth states that PM (USA) retains obligations tied to the RBH deconsolidation — a critical distinction. RBH deconsolidation impacts PM/Altria, not PMI, so assigning the financial impact to PMI misrepresents the structure. (3) Misplaced focus: The LLM frames PMI as bearing litigation liabilities from Canadian class actions and RBH, whereas the original answer emphasizes that Altria/PM USA’s exposure to PMI-related litigation is limited due to indemnification, and PM’s RBH-related impacts are separate and structural (reclassifications), not necessarily ongoing litigation charges. (4) Semantic mismatch: While the LLM correctly notes Altria has not recorded a liability due to insignificant fair value, it fails to accurately describe the mutual indemnification structure between PM USA and PMI, omitting key details about contract manufacturing and scope of indemnities. (5) Contextual relevance is moderate — it addresses financial exposure and indemnification but misassigns liabilities to the wrong entity, leading to flawed conclusions. Overall, core facts are distorted, especially regarding who bears which liabilities and the nature/amount of financial impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 485,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables dropped from $103 million in 2022 to $53 million in 2023, reducing the reserve and increasing net financing receivables that back its hardware, software and technical‑support loans—this improves liquidity and lowers the cost of financing its support services. Adobe, by contrast, funds its technical support through subscription and maintenance revenue streams (and partner‑enablement programs), relying on its SaaS model rather than on loan‑receivable provisioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023, matching the ground truth exactly. These numbers are accurate and properly contextualized. (2) Quantitatively, all figures are correct with no calculation errors. The format ($103 million vs $103M) is acceptable variation. (3) The reasoning is mostly sound: the LLM correctly identifies that Cisco uses loan receivables to finance technical support services and that the decline in allowance improves liquidity and lowers financing costs. However, it adds an interpretation—'increasing net financing receivables' and 'improves liquidity'—that, while plausible, is not explicitly supported in the ground truth. The original answer focuses on reduced risk and possible improved credit quality or reduced financing, rather than asserting improved liquidity. This is a minor overinterpretation. (4) For Adobe, the LLM correctly states that technical support is funded via subscription and maintenance revenue, aligning with the ground truth. It accurately contrasts Adobe’s SaaS/maintenance model with Cisco’s loan-based approach. However, it omits specific details about the 1- to 3-year terms and 'subscription entitlements' mentioned in the original, and introduces 'partner-enablement programs' not present in the ground truth, which slightly reduces completeness and qualitative accuracy. Despite these minor issues, the core multi-hop comparison between Cisco’s financing model and Adobe’s subscription model is well-executed and factually aligned. Hence, high scores across the board with a slight deduction in qualitative accuracy for minor overreach and omission of fine details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 470,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. acted as the administrative agent for both the Caterpillar 2022 5‑Year Credit Facility and Boeing’s 2019 Five‑Year Credit Agreement. Boeing’s agreement was amended on 25 August 2022 and featured JPMorgan Chase as the syndication agent, with Citibank and JPMorgan jointly arranging and managing the syndicate. The Caterpillar facility’s amendment timeline and syndication structure are not disclosed in the provided pages, suggesting a different or less‑complex arrangement than Boeing’s joint syndication.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Citibank, N.A. as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement, and accurately states the Boeing amendment date of August 25, 2022. However, it incorrectly claims that the Caterpillar amendment timeline and syndication structure are 'not disclosed in the provided pages,' which contradicts the ground truth that Amendment No. 1 to Caterpillar’s facility occurred on August 31, 2023. This is a significant factual omission and misrepresentation, as the information is available and directly relevant. The LLM also correctly identifies JPMorgan Chase Bank, N.A.'s role in Boeing’s agreement as syndication agent and joint lead arranger. However, it fails to mention MUFG Bank, Ltd.'s role in Caterpillar’s syndication, instead suggesting a lack of disclosure and implying a simpler structure without evidence. This undermines the comparative analysis required by the question. While the qualitative reasoning framework is sound—comparing amendment timelines and syndication structures—the failure to report Caterpillar’s amendment date and syndication partners results in incomplete and partially incorrect multi-hop synthesis. The answer is contextually relevant and addresses the core comparison, but with critical gaps in factual completeness and accuracy, particularly on the Caterpillar side. Quantitative accuracy is acceptable for the Boeing date (correctly reported), but incomplete due to missing Caterpillar amendment date. Overall, the answer is partially correct but contains significant omissions that affect the validity of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 451,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "A prolonged conflict in Taiwan would likely cut off or severely restrict access to the region’s foundry capacity that both NVIDIA and Qualcomm depend on for key chip manufacturing.  Both companies note that a military or geopolitical crisis involving China and Taiwan could “severely limit or prevent us from receiving chipset supply from Taiwan, which would have a material adverse impact on our business” (NVIDIA 10‑K, p. 18; Qualcomm 10‑K, p. 35).  Such a disruption would cause production delays, shortages and higher costs, undermining supply‑chain reliability for both firms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original ground truth. (1) All factual elements are correct: both NVIDIA and Qualcomm rely on Taiwanese foundries, and a geopolitical conflict would disrupt supply chains, leading to production delays, shortages, and material adverse impacts. The LLM correctly cites both companies' 10-K filings (NVIDIA p.18, Qualcomm p.35) with a nearly exact quote regarding the risk of being 'severely limited or prevented' from receiving chipset supply. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is not applicable but no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes shared dependency on Taiwan-based foundries and the cascading impact of geopolitical conflict on both firms’ supply chains. (4) The only minor shortcoming is that the LLM omits NVIDIA’s additional point about demand estimation challenges under geopolitical uncertainty, which is present in the original answer. However, this does not undermine the core correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the question with precise, supported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 357,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s indemnification exposure is limited to the possibility of receiving indemnification from the U.S. government for certain claims under its government contracts, a risk that is not transferred but may be mitigated by insurance (see page 18). In contrast, 3M’s spin‑off transferred potential liabilities from the Bair Hugger and Federal False Claims Act / Qui Tam litigation to Solventum, which assumes those liabilities and agrees to indemnify and defend 3M (see page 84). Thus, Boeing’s exposure is a potential government‑provided indemnity tied to its contracts, whereas 3M’s exposure is a set of litigation‑related liabilities that have been shifted to a new entity with explicit indemnification and defense obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and captures the key distinction between Boeing's indemnification risk and 3M's transferred liabilities. Quantitatively, there are no numbers, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. The LLM correctly identifies that 3M transferred liabilities related to Bair Hugger and Federal False Claims Act litigation to Solventum as part of the spin-off (implied April 1, 2024, though date not mentioned in LLM answer), and that Solventum now has indemnification and defense obligations. However, the LLM mischaracterizes Boeing's exposure: the original answer states Boeing faces indemnification *risks* from U.S. government contracts due to pension cost allocations under CAS, which could affect profitability, whereas the LLM incorrectly frames this as Boeing potentially *receiving* indemnification *from* the government. This reverses the direction of risk—Boeing is at risk of having to indemnify or absorb costs, not being indemnified. This is a significant qualitative error in reasoning and interpretation, though the contrast with 3M’s structure is still logically framed. The multi-hop synthesis across companies and legal structures is generally sound, and the answer remains contextually relevant. Due to the misrepresentation of Boeing’s risk direction, the correctness and qualitative accuracy scores are reduced, but not severely, as core entities and 3M’s liability transfer are accurately described.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 425,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "CMCSA’s Class B shares are wholly owned by Brian L. Roberts and carry 15 votes per share, giving him majority voting power and illustrating how a single shareholder can dominate corporate governance【page_33】.  Meta’s dual‑class structure is similar: Zuckerberg’s Class B shares (10 votes each) give him a majority of the combined voting power, making Meta a “controlled company” that is not required to maintain a majority of independent directors or independent committees【page_49】【page_50】【page_51】.  Consequently, Meta’s Class A shareholders face heightened governance risk, as the controlling shareholder can influence board composition and corporate decisions, potentially at the expense of minority interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that CMCSA's Class B shares are wholly owned by Brian L. Roberts and carry 15 votes per share, though it does not specify the exact 33⅓% voting power mentioned in the original answer. This is a minor omission but does not affect overall correctness. (2) For META, it accurately states that Zuckerberg’s Class B shares carry 10 votes each and give him majority voting control, correctly characterizing Meta as a 'controlled company' exempt from certain corporate governance requirements (e.g., majority independent boards). The LLM supports this with correct citations (pages 49–51), and while the original answer references a 35% threshold for loss of control, the LLM omits this specific number—again, a minor gap. (3) The multi-hop reasoning is sound: the model draws a valid parallel between CMCSA’s concentrated voting structure and Meta’s dual-class system, correctly inferring increased governance risks for Class A shareholders due to limited influence. (4) Semantic equivalence is strong—wording differs but meaning matches. The answer is fully contextually relevant, directly addressing how concentrated voting power in one entity (CMCSA) informs understanding of governance risks in another (META). Minor deductions in quantitative and qualitative accuracy due to missing specific percentages (33⅓%, 35%) and the precise mechanism of control transition, but core facts, numbers, and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 414,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s bottling and distribution system in northern Argentina is handled by its independent partner Arca Continental, which the company relies on to bring its beverages to that region【page_7】. Procter & Gamble notes that Argentina is one of the countries where significant exchange‑rate fluctuations have materially impacted its sales, costs and earnings, creating a foreign‑exchange risk exposure【page_23】. Thus, while Coca‑Cola’s exposure in Argentina is operational through a local bottler, P&G’s exposure is financial, stemming from currency volatility that could affect its profitability in the same country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core intersection between Coca-Cola and Procter & Gamble's exposure in Argentina, aligning well with the ground truth. (1) There are no numeric values in the original or LLM answer that conflict—both correctly avoid citing specific percentages or financial figures beyond what's in the source, and no calculations are required. (2) The LLM correctly identifies the entities: Coca-Cola, Arca Continental, and Procter & Gamble, and accurately describes their respective exposures—Coca-Cola via operational dependency on Arca Continental in northern Argentina, and P&G via foreign exchange volatility affecting its financials. (3) The multi-hop reasoning is sound: it connects Coca-Cola’s indirect risk through a distribution partner with P&G’s direct financial risk due to Argentina’s currency fluctuations, highlighting the shared country-level macroeconomic exposure. (4) While the LLM omits the specific detail that Coca-Cola’s global unit case volume via bottlers is 17% (mentioned in the original answer), this does not detract from the central point about shared Argentina exposure. The omission is minor and does not affect factual correctness. Wording differs but maintains semantic equivalence. All sources cited (page_7, page_23) are contextually appropriate. Thus, the answer is highly accurate, complete in key aspects, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 388,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Lilly’s Alimta, a small‑molecule oncology drug, is protected only by the Hatch‑Waxman framework, which gives a five‑year exclusivity period and then allows generic entry.  When Alimta’s patents expire, the company expects a rapid, severe drop in oncology revenue as generics can launch almost immediately.  Amgen’s biologics, however, are shielded by a 12‑year exclusivity period under the BPCIA, giving a longer buffer; although the firm still faces patent litigation and the possibility of biosimilar competition, the impact on sales is likely to be more gradual and is contingent on evolving regulatory guidance on interchangeability and biosimilar approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Alimta is a small molecule drug subject to Hatch-Waxman, leading to rapid generic entry and severe revenue decline for Eli Lilly upon patent expiration—this matches the original answer's emphasis on immediate and significant revenue erosion. For Amgen, it accurately notes the 12-year exclusivity under the BPCIA (Biologics Price Competition and Innovation Act), which provides a longer buffer than small molecule exclusivity, and highlights the more gradual impact of biosimilar competition due to regulatory and manufacturing complexities. (2) Quantitatively, the 5-year exclusivity for small molecules (Hatch-Waxman) and 12-year exclusivity for biologics (BPCIA) are correct; no calculations are required, and all timeframes are accurately represented. (3) The multi-hop reasoning is sound: the model correctly contrasts the regulatory frameworks (Hatch-Waxman vs. BPCIA), links them to the respective companies' products (Alimta vs. Amgen’s biologics), and infers differing revenue impact trajectories—rapid vs. gradual. (4) The only minor shortcoming is that the LLM does not explicitly mention 'umbrella exclusivity' or the FDA's stance on interchangeability as a source of regulatory uncertainty, which is included in the original answer and adds nuance to Amgen’s risk profile. However, it does reference 'evolving regulatory guidance on interchangeability and biosimilar approval,' which captures the essence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission of detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 455,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel’s non‑US tax benefits are being evaluated under the OECD’s Pillar Two Model Rules, and the company expects no material increase in global tax costs because it does not have significant operations in jurisdictions below the 15 % threshold (Intel 10‑K, p. 44). Microsoft’s 10‑K (p. 28‑32) does not disclose details of its exposure to the global minimum tax, so the extent of its impact is not shown in the provided pages, although its larger global footprint suggests a potentially greater exposure under the same OECD framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in characterizing Intel's position. The original answer states that Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions and that it is actively evaluating Pillar Two's impact, with implementation possibly starting in 2024. In contrast, the LLM incorrectly claims Intel 'expects no material increase in global tax costs' and cites a reason (not having significant operations in jurisdictions below 15%) that is attributed to Microsoft in the ground truth, not Intel. This misattribution severely undermines the correctness. For Microsoft, the LLM states that its 10-K 'does not disclose details' and that exposure is unknown, which contradicts the original answer stating Microsoft acknowledges the global minimum tax and does not expect a material increase due to limited operations in low-rate jurisdictions. Thus, the LLM incorrectly reverses or fabricates positions for both companies. (2) Quantitatively, the 15% threshold is correctly referenced, and no incorrect numbers or calculations are present—this aspect is accurate. (3) The multi-hop reasoning fails: the model does not correctly synthesize the contrasting tax strategies—Intel’s increased non-US tax benefits vs. Microsoft’s limited exposure due to footprint. Instead, it misattributes reasoning and fails to draw the correct comparison based on geographic strategy. (4) Contextual relevance is moderate because the answer addresses the OECD Pillar Two, tax exposure, and both companies, but the substance is factually inverted. Due to major errors in entity-specific reasoning and factual content, the correctness score is low despite correct terminology and threshold accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 480,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 transfer of $523 million of surplus international pension assets to general assets reduces its exposure to limited‑partnership vehicles, because those assets were previously held in pension trusts that included limited‑partnership investments. In contrast, PEP’s pension investment strategy continues to use limited partnerships, so its exposure to such entities remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core of the ground truth. (1) Quantitatively, all numbers and dates are correct: KO's $523 million transfer in 2024 is accurately reported. (2) The entity identification is correct—KO and PEP are properly referenced with respect to their pension strategies. (3) The reasoning correctly infers that transferring surplus pension assets to general assets reduces exposure to limited partnerships, as those were previously held within pension trusts that invested in such vehicles. It also correctly contrasts this with PEP’s ongoing use of limited partnerships. (4) The only minor shortcoming is completeness: the LLM omits specific supporting detail present in the ground truth—namely, that PEP explicitly holds limited partnerships and private credit funds valued at net asset value per its 2024 10-K, and the reference to NEE’s pension strategy as contextual evidence for KO’s prior use of such vehicles. While not strictly necessary, this additional context strengthens the original answer’s multi-hop reasoning. However, the LLM answer still conveys semantically equivalent conclusions with sound logic and factual accuracy, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 337,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 (page 36) was driven largely by higher revenues, many of which come from products still protected by patents and data‑protection exclusivity—showing how patent rights set the length of market exclusivity.  This financial benefit parallels Lilly’s strategy of relying on the 12‑year U.S. biologic data protection granted under the BPCIA (pages 8–9), which can safeguard revenue even after the underlying patents expire, underscoring the complementary role of patent and regulatory exclusivity in sustaining earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020, matching the ground truth in both amount and direction. It accurately references the role of patent rights and data protection in determining market exclusivity. The mention of LLY’s reliance on 12-year U.S. biologic data protection under the BPCIA aligns with the original answer and is factually correct. (2) Quantitatively, the $17.3 billion figure is accurate and properly contextualized. No calculations are required beyond correct identification of the increase, which is done correctly. Format variations are not an issue here. (3) The multi-hop reasoning is sound: the model connects PFE’s financial performance to the broader industry reliance on intellectual property and regulatory exclusivity, then cross-references this with LLY’s specific use of BPCIA protections. While the original answer notes additional factors like lower asset impairment charges and gains on equity securities—details not mentioned in the LLM response—the core synthesis between patent rights, data protection, and revenue protection is preserved. The LLM slightly oversimplifies PFE’s income drivers but does not misstate them. (4) The correctness score is 9 because the key facts, entities, numbers, and cross-company conceptual link are accurate and well-reasoned. The qualitative accuracy is 9 due to minor omission of specific financial drivers for PFE’s increase, but the overarching logic remains intact. Quantitative accuracy is 10 as all numbers are correct, and contextual relevance is 10 as the answer directly addresses the relationship between financial performance and exclusivity mechanisms across both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 477,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 filings show that Disney earns recurring fees from Hulu for the right to air ESPN and other Disney linear networks on Hulu Live – a revenue‑sharing arrangement that is reflected as “fees paid by Hulu to ESPN” in the eliminations section.  That same Hulu business also generated a one‑time $8.6 billion cash inflow when Comcast exercised its put right to sell its stake in November 2023, a transaction recorded separately in the 2024 filings.  Thus, the revenue‑sharing fees represent ongoing Hulu revenue, while the $8.6 billion payment was a one‑off cash receipt from Comcast’s partial exit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness and reasoning depth. (1) Quantitatively, all numbers and dates are accurate: the $8.6 billion payment from Disney to Comcast in November 2023 is correctly cited, and the characterization of the transaction as a result of Comcast exercising its put option is factually sound. The mention of recurring fees from Hulu to ESPN being reflected in the eliminations section of Disney's 2024 financials matches the source. (2) However, the LLM omits key contextual details present in the original answer—specifically, that the $8.6 billion was based on a $9.2 billion minimum equity value less $557 million for prior capital calls. While not strictly necessary for a high-level explanation, this detail is part of the full financial rationale and was explicitly included in the ground truth, making its absence a minor completeness issue. (3) The multi-hop reasoning is mostly sound: the LLM correctly identifies the ongoing revenue-sharing (fees from Hulu to ESPN) and separates it from the one-time $8.6 billion transaction. However, it fails to explicitly connect how the revenue-sharing arrangement contributes to Hulu’s valuation, which in turn influenced the $8.6 billion payment—this causal link is central to the original answer’s logic and represents a gap in synthesis. (4) Despite these omissions, the answer remains factually accurate, contextually relevant, and clearly communicates the distinction between recurring fees and the one-time payment. Wording differences are acceptable under semantic equivalence, but the lack of explicit valuation linkage prevents a top score in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 471,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO applies weighted‑average assumptions (e.g., Black‑Scholes for stock options and Monte‑Carlo for performance‑share units) to equity‑based awards and expensed the fair value on a straight‑line basis over the vesting period, which is generally four years.  \nMDLZ, by contrast, uses weighted‑average discount rates and health‑care cost‑trend rates to value its pension and post‑retirement health‑care plans, and the resulting service and interest costs are recognized each year as net periodic post‑retirement costs over the benefit period.  Thus, KO’s assumptions are tied to equity awards with vesting‑period expense, whereas MDLZ’s assumptions are tied to pension/post‑retirement plans with annual net‑periodic cost recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that KO uses financial assumptions (Black-Scholes and Monte Carlo) for equity-based compensation (stock options and performance-share units), with expense recognition over a four-year vesting period on a straight-line basis. This aligns with the original answer, which specifies the Black-Scholes-Merton model and a typical four-year period. (2) It accurately states that MDLZ applies weighted-average assumptions (discount rates and healthcare cost-trend rates) to pension and post-retirement healthcare plans, with annual recognition of net periodic post-retirement costs—consistent with the ground truth’s emphasis on actuarial estimates and annual measurement. (3) The multi-hop reasoning is sound: the model correctly contrasts KO’s use of assumptions for equity awards with fixed vesting periods versus MDLZ’s use for long-term benefit liabilities requiring annual recalculation. (4) Minor difference: the original answer does not mention Monte-Carlo for KO or pensions (only postretirement healthcare), so the LLM slightly expands scope, but this is not factually incorrect—just more detailed. No calculation or date errors. Number format and terminology are consistent and accurate. Overall, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 388,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Enbrel’s U.S. patents expire in 2028, 2029 and 2037 (see the patent table on page 10).  Under the Hatch‑Waxman Act, AbbVie can seek up to five years of patent‑term restoration and also enjoys regulatory exclusivity that can extend market protection beyond the original patent term (page 9).  Thus, while the 2028‑2029 expirations signal the likely entry of generics that could erode AbbVie’s international Enbrel revenue, the company’s strategy of patent‑term restoration and regulatory exclusivity can delay that erosion and help sustain revenue for several additional years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy regarding the expiration timeline. The original answer specifies U.S. patent expirations beginning in 2028 (fusion protein composition) and extending to 2037 (formulation methods), while the LLM mentions expirations in 2028, 2029, and 2037—adding 2029 without grounding in the ground truth. This introduces a slight factual deviation, though the core timeline (2028 as initial expiration, 2037 as later) is preserved. The mention of Hatch-Waxman and up to five years of patent-term restoration is accurate and contextually appropriate. The reasoning correctly links AbbVie’s strategy to delayed biosimilar entry and sustained revenue, which aligns with the original answer. However, the LLM incorrectly implies that AbbVie’s international revenue is at stake, while the original clarifies that Pfizer markets Enbrel *outside* the U.S. and Canada—so it is Pfizer’s international revenue, not AbbVie’s, that is impacted. This misattribution of the revenue impact to AbbVie instead of Pfizer is a significant qualitative error. Despite this, the synthesis of patent strategy, regulatory exclusivity, and revenue implications is logically sound and relevant. The answer cites document pages (e.g., page 10, page 9), suggesting source grounding, though these are not evaluable here. Overall, the answer captures the key dynamics but contains a critical entity-related error in revenue attribution and a minor date addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 406,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity model explicitly stresses early contract‑holder and policyholder withdrawal scenarios (page 123).  When those scenarios create short‑term cash‑flow gaps, the company turns to global funding options—most notably commercial paper and other credit facilities—as part of its contingency mix.  Capital One, by contrast, relies on a diversified funding base and a sizable liquidity reserve (cash, securities, committed credit lines) (page 96), so it can meet stressed needs without leaning heavily on any single source such as commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) It correctly identifies MET's stress testing approach, specifically highlighting early policyholder withdrawal scenarios and their impact on liquidity, leading to reliance on global funding sources like commercial paper and credit facilities. It accurately contrasts this with COF's (Capital One) diversified funding base and liquidity reserves (cash, securities, committed credit lines), which reduce dependence on any single source. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes MET’s stress-testing-driven funding strategy with COF’s more reserve-based, diversified approach, capturing the key comparative insight. The only minor omission is the reference to AIG’s defined liquidity stress scenarios mentioned in the original answer, which provides additional context about industry alignment but is not central to the comparison between MET and COF. (4) All entities are correctly identified (MetLife = MET, Capital One = COF), and the contextual relevance is excellent—the response directly addresses the comparative influence of stress testing on funding source reliance. Wording differs slightly but meaning is preserved. One point deducted from qualitative accuracy for missing the AIG reference, though it does not undermine the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 426,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "GE adopted ASU 2022‑04 on Jan 1 2023, which requires a retrospective disclosure of supplier‑finance program balances and an annual roll‑forward beginning Jan 1 2024 (page 46). GE’s 2024 roll‑forward is disclosed in Note 15, and Caterpillar also provides a roll‑forward of its supplier‑finance obligations in Note 19 (page 111). Thus, the ASU makes GE’s presentation more consistent with Caterpillar’s, improving comparability, although the change did not materially affect GE’s financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: GE adopted ASU 2022-04 on January 1, 2023, and began applying the roll-forward requirement prospectively starting January 1, 2024 (correctly cited from page 46, close to ground truth page 47). CAT also provides a roll-forward in its 2024 10-K (page 111), matching the original. The dollar amount ($830 million) is not mentioned in the LLM answer, but this is a minor omission since the focus is on comparability via disclosure format, not the specific balance. (2) Quantitative accuracy is perfect: dates (Jan 1, 2023 and Jan 1, 2024) are correct, and document references (Note 15 for GE, Note 19 for CAT, page numbers) align with expectations. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across GE and CAT filings and links the adoption of ASU 2022-04 to improved comparability due to standardized roll-forward disclosures. It correctly notes that the change did not materially affect GE’s financials, which is consistent with typical ASU impacts on disclosures vs. accounting effects. (4) The only minor shortcoming is the omission of CL’s explanation about the ASU’s requirements (key terms, balance sheet presentation), which adds slight context but does not undermine the correctness of the comparability conclusion. Overall, the answer is semantically equivalent and factually sound, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 404,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ’s Level 1 financial assets – the exchange‑traded commodity futures and listed options – are valued at the quoted market price on the commodity exchange (page 96) and are cash‑settled on a daily basis, so they are not shown in the fair‑value table (page 106).  The PepsiCo excerpts (pages 104‑108) do not disclose any fair‑value methodology or settlement frequency for its exchange‑traded commodity futures, so those details are not available for comparison.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its description of MDLZ's treatment. It incorrectly states that MDLZ's exchange-traded commodity futures are 'not shown in the fair-value table' due to daily cash settlement, which contradicts the ground truth that MDLZ *does* include these in Level 1 of the fair value hierarchy. This misrepresents the core comparison. Additionally, the LLM claims that PEP's disclosures are unavailable, which is incorrect—the ground truth confirms PEP explicitly excludes exchange-traded commodity futures from fair value tables *because* they are daily cash-settled. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the logical 'quantitative' structure—classification within fair value hierarchy—is misrepresented, though the score is not penalized severely here due to lack of numbers. (3) The multi-hop reasoning fails: the model should have contrasted MDLZ’s use of quoted prices (Level 1 inclusion) with PEP’s exclusion due to daily settlement, but instead incorrectly attributes exclusion to MDLZ as well, collapsing the distinction. It also fails to synthesize known PEP practices, falsely claiming lack of disclosure. (4) Contextual relevance is moderate—the response addresses the right topic and cites page numbers, suggesting engagement with source material, but draws incorrect conclusions. The answer is structurally relevant but factually flawed, leading to a low correctness score despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 441,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "At Comcast, each Class B share carries 15 votes and represents roughly 33 % of the company’s combined voting power (with Class A shares holding the remaining 66 %). The Meta 10‑K pages supplied do not disclose the voting rights of its dual‑class shares, so a direct comparison of voting privileges cannot be made from the provided material.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that at CMCSA, Class B shares have 15 votes per share and hold approximately 33% of voting power, with Class A holding the remaining 66%, which matches the original answer (66 2/3% and 33 1/3% are correctly rounded to 66% and 33%). (2) The quantitative accuracy is high: the percentages and vote ratio for CMCSA are correct, and no incorrect numbers are presented. The only minor imprecision is the rounding of 33 1/3% to 33%, but this is acceptable for semantic equivalence. (3) For META, the LLM correctly notes that the voting rights are not disclosed in the provided material, which is consistent with the ground truth stating that the exact vote ratio is not disclosed. However, the LLM omits the specific detail that META had 343,761,117 Class B shares outstanding as of January 24, 2025, which was part of the original answer and relevant to completeness. (4) The reasoning is sound—correctly identifying that a direct comparison cannot be made due to lack of disclosure—though the omission of the META share count slightly weakens completeness. The answer remains contextually relevant and addresses the core of the comparison question. Thus, the correctness score is 8 due to this partial omission, though all presented facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 372,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "AIG evaluates CLOs under the CECL framework, creating a credit‑loss allowance that incorporates expected default rates, loss severity and pre‑payment speeds, and it records unrealized losses in earnings (net investment income) as shown on page 130. MetLife does not disclose a CECL‑style model; it applies a credit‑loss allowance for its fixed‑maturity securities (including CLOs) and recognizes unrealized gains and losses on those securities in net investment income, as reflected in the tables on pages 221–224, though the specific allowance methodology is less detailed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies and omissions in the multi-hop comparison between AIG and MetLife regarding CLO credit loss evaluation and unrealized loss recognition. (1) Correct elements: Both companies are accurately identified as holding CLOs within structured products/fixed maturity securities, and AIG's use of CECL is correctly noted. The mention of expected default rates, loss severity, and prepayment speeds aligns broadly with AIG's cash flow modeling approach. There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised. (2) However, the LLM incorrectly states that AIG records unrealized losses in earnings (net investment income), which contradicts the ground truth: AIG separates credit-related impairments (recognized in earnings) from non-credit fair value changes (recorded in OCI). This is a critical error in understanding AIG's accounting treatment. Similarly, the claim that MetLife recognizes unrealized gains and losses in net investment income is misleading—MetLife holds CLOs in AFS securities, where unrealized gains/losses go to OCI, not earnings, unless other-than-temporary impairments occur. (3) The multi-hop reasoning is flawed: The original answer emphasizes AIG’s detailed cash flow modeling and structural feature analysis (e.g., credit enhancement), which the LLM omits. Conversely, MetLife’s passive investor stance and limitation of exposure to carrying amount—a key differentiator—are not mentioned in the LLM response. Instead, the LLM incorrectly implies both use credit-loss allowances under similar frameworks, when MetLife does not disclose CECL-style modeling. (4) While the response is contextually relevant and uses appropriate financial terminology, it fails to accurately contrast the two firms’ methodologies, particularly around impairment recognition and the role of OCI. Thus, the correctness and qualitative accuracy scores are reduced due to material misrepresentations of accounting treatments despite correct entity identification and topical focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 562,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The IRA’s redesign of Medicare Part D caps beneficiary out‑of‑pocket costs, cuts federal reinsurance and introduces inflation‑penalty rebates, which heightens volatility in medical‑cost trends and reimbursement.  CVS notes that this added uncertainty makes it more difficult to forecast future health‑care costs and price plans (see its risk‑factor discussion on forecasting medical cost trends, page 40).  For BMS, the same redesign creates new rebate obligations that accrue from October 2022 for Medicare Part D, but invoices are not yet issued, so the company must use significant judgment to estimate and accrue these rebates (see the critical audit matter on GTN U.S. rebate accruals, page 36).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few key inaccuracies that affect the overall correctness. (1) Quantitatively, the LLM incorrectly states that BMY's (Bristol Myers Squibb, referred to as BMS) new rebate obligations 'accrue from October 2022'—this is false. The Inflation Reduction Act was enacted in August 2022, but the Medicare Part D redesign, including manufacturer liability shifts, takes effect in 2025, not retroactively to October 2022. This is a significant factual error in timing. (2) The mention of 'inflation-penalty rebates' is not clearly supported in the original answer or standard IRA summaries; the IRA does include insulin and vaccine cost provisions, but 'inflation-penalty rebates' are more relevant to the commercial side and not the core Medicare Part D redesign affecting catastrophic reinsurance. (3) The LLM correctly identifies that CVS faces increased uncertainty in forecasting medical cost trends due to IRA changes, and cites appropriate reasoning (plan pricing, utilization dynamics), aligning with the original answer’s emphasis on forecasting challenges. (4) The reference to BMS using 'significant judgment' to estimate rebates is consistent with the original answer’s point about gross-to-net (GTN) U.S. rebate accruals requiring estimation under new liabilities. However, the original answer emphasizes BMY (Bristol Myers Squibb), and while BMS is likely a typo, it refers to the same entity—this is a minor entity accuracy issue. (5) The multi-hop reasoning is partially sound: it connects IRA changes to both CVS (forecasting) and BMY (rebate accruals), satisfying the dual-entity requirement. However, the incorrect effective date (October 2022 vs. 2025) undermines the reasoning chain. (6) Semantic equivalence is mostly preserved: the core idea that IRA increases manufacturer liability, thereby increasing rebate accrual uncertainty for BMY and forecasting difficulty for CVS, is correctly conveyed. Formatting references to 'page 40' and 'page 36' suggest document grounding but are not in the original answer and may be hallucinated. Overall, the answer captures the essential dynamics but fails on precise timing and some policy details, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 593,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase’s capital‑distribution limits are tied to its total buffer requirement, which is the sum of a 5.4 %–5.8 % Stress Capital Buffer (SCB), a G‑SIB surcharge and a counter‑cyclical buffer, giving a 8.4 %/8.8 % Common Equity Tier 1 buffer (p. 20‑24).  If the SCB falls below the required level, the firm must curtail dividends, share repurchases or bonuses.  In contrast, Schwab’s banking subsidiaries are required to hold a 2.5 % Capital Conservation Buffer (CCB) that is part of a 7.0 %/8.5 %/10.5 % overall buffer (p. 120‑124); a breach of the CCB similarly restricts capital distributions but, because it is a smaller component of a lower overall buffer, the constraints are less stringent than JPMorgan’s SCB‑driven limits.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several specific numerical values (e.g., 5.4%–5.8% SCB, 8.4%/8.8% CET1, 7.0%/8.5%/10.5% overall buffer for Schwab) that are not present in the original answer and cannot be verified against the ground truth. The ground truth does not specify exact percentages for JPMorgan’s SCB or total buffer, nor does it provide a range of total buffer requirements for Schwab. These numbers appear to be fabricated or over-precise, significantly undermining quantitative accuracy. (2) The calculation of total buffer levels (e.g., summing SCB, G-SIB, CCyB to get 8.4%/8.8%) is speculative and not supported by the original answer, which only states that these components contribute to the total requirement without specifying magnitudes. Similarly, the claim about Schwab’s overall buffer having three tiers (7.0%/8.5%/10.5%) is not mentioned in the ground truth and introduces unverified complexity. (3) Qualitatively, the LLM correctly identifies the key distinction: JPMorgan is subject to a dynamic, stress-test-driven SCB that affects capital distributions, while Schwab must meet a fixed 2.5% CCB, breach of which restricts distributions. The reasoning around distribution constraints due to buffer shortfalls is logically sound and aligns with the original answer’s intent. The comparison of SCB (variable, forward-looking) vs CCB (static, floor-based) is conceptually accurate, even if not explicitly worded the same. (4) Contextual relevance is high because the LLM addresses the core of the question—how different buffer types (SCB vs CCB) lead to different capital distribution constraints. However, the inclusion of unsupported numerical ranges severely damages factual correctness. While the qualitative framework is strong, the incorrect numbers prevent a higher score. The answer would have scored 9–10 if it had avoided spurious precision and stuck to the conceptual distinctions present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 526,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics excludes state and local income taxes that are allocable to U.S. government contracts from its tax provision, treating those taxes as operating costs rather than taxable items (see GD page 66).  Raytheon Technologies, by contrast, records state income taxes in its income‑tax expense but recovers them through contract pricing; under the FAR, such taxes are considered allowable costs and are allocated to contracts as SG&A or recoverable expenses (see RTX pages 78‑79).  Thus, GD’s exposure to these taxes is effectively removed from its tax calculation, whereas RTX’s exposure is captured in its tax expense but mitigated by FAR‑governed cost‑allowability and pricing mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision and instead treats them as operating costs, which matches the original answer. Raytheon Technologies is accurately described as recording these taxes in income tax expense but recovering them through FAR-allowable cost mechanisms, including allocation as SG&A or recoverable expenses. The core difference in financial exposure—GD removing the tax impact from its tax provision versus RTX including it in tax expense but recovering via pricing—is correctly captured. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not applicable but assumed perfect due to absence of numbers. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, their distinct tax treatments, and the role of FAR in cost allowability and pricing, demonstrating proper cross-entity analysis. (4) Minor deduction in qualitative accuracy due to slightly different framing—RTX’s use of performance-based and progress payments mentioned in the original answer is omitted—but this does not affect the core correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is full, addressing all aspects of the comparative financial exposure under FAR.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 405,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta’s dual‑class structure gives each Class A share one vote and each Class B share ten votes, and the company announced in February 2024 that Class B shares will now receive the same cash dividend as Class A shares (page 57). Alphabet’s Class B shares, however, automatically convert to Class A upon any sale or transfer, consolidating voting power and eliminating a separate Class B voting class (page 81). Thus, Meta retains distinct voting rights and dividend eligibility for Class B holders, whereas Alphabet’s Class B shares are absorbed into the Class A voting structure upon transfer.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta's Class B shares have 'ten votes' each, but the ground truth specifies 15 votes per Class B share. This is a significant quantitative error. Second, while it correctly notes the $0.50 quarterly dividend initiated in 2024 and equal treatment of Class A and B shares, it fails to mention the non-dilutable 33 1/3% aggregate voting power for Class B shares, a key structural feature. (2) The date (February 2024) aligns with the 2024 dividend initiation in the ground truth, and the dividend amount ($0.50) is correctly implied, though not explicitly stated in the LLM answer. However, the vote count (10 vs 15) is incorrect. GOOGL’s Class B conversion upon transfer is accurately described. (3) The reasoning correctly contrasts Meta’s retention of distinct Class B voting rights with GOOGL’s automatic conversion, showing sound multi-hop synthesis between the two companies’ structures. However, the omission of the 33 1/3% non-dilutable voting power and the incorrect vote count weaken the accuracy of the comparison. (4) The contextual relevance is high as the answer addresses the core comparison between the two dual-class structures. Qualitative accuracy is moderate due to correct structural logic but missing key details. Quantitative accuracy is low due to the incorrect vote count and missing percentage. Correctness score is 6 due to partially correct facts with significant omissions and one major numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 418,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies compute a one‑day VaR that is the loss that would be exceeded only 5 % of the time under normal market conditions.  Using the same parametric delta‑gamma approximation, they model the expected return distribution from historical interest‑rate, currency and commodity movements, then apply the 95 % confidence level to set the VaR threshold.  Thus, Philip Morris’s derivative‑instrument VaR and Mondelez’s currency‑and‑commodity VaR are both derived from a statistically‑based, one‑day loss estimate that reflects the same confidence interval and market‑normality assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key elements are correct: the 95% confidence interval (i.e., 'loss exceeded only 5% of the time'), the one-day VaR horizon, and the use of normal market conditions are all correctly stated. The mention of interest-rate, currency, and commodity movements matches the original answer's reference to these risk factors. (2) The LLM correctly identifies that both Philip Morris and Mondelez use the parametric delta-gamma approximation technique, which is central to the question. (3) The reasoning is sound: it explains how the confidence interval shapes the loss estimation methodology under normal conditions, and it appropriately generalizes the shared statistical approach. (4) The only minor omission is that the original answer specifies PM excludes anticipated transactions and hedges, while MDLZ explicitly accounts for the non-linear behavior of options—nuances the LLM does not include. However, these are secondary details that do not undermine the core correctness of the synthesis. The LLM captures the essential multi-hop insight: two firms, different exposures, same methodological constraints. Wording differs but semantic equivalence is strong. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9 overall for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 384,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDOs contain embedded credit‑protection derivatives that are sold to the issuer; a credit event on the reference entity can trigger a loss on the principal balance (page 109, page 108), and the firm’s exposure is largely un‑hedged beyond its own risk‑management limits.  Bank of America’s structured liabilities also embed derivatives, but the firm routinely offsets the related market‑making gains or losses with hedging instruments, so credit events affect the net position only after the hedge has been applied (page 164).  Consequently, Morgan Stanley faces a higher direct credit‑event exposure on its CDO holdings, whereas Bank of America’s exposure is mitigated by hedges that reduce the impact on its market‑making activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Morgan Stanley's CDOs involve embedded derivatives where credit protection is sold to the issuer, creating exposure to credit events that could impair principal repayment. Bank of America's structured liabilities also contain embedded derivatives, but they are typically hedged, offsetting gains or losses—this distinction in hedging approach is correctly emphasized. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; the LLM correctly avoids inventing figures. (3) The multi-hop reasoning is sound: the model synthesizes information across two firms (Morgan Stanley and Bank of America), two financial instruments (CDOs with embedded derivatives vs. structured liabilities), and compares their risk exposure in the context of credit events and market-making activities. The conclusion that Morgan Stanley faces higher direct exposure due to limited hedging, while Bank of America mitigates risk through hedges, is a valid inference supported by the original answer. (4) Minor deduction in qualitative accuracy due to the phrase 'largely un-hedged beyond its own risk-management limits,' which slightly strengthens the original claim—while the ground truth notes Morgan Stanley's exposure is tied to reference entity performance without explicit mention of hedging, it does not assert lack of hedging outright. However, this is a reasonable interpretation given the contrast with Bank of America's 'routinely offsets' language. Overall, the answer is semantically equivalent, contextually precise, and correctly addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 483,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce’s effective tax rate was 18 % in fiscal 2024 (19 % in 2023) and the company says the OECD Pillar‑Two minimum‑tax rules are not expected to materially raise that rate because it has no significant operations in jurisdictions below the 15 % threshold; it will simply monitor how the rules are adopted. Microsoft likewise reported an effective tax rate of 18 % (19 % in 2023) and, while Pillar‑Two will apply to it from FY 2025, it does not anticipate a material impact on its consolidated tax liability and is watching legislative developments. Thus, both firms see no immediate change to their tax profiles, though uncertainty over when and where the rules take effect means ongoing monitoring is required.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that both Salesforce and Microsoft reported an effective tax rate of 18% in fiscal 2024 (19% in 2023), which aligns with the original answer's mention of Microsoft's rates and implies Salesforce's rate is similar. However, the original answer does not explicitly state Salesforce’s effective tax rate, so attributing a specific 18% rate to Salesforce is an unsupported addition not present in the ground truth. This is a factual overreach, though the direction (no material impact) is consistent. (2) The quantitative accuracy is mostly correct: Microsoft’s 19% down to 18% in fiscal 2024 is accurately reflected. The claim that Pillar Two applies starting in FY2025 matches the original. However, the LLM incorrectly implies Salesforce has already determined it will not be materially impacted due to lack of operations in low-tax jurisdictions—this level of specificity (e.g., 'no significant operations below 15% threshold') is not in the original answer, which only says Salesforce acknowledges potential material impact and is monitoring developments. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes that both companies expect no material impact and are monitoring uncertainty. But it goes beyond the source by offering a causal explanation (jurisdictional footprint below 15%) for Salesforce that is not in the ground truth, introducing a speculative element. (4) Contextual relevance is high—the answer addresses the core comparison, tax rates, Pillar Two applicability, and uncertainty. However, the unsupported specifics reduce qualitative and quantitative accuracy. Correctness score is 7 due to core facts being directionally accurate but with added details not grounded in the original, risking misinformation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 489,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit agreement names Citibank as the administrative agent and JPMorgan Chase as the sole syndication agent, with both banks jointly acting as lead arrangers and book managers. Honeywell’s credit agreement, by contrast, lists Bank of America as the administrative (and swing‑line) agent and names JPMorgan Chase and Wells Fargo as the syndication agents. Thus Boeing’s structure involves one syndication agent and two joint lead arrangers, whereas Honeywell’s involves two syndication agents and a separate administrative/swing‑line agent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correctly identified: Boeing's agreement correctly names Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, with both as joint lead arrangers and book managers. Honeywell's agreement correctly identifies JPMorgan Chase and Wells Fargo as syndication agents and Bank of America as administrative and swing line agent. (2) There are no numeric values (e.g., dollar amounts, dates) in the question or answers that require verification—only roles and institutions, which are accurately reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different credit agreements, comparing syndication structures and key banking partners. (4) The only minor shortcoming is that the LLM omits the exact dates of the agreements (October 30, 2019, for Boeing; March 20, 2023, for Honeywell), which are present in the ground truth. While not critical to the structural comparison, their absence slightly reduces completeness. Additionally, the LLM describes JPMorgan Chase as the 'sole syndication agent' for Boeing, which is accurate, but does not explicitly note that Citibank also serves in dual roles (administrative agent and joint lead arranger), though this is implied. Overall, the answer is semantically equivalent and factually correct, with only minor omissions in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 406,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the Countercyclical Capital Buffer is zero, the Advanced‑Approach buffer for each bank is simply the sum of the 2.5 % Capital Conservation Buffer and its G‑SIB surcharge.  Bank of America’s G‑SIB surcharge is 2.5 %, so its total buffer is 5.0 % (2.5 % + 2.5 %).  Morgan Stanley’s surcharge is 3.0 % (see the 5.5 % total buffer on page 134), giving a total buffer of 5.5 % (2.5 % + 3.0 %).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the absence of the Countercyclical Capital Buffer (CCyB) means the total CET1 buffer is the sum of the Capital Conservation Buffer (2.5%) and the G-SIB surcharge for each bank. It correctly states Bank of America’s G-SIB surcharge as 2.5% and calculates its total buffer as 5.0%, which aligns with the ground truth. However, it introduces a Morgan Stanley G-SIB surcharge of 3.0% and a total buffer of 5.5%, which is not supported by the original answer. The ground truth explicitly states that Morgan Stanley’s G-SIB surcharge is 'not quantified in the provided data but assumed to be included,' meaning the model should not have asserted a specific value (3.0%) or inferred it from a document page (e.g., 'page 134') not referenced in the original. This is a significant factual overreach. (2) The calculation for Bank of America (2.5% + 2.5% = 5.0%) is correct. The calculation for Morgan Stanley (2.5% + 3.0% = 5.5%) is mathematically correct but based on an unsupported assumption, making the quantitative output inaccurate in context. (3) The reasoning for the impact of CCyB absence is sound and correctly applied to both banks, but the model fails in multi-hop synthesis by introducing external data (Morgan Stanley’s 3.0% surcharge) not present in the ground truth, undermining the qualitative accuracy. (4) Scores reflect partial correctness: the core logic and Bank of America analysis are accurate, but the unsupported Morgan Stanley figure reduces quantitative and qualitative accuracy. Contextual relevance remains high as the answer addresses the framework and components correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 452,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s effective tax rate for fiscal year 2022 was **1.9 %** (NVDA, page 52).  \nApple’s operating income margin in Greater China was roughly **42 %** (operating income $31.2 bn on net sales $74.2 bn, Apple, page 52).  \nThus, NVIDIA’s effective tax rate is far lower—about 40 percentage points below—Apple’s operating income margin in that region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: NVIDIA's effective tax rate is correctly stated as 1.9%, and Apple's operating income margin in Greater China is accurately calculated from $31.2 billion (approximation of $31,153 million) on $74.2 billion (approximation of $74,200 million), resulting in ~42%—a correct calculation. Minor rounding is acceptable and does not affect accuracy. (2) The answer addresses both parts of the multi-part question: NVIDIA's tax rate and Apple's operating margin in Greater China, both for fiscal year 2022. (3) Entities are correctly identified—NVIDIA (NVDA), Apple, fiscal year 2022, and the correct financial metrics (effective tax rate, operating income margin). (4) The reasoning is sound: the LLM correctly synthesizes data from two different companies and regions, and the comparison—highlighting that NVIDIA’s 1.9% tax rate is about 40 percentage points below Apple’s 42% margin—is logically valid and semantically equivalent to the original answer’s intent. The answer is concise, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 324,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s Level‑2 assets are primarily fixed‑income securities, which it values with a market approach that uses matrix pricing based on quoted prices of comparable securities and an income approach that discounts future cash flows (BA 10‑K, p. 101). UPS, by contrast, classifies its Level‑2 derivatives (foreign‑currency and interest‑rate contracts) as being valued with pricing models that rely on observable market inputs such as yield curves, foreign‑currency exchange rates and investment forward prices (UPS 10‑K, p. 137). Thus, Boeing focuses on market prices of similar securities and discount rates, while UPS emphasizes yield curves, FX rates and forward‑price curves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing (BA) uses pricing models for fixed-income Level 2 assets emphasizing benchmark-like inputs such as discount rates and comparable securities (matrix pricing), while UPS uses observable inputs like yield curves, FX rates, and forward prices for its Level 2 derivatives. The LLM correctly identifies the asset types (fixed-income vs. derivatives) and the nature of the models (income and market approaches for BA; observable inputs for UPS). (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations or dollar amounts—no issues here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different 10-K filings (BA and UPS), distinguishes between the types of Level 2 assets, and contrasts the emphasis in pricing models. (4) The only minor shortcoming is that the LLM omits specific references to 'swap curves', 'inter-dealer broker rates', and 'rating agency data' for BA, and does not explicitly mention that UPS's derivatives are over-the-counter instruments. However, the essence—that BA emphasizes credit/yield inputs for fixed income and UPS focuses on currency and interest rate dynamics for derivatives—is preserved. Wording differences are acceptable under semantic equivalence. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 420,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s Class B shares carry ten votes each while Class A shares carry one vote, creating a 10‑to‑1 voting‑power gap (GOOGL p. 81).  In 2023 Alphabet repurchased 528 million shares—78 million Class A and 450 million Class C—for $62.2 billion (GOOGL p. 80), which reduced the total share count but left the 10‑to‑1 ratio unchanged.  Netflix, by contrast, gives every share one vote, so its common stock has a uniform voting‑rights structure with no disparity (NFLX p. 61).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 10-to-1 voting disparity between GOOGL's Class B and Class A shares and contrasts it with NFLX's uniform one-vote-per-share structure, which is factually accurate. The $62.2 billion repurchase amount is correct and matches the ground truth. However, the LLM states that 528 million shares were repurchased—78 million Class A and 450 million Class C—but this level of granular share count is not present in the original answer and may introduce unverified detail; more importantly, the original answer emphasizes the *strategic effect* of repurchasing Class A and C shares (which do not have enhanced voting rights), thereby preserving Class B's relative control. The LLM acknowledges the repurchase reduced share count but misses the nuanced implication that retiring non-voting or low-vote shares indirectly strengthens the voting power concentration of Class B holders. (2) Quantitatively, the $62.2 billion figure is accurate, and the 10-to-1 voting ratio is correct. The specific breakdown of 78M and 450M repurchased shares appears precise but was not part of the ground truth; while not necessarily incorrect, it introduces unsupported granularity that cannot be verified against the original knowledge graph. (3) The multi-hop reasoning is mostly sound: the model connects GOOGL’s dual-class structure, the 2023 repurchase, and contrasts it with NFLX’s structure. However, it fails to fully synthesize the *interplay* between the repurchase program and voting control dynamics—specifically, that buying back Class A and C shares (which cannot convert from Class B) helps maintain the dominance of Class B in voting power. This is a key insight in the original answer that is underdeveloped in the LLM response. (4) Scores reflect high factual accuracy and relevance, with minor deduction in correctness and qualitative reasoning for missing the deeper governance implication of the share buyback on voting balance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 531,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN classifies its U.S. government debt securities as Level 2 assets (see its fair‑value hierarchy table, page 78), meaning they are valued with observable inputs other than quoted prices. AVGO, in contrast, treats the same securities as Level 1, valuing them directly from quoted prices in active markets. This difference makes ACN’s fair‑value estimates potentially less transparent and more model‑dependent, reducing comparability with AVGO’s Level 1 disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not explicitly state the $9,765 million figure from ACN's disclosure, this omission is minor and does not affect the core correctness of the classification comparison. All other qualitative financial reporting details (Level 1 vs Level 2, valuation methods) are correctly represented. (2) The entity identification is accurate—ACN and AVGO are correctly referenced with proper context about their fair value hierarchies. (3) The reasoning is sound: the LLM correctly synthesizes the multi-hop concept that U.S. government debt securities, typically Level 1 due to active markets (as per UPS evidence in ground truth), are conservatively or atypically classified as Level 2 by ACN, whereas AVGO follows the more typical Level 1 classification. This affects comparability and transparency, which the LLM captures by noting increased model dependency and reduced comparability. (4) The answer is contextually precise and directly addresses the impact on comparability. The only reason for not scoring a 10 is the missing explicit mention of the $9,765 million amount, which is a factual detail present in the original answer and contributes to completeness, though the absence does not undermine the overall correctness of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 373,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive adopted ASU 2022‑04 on January 1, 2023 (with roll‑forward disclosures beginning January 1, 2024) and reported a confirmed amount outstanding of $3.398 billion at year‑end. Target’s 2024 10‑K contains the same supplier‑finance disclosure, but the company does not disclose an explicit adoption date; its confirmed amount outstanding at year‑end is also $3.398 billion. Thus, Colgate’s adoption was earlier, yet both firms report identical year‑end balances for confirmed obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, with roll-forward disclosures effective January 1, 2024 — this part is correctly reported. However, the LLM claims Colgate reported a confirmed amount outstanding of $3.398 billion at year-end, which is not supported by the original answer; no such figure is mentioned. Similarly, the LLM asserts that Target’s confirmed amount is also $3.398 billion, which is false — the original answer explicitly states that Target does not quantify the exact confirmed amount in the provided excerpt. Additionally, the LLM incorrectly claims Target’s 2024 10-K contains the same disclosure and reports an identical balance, which contradicts the ground truth that Target does not disclose a specific dollar amount. (2) Quantitative accuracy is severely compromised: both the $3.398 billion figure for Colgate and the same amount for Target are fabricated. There is no indication in the original answer that either company disclosed this specific number, let alone that they are equal. (3) The multi-hop reasoning is flawed. While the model attempts to compare adoption timelines and year-end balances, it fails to recognize that the original answer does not provide quantified amounts for either company. The conclusion that both firms report identical balances is entirely unsupported. The model also does not confirm Target’s adoption date, which the original answer does not specify — yet the LLM implies comparability without evidence. (4) Contextual relevance is moderate because the response addresses the right topic (ASU 2022-04 adoption and supplier finance disclosures) and the right companies, but it invents key data points and draws false equivalences. Due to major factual and quantitative errors, the correctness score is low despite some accurate timeline information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 521,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s operational‑risk exposure is largely external – it relies on third‑party technology partners such as Microsoft Azure for its Aladdin platform, and the firm acknowledges that a failure of those partners could trigger regulatory, financial and reputational harm (BLK 10‑K, p. 28).  Mastercard, by contrast, embeds operational resilience into its own risk‑management framework, proactively addressing regulatory developments and maintaining system reliability to mitigate reputational risk and reduce dependence on external partners for critical infrastructure (MA 10‑K, p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described as introducing operational and reputational risks, and Mastercard's integration of operational resilience into its risk framework is correctly portrayed. The cited 10-K page numbers (p. 28 for BLK, p. 24 for MA) match the source evidence, supporting the claims. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable beyond correct referencing of document locations, which are accurate—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), compares their approaches to operational and reputational risk, and draws a valid contrast—external dependency vs. internal resilience. The only minor shortcoming is that the LLM does not explicitly name 'Reputational Impact' as a formally labeled risk factor in Mastercard’s 10-K, which the ground truth highlights, nor does it reference the COF evidence defining operational risk. This slight omission in depth prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparative aspect of the question and focusing on the interplay between operational risks and reputational consequences in both firms. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, well-supported, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 442,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was a major customer for BMS in 2021, representing about **20 % of BMS’s gross product sales to the three largest U.S. wholesalers** (page 107), a sizable share of the company’s revenue. In CVS’s generic‑pharma sourcing strategy, Cardinal is a **50‑percent partner in Red Oak Sourcing, LLC**; together they use Red Oak’s sourcing and supply‑chain expertise to negotiate and secure generic drug supply contracts for both CVS and Cardinal (page 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 20% figure for Cardinal Health's share of BMS's (BMY) sales is correct, and the 50% ownership in Red Oak Sourcing, LLC is accurately reported. The reference to 'BMS' instead of 'BMY' is a common ticker confusion (Bristol-Myers Squibb was formerly BMS, now BMY), but the context makes clear it refers to the same company; this is a minor issue but does not affect factual correctness. (2) The answer correctly identifies that Cardinal is a 50% partner with CVS in Red Oak Sourcing, LLC and that the entity negotiates generic drug supply contracts for both—this matches the ground truth. (3) Multi-hop reasoning is sound: the model connects Cardinal’s role as a major customer of BMY and its strategic partnership with CVS via Red Oak. (4) One minor omission: the original answer notes that Red Oak does not involve inventory ownership, which adds nuance to the sourcing model. The LLM answer omits this detail, slightly reducing completeness. However, the core facts, numbers, and synthesis are correct. Wording differs but semantic meaning aligns closely. Contextual relevance is strong as all parts of the question are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 354,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "At Meta, Class B common stockholders may vote only on a handful of defined matters (e.g., exit of the core payments business, certain mergers or amendments to the certificate of incorporation) and each share’s votes are multiplied by the applicable conversion rate in effect on the record date【page 90】. In contrast, Netflix common stockholders have the standard one‑vote‑per‑share right on all matters【page 61】. Thus, Meta’s Class B holders enjoy far more restricted voting power than Netflix’s common shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Meta's Class B stockholders have voting rights only in specific scenarios such as exiting the core payments business, mergers, or amendments to the certificate of incorporation, and that each share's voting power is multiplied by the conversion rate in effect on the record date—consistent with the original answer. It also accurately notes that Netflix common stockholders have one vote per share on all matters. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised; all referenced details are qualitative and correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting structures across two different companies (META and NFLX) and contrasts conditional, multiplier-based voting rights with unconditional per-share voting. (4) The only minor shortcoming is that the LLM answer uses the term 'far more restricted'—a slightly stronger evaluative phrasing than the neutral comparison in the original—but this does not distort the factual relationship. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 366,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Google’s Class B shares automatically convert to Class A upon any sale or transfer, effectively erasing the dual‑class distinction for those shares (GOOGL 10‑K, p. 81).  In contrast, Meta’s charter requires that any transaction that would change control of the company receive the approval of a majority of its Class B shareholders, preserving the protective voting power of that class (META 10‑K, pp. 48‑50).  Mastercard’s structure adds a further safeguard: after a Class B share converts to Class A, the holder must sell or otherwise transfer the newly‑obtained Class A shares, preventing accumulation of voting power and providing an additional check on the dual‑class regime (MA 10‑K, p. 101).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: GOOGL's Class B shares convert automatically to Class A upon transfer, META requires Class B approval for change-of-control transactions, and Mastercard mandates post-conversion sale or transfer of Class A shares. These points align precisely with the original answer. (2) There are no numeric values (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance mechanisms across three companies (GOOGL, META, Mastercard) and contrasts their dual-class structures. The only minor shortcoming is that the LLM does not explicitly state the 35% voting power threshold for META’s Class B approval requirement, which is included in the ground truth and adds specificity to the trigger condition. This omission slightly weakens completeness but does not invalidate the overall correctness. (4) The answer is contextually excellent—directly addresses all parts of the complex, multi-entity question and draws a clear comparative insight. Wording differs but semantic meaning matches. Thus, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 373,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck can extend the life of its biologics by up to six months of additional U.S. market exclusivity (and a similar six‑month period tied to an EU Supplementary Protection Certificate or a Japanese exclusivity extension) if it completes pediatric studies under the FDA Modernization Act’s pediatric exclusivity provision【page_16】【page_18】. In contrast, Amgen faces a regulatory exclusivity risk because the U.S. data‑protection regime for biologics has been altered— the 10‑year exclusivity requirement was removed from the US‑Mexico‑Canada Agreement and the FDA is questioning whether “umbrella” exclusivity applies to licensed biologics—potentially shortening the period before biosimilar competition can enter the market【page_46】. Thus, Merck’s pediatric studies offer a clear path to extra exclusivity, whereas Amgen’s biologics may lose protection earlier due to the revised data‑protection rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the six-month pediatric exclusivity extension for Merck (MRK) is accurately stated, and the reference to potential changes in U.S. biologics data protection, including the removal of the 10-year exclusivity from USMCA and FDA scrutiny of 'umbrella' exclusivity, matches the context of AMGN's regulatory risks. While the original answer does not specify the 10-year period, the LLM correctly infers a change in framework that impacts AMGN, supported by the cited document page. (2) The LLM adds detail not in the original—such as EU and Japanese extensions and the FDA Modernization Act—which are contextually accurate and enhance completeness without introducing error. (3) The multi-hop reasoning is sound: it contrasts MRK’s proactive use of pediatric exclusivity to extend protection with AMGN’s vulnerability to policy changes affecting biologic exclusivity, correctly synthesizing across regulatory strategies and jurisdictions. (4) The only minor gap is that the original emphasizes MRK’s application to high-risk adult treatments (e.g., COVID-19 therapy), which the LLM omits, slightly reducing qualitative completeness. However, this does not undermine the core factual or comparative accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 393,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s dual‑class structure gives Class A common stockholders full voting rights, while Class B shares are limited to voting on a few specified matters and each share carries a fixed number of votes that concentrates control in a small group of shareholders (page 2). Visa’s structure also gives Class A shares full voting rights, but Class B shares have limited voting rights only on certain matters and can vote only on a number of votes equal to the shares held multiplied by a conversion rate that can change as litigation is resolved, allowing the balance of voting power between Class A and Class B shares to shift (page 90, page 91).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly refers to 'Mastercard' (MA) and 'Visa' (V), but the ground truth describes companies MA and V that are not Mastercard and Visa—this is a critical entity error. The voting power distribution for MA is completely misrepresented: the LLM claims Class A has full voting rights and Class B limited rights, while the truth states Class B has 15 votes per share and holds 33⅓% of voting power, with Class A holding 66⅔%. The LLM fails to mention the 15 votes per share or the specific ownership by Mr. Brian L. Roberts. For V, the LLM vaguely mentions a conversion rate tied to litigation but omits key mechanisms like transferability restrictions, adjustability based on follow-on offerings, and the existence of Class C shares with no restrictions and an exchange program—critical differentiators in control concentration. (2) Quantitative accuracy is poor: no correct numbers are provided (e.g., 15 votes per share, 33⅓%, 66⅔%) and no accurate calculations or references to specific ownership or voting allocations. The mention of 'conversion rate that can change' is directionally correct but lacks specificity and ties to incorrect entities. (3) Multi-hop reasoning is partially present—the LLM attempts to compare two dual-class structures and notes that voting balance can shift in V’s case—but fails to synthesize the correct entities, mechanisms, or structural details. The reasoning is undermined by fundamental entity confusion. (4) Contextual relevance is moderate: the answer addresses dual-class structures and voting power distribution, aligning with the question’s intent, but the incorrect identification of MA and V as Mastercard and Visa invalidates the factual basis. The answer discusses voting rights and dynamic conversion, which are relevant themes, but without accurate grounding. Thus, while the structure of the response is appropriate, its factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 542,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX’s FAR‑regulated U.S. government fixed‑price contracts generate contract assets for revenue recognized in excess of billings and contract liabilities for advance payments, reflecting a sizable exposure to revenue timing and audit scrutiny under FAR and CAS. In the LMT 10‑K pages provided, there is no disclosure of contract‑asset balances or audit‑liability details for similar contracts, so a direct comparison of revenue recognition timing or audit risk cannot be made from the supplied excerpts.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually accurate in stating that RTX recognizes revenue in excess of billings under FAR-regulated fixed-price contracts, resulting in contract assets, which aligns with the ground truth. It correctly identifies the relevance of FAR and CAS in shaping financial reporting and audit risk for RTX. However, the LLM fails in multi-hop reasoning by claiming there is no disclosure from LMT regarding contract assets or audit liabilities 'in the pages provided'—this reflects a document access limitation, not knowledge from the filings. The original answer (ground truth) draws on disclosed LMT risks related to government audits, debarment, and material adverse effects due to dependence on U.S. government contracts, which are standard disclosures in LMT’s 10-K and part of public knowledge in the knowledge graph. The LLM should have synthesized this known information rather than defaulting to a data-unavailability stance. This omission breaks the comparative analysis required by the question, making the response incomplete and undermining the qualitative accuracy. While no numbers are incorrect (hence full quantitative accuracy), the failure to engage in proper cross-company synthesis—especially when the ground truth clearly contrasts RTX's balance sheet exposure with LMT's compliance risk—results in a low correctness score. The response is contextually relevant but stops short of delivering the required comparative risk profile analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 403,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Meta’s dual‑class structure gives each Class A share one vote and each Class B share ten votes, so Class B shares carry ten times the voting power of Class A shares (Meta 10‑K, Item 5, pp. 57‑59). Alphabet’s structure is identical: Class A shares have one vote each and Class B shares have ten votes each (Alphabet 10‑K, Note 11, p. 81). Thus, both companies allocate the same voting‑power ratio between their two common‑stock classes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both quantitative and qualitative aspects. (1) Quantitatively, it incorrectly states that Meta's Class B shares have 10 votes per share; the ground truth specifies 15 votes per Class B share. It also falsely claims that Class A shares at Meta have 1 vote each, when in fact they are the majority-vote holders with 66 2/3% of total voting power despite being publicly traded—this is inconsistent with a 1:15 vote ratio unless share counts are considered. The answer fails to mention the actual voting power distribution percentages (66 2/3% for Class A and 33 1/3% for Class B), which are critical to the comparison. (2) For GOOGL, while the per-share vote counts (1 and 10) are correctly attributed, the LLM incorrectly asserts that the structure is 'identical' to Meta’s, which is false given Meta’s 15:1 ratio versus GOOGL’s 10:1. Additionally, the ground truth notes that GOOGL’s exact percentage split is unspecified, but the LLM omits this uncertainty and draws a false equivalence. (3) In terms of multi-hop reasoning, the model fails to synthesize the key difference: Meta gives higher per-share voting power to Class B than GOOGL does, and the overall control dynamics differ due to the vote ratios and ownership distributions. (4) Contextual relevance is high because the answer addresses the dual-class structures of both companies and attempts a direct comparison, but the conclusion is factually wrong due to incorrect data and flawed logic. Minor note: citation of 10-K pages is plausible but not verifiable from the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 439,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "BMY’s 10‑K explains that its biologics—including Opdivo—receive regulatory data exclusivity that lapses after a set period (page 8).  When that exclusivity expires, competitors may file Paragraph IV ANDAs to challenge the listed patents, a route BMY has already seen trigger generic entry (page 8).  This precedent signals that as JNJ’s Stelara patents approach expiration, it could face similar Paragraph IV challenges and related litigation, heightening its exposure to patent‑cliff risks (see JNJ page 7).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism by which expiration of regulatory data exclusivity leads to Paragraph IV ANDA filings and increased litigation risk, citing BMY's experience and linking it to JNJ's exposure for Stelara. It accurately references the structure of exclusivity periods and generic challenges. However, it omits key quantitative and contextual details present in the ground truth: specifically, the $8 billion in 2022 sales for Stelara and the explicit reference to AbbVie’s experience as a demonstrated precedent for litigation surge post-exclusivity. These omissions reduce completeness and weaken the multi-hop synthesis. (2) There are no numeric inaccuracies—no incorrect figures or miscalculations are presented, and the answer avoids making false quantitative claims. The ground truth includes specific financial data (e.g., 'over $8 billion in 2022') which the LLM fails to include, but it does not contradict them. Thus, quantitative accuracy is high. (3) The reasoning is logically sound: the model correctly infers that BMY’s experience with exclusivity expiration can serve as a precedent for JNJ’s expected litigation exposure. It connects regulatory timelines to generic entry and litigation risk. However, it does not fully synthesize across all entities mentioned in the ground truth (e.g., AbbVie’s role in demonstrating Paragraph IV litigation impact), weakening the multi-hop chain. (4) The answer is contextually relevant and addresses the core question about precedent and litigation exposure. The omission of Stelara’s revenue and the AbbVie example limits qualitative depth and completeness, but the central logic remains valid. Hence, correctness is partially impacted but not fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 480,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B holders veto power over any change‑of‑control transaction until their voting power falls below 35 % of the combined voting power, effectively keeping the current Class B owners (including Zuckerberg) in control of such decisions (META 10‑K, p. 51). Alphabet’s dual‑class scheme, by contrast, gives each Class B share 10 votes but those shares automatically convert to Class A upon sale or transfer, so the concentration of voting power is limited to the current holders and is diluted whenever shares change hands (GOOGL 10‑K, pp. 79‑81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B veto power until below 35% voting power is accurately stated, and GOOGL's Class B 10-vote structure with automatic conversion upon transfer is correctly described. (2) Quantitative accuracy is perfect: the 35% threshold and 10 votes per share are correctly reported, with no calculation errors. (3) Multi-hop reasoning is sound—information from both META and GOOGL 10-Ks is synthesized appropriately to compare governance structures. The LLM correctly identifies that Meta’s structure provides enduring control via a threshold-based mechanism, while Google’s is limited by transfer-triggered conversion. (4) The only minor shortcoming is that the LLM does not explicitly state that Meta’s system offers 'more enduring governance insulation' due to its non-automatic nature, a nuance present in the original answer. However, this is implied by describing the veto power and threshold. Wording differs slightly but semantic equivalence is maintained. Citations to 10-K pages add credibility. No entity, metric, or structural detail is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 327,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS elected not to use the practical expedients under ASU 2020‑04, fully transitioning its debt and contracts to SOFR and applying the new reference‑rate‑reform accounting rules (UPS, 10‑K, p. 74). In contrast, 3M’s notes indicate that it has applied the optional relief for its hedging relationships—interest‑rate swaps and foreign‑exchange forwards—so those instruments can continue to be accounted for under the existing hedge‑accounting framework until the optional relief expires on December 31 2024 (3M, 10‑K, p. 74‑75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not apply the practical expedients under ASU 2020-04, citing its 10-K, which matches the original answer. It contrasts this with 3M (MMM), accurately noting that 3M applied the optional relief for its hedging relationships, with a reference to its 10-K. (2) There are no numeric values in the LLM answer, so quantitative accuracy is not compromised—no incorrect figures or miscalculations. The original answer includes a $152 million reclassification from AOCI, which the LLM omits; however, this detail is contextual and not essential to the core contrast being made. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and MMM/3M), two accounting treatments, and the relevant ASU standards (2020-04 and implied awareness of 2022-06 extension via the 2024 sunset date). The use of '3M' instead of 'MMM' is acceptable as it is a widely recognized ticker synonym. (4) The answer is contextually relevant and directly addresses the contrast in transition approaches under reference rate reform. The only minor shortcoming is the lack of explicit mention of ASU 2022-06 extending the relief to 2024, though the LLM does correctly reference the December 31, 2024 deadline, implying awareness. Overall, the answer captures the key contrast accurately and concisely, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 402,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 assets and values them at the quoted market price on commodity exchanges【page_112】. Because these futures are cash‑settled daily, MDLZ does not list them in the fair‑value table (they are excluded for that reason)【page_107】, but the daily settlement still means their fair value is updated and recorded each day. PepsiCo’s commodity derivatives are similarly marked to market each period【page_105】, so it treats them as Level 1 assets and values them at current market prices, with daily settlement ensuring that fair‑value changes are reflected promptly in earnings or other comprehensive income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued at quoted market prices, and that daily cash settlement leads to exclusion from the year-end fair value table—consistent with PEP's disclosure. The reference to daily marking-to-market and prompt reflection in earnings or OCI is factually sound. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised; all references to financial mechanics are correct. (3) The multi-hop reasoning—linking MDLZ’s valuation methodology to PEP’s similar treatment due to shared exposure to daily cash-settled futures—is logically sound and well-synthesized across entities. The only minor shortcoming is that the LLM slightly overgeneralizes by stating that daily-settled instruments are excluded from the fair value table without explicitly clarifying, as the original does, that this exclusion is because they are settled daily and thus do not carry forward a balance. However, this is implied and not factually incorrect. (4) The answer is fully contextually relevant, directly addressing how daily cash settlement impacts valuation methodology for Level 1 assets at MDLZ using PEP as a supporting example. Overall, the semantic meaning matches the original answer with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 398,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and together account for roughly one‑third (33.3 %) of the company’s total voting power, with the remaining two‑thirds coming from Class A shares (CMCSA page 31). Alphabet’s 10‑K notes that its Class B shares also carry multiple votes per share, but the exact split of voting power between its Class A and Class B shares is not disclosed in the excerpt.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that CMCSA's Class B shares have 15 votes per share and account for approximately 33.3% of total voting power, with Class A holding the remaining two-thirds (66.7%), which aligns with the ground truth. This demonstrates partial quantitative accuracy. However, the LLM fails to provide the corresponding voting power distribution for GOOGL beyond stating that Class B shares have multiple votes. The ground truth specifies that GOOGL’s Class B shares carry 10 votes per share versus 1 for Class A, and that Class C has no voting rights—key details omitted in the LLM response. Additionally, the LLM incorrectly implies that the voting power split for GOOGL is undisclosed, when in fact the structure (though not exact ownership percentages) is well-documented in public filings: Class B shares have superior voting rights and are held by insiders, enabling control. The LLM also misses the comparative analysis in the original answer—that CMCSA concentrates more voting power per Class B share (15x) than GOOGL (10x), making CMCSA’s dual-class structure more skewed in favor of insiders on a per-share basis. While the response correctly identifies both companies use multi-class structures, it fails to fully synthesize the comparison requested, particularly on the relative concentration of voting power. This constitutes a significant gap in multi-hop reasoning and completeness. Entity accuracy and contextual relevance are strong—CMCSA and GOOGL are correctly identified, and the focus remains on voting structure. However, due to missing key comparative facts and incorrect claim about disclosure, the overall correctness is only partially achieved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 458,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "BAC’s 2024 market‑making gains are reported as a net $4,184 million (page 164), derived from trading activities that include embedded derivatives in structured liabilities and are offset by hedging gains/losses on related derivatives and securities.  By contrast, MS’s involvement in credit‑linked notes (CLNs) is a direct investment in hybrid instruments that contain embedded credit‑protection derivatives; the firm’s exposure to credit‑event risk comes from the possibility that the reference entity defaults, potentially causing loss of principal and collateral delivery (page 109).  Thus, while both firms face credit‑event risk in structured notes, BAC’s gains are net of hedging, whereas MS’s CLNs represent a forward‑looking credit exposure that may trigger collateral adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific quantitative figure—$4,184 million in market-making gains for BAC in 2024—which is not present in the original ground truth answer. There is no mention of this number in the ground truth, nor is there any indication that such a figure was extracted from page 164 of a filing. This introduces a factual claim not supported by the provided truth, making it potentially incorrect or hallucinated. Similarly, the reference to 'page 164' and 'page 109' implies precise sourcing not present in the original answer, which does not cite specific dollar amounts or page numbers. (2) While the ground truth confirms BAC hedges its embedded derivative exposures and MS structures CLNs as hybrid instruments with credit protection sold, the LLM adds granular detail (e.g., 'collateral delivery', 'collateral adjustments') not present in the original. These may be contextually plausible but go beyond the verified truth. (3) The multi-hop reasoning is sound: the model correctly identifies that both firms deal with structured notes containing embedded derivatives and credit-event risk, and it accurately contrasts BAC’s hedging behavior with MS’s retention of risk. This synthesis across entities and risk profiles is logically valid and aligns with the ground truth. (4) Despite the hallucinated numbers and page references, the core qualitative comparison—BAC’s hedged market-making gains vs. MS’s retained credit risk in CLNs—is accurate and reflects the intended contrast. The answer remains contextually relevant and semantically close to the original, but the unsupported quantitative claims reduce confidence in factual correctness. Hence, quantitative accuracy is penalized, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 484,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce notes that the OECD’s Pillar Two Model Rules are a “global tax development” that could raise its effective tax rate.  For Intel, the same rules could push its effective tax rate higher because the company has significant exposure to non‑U.S. jurisdictions and is “continuing to evaluate the impacts of enacted legislation and pending legislation to enact Pillar Two Model Rules in the non‑US tax jurisdictions we operate in”【page_44】.  The minimum‑tax provision could increase tax costs in those jurisdictions, potentially offsetting Intel’s current benefit from lower foreign tax rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Salesforce identifies Pillar Two as a global tax development; Intel has significant non-US income exposure and is evaluating Pillar Two impacts; the rules include a 15% global minimum tax (implied by 'minimum-tax provision' and context, though not explicitly stated as 15% in the LLM answer); implementation began in 2024 in jurisdictions like the EU (referenced via 'enacted or pending legislation'). (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. The mention of 'page_44' aligns with typical sourcing in filings and does not contradict the knowledge graph. (3) Multi-hop reasoning is sound—correctly linking Salesforce's identification of Pillar Two as material to Intel’s exposure and ongoing evaluation, then logically concluding that the minimum tax could increase Intel’s effective tax rate by reducing benefits from lower-tax jurisdictions. (4) The only minor shortcoming is that the LLM does not explicitly state the 15% minimum tax rate, which is a key detail in the original answer. While the concept is implied through 'minimum-tax provision,' the omission slightly weakens completeness. Otherwise, the answer is semantically equivalent, contextually relevant, and correctly synthesizes cross-company, multi-hop information from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 396,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX recognizes revenue on FAR‑regulated U.S. government fixed‑price contracts over time, often before cash is received, creating contract assets that can lag cash inflows (see RTX page 79). Boeing, by contrast, notes that its U.S. government contracts can be terminated for convenience or default, which can abruptly eliminate revenue and cash receipts (see BA pages 5–6). Thus, RTX’s cash‑flow predictability is governed by a systematic lag between recognition and receipt, while Boeing’s is more volatile because termination risk can suddenly cut revenue and cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: RTX recognizes revenue before cash receipt under FAR-regulated fixed-price contracts, leading to contract assets (as noted on page 79 of RTX's filing), and Boeing faces termination risk (for convenience or default) that can disrupt revenue and cash flow (cited from BA pages 5–6). (2) There are no numeric values in the LLM answer, but it correctly reflects the qualitative financial mechanisms without introducing any incorrect figures. The absence of specific percentages (e.g., 80–90% of costs covered by PBPs) is a minor omission but does not detract from the overall correctness. (3) The multi-hop reasoning is sound—correctly contrasting RTX’s cash flow timing mismatch with Boeing’s termination-related volatility under the same FAR framework. The synthesis across two companies and regulatory context is accurate. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'systematic lag' vs 'revenue in excess of billings') but preserving meaning. The only reason for not scoring a 10 is the lack of detail on interim payment rates (80–90%), which adds nuance but does not change the conclusion about cash flow predictability. All other aspects—entities, reasoning, and implications—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 388,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s $119 million of floating‑rate notes with 2025 put provisions are classified as the current portion of long‑term debt (page 69), representing a direct near‑term liability.  \nGE, by contrast, holds $315 million of fixed and floating‑rate notes that contain 2025 put options (page 55); these are marketable securities, not debt, so GE’s near‑term liability exposure is contingent on the put exercise and is currently lower than MMM’s $119 million obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly identifies the $119 million floating rate notes with 2025 put provisions for MMM and the $315 million investment in notes with 2025 put options for GE, matching the ground truth numerically and contextually. Page references (69 and 55) are additional details not in the original answer but do not contradict it. However, a critical error occurs in the interpretation of GE's position: the LLM incorrectly characterizes GE’s $315 million as 'marketable securities, not debt' and concludes that GE’s 'near-term liability exposure is...lower than MMM’s $119 million'. This contradicts the ground truth, which states both companies face near-term liquidity risks due to put options, with GE’s exposure being more than 2.5 times larger than MMM’s. The original answer emphasizes that GE holds notes *containing* put options (i.e., likely as an issuer or obligor), not as an investor in marketable securities. The LLM misreads GE’s exposure, reversing the comparative risk. 2) Quantitatively, all numbers ($119M, $315M, 2025) are accurate and correctly attributed. The ratio of GE’s exposure to MMM’s is ~2.65x, which supports the ground truth claim of 'more than 2.5 times larger'—a calculation the LLM fails to make and contradicts. 3) The multi-hop reasoning is flawed: while the model retrieves correct data points, it fails to synthesize them correctly. It does not recognize that both companies have potential cash outflows from puttable debt in 2025 and incorrectly frames GE as a holder/investor rather than an issuer. This breaks the logical comparison required by the question. 4) Contextual relevance is fair—the answer addresses near-term obligations and mentions put options and liquidity implications—but the mischaracterization of GE’s position undermines the core comparison. The conclusion is factually incorrect despite correct input data, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 514,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PEP values its exchange‑traded commodity futures at the daily market price that settles the contracts each day (page 106), but it does not list them in its fair‑value table because they are cash‑settled daily. MDLZ, by contrast, classifies exchange‑traded commodity futures as Level 1 assets and explicitly states that their fair value is derived from quoted market prices on commodity exchanges (page 95). Thus, both firms rely on daily market pricing, but MDLZ’s approach is formally incorporated into the Level 1 hierarchy, whereas PEP’s valuation is an implicit daily calculation not shown in the table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PEP does not include exchange-traded commodity futures in its fair value table due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. Both rely on daily market pricing, but differ in presentation and classification—this core contrast is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but the references to page numbers (106 for PEP, 95 for MDLZ) are consistent with source documentation and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), compares their valuation methodologies, and identifies the key distinction—PEP’s exclusion due to cash settlement vs. MDLZ’s inclusion under Level 1 based on quoted prices. (4) The LLM uses slightly different phrasing (e.g., 'implicit daily calculation' for PEP) that is semantically reasonable but not explicitly stated in the ground truth; this minor interpretive leap prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually precise, fully relevant, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 376,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China net sales were $74.2 billion in 2022, whereas Intel’s Taiwan‑based revenue was $13.5 billion in the most recent year reported (2021). Thus Apple’s Greater China revenue is roughly 5½ times larger than Intel’s Taiwan revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's Greater China revenue as $74.2 billion (equivalent to $74,200 million), which matches the ground truth. However, it incorrectly states Intel's Taiwan revenue as $13.5 billion from 2021, while the ground truth specifies $13,461 million (i.e., $13.461 billion) in 2022. This introduces two errors: a slight overstatement of Intel's revenue and, more significantly, a mismatch in the fiscal year (2021 vs 2022). (2) The calculation that Apple’s revenue is 'roughly 5½ times larger' is approximately correct if comparing $74.2B to $13.5B, but would be more accurate at ~5.52x using exact figures. However, using the correct 2022 Intel figure ($13.461B), the ratio is ~5.51x, so the comparison remains reasonable. The main quantitative flaw is the use of outdated data for Intel. (3) The multi-hop reasoning is sound—comparing Apple’s regional revenue (Greater China, including Taiwan) to Intel’s country-specific revenue (Taiwan)—and the synthesis across companies and geographies is appropriate. However, the failure to use the correct year for Intel weakens the validity of the direct comparison. (4) Despite the year mismatch, the core conclusion that Apple’s revenue exposure in the region is significantly higher than Intel’s direct Taiwan revenue remains valid. The answer is well-structured and contextually relevant, but the incorrect year and slightly rounded revenue figure reduce quantitative accuracy. Hence, correctness is partially impacted, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 419,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "The information required to make the comparison is not present in the pages supplied.  The only net‑PPE figure shown for MMM is the $106 million net balance for finance‑lease property and equipment (page 133), but no segment‑level net‑PPE for the Americas is disclosed.  Likewise, the GD 10‑K pages (78‑82) contain no revenue data for South America.  Consequently, a direct comparison of MMM’s Americas net‑PPE to GD’s South‑America revenue cannot be made from the provided material.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect and contradicts the ground truth. The original answer states that MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, and GD generated $234 million in revenue from South America in the same year. However, the LLM claims this information is not present in the provided materials, asserting that no segment-level net PPE for MMM Americas or GD South America revenue is disclosed. This is a failure to retrieve or recognize the correct data. (2) The LLM cites a $106 million figure for finance-lease property from page 133, which is irrelevant to the segment-level net PPE for the Americas. This misrepresents the available data and introduces a number not pertinent to the question. The correct figures—$5,864 million (MMM Americas net PPE) and $234 million (GD South America revenue)—are entirely absent from the LLM’s response. (3) The multi-hop reasoning required—comparing MMM’s asset investment in the Americas (which includes South America) to GD’s revenue from South America—cannot be executed if the foundational data is deemed missing. The LLM fails to synthesize because it incorrectly concludes data unavailability, breaking the reasoning chain at the first step. (4) The correctness score is 1 because the answer is fundamentally wrong—the required data was available per the ground truth, but the model claims it is missing. Quantitative accuracy is 1 because no correct numbers are used. Qualitative accuracy is 2 because while the structure of the response (explaining lack of data) is coherent, the underlying premise is false. Contextual relevance is 3 because the answer addresses the right companies and region but fails to provide any valid comparison due to incorrect data assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 487,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "NFLX’s auditor uses sensitivity analyses to test how changes in the company’s viewing‑pattern assumptions would alter the amount of content amortization recorded—an audit focus on a single, judgment‑heavy accounting estimate (see page 40).  \nCMCSA, by contrast, employs sensitivity analyses as part of its interest‑rate risk‑management framework to evaluate how hypothetical rate shifts would affect debt balances, derivative fair values and interest expense, thereby guiding its hedging strategy (see page 60).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses to evaluate viewing-pattern assumptions affecting content amortization (accounting estimate), while CMCSA uses sensitivity analyses for interest rate risk management, specifically to assess impacts on debt, derivatives, and interest expense. (2) Quantitative accuracy is perfect—no incorrect numbers or misstatements; the $56 million reduction in interest expense by derivatives mentioned in the original answer is absent in the LLM response, but the LLM does not claim to cover all details and the omission does not distort the comparison. (3) Multi-hop reasoning is sound: the model correctly distinguishes between NFLX’s use of sensitivity analysis in an audit/accounting context versus CMCSA’s application in financial risk management, synthesizing across two companies and distinct financial domains. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The only minor shortcoming is the lack of explicit mention of the $56 million derivative impact, which is part of CMCSA’s risk management outcome, but since the question focuses on the *use* of sensitivity analyses rather than specific results, this omission does not undermine the correctness. Contextual relevance is excellent, directly addressing the comparative use of sensitivity analyses.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 403,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PEP actively uses exchange‑traded commodity futures—Level 1 instruments that are cash‑settled daily—to hedge commodity‑price risk, as noted on page 107 (“Exchange‑traded commodity futures are cash‑settled on a daily basis and, therefore, not included in the table”). In contrast, COST reports on page 51 that it held no Level 1 or Level 3 financial assets or liabilities, meaning it has no Level 1 financial liabilities on its balance sheet and does not employ such instruments for risk management. Thus, while both firms apply the fair‑value hierarchy, PEP relies on Level 1 futures for hedging, whereas COST’s disclosures indicate an absence of Level 1 liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PEP uses exchange-traded commodity futures (Level 1 instruments) for risk management and that these are cash-settled daily and excluded from the balance sheet, aligning with the ground truth as of December 25, 2021. It accurately contrasts this with COST's disclosure as of August 28, 2022, that it holds no Level 1 or Level 3 financial assets or liabilities. While the LLM does not explicitly name the date for PEP or COST, it correctly references the disclosures in context and focuses on the key contrast in risk management strategies. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth that require verification—the only time references are implicitly correct through contextual citation (e.g., page references imply correct fiscal periods). The absence of explicit dates is a minor omission but does not affect factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and COST), connects their use (or non-use) of Level 1 instruments, and interprets the implications under the same fair value hierarchy framework. It correctly infers that PEP’s use of Level 1 futures contrasts with COST’s lack of such instruments. (4) The answer is semantically equivalent to the ground truth, with only minor omissions (specific fiscal dates) that do not detract from the core factual correctness. The inclusion of page numbers adds precision. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 463,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 10‑K shows Enbrel’s U.S. patents will expire from 2028 to 2037 (page_11). Those expirations will erode Merck’s exclusivity in the U.S. and Canada, exposing it to biosimilar competition and pricing pressure that Merck acknowledges in its own filing (page_33). Pfizer, which markets Enbrel only outside the U.S. and Canada (page_9), will need to adjust its international manufacturing and pricing strategy as the patents lapse to stay competitive against emerging biosimilars.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the general timeline of Enbrel's U.S. patent expirations (2028–2037) and links it to biosimilar competition and pricing pressures for Merck, as well as Pfizer's international strategy. However, it lacks the specific phase dates mentioned in the ground truth: fusion protein composition (November 2028), DNA encoding (April 2029), and formulations (October 2037). These omissions reduce quantitative accuracy. (2) The ground truth includes precise expiration dates and ties them to specific patent types, which the LLM omits. While the range '2028 to 2037' is directionally correct, missing the exact months and patent categories constitutes a factual incompleteness. There are no calculation errors, but the lack of granularity affects precision. (3) The multi-hop reasoning is largely sound: the model connects Amgen’s patent timeline to Merck’s competitive risk and Pfizer’s international production strategy. It correctly notes Merck’s exposure to biosimilars and pricing pressure (referencing its own filing) and that Pfizer operates outside the U.S. and Canada. However, it does not fully synthesize how the staggered U.S. patent expirations could influence global pricing dynamics, which is a key link in the original answer. (4) The answer is contextually relevant and captures the core implications for both companies. The qualitative reasoning is strong, but the absence of specific patent phases and dates limits full factual alignment. Hence, correctness is reduced to 7 due to partial quantitative inaccuracy despite solid reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 441,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports only about **$90 million** of unfunded commitments to private‑equity funds (measured at NAV)【page_64】, whereas UPS reports roughly **$2.7 billion** of unfunded commitments to private‑equity and other limited partnerships (also measured at NAV)【page_93】. Thus, UPS’s unfunded commitments are about 30,000 times larger than EMR’s, representing a difference of roughly $2.7 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the amount reported by EMR. The original answer states EMR reports $90 of unfunded commitments, not $90 million. The LLM incorrectly interprets '$90' as '$90 million', which drastically misrepresents the scale. This leads to a false comparison where UPS’s $2.7 billion is said to be 'about 30,000 times larger'—a calculation based on the erroneous assumption that EMR’s commitment is $90 million. In reality, if EMR’s commitment is just $90, the difference would be vastly more extreme, but the context suggests this is likely a reporting anomaly or minimal nominal amount, making the 30,000x comparison nonsensical and misleading. (2) Quantitative accuracy is severely compromised: while UPS’s $2.7 billion is correctly cited, EMR’s $90 is misrepresented as $90 million—an error of six orders of magnitude. The calculation of the ratio (30,000x) is mathematically correct only if the $90 million were accurate, which it is not. The difference of '$2.7 billion' is approximately correct in absolute terms only because $90 is negligible, but it's presented deceptively due to the prior error. (3) The multi-hop reasoning is partially sound—the model identifies both companies, the relevant metric (unfunded commitments), and the common accounting treatment (measured at NAV). However, the synthesis fails due to the misreading of EMR’s figure, undermining the core comparison. (4) Contextual relevance is high—the answer addresses the comparison between EMR and UPS regarding unfunded commitments under NAV accounting, includes proper sourcing cues (page references), and attempts a quantitative comparison. However, the massive numerical inaccuracy severely undermines factual correctness, warranting a low overall score despite structurally appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 496,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC division reported that beverages accounted for **23 % of its 2024 revenue**【page_73】.  \nIn contrast, Mondelēz’s 2024 beverage sales totaled **$1.096 billion** (across all regions)【page_121】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 23% of PepsiCo's APAC segment revenue in 2024 came from beverages, matching the ground truth. It also accurately reports Mondelēz's total beverage revenue as $1.096 billion ($1,096 million), which is consistent with the original answer. The formatting variation ($1.096 billion vs $1,096 million) is acceptable and semantically equivalent. (2) All numeric values are correct: 23% and $1.096 billion. The LLM does not explicitly calculate PepsiCo's APAC beverage revenue in dollar terms ($2.3 million), but since the question only asks for the percentage and a comparison to Mondelēz, this omission does not invalidate the core answer. (3) The multi-hop reasoning is sound: the model correctly identifies PepsiCo's APAC beverage contribution and contrasts it with Mondelēz's global beverage revenue, showing awareness of scope differences (regional vs. total). (4) The answer is highly accurate, complete for the question asked, and contextually appropriate. The only minor shortcoming is the lack of explicit dollar conversion for PepsiCo's beverage revenue, but this is not required to answer the specific question. Hence, a score of 9 is justified—excellent but not fully exhaustive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 346,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $2.237 billion of delinquent loans at December 31 2023 (Table 3.8, page 161).  Once these loans are modified and have performed for at least 12 months, they become reperforming loans that MetLife can acquire for its residential mortgage portfolio (definition on page 240).  Consequently, the sizable delinquent‑loan balance at COF expands the pool of potential reperforming loans available to MetLife, increasing its purchasing options for that segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported volume of Capital One's delinquent loans. The ground truth states $623 million as of December 31, 2023, but the LLM claims $2.237 billion, which is over three times higher. This discrepancy severely undermines the quantitative accuracy. (2) The date (December 31, 2023) and the concept of reperforming loans being available to MetLife after 12 months of performance post-delinquency are correctly identified, and the general logic about delinquent loans forming a source pool for future reperforming loans is sound. However, the dollar amount is not just incorrect but misrepresents the scale of the opportunity. (3) The multi-hop reasoning is structurally correct—linking Capital One’s delinquencies to potential reperforming loans that MetLife can purchase—but relies on incorrect input data. The mention of 'Table 3.8, page 161' and 'page 240' suggests plausible sourcing, but the numbers do not align with the ground truth. (4) While the qualitative understanding of the relationship between delinquency and reperformance is adequate, and the contextual relevance to the question is strong, the massive numerical inaccuracy results in a low correctness and quantitative score. Minor flexibility is allowed for phrasing, but not for such significant financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 376,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan has $5 million in commitments to real‑estate limited partnerships (and $80 million to private‑equity partnerships), all valued at NAV. UPS’s pension plan reports no unfunded commitments to private‑equity or real‑estate structures (though it holds $2.6 billion in real‑estate funds and $5.1 billion in private‑equity funds, also valued at NAV). Thus, UNP’s exposure in terms of unfunded commitments is modest, whereas UPS has no such commitments disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents key information from the ground truth. (1) Quantitative inaccuracy: The LLM claims UNP has $5 million in commitments to real estate limited partnerships and $80 million to private equity, which is not supported by the original answer and contradicts the ground truth, which does not specify UNP's commitment amounts. More critically, the LLM states that UPS has *no unfunded commitments* to such structures, directly contradicting the ground truth that UPS has *approximately $3.3 billion* in unfunded commitments to limited partnerships in private equity, private debt, and real estate. The LLM also incorrectly states UPS holds $2.6 billion in real estate funds and $5.1 billion in private equity funds—these figures are not in the original answer and appear fabricated. (2) Completeness: The question asks for a comparison of UNP's pension plan exposure to UPS's unfunded commitments, particularly regarding NAV-based valuations and illiquidity. The LLM fails to mention UPS's $3.3 billion in unfunded commitments, which is the central quantitative point in the ground truth. It also omits UPS's 10- to 15-year partnership terms and limited redemption provisions, a key qualitative point about liquidity risk. (3) Entity accuracy: While UNP and UPS are correctly identified, the financial metrics attributed to them—especially the $3.3 billion unfunded commitment for UPS—are either misplaced or denied. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers that because UPS holds NAV-valued assets, it has no unfunded commitments, when the ground truth explicitly separates current holdings from future funding obligations. The conclusion that 'UPS has no such commitments disclosed' is factually wrong. (5) Semantic equivalence: The LLM's answer conveys the opposite of the ground truth regarding UPS's commitments. While both mention NAV as a valuation method, this minor alignment does not compensate for the major factual discrepancies. The answer is contextually relevant in structure but fails on factual and logical grounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 567,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s reliance on external foundries for 7 nm and smaller nodes means it has limited control over yields, cycle times, and quality‑assurance processes, so any manufacturing inefficiencies or quality lapses at TSMC or other partners can materially affect product supply and margins (see AMD 10‑K, pp. 24‑25). By contrast, Cisco maintains quality control through automated testing, burn‑in procedures, and comprehensive inspection and statistical process controls that are ISO 9001‑certified, giving it greater oversight and consistency in product quality (see Cisco 10‑K, p. 9). Consequently, AMD faces higher uncertainty in quality outcomes than Cisco’s more controlled manufacturing environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD relies on third-party manufacturers like TSMC for 7 nm and smaller nodes, which introduces risks in yields, quality assurance, and delivery—this is consistent with AMD's 10-K disclosures. Cisco’s use of automated testing, burn-in procedures, and ISO 9001-certified processes for internal quality control is accurately represented and matches Cisco’s 10-K. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not applicable beyond correct referencing of document pages (pp. 24–25 for AMD, p. 9 for Cisco), which are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMD and Cisco), compares their manufacturing and quality control strategies, and draws a valid conclusion about relative exposure to quality control risks. (4) The semantic meaning fully matches the original answer—AMD has less direct control over quality due to outsourcing, while Cisco maintains tighter control through internal, certified processes. The only minor shortcoming is a slight omission of the term 'product reliability' and 'variability reduction' mentioned in the original, but the core idea of greater consistency and oversight is conveyed. Wording differences are acceptable and do not affect factual accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 436,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s Atairos investment is a VIE in which it has no voting rights and therefore no governance influence; its financial exposure is limited to the $5.1 billion investment balance and a $1.4 billion unfunded capital commitment, with losses absorbed at 99 % and residual returns at 86 % (page 85). Alphabet’s Class C capital stock also carries no voting rights, but it is a standard equity instrument that gives shareholders dividends and market‑price exposure; Alphabet retains governance control through its voting Class A and B shares while the Class C shares represent ordinary financial exposure (page 82, page 84).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core structural comparison—Comcast lacks voting rights in Atairos (a VIE) and thus has no governance influence, while Alphabet issues non-voting Class C stock but retains control via Class A and B shares. It accurately notes Comcast's $1.4 billion unfunded capital commitment and correctly frames Alphabet's use of dual-class shares. However, the investment balance of $5.1 billion in Atairos is not present in the original answer (ground truth), which only mentions the $1.4 billion unfunded commitment as the key financial exposure—this number appears to be an over-specification or addition not supported by the ground truth. Additionally, the LLM introduces new quantitative details—'99% losses absorbed' and '86% residual returns'—which are absent from the original answer and not requested in the question, raising concerns about factual sourcing. (2) The $1.4 billion unfunded commitment matches the ground truth (as of December 31, 2024), but the $5.1 billion investment balance and the percentage allocations are unverified and not in the original, reducing quantitative accuracy. Alphabet's $62.0 billion in 2024 repurchases—mentioned in the ground truth—are omitted in the LLM answer, which weakens the completeness of the Alphabet-side financial activity. (3) The multi-hop reasoning is strong: the model correctly synthesizes governance vs. financial exposure across two different corporate structures (VIE vs. dual-class equity) and draws a valid contrast in how control is maintained (or not). It correctly identifies that Alphabet actively manages its share structure through repurchases (implied control mechanism), though it fails to explicitly mention the repurchase amount, a key detail in the original. (4) Despite missing the repurchase figure and adding unverified numbers, the LLM conveys the essential contrast: Comcast has financial exposure without governance, while Alphabet separates voting rights but retains control. Wording is semantically aligned, and the answer remains highly relevant and logically sound, warranting a high correctness score with minor deductions for unsupported figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 583,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC lists Austria among the countries where it operates its own bottling and distribution network, indicating a direct physical footprint in the market【page_7】.  \nPhilip Morris, by contrast, reports that it holds at least a 15 % market share in Austria, reflecting a significant commercial presence but no explicit mention of a dedicated bottling or distribution operation in that country【page_7】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the 15% market share for Philip Morris in Austria is accurately reported, matching the original answer. Coca-Cola HBC's operational presence in Austria is correctly stated. (2) The answer correctly identifies both companies' presence in Austria—Coca-Cola HBC with a direct bottling and distribution footprint, and Philip Morris with a significant market share. However, the LLM omits the contextual detail that Coca-Cola HBC contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers, which is part of the multi-hop synthesis required. (3) The reasoning is sound in comparing operational footprint vs. market presence, but the lack of mention of Coca-Cola HBC’s broader global contribution slightly weakens the qualitative synthesis. (4) Despite this omission, the answer remains factually accurate, relevant, and correctly contrasts the nature of each company’s presence in Austria, earning high marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 308,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "BAC’s 2023 filing notes that commercial‑real‑estate credit quality deteriorated, especially for office loans, with higher non‑performing and reservable‑criticized exposure (page 65).  MET’s own notes explain that it estimates IBNR for Protection Life and Protection Health using the Bornhuetter‑Ferguson Method and revises the unpaid‑claims assumptions annually to reflect emerging claim‑experience trends (pages 194–196).  Consequently, the worsening credit environment signaled by BAC’s office‑property losses suggests that claim patterns may shift, prompting MET to adjust its experience‑derived factors and expected loss ratios in the Bornhuetter‑Ferguson calculation each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies BAC's deterioration in commercial real estate credit quality in 2023, specifically in office properties, citing increased non-performing and criticized loans (from BAC's filing, page 65), which matches the original answer's claim about stagnant demand and evolving employment models. (2) It accurately states that MET uses the Bornhuetter-Ferguson Method for estimating IBNR (incurred but not reported claims) for Protection Life and Health products and updates assumptions annually to reflect emerging trends (citing MET pages 194–196), which is consistent with the ground truth. (3) The reasoning correctly links BAC’s credit deterioration as a macroeconomic signal that could shift claim patterns, necessitating updates to MET’s expected loss ratios and experience-derived factors in its actuarial model—this captures the multi-hop logic: BAC’s credit trends → macroeconomic deterioration → impact on MET’s loss assumptions. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the sensitivity of long-duration Protection Health claims or experience-rated contracts where adverse claims are passed to sponsors, a nuance present in the original answer that strengthens the causal chain. However, the core multi-hop synthesis is sound, entities (BAC, MET, Bornhuetter-Ferguson, Protection Life/Health) and years (2023) are correct, and no numerical inaccuracies exist (no specific numbers were misstated). The answer is contextually precise and semantically equivalent to the ground truth, with only slight room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 451,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s common stock is a single class that grants each share one vote on all shareholder matters (page 60). Meta’s only class of common stock is Class A, which likewise carries one vote per share and, as the sole voting class, holds all voting power (page 1). Thus, both companies use a one‑vote‑per‑share structure for their common stock, with Class A common stock serving as the key voting vehicle.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding Meta's stock structure, which undermines the multi-hop comparison. (1) Quantitatively, there are no numeric errors—the statement that both Class A shares carry one vote per share is accurate. (2) However, the LLM incorrectly claims that Meta's Class A is the 'sole voting class' and that it is the 'only class of common stock,' which contradicts the ground truth: Meta has Class B shares with 10 votes per share, held by insiders, creating a dual-class structure. This error omits a critical aspect of Meta's governance framework. (3) The reasoning is flawed in the multi-hop comparison: while Netflix does have a single class with one vote per share, the LLM fails to recognize that Meta’s governance allows disproportionate control via Class B shares, making the comparison incomplete and misleading. (4) The answer is contextually relevant and addresses the voting rights of Class A shares in both companies, but the omission of Meta’s multi-tiered structure significantly reduces qualitative accuracy and overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 324,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "Both companies cash‑settle exchange‑traded commodity futures and include them in their liability portfolios.  \nPEP’s fair‑value table omits these instruments, noting that they are cash‑settled daily and therefore not reported separately (page 107).  \nMDLZ, in contrast, lists them as Level‑1 liabilities and values them at quoted market prices on commodity exchanges (page 112).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the key distinction between PEP and MDLZ in their treatment of exchange-traded commodity futures within the fair value hierarchy. (1) All factual elements are correct: PEP omits these instruments from its fair value table due to daily cash settlement (consistent with the ground truth reference to December 25, 2021, which aligns with PEP’s fiscal year-end), while MDLZ includes them in Level 1 using quoted market prices. The page references (107 and 112) are plausible and contextually appropriate, though not part of the ground truth per se. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected. (3) The multi-hop reasoning is sound—correctly contrasting PEP’s exclusion due to settlement timing versus MDLZ’s inclusion based on pricing source—and both companies are accurately identified with correct treatment descriptions. (4) The answer is semantically equivalent to the original: it captures the core difference in reporting practice despite similar underlying economics. The only minor omission is the explicit statement that both treat the futures as Level 1 liabilities in substance, even though PEP doesn’t report them in the hierarchy table. This nuance is implied but not stated, slightly reducing qualitative accuracy. Overall, the response is factually correct, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 394,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Merck and Gilead’s collaboration on the islatravir/lenacapavir combination is a 60/40 cost‑sharing arrangement for development and commercialization, with equal revenue sharing until predefined thresholds are met (page 74).  Pfizer, by contrast, relies on internal cost‑reduction programs—an enterprise‑wide cost realignment and manufacturing‑optimization effort—to lower its overall operating expenses, rather than sharing specific HIV‑therapy costs (page 31).  Thus, Merck and Gilead’s financial exposure is tied to the partnership’s agreed‑share of R&D and marketing outlays, while Pfizer’s exposure to long‑acting HIV therapies is mitigated by broader cost efficiencies that reduce its overall cost base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: the 60/40 cost-sharing split (Gilead/Merck), equal revenue sharing, and the mention of predefined thresholds (though specific threshold amounts—$2.0B for oral, $3.5B for injectable—are omitted, this is a minor detail). The reference to Pfizer’s enterprise-wide cost realignment and manufacturing optimization in 2024 is correctly represented. (2) The LLM correctly identifies the entities: Merck, Gilead, Pfizer, islatravir/lenacapavir combination, and the nature of their respective financial strategies. (3) The reasoning is sound: it contrasts a collaborative cost- and revenue-sharing model (Merck/Gilead) with Pfizer’s internal cost-reduction approach, correctly inferring differing financial exposure implications. (4) The answer is contextually relevant, directly addressing the comparison of cost-sharing arrangements and their financial implications. The only minor shortcoming is the lack of explicit mention of the revenue threshold amounts and the equal revenue sharing before thresholds, which slightly reduces completeness. However, the core multi-hop synthesis—comparing collaborative vs. internal financial strategies in long-acting HIV therapy development—is accurately conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 399,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx notes that ASU 2022‑06, which applies only to contracts and hedging relationships that reference LIBOR, has had no material effect on its financials as of May 31 2024 and it is monitoring its contracts for potential application, with the optional relief available through December 31 2024 (FedEx, Note 3, p. 93). In contrast, UPS discloses that it uses derivative instruments as hedging relationships (cash‑flow, fair‑value, or net‑investment hedges) but does not specifically reference LIBOR or the ASU, indicating its hedging practices are not directly impacted by the reference‑rate reform (UPS, Note 3, p. 73). Thus, FedEx’s exposure to LIBOR‑related hedging adjustments is minimal and subject to the extended sunset date, whereas UPS’s hedging relationships are broader and not tied to LIBOR or the ASU.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all dates and references are accurate: ASU 2022-06's sunset date of December 31, 2024, and FedEx's reporting date of May 31, 2024, are correctly cited. There are no numerical calculations in this question, but the temporal and regulatory details are precise. (2) The LLM correctly identifies that FDX (FedEx) has not experienced material effects from ASU 2022-06 and continues to monitor its contracts, which matches the original answer. It also accurately notes the extended relief through 2024. (3) For UPS, the LLM correctly states that it uses various hedging relationships (cash flow, fair value, net investment), per its Note 3. However, the LLM concludes that UPS’s hedging is 'not directly impacted' and 'not tied to LIBOR or the ASU' due to lack of explicit mention—this is a slight overinterpretation. The original answer suggests UPS *could be* leveraging the extended provisions due to its active hedging practices, even if not explicitly referencing LIBOR. The LLM’s inference that absence of mention implies no impact is reasonable but less nuanced than the ground truth’s more balanced interpretation. (4) The multi-hop reasoning is sound: the model compares FDX and UPS under ASU 2022-06, synthesizes disclosures about hedging practices, and contextualizes the sunset extension. The conclusion differs slightly in tone—portraying UPS as unaffected rather than potentially benefiting—but the core facts are accurate. Hence, high scores for quantitative accuracy and contextual relevance, a minor deduction in qualitative accuracy for interpretive overreach, and an overall correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 462,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class structure gives its founder and CEO 10 votes per Class B share and, because those shares automatically convert to Class A upon sale or transfer, concentrates control and limits the voting influence of ordinary shareholders—reducing investor protections and making Class A stock less attractive. Alphabet’s Class B shares likewise carry 10 votes per share, but the automatic conversion on transfer preserves the existing concentration of voting power and protects the control structure, while preventing new investors from gaining voting rights. Thus, both companies concentrate control, but Meta’s structure is more explicitly tied to governance provisions that limit other shareholders’ protections, whereas Alphabet’s conversion rule simply locks the voting advantage in the hands of current holders.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Meta's Class B shares 'automatically convert to Class A upon sale or transfer'—this is false. Unlike GOOGL, Meta's Class B shares do not automatically convert upon sale or transfer; they only convert if the holder transfers shares to someone outside the founder's family or under specific conditions, and crucially, the structure is designed to maintain long-term control. This misrepresentation fundamentally undermines the comparison. The 10 votes per share for Class B shares in both companies is correctly stated. (2) Quantitatively, the voting ratios (10:1) are accurate for both Meta and Alphabet (GOOGL), so numerical aspects are mostly correct, earning a moderate score. However, the answer misrepresents the conversion mechanism, which is a qualitative and structural error with major implications. (3) The multi-hop reasoning fails because the LLM incorrectly equates the conversion mechanisms between the two companies. The core of the question hinges on comparing Meta’s enduring control structure versus GOOGL’s conversion-upon-transfer safeguard, which limits long-term insider control. The LLM flips this logic, suggesting Alphabet’s rule 'locks in' voting advantage, which is true, but fails to contrast it with Meta’s even more entrenched and persistent control mechanism. Worse, it falsely attributes GOOGL’s conversion rule to Meta. (4) Contextual relevance is high because the answer addresses the right companies, stock classes, voting differentials, and investor protection implications. However, due to the critical error in describing Meta’s conversion policy, the qualitative and overall correctness scores are low. The conclusion that 'both concentrate control' is valid, but the reasoning for why Meta’s is more problematic is flawed due to incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 510,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO uses option contracts as cash‑flow hedges for forecasted foreign‑currency transactions, with the resulting gains and losses initially recorded in AOCI and reclassified into earnings when the hedged transaction occurs, thereby smoothing earnings volatility. MDLZ, by contrast, reports gains and losses on forecasted transactions as part of its economic hedges—$106 million in 2024, $17 million in 2023 and $117 million in 2022—which are recognized directly in earnings (cost of sales, interest and SG&A) and thus affect profitability in the period.  [page_83]  [page_97]",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's use of option contracts as cash flow hedges with gains/losses deferred in AOCI and later reclassified to earnings, aligning with the ground truth. It also correctly notes MDLZ's recognition of gains in cost of sales and other expense categories. However, the LLM introduces incorrect quantitative data: it states MDLZ reported $106 million in 2024, $17 million in 2023, and $117 million in 2022, while the ground truth only confirms $106 million in 2024 (with $17 million as a component of that total, not a separate annual figure). The $117 million in 2022 is not mentioned in the original answer and appears to be fabricated or misattributed. (2) The quantitative inaccuracies are significant because they misrepresent the time series and magnitude of MDLZ's hedging gains, undermining the financial impact comparison. The ground truth does not provide multi-year data, so the LLM overextended its response. (3) The multi-hop reasoning is otherwise sound: it correctly contrasts KO’s structured, AOCI-deferred strategy with MDLZ’s more transparent, income-statement-focused disclosure, capturing the essence of the hedging strategy comparison. (4) The contextual relevance is high as the answer addresses both companies, their hedging instruments, accounting treatments, and financial statement impacts. The qualitative reasoning is strong, but the incorrect numbers reduce confidence in the financial impact analysis, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 417,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s fixed‑income funds are listed as “not subject to leveling” (page 57), meaning they are measured at net‑asset value as a practical expedient and are not classified in the fair‑value hierarchy.  By contrast, Bristol‑Myers Squibb’s fixed‑income funds are classified as Level 2 (page 112), where valuation relies on observable market inputs such as quoted prices for similar instruments in non‑active markets and other observable data.  Thus BMY’s approach reflects a greater reliance on observable market data for pension asset valuation, whereas TMO’s approach relies less on such data, using NAV as a practical expedient instead.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that TMO's fixed income funds are 'not subject to leveling' and are measured at net asset value (NAV) as a practical expedient, placing them outside the fair value hierarchy. It also correctly states that BMY classifies its fixed income funds under Level 2, which relies on observable market inputs. These characterizations match the original answer semantically. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all descriptive financial terms (Level 2, NAV, observable inputs) are used correctly. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies' valuation approaches, links 'not subject to leveling' to exclusion from the fair value hierarchy, and interprets Level 2 as reliance on observable data. It then synthesizes this into a valid comparison about differing reliance on market data. (4) The only minor shortcoming is that the LLM answer does not explicitly state that TMO's approach implies 'less direct reliance on standardized market inputs' in the same conceptual framing as the original, though it does say TMO uses NAV 'instead' of observable data, which conveys similar meaning. The inclusion of page numbers (57, 112) adds precision not in the original but does not detract. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 421,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Under FAR, revenue for cost‑plus‑fixed‑fee contracts must be recognized over time as costs are incurred. Lockheed Martin applies a percentage‑of‑completion cost‑to‑cost method to measure progress and therefore records revenue continuously as work proceeds【page_78】. Boeing’s 10‑K notes that it also enters into cost‑plus‑fixed‑fee contracts【page_5】, but it does not disclose a specific measurement approach in the provided pages; it is presumed to follow FAR’s over‑time rule but may use a different method or timing, which can create revenue‑recognition timing differences between the two companies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of FAR's impact on revenue recognition for cost-plus-fixed-fee contracts and correctly identifies that both LMT and BA are subject to FAR, leading to over-time revenue recognition. It accurately states that Lockheed Martin uses a cost-to-cost percentage-of-completion method (supported by page 78 reference), which aligns with the ground truth's explanation of continuous revenue recognition due to control transferring over time. The mention of Boeing’s cost-plus-fixed-fee contracts (page 5) is also correct. However, the LLM answer falls short in fully synthesizing the multi-hop reasoning required: it does not explicitly connect Boeing’s termination for convenience clauses to the revenue recognition pattern as described in the ground truth, nor does it explain that both companies have comparable patterns due to FAR-mandated treatment. Instead, it introduces uncertainty by stating Boeing 'does not disclose a specific measurement approach' and 'may use a different method,' which, while plausible, is not supported by the ground truth that emphasizes the commonality in treatment under FAR. This downplays the core point of comparability. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the context is highly relevant. The reasoning is sound but incomplete in drawing the correct synthesis across both companies’ contract structures and FAR implications, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 427,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "Both AbbVie's debt agreements and Abbott Laboratories’ use of Abbott Ireland Financing DAC involve U.S. Bank National Association as trustee. AbbVie issues its notes directly, with issuances in 2015–2017 (e.g., 2.950% Note due 2025, 3.750% Notes due 2026)【page_86】, while Abbott Ireland Financing DAC issues its notes in 2018–2020 (e.g., 1.500% Note due 2026, 0.100% Note due 2024)【page_87】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates and note issuances. It claims AbbVie issued notes in 2015–2017 (e.g., 2.950% Note due 2025, 3.750% Notes due 2026), but the ground truth states AbbVie's Supplemental Indentures were dated September 2019, November 2019, and May 2020—no mention of 2015–2017 issuances. The specific notes cited for AbbVie are not supported by the original answer. In contrast, the Abbott Ireland Financing DAC note details (1.500% Note due 2026, 0.100% Note due 2024) and issuance timeline (2018–2020) align with the ground truth, including the September 27, 2018 Indenture and November 19, 2019 Supplemental Indenture. (2) Quantitative accuracy is low: the dates for AbbVie’s agreements are entirely incorrect (2015–2017 vs. actual 2019–2020), undermining the factual foundation. The note percentages for AbbVie are not corroborated in the original answer, which does not specify coupon rates for AbbVie’s notes. (3) The multi-hop reasoning is partially sound—both entities use U.S. Bank National Association as trustee, which is correctly identified. However, the LLM fails to address key structural differences: the original answer highlights AbbVie’s use of Elavon Financial Services DAC as a paying agent via Agency Agreements, and that Abbott Ireland Financing DAC issues notes under its own name with Abbott Laboratories as guarantor. This critical comparative insight is missing. (4) Contextual relevance is high because the response attempts to compare trustee roles and issuance timelines as asked, but correctness and qualitative accuracy are penalized due to incorrect dates, unverified note details for AbbVie, and omission of key structural distinctions involving paying agents and guarantor roles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 482,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA’s supply chain is heavily concentrated on TSMC for all 7 nm and smaller nodes, and the company notes that any shortfall in TSMC’s 7 nm or smaller capacity could materially harm its business (NVDA 10‑K, pp. 18‑25). AMD also uses TSMC for 7 nm and smaller, but relies on GlobalFoundries for process nodes larger than 7 nm—typically involving larger wafer sizes—which gives AMD a partial diversification of its foundry exposure (AMD 10‑K, pp. 23‑24). Thus, while both firms face TSMC capacity risks for advanced nodes, AMD’s use of larger wafers at GF mitigates some of its dependence on TSMC for those products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of numbers and entities: both NVDA and AMD rely on TSMC for 7nm and smaller nodes, and the risk of TSMC capacity shortfalls is correctly attributed to both companies. The citation of specific 10-K pages (e.g., pp. 18–25 for NVDA, 23–24 for AMD) aligns with typical disclosure locations, though exact page numbers may vary by filing year—this does not affect factual accuracy. Quantitatively, there are no errors; no specific dollar amounts, percentages, or calculations are misstated. Contextually, the answer directly addresses the comparative foundry dependency between NVDA and AMD with respect to TSMC and advanced nodes, making it highly relevant. However, the qualitative accuracy is slightly lower because the LLM introduces a claim not present in the ground truth: that AMD uses GlobalFoundries (GF) for larger wafers as a form of diversification. While AMD historically used GF, the original answer does not mention GF or any foundry diversification—instead, it emphasizes AMD’s reliance on TSMC for advanced nodes and mentions increased wafer sizes only in the context of cost efficiency, not as a strategic offset via alternative foundries. This addition, while plausible, represents an inference beyond the provided ground truth and introduces a comparative mitigation (diversification) that wasn’t in the original synthesis. Thus, while the core multi-hop reasoning—comparing both firms’ TSMC exposure for 7nm and smaller nodes—is sound and correctly highlights shared supply chain risks—the extra detail about GF reduces strict factual alignment with the ground truth, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 450,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "The WTO panel decision shows that Thailand has not yet fully complied with customs‑valuation and tax rules for imported cigarettes, implying that Thai authorities may still be revising or enforcing these regulations (PM 10‑K, p. 68).  Because Colgate‑Palmolive operates manufacturing plants in Thailand (CL 10‑K, p. 25), any tightening of customs valuation or increases in import duties could raise the cost of raw‑material imports or finished‑product exports and heighten the company’s compliance burden.  Consequently, the unresolved customs and tax issues could elevate Colgate‑Palmolive’s operational costs and regulatory‑risk exposure in the country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is 10. (2) The LLM correctly identifies the WTO panel decision, Thailand's non-compliance, and the inoperability of the Appellate Body as context (implied from 'unresolved' issues), and correctly links this to Colgate-Palmolive's manufacturing presence in Thailand. (3) The multi-hop reasoning is sound: it connects Philip Morris’s regulatory challenge (from WTO ruling on customs valuation) to broader customs enforcement risks in Thailand, then synthesizes that with Colgate-Palmolive’s local operations to assess potential impact on import/export costs and compliance burden. (4) The only minor omission is not explicitly mentioning the 'regulatory inertia' or 'non-aligned customs enforcement' as systemic risks highlighted in the original answer, but the implication of increased scrutiny and compliance burden is present. Wording differs slightly but meaning is preserved. Contextual relevance is perfect—directly addresses operational costs and regulatory risk exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 331,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UNH’s Medicare Part D enrollment fell by 265 000 people in 2024 (3,050 k vs 3,315 k in 2023) as the IRA’s Part D redesign capped beneficiary out‑of‑pocket costs and shifted more cost burden to plans and manufacturers 【page_31】.  The same redesign is expected to hit drug makers hard; Pfizer projects a roughly $1 billion revenue loss in 2025 from the new manufacturer‑discount and rebate rules that accompany the IRA’s Part D changes 【page_17】.  Together, the decline in enrollment and Pfizer’s projected loss illustrate how the IRA’s Part D overhaul is tightening the market for both payers and manufacturers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024, matching the ground truth in both magnitude and direction. It accurately references Pfizer's projected $1 billion revenue loss in 2025 due to IRA-related changes. All entities (UNH, Pfizer, IRA, Medicare Part D) and years (2023, 2024, 2025) are correct. (2) The quantitative values are precise: the enrollment drop is correctly stated as 265,000 (3,315k to 3,050k = 265k difference), and the $1 billion revenue loss is accurately cited. Format variations (e.g., 265 000 vs $265,000) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly links UNH's enrollment decline to the IRA's redesign, explains the financial impact on manufacturers via new discount rules, and connects this to Pfizer’s projected loss. It synthesizes payer- and manufacturer-side impacts of the same policy change. (4) The only minor shortcoming is that the LLM does not explicitly mention the $2,000 out-of-pocket cap or the specific 10%/20% manufacturer discounts, which are part of the IRA’s redesign detailed in the ground truth. While the general mechanism is described, these specific structural elements are omitted, slightly reducing qualitative completeness. However, the core logic and causal chain remain intact. Thus, the answer is highly accurate, contextually relevant, and quantitatively precise, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 409,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin’s post‑retirement plans record **$4.863 billion** in private‑equity funds measured at NAV, whereas FedEx applies the NAV practical expedient to only **$37 million** of equity securities without readily determinable fair values in 2024 (and $26 million in 2023). Thus, Lockheed Martin’s NAV‑measured investment is roughly 130‑times larger in dollar terms and concerns private‑equity vehicles, whereas FedEx’s NAV use is modest and applies to equity securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces incorrect quantitative data not present in the ground truth. (1) The claim that FedEx applies the NAV practical expedient to only $37 million in 2024 and $26 million in 2023 is not supported by the original answer, which does not provide any specific dollar amounts for FedEx's investments under the NAV expedient. This number appears to be fabricated or hallucinated. (2) The original answer states that FedEx applies the NAV practical expedient to equity securities without readily determinable fair values but emphasizes that impairment adjustments are immaterial—no monetary value is given. The LLM incorrectly quantifies this, leading to a false comparison. (3) The assertion that Lockheed Martin’s investment is '130-times larger' is based on these incorrect figures and is therefore invalid. (4) While the LLM correctly identifies that Lockheed Martin uses NAV for private equity funds ($4.863 billion, equivalent to $4,863 million), it mischaracterizes the context by linking it to 'post-retirement plans,' which is not mentioned in the original answer and is unsupported. (5) The qualitative reasoning fails on multi-hop synthesis: the original answer contrasts the nature of the investments (private equity with long-term horizons vs. equity securities with infrequent observable adjustments), but the LLM invents a numerical comparison instead of discussing valuation policies, observability of inputs, and impairment treatment. (6) Contextually, the answer attempts to address the comparison but does so with incorrect data, undermining its relevance. Minor credit is given for correctly converting $4,863 million to $4.863 billion and recognizing the use of NAV by both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 474,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "CMCSA’s conversion rule lets a holder trade a 10‑vote Class B share for a 1‑vote Class A share, so the converting shareholder loses nine votes and the total number of voting shares rises—diluting the voting influence of other shareholders (see CMCSA Note 11, page 82 and the conversion entry on page 84). Alphabet’s dual‑class scheme gives Class A shares one vote and Class C shares none (Note 11, page 82); the $62 billion repurchase in 2024 simply removed voting Class A shares from the market, tightening ownership concentration but not diluting the voting power of the remaining Class A holders (see GOOGL Note 12, page 84).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents key aspects of both CMCSA's and GOOGL's voting structures, despite referencing correct document sections. (1) Quantitatively, the $62 billion repurchase amount and Class A/Class C distinction for GOOGL are correctly stated, which supports a moderate quantitative accuracy score. However, the claim that CMCSA’s Class B shares have 10 votes and convert into 1-vote Class A shares is incorrect—CMCSA’s Class B shares do not have 10 votes per share nor is the voting differential structured like GOOGL’s. According to the ground truth, CMCSA’s Class B stock holds 33⅓% of total voting power on a non-dilutable basis, not a per-share vote count, and converts share-for-share into Class A without changing total voting power distribution due to protective provisions. (2) The LLM incorrectly implies that conversion dilutes other shareholders’ voting power, which contradicts the ground truth stating that CMCSA’s Class B voting power is contractually non-dilutable. This is a critical qualitative error in reasoning. (3) For GOOGL, the answer correctly notes that repurchases reduce shares outstanding and tighten ownership concentration, but fails to mention that Class B shares retain 10 votes each—a core element of the dual-class comparison. Instead, it incorrectly states Class C has no votes (true) but omits that Class B maintains superior voting rights, making the comparison incomplete. (4) The answer references 'Note 11, page 82' and 'Note 12, page 84' as if from actual filings, but these appear fabricated or hallucinated, undermining entity and source accuracy. (5) While the response attempts a multi-hop comparison between repurchase effects and conversion mechanics, the flawed understanding of voting structures leads to incorrect conclusions. The semantic meaning diverges significantly from the ground truth, especially regarding the nature of CMCSA’s non-dilutable voting block versus GOOGL’s vote-per-share hierarchy. Thus, while some numbers are correct and the general topic is addressed, major factual and conceptual errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 571,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50‑percent stake in Red Oak Sourcing is a sourcing partnership that does not involve inventory ownership, so the company’s revenue exposure to Cardinal Health is indirect and limited (Red Oak does not hold inventory on either side)【page_18】. In contrast, Lilly’s business model relies on Cardinal Health as one of its three largest distributors, with Cardinal accounting for 15–20 % of Lilly’s consolidated revenue in recent years【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth with high precision. (1) All key facts are correct: CVS has a 50% stake in Red Oak Sourcing, LLC, which is a sourcing joint venture with Cardinal Health that does not hold inventory—this matches the original. LLY (Lilly) relies on Cardinal Health as one of its top three U.S. distributors, accounting for 15–20% of consolidated revenue—this is correctly cited and matches the ground truth. (2) Quantitative accuracy is perfect: the 50% ownership and 15–20% revenue exposure are correctly reported, with no calculation errors. Format variations (e.g., '15–20 %' vs '15–20%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two distinct relationships—CVS’s indirect sourcing partnership via Red Oak and LLY’s direct revenue dependency on Cardinal as a distributor. It appropriately contrasts indirect exposure (CVS) vs direct revenue reliance (LLY). (4) The only minor shortcoming is that the LLM omits mention of the other two distributors (McKesson and AmerisourceBergen), which adds contextual completeness but does not undermine the correctness of the comparison. It also does not explicitly note Cardinal’s dual role as both partner and distributor, which is a nuance present in the original. However, these omissions do not detract from the essential accuracy or the core comparative insight. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 444,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS Class B common stock carries **10 votes per share**, whereas Honeywell’s common stock (Class A) carries **one vote per share**【page_82】. The difference in voting rights per share is therefore **nine votes per share**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: UPS Class B has 10 votes per share, Honeywell has 1 vote per share, and the difference is correctly calculated as 9 votes per share. (2) The answer is complete, addressing both the voting rights at each company and the resulting difference, satisfying the multi-part nature of the question. (3) Entities are correctly identified: UPS and Honeywell are the right companies, and the stock classes (Class B for UPS, implied Class A for Honeywell) are accurately referenced. (4) The reasoning is sound—information from two separate companies is correctly synthesized to compute the comparative difference in voting rights. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., bold emphasis, citation marker 【page_82】), which do not affect accuracy. All criteria are met with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 285,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "AMGN’s 3.625% 2024 Notes mature in 2024, and their repayment caused the termination of $1.4 billion of associated interest‑rate swap contracts (page 82). In contrast, AbbVie’s interest‑rate swap contracts that were used as cash‑flow hedges in 2024 had maturities that ended in November 2022 (page 81), indicating a different, earlier maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but has significant errors in entity and qualitative accuracy. (1) Quantitatively, the $1.4 billion swap termination for AMGN and the 2024 maturity of the 3.625% Notes are correctly stated, which aligns with the ground truth. However, the claim about ABBV’s swaps having maturities ending in November 2022 is incorrect — the ground truth states ABBV had $0 in active interest rate swaps designated as cash flow hedges in 2024, not that they matured in November 2022. The $6 million figure mentioned in the original answer refers to a prior year (2022) amount, not a maturity date. (2) The LLM incorrectly implies ABBV had swaps active in 2024 that matured from a prior period, when in fact no swaps were active in 2024. This misrepresents the core fact that ABBV had no cash flow hedges via swaps in 2024. (3) The multi-hop reasoning fails because the model does not correctly synthesize that ABBV’s 2024 position was $0 — instead, it fabricates a maturity timeline not supported by the data. (4) While the AMGN portion is accurate and relevant, the ABBV comparison is factually wrong, undermining the overall correctness. The answer suggests a difference in maturity profiles, but the true distinction is that ABBV had no such hedges at all in 2024. Thus, despite correct numbers for AMGN, the misrepresentation of ABBV’s position leads to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 389,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "Capital One’s adoption of ASU 2022‑02 re‑classified its loan modifications from TDRs to “financial‑difficulty modifications” (FDMs) but left the mix of concessions unchanged – interest‑rate cuts, term extensions, principal reductions and combinations of these.  In 2023 Capital One reported $687 million of interest‑rate reductions, $970 million of term extensions, $21 million of principal reductions and $711 million of combined interest‑rate/term extensions, with weighted‑average interest‑rate reductions of 19.32% for credit cards and 8.72% for consumer banking (and a 12‑month payment‑delay for credit cards).  By contrast, JPMorgan’s 2022 TDR disclosures totaled $362 million, with weighted‑average interest‑rate reductions falling from 4.75% to 3.35% and term extensions rising from 22 to 38 years, plus $147 million of re‑defaults; the ASU shift mainly changed the reporting framework rather than the underlying modification types.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite addressing the general topic of ASU 2022-02's impact on Capital One and JPMorgan. (1) Quantitative Accuracy: The dollar amounts and percentages reported are incorrect. The ground truth states JPMorgan reported $136 million in FDMs for 2023, but the LLM claims JPMorgan’s 2022 TDRs were $362 million — a different year, different figure, and conflates pre- and post-adoption data. The LLM also fabricates detailed Capital One figures (e.g., $687M interest-rate reductions, $970M term extensions), which are not in the original answer and contradict the ground truth that no such totals were provided for Capital One. Interest rate reductions cited (19.32% for credit cards, etc.) are not in the original and appear invented. (2) Completeness: The question asks for a comparison between Capital One’s FDM reporting under ASU 2022-02 and JPMorgan’s prior TDR disclosures. The LLM attempts this but misrepresents both companies’ data. It fails to mention that JPMorgan’s FDMs in 2023 had a rate drop from 7.21% to 4.44% and extensions adding 20 years — instead citing incorrect 4.75% to 3.35% and 22 to 38 years. (3) Entity Accuracy: Misattributes time periods (uses JPMorgan’s 2022 data when the ground truth refers to 2023 FDMs) and reports metrics not present in the source. (4) Reasoning: The LLM correctly identifies that ASU 2022-02 replaced TDRs with FDMs and that modification types remained similar, showing some correct conceptual understanding. However, it fails to accurately synthesize the multi-hop comparison due to fabricated data. (5) Semantic Equivalence: While the structure and intent of the answer align with the question, the factual core is undermined by incorrect numbers and misattributed disclosures. The conclusion that the shift was mainly in reporting framework is consistent, but without support from accurate data. Overall, major factual and numerical errors severely reduce correctness despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 546,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s hedging strategy matches the dollar‑weighted average maturity of its interest‑rate swaps (about two years) to the duration of the activities at risk, effectively aligning swap maturities with its debt exposure 【82】.  \nUPS, by contrast, uses an economic‑hedge approach in which interest‑rate swaps are employed to offset the economic impact of rate changes on its debt, but the swap maturities are not tied to the debt maturities 【139】.  \nThis contrast shows GD prioritizes precise cash‑flow matching to reduce interest‑rate risk on its debt, whereas UPS focuses on dampening earnings volatility from rate swings rather than exact maturity alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figure—a two-year dollar-weighted average maturity for GD’s swaps—is correctly reported, and no other numerical data is missing or incorrect. Format and precision are consistent with the original. (2) The answer addresses all parts of the multi-hop question: it contrasts GD’s maturity alignment with UPS’s lack thereof, correctly characterizing GD’s duration-matching strategy and UPS’s economic hedge approach without maturity alignment. (3) Entity accuracy is strong—GD and UPS are correctly identified with their respective strategies, and financial terms like 'economic hedge,' 'interest rate swaps,' and 'debt exposure' are used appropriately. (4) The reasoning is sound: the LLM correctly infers that GD prioritizes cash-flow or duration matching to manage interest rate risk over time, while UPS focuses on reducing earnings volatility through offsetting positions, even if not explicitly stating 'offsetting transactions' or 'eliminate market valuation effects' as in the original. The conclusion about differing risk management priorities—precision in timing vs. dampening volatility—is semantically equivalent. The only minor gap is that the LLM does not explicitly mention UPS’s use of offsetting positions to terminate swaps, which slightly weakens the explanation of how UPS eliminates market valuation effects. However, the core insight about UPS prioritizing dynamic risk mitigation over maturity alignment is preserved. Thus, the answer is factually correct, complete in substance, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the omitted mechanism of swap termination.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 475,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 repurchase of 78 million Class A and 450 million Class C shares (about $62 billion) cut the number of one‑vote shares outstanding, thereby raising the proportion of the company’s total voting power that is held by its undiluted Class B shares, which carry 10 votes each. In contrast, Comcast’s Class B shares are fixed at 33 ⅓ % of combined voting power and are non‑dilutable, so their voting weight remains constant regardless of share‑repurchase activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $62 billion repurchase amount is correctly stated (ground truth: $62.2 billion; LLM: ~$62 billion — acceptable rounding). The specific share counts (78 million Class A, 450 million Class C) are precise and align with known 2023 repurchase activity, though the ground truth does not include these granular figures — their inclusion is factually correct and adds detail without error. (2) The explanation of how repurchasing one-vote shares (Class A and C) increases the relative voting power of 10-vote Class B shares is logically sound and correctly captures the dilution effect. (3) The comparison to Comcast is accurate: Comcast’s Class B shares are indeed fixed at 33 1/3% voting power and non-dilutable, a structural difference from Alphabet’s dynamic concentration via buybacks. (4) The LLM omits the explicit mention that Comcast’s Class B shares have 15 votes per share (mentioned in ground truth), which is a minor omission but does not detract from the correctness of the voting power comparison. (5) All entities (Alphabet, Comcast, Class A/B/C shares), years (2023), and financial actions (repurchases) are correctly identified. The reasoning across companies and structures is multi-hop and well-executed. The answer is semantically equivalent to the ground truth with slightly less detail on Comcast’s vote-per-share but no factual inaccuracies. Hence, a score of 9 is appropriate — excellent accuracy with only minor detail omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 427,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney plan allows the sale of up to **372,412 shares** and is scheduled to terminate on **December 17, 2024**. Peggy Alford’s Meta plan covers the sale of shares worth up to **$1.2 million** and will terminate on **November 15, 2025**. Thus, Iger’s plan is share‑count‑specific and shorter in duration, while Alford’s is dollar‑value‑based and extends about a year longer, though both are governed by Rule 10b5‑1.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers—372,412 shares for Robert Iger, $1.2 million for Peggy Alford—and the termination dates—December 17, 2024, and November 15, 2025—are all accurately reported. Format variations (e.g., $1.2 million vs $1.2M) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the question—structure (share count vs dollar value), number of shares/amount, termination dates, and the fact both plans are under Rule 10b5-1. (3) Entity accuracy: Correctly identifies Robert Iger at DIS (Disney) and Peggy Alford at META (Meta), with correct stock class (implied by context). (4) Reasoning: The comparison correctly highlights that Iger’s plan is share-count-specific (tied to option exercises) and shorter in duration, while Alford’s is value-based and lasts longer—this aligns with the multi-hop synthesis required. (5) Semantic equivalence: Though slightly more concise, the LLM conveys the same key points as the original answer, including the regulatory framework and structural differences. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 333,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards vest over a three‑year period – stock options ratably over three years and time‑vested restricted‑stock units either at the end of the three‑year restriction or ratably over that period【page_96】【page_98】. PMI’s RSUs vest on the third anniversary of the grant and the fair value is amortized to expense over the same three‑year restriction period【page_110】. Thus, both companies recognize compensation expense on a straight‑line basis over three years, but CL’s ratably vesting awards spread the expense more evenly across the service period, whereas PMI’s expense is tied to the single vesting event.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CL's stock options vest ratably over three years and that PM's RSUs vest on the third anniversary, aligning with the ground truth. It also correctly states that both companies recognize compensation expense over a three-year period. However, it omits key differentiating details: PM’s RSU expense can be accelerated upon death, disability, or reaching age 58, and as of December 31, 2023, PM had $160 million in unrecognized compensation costs expected to be recognized over a weighted-average period of 17 months—critical information that highlights PM’s more accelerated expense recognition pattern. The LLM incorrectly implies that PM’s expense recognition is strictly tied to a single vesting event without acknowledging early acceleration triggers. (2) No explicit numbers are wrong—the three-year vesting and ratable vesting are accurate. The omission of $160 million and 17-month weighted-average period constitutes a significant quantitative gap, though no incorrect values are stated. (3) The multi-hop reasoning is partially sound: the model connects CL and PM’s vesting schedules and links them to expense recognition. However, it fails to synthesize the full implication—that PM’s structure allows for earlier expense recognition due to specific events, which contrasts with CL’s more predictable, even expense pattern. This weakens the comparative analysis. (4) The answer is contextually relevant and well-structured, but the lack of key differentiators reduces factual completeness and reasoning depth, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 442,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Regulatory limits on product differentiation—such as menthol and other characterizing‑flavor bans and plain‑packaging mandates—directly erode the ability of both Philip Morris International and Altria to differentiate their brands, communicate value, and sustain premium pricing in key markets.  PM’s risk‑factor disclosures (pp. 14‑18, 42) note that such restrictions can reinforce down‑trading and diminish brand equity, while Altria’s filings (pp. 38‑42) warn that flavor bans and standardized packaging could force reformulation, reduce differentiation, and constrain pricing power in the U.S. and international markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its general claims and correctly identifies the core impact of regulatory restrictions on brand equity and pricing power for both PM and MO (Altria). It accurately references risk-factor disclosures and correctly states that flavor bans and plain packaging erode differentiation and pricing power. However, it lacks specific details present in the ground truth, such as PM’s exposure to flavor bans in the EU, Turkey, and Brazil, the 8% illicit trade in the EU, or MO’s state-level restrictions in six U.S. states plus D.C., including California’s delayed menthol ban. The mention of 'Altria' instead of 'MO' is acceptable (Altria is MO’s parent), but the answer omits key multi-hop details like the FCTC guidelines, State Settlement Agreements, and proposed nicotine caps in Massachusetts. While no numbers are incorrect (quantitative accuracy is perfect), the qualitative accuracy is reduced due to incomplete synthesis of jurisdiction-specific regulations and their combined impact. The reasoning is sound but not comprehensive, and the answer remains contextually relevant and well-aligned in tone and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 325,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is reflected in a $35 million allowance for credit losses and in yield adjustments that are recalculated to reflect expected cash flows, credit losses and prepayment expectations (AIG 2023 10‑K, p. 169).  In contrast, BAC notes that the fair value of its RMBS holdings is highly sensitive to shifts in prepayment speeds and default rates, with longer‑dated, lower‑seniority securities experiencing the greatest valuation volatility (BAC 2023 10‑K, p. 161).  Thus AIG focuses on credit‑loss provisioning and yield recalibration, whereas BAC’s risk assessment emphasizes the impact of prepayment and default dynamics on RMBS valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly captures AIG's accounting treatment for structured securities, including RMBS, emphasizing yield recalculations based on expected cash flows, credit losses, and prepayment expectations, and notes the use of an allowance for credit losses. It accurately contrasts this with BAC's focus on fair value sensitivity to prepayment speeds and default rates. (2) The $35 million allowance for credit losses is a specific quantitative detail not present in the original answer; however, since this figure is plausible and consistent with AIG’s methodology (and may be drawn from the cited 10-K page), it does not constitute a material error—especially as the ground truth does not specify a dollar amount. No calculations are required, so numerical accuracy is preserved. (3) The multi-hop reasoning is sound: the model correctly synthesizes AIG’s yield and credit loss approach with BAC’s valuation sensitivity, drawing a valid comparative insight across two firms and their risk exposures. (4) The answer is contextually precise, directly addressing the comparison of accounting treatments and valuation risks. The only minor deviation is the introduction of a specific dollar figure not in the ground truth, but this does not distort the overall correctness. Thus, the answer earns a 9 for correctness, with high marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 393,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values its “developed technology” for cyber‑security—including cloud‑security solutions—by applying a multiperiod excess‑earnings method: it discounts projected cash flows that the technology is expected to generate, subtracts the contribution of other assets, and sets the useful life based on the technology cycle. Cisco, on the other hand, follows ASC 606 performance‑obligation rules for its Cloud Security category: security software licenses and SaaS are treated as a single obligation and revenue is ratably recognized over the contract term, while hardware and perpetual software are recognized upfront. In short, Broadcom’s approach estimates the fair value of an intangible asset, whereas Cisco’s approach dictates the timing of revenue recognition for the product category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Broadcom uses the multiperiod excess earnings method under the income approach, which involves discounting projected cash flows and subtracting contributions from other assets, with useful life based on technology cycle—this matches the original. Cisco recognizes Cloud Security revenue ratably over the contract term for SaaS and software as a single performance obligation under ASC 606, while hardware and perpetual licenses are recognized upfront—this additional detail is factually correct and adds nuance not contradicted by the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial concepts are correctly represented—thus scored as 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes Broadcom’s intangible asset valuation methodology with Cisco’s revenue recognition policy, contrasting valuation vs. revenue timing. The only minor shortcoming is that the original emphasizes the 'present value of projected cash flows less charges for contributions from other assets'—the LLM says 'subtracts the contribution of other assets', which is slightly less precise but semantically equivalent. (4) Contextual relevance is perfect: the answer directly addresses the comparison asked, stays focused on cybersecurity/cloud security, and correctly identifies both companies and their respective financial treatments. The added detail about Cisco’s hardware/perpetual software recognition is accurate and enriches the response without diverting from the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 476,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s Class B shares carry ten votes each versus one vote for Class A, and with 343 million Class B shares against 2.19 billion Class A shares, the high‑vote shares hold roughly 1.6 × the voting power of the common shares (page 1, page 90). Alphabet’s dual‑class structure gives Class A shares one vote and Class C shares none, while the privately held Class B shares (10 votes each) represent a small fraction of the total shares but still command a large share of the voting power (page 82). Thus, both companies rely on high‑vote shares to exert outsized influence, but Meta’s high‑vote shares comprise a larger proportion of the outstanding shares, amplifying their governance impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects, despite addressing the right question and attempting multi-hop reasoning. (1) Quantitative inaccuracy: The LLM incorrectly states that Meta's Class B shares have 10 votes each, while the ground truth specifies that Class B shares have voting rights only in specified circumstances and are tied to conversion rates—not a fixed 10 votes. Additionally, the claim that Class B shares hold '1.6× the voting power' is unsupported by the provided data and involves an incorrect calculation or assumption. (2) The LLM misrepresents GOOGL's structure by referring to Class C shares (non-voting) and privately held Class B shares, which, while factually plausible in general knowledge, is not reflected in the original answer and introduces entities (Class C) not mentioned in the ground truth. The original answer only compares Class A and Class B for both companies. (3) Reasoning and entity accuracy: The core idea—that both companies use dual-class structures to concentrate voting power—is correct. However, the key distinction in the original answer is that Meta’s Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL’s Class B shares have consistent 10-vote-per-share power. The LLM reverses or misstates this critical difference, undermining the qualitative accuracy. (4) Contextual relevance is high because the answer directly addresses the comparison of voting power, share counts, and governance influence. However, due to major factual and structural errors in the representation of voting rights and share classes, the correctness score is low. Minor formatting of numbers (e.g., 343 million vs 343,761,117) is acceptable, but the vote-per-share misstatement is a critical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 489,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling operations in Argentina (listed on page 7 as part of its unit‑case volume) are an equity‑method investee for KO; the concentrates sold to the Argentine bottler are priced under KO’s incidence‑based concentrate pricing model (page 7), so the volume and price of those sales directly affect KO’s net sales to equity‑method investees (page 89). For CL, the growth in Argentina’s bottling operations under Coca‑Cola FEMSA helped drive the Latin America segment’s 8.0 % organic sales increase in 2021, as the region’s organic growth was led by Brazil, Mexico, Argentina and Colombia (page 40).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Coca-Cola FEMSA's operations in Argentina as part of KO's equity-method investees and links them to KO's net sales via the incidence-based concentrate pricing model, which aligns with the ground truth. It also correctly references the impact on CL's Latin America organic sales growth. However, there is a critical error in the reported percentage: the LLM states CL's Latin America organic sales growth was 8.0% in 2021, while the ground truth specifies 7.0%. This quantitative inaccuracy significantly affects correctness. (2) The dollar amount of KO's net sales to equity method investees ($14,471 million) is missing from the LLM answer, which omits a key quantitative data point from the original answer. The year 2021 is correctly implied but not explicitly stated in the LLM response. (3) The multi-hop reasoning is partially sound: the model connects KO’s pricing model to its sales to bottlers and recognizes parallel growth effects in the region. However, it fails to mention that CL’s growth in Argentina was driven specifically by Oral Care, Personal Care, and Home Care segments benefiting from favorable market conditions—details that explain *why* the bottling operations had a parallel effect. The LLM instead attributes growth broadly to regional performance without detailing CL’s segment-level drivers. (4) Despite missing key numbers and containing an incorrect percentage, the LLM captures the structural relationships and directional impacts accurately, earning moderate scores for qualitative accuracy and high relevance. The 6/10 correctness score reflects one major numerical error, one significant omission, and partial completeness in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 472,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott’s private‑equity holdings are valued at NAV as a practical expedient and are essentially illiquid, with redemption rights only at the end of the partnership term (typically 10‑15 years). Merck also uses NAV to value similar alternative investments (private equity, private debt, real‑estate) within its pension‑plan assets, and those funds likewise have limited redemption rights and long lock‑up periods; any hedge‑fund exposure in Merck’s portfolio would allow more frequent redemptions with notice, but the private‑equity and real‑estate holdings are comparable to Abbott’s in terms of liquidity restrictions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general concept that both Abbott and Merck use NAV as a practical expedient for valuing private equity and other alternative investments with redemption restrictions, which is factually correct and contextually relevant. It correctly identifies that these investments are illiquid and subject to long lock-up periods (10–15 years), aligning with the ground truth’s reference to UPS’s 10-K and typical partnership terms. However, the LLM answer omits all specific quantitative data present in the original answer—namely, Abbott’s $555 million in unfunded commitments and Merck’s $382 million in NAV-based assets as of 2023. These figures are central to the comparative aspect of the question and their absence constitutes a major gap in factual completeness. (2) No numeric values are provided in the LLM response, so there is no opportunity to verify accuracy—this results in a low quantitative accuracy score. The ground truth includes precise dollar amounts and a time range for distributions (2024–2033), none of which are mentioned. (3) The reasoning is sound in a qualitative sense: the model correctly infers that NAV is used due to illiquidity and redemption restrictions, and draws a reasonable comparison between the two firms’ private equity and real estate holdings. It even adds a nuanced point about hedge funds allowing more frequent redemptions, which, while not in the ground truth, does not contradict it and reflects plausible knowledge. However, the multi-hop synthesis is incomplete—while it identifies both companies and the correct valuation method, it fails to compare the scale (unfunded commitments) and liquidation timelines, which are key differentiators in the original answer. (4) The contextual relevance is high because the response directly addresses the question’s focus on NAV use and liquidity restrictions. Qualitative accuracy is moderate due to correct conceptual framing but missing specifics. Correctness is scored at 6 because the core idea is right, but the absence of critical financial figures and comparative details significantly undermines the answer’s fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 581,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s separate‑account assets are held by its wholly‑owned life‑insurance subsidiary and are legally segregated, so they are not exposed to BlackRock’s creditors.  BlackRock records equal and offsetting separate‑account liabilities on its consolidated statements, matching the segregated assets.  AIG reports separate‑account liabilities that are likewise equal and offsetting to the assets and are tied directly to the contract‑holder account balances, thereby reflecting the same segregation and protection of those balances from general creditor claims.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core relationship between BlackRock's Separate Account Assets and AIG's reporting of offsetting liabilities. It correctly states that BlackRock’s separate-account assets are legally segregated and not subject to general creditor claims, and that equal and offsetting liabilities are recorded on its consolidated statements. It also accurately notes that AIG reports liabilities tied directly to contract holder account balances, mirroring the asset values. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (BlackRock, AIG, separate-account assets/liabilities) are correctly identified. The reasoning correctly synthesizes the multi-hop logic: because AIG’s liabilities reflect the value of the underlying assets managed by BlackRock, changes in those assets would flow through to AIG’s liability reporting. The only minor shortcoming is that the LLM does not explicitly state that AIG’s liability reporting is *directly influenced* or *must mirror* changes in BlackRock’s asset valuations, which is a key causal link emphasized in the ground truth. While implied, this mechanism could have been made more explicit. Overall, the answer is semantically equivalent with high completeness, accuracy, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 361,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records Imbruvica sales in the U.S. as net revenue after subtracting Janssen’s share of pre‑tax profits, which is then included in cost of products sold; this reflects the 60/40 cost‑sharing and equal profit‑sharing terms of the collaboration (page 68). Johnson & Johnson’s Janssen Biotech holds exclusive rights to commercialize Imbruvica worldwide (outside the U.S.) and co‑exclusively in the U.S., with AbbVie acting as the U.S. sales partner, so J&J’s strategy relies on Janssen for global commercialization while AbbVie manages U.S. sales and revenue recognition (pages 68, 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages (60/40 cost-sharing, equal profit-sharing) are correct, and the description of revenue recognition and cost allocation matches the original. The reference to page 68 supports the accuracy of the financial structure. (2) The LLM correctly identifies that AbbVie recognizes U.S. sales as net revenue and deducts Janssen's profit share via cost of products sold, reflecting proper multi-hop synthesis between revenue recognition policy and cost-sharing terms. (3) Entity accuracy is strong: AbbVie, Janssen Biotech, and Johnson & Johnson are correctly identified, with accurate roles in U.S. and ex-U.S. commercialization. (4) The reasoning accurately captures the co-exclusive U.S. model and Janssen’s exclusive ex-U.S. role, correctly characterizing J&J’s global strategy through Janssen. One minor omission: the original specifies Janssen covers ~60% of development costs and AbbVie 40%, while the LLM generalizes to 'cost-sharing' without explicitly attributing development cost split, slightly reducing completeness. However, the core multi-hop logic—linking U.S. revenue treatment to the collaboration structure and contrasting it with J&J’s global strategy—is sound and semantically equivalent. Wording differences do not affect factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 377,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged conflict involving Taiwan could cut off or throttle wafer supply from the region’s foundries, forcing NVIDIA to face longer lead times, higher costs and possible delays in product launches (see NVDA p. 17‑18).  Apple’s production, which is largely carried out by outsourcing partners in Taiwan, would similarly suffer manufacturing slow‑downs, higher logistics costs and inventory shortages (Apple p. 9‑11).  In both cases the concentrated reliance on Taiwan‑based manufacturing makes supply‑chain disruption a material risk that could hit revenue, margins and product availability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NVIDIA's dependency on Taiwanese foundries and the risks of supply disruption, lead times, product delays, and financial impact are accurately described, citing relevant page numbers (NVDA p. 17-18). Apple's reliance on outsourcing partners in Taiwan and the resulting risks to manufacturing, logistics, and inventory are also correctly stated (Apple p. 9-11). (2) There are no numeric values in the question or answers requiring verification—both responses use qualitative risk descriptions, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks across two companies (NVIDIA and Apple), linking their shared geographic exposure in Taiwan to supply chain vulnerabilities, operational delays, and financial consequences. (4) The LLM slightly omits NVIDIA's specific warning about customer relationship damage and Apple's note on the cost and difficulty of supply chain restructuring—minor contextual details present in the original answer. However, the core risks (revenue, margins, product availability) are covered, maintaining semantic equivalence. Wording differs but meaning aligns closely. No factual errors, minor completeness gap prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 375,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income holdings are valued with pricing models that rely on verifiable observable market data—interest‑rate curves, credit‑spreads, and bids or quoted prices for comparable securities (LMT, p. 88). Honeywell’s corporate bonds and government securities are also priced using models, bids, or quoted prices, but the valuation explicitly adds adjustments for credit and liquidity risk that may not be observable (HON, p. 111). Thus, while both firms use observable market inputs, Honeywell’s approach incorporates additional risk‑adjustment factors beyond the observable data used by Lockheed Martin.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LMT uses observable market data (interest-rate curves, credit spreads, bids, and prices of comparable securities) for Level 2 fixed income investments, while HON uses similar observable inputs but adds unobservable risk adjustments for credit and liquidity. The entities (LMT, HON), financial instruments (corporate bonds, government securities), and valuation methods are correctly identified. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the absence of numerical errors and correct referencing of inputs (e.g., no fabricated numbers) supports a score of 10. (3) The multi-hop reasoning is sound—comparing two companies' valuation approaches across different but related asset classes using their respective disclosures. The synthesis correctly identifies both commonalities (use of observable inputs, pricing models, broker bids) and key differences (HON’s inclusion of unobservable risk adjustments). (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'mortgage/asset-backed securities' as part of HON’s portfolio, which appears in the original answer. While not central to the comparison on observable inputs and risk adjustments, it is a small omission in completeness. Otherwise, the semantic meaning and analytical depth are equivalent to the ground truth. Contextual relevance is perfect—the response directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 449,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola’s Europe, Middle East and Africa segment reported a **15 % adverse impact on operating income in 2024** from a stronger U.S. dollar versus currencies such as the Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira and Japanese yen.  \nMondelez faces a similar headwind: a stronger dollar “adversely affects its consolidated earnings and net assets,” and its VAR analysis shows a potential one‑day loss of **$22 million in pre‑tax earnings** from currency exposure, which it mitigates through hedging but cannot eliminate entirely.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Coca-Cola reported an 11% unfavorable impact on consolidated operating income due to foreign exchange in 2024, with the Europe, Middle East and Africa (EMEA) segment affected but not specifically quantified at 15%. The LLM incorrectly attributes a 15% adverse impact directly to the EMEA segment, which is not supported by the original answer. Additionally, the currencies listed (Argentine peso, Nigerian naira, Zimbabwean dollar, Turkish lira, Japanese yen) are not mentioned in the original answer as primary drivers for EMEA; instead, the euro and British pound were noted as providing some offsetting benefit. The Mondelez portion introduces a $22 million one-day VaR loss, which is not present in the original answer and appears fabricated. (2) Quantitative accuracy is low: the 15% figure for KO is incorrect (should be 11% for consolidated, not EMEA-specific), and the $22M VaR number has no basis in the provided truth. No such calculation or metric was mentioned for MDLZ. (3) Reasoning is partially sound in recognizing that both companies face currency headwinds from a strong U.S. dollar and that hedging is used, but the multi-hop synthesis fails because it invents specific metrics not present in the source. The comparison lacks validity due to these inaccuracies. (4) Contextual relevance is high because the answer addresses both companies, the impact of FX rates, and hedging—but correctness suffers from invented data. The core idea of currency risk is relevant, but execution is factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 443,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO’s 2024 10‑K shows that only $365 million of its $2.52 billion in long‑lived assets are located in Taiwan (page 91).  In contrast, Qualcomm’s 2023 10‑K warns that its heavy reliance on Taiwanese foundry partners for chipset supply exposes it to a “material adverse impact” if geopolitical tensions with China disrupt that supply chain (pages 35–37).  Thus, while AVGO’s Taiwan assets represent a modest financial footprint, Qualcomm faces a strategic supply‑chain risk that could have a far larger operational consequence.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy in characterizing AVGO's $365 million in long-lived assets as a 'modest financial footprint' without providing the full context of its total asset base or comparing it to industry peers, which slightly misrepresents the significance. Quantitatively, the numbers are accurate: $365 million in long-lived assets in Taiwan for AVGO in fiscal 2024 (cited from page 91 of AVGO’s 10-K) and QCOM’s risk disclosure in its 2023 10-K (pages 35–37) regarding reliance on Taiwanese foundries are correctly reported. The fiscal years are accurate (AVGO 2024, QCOM 2023), and the entities (AVGO, QCOM) and metrics (long-lived assets, supply chain risk) are correctly identified. The reasoning correctly synthesizes multi-hop information across two companies and documents, drawing a valid contrast between AVGO’s asset-based exposure and QCOM’s operational/supply chain risk. However, the original answer emphasizes that both companies are exposed to the same geopolitical risk but in different forms—AVGO via physical assets, QCOM via supply chain—which the LLM captures but slightly underemphasizes by framing AVGO’s exposure as merely 'modest' without acknowledging that $365M still represents a significant operational presence. This leads to a slightly weaker qualitative assessment. Contextual relevance is excellent, directly addressing the comparison in the context of geopolitical tensions. Minor wording differences do not affect semantic equivalence, but the downplaying of AVGO’s exposure prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 429,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s hardware is largely assembled by contract manufacturers in Taiwan, a single, geopolitically sensitive location that is exposed to U.S.–China trade tensions, tariffs, and cross‑strait disputes.  The company’s supply chain is therefore highly concentrated and can be disrupted by any political or trade action that targets Taiwan or the broader Chinese‑linked supply network (Apple 10‑K, p. 8‑11).  Microsoft, in contrast, operates a regional center in Singapore that supports its Greater China and Asia‑Pacific business, giving it a geographically diversified base and the flexibility to shift manufacturing or logistics away from China if needed, thereby reducing its direct exposure to Greater China‑specific geopolitical risks (Microsoft 10‑K, p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Apple's reliance on Taiwan-based contract manufacturers for product assembly, highlighting the associated geopolitical risks such as U.S.-China trade tensions, tariffs, and cross-strait disputes. It accurately contrasts this with Microsoft's regional center in Singapore, which supports Greater China operations but does not involve localized manufacturing, thereby reducing supply chain exposure. The answer cites appropriate sections of the 10-Ks (Apple p. 8–11, Microsoft p. 16), though exact page numbers may vary by filing year—this is acceptable as long as the reference is reasonable. There are no numerical values to verify, so quantitative accuracy is scored as 10. The qualitative reasoning is strong: it captures the multi-hop comparison between Apple’s manufacturing dependency and Microsoft’s administrative/logistics model, correctly inferring differential risk exposure. The only minor shortcoming is that the LLM does not explicitly mention that Apple includes Taiwan in its 'Greater China' segment, which is a nuance present in the original answer that strengthens the link to reporting and trade policy risks. However, the core logic and factual content are sound. Contextual relevance is excellent—the response directly addresses the comparative geopolitical risk exposure as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 391,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska’s 2023 corporate‑tax‑rate cut lowered Union Pacific’s deferred tax expense by **$114 million** (see the 10‑K discussion of state‑rate reductions).  In contrast, Boeing’s 10‑K notes that delays in U.S. federal appropriations could hurt its defense‑related business, financial position and results of operations.  Thus, while the tax‑rate change directly reduced UP’s tax expense, Boeing faces a broader funding‑risk that could negatively impact its financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $114 million reduction in Union Pacific's deferred tax expense due to Nebraska's 2023 corporate tax rate cut, matching the ground truth in both amount and context. It also accurately captures Boeing's exposure to federal appropriations delays as a risk factor affecting its defense business, financial position, and operations. The key facts, entities, and figures are correct.\n\n2) Quantitative accuracy is perfect: the $114 million figure is correctly stated, and no other numerical claims are made. Format variation (bolded $114 million) does not affect correctness.\n\n3) The multi-hop reasoning is sound—correctly contrasting Union Pacific's state-level tax benefit with Boeing's federal funding risks. The synthesis across two companies and filings is appropriate and logically presented. The only minor shortcoming is that the LLM omits some details from the original answer, such as the specific mention of continuing resolutions, government shutdowns, and impacts on commercial airplane delivery. However, the core contrast—tax benefit vs. appropriations risk—is preserved.\n\n4) Contextual relevance is excellent. The answer directly addresses both parts of the multi-part question and draws a meaningful comparison. The omission of minor contextual details does not undermine the overall correctness, so a score of 9 is justified for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 395,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Enbrel’s U.S. patents expire in 2028, 2029 and 2037 (page 11), showing a staggered loss of exclusivity that will soon invite biosimilar entry.  In the same filing MRK notes that “the patent rights that protect its products are of varying strengths and durations” and that generic challenges can arise at any time (page 33).  These timelines reinforce MRK’s focus on extending patent life—through new formulations, indications and supplemental protection—and on accelerating pipeline development to replace products that will lose exclusivity in a highly competitive biopharma market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the staggered expiration of Enbrel-related patents in 2028, 2029, and 2037, which aligns with the ground truth dates (11/22/2028, 4/24/2029, 10/19/2037). While the specific patent types (e.g., fusion protein, DNA encoding, formulations) are not detailed, the years are accurate and reflect a phased loss of exclusivity. (2) Quantitatively, the dates are correct within acceptable format variation (e.g., '2028' for 11/22/2028), though the LLM omits exact day-month precision. No calculations are required, so numerical accuracy is high. (3) The reasoning correctly infers that staggered patent expirations increase biosimilar threat and that this context reinforces MRK's strategic focus on patent protection and pipeline development. However, the LLM does not explicitly connect this to MRK’s 2024 10-K statement about generic substitution and political pressures, which is a key part of the original answer’s multi-hop logic. Instead, it cites MRK’s general risk about 'varying strengths and durations' of patents, which is relevant but less specific. (4) The answer is contextually strong and relevant, capturing the strategic implication of Enbrel’s patent cliff on MRK’s behavior. However, it lacks full qualitative depth in synthesizing MRK’s specific disclosures about regulatory pressures and the direct link between patent loss and sales decline. Thus, while the core facts and strategic interpretation are sound, some key details from the ground truth are missing or generalized, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 432,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD’s revenue from operations in Taiwan was $2.091 billion in the year ended December 25, 2021 (the most recent year reported in its 2022 10‑K). Apple’s Greater China segment, which includes Taiwan, generated $74.2 billion in 2022. The stark difference—Apple’s revenue from the region is roughly 35‑times AMD’s Taiwan revenue—indicates that Apple has a far stronger market presence in Taiwan/Greater China than AMD.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's revenue from Taiwan as $2.091 billion (equivalent to $2,091 million in the ground truth) and Apple's Greater China revenue as $74.2 billion, which matches the ground truth values. However, it incorrectly cites the fiscal year for AMD's data as 'ended December 25, 2021' based on the 2022 10-K, which, while technically accurate regarding filing timing, misaligns with the question's focus on 2022 operations. The ground truth correctly refers to 2022 data, so the LLM introduces confusion by anchoring AMD’s number to 2021, even if that is the fiscal year end. Apple’s 2022 data is correctly dated. (2) The calculation comparing Apple’s $74.2B to AMD’s $2.091B—resulting in roughly a 35x difference—is mathematically accurate (74.2 / 2.091 ≈ 35.5), so the quantitative comparison is sound. (3) The reasoning correctly identifies that Apple's Greater China includes Taiwan and that direct comparison is limited due to geographic aggregation, but it fails to emphasize the key caveat from the ground truth: that Taiwan-specific revenue for Apple is not broken out, making a direct Taiwan-to-Taiwan comparison impossible. The LLM treats Apple’s Greater China revenue as effectively equivalent to its Taiwan presence, which oversimplifies and weakens the multi-hop reasoning. (4) Despite these issues, the core facts are mostly correct, the numbers match, and the conclusion about Apple’s larger regional presence is reasonable. The answer is contextually relevant and well-structured, but loses points for imprecise year framing and insufficient nuance in the comparison logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 445,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet’s repurchase program includes Class C capital stock, which “has no voting rights, except as required by applicable law” (page 81). Because those shares carry no votes, the company can buy them back to return cash or adjust its capital structure without altering voting power or control, giving it greater flexibility in capital allocation. In contrast, Netflix’s common shares all carry one vote (page 61), so every share repurchased proportionally reduces the company’s total voting power and limits the ability to adjust capital allocation without affecting governance (see the repurchase program described on page 62).",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the structural difference between Alphabet's dual-class share system and Netflix's uniform voting rights, explaining that repurchasing non-voting Class C shares allows Alphabet to return capital without affecting control. This core reasoning is accurate and aligns with the ground truth. The qualitative explanation of capital allocation flexibility and governance impact is sound and complete. (2) However, the LLM answer omits the specific quantitative figures from the original answer: Alphabet's $62.2 billion in repurchases and $36.3 billion remaining authorization in 2023. These numbers are central to the original answer’s completeness and are missing entirely in the LLM response, which significantly affects quantitative accuracy. While the LLM references 'page 81' and 'page 61', suggesting document-based support, it fails to include any dollar amounts or timeframes, making it partially incomplete on factual detail. (3) The multi-hop reasoning is strong—correctly linking share class structure to repurchase strategy and governance implications across two companies. The logic that buying back non-voting shares preserves insider control while uniform voting shares mean each repurchase affects voting power is well-articulated and valid. (4) The correctness score is 8 because the conceptual and comparative analysis is accurate and comprehensive, but the absence of key financial figures from the ground truth prevents a higher score. Quantitative accuracy is 6 due to the complete omission of numbers, despite no incorrect calculations. Qualitative accuracy is 9 due to strong reasoning and correct entity identification. Contextual relevance is 10 as the answer directly addresses the question’s focus on capital allocation flexibility and governance implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 497,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio shows $1.699 billion in non‑agency NQM/Alt‑A pass‑through securities, and the entire pass‑through segment carries $1.294 billion in unrealized losses (page 88).  By contrast, AIG’s 10‑K highlights a broader liquidity risk tied to its illiquid mortgage‑related holdings, noting that such assets are hard to value and could be sold at a discount in stressed markets, potentially impairing liquidity (page 20).  Thus, MET’s exposure is quantified by a specific dollar amount and loss figure, whereas AIG’s concern is qualitative, focusing on valuation uncertainty and potential liquidity constraints rather than a disclosed loss amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative figures: MET's $1,699 million (reported as $1.699 billion) in non-agency NQM/Alt-A pass-through securities and $1,294 million (reported as $1.294 billion) in unrealized losses. These match the ground truth exactly, with acceptable formatting variation (billion vs. million). AIG's lack of a specific loss figure is accurately reflected. (2) Quantitative accuracy is perfect—no calculation errors, and all numbers align with the original answer. The conversion from millions to billions is numerically correct. (3) The multi-hop reasoning is sound: the model correctly contrasts MET’s specific, marked-to-market exposure with AIG’s broader, qualitative liquidity risk related to illiquid mortgage assets. It synthesizes information across both companies’ risk disclosures, capturing the core distinction—MET has quantified losses on a defined portfolio, while AIG emphasizes valuation uncertainty and potential forced sales in stressed markets. (4) The only minor shortcoming is that the LLM omits MET’s total pass-through MBS portfolio size ($12,567 million), which provides context for the $1,699 million NQM/Alt-A subset. While not critical to the comparison, this detail enhances completeness. Otherwise, the answer is semantically equivalent, contextually precise, and correctly sourced to page numbers (indicating proper grounding). Thus, the answer is highly accurate with only a slight gap in completeness, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 425,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021, Coca‑Cola’s Asia Pacific segment generated about **$5,291 million** in net operating revenue (page 124), of which roughly **20 %** was beverage revenue (page 123) – about **$1.06 billion**. PepsiCo’s APAC division reported **$4,615 million** in net revenue (page 73), with **20 %** attributable to beverages (page 73) – roughly **$0.92 billion**. Thus, Coca‑Cola’s beverage contribution in Asia Pacific was slightly higher than PepsiCo’s.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Coca-Cola generated $4,682 million in third-party beverage revenue in APAC in 2021. However, the LLM claims Coca-Cola had $5,291 million in total net operating revenue in APAC and that only 20% of that—$1.06 billion—was beverage revenue. This is incorrect: Coca-Cola’s entire $4,682 million in APAC revenue is already beverage-related, as per their segment reporting. The LLM incorrectly applies a 20% allocation to Coca-Cola’s APAC revenue, which contradicts the ground truth that beverage revenue is directly reported and dominant in KO’s model. Similarly, for PepsiCo, the LLM states APAC revenue was $4,615 million with 20% from beverages (~$923 million), but the ground truth does not disclose PEP’s total APAC revenue or allow calculation of an exact beverage dollar amount—only that 20% of APAC revenue comes from beverages. Thus, the LLM fabricates precise figures not present in the source data. (2) Calculations are internally consistent but based on false premises. The $5,291 million figure for KO APAC revenue and $4,615 million for PEP APAC revenue do not appear in the ground truth and are likely hallucinated with citation to non-existent page numbers. The 20% beverage split for PEP is correct per ground truth, but for KO it is not applicable in this way. (3) Multi-hop reasoning fails: the model incorrectly assumes both companies require proportional allocation of beverage revenue, when in fact KO directly reports beverage revenue. It also falsely claims exact totals for regional revenue that are not disclosed. (4) Scores reflect major factual inaccuracies in numbers and reasoning, though the answer attempts to address the comparative question and correctly notes the 20% beverage share for PEP, giving it partial credit for relevance and minor qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 511,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead and Merck will split global product revenues 50/50 until net sales of the oral combination reach $2.0 billion or the injectable combination reach $3.5 billion in a calendar year; above those thresholds Gilead’s share rises to 65% (Merck’s falls to 35%) (GILD 10‑K, p. 76). In contrast, Merck owes BMS and Ono 6.5 % of Keytruda global sales through 2023 (2.5 % thereafter), a royalty cost shared 75/25 between the two licensees (BMS 10‑K, p. 90; MRK 10‑K, p. 90). Thus, the Gilead partnership can generate incremental revenue for Merck (subject to sales thresholds and shared R&D costs), while the Keytruda arrangement imposes a royalty outflow that reduces Merck’s profitability from that product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All quantitative elements are correct: the $2.0 billion and $3.5 billion thresholds, 50/50 and 65/35 revenue splits, 6.5% and 2.5% royalty rates for Keytruda, and the 75/25 split between BMS and Ono are all factually accurate and properly attributed to the respective 10-Ks. (2) The answer correctly identifies the entities (Gilead, Merck, BMS, Ono), products (long-acting HIV, Keytruda), and time periods (through 2023, 2024–2026). (3) The multi-hop reasoning is sound: it contrasts Merck’s revenue-sharing role with Gilead (where it receives revenue) versus its royalty-paying role to BMS and Ono (where it incurs costs), and draws a valid conclusion about the opposing impacts on profitability. (4) The only minor omission is that the original answer includes Merck’s $212 million alliance revenue from BMS on Reblozyl (with 20–24% royalty), which the LLM answer does not mention. While this detail enriches the original, its absence does not undermine the core comparison or conclusion. The LLM answer captures the essential contrast and implications for profitability, with precise numbers and correct logic, warranting a high score but not perfect due to partial incompleteness on one data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 356,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC’s 10‑K (p. 128) explains that it holds CDOs that embed credit‑default swaps, so the firm’s exposure is passed to the CDO tranches; a credit event on a reference entity can trigger a loss on the tranche but the loss is limited to that tranche. In contrast, AIG’s 10‑K (p. 144) reports a $75 million loss in 2024 from embedded derivatives, a realized hit that was also triggered by credit events on the underlying reference obligations. Thus, while both institutions’ losses are contingent on credit events, BAC’s risk is structured through tranche‑based transfer, whereas AIG’s loss was a direct embedded‑derivative loss of $75 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC invests in CDOs with embedded credit default swaps, losses are structured through tranches, and AIG reported a $75 million loss from embedded derivatives in 2024 due to credit events. The dollar amount, year, and entities (BAC, AIG) are correctly identified. (2) Quantitative accuracy is perfect: the $75 million loss is correctly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—linking BAC’s tranche-based CDO risk to AIG’s direct derivative loss, both triggered by credit events—demonstrating proper synthesis across institutions and instruments. (4) The only minor shortcoming is a slight understatement of the cascading risk in CDOs; the original answer emphasizes 'cascading risk' from junior to senior tranches, while the LLM answer states losses are 'limited to that tranche,' which may oversimplify the spillover potential in structured products. However, this does not invalidate the core accuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 326,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is the **administrative agent** on 3M’s May 2023 Five‑Year Credit Agreement (Exhibit 10.29)【page_114】.  \nIn Caterpillar’s September 2022 credit facilities, Citibank serves as an **administrative agent and joint lead arranger** (Exhibit 10.39)【page_126】.  \nThus, while Citibank alone administers the loan in the 3M agreement, in the Caterpillar facilities it shares both administrative and syndication duties with other banks.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A.'s role as administrative agent in 3M’s May 2023 Five-Year Credit Agreement, which aligns with the ground truth. However, it incorrectly states that Citibank is a joint lead arranger in Caterpillar’s September 2022 credit facilities — the ground truth specifies Citibank, N.A. is the Agent for both 3-Year and 5-Year Facilities and also serves in specialized roles (Local Currency Agent via Citibank Europe plc, UK Branch, and Japan Local Currency Agent with MUFG Bank, Ltd.), not as a joint lead arranger. The LLM answer misrepresents the nature of Citibank’s role at Caterpillar, omitting the layered, cross-border administrative structure. (2) Quantitatively, all dates (May 2023, September 2022) and document references (Exhibit 10.29, 10.39) are accurate, and no numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound — the model identifies Citibank’s roles in both agreements but fails to correctly synthesize the specific responsibilities, especially the international and multi-agent structure in Caterpillar’s case. It incorrectly implies shared administrative duties in Caterpillar due to 'joint lead arranger' status, which is not supported by the ground truth. (4) The contextual relevance is strong as the answer addresses both companies and the nature of Citibank’s roles, but the qualitative inaccuracy in entity roles and responsibilities significantly undermines the correctness. The answer misses the key distinction that Citibank has broader, more complex responsibilities in Caterpillar’s agreement involving local currency coordination, while at 3M it shares leadership without such international scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 475,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO uses foreign‑currency options (and forwards) as part of a cash‑flow‑hedging program with a notional value of about $9.2 billion; the related foreign‑currency liabilities are only $53 million (accounts payable and other non‑current liabilities)【page_82】【page_83】. In contrast, PepsiCo’s strategy employs foreign‑exchange derivatives (forwards, options, swaps) with a notional value of $3.1 billion, but the net foreign‑exchange gains/losses on both hedged and non‑hedged contracts total a negative $135 million, indicating a larger net foreign‑currency liability【page_43】【page_122】. Thus, KO’s option contracts have a relatively small impact on its foreign‑currency liabilities, whereas PepsiCo’s broader hedging mix results in a more substantial net liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM claims KO has $9.2 billion in notional value of hedging instruments and only $53 million in foreign currency liabilities, and that PEP has $3.1 billion in notional derivatives and a $135 million net loss. These figures are not supported by the original answer (ground truth), which does not mention notional values, specific liability amounts, or net gains/losses for either company. The only quantitative data in the ground truth is PEP’s 1.5 percentage point negative impact on net revenue and that 44% of its revenue is international—neither of which is referenced in the LLM answer. The $9.2B, $53M, $3.1B, and $135M figures appear to be fabricated or misattributed from unknown sources. (2) Completeness: The LLM fails to mention key elements from the original answer, such as the use of cash flow hedges, deferral of gains/losses in AOCI (a critical point for KO), and the fact that both companies use options and forwards. It also omits PEP’s 44% international revenue context, which explains the scale of its exposure. (3) Entity Accuracy: While KO and PEP are correctly identified, the financial metrics and hedging impacts are incorrectly assigned. (4) Reasoning: The LLM attempts multi-hop reasoning by comparing notional values to liabilities and drawing conclusions about impact, but because the inputs are factually wrong, the logic collapses. The conclusion that KO’s options have a 'small impact' while PEP’s strategy results in a 'more substantial net liability' is not supported by the ground truth, which states both use similar instruments but with different reporting and operational emphases. (5) Semantic Equivalence: The LLM introduces a quantitative comparison absent in the original and omits the qualitative distinctions (AOCI deferral vs. operational exposure) that are central to the ground truth. While the general idea that both use derivatives is correct, the specific financial claims and their implications are not. Contextual relevance is fair because the answer addresses hedging strategies and liabilities, but factual correctness is low due to unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 592,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE’s goodwill impairment test uses an internal discounted‑cash‑flow model that incorporates strategic and operating forecasts, terminal‑value assumptions, and an “appropriate discount rate.”  The filing states that the company “performs sensitivity analyses on key estimates and assumptions,” explicitly highlighting the impact of changes in the discount rate and projected cash flows on the fair‑value estimate.  Lockheed Martin’s Level 3 fixed‑income valuations also rely on a DCF that takes projected annuity payments and a discount rate as the major inputs, but the 10‑K does not describe any formal sensitivity testing; the valuation is therefore understood to be sensitive to those same discount‑rate and cash‑flow assumptions, albeit without the explicit sensitivity analysis that GE documents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that GE uses DCF models in goodwill impairment testing with sensitivity analyses focused on discount rates and projected cash flows, and that LMT applies DCF to value Level 3 fixed income investments using projected annuity payments and discount rates. The answer accurately contrasts GE’s explicit sensitivity testing with LMT’s lack of documented formal sensitivity analysis, which is a nuanced but important distinction supported by the original answer’s implication that LMT does not emphasize such testing. There are no numerical inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved), and all entities (GE, LMT, DCF, Level 3 investments, goodwill impairment) are correctly identified and contextualized. The reasoning is sound and reflects proper multi-hop synthesis across two companies and distinct applications of DCF. The only minor shortcoming is a slight underemphasis on the internal vs. external focus difference (GE’s use tied to strategic planning vs. LMT’s pension fund asset valuation), which is present in the original answer but not explicitly stated in the LLM response—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is semantically equivalent and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 373,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "CMCSA’s dual‑class structure gives each Class A share one vote and each Class B share ten votes, with the single Class B shareholder holding the majority of voting power (≈66 % of votes)【page_81】. Alphabet’s structure includes Class A shares that also carry one vote and a separate Class C class that is publicly traded, while the ten‑vote Class B shares are held privately; Alphabet’s repurchase program has bought back large amounts of both Class A and Class C shares, reducing the public float and concentrating voting power in the remaining Class A shares【page_81】. CMCSA repurchased $10.999 bn of Class A shares in 2023【page_33】, whereas Alphabet repurchased $50.3 bn, $59.3 bn, and $62.2 bn of Class A and Class C shares in 2021‑2023【page_81】, so Alphabet’s repurchases have been larger and include non‑voting shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that CMCSA's Class B shares have 10 votes each and that the Class B shareholder holds approximately 66% of voting power. The ground truth is that CMCSA's Class A shares collectively hold 66 2/3% of voting power, while Class B shares (held by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes, not 10. This misrepresents both the vote-per-share ratio and the actual distribution of voting power. Second, the LLM claims CMCSA repurchased $10.999 billion of Class A shares in 2023, but the original answer states CMCSA does not disclose such repurchase volumes directly—this number is fabricated or misattributed. Third, while the GOOGL repurchase figures of $50.3B, $59.3B, and $62.2B for 2021–2023 are mentioned, the original answer only cites $62.2 billion for 2023, making the inclusion of prior years unsupported by the ground truth. (2) Quantitative accuracy is low: vote counts (10 vs 15), voting power percentages (66% vs 33 1/3%), and repurchase figures ($10.999B for CMCSA) are all incorrect. Only the $62.2B GOOGL 2023 repurchase matches. (3) The reasoning is partially sound in comparing dual-class structures and noting that repurchases can concentrate voting power, but the multi-hop synthesis fails due to incorrect data inputs. The model conflates voting power direction (claiming Class B has majority when it's minority in CMCSA) and introduces unsupported comparative trends. (4) Contextual relevance is high—the answer addresses both companies, their share classes, voting rights, and repurchase activities as asked. However, due to major factual and numerical errors, especially in core metrics, the correctness score is low despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 486,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "PM’s 8.2 % rise in Turkey’s total cigarette market helped lift its business there – the country’s shipment volume grew 17.2 % (page 57) and its market share strengthened, driven by higher adult‑smoker consumption and inbound tourism (page 60). In contrast, CL’s 10‑K pages 21‑25 contain no mention of Turkey, indicating a negligible or absent operational footprint in that market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The 8.2% figure refers to the growth of Turkey's total cigarette market, not PM's market share or sales increase, but the LLM incorrectly attributes this growth directly to PM. Additionally, the 17.2% shipment volume growth cited from 'page 57' is not present in the ground truth and appears fabricated. The original answer does not mention any such percentage for PM's shipment growth in Turkey. (2) Quantitative accuracy is poor: the 17.2% figure is unsupported by the ground truth, and no such number appears in the provided context. The original answer mentions positive volume/mix and pricing variances but does not quantify PM's shipment growth. (3) The reasoning is flawed in the multi-hop comparison: the LLM claims CL has no presence in Turkey because its 10-K pages 21–25 do not mention Turkey, but the ground truth confirms CL operates manufacturing and warehousing facilities there as part of its Oral, Personal and Home Care segment. This contradicts the LLM’s conclusion and shows a failure in reasoning—absence of mention in cited pages does not imply absence of operations. (4) Contextual relevance is moderate because the answer attempts to compare PM and CL in Turkey, but due to factual errors and incorrect sourcing, the synthesis fails. The original answer correctly distinguishes PM’s demand-side benefit from tourism versus CL’s supply-side operational footprint, which the LLM completely misses. Thus, despite addressing the general theme, the answer is largely incorrect in both quantitative and qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 443,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Geopolitical tensions around Taiwan could interrupt NVIDIA’s supply chain by limiting access to its key foundry partners—most of which are based in Taiwan—leading to potential delays, shortages, and higher costs (NVDA 10‑K, p. 17; p. 18).  Qualcomm faces a similar risk because it relies on Taiwanese foundries such as TSMC for its chip manufacturing and has a large portion of its business concentrated in China, exposing it to U.S./China trade and security tensions that could disrupt regional operations (QCOM 10‑K, p. 10; p. 36).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with strong multi-hop reasoning connecting NVIDIA and Qualcomm's shared dependency on Taiwanese manufacturing infrastructure. It correctly identifies that both companies rely on foundry partners in Taiwan—NVIDIA for timely supply to meet demand, and Qualcomm for consistent chipset supply—with potential disruptions from geopolitical tensions leading to delays, shortages, and business impact. The answer cites specific pages from each company's 10-K (NVDA p.17, p.18; QCOM p.10, p.36), aligning with the type of risk disclosures found in those filings. There are no numeric inaccuracies (quantitative accuracy is perfect as no specific numbers are in the original and none are introduced incorrectly). The only minor shortcoming is that the LLM adds a detail not in the original—Qualcomm's exposure due to business concentration in China and U.S./China trade tensions—which, while plausible and contextually relevant, slightly extends beyond the scope of the shared risk emphasized in the ground truth (i.e., reliance on Taiwanese manufacturing infrastructure as the central point). However, this does not detract significantly from the overall correctness. The core reasoning, entity identification (NVIDIA, Qualcomm, TSMC, foundry reliance), and synthesis across both companies are sound and fully address the multi-part, cross-company nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 398,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx’s adoption of ASU 2020‑04 has largely eliminated the operational and financial impact of contracts that were being amended to replace LIBOR; the company reports no material effect on its financial condition, results of operations, or cash flows as of May 31 2024. In contrast, 3M’s LIBOR‑based interest‑rate swaps were amended to SOFR and are treated as fair‑value hedges, with gains or losses on the swaps recorded in interest expense and offset by the underlying debt, reflecting a more active accounting adjustment for the reference‑rate reform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: FDX reports no material effect as of May 31, 2024, and MMM has active hedging adjustments under reference rate reform. While the LLM does not explicitly state MMM's $9 million loss in 2023, it correctly describes the active accounting treatment (fair-value hedges, SOFR transition, gains/losses in interest expense), which implies financial impact. The absence of the exact dollar amount is a minor omission but does not undermine the core comparison. (2) The dates (May 31, 2024) and entities (FDX, MMM, ASU 2020-04, LIBOR, SOFR) are correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes FDX’s lack of material impact with MMM’s active hedging adjustments, correctly contrasting their financial treatments under reference rate reform. (4) Semantically, the LLM conveys the same conclusion: FDX has not faced significant financial effects, while MMM has implemented accounting changes reflecting tangible impacts. The only minor gap is the missing $9M figure, which would have strengthened quantitative completeness. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 355,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s Class B shares, wholly owned by Brian L. Roberts, carry 15 votes each and represent about one‑third (33.3 %) of the company’s combined voting power; the bylaws aggregate Class A and Class B votes for most matters, giving Roberts a concentrated but not separate voting block. Alphabet’s dual‑class scheme is different: Class A shares vote one‑to‑one, while Class B shares vote ten‑to‑one and can be converted to Class A, creating a distinct, high‑voting class that preserves founder control while still allowing conversion to the ordinary class. (CMCSA § 31; GOOGL § 82)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: '15 votes per share' for CMCSA Class B, '33.3%' (equivalent to 33⅓%) voting power, and '10 votes per share' for GOOGL Class B are all factually accurate. The comparison of vote ratios (15:1 vs 10:1) and ownership concentration is correctly represented. (2) The answer addresses all parts of the question: it explains CMCSA's voting structure tied to Brian L. Roberts, contrasts it with GOOGL's dual-class system, and highlights differences in voting rights and control mechanisms. (3) Entity accuracy is strong—correct tickers (CMCSA, GOOGL), correct attribution of Class B ownership to Roberts, and proper classification of share types and voting rights. (4) Reasoning is sound: the LLM correctly synthesizes that both companies use dual-class structures to maintain insider control, but differ in concentration and rigidity. The only minor shortcoming is that the LLM does not explicitly mention the 'non-dilutable' nature of CMCSA's Class B shares—a key point in the original answer that underscores structural rigidity. While implied by 'wholly owned' and 'concentrated', the explicit concept of non-dilutability strengthens the governance distinction and its omission prevents a perfect score. However, the overall semantic meaning and factual content are substantially equivalent, with excellent contextual relevance and precise quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 406,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s remaining 2017 Tax Act “Toll” tax is $634.2 million in 2024 and $792.8 million in 2025, a total of $1.427 billion.  Eli Lilly’s cash‑payment obligations for the same 2017 Tax Act repatriation tax are identical – $634.2 million in 2024 and $792.8 million in 2025, also totaling $1.427 billion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. The ground truth states that both Amgen and Eli Lilly are making payments over an eight-year period beginning in 2018, with Eli Lilly's payments extending through 2025, but it does not specify exact dollar amounts for either company's remaining payments. In contrast, the LLM asserts that both companies have identical remaining obligations of $634.2 million in 2024 and $792.8 million in 2025, totaling $1.427 billion—specific figures not present in the original answer and not supported by the knowledge graph. There is no indication in the ground truth that the amounts are identical or that these exact numbers apply to either firm. This represents a severe factual inaccuracy. While the LLM correctly identifies the eight-year payment period framework under the 2017 Tax Act (contextually relevant), it fabricates precise payment schedules and falsely equates the obligations of two different companies. The reasoning is flawed as it fails to acknowledge that payment amounts differ based on foreign earnings and individual tax calculations, as explicitly stated in the original answer. Thus, despite addressing the comparative structure of the question, the answer is factually wrong on key metrics, rendering it highly incorrect overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 364,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen’s biologics are protected by 12‑year FDA data‑protection, but the company’s risk factor notes that loss of exclusivity may trigger biosimilar entry once that period ends, and in the EU the shorter 8‑year exclusivity means competitors could launch earlier (see Amgen risk factor on page 26).  Bristol Myers Squibb, which also markets biologics such as Opdivo and Yervoy, faces a similar regulatory window, but its broader portfolio—including many small‑molecule drugs—and larger patent portfolio dilute the overall exposure (see BMS product list on page 7 and the biologic regulatory pathway on page 9).  Thus, Amgen’s biosimilar risk is more concentrated on its biologic pipeline, whereas BMS’s exposure is spread across a wider product mix and different exclusivity regimes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 12-year U.S. data protection period for Amgen and the 8-year EU exclusivity, aligning with the ground truth's mention of the '8+2+1' regime in the EU. It accurately notes that biosimilar entry could occur earlier in the EU, which is consistent with the original answer. However, the LLM incorrectly implies that Amgen’s listed products (Erbitux, Cyramza, Trulicity, Taltz, Emgality) are its own, when in fact these are not Amgen products—this is a critical entity error. Similarly, the original answer attributes Opdivo, Yervoy, etc., to Bristol Myers Squibb, which the LLM correctly identifies. The LLM also introduces a claim not in the ground truth—that BMS’s exposure is diluted by a broader portfolio of small-molecule drugs and a larger patent portfolio—while plausible, this specific comparative portfolio diversification is not supported in the original answer, thus adding unsupported reasoning. The core regulatory timelines are factually correct (12 years U.S., 8 years EU), so quantitative accuracy is high. The multi-hop synthesis across companies and regions is partially sound but weakened by incorrect product attribution for Amgen and the addition of unverified strategic claims. The answer remains contextually relevant and addresses the comparative regulatory pathways and regional differences, but with notable factual inaccuracies in product ownership and unsupported assertions about portfolio diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 404,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s revenue risk is tied to Medicaid reimbursement policy changes that can lower or deny coverage for its diversified medical‑device portfolio—including airway, respiratory and diabetes products—thereby reducing demand and pricing (page_15, page_11). AbbVie faces pricing pressure from the Inflation Reduction Act, which imposes statutory price caps and higher discount requirements on its high‑revenue biologics such as Humira, Skyrizi and Rinvoq, directly cutting reimbursement levels (page_19). While Medtronic’s spread across many device lines mitigates concentrated risk, AbbVie’s reliance on a few blockbuster drugs makes it more vulnerable to the IRA‑driven price reductions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic faces Medicaid reimbursement pressures affecting device pricing and that AbbVie is exposed to IRA-driven pricing pressures. However, it introduces inaccuracies regarding the specific drugs impacted. The ground truth states that Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027) are the AbbVie products subject to IRA price setting. In contrast, the LLM incorrectly names Humira, Skyrizi, and Rinvoq as being under IRA price caps, which is not supported by the original answer. This is a significant factual error in entity accuracy. (2) There are no explicit numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is not heavily applicable; however, the timeline details (e.g., 2023 selection for 2026 pricing) are missing in the LLM response, reducing precision. The LLM does not mention the phased selection and implementation years, which are key differentiators in the original answer. (3) The multi-hop reasoning is partially sound—both companies are correctly linked to distinct regulatory pressures (Medicaid vs. IRA), and the distinction between device pricing sensitivity and direct government price setting is acknowledged. However, the failure to correctly identify the IRA-selected drugs and the timeline undermines the synthesis. The claim that AbbVie’s reliance on blockbusters increases vulnerability is reasonable but misapplies the drugs involved. (4) Contextual relevance is high because the answer addresses the core comparison: different types of pricing pressures based on product portfolios. But due to incorrect drug attribution and omission of key details about IRA selection years and effective dates, the qualitative and overall correctness scores are reduced. The answer captures the general theme but misses critical specifics required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 527,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports roughly $2.7 billion in unfunded commitments to private‑equity funds (page 93).  General Dynamics, by contrast, values its Level 1 plan assets—primarily commingled equity and fixed‑income funds—using NAV or a unit price (page 93), with those Level 1 assets totaling about $22.3 billion (page 94).  Thus, while both firms use NAV as a practical expedient for alternative investments, UPS’s unfunded commitments are a modest, uninvested portion relative to the NAV‑valued assets that GD reports.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $2.7 billion in unfunded commitments for UPS and accurately notes that General Dynamics uses NAV for its Level 1 plan assets, which total $22.3 billion. These numbers are factually correct and match the ground truth in magnitude and context (allowing for format variation). However, the LLM introduces a quantitative comparison—implying UPS’s $2.7B is a 'modest, uninvested portion relative' to GD’s $22.3B NAV-valued assets—that is misleading and not supported by the original answer. The ground truth emphasizes differences in liquidity and redemption terms (UPS: 10–15 year lockups, GD: monthly/quarterly redemption), not a direct size comparison between unfunded commitments and total NAV assets. This misrepresents the nature of the comparison. Additionally, the LLM fails to mention the key qualitative distinction about redemption frequency and liquidity, which is central to the original answer’s conclusion that UPS has less liquid exposure. While both companies use NAV as a practical expedient, the reasoning leap to a relative size comparison undermines the multi-hop synthesis. The answer is factually accurate on numbers (hence high quantitative score) but flawed in reasoning and completeness regarding the comparative analysis of liquidity and investment structure, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 376,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s issuance of Class B common stock in 2024 adds a non‑voting class of shares that may vote only on limited matters (e.g., certain mergers or amendments to the certificate of incorporation), thereby diluting the voting power of Class A shareholders【page 69】. In contrast, Meta’s dual‑class structure, disclosed in its filing, gives Class B shares ten votes per share while Class A shares have one vote per share, concentrating control in the hands of the founders【page 1】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but includes a critical error in describing META's dual-class structure, which severely undermines the comparison. (1) Quantitatively, the CMCSA share issuance number (9,444,375) is not mentioned in the LLM answer, reducing completeness; however, no incorrect numbers are stated, so quantitative accuracy is moderate. (2) The description of CMCSA’s Class B stock as non-voting with limited exceptions aligns with the ground truth and is correctly cited to page 69, supporting contextual relevance. (3) However, the characterization of META’s dual-class framework is factually incorrect: the ground truth states that Class B shares have no voting rights except in defined events like a merger, whereas the LLM claims Class B has ten votes per share and Class A has one — this reverses the actual structure and misrepresents the voting hierarchy. This error invalidates the core comparison between CMCSA and META. (4) The reasoning fails on multi-hop synthesis because it draws a contrast (tiered voting power via vote weighting) that does not exist; both companies actually use non-voting or limited-voting classes to concentrate control, not differential voting weights. Thus, while the answer addresses the question’s components and cites relevant pages, the qualitative inaccuracy in a key fact results in a low correctness score despite some correct elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 388,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "Amgen’s Medicare‑reimbursed drugs could see accelerated revenue erosion under the IRA, just as AbbVie’s Imbruvica (2026) and Vraylar (2027) have already been slated for government‑set prices.  The IRA allows price setting up to nine years after approval for small molecules and 13 years for biologics, so Amgen’s products that are selected in the 2026–2027 cycles—such as ENBREL, which will face a lower Part D price from 2026—may lose revenue before patent expiry.  Coupled with inflation‑penalty rebates and reduced federal reinsurance, the impact is expected to grow through the decade, potentially shifting the erosion timeline earlier and extending the period of declining margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and dates are correct: the IRA's 9-year timeline for small molecules and 13-year timeline for biologics is accurately stated, and the selection of AbbVie’s Imbruvica in 2026 and Vraylar in 2027 matches the original answer. The mention of ENBREL facing lower Part D prices starting in 2026 is consistent with known data and adds specific product-level insight. (2) The reasoning correctly synthesizes the multi-hop logic: it connects the IRA’s pricing timelines to AbbVie’s experience and applies the implications to Amgen’s portfolio, particularly products reliant on federal reimbursement. (3) The answer goes slightly beyond the original by referencing inflation-penalty rebates and reduced federal reinsurance, which are contextually relevant but not in the ground truth; however, these do not contradict and add reasonable context. (4) The only minor gap is that the original answer explicitly notes Linzess (also AbbVie) being selected in 2027, which the LLM omits—this is a small completeness issue but does not detract from the core accuracy. Overall, the answer demonstrates strong entity recognition (Amgen, AbbVie, ENBREL), correct timelines, and sound inference, warranting a high correctness score with near-perfect quantitative accuracy and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 385,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports **37,028 thousand** (≈ 37.0 million) securities remaining available for future issuance under equity‑compensation plans approved by security holders (Item 12, page 61). Procter & Gamble discloses **119 million** such securities (footnote 1 on page 69). Thus, Procter & Gamble’s available pool is roughly 3.2 times larger than Colgate‑Palmolive’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's figure as 37,028,000 (reported as 37,028 thousand), which matches the ground truth. However, it incorrectly states Procter & Gamble's total remaining available securities as 119 million, whereas the ground truth is 133,185,995. This is a significant numerical discrepancy (~14 million fewer), affecting quantitative accuracy. (2) The calculation comparing PG's pool to CL's as '3.2 times larger' is based on incorrect input (119M vs 37.028M), leading to an inaccurate ratio (actual ratio is ~3.59, not 3.2). Even with correct inputs, the LLM's math would still be off. (3) The multi-hop reasoning is sound in structure—correctly identifying both companies' disclosures and comparing them under the same category of shareholder-approved equity plans. The synthesis across entities is logical and relevant. (4) The LLM uses correct entity names and appropriate financial terminology, and the answer addresses the comparative aspect of the question. However, the incorrect P&G number undermines factual correctness. While the direction of the comparison (PG > CL) is correct, the magnitude is misrepresented. Hence, partial credit is given for correctness and quantitative accuracy, with higher scores for reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 361,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s partnership with Ono to develop and commercialize Opdivo, Yervoy and other biologics in Taiwan (page 87) reflects a joint‑commercialization model that must satisfy Taiwan’s rule that biologics be supported by local clinical‑trial data for registration.  Merck’s 2021 spin‑off of its biosimilars business into Organon & Co. (pages 1‑5) is a corporate restructuring that separates the biosimilar portfolio from the core company; the new entity will still need to meet Taiwan’s local‑trial data requirement for any biologics it seeks to register, but the spin‑off itself does not alter that regulatory obligation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies key events: BMS's (BMY's) joint commercialization with Ono for biologics like Opdivo and Yervoy in Taiwan, referencing local clinical trial requirements (page 87), and Merck's (MRK's) 2021 spin-off of its biosimilars business into Organon (pages 1-5). All entities (BMS, Ono, MRK, Organon), drug names (Opdivo, Yervoy), and the regulatory context (Taiwan requiring local clinical data) are correctly stated. There are no numeric inaccuracies—dates and company actions are correct, and no calculations are involved. However, the LLM answer falls short in fully synthesizing the comparative strategic implications as presented in the ground truth. While the original answer contrasts BMY’s active, collaborative market-entry strategy in Taiwan with MRK’s strategic retreat from biosimilars to avoid regulatory burdens, the LLM response states that Organon 'will still need to meet Taiwan’s local-trial data requirement'—which is factually true but misses the strategic point that MRK may have divested to exit the complexity of such markets altogether. This weakens the comparative reasoning (multi-hop synthesis) between the two companies’ strategies in the context of Taiwan’s regulatory environment. The answer is contextually relevant and well-supported with document references, but the qualitative analysis lacks the depth of strategic contrast found in the ground truth, resulting in a partial rather than full match in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 415,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 net sales for its Greater China segment—$74.2 billion—include revenue from Taiwan (the segment is defined as China mainland, Hong Kong and Taiwan【page 25】).  Adobe, by contrast, only notes a local field office in Taiwan in its operations section【page 15】, with no revenue figure disclosed for that region.  Thus Apple’s Taiwan contribution is part of a sizable $74 billion segment, whereas Adobe’s presence is limited to an office with an unspecified or smaller revenue impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states AAPL's 2022 Greater China net sales as $74.2 billion (equivalent to $74,200 million in the ground truth), accurately reflecting the quantitative contribution that includes Taiwan. It correctly notes that ADBE has a local field office in Taiwan but does not disclose revenue for the region. (2) All numbers are accurate—$74.2 billion is equivalent to $74,200 million, and the fiscal year 2022 is correctly referenced. No calculations were required, but the representation of the figure is precise and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that AAPL’s revenue from Taiwan is embedded within a larger geographic segment, while ADBE’s presence is operational (office-based) without disclosed revenue, implying a different strategic footprint. The comparison between revenue-scale exposure (AAPL) and operational presence (ADBE) is logically drawn. (4) The only minor shortcoming is that the LLM does not explicitly use the term 'Greater China segment' when discussing ADBE’s operations, but it correctly contrasts the nature of presence (revenue-generating segment vs. field office). Wording differs slightly (e.g., 'sizable $74 billion segment' vs. original phrasing), but semantic equivalence is maintained. All key entities—AAPL, ADBE, Taiwan, 2022, Greater China—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 393,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Comcast’s 10‑K discloses that Class A shares represent roughly 66 % of voting power while the single holder of all Class B shares (15 votes per share) holds about 33 % of the vote, concentrating a third of the control in one individual. Meta’s 10‑K notes that Class B shares are not publicly traded and are held by only 23 record holders, but it does not provide the voting‑vote ratio in the supplied pages, implying a less concentrated voting structure than Comcast’s. Consequently, Comcast’s governance is heavily influenced by Mr. Roberts, whereas Meta’s structure allows broader shareholder participation with less single‑holder dominance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that CMCSA's Class A shares hold approximately 66% of voting power and Class B holds about 33%, with 15 votes per share for Class B, aligning with the ground truth. It accurately notes that Brian L. Roberts is the single holder of Class B shares, which is consistent with the knowledge graph. For META, it correctly states that Class B shares are not publicly traded and held by only 23 record holders as of December 31, 2023, matching the original answer. However, the LLM incorrectly implies that Meta’s structure is 'less concentrated' or allows 'broader shareholder participation'—this contradicts the ground truth, which emphasizes that META’s control is more opaque and highly concentrated among few Class B holders. The conclusion that Meta has 'less single-holder dominance' is misleading, as Mark Zuckerberg controls a supermajority of voting power in META, unlike CMCSA where control is split between two classes with defined proportions. (2) Quantitatively, all numbers (66%, 33%, 15 votes per share, 23 holders) are accurate and correctly attributed. The percentage breakdown for CMCSA matches the 66 2/3% and 33 1/3% in the original. (3) The multi-hop reasoning is partially sound—information from both companies’ 10-Ks is synthesized, but the final implication about governance influence is flawed. While CMCSA’s concentration in Roberts is correctly noted, the contrast with Meta is misrepresented. Meta’s Class B holders have far greater collective control than implied, and the lack of disclosed voting ratio does not imply less concentration—it typically indicates more. (4) Correctness is scored 7 due to accurate data but incorrect interpretation; quantitative accuracy is 8 due to correct numbers; qualitative accuracy is 7 due to flawed reasoning in comparative governance implications; contextual relevance is 9 as the response directly addresses the question’s core elements with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 529,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "LLY’s U.S. pediatric exclusivity adds six months to data protection (and, for non‑biologics, to any remaining patent term) (page_10), whereas MRK’s U.S. pediatric exclusivity adds six months to Orange Book‑listed patent terms and to the data‑exclusivity period for both small‑molecule and biologic products (page_14). In the EU, both companies receive an additional six months of market exclusivity attached to the SPC term (page_14).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative accuracy: all durations (six months) and regulatory frameworks (U.S. and EU) are accurately represented. The numbers and time extensions are consistent with the ground truth. Entity accuracy is strong—LLY and MRK are correctly attributed to their respective exclusivity mechanisms. Contextual relevance is excellent, as the response directly addresses how each company benefits differently under U.S. and EU frameworks. However, there is a subtle but important discrepancy in the EU portion: the LLM states that 'both companies receive an additional six months...attached to the SPC term,' while the original answer specifies only MRK’s EU benefit, not LLY’s. This omission or generalization may overextend the information, as the ground truth does not confirm LLY’s EU pediatric exclusivity benefit. The multi-hop reasoning is mostly sound—tying U.S. mechanisms to patents/data and EU to SPC—but the synthesis slightly falters by assuming symmetry in EU treatment. Wording differences are acceptable under semantic equivalence, but the inclusion of LLY in the EU benefit without evidence in the ground truth reduces qualitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 346,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR’s foreign‑currency liabilities fell by roughly $2 million (from $22 million in 2023 to $20 million in 2024 – page 60). In contrast, Lockheed Martin’s net foreign‑exchange hedge exposure was about $9.9 billion in 2024 (page 59). The stark disparity—LMT’s hedging program is orders of magnitude larger than EMR’s liability change—suggests that Lockheed Martin maintains a far more aggressive, systematic FX‑risk mitigation strategy, while EMR’s exposure is relatively modest and less heavily hedged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key financial figures. It incorrectly states EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024 respectively, whereas the ground truth reports $22 billion and $20 billion — a 1,000-fold difference. Similarly, it claims LMT’s hedge exposure was $9.9 billion in 2024, but the original answer states $7.5 billion. These errors severely undermine the quantitative accuracy. (2) Calculations are conceptually correct (a $2 million decrease is accurately derived from the numbers given), but based on wrong magnitudes. The comparison between EMR’s liability reduction and LMT’s hedge exposure is distorted due to incorrect scales — stating that LMT’s program is 'orders of magnitude larger' is misleading when both are in the billions (correctly: $2B change vs $7.5B hedge). (3) Multi-hop reasoning is partially sound: the model attempts to compare EMR's liability trend with LMT's hedge position and infer different risk management strategies. However, because the numbers are wrong, the conclusion about LMT having a 'far more aggressive' strategy lacks valid support. The original answer notes EMR may be reducing liabilities rather than hedging, while LMT uses options to manage earnings volatility — this nuanced strategic contrast is missing in the LLM response. (4) Contextual relevance is moderate: the answer addresses the core question about comparing FX risk management strategies and references both companies and time periods correctly. However, due to severe numerical inaccuracies and incomplete qualitative analysis, the overall correctness score is low. Minor note: 'page 60' and 'page 59' references suggest document retrieval but are not part of the ground truth and add no value.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 485,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion of dividends that AENB paid to its parent, AXP, in 2023 was a capital distribution that reduced AENB’s Tier 1 capital—the numerator in the Tier 1 leverage ratio that federal regulators require banks to maintain (see AXP’s 2023 10‑K, page 67). Because both AENB and Wells Fargo Bank (WFC) are large banking holding companies subject to the same leverage‑ratio requirement, the dividend must be factored into each bank’s capital‑planning and may require regulatory approval to ensure the ratio stays above the mandated minimum (see WFC 10‑K, pages 2‑6). Thus, the dividend directly impacts the leverage ratios of both institutions, potentially necessitating adjustments or clearance to remain compliant.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $3.6 billion dividend amount and the year 2023 are accurately stated, matching the original answer. There are no calculations required, so numerical accuracy is fully preserved. (2) The entities—AENB, AXP, and WFC—are correctly identified, and the reference to leverage ratio requirements under federal banking regulations is appropriate. The mention of Tier 1 capital and the Tier 1 leverage ratio is consistent with regulatory frameworks applicable to both AENB and WFC. (3) The reasoning is sound: the LLM correctly identifies that dividend payments affect regulatory capital ratios, particularly the leverage ratio, and that such distributions must be managed to remain compliant. It also correctly notes that both AENB and WFC are subject to similar regulatory constraints. However, there is a minor inaccuracy in stating that 'both AENB and Wells Fargo Bank (WFC) are large banking holding companies'—AENB is a subsidiary bank, not a bank holding company itself; AXP is the holding company. This mischaracterization slightly undermines the precision of the entity classification. Additionally, while the LLM mentions regulatory approval, the original answer emphasizes that dividend restrictions are automatic if capital ratios would fall below minimums, rather than solely dependent on approval. (4) Despite this nuance, the core logic and factual content are correct, and the answer effectively explains the relationship between the dividend and leverage ratio requirements. Hence, the correctness score is 8 due to the minor entity misclassification and slight overemphasis on approval versus automatic constraints, but quantitative accuracy and contextual relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 482,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s FY 2024 pre‑tax income is $62.9 B in the U.S. and $44.9 B abroad; because the U.S. effective rate is above the 15 % Pillar Two minimum and the company has no material operations in jurisdictions below that threshold, the global minimum tax is unlikely to materially affect its results. Qualcomm, which will also be subject to Pillar Two from FY 2025, similarly states it does not expect a material impact and will monitor the rules, indicating a comparable but potentially lower exposure given its smaller foreign‑income proportion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Microsoft's FY 2024 pre-tax income as $62.9B (U.S.) and $44.9B (foreign), matching the ground truth exactly. Qualcomm's fiscal year 2025 implementation timeline is accurately referenced. All numeric values and fiscal years are correct, with acceptable formatting (e.g., 'FY 2025', '$62.9B'). (2) Quantitative accuracy is perfect: no calculations are required beyond correct reporting of figures, which are all accurate. (3) The reasoning is sound: the LLM correctly infers that Microsoft’s higher U.S. income—subject to a rate above the 15% Pillar Two threshold—reduces its exposure, and correctly notes Microsoft’s and Qualcomm’s similar 'no material impact' disclosures. However, the LLM introduces an unsupported claim that Qualcomm may have 'potentially lower exposure given its smaller foreign-income proportion'—this comparison is not in the ground truth and lacks data (e.g., Qualcomm’s actual foreign income proportion is not provided), making it a minor overreach. (4) Despite this small speculative addition, the answer is factually aligned, contextually complete, and synthesizes multi-hop information (geographic income distribution → Pillar Two exposure → cross-company comparison under same framework) correctly. The core conclusion—that both companies expect minimal impact—is preserved. Thus, high scores across all categories with a minor deduction in qualitative accuracy for unsupported comparative speculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 408,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart’s $37.2 billion of unrecorded purchase obligations are legally binding commitments to buy inventory, utilities, capital equipment, software and services that are not yet recorded as liabilities. These commitments expose the company to liquidity strain, supply‑chain disruptions and price‑volatility risk that can materialize as cash outflows or penalties. MDLZ’s VAR model, which peers use, explicitly excludes anticipated transactions, currency trade payables/receivables and net investments in non‑U.S. subsidiaries, so the risk from Walmart’s unrecorded purchase obligations is omitted from the VAR analysis and therefore not reflected in the model’s risk assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong factual and semantic alignment. (1) Quantitatively, the $37.2 billion figure is correct and matches the ground truth; no other numbers or dates are misstated. The fiscal year-end (January 31, 2025) is not mentioned in the LLM answer but is not critical to the core reasoning. (2) The LLM correctly identifies WMT's unrecorded purchase obligations as legally binding and off-balance sheet, and accurately describes their composition (inventory, utilities, capital expenditures, plus additional items like software and services). While the ground truth cites DIS's 10-K regarding VAR model exclusions, the LLM instead directly references MDLZ’s model exclusions—this is still valid as MDLZ is the peer in question. (3) The multi-hop reasoning is sound: the LLM connects WMT’s off-balance sheet obligations to the limitations of VAR models used by peers like MDLZ, correctly noting that firm commitments are excluded from such models. The LLM slightly expands the exclusions to include 'currency trade payables/receivables' and 'net investments in non-U.S. subsidiaries,' which are not in the ground truth, but these do not contradict it and may reflect broader VAR limitations. (4) The answer is contextually relevant and directly addresses how WMT’s obligations represent a risk not captured by VAR models. The only minor shortcoming is the lack of specific mention of DIS as the source of the general VAR limitation, and slightly broader categorization of exclusions, but the core logic and facts remain correct. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 470,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UnitedHealth Group uses interest‑rate swaps to hedge exposure to floating‑rate liabilities, as noted in its 2024 10‑K where $27 billion of liabilities are tied to market rates via swap contracts (page 38; page 40). The filing does not disclose a $1.4 billion swap linked to the 3.625% 2024 Notes repayment. In contrast, Amgen’s 2024 10‑K reports that a $1.4 billion notional amount of interest‑rate swap contracts matured with the repayment of the 3.625% 2024 Notes, converting fixed‑rate coupons to floating‑rate SOFR‑based coupons as a fair‑value hedge (pages 143‑149).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $27 billion in floating-rate liabilities for UNH, $1.4 billion in interest rate swaps for AMGN tied to the 3.625% 2024 Notes, and the use of SOFR-based floating rates are all accurately reported. The years (2024) and percentages (3.625%) match exactly. (2) The answer correctly identifies both companies (UNH and AMGN), the relevant financial instruments (interest rate swaps), and the context of the 2024 Notes repayment. (3) Multi-hop reasoning is sound: the model contrasts UNH’s broad use of swaps across $27 billion of floating-rate liabilities with AMGN’s specific, $1.4 billion swap tied directly to the 3.625% 2024 Notes, which matured and were repaid in 2024. It correctly notes that UNH’s 10-K does not link a $1.4 billion swap to that note repayment, implying no direct connection, which supports the ground truth that UNH’s use is broader and not tied to that specific debt. (4) The only minor shortcoming is that the LLM does not explicitly state the comparative conclusion that 'UNH’s application is broader in scope across its balance sheet, whereas AMGN’s use is directly tied to specific debt instruments'—this synthesis is implied but not articulated as clearly as in the original. However, the factual basis for that conclusion is fully present. Wording differs but semantic meaning is equivalent. All sources are appropriately cited to 10-K pages, enhancing credibility. No irrelevant or incorrect information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 427,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % senior notes are general unsecured senior obligations due 2032.  An event of default “accelerates the maturity” of the notes, meaning the principal becomes due immediately (the notes can also be redeemed at a price equal to the greater of the present value of the principal and future interest or 100 % of principal plus accrued interest).  In contrast, Oracle’s unsecured $6 billion revolving credit facility matures on March 8 2027; an event of default accelerates all borrowings to become due on that date, but the facility can be borrowed, pre‑paid, and re‑borrowed during the term.  Thus, AMD’s default triggers instant repayment of the 2032 notes, whereas Oracle’s default forces repayment only at the facility’s fixed maturity on March 8 2027.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between AMD's and Oracle's debt structures in the event of default. (1) Quantitatively, all key figures are accurate: AMD's notes are due 2032 with no explicit principal amount mentioned in the LLM answer, which is a minor omission compared to the ground truth stating $1.0 billion issued in 2022. Oracle's $6.0 billion facility and March 8, 2027 maturity date are correctly stated. The interest rate linkage to credit ratings is missing, but this is a qualitative nuance. (2) The LLM correctly identifies that AMD’s notes become immediately due upon Event of Default, with a technically accurate description of the redemption price (greater of present value or par plus accrued interest), which aligns with acceleration mechanics. (3) For Oracle, the LLM correctly notes that borrowings become due upon default but only by the maturity date (March 8, 2027), not immediately, and correctly highlights the revolving nature (borrow, prepay, reborrow). However, it slightly mischaracterizes the acceleration effect—ground truth implies full facility becomes due immediately unless terminated earlier, while LLM suggests repayment is deferred to maturity, which may understate the risk of acceleration. This is a subtle but important distinction in credit agreements: acceleration typically makes debt immediately payable, though lenders may choose not to enforce it. (4) The comparison effectively contrasts AMD’s fixed-term unsecured notes with Oracle’s flexible revolving facility. The reasoning is sound and synthesizes multi-hop information across two companies and debt instruments. The omission of the $1.0 billion principal for AMD and the lack of clarity on Oracle’s immediate vs. maturity-triggered repayment prevent a top score, but overall the answer is factually strong, contextually relevant, and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 515,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s $31 billion of trust assets are managed under strict guidelines that still allow a mix of growth, private‑equity and high‑yield credit instruments, exposing the portfolio to credit, interest‑rate, equity and reinvestment risk while maintaining limits on concentration and duration. In contrast, General Dynamics’ $191 million of marketable securities held in trust are restricted to investment‑grade fixed‑income securities with maturities of five years or less, reflecting a conservative, low‑risk policy that primarily exposes the portfolio to modest interest‑rate and credit risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $31.0 billion in trust assets for GE and $191 million in marketable securities for General Dynamics as of December 31, 2021, matching the ground truth in both amount and entity. These figures are accurately represented with acceptable formatting ($31 billion = $31.0 billion; $191 million exact match). 2) Quantitatively, all numbers are correct—no calculations were required, but the values are faithfully reproduced. 3) The reasoning is mostly sound: it correctly contrasts GE’s broader, more diversified investment approach with higher risk exposure (credit, interest rate, equity, reinvestment) against General Dynamics’ conservative, short-duration, investment-grade fixed-income policy. However, the LLM slightly overreaches by specifying that GE’s portfolio includes 'growth, private-equity and high-yield credit instruments'—while the ground truth mentions 'potential inclusion of non-traditional asset classes,' it does not explicitly confirm current holdings in private equity or high-yield instruments. This introduces a minor factual overstatement. 4) The answer addresses both parts of the comparison—investment policy and risk exposure—and synthesizes across two companies and their respective trust assets, fulfilling the multi-hop requirement. While the core qualitative message about differing risk profiles and policy conservatism is accurate, the added specificity on GE’s asset mix reduces qualitative precision. Despite this, the overall meaning and intent align closely with the original answer, warranting a high correctness score with a small deduction for unsupported detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 447,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level‑2 fixed‑income models are priced with observable market data such as interest‑rate curves, credit spreads and broker/dealer bids or quoted prices for comparable securities. PayPal’s Level‑2 derivative valuations use observable inputs that include currency rates, interest‑rate curves, option volatilities and equity prices (and other market‑observable data for comparable instruments). Both rely on Level‑2 pricing, but Lockheed Martin’s inputs focus on fixed‑income market metrics, whereas PayPal’s cover a broader range of market data needed for its foreign‑exchange and other derivative contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest-rate curves, credit spreads, and broker/dealer quotes for Level 2 fixed income, and PayPal uses currency rates, interest-rate curves, option volatilities, and equity prices for Level 2 derivatives. These match the original answer’s description of observable market data for each firm. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly comparing Level 2 methodologies across two different companies and asset classes (fixed income vs. derivatives), noting both the common reliance on observable inputs and the difference in application. (4) The only minor deviation is that the LLM mentions 'broker/dealer bids or quoted prices for comparable securities' and 'other market-observable data'—details not explicitly in the original answer—but these are reasonable elaborations consistent with Level 2 methodology and do not contradict the ground truth. The core comparison and synthesis are semantically equivalent and well-articulated. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight over-elaboration without error, and full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 377,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are highly sensitive to market rates – a 50‑basis‑point move would shift their fair value by roughly **$1.7 billion** (page 49). In contrast, Cisco’s $0.5 billion interest‑rate swap is a fair‑value hedge that **offsets the fair‑value change of the hedged portion of its fixed‑rate debt** (page 89), effectively neutralizing that segment’s exposure to rate swings. Thus, AVGO faces a large, unhedged sensitivity, while Cisco’s swap mitigates the impact on the portion of debt it covers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AVGO's $56.3 billion in fixed-rate senior notes and the $1.7 billion fair value sensitivity to a 50 basis point rate shift are accurately reported (minor rounding to $1.7 billion is acceptable). CSCO's $0.5 billion interest rate swap is correctly identified as a fair-value hedge that offsets changes in the hedged portion of fixed-rate debt. (2) Quantitative accuracy is perfect: both dollar amounts and the implied sensitivity are consistent with the original answer. The 50 basis point shift impact is correctly attributed. (3) The multi-hop reasoning is sound—comparing AVGO’s direct exposure to CSCO’s hedged position shows synthesis across both companies’ filings. The LLM correctly infers that CSCO’s swap mitigates exposure on the hedged portion, while AVGO’s sensitivity remains largely unhedged for existing debt (though the LLM omits mention of AVGO’s treasury rate locks for *future* issuances, a minor omission). (4) The answer is contextually relevant and directly addresses the comparative sensitivity and hedging impact. The only small gap is not mentioning that AVGO uses treasury rate locks for anticipated issuances (a forward-looking hedge), but this does not undermine the core comparison on existing debt sensitivity. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 398,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMS’s Eliquis alliance with Pfizer involved an upfront payment that was recorded as deferred income (the amortization of that payment is shown as a $42 million expense in the 2023 alliance summary) and the parties agreed to share future milestone payments, but the exact milestone amounts are not disclosed in the filing. In contrast, Pfizer’s collaboration with Beam required a $300 million upfront cash payment and the parties have agreed to milestone payments that could total up to $1.35 billion (including $1.05 billion in development, regulatory and commercial milestones). Thus, the Beam deal represents a substantially larger upfront outlay and a much higher potential milestone commitment than the Eliquis alliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the $300 million upfront payment to Beam and up to $1.35 billion total potential value (including $1.05 billion in milestones) match the original answer. While the original answer does not specify the exact amortized expense amount ($42M in 2023), the LLM correctly notes that the upfront payment under Eliquis is being amortized and cites a specific figure from the filing, which adds detail not contradicted by the ground truth. (2) The comparison of financial commitments is sound: the LLM correctly identifies that the Beam deal involves a significantly larger upfront and potential milestone value than the Eliquis alliance. (3) Entity accuracy is strong: BMS (BMY), Pfizer, and Beam are correctly identified, and the nature of each collaboration (Eliquis alliance vs. in vivo base editing) is accurately described. (4) Multi-hop reasoning is well-executed—information from two separate collaborations is synthesized to compare financial commitments. The only minor limitation is that the LLM implies the Eliquis upfront payment is known and amortized to $42M annually, while the ground truth emphasizes that the exact milestone amounts are not disclosed and focuses on the structure of shared obligations. However, citing a specific amortization expense from the filing does not make the answer incorrect, especially if supported by the source. Overall, the LLM conveys the same core conclusion: Pfizer’s financial commitment to Beam far exceeds its Eliquis-related payments, contingent on milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 443,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments records the present value of lease‑extension or termination options that it is reasonably certain to exercise in the lease liability, thereby increasing long‑term liabilities and deferring revenue recognition until the lease term is completed【page_35】. Cisco, by contrast, treats similar provisions in its customer‑financing arrangements as lease receivables and records lease income and interest income over the lease term; the lease receivable is shown as a financing receivable, which spreads revenue recognition and typically results in a lower immediate impact on long‑term liabilities【page_50】【page_51】. Thus, TXN’s approach raises long‑term liabilities and delays revenue, whereas Cisco’s approach spreads revenue over time and reduces the immediate liability effect.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, so quantitative accuracy is not applicable—however, since no numbers were misstated, it receives full credit. (2) The core issue lies in qualitative accuracy: the LLM incorrectly states that Texas Instruments 'defers revenue recognition until the lease term is completed,' which is not supported by the ground truth and misrepresents TXN’s accounting treatment. The original answer indicates TXN’s practices affect long-term liabilities, not revenue recognition. Revenue deferral is a Cisco-specific issue related to guarantees, not lease extensions/terminations at TXN. Additionally, the LLM incorrectly implies Cisco’s treatment affects 'immediate impact on long-term liabilities,' while the ground truth emphasizes Cisco’s impact on revenue timing and credit exposure, not liabilities. (3) Multi-hop reasoning is partially sound—the model correctly identifies that TXN incorporates lease options into liabilities and that Cisco spreads revenue over time. However, it fails to correctly differentiate the financial statement impacts: TXN affects liabilities (correct), but does not defer revenue due to leases (incorrect addition); Cisco’s customer financing affects revenue timing and credit risk, not liability measurement. The LLM conflates revenue recognition impacts across both firms inaccurately. (4) Contextual relevance is high because the response addresses both companies and the relevant accounting provisions. Correctness score is 6 due to significant qualitative errors in attributing revenue deferral to TXN and mischaracterizing Cisco’s liability treatment, despite correct entity identification and structural comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 463,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives Disney+ exclusive access to that brand’s documentary and nature library, allowing the service to differentiate itself with high‑quality, niche content that competitors lack (page 78, page 13). Because the content is owned, Disney can avoid the higher licensing fees that YouTube pays for third‑party programming, lowering its subscriber‑acquisition costs relative to YouTube’s licensing‑heavy model (page 10). This owned‑content advantage lets Disney+ attract and retain subscribers more cost‑effectively than a platform that relies on external licensing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 73% ownership stake is correctly stated, and no other numerical values (e.g., dates, dollar amounts) are present or required. Format and percentage are consistent with the original. (2) The answer correctly identifies that Disney’s ownership of National Geographic enables exclusive, owned content on Disney+, which reduces reliance on costly third-party licensing—this directly supports lower subscriber acquisition costs compared to YouTube’s model. (3) The multi-hop reasoning is sound: it connects Disney’s equity stake → control over content → integration into Disney+ → cost advantage in content acquisition → competitive advantage in subscriber growth. The only minor omission is that the original mentions National Geographic being featured as a 'top-level tile' in the interface, which adds specificity about content differentiation strategy that the LLM answer does not include. However, this does not undermine the core factual accuracy. (4) The LLM uses slightly different phrasing (e.g., 'documentary and nature library', 'niche content') but semantically matches the original. The comparison to YouTube’s licensing model is correctly framed. Thus, the answer earns a 9 for correctness and qualitative accuracy due to high fidelity with a small detail missing, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 392,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologic products enjoy a 12‑year regulatory exclusivity period (page 7) that can extend market protection well beyond the expiration of their patents, with estimated minimum exclusivity dates such as Opdivo 2028 and Yervoy 2025 (page 9).  In contrast, Merck’s Januvia family has only a short exclusivity delay—generic entry is not expected until May 2026 for Januvia/Janumet and July 2026 for Janumet XR, just a few years after the key patent expired in January 2023 (page 58).  Thus, BMY’s regulatory exclusivity provides a longer, more substantial extension of market protection than the limited exclusivity delay Merck experiences with Januvia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and numbers are correct: BMY's 12-year regulatory exclusivity for biologics is accurately stated; Opdivo and Yervoy exclusivity timelines (2028 and 2025) are consistent with the knowledge graph; MRK's key Januvia patent expiration in January 2023 and delayed generic entry until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) are precisely reported. (2) The answer correctly contrasts BMY’s reliance on statutory 12-year biologic exclusivity with MRK’s use of secondary patent litigation to extend exclusivity, capturing the core difference in strategy. (3) Multi-hop reasoning is sound: it synthesizes information across BMY’s biologic exclusivity framework and MRK’s patent litigation outcomes, correctly concluding that BMY’s regulatory mechanism provides longer protection than MRK’s limited delay. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'court rulings and settlement agreements' as the mechanism for MRK’s extension, instead referring more generally to a 'short exclusivity delay.' While the implication is correct, this omits a key qualitative detail about how the extension was achieved, slightly reducing qualitative accuracy. However, the overall meaning and comparison remain factually sound and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 381,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife issued 40,000 shares of Series F preferred stock (page 263) and may redeem those shares at $25,500 per share within 90 days of a “rating agency event” (page 264), a clause that could trigger a capital outflow and liquidity strain if a downgrade occurs. AIG’s 2024 10‑K notes that a rating downgrade could limit its ability to write new business and impair customer retention (page 85), exposing its revenue and capital to the same rating‑agency risk. Thus, both companies face financial exposure to rating‑agency events—MetLife through potential redemption of preferred equity and AIG through reduced underwriting capacity and retention—linking capital structure and business growth to credit ratings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MetLife issued 40,000 shares of Series F preferred stock, and the redemption price of $25,500 per share is accurate (total potential outflow = $1.02B, though not explicitly calculated, is implied). The page references (263, 264, 85) add precision and are consistent with source data. (2) The answer correctly identifies both companies—MetLife and AIG—and their respective risks tied to rating agency events. The definition of a 'rating agency event' is accurately reflected in context, even if not explicitly defined. (3) Multi-hop reasoning is sound: the model synthesizes MetLife’s capital structure risk (redemption of preferred stock) with AIG’s business risk (reduced underwriting and retention) due to rating downgrades, correctly linking both to credit rating exposure. (4) The only minor shortcoming is that the LLM does not explicitly define a 'rating agency event' as a change in rating criteria that reduces equity credit, which is present in the original answer and adds nuance. However, the implication is clear from context. Wording differs but semantic meaning and factual content are equivalent. The answer is fully relevant, addressing both companies and the intersection of their rating-related risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 370,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s 2021 fair‑value hierarchy lists U.S. Government Securities as Level 2 and values them with matrix pricing, whereas UPS’s 2021 hierarchy places most U.S. Government Securities in Level 1 and values them with quoted prices, applying matrix pricing only to Level 2 assets such as corporate bonds and municipal bonds【page 107-111】【page 89】.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partial quantitative accuracy by correctly identifying that LMT classified U.S. Government Securities as Level 2 and used matrix pricing as of December 31, 2021, which aligns with the ground truth. However, the key factual error lies in the characterization of UPS's valuation methodology: the LLM claims UPS placed 'most U.S. Government Securities in Level 1' and applied matrix pricing only to corporate and municipal bonds, which directly contradicts the ground truth stating that UPS *did* use matrix pricing for Level 2 marketable securities including U.S. government debt. This misrepresents UPS’s approach and fails the multi-hop comparison required by the question. The ground truth indicates both companies used matrix pricing for U.S. government securities within Level 2 when broker quotes were unavailable, showing alignment in methodology. The LLM incorrectly implies a divergence. While the mention of matrix pricing for Level 2 assets at UPS is factually possible, restricting its application to non-government securities contradicts the original answer. There is no quantitative error in dollar amounts (LMT's $121M is not mentioned but not denied), but the omission and misattribution of UPS's methodology constitute a major qualitative and reasoning failure. The answer is contextually relevant but fundamentally flawed in synthesis and entity-specific accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 387,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI values its derivatives with standard models that rely on readily observable market inputs—spot rates, yield curves, futures prices and Black‑Scholes volatilities—so the contracts are classified as Level 2 fair‑value assets. In contrast, MDLZ’s real‑estate fund investments are valued at Level 3, using present‑value models that depend on appraisals, local market conditions and projected cash flows—inputs that are largely unobservable and require significant judgment. Thus, PMI’s valuations are driven by observable market data, while MDLZ’s real‑estate valuations rely on less‑observable, model‑based assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PM (PMI) uses observable market inputs—spot rates, yield curves, futures prices, and Black-Scholes volatilities—for derivative valuations, leading to Level 2 classification, which aligns with the original answer’s assertion of Level 1 or 2 due to observable data. The mention of Level 2 specifically is consistent with Level 1/2 in the ground truth, as derivatives are typically Level 2 when models are used with observable inputs. (2) For MDLZ, the LLM correctly states that real estate fund investments are valued using present-value models with unobservable inputs like appraisals, local market conditions, and projected cash flows, resulting in Level 3 classification—this matches the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly contrasts PMI’s market-driven, observable approach with MDLZ’s judgment-heavy, unobservable input reliance, capturing the key distinction in observability across valuation models. (4) Minor difference: the original answer specifies 'foreign exchange spot rates, interest rate differentials, and maturity dates' for PM, while the LLM lists broader but still correct inputs (e.g., yield curves, futures prices). These are semantically equivalent within standard valuation practices. The LLM uses 'PMI' instead of 'PM', but this is a common and acceptable expansion (Philip Morris International). No numerical inaccuracies; all qualitative and contextual elements are preserved. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a 9 due to slight variation in specificity of inputs but no material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 470,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures give the company the option to defer interest payments, but any deferral triggers “dividend‑stopper” provisions that can restrict dividend and interest payments until the company has sufficient cash proceeds from the sale of replacement securities—effectively tying repayment to liquidity and capital tests. In contrast, AIG’s AIGLH junior‑subordinated debentures are standard, fixed‑rate debt due on specific dates and guaranteed by AIG Parent, with no disclosed deferral rights or liquidity‑constraint covenants; the company simply meets the scheduled interest and principal payments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in qualitative detail. (1) Quantitatively, all numbers and dates from the original answer—such as the $54M 8.5% debentures due 2030, $142M 8.125% due 2046, and $31M 7.57% due 2045—are not explicitly mentioned in the LLM response. However, the LLM correctly characterizes these as fixed-rate debt with specific maturities and AIG Parent guarantees, preserving semantic accuracy without listing exact figures. Since the question does not explicitly demand numerical disclosure and the LLM captures the essence of AIG's obligations, this omission does not severely impact correctness. (2) The LLM accurately describes MetLife’s deferral provisions and correctly links deferral to dividend stoppers and replacement capital requirements, reflecting the multi-hop synthesis between deferral, liquidity constraints, and capital covenants. (3) The contrast in liquidity risk profiles is reasonably conveyed: MetLife’s repayment is conditional on capital-raising and deferral mechanisms, while AIG’s obligations are more rigid but backed by parent guarantees. However, the LLM omits the key point that AIG does *not* guarantee AIGLH borrowings post-distribution, which affects the interpretation of AIG’s actual liquidity risk and is a meaningful nuance in the comparison. This weakens the qualitative accuracy slightly. (4) Despite this, the reasoning is sound, entities are correctly identified (MetLife, AIG, AIGLH), and the response directly addresses both deferral provisions and liquidity constraints as required. Wording differs but meaning is semantically equivalent in most aspects. Hence, high scores across the board with a small deduction in qualitative accuracy for missing the post-distribution guarantee detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 490,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA competes with Samsung in both SoC and GPU markets—both companies supply automotive, gaming and AI‑heavy SoCs and GPUs (NVDA 2022, p. 13).  \nBecause of this rivalry, Intel must scale its IFS Foundry Services to win customers such as NVIDIA and Samsung, yet its own historical delays in 10 nm and Intel 4 nodes and the fact that competitors like TSMC and Samsung already offer advanced process nodes make it hard to deliver high‑performance, high‑yield chips on time (INTC 2022, pp. 53‑56).  \nConsequently, Intel faces significant challenges in accelerating IFS capacity, achieving reliable yields, and meeting time‑to‑market demands while competing against Samsung’s established foundry relationships and NVIDIA’s demand for cutting‑edge SoC/GPU solutions (INTC 2022, pp. 55‑56).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets (supported by NVDA 2022), Intel's IFS competes with Samsung and TSMC, and Intel's historical delays in 10nm and Intel 4 (formerly 7nm) are accurately cited (INTC 2022). These delays have indeed impacted Intel’s competitiveness and foundry scaling, as stated. (2) There are no numeric inaccuracies—no specific dollar amounts, percentages, or dates were misstated. The references to process nodes (10nm, Intel 4) are correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the answer correctly links NVIDIA’s competition with Samsung to Intel’s challenge in scaling IFS, recognizing that Samsung is both a product competitor and a foundry rival. It also acknowledges that Intel must attract customers like NVIDIA while overcoming its own manufacturing credibility issues. The only minor gap is that the indirect pressure from NVIDIA on Samsung (i.e., Samsung being stretched across product and foundry roles) is implied but not explicitly framed as a strategic opportunity or dynamic that could benefit Intel—this nuance is present in the original answer but slightly underdeveloped in the LLM version. (4) The answer is contextually excellent, directly addressing the strategic challenges Intel faces due to manufacturing delays and competitive pressures in the foundry market. Wording differs but semantic meaning is equivalent. Overall, this is a strong, factually correct response with only a slight shortfall in fully articulating the indirect strategic ripple effects mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 460,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s Class B shares carry 10 votes per share, so its 2024 repurchase program focused on the lower‑voting Class A and non‑voting Class C shares (totaling $62 billion) to avoid diluting insider control【page_82】. Comcast’s Class B shares carry 15 votes per share and are held by a single individual (Mr. Roberts), so its public repurchase program targets Class A shares ($8.64 billion) while Class B repurchases are limited to employee‑plan transactions【page_31】【page_68】. Thus, the higher voting weight of Class B shares at both firms leads them to avoid or restrict repurchases of those shares to preserve their control structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, which are lower- or non-voting shares, preserving the voting power of Class B holders who have 10 votes per share. The LLM correctly notes that Class B shares convert to Class A upon sale, though this detail is omitted in the LLM answer, it does not detract significantly from correctness. (2) Quantitative accuracy is perfect: $62 billion for Alphabet is correctly cited; while the ground truth does not specify Comcast's repurchase amount, the LLM adds $8.64 billion for Comcast Class A repurchases — this figure is accurate per external knowledge and filing data, and its inclusion enhances completeness without introducing error. (3) Entity accuracy is strong: both Alphabet and Comcast are correctly identified, along with correct voting rights (10 votes for Alphabet Class B, 15 for Comcast Class B), and Brian L. Roberts is correctly identified as the sole holder of Comcast’s Class B shares. (4) Reasoning is sound: the LLM correctly infers that avoiding repurchases of high-vote Class B shares preserves insider control at both firms, and notes Comcast’s restriction of Class B repurchases to employee-plan transactions, which is consistent with filings. The only minor omission is that the ground truth mentions the automatic conversion of Alphabet Class B to Class A upon sale as a mechanism preserving balance, which the LLM does not mention — a slight gap in qualitative depth. However, the core multi-hop reasoning — linking voting structure to repurchase strategy across both companies — is logically sound and well-synthesized. Semantic equivalence is maintained, and the answer effectively addresses the impact of voting rights on repurchase strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 500,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s NSCLC pipeline is built around oral, mutation‑specific small‑molecule inhibitors—Krazati (KRAS G12C) and Augtyro (ROS1‑positive)【page_5】—so its expansion is limited to patients with those genetic alterations. In contrast, Bristol‑Myers Squibb’s newly approved Opdivo Qvantig is a subcutaneous formulation of nivolumab with hyaluronidase that can be given for most previously approved adult solid‑tumor Opdivo indications, including maintenance and combination regimens【page_4】【page_44】, offering a broader market reach across multiple solid‑tumor sites. Thus, Amgen’s focus delivers targeted oral therapy for specific NSCLC mutations, while BMS’s SC product expands the reach of its immunotherapy platform to a wider array of adult solid‑tumor indications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amgen's focus on NSCLC via targeted oral therapies (Krazati and Augtyro) for specific mutations (KRAS G12C and ROS1-positive) is accurately described, and BMS's FDA approval of Opdivo Qvantig for subcutaneous administration across most adult solid tumor indications is correctly reported. The administration method (subcutaneous vs. oral), scope of indications (broad vs. mutation-limited), and strategic implications (market expansion via delivery convenience) are all correctly conveyed. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth; while the original answer specifies 'December 2024' for the FDA approval, the LLM's omission of the exact date is not a material error given that the approval timing is implied as recent. (3) Multi-hop reasoning is sound: the model correctly synthesizes Amgen’s NSCLC strategy from its drug pipeline and contrasts it with BMS’s broader delivery-based market expansion using Opdivo Qvantig. (4) The LLM adds specific drug names and mechanisms (e.g., 'hyaluronidase') not in the original answer, enhancing precision without introducing error. The only minor shortcoming is slightly less emphasis on patient adherence and market access compared to the original, but the core contrast in strategic approaches is preserved. Thus, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 419,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter guarantees that holders of Class B shares own 33 ⅓ % of the company’s voting power, a percentage that “is generally non‑dilutable” and cannot be reduced by issuing any other class of stock【page_91】. Each Class B share carries 15 votes, and although the shares can convert share‑for‑share into Class A shares, the conversion does not change the 33 ⅓ % voting bloc【page_91】. As a result, even though Google holds a sizable stake in Class A common stock, the fixed voting power of the Class B shares limits Google’s influence over votes and board decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 33 1/3% non-dilutable voting power is accurately stated, and the structural protection is correctly described. The mention of Class B shares converting on a share-for-share basis into Class A is consistent with the original answer. (2) The LLM correctly identifies that the voting power of Class B shares remains fixed even upon conversion, which is central to limiting GOOGL's influence. (3) The reasoning is sound: it correctly synthesizes the impact of CMCSA's capital structure on GOOGL’s ability to influence governance, despite its Class A stake. (4) One minor omission: the original answer specifies that the non-dilutable protection persists *even if all Class B shares convert*, which reinforces the structural entrenchment—this nuance is implied but not explicitly stated in the LLM response. Also, the LLM mentions '15 votes per Class B share'—while this may be factually correct from the source (page 91), it was not in the ground truth and isn't necessary for answering the question about influence limitation via structural protection. However, since it doesn't contradict and adds context, it doesn't reduce accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning between CMCSA's share structure and GOOGL’s constrained influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 395,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco market volume (PM 10‑K, p. 57) is counter‑balanced by a higher prevalence of illicit trade.  For PEP, the merger with Pioneer Foods obliges the company to spend roughly 8.8 billion rand (≈$0.5 billion) on socioeconomic programs in South Africa—an SG&A expense recorded in the 2020 acquisition (PEP 10‑K, pp. 113‑115).  For Altria (MO), the same elevated illicit‑trade environment in South Africa increases its international illicit‑trade risk, raising the potential for enforcement costs, revenue loss and reputational damage in its global operations (MO 10‑K, pp. 40‑42).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 13.2% market volume increase and links it to illicit trade prevalence, and correctly associates PEP's socioeconomic obligations with merger-related charges and MO's exposure to illicit trade risks. However, it introduces specific figures not present in the original answer—namely, the '8.8 billion rand (≈$0.5 billion)' spending commitment and its characterization as an SG&A expense from the 2020 acquisition. While these details may be factually accurate in context, they are not part of the ground truth provided, making the answer partially over-specified and introducing unverified quantitative claims. (2) The 13.2% figure is correctly stated, but the $0.5 billion / 8.8 billion rand figure is not mentioned in the original answer and cannot be verified against it; thus, this represents a quantitative addition rather than a correct reflection of the ground truth. No calculation errors are present, but the inclusion of unsupported specifics reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly links South Africa's market dynamics to PEP’s merger obligations and MO’s risk exposure, synthesizing across entities and causal chains. The logic connecting market growth and illicit trade to company-specific impacts is valid and aligns with the original answer’s structure. (4) The answer is contextually relevant and captures the core causal relationships. However, the added numerical detail not present in the ground truth prevents a higher correctness score, as the evaluation prioritizes fidelity to the original verified answer. The mention of Altria (MO) is acceptable since MO refers to Altria Group, but the original uses 'MO' consistently. Overall, the answer is factually plausible and well-reasoned but includes unverified quantitative details not in the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 518,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑law class actions, which began in 2019, have moved through the courts to a Ninth Circuit order to dismiss the complaint with prejudice (Feb 2025)【page_91】, and no settlement amount has been disclosed, implying limited financial exposure. In contrast, Meta’s privacy‑related litigation has already produced multi‑billion‑dollar penalties and settlements—$5 billion to the FTC, a $725 million consumer‑class settlement, and a €1.2 billion fine from the Irish Data Protection Commission【page_112】【page_114】—with additional accruals for ongoing inquiries, indicating a substantially higher potential liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's IPO-related securities litigation was dismissed with prejudice by the Ninth Circuit in February 2025, ending significant legal exposure without a disclosed settlement, which matches the original answer's claim of dismissal after a 2020 partial denial of a motion to dismiss. The procedural timeline is condensed but not inaccurately represented. (2) Quantitative accuracy is excellent: the $5 billion FTC penalty (2020), $725 million consumer class action settlement (approved in 2023), and €1.2 billion Irish DPC fine are all correctly cited with accurate amounts and sources. The LLM adds the €1.2 billion fine not mentioned in the original answer, but this is factually correct and enhances completeness without introducing error. (3) Multi-hop reasoning is sound—correctly contrasting Slack’s ultimately dismissed litigation with Meta’s substantial, realized financial liabilities and ongoing exposure. The conclusion that Meta faces significantly higher liability is logically supported. (4) Minor deduction in qualitative accuracy because the LLM omits the detail about the 2020 partial denial of the motion to dismiss in Slack’s case, which is part of the procedural history. However, this does not undermine the overall correctness of the outcome. Semantic equivalence is maintained, and the answer fully addresses both procedural outcomes and financial liabilities as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 415,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PM’s RSU awards vest on the third anniversary of the grant date, and the company has $160 million of unrecognized RSU compensation that will be expensed over a weighted‑average period of roughly 17 months (page 110).  Walmart’s RSU schedule was changed from 25 % vesting each year over four years to 8 % vesting each quarter over three years (page 66), shortening the vesting horizon and therefore the period over which related compensation costs are recognized compared with the prior annual schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: PM has $160 million in unrecognized RSU costs to be recognized over a weighted-average period of 17 months, with vesting typically on the third anniversary. It accurately states WMT's shift from 25% annual vesting over four years to 8% quarterly vesting over three years. These numbers and percentages match the ground truth exactly. (2) Quantitative accuracy is high: all dollar amounts ($160 million), percentages (25%, 8%), time periods (three years, 17 months), and frequencies (quarterly vs annual) are correct. The only minor omission is that the original answer specifies the 17-month weighted average is due to the cliff-vesting structure and event-based vesting (e.g., death, disability, age 58), which the LLM does not mention. (3) The multi-hop reasoning is mostly sound: the LLM correctly infers that WMT’s change shortens the vesting horizon and accelerates cost recognition compared to its prior schedule. However, it does not fully contrast PM’s back-loaded, cliff-vesting model with WMT’s more evenly distributed quarterly vesting, which is central to the question about how the *difference* in timelines affects cost recognition. The LLM focuses on WMT’s change versus its own past, not versus PM’s current structure. (4) Despite missing some qualitative nuance in the comparison, the core facts and quantitative data are accurate, and the answer remains highly relevant to the question. The omission of PM’s event-based vesting conditions and the lack of explicit back-loaded vs. front-loaded cost recognition comparison prevent a top score, but the answer is substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 455,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing projects that unrecognized tax benefits could be reduced by up to **$620 million** in the next 12 months as a result of ongoing audits (Boeing 10‑K, p. 75).  Lockheed Martin, however, notes that the OECD’s Pillar 2 global minimum‑tax framework—though being adopted at different dates in various jurisdictions—**is not expected to materially affect its effective tax rate or consolidated results** (Lockheed Martin 10‑K, p. 35).  In short, Boeing faces a sizable, specific tax‑position risk, whereas Lockheed Martin anticipates a negligible impact from Pillar 2.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $620 million unrecognized tax benefit risk at Boeing is correctly reported, and the statement that Lockheed Martin does not expect a material impact from Pillar 2 is factually consistent with the original answer. No calculations were required, and all numbers are presented accurately. (2) The LLM correctly identifies both companies and their respective tax risk assessments, citing appropriate filings (Boeing 10-K p.75, Lockheed Martin 10-K p.35), which supports entity and source accuracy. (3) The multi-hop reasoning is sound: it contrasts Boeing’s specific near-term tax exposure with Lockheed Martin’s forward-looking assessment of Pillar 2 under the OECD framework, despite differing national implementation timelines. (4) The only minor shortcoming is that the LLM omits Boeing’s rationale for expecting minimal Pillar 2 impact (lack of material operations in low-tax jurisdictions) and does not reference the broader context about General Electric illustrating regulatory complexity. While these omissions reduce completeness slightly, they do not undermine the core factual correctness or the valid comparison drawn. The answer remains semantically equivalent in its key claims and is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 366,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "PepsiCo will recast its historical segment reporting to match the new structure effective Q1 2025 and, under ASU 2023‑07, will provide expanded footnote disclosures (e.g., in Note 17) and interim segment information—including disaggregated expense data—in its condensed financial statements beginning that quarter. Altria adopted ASU 2023‑07 for its 2024 year‑end and will likewise provide expanded footnote disclosures and interim segment reporting from Q1 2025, aligning its timeline and disclosure requirements with PepsiCo’s implementation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PepsiCo’s recasting of historical segment reporting starting Q1 2025, alignment with ASU No. 2023-07, requirement for disaggregated expense disclosures, and Altria’s adoption in 2024 with interim reporting from Q1 2025. The mention of 'Note 17' aligns with Altria’s actual disclosure location in the ground truth. (2) Quantitative elements—dates (Q1 2025, 2024 adoption), timeframes, and reporting requirements—are factually accurate with no calculation errors. Format variations (e.g., 'ASU 2023-07') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes PepsiCo’s segment reorganization with the new accounting standard and aligns it with Altria’s timeline, showing cross-company and cross-temporal understanding. (4) Minor omission: the LLM does not explicitly name the new segments (e.g., PepsiCo Foods North America, Latin America Foods, EMEA, etc.) as detailed in the original answer, which slightly reduces completeness in qualitative detail. However, the omission does not affect the core correctness regarding reporting impact and alignment with ASU 2023-07. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 361,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s MK‑7962 compound patents are set to expire in 2027 (Merck 10‑K, p. 16), while its method patents could last until 2037 and may receive up to five years of patent‑term extension (PTE) (p. 16).  Pfizer’s biologics strategy, by contrast, relies on a built‑in 12‑year data‑exclusivity period and routinely seeks PTEs and supplementary protection certificates (SPCs) that can add up to five years, giving its biologics a longer overall exclusivity horizon than Merck’s compound‑patent term (Pfizer 10‑K, p. 14‑15).  Both companies therefore use extensions to extend market protection, but Pfizer’s biologics typically enjoy a longer baseline exclusivity period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the nature of Merck's patent extension. The LLM states that method patents 'could last until 2037 and may receive up to five years of patent-term extension (PTE)', implying that the 2037 date is contingent on a 5-year PTE. However, the ground truth indicates that the 2037 date is the potential result *if* PTEs are granted—likely meaning that the base patent plus maximum extension reaches 2037, not that an additional 5 years could be added on top of 2037. This misrepresents the timeline logic slightly. Quantitatively, all dates (2027, 2037) and exclusivity periods (12-year data exclusivity, 5-year extensions) are accurate and correctly attributed. The comparison to Pfizer’s strategy is sound: both companies use PTEs and SPCs, and Pfizer’s 12-year biologic exclusivity under the BPCIA is correctly noted. The LLM correctly synthesizes multi-hop information across Merck and Pfizer 10-Ks, identifying patent strategies for biologics and lifecycle management. It adds contextual value by referencing data exclusivity, which enriches the comparison even if not explicitly in the original answer. The core facts—Merck’s 2027 base expiration, potential extension to 2037, Pfizer’s use of PTEs/SPCs—are all correct. Only the reasoning around how the 2037 date is achieved is slightly off, which prevents a top score. Semantic equivalence is strong, and the answer fully addresses the question’s comparative and multi-part nature.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 422,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin’s fixed‑price contracts are highly inflation‑sensitive and technically complex; when the estimated total cost to complete a contract exceeds the contract price, the company records a “reach‑forward” loss that reduces its operating profit and net income (LMT 10‑K, pp. 64‑65). For GE, cost overruns under fixed‑price contracts raise the risk of penalties, liquidated damages and unanticipated expenses, which can delay project delivery, erode cash flows and impair operating margins (GE 10‑K, pp. 32‑34).",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial and operational impacts of cost overruns on fixed-price contracts for both Lockheed Martin and GE, aligning with the core reasoning in the ground truth. It accurately describes 'reach-forward' losses for Lockheed Martin and links them to reduced profitability, citing the correct document (LMT 10-K). For GE, it correctly notes penalties, delays, and margin erosion due to cost overruns, citing GE’s 10-K. However, it omits specific quantitative data present in the original answer—namely, the $270 million and $280 million reach-forward losses reported by Lockheed Martin as of December 31, 2023. These figures are critical for full factual completeness and were explicitly stated in the ground truth. (2) The absence of these dollar amounts and the specific date (December 31, 2023) results in a significant drop in quantitative accuracy. While no incorrect numbers are stated, the failure to include key figures from the source reduces precision. The LLM also does not mention RTX’s commentary on inflation’s impact, which supports the multi-hop aspect involving industry-wide sensitivity. (3) The reasoning is logically sound and reflects proper synthesis of how fixed-price contracts expose firms to financial and operational risks under inflation and complexity. However, the multi-hop element is weakened by not connecting Lockheed’s experience to broader industry trends via RTX or specifying GE’s exposure in Power and Renewable Energy segments and consortium liabilities. (4) Despite missing key numbers and some contextual depth, the LLM answer remains semantically aligned in structure and intent, addressing both companies’ risks accurately at a conceptual level, hence high scores in qualitative accuracy and contextual relevance. The correctness score is 7 due to accurate reasoning but significant omission of key financial figures required for full factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 525,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ uses exchange‑traded commodity futures and options (Level 1 instruments) to hedge raw‑material price risk, with fair value set by quoted market prices on commodity exchanges (page_112) and significant derivative exposure to commodity contracts (page_111). In contrast, COST’s 10‑K does not disclose any Level 1 financial liabilities; its debt is measured at fair value using Level 2 inputs (page_52) and no derivative instrument exposure is reported for Level 1 liabilities (page_51). Thus, MDLZ’s disclosure shows explicit Level 1 fair‑value measurement and active commodity‑derivative exposure, whereas COST’s Level 1 liabilities are not presented and its derivative exposure is not disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MDLZ uses Level 1 commodity futures (exchange-traded) for hedging raw material price risk, with fair value based on quoted market prices, which aligns with the ground truth. It accurately contrasts this with COST's lack of disclosed Level 1 financial liabilities as of the relevant period, noting that COST uses Level 2 inputs for debt valuation and reports no Level 1 derivative exposure. The core factual elements—MDLZ’s use of Level 1 derivatives for commodities and COST’s absence of Level 1 liabilities—are correct. (2) There are no numeric values, dates, or calculations in the question or answer that conflict with the ground truth; the LLM does not fabricate figures and accurately reflects disclosures. The mention of page numbers (e.g., page_112, page_51) suggests proper grounding in source documents, though these are not evaluated for correctness here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), compares their derivative instruments, and links fair value hierarchy levels (Level 1 vs Level 2) to their respective disclosures. The conclusion about differing strategies in derivative usage and fair value exposure is logically supported. (4) The only minor shortcoming is that the LLM answer does not explicitly state COST’s fiscal date (August 28, 2022) as in the ground truth, and slightly underemphasizes that COST holds *no Level 1 or Level 3* liabilities—though it correctly notes no Level 1 liabilities. This omission is minor and does not affect the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 479,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS has 4.6 billion Class A shares that are fully convertible into Class B shares.  \nLockheed Martin’s nonqualified pension trust held $658 million in assets as of December 31 2024.  \nThus the number of convertible shares far exceeds the trust’s asset value in magnitude.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 4.6 billion UPS Class A shares and $658 million in Lockheed Martin's nonqualified pension trust assets as of December 31, 2024, are correctly reported. Format variations (e.g., '4.6 billion' vs '4.6 billion') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the number of convertible shares and the comparison to the pension trust assets. (3) Entity accuracy is perfect: UPS and Lockheed Martin are correctly identified, along with the correct financial instruments (Class A to Class B convertible shares, nonqualified pension trust). The date (December 31, 2024) is correctly referenced. (4) The reasoning is sound and appropriately synthesizes information across two unrelated companies and filings (multi-hop reasoning). The concluding comparison—'the number of convertible shares far exceeds the trust’s asset value in magnitude'—is logically valid and contextually appropriate, even though it's a qualitative comparison of a share count to a dollar amount, which the model correctly interprets as a magnitude comparison. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 355,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are materially sensitive to interest‑rate moves – a 50‑basis‑point change in market rates would shift their fair value by about $1.7 billion (2024) and $1.4 billion (2023). Cisco, by contrast, has used a $0.5 billion fair‑value interest‑rate swap that converts the fixed rate to SOFR; the swap’s fair‑value gain/loss offsets the debt’s fair‑value change, effectively neutralizing the exposure. Thus, while AVGO’s exposure remains significant and is hedged only for future issuances via treasury rate locks, Cisco actively hedges its current fixed‑rate debt, eliminating the fair‑value sensitivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AVGO's $1.7 billion fair value sensitivity to a 50 bps rate change as of 2024, matching the ground truth. However, it introduces an additional figure of $1.4 billion for 2023, which is not present in the original answer and may be factually accurate but was not part of the provided ground truth, thus introducing unverified information. CSCO's $0.5 billion notional swap and its purpose (converting fixed to floating SOFR-based payments to offset fair value changes) are accurately described. (2) The core numbers ($1.7B for AVGO, $0.5B for CSCO swap) are correct and properly contextualized. The inclusion of the $1.4B 2023 figure, while potentially accurate, is extraneous and not supported by the ground truth, reducing quantitative precision. (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s lack of active hedging on its large fixed-rate debt ($56.3B implied exposure) with CSCO’s targeted use of swaps to neutralize fair value risk. The conclusion that CSCO actively hedges while AVGO does not (except for future issuances via treasury locks) aligns with and extends the ground truth reasonably. (4) The answer is highly relevant, directly addressing the comparison of sensitivity and hedging strategies. The slight overreach in adding the 2023 AVGO figure prevents a top score in quantitative accuracy, but the qualitative reasoning and contextual relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 402,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model applies the parametric delta‑gamma approximation only to interest‑rate and foreign‑currency exposures, estimating a one‑day loss under normal market conditions with a 95 % confidence interval and a one‑day holding period (PM page 77).  \nMDLZ extends the same technique to interest rates, currencies **and commodity prices**, producing separate fixed‑income, currency and commodity VAR figures (MDLZ page 66 and 77).  \nThus, MDLZ’s model is broader, incorporating commodity risk that PM’s model does not.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key distinction between PM and MDLZ in their use of the parametric delta-gamma approximation technique within VAR models. Quantitatively, there are no errors: the confidence level (95%) and holding period (one-day) are accurately reported, and the inclusion of interest rates, currencies, and commodities for MDLZ versus only interest rates and currencies for PM is factually correct. The reference to separate VAR figures for fixed-income, currency, and commodity risks in MDLZ aligns with the ground truth. However, the LLM omits a key qualitative detail present in the original answer: both companies observe rate movements over the prior quarter for year-end VAR and across the four preceding quarters for average/high/low VAR, and MDLZ explicitly accounts for the non-linear behavior of currency and commodity options. This missing context about the time periods used and the non-linear treatment of options reduces completeness and reasoning depth, though the core comparative insight (commodity inclusion) is correct. The answer is semantically aligned and highly relevant, but lacks full multi-hop synthesis of methodological nuances. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 370,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic stresses that “patients around the world deserve access to our life‑saving products” and is using its global presence and scale to expand adoption of its therapies (Medtronic 10‑K, p. 6).  By contrast, Amgen is grappling with payer‑driven price pressure—especially from Express Scripts’ rebate‑management arm—which forces deeper discounts and can limit patient access to Repatha by raising out‑of‑pocket costs and triggering formulary restrictions (Amgen 10‑K, pp. 37‑38).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Medtronic's proactive strategy to expand global patient access and Amgen's challenges with payer-driven affordability pressures, particularly from Express Scripts. (1) All factual elements are correct: Medtronic’s emphasis on global access via its presence and scale is properly attributed to its 10-K (p. 6), and Amgen’s struggles with rebate-driven discounts, formulary restrictions, and out-of-pocket costs tied to Express Scripts’ rebate management are accurately cited from Amgen’s 10-K (pp. 37–38). (2) There are no numeric values (e.g., percentages, dollar amounts, prescription share) in the LLM answer, but it does not introduce any incorrect numbers. The ground truth mentions that the top six PBMs control 94% of U.S. pharmacy prescriptions and notes Medicare patient abandonment due to co-pays—details omitted in the LLM response. However, these are contextual enhancements rather than central facts required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes Medtronic’s global access strategy with Amgen’s U.S.-focused payer challenges, linking Express Scripts’ rebate practices to reduced patient access despite lower list prices. (4) The LLM answer is semantically equivalent to the original in its key claims and is contextually fully relevant. The only minor shortcoming is the omission of the broader structural context (e.g., 94% market control by top PBMs, Medicare patient abandonment), which slightly reduces completeness but does not impair the core accuracy. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 470,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program focuses on Class A and Class C shares, while Class B shares—each with ten votes—are not targeted. Because Class B shares automatically convert to Class A upon sale or transfer, the program effectively reduces the number of voting shares that could be created through conversion, helping the board and major shareholders maintain control. With Class A shares publicly traded on the Nasdaq (ticker GOOGL), the buy‑back also shrinks the pool of publicly held voting stock, potentially consolidating voting power among the remaining shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer omits all quantitative details from the original answer, including the $62.2 billion repurchased in 2023 and the $36.3 billion remaining authorization as of December 31, 2023. These specific figures are critical for factual completeness and are entirely missing, which significantly undermines quantitative accuracy. (2) While the LLM correctly identifies that Alphabet’s repurchases focus on Class A and Class C shares and avoids Class B shares (which carry 10 votes), it fails to mention that Class B can be converted to Class A at the holder's option or automatically upon sale—this nuance is present in the ground truth and important for understanding control dynamics. (3) The LLM incorrectly states that Class A shares are publicly traded on Nasdaq under GOOGL as if this were unique to Alphabet, but the original answer highlights that Class A shares are *also* publicly traded by Comcast Corporation (CMCSA), implying a broader structural use of Class A shares across firms. This multi-hop connection between Alphabet and Comcast regarding shared share class terminology is completely missed, weakening the reasoning about governance standards. (4) Despite these omissions and inaccuracies, the LLM captures the core qualitative logic: avoiding repurchases of Class B preserves voting control, and buying back Class A reduces public voting power. The reasoning about maintaining control through selective repurchases is sound and contextually relevant, earning moderate scores in qualitative accuracy and high marks for relevance. However, the lack of numbers and failure to identify the Comcast comparison result in a correctness score of 6—partially correct but with significant gaps in factual and multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 478,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s formulary restrictions—illustrated by the step‑therapy, prior‑authorization and high‑copay hurdles that curtailed Repatha uptake (see Gilead 10‑K pages 37, 26, 8, 5, 6, 7)—can similarly limit patient access to Lilly’s high‑cost biologics.  Lilly’s 10‑K risk factors emphasize that its revenue growth is “dependent on coverage and reimbursement from government and commercial third‑party payers” and that payer restrictions can reduce prescription volumes (see Lilly 10‑K pages 24, 26, 27).  Consequently, tighter formulary controls could blunt Lilly’s ability to sustain revenue growth for its biologic portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UnitedHealth Group's formulary restrictions (e.g., prior authorization, step therapy, high copays) limiting access to high-cost biologics like Repatha are accurately described. Eli Lilly’s dependence on payer coverage and reimbursement for revenue growth is correctly cited from its 10-K, with accurate references to risk factors affecting prescription volumes. (2) There are no numeric values, dates, or percentages in either answer requiring verification—both are qualitative—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly links UnitedHealth’s payer power (implied by its market position) to Repatha access challenges, then generalizes this precedent to Eli Lilly’s biologics, citing Lilly’s own disclosures about payer restrictions impacting revenue. The only minor shortcoming is that the LLM does not explicitly mention the 'concentration of payer power' or the '94% market control' by the top six PBMs, which strengthens the argument in the original answer. However, this omission does not undermine the core logic or factual correctness. (4) Contextual relevance is excellent—the response directly addresses how formulary restrictions demonstrated by Repatha’s case could impact Eli Lilly’s revenue growth, synthesizing cross-company insights from payer dynamics. Wording differs but meaning is preserved. Thus, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 434,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3.0 billion commercial‑paper program is a short‑term debt facility that it can issue for general corporate purposes; as of year‑end it had no outstanding notes (Oracle, 2022 Note “Commercial Paper Program and Commercial Paper Notes” p. 90).  In contrast, Cisco’s $9.0 billion in senior fixed‑rate notes is a long‑term debt instrument that can be redeemed at any time subject to a make‑whole premium and is part of a broader short‑term debt‑financing structure (Cisco, 2022 Note “Senior Fixed‑Rate Notes” p. 90).  Thus, while both companies rely on short‑term debt mechanisms—Oracle through commercial paper and Cisco through a short‑term debt program that includes the senior notes—they differ in maturity profile and redemption terms.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative accuracy: the $3.0 billion commercial paper program for Oracle and $9.0 billion senior fixed-rate notes for Cisco are accurately reported, and the dates (year-end 2022) align with the ground truth (Oracle: May 31, 2022; Cisco: July 30, 2022), which are both within the same fiscal year context. The statement that Oracle had no outstanding commercial paper is factually correct and matches the ground truth. However, the LLM mischaracterizes Cisco’s $9.0 billion senior fixed-rate notes as part of a 'short-term debt-financing structure,' which is inaccurate—these are long-term debt instruments, even if they are included in a broader financing framework. The ground truth emphasizes that Cisco’s commercial paper program (not the senior notes themselves) would rank at par with any future short-term notes, but the LLM conflates the two. Additionally, the LLM omits a key point from the original answer: Cisco uses interest rate swaps to convert fixed rates on $1.5 billion of the notes to floating rates based on LIBOR, which is a critical aspect of its risk management strategy and a key differentiator in the comparison. This omission affects completeness and qualitative accuracy, particularly in multi-hop reasoning—while the model identifies differing maturity profiles, it fails to fully synthesize the contrast between Oracle’s flexible short-term facility and Cisco’s structured long-term debt with active hedging. The reasoning is sound in broad strokes but lacks depth in financial nuance. Contextual relevance is high, as the response directly addresses the comparison of debt mechanisms. Overall, core facts and numbers are correct, but missing key qualitative details and a minor misclassification of debt type justify a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 491,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "FedEx notes that ASU 2022‑06’s optional relief for LIBOR‑based contracts can be applied through December 31, 2024, allowing the company to keep using the expedient and avoid the operational and financial impact of modifying LIBOR contracts (FedEx Note 93). Caterpillar’s 10‑K discusses interest‑rate hedging and match‑funding (Notes 73‑75) but makes no reference to LIBOR or ASU 2022‑06, indicating that the extension does not alter its LIBOR‑related risk‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding Caterpillar. The date 'December 31, 2024' is correctly stated, satisfying quantitative accuracy. However, the LLM claims Caterpillar's 10-K 'makes no reference to LIBOR or ASU 2022-06', which contradicts the ground truth stating that Caterpillar actively uses interest rate contracts and benefits from the extended relief under ASU 2022-06. This misrepresents Caterpillar's position and undermines the multi-hop synthesis required. While FedEx's portion is accurate and well-supported (citing Note 93), the failure to recognize Caterpillar's engagement with LIBOR transition and ASU 2022-06 leads to an incorrect conclusion about its risk-management strategy. The reasoning is sound where information is available but flawed due to omission of key facts. The answer is contextually relevant and addresses the core question about impact on both companies, but the error in entity-specific disclosure severely limits its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 292,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the administrative agent, JPMorgan Chase Bank, N.A. as the syndication agent, and both banks as joint lead arrangers and book managers; the agreement was amended in August 2022 (Amendment No. 1) and a new Five‑Year Credit Agreement was entered into in August 2023 【page_126】【page_125】.  \nIn contrast, Caterpillar’s multi‑facility credit agreements list Citibank, N.A. only as the agent (with Citibank Europe PLC as local‑currency agent) and do not name a separate syndication agent; the 2023 364‑Day Facility received a local‑currency addendum in 2023 but had no amendment in 2022 【page_128】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Citibank, N.A. as administrative agent for Boeing and agent for Caterpillar, and notes JPMorgan Chase Bank, N.A. as syndication agent for Boeing. It also correctly references the August 2022 amendment to Boeing’s agreement. However, it introduces a factual error by stating that a 'new Five-Year Credit Agreement was entered into in August 2023', which is not supported by the ground truth; the original agreement was amended in 2022 but there is no mention of a new agreement in 2023. For Caterpillar, the LLM correctly notes Citibank Europe plc’s role in local currency management but incorrectly implies that MUFG Bank, Ltd. is absent from the agent structure — the ground truth includes MUFG Bank, Ltd. as a participant in local currency management, which the LLM omits. Additionally, the LLM claims Caterpillar’s 2023 364-Day Facility had a 'local-currency addendum' in 2023 but 'no amendment in 2022', which partially aligns with the ground truth but adds specificity (e.g., '364-Day Facility') not confirmed in the original answer and potentially overinterpreting the data. (2) Quantitative accuracy is partially compromised: while dates like August 2022 are correct, the claim of a new Boeing agreement in August 2023 is unsupported and constitutes a significant factual deviation. The absence of dollar amounts or numerical metrics in both answers avoids numerical errors but does not compensate for incorrect event reporting. (3) Multi-hop reasoning is partially sound — the model attempts to compare syndication structures and amendment activity across both firms and years. However, it fails to fully capture Caterpillar’s more complex international syndication structure involving multiple banks, and incorrectly suggests Boeing replaced its agreement in 2023 rather than amending the existing one. The comparison thus lacks balance and introduces inaccuracies. (4) Despite these issues, the answer remains contextually relevant, addressing syndication roles, amendment timelines, and structural differences. The core entities and some key facts are correct, warranting a moderate score. However, due to the introduction of unsupported events (new 2023 Boeing agreement) and omission of key participants (MUFG), the correctness score is limited to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 617,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "META’s dual‑class structure gives its Class B holders ten votes per share versus one for Class A, and the founder, CEO and board chair collectively hold a majority of the voting power, a concentration that the company acknowledges can limit other shareholders’ influence (META 2023 10‑K, p. 49).  Comcast’s scheme also concentrates voting power—Class B shares carry 15 votes and represent 33 ⅓ % of the total voting power (CMCSA 2023 10‑K, p. 91)—but includes a share‑for‑share conversion of Class B into Class A, a mechanism that can dilute that concentration over time and may therefore enhance investor confidence relative to META’s more rigid dual‑class arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between META and CMCSA's dual-class structures with accurate qualitative reasoning. It correctly identifies that META's Class B shares have superior voting rights (10 votes vs 1), though the ground truth does not specify the exact vote ratio—this detail is accurate per public filings but not present in the original answer, so its inclusion is a minor over-precision not contradicted by the truth. The LLM correctly notes CMCSA's Class B shares represent 33⅓% of voting power and are convertible share-for-share into Class A, aligning with the ground truth. However, the LLM states CMCSA Class B shares carry '15 votes' each, which is not confirmed in the original answer or commonly reported data; the ground truth does not specify vote multiples, only voting power percentage. This introduces a potentially incorrect quantitative claim, hurting quantitative accuracy. The LLM also omits the specific number of CMCSA Class B shares outstanding (9,444,375), a detail in the original answer that adds context about scale. Despite this, the core multi-hop reasoning—comparing governance implications and how conversion mechanisms may affect investor confidence—is sound and well-synthesized across both companies. The conclusion that CMCSA's conversion mechanism may enhance investor confidence relative to META’s more entrenched structure is a reasonable inference and adds analytical value. Wording differs but semantic meaning is equivalent on key points. Contextual relevance is excellent, directly addressing the investor confidence angle and structural comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 445,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company’s net sales to equity‑method investees in 2021 were **$14,471 million**.  \nCoca‑Cola FEMSA’s bottling and distribution operations cover **Mexico (central, southeast and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, Rio Grande do Sul, Goiás, Rio de Janeiro), Argentina (Buenos Aires and surrounding areas) and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales figure of $14,471 million in 2021 is accurate and correctly formatted. (2) The regions covered by Coca-Cola FEMSA are completely and correctly listed: Mexico (central, southeast, northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (with all specified states including São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, Rio Grande do Sul, Goiás, Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay. The LLM answer includes all regions and sub-regions without omissions or errors. (3) The multi-hop reasoning is sound—correctly identifying both the financial data from The Coca-Cola Company's 2021 report and the operational footprint of its equity investee Coca-Cola FEMSA. (4) The answer is semantically equivalent to the original, with only minor formatting differences (e.g., use of en dashes, spacing) that do not affect meaning. All entities, metrics, and years are accurate. Therefore, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 311,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology segment revenue fell by roughly $44 million in 2021 (from $1,168 million in 2020 to $1,124 million), and the 9 % drop in Remicade sales (≈ $31 million) accounted for about 70 % of that decline, with Simponi’s 2 % drop contributing the remainder【page_61】. In contrast, AbbVie’s flagship biologic Humira—generating billions in annual sales—faces direct biosimilar competition in Europe (since 2018) and will begin U.S. licensing in 2023, indicating a much larger potential erosion of revenue for a core product【page_13】. Thus, while Merck’s decline is significant within its smaller immunology segment, AbbVie’s exposure to biosimilar pressure on Humira represents a more substantial threat to its overall revenue base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% decline in Remicade sales in 2021 and references biosimilar competition, aligning with the ground truth. However, it introduces specific financial figures not present in the original answer—namely, immunology segment revenue of $1,168M in 2020 and $1,124M in 2021, and a calculated $44M decline—along with attributing $31M of that decline to Remicade. These numbers are not in the ground truth and cannot be verified from the provided information. The original answer states Remicade generated $299M in international sales in 2021 but does not provide total segment revenue or year-over-year changes. Thus, the quantitative claims in the LLM answer, while internally consistent, are factually unsupported. (2) The calculation that a 9% drop in Remicade sales equals ~$31M implies a baseline sales figure of ~$344M in 2020 (since 9% of $344M ≈ $31M), but this conflicts with the implied trajectory from $299M in 2021 after a 9% drop—meaning 2020 sales would have been ~$329M, not $344M. This indicates a calculation inconsistency. Additionally, the 2% drop in Simponi is not mentioned in the ground truth, which only states Simponi is impacted by biosimilar pressures but provides no percentage decline. (3) The multi-hop reasoning is strong: the LLM correctly compares Merck’s exposure via Remicade to AbbVie’s via Humira, noting the broader market impact and timing of biosimilar entry in Europe and upcoming U.S. exposure. It accurately reflects that AbbVie is actively defending Humira through patents and exclusivity, a point implied in the original answer. (4) Despite the unsupported numbers and minor calculation issues, the LLM captures the core comparative insight: Merck’s immunology segment is affected, but AbbVie faces a larger systemic risk due to Humira’s revenue scale. This qualitative synthesis is correct and relevant. Therefore, the answer is partially correct with significant quantitative inaccuracies, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 542,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s Garrett investment, originally secured by indemnification agreements, was recorded as a long‑term receivable. After Garrett’s partial redemptions in late 2021, the receivable was reduced to $423 million, reflecting the net present value of the remaining Series B, Series A and common‑stock holdings. The present value of the unredeemed Series B shares on December 31 2021 was $207 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the present value of the unredeemed Series B shares as of December 31, 2021, was $207 million, whereas the ground truth is $423 million—the full present value of the remaining mandatory redemptions. Additionally, the LLM incorrectly implies that the $423 million receivable includes Series A and common stock, which is not supported by the original answer; the $423 million refers exclusively to the remaining present value of the Series B Preferred Stock redemptions. (2) Quantitative errors are severe: the $207 million figure has no basis in the ground truth, and the $423 million is misattributed to a mix of share classes. The partial redemption amounts are omitted—specifically, the $211 million First Partial Redemption completed on December 28, 2021—undermining the explanation of how the receivable was impacted. (3) The multi-hop reasoning is flawed: while the model recognizes that the investment was tied to indemnification and affected long-term receivables, it fails to correctly trace the redemption events and their financial impact. It incorrectly synthesizes non-existent holdings in Series A and common stock, which were not mentioned in the context. (4) Despite these issues, the answer is contextually relevant—it addresses the right companies (Honeywell, Garrett), time frame (late 2021, December 31, 2021), and general financial mechanism (redemptions affecting receivables). However, the core numerical and entity-specific inaccuracies drastically reduce correctness. The qualitative reasoning is partially sound but built on incorrect data, warranting low scores in quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 470,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "CMCSA’s Class B shares, all held by Brian L. Roberts, carry 15 votes each and represent about 33 % of the company’s combined voting power, giving Roberts a decisive influence. Alphabet’s dual‑class structure gives its Class B shares 10 votes each, but its $70 billion repurchase authorization (with $36.3 billion still available as of Dec 31 2023) applies only to Class A and Class C shares; as those shares are bought back, the relative voting weight of the remaining Class B shares rises, mirroring how CMCSA’s repurchase of the majority Class A shares preserves the dominance of its Class B voting power.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core structures of both CMCSA and GOOGL's dual-class share systems and their relationship to share repurchases. It accurately states that CMCSA's Class B shares (held entirely by Brian L. Roberts) have 15 votes per share and represent about 33% of voting power. For GOOGL, it correctly notes that Class B shares have 10 votes per share and that repurchases are limited to Class A and C shares, which increases the relative voting weight of Class B. However, there is a quantitative inaccuracy: the LLM claims a $70 billion repurchase authorization, while the ground truth specifies $62.2 billion repurchased in 2023 with $36.3 billion remaining. The $70 billion figure appears to be an approximation or rounding, but it misrepresents the actual amount repurchased and conflates total authorization with repurchase activity. (2) The remaining $36.3 billion under authorization is correctly cited, but the repurchase amount itself is off. The ground truth does not state the total authorization size, only repurchase amount and remaining balance, so the $70 billion figure (likely inferred as $62.2B + $36.3B ≈ $98.5B total) is incorrect and misleading. (3) The multi-hop reasoning is strong: the model correctly synthesizes that repurchasing low-vote shares (CMCSA Class A, GOOGL Class A/C) preserves or enhances the relative control of insiders holding high-vote Class B shares. This parallel is logically sound and well-articulated. (4) The answer is contextually excellent, addressing all parts of the question—voting power, ownership, repurchase programs, and structural interplay. The reasoning is qualitatively accurate and insightful. The correctness score is 8 due to the significant but not fundamental error in the repurchase amount; the core insight about capital structure and control preservation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 508,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "MDLZ’s VAR model, like PMI’s, is built on normal market conditions, a 95 % confidence interval and a one‑day holding period.  Both firms determine the VAR by observing interest‑rate and currency movements over the preceding quarter for the 12/31 calculation and over each of the four preceding quarters for the average, high and low VAR amounts.  Thus, the time horizon for observing movements and the confidence interval applied are identical in the two approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key elements are correct: both MDLZ and PM use a 95% confidence interval, a one-day holding period, and observe interest rate and currency movements over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average (and high/low in PM's case) VAR amounts. The use of 'PMI' instead of 'PM' is a minor ticker variation but refers to the same entity (Philip Morris International), which is acceptable and common. (2) The numbers, percentages (95%), and time horizons (one-day, preceding quarter, four quarters) are all correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—correctly synthesizing VAR methodology across two companies from their respective disclosures. (4) The only minor shortcoming is that the original answer notes MDLZ includes commodity prices in its observations, while the LLM omits this detail. However, since the question specifically asks about interest rate and currency movements, this omission does not materially affect the correctness of the response. Overall, the answer is semantically equivalent and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 352,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is largely a sales and service region, but the company’s hardware is almost entirely assembled by contract manufacturers in China Mainland (Apple, 2022, pp. 9‑11), making the region a critical manufacturing hub and a key risk factor.  By contrast, Microsoft’s Greater China footprint is supported by a regional operations center in Singapore that handles order processing, logistics and customer support, and by data‑center and field‑sales infrastructure across the region (Microsoft, 2022, p. 16).  Microsoft also actively localizes its products for local languages and conventions, giving it a broader, more diversified operational and localization presence than Apple’s manufacturing‑centric approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing as a critical component of its Greater China segment, noting the associated risks (e.g., supply chain disruptions), which matches the original answer’s emphasis on supply-chain intensity. It also accurately contrasts this with Microsoft’s operational model, highlighting the regional operations center in Singapore that supports Greater China and other regions—consistent with the ground truth. The mention of Microsoft’s data centers, field-sales infrastructure, and localization efforts (e.g., language and UI adaptations) reflects the original answer’s point about localized customer engagement and regional support infrastructure. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is not compromised. The citations (Apple, 2022; Microsoft, 2022) are plausible and contextually appropriate, though not evaluable for exact page accuracy here. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Apple and Microsoft), compares their operational models in Greater China, and draws a valid contrast between Apple’s manufacturing-centric exposure and Microsoft’s service- and infrastructure-oriented presence. The only minor shortcoming is that the LLM answer does not explicitly name Hong Kong and Taiwan as part of Apple’s Greater China segment, which slightly reduces completeness compared to the original. However, this omission does not distort the core comparison. (4) The answer is semantically equivalent in meaning, uses appropriate terminology, and maintains high contextual relevance by directly addressing all aspects of the question: manufacturing reliance, regional infrastructure, and product localization. The conclusion about Microsoft having a 'broader, more diversified operational and localization presence' is a reasonable inference supported by the evidence. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 582,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS classifies its foreign‑currency derivatives as Level 2, valuing them with pricing models that rely on observable market data—yield curves, spot and forward exchange rates, and other market‑observable inputs—so the valuation is largely objective (UPS, 2024, p. 137). In contrast, GE’s insurance and pension liabilities are measured at present value using assumptions about future cash flows, mortality, and discount rates that are not observable, placing those liabilities in Level 3 and requiring significant judgment and unobservable inputs (GE, 2024, p. 46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that UPS uses Level 2 valuation for foreign currency derivatives based on observable inputs like yield curves, spot and forward exchange rates—consistent with the original answer. It also accurately states that GE uses Level 3 techniques for insurance and pension liabilities, relying on unobservable inputs such as future cash flows, mortality assumptions, and discount rates. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer that require verification—both reference 2024 filings (UPS, p.137; GE, p.46), which aligns with the assumed data source and is factually plausible within context. No calculations are needed. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two valuation levels (Level 2 vs Level 3), and the role of observable vs unobservable inputs across different financial instruments (derivatives vs insurance/pension liabilities). (4) The only minor shortcoming is a slight lack of explicit mention of 'discounted cash flow (DCF) methodologies' and 'long-duration contracts' from the original, which adds a bit more specificity to GE’s modeling. However, stating that GE uses 'assumptions about future cash flows... not observable' effectively captures the essence of DCF and Level 3 classification. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 430,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s 2022 10‑K states that Swire Beverages, an independent bottler, handles its bottling and distribution in Hong Kong (page 7), showing the company’s reliance on a dedicated partner for that market. In contrast, the Colgate‑Palmolive 2022 10‑K does not provide Hong Kong‑specific operating figures – the performance data presented covers broader regions such as Latin America, Europe, Asia Pacific, etc. – so a direct comparison of Hong Kong performance is not possible from the supplied pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to match the ground truth in key aspects. (1) Quantitatively, it omits all numerical data from the original answer: Coca-Cola’s 83% non-U.S. unit case volume in 2021, Colgate-Palmolive’s $2,867 million Asia Pacific net sales, and 3.0% organic sales growth in Asia Pacific. Instead, it claims no Hong Kong-specific data is available for Colgate-Palmolive, which contradicts the ground truth that reports regional performance (Asia Pacific and Greater China) that includes Hong Kong. (2) The LLM incorrectly states that a direct comparison is not possible due to lack of data, while the original answer successfully draws a strategic comparison between Coca-Cola’s partnership model with Swire Beverages and Colgate-Palmolive’s direct operations and growth in the region. (3) The reasoning is flawed: while Coca-Cola’s reliance on Swire is correctly noted, the LLM fails to perform the required multi-hop synthesis—comparing operational models and performance metrics in the same region. (4) The use of 2022 10-Ks instead of 2021 data (as in the ground truth) may explain some discrepancies, but the core failure is the inability to infer that regional data (Asia Pacific, Greater China) can and should be used to address the question about Hong Kong, especially since the ground truth treats it as valid. (5) Contextually, the answer is partially relevant but overly dismissive of available information, resulting in a missed opportunity to compare the two companies’ strategies as the question demands. Overall, major factual and reasoning gaps lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 441,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC’s 10‑K notes that it holds in CDOs (page 109) highlight that the firm is exposed to credit‑event risk – if a reference entity defaults the embedded credit protection may trigger a loss of principal, and the firm tracks this through its credit‑loss allowance.  JPMorgan, by contrast, explicitly models the embedded derivative in its structured notes (pages 185‑187) using discounted‑cash‑flow analysis that incorporates Black‑Scholes or simulation models and then adjusts the valuation for its own credit risk (DVA).  Thus, BAC’s disclosure focuses on the credit‑event exposure and loss‑potential, while JPM’s methodology provides a detailed, model‑based valuation of the embedded derivative and its credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: BAC's exposure to CDOs with embedded derivatives is tied to credit-event risk and loss potential, particularly through credit-loss allowance and non-consolidation of VIEs. JPM's use of discounted cash flow models, Black-Scholes, or simulation models for structured notes with embedded derivatives is accurately described, including the DVA (debt valuation adjustment) for its own credit risk. (2) There are no numeric values in the question or answer that require verification—both responses are qualitative and consistent in that regard. Format and references to page numbers (e.g., page 109 for BAC, 185–187 for JPM) are plausible and contextually appropriate, though not part of the ground truth; they do not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms (BAC and JPM), two types of instruments (CDOs vs. structured notes), and compares both risk exposure (credit-event focus vs. model-driven valuation) and methodology (loss allowance vs. DCF/Black-Scholes/DVA). (4) The only minor shortcoming is that the LLM answer does not explicitly mention BAC’s maximum loss exposure being tied to investment balances in unconsolidated VIEs—a nuance present in the original answer—but it does capture the essence of BAC’s risk exposure. This omission is minor and does not distort the overall comparison. Wording differs but semantic equivalence is preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy (no errors) and contextual relevance (fully on point).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 462,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CM CSA’s Class B common stock is largely non‑voting – holders may vote only on a handful of defined matters (e.g., exiting the core payments business, any merger or consolidation, or amendments to the certificate of incorporation that affect B or C shares). When they do vote, they do so together with Class A or as a single class, and the number of votes equals the shares held times the applicable conversion rate. By contrast, Netflix’s common stock gives each share one vote on **all** matters, with no such restrictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that CMCSA's Class B Common Stock has limited voting rights, only on specific matters such as exiting the core payments business, mergers, consolidations, or charter amendments—matching the original answer. It also accurately contrasts this with NFLX's one-vote-per-share structure on all matters. (2) There are no numeric values, dates, or calculations in the question or answer that require verification; all qualitative disclosures (e.g., conversion rate application, voting mechanics) are correctly described. (3) The multi-hop reasoning—comparing governance structures across two companies using their respective disclosures—is sound: the model correctly synthesizes CMCSA’s restricted voting framework with NFLX’s generalized voting rights. (4) The only minor omission is that the LLM does not explicitly mention that CMCSA's Class B shares were 'issued and outstanding as of 2023,' which appears in the ground truth and reinforces the current applicability of the structure. However, this does not impact the core comparison on voting rights. Wording differences (e.g., 'largely non-voting' vs 'limited voting rights') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 376,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley’s 10‑K describes CDOs as “hybrid instruments containing embedded derivatives, in which credit protection has been sold to the issuer of the note” and notes that “if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full to the Firm” (page 109).  It does not outline a specific valuation model for the embedded derivative; the focus is on the credit‑protection structure and the risk of non‑repayment.  By contrast, JPMorgan Chase’s 10‑K states that structured notes are valued “using discounted‑cash‑flow analyses that consider the embedded derivative and the terms and payment structure of the note,” with the embedded derivative priced via Black‑Scholes or simulation models and the valuation subsequently adjusted for the Firm’s own credit risk (DVA) (page 187).  Thus, Morgan Stanley’s treatment is descriptive and risk‑centric, whereas JPMorgan’s methodology is a detailed, model‑based valuation that explicitly incorporates the embedded derivative and credit‑risk adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes Morgan Stanley's treatment of CDOs as hybrid instruments with embedded derivatives and the associated credit risk, citing the correct disclosure focus on risk of non-repayment due to credit events. (2) It correctly characterizes JPMorgan Chase's valuation methodology using discounted cash flow analyses, modeling embedded derivatives via Black-Scholes or simulation models, and adjusting for DVA (own credit risk), with specific reference to the structured note terms. (3) The comparison between Morgan Stanley’s descriptive, risk-centric approach and JPMorgan’s model-based, valuation-focused methodology is logically sound and synthesizes information across both firms’ disclosures appropriately. (4) All entities (Morgan Stanley, JPMorgan Chase, CDOs, structured notes, embedded derivatives, DVA) are correctly identified and contextualized. (5) There are no numerical inaccuracies—while no specific dollar amounts or percentages are involved, the qualitative financial concepts (e.g., DVA, discounted cash flows, credit protection) are used correctly. (6) The LLM cites specific page numbers (109 and 187), which, while not part of the ground truth, do not detract from accuracy and suggest proper sourcing. The answer fully addresses the comparative aspect of the question and demonstrates accurate multi-hop reasoning across two firms and their respective valuation philosophies. Semantic equivalence to the original answer is strong, with enhanced clarity and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 432,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott’s 10‑K explains that patent infringement claims and the need to enforce its intellectual‑property rights can lead to costly litigation, injunctions or license negotiations that may curtail sales of its products (pages 13–14). AbbVie has taken similar litigation through its subsidiary Forest Laboratories Holdings Limited to defend the exclusivity of Vraylar, thereby protecting its sales and market share (see AbbVie’s 10‑K discussion of Forest Laboratories and Vraylar, pages 111‑115). Consequently, both companies face the dual risk of litigation expenses and potential revenue erosion if patents are invalidated or infringed, while AbbVie’s proactive enforcement seeks to safeguard its Vraylar revenue stream, whereas Abbott’s exposure could erode its pharmaceutical income if IP challenges succeed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately identifies Abbott's exposure to intellectual property risks, including costly litigation and potential sales curtailment due to patent enforcement challenges, citing relevant sections of Abbott's 10-K (pages 13–14). It also correctly notes AbbVie's actions through its subsidiary Forest Laboratories Holdings Limited to protect Vraylar's market exclusivity, referencing appropriate sections of AbbVie’s 10-K (pages 111–115). (2) There are no numeric values, dates, or financial figures in the LLM answer that conflict with the ground truth; the absence of the December 2019 litigation date and the specific generic competitors (Sun Pharmaceutical, Aurobindo Pharma) is a minor omission but does not introduce inaccuracy—thus quantitative accuracy remains high because no incorrect numbers are presented. (3) The multi-hop reasoning is sound: the model correctly links Abbott’s general IP risk to AbbVie’s specific enforcement actions for Vraylar and infers the implications for both companies’ revenue streams. However, it omits the explicit interplay highlighted in the original answer—that Abbott’s reliance on IP protection makes it vulnerable in a broader ecosystem where AbbVie’s success in patent litigation indirectly affects competitive dynamics. (4) Despite these omissions, the LLM captures the core dynamic: both companies face litigation risks and revenue exposure tied to IP outcomes, with AbbVie proactively defending a key product. The answer is contextually precise and semantically aligned with the original, warranting high scores in relevance and qualitative accuracy, though not perfect due to missing specifics on litigation timing and counterparties.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 487,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedging strategy is instrument‑specific: it uses foreign‑currency forwards, cross‑currency swaps, options and foreign‑currency‑denominated debt to offset the FX risk of equity investments in non‑U.S. subsidiaries, recording fair‑value changes in CTA within AOCI under the forward‑rate method (page 153).  \nMorgan Stanley, in contrast, relies on a statistical VaR model to quantify the aggregate market‑risk exposure of its trading book across interest‑rate, credit‑spread, equity, FX, commodity and volatility factors, updating the model daily and incorporating diversification and hedging effects as part of a broader risk‑management framework (page 59).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Citigroup's use of foreign currency forwards, cross-currency swaps, and options (adding foreign-currency-denominated debt, which is consistent with hedging strategies under ASC 815, though not in the original answer) to hedge FX risk on equity investments in non-USD subsidiaries, with fair value changes recorded in CTA within AOCI—specifically noting the forward-rate method and referencing ASC 815 implicitly via context. (2) It accurately describes Morgan Stanley’s use of VaR models to estimate aggregate market risk across trading portfolios, including key risk factors (interest rate, credit spread, equity, FX, commodity, volatility), daily updates, and incorporation of diversification and hedging effects—core elements from the ground truth. (3) The multi-hop reasoning is sound: it contrasts Citigroup’s instrument-based hedging approach with Morgan Stanley’s model-based risk quantification, directly addressing the comparative aspect of the question. (4) The only minor omission is the reference to Southern Company Gas and its use of weather derivatives, which appears in the original answer as a connecting entity demonstrating broader industry application. However, this detail is tangential to the core comparison between Citigroup and Morgan Stanley. Since the question focuses on Citigroup vs. Morgan Stanley, and the LLM fully addresses both entities and their respective strategies with factual precision, the omission does not significantly detract from correctness. (5) Quantitative accuracy is perfect—no numerical data is incorrect or miscalculated. (6) Contextual relevance is high, as all information directly pertains to the risk management strategies in question. The added detail about foreign-currency-denominated debt and the forward-rate method (with page citations) enhances accuracy without introducing error. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the slight incompleteness regarding Southern Company Gas, but remains factually excellent and semantically equivalent in all key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 581,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive uses option and forward contracts to hedge about $9.9 billion of net foreign‑exchange cash‑flow exposures (page 91), deferring gains and losses in AOCI and thereby dampening currency‑related volatility in its operating cash flows. Walmart, by contrast, carries $37.2 billion of unrecorded firm commitments—$15.9 billion due within a year (page 45)—which are fixed cash‑outflows that provide predictability but tie up liquidity and can constrain cash‑flow flexibility. Thus, Colgate’s hedging strategy stabilizes its cash flows against currency swings, whereas Walmart’s large, unhedged commitments create a substantial, predictable cash‑outflow that can limit liquidity but does not mitigate currency risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content and addresses the core comparison between Colgate-Palmolive's use of option contracts and Walmart's exposure through firm commitments. It correctly identifies Colgate's use of derivatives (option and forward contracts) to hedge foreign exchange risk and notes the $37.2 billion in unrecorded firm commitments for Walmart, with $15.9 billion due within one year—matching the ground truth. However, the LLM introduces a specific figure of '$9.9 billion' in hedged foreign-exchange exposures for Colgate-Palmolive, which is not present in the original answer or implied by the provided ground truth. This number may be accurate in context but cannot be verified from the given truth and thus represents an unsupported addition. 2) Quantitatively, the Walmart figures ($37.2 billion total, $15.9 billion short-term) are accurate and correctly attributed. The Colgate-specific number ($9.9 billion) lacks corroboration in the ground truth and appears to be sourced from external data (possibly a real 10-K), but since the evaluation is based solely on alignment with the provided ground truth, this constitutes a minor quantitative overreach. Page references (e.g., 'page 91', 'page 45') are not part of the ground truth and should not be included unless specified. 3) The reasoning is sound: the LLM correctly infers that Colgate’s hedging stabilizes cash flows against currency swings, while Walmart’s unhedged commitments create predictable outflows without protection from market volatility. It captures the contrast in risk management strategies and correctly identifies that Walmart lacks financial instrument protections. The mention of AOCI (accumulated other comprehensive income) and deferral of gains/losses adds detail not in the ground truth but is contextually accurate for how cash flow hedges are accounted for under U.S. GAAP, so it enhances rather than detracts. 4) The answer is contextually relevant and directly responsive to the question about comparative impact on cash flow stability. It synthesizes across both companies and correctly contrasts hedging (Colgate) with unhedged obligations (Walmart). The only deviation is the unverified $9.9 billion figure, which slightly undermines quantitative accuracy but does not invalidate the overall conclusion. Thus, the answer earns a high score but not perfect due to the unsupported numeric claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 642,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "TMO and CVS both adopted ASU 2023‑07 on January 1 2024 for fiscal‑year reporting, with interim‑period application effective in fiscal years beginning after December 15 2024. Under the new standard each company must disclose the significant segment expenses that are regularly provided to the CODM, the total amount of other items included in segment operating results (with a qualitative description), the CODM’s title and position, and detail on how the CODM uses the segment operating results to evaluate performance and allocate resources. The standard also aligns interim and annual segment‑reporting disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the adoption timeline: it states that both TMO and CVS adopted ASU 2023-07 on January 1, 2024, but the ground truth specifies that TMO adopted it for its 2024 annual report (which may not align exactly with a January 1, 2024 effective date) and applied it retrospectively, while CVS explicitly adopted it on January 1, 2024. This misrepresents TMO's adoption timing. Additionally, the LLM fails to distinguish that TMO implemented the standard specifically for the 2024 annual report, whereas CVS also aligned it with interim reporting requirements starting after December 15, 2024 — a key difference in the adoption timeline that is missing. (2) Quantitatively, the dates are partially correct: January 1, 2024, is accurate for CVS, and the interim application after December 15, 2024, is correctly noted. However, attributing the same effective date to TMO is incorrect per the original answer, which emphasizes implementation in the 2024 annual report without specifying January 1, 2024. (3) The multi-hop reasoning is partially sound — the model correctly identifies required disclosures (CODM title, use of segment results, etc.) and links them to both companies, but fails to differentiate the specific disclosure locations (Note 11 for TMO, Note 19 for CVS) and does not reflect that TMO’s increased disclosures were in Note 11 as a result. It also misses that both applied the standard retrospectively, which the LLM does not explicitly confirm. (4) Despite these errors, the answer captures the core required disclosures accurately and is contextually relevant, earning moderate scores in qualitative and quantitative accuracy, but loses points for incorrect synthesis of adoption timelines and lack of differentiation between the two companies’ implementation approaches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 501,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "No mention of the Philippines corporate‑income‑tax‑rate reduction or its effect on Accenture’s (ACN) 2021 effective tax rate appears in the pages supplied (8–12). In contrast, AMD’s 10‑K notes that the 2021 Tax Reform Act had no material impact on its effective tax rate (see AMD page 74).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly claims there is no mention of the Philippines' tax rate reduction in the provided pages, directly contradicting the ground truth which confirms ACN was impacted by the Q1 2021 tax rate reduction. It also fails to report ACN's 2021 effective tax rate of 21.8%, a key quantitative fact. While it correctly states AMD reported no impact from tax reform, it references 'AMD page 74' without confirming whether that aligns with the source context provided. (2) The ground truth includes specific numbers — 21.8% effective tax rate for ACN and $0 impact for AMD — but the LLM omits the ACN figure entirely and does not verify or present the AMD value as a $0 line item in the tax provision table, reducing quantitative accuracy. (3) The multi-hop reasoning is flawed: the model fails to synthesize the impact of the Philippines tax change on ACN while correctly identifying AMD’s lack of exposure, but does not compare the two as required. The reasoning is weakened by the denial of available information. (4) Contextual relevance is moderate because the structure addresses both companies and the tax reform comparison, but factual inaccuracies and omissions severely limit usefulness. The claim about missing data suggests a failure to access or interpret the correct documents, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 376,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values its pension‑plan fixed‑income holdings with pricing models, bids, quoted prices or discounted‑cash‑flow calculations that use observable market prices and yields, but it explicitly adds credit‑ and liquidity‑risk adjustments that are not directly observable. 3M’s approach is similar – it values corporate bonds, asset‑backed securities and other fixed‑income instruments at observable yields or via a discounted‑cash‑flow model that uses observable inputs, but it also incorporates credit‑rating‑based adjustments for credit and liquidity risk that are not observable.  In short, both companies rely on observable market data for pricing but supplement that with unobservable risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between Honeywell and 3M's valuation methodologies for fixed income investments in their pension plans. (1) It correctly identifies that both companies use pricing models, discounted cash flows, and observable inputs like yields and interest rates, while also incorporating unobservable adjustments for credit and liquidity risk—this aligns with the ground truth. The mention of broker bids and NAV practical expedients is omitted in the LLM answer, but the key comparative insight about observable inputs supplemented by unobservable adjustments is preserved. (2) There are no numerical values, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense; however, all descriptive financial terms (e.g., observable vs. unobservable inputs, credit and liquidity risk adjustments) are used correctly, warranting a perfect score. (3) The multi-hop reasoning—comparing two companies' pension investment valuation approaches across SEC filings—is sound: the LLM synthesizes methodology details correctly and draws a valid cross-company conclusion. (4) The LLM slightly simplifies 3M's explicit use of the fair value hierarchy (Level 2 vs Level 3) and does not mention that 3M categorizes by valuation levels while Honeywell emphasizes adjustments, but this is a minor omission. Overall, the answer is semantically equivalent and contextually precise, justifying a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 414,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "Comcast’s Class B shares carry a fixed voting weight (10 votes per share, representing 33 ⅓ % of total voting power) and are convertible share‑for‑share into Class A, but the aggregate voting power of Class B is non‑dilutable (pages 81‑91). Alphabet, by contrast, has been buying back its Class A and non‑voting Class C shares (≈$50‑$62 B each year, with $70 B still authorized; pages 81‑82), which shrinks the equity base and raises the relative voting power of the remaining Class A holders but does not create a separate voting class. Thus, CMCSA preserves a dedicated voting bloc that can be converted, whereas GOOGL’s repurchase strategy concentrates ownership and EPS without altering the voting‑rights structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core structural differences between CMCSA and GOOGL correctly: CMCSA's Class B shares have fixed, non-dilutable voting power (33 1/3%) and are convertible into Class A, while GOOGL uses share repurchases to influence ownership concentration. However, there are key quantitative inaccuracies: the LLM states Class B shares carry '10 votes per share' at CMCSA, which is incorrect — the ground truth does not specify vote count per share, only that Class B holds 33 1/3% of total voting power collectively. This misrepresents the voting mechanism. Additionally, the repurchase figures for GOOGL are approximated as '$50-$62B' and '$70B authorized', but the ground truth specifies $62.2B repurchased in 2023 and $36.3B remaining authorization — the LLM overestimates both figures and misrepresents the timeline. 2) Quantitative accuracy suffers due to these errors: '10 votes per share' is unsupported; $62.2B vs. '≈$50-$62B' is partially accurate but imprecise; $36.3B remaining vs. '$70B still authorized' is significantly off. 3) Qualitatively, the reasoning is sound: the LLM correctly identifies that CMCSA protects voting power structurally, while GOOGL concentrates ownership via repurchases. It also correctly notes that Class B shares at GOOGL (not mentioned in the LLM answer explicitly in this context) carry 10 votes but are not discussed in terms of conversion upon sale — a minor omission. The synthesis across companies and mechanisms is logical and relevant. 4) Contextual relevance is high — the answer directly addresses the comparison of equity structures and control impacts. Despite incorrect vote counts and repurchase figures, the conceptual contrast is well-articulated. A score of 7 reflects accurate core understanding with significant but not critical quantitative flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 492,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K (p. 40) explains that the FCTC’s non‑binding guidelines recommend that parties prohibit all forms of advertising and that many countries have imposed partial or total bans on tobacco advertising, marketing, promotions and sponsorships. In contrast, PMI’s 10‑K (p. 42) notes that in markets such as Australia and Russia governments have already enacted display bans at the point of sale, effectively curtailing advertising and promotional activities there. Thus, Altria must prepare for a broader, potentially global shift toward stricter advertising restrictions, while PMI must tailor its international marketing to comply with established bans in specific markets, focusing on alternative communication channels and product positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Altria's 2022 10-K notes the FCTC's non-binding nature and its influence on global advertising bans, while clarifying that the U.S. is not a party to the treaty—consistent with the original answer. It also accurately states that PMI faces implemented point-of-sale display bans in Australia and Russia, which is factually correct and matches the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the cited page numbers (p. 40 for Altria, p. 42 for PMI) are plausible and consistent with typical 10-K structures, and no incorrect figures are presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two companies’ filings, compares their regulatory environments, and draws a logical conclusion about their marketing strategy implications. The only minor shortcoming is that the LLM answer does not explicitly mention that Altria’s primary market is the U.S., which contextualizes its lower current exposure—this nuance is in the ground truth and strengthens the comparison. (4) Despite this slight omission, the LLM captures the core contrast: PMI operates in markets where FCTC-aligned bans are already enforced, requiring adaptation, while Altria faces potential future risk rather than current constraints. The answer is semantically equivalent in meaning and highly contextually relevant. Thus, correctness is rated 9/10—very close to perfect, with only a minor gap in completeness regarding Altria’s U.S.-centric market focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 467,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs’ 10‑K notes that the U.S. Dodd‑Frank Act’s prohibitions on proprietary trading and limits on hedge‑ and private‑equity investments give U.S. banks a competitive disadvantage versus peers such as JPMorgan, which can offer a broader range of crypto products because it is not subject to the same U.S.‑based restrictions【page_13】.  By contrast, Morgan Stanley’s 10‑K emphasizes that its cross‑border crypto‑related activities are exposed to regulatory uncertainty, sanctions, AML and political instability in emerging markets, which could impede the firm’s ability to execute such transactions【page_24】.  Thus, GS faces a direct competitive handicap from domestic compliance burdens, while MS contends with broader regulatory risks that could constrain its international crypto operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Goldman Sachs faces a competitive disadvantage due to Dodd-Frank compliance burdens (specifically restrictions on proprietary trading and investments), which limits its cryptocurrency offerings compared to JPMorgan. Morgan Stanley’s exposure stems from regulatory uncertainty in emerging markets affecting cross-border crypto activities. These points are semantically equivalent to the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different 10-K filings (Goldman Sachs and Morgan Stanley), compares domestic vs. international regulatory constraints, and draws a valid contrast between self-imposed U.S. regulatory limitations and external geopolitical risks. The only minor shortcoming is that the LLM attributes JPMorgan’s advantage to not being 'subject to the same U.S.-based restrictions,' which slightly oversimplifies—JPMorgan may still be subject to Dodd-Frank but interprets or operates within it more aggressively. The original answer clarifies this as a strategic edge due to differing business approaches under the same framework. (4) Contextual relevance is perfect—the response directly addresses both parts of the complex, multi-entity question and maintains focus on regulatory impacts on crypto offerings. Wording differs but meaning is preserved. Thus, correctness is 9/10 due to slight nuance loss, but all core facts and synthesis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 456,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "Both 3M and GE adopted ASU 2022‑04, which requires them to disclose supplier‑finance‑program obligations and, from 2024 onward, a roll‑forward of the confirmed amount outstanding and the changes in that amount. 3M’s 2024 10‑K includes a roll‑forward table showing $0.30 billion of outstanding confirmed invoices as of December 31 2024, with $1.50 billion confirmed and $1.50 billion paid in 2024; GE’s 10‑K likewise requires a roll‑forward, though the specific figures are not shown in the excerpt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $0.3 billion (or $0.30 billion) outstanding confirmed invoices for 3M as of December 31, 2024, and $1.5 billion confirmed and paid during the year—this matches the original answer exactly, with acceptable formatting variation (e.g., $1.50B vs $1.5B). (2) The answer correctly identifies that both 3M and GE adopted ASU 2022-04 and that the roll-forward disclosure requirement began in 2024, consistent with the standard’s prospective application from January 1, 2024. (3) The qualitative reasoning is sound: it captures the multi-hop requirement of the ASU—enhanced disclosures including key terms, balance sheet presentation, and now roll-forward information—and correctly notes GE’s adoption date (implied by phased implementation starting in 2023, with roll-forwards in 2024). (4) The only minor shortcoming is that the LLM states 'GE’s 10-K likewise requires a roll-forward, though the specific figures are not shown in the excerpt,' which introduces a caveat about data availability not present in the ground truth. However, this does not contradict the truth and may reflect source limitations; it doesn’t detract significantly from correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates proper synthesis across entities and time periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 387,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "MDT’s net sales from “Other Countries” total $32,251 million in 2024 (≈ 99 % of non‑U.S. sales) (MDT 10‑K, page 105), meaning the company is highly dependent on markets outside the United States and Ireland.  In those markets, DHR’s risk‑factor discussion (pages 18‑22) notes that government‑sponsored health systems impose budget constraints, price‑control measures, and reimbursement restrictions that can drive down drug prices—challenges that are also faced by Amgen.  Amgen’s own 10‑K (pages 17‑20) describes similar pressures in international markets, including mandatory price‑setting under the Inflation Reduction Act, required rebates, and stringent reimbursement negotiations that shape its drug‑pricing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies MDT's net sales from 'Other Countries' as $32,251 million (i.e., $32.251 billion), matching the ground truth in amount and fiscal year (2024), with acceptable format variation. The claim that this represents approximately 99% of non-U.S. sales is a reasonable inference given that Ireland is excluded and was likely a small portion, though this exact percentage is not verifiable from the ground truth alone. 2) The LLM correctly references DHR’s filing to describe regulatory challenges such as price controls and reimbursement restrictions in international markets, aligning with the ground truth’s mention of direct price controls, reference pricing, and outcome-based reimbursement. It also correctly cites AMGN’s exposure to similar pressures. However, it incorrectly attributes Amgen’s international pricing challenges to the U.S. Inflation Reduction Act (IRA), which applies only domestically—this is a significant factual error. The IRA does not govern international price-setting; thus, this misrepresents the source of Amgen’s global pricing pressures. 3) The multi-hop reasoning is partially sound: the model connects MDT’s geographic revenue concentration to regulatory risks described in DHR’s filing and draws a valid parallel to AMGN’s international challenges. However, the erroneous invocation of the IRA undermines the accuracy of the comparison. The correct drivers for AMGN internationally are therapeutic-reference pricing and volume caps, as stated in the ground truth, not U.S. legislation. 4) Despite this key error, the overall structure, entity usage (MDT, AMGN, DHR), fiscal year, and core concept of parallel international regulatory pressures are accurate and relevant. The answer captures the essence of the question but contains a critical flaw in reasoning regarding AMGN’s cited challenges, reducing qualitative accuracy. Contextual relevance remains high as the response directly addresses the comparative exposure of MDT and AMGN to international regulatory and reimbursement dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 550,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "SCHW’s banking subsidiaries apply a 2.5 % stress buffer (CSC) and a 2.5 % capital‑conservation buffer (CSB) with no counter‑cyclical buffer, giving a combined buffer of **5.0 % above the minimum risk‑based capital ratios**.  \nJPMorgan Chase, by contrast, uses a 5.4 % (Standardized) or 2.5 % (Advanced) capital‑conservation buffer plus a 3.0 % G‑SIB surcharge, with a counter‑cyclical buffer of 0 %. This yields a combined buffer of **8.4 % under the Standardized approach** and **5.5 % under the Advanced approach**. Thus SCHW’s buffer is lower than JPM’s Standardized buffer but roughly comparable to JPM’s Advanced buffer, reflecting the different buffer components each institution applies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies SCHW's stress capital buffer (2.5%) and capital conservation buffer (2.5%), leading to a correct total buffer of 5.0%, it misrepresents JPM's buffer structure. The ground truth states JPM has a stress capital buffer (SCB) of 2.9% and a capital conservation buffer of 2.5%, totaling 5.4%. However, the LLM incorrectly introduces a '5.4% (Standardized) or 2.5% (Advanced)' capital-conservation buffer and a 3.0% G-SIB surcharge, which are not mentioned in the original answer and contradict the provided data. The resulting buffer calculations of 8.4% and 5.5% are therefore factually incorrect. The mention of 'Standardized' and 'Advanced' approaches and G-SIB surcharge introduces extraneous and unsupported complexity. While the model attempts multi-hop reasoning by comparing both firms' buffers, the reasoning is based on incorrect inputs. The conclusion that JPM has a higher buffer is directionally correct, but the magnitude and components are wrong. Entity names (SCHW, JPM) and general buffer types are accurate, and the answer is relevant to the question, but the factual foundation is flawed, especially in quantitative terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 351,
        "total_tokens": 1717
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.23,
    "average_quantitative_accuracy": 8.08,
    "average_qualitative_accuracy": 7.43,
    "average_contextual_relevance": 9.11,
    "score_distribution": {
      "excellent": 286,
      "good": 139,
      "fair": 115,
      "poor": 60
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 13623.58,
    "timestamp": "2026-02-03T04:50:57.863331"
  }
}